PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cervantes-Barragan, L; Chai, JN; Tianero, MD; Di Luccia, B; Ahern, PP; Merriman, J; Cortez, VS; Caparon, MG; Donia, MS; Gilfillan, S; Cella, M; Gordon, JI; Hsieh, CS; Colonna, M				Cervantes-Barragan, Luisa; Chai, Jiani N.; Tianero, Ma. Diarey; Di Luccia, Blanda; Ahern, Philip P.; Merriman, Joseph; Cortez, Victor S.; Caparon, Michael G.; Donia, Mohamed S.; Gilfillan, Susan; Cella, Marina; Gordon, Jeffrey I.; Hsieh, Chyi-Song; Colonna, Marco			Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8 alpha alpha(+) T cells	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; IMMUNE-SYSTEM; MICROBIOTA; DIFFERENTIATION; METABOLITES; REG; INFLAMMATION; MATURATION; INDUCTION; ANTIGENS	The small intestine contains CD4(+)CD8 alpha alpha(+) double-positive intraepithelial lymphocytes (DP IELs), which originate from intestinal CD4(+) T cells through down-regulation of the transcription factor Thpok and have regulatory functions. DP IELs are absent in germ-free mice, which suggests that their differentiation depends on microbial factors. We found that DP IEL numbers in mice varied in different vivaria, correlating with the presence of Lactobacillus reuteri. This species induced DP IELs in germ-free mice and conventionally-raised mice lacking these cells. L. reuteri did not shape the DP-IEL-TCR (TCR, T cell receptor) repertoire but generated indole derivatives of tryptophan that activated the aryl-hydrocarbon receptor in CD4(+) T cells, allowing Thpok down-regulation and differentiation into DP IELs. Thus, L. reuteri, together with a tryptophan-rich diet, can reprogram intraepithelial CD4(+) T cells into immunoregulatory T cells.	[Cervantes-Barragan, Luisa; Chai, Jiani N.; Di Luccia, Blanda; Cortez, Victor S.; Gilfillan, Susan; Cella, Marina; Hsieh, Chyi-Song; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Chai, Jiani N.; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Tianero, Ma. Diarey; Donia, Mohamed S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ahern, Philip P.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Ahern, Philip P.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA; [Merriman, Joseph; Caparon, Michael G.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Princeton University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313; Donia, Mohamed/0000-0002-9604-2912; Cervantes-Barragan, Luisa/0000-0003-1662-7345; Merriman, Joseph/0000-0002-0725-2265; Ahern, Philip/0000-0002-2083-3224	Rainin foundation; NIH [U01 AI095542, DK103039, RO1-DK094995, RO1 CA176695, DK30292]; Burroughs Wellcome Fund; NIH Director's New Innovator Award [1DP2AI124441]; Sir Henry Wellcome Postdoctoral fellowship [096100]; Swiss National Science Foundation [PBSKP3-134332]; Swiss Foundation for Medical-Biological Grants [PASMP3-145751]; NATIONAL CANCER INSTITUTE [R01CA176695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070759, DP2AI124441, U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292, R01DK094995, R01DK103039] Funding Source: NIH RePORTER	Rainin foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sir Henry Wellcome Postdoctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Medical-Biological Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Karlsson and D. O'Donell for their assistance in the gnotobiotic facility and J. Hoisington-Lopez from the DNA Sequencing Innovation Lab at the Edison Family Center for Genome Sciences and Systems Biology for her sequencing expertise. We thank members of our laboratory, in particular J. Bando, for their suggestions and critical reading of this manuscript. This work was supported by the Rainin foundation, NIH grants U01 AI095542 and DK103039 (M.Co.), NIH grant RO1-DK094995 and the Burroughs Wellcome Fund (C.-S.H.), NIH grant RO1 CA176695 (M.Ce.), NIH grant DK30292 (J.I.G.), and NIH Director's New Innovator Award ID 1DP2AI124441 (M.S.D.). P.P.A. is the recipient of a Sir Henry Wellcome Postdoctoral fellowship (096100). L.C.-B. was supported by the Swiss National Science Foundation (fellowship PBSKP3-134332) and the Swiss Foundation for Medical-Biological Grants (fellowship PASMP3-145751). The data reported in this manuscript are presented in the main paper and in the supplementary materials.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rijnen L, 1999, APPL ENVIRON MICROB, V65, P4873; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Telesford KM, 2015, GUT MICROBES, V6, P234, DOI 10.1080/19490976.2015.1056973; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023618; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	32	346	367	9	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					806	810		10.1126/science.aah5825	http://dx.doi.org/10.1126/science.aah5825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28775213	Green Accepted			2022-12-28	WOS:000408327900044
J	Jin, Y; Eser, U; Struhl, K; Churchman, LS				Jin, Yi; Eser, Umut; Struhl, Kevin; Churchman, L. Stirling			The Ground State and Evolution of Promoter Region Directionality	CELL			English	Article							RNA-POLYMERASE-II; DIVERGENT TRANSCRIPTION; CORE PROMOTERS; YEAST; GENE; INITIATION; MECHANISM; DISTINCT; UPSTREAM; PROTEIN	Eukaryotic promoter regions are frequently divergently transcribed in vivo, but it is unknown whether the resultant antisense RNAs are a mechanistic by-product of RNA polymerase II (Pol II) transcription or biologically meaningful. Here, we use a functional evolutionary approach that involves nascent transcript mapping in S. cerevisiae strains containing foreign yeast DNA. Promoter regions in foreign environments lose the directionality they have in their native species. Strikingly, fortuitous promoter regions arising in foreign DNA produce equal transcription in both directions, indicating that divergent transcription is a mechanistic feature that does not imply a function for these transcripts. Fortuitous promoter regions arising during evolution promote bidirectional transcription and over time are purged through mutation or retained to enable new functionality. Similarly, human transcription is more bidirectional at newly evolved enhancers and promoter regions. Thus, promoter regions are intrinsically bidirectional and are shaped by evolution to bias transcription toward coding versus non-coding RNAs.	[Jin, Yi; Struhl, Kevin] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Eser, Umut; Churchman, L. Stirling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Churchman, LS (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	kevin@hms.harvard.edu; churchman@genetics.med.harvard.edu	Jin, Yi/H-4859-2011		NIH [R01-HG007173, R01-GM117333, R01-GM30186]; Burroughs Wellcome Fund Career Award at the Scientific Interface; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117333, R01GM030186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Niu, Z. Moqtaderi, A. Mayer, and K. Harlen for technical advice; J. Geisberg for sharing TFIIB antisera; C. Patil for advice and editing; and S. Eddy, C. Weisman, and members of the Churchman and Struhl labs for valuable discussions. This work was supported by grants from the NIH (R01-HG007173 and R01-GM117333 to L.S.C.; R01-GM30186 to K.S.) and a Burroughs Wellcome Fund Career Award at the Scientific Interface (to L.S.C.).	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; [Anonymous], NUCL ACIDS RES, V39, P2032; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BRENT R, 1984, NATURE, V312, P612, DOI 10.1038/312612a0; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2017, MOL CELL, V65, P1, DOI 10.1016/j.molcel.2016.12.017; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Boer CG, 2014, GENOME RES, V24, P154, DOI 10.1101/gr.164327.113; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Eser U., 2016, FIDDLE INTEGRATIVE D; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gu K, 2008, BIOMETRICAL J, V50, P283, DOI 10.1002/bimj.200710403; Harlen KM, 2016, CELL REP, V15, P2147, DOI 10.1016/j.celrep.2016.05.010; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hughes AL, 2012, MOL CELL, V48, P5, DOI 10.1016/j.molcel.2012.07.003; IYER V, 1995, MOL CELL BIOL, V15, P7059; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lubliner S, 2015, GENOME RES, V25, P1008, DOI 10.1101/gr.188193.114; Lubliner S, 2013, NUCLEIC ACIDS RES, V41, P5569, DOI 10.1093/nar/gkt256; Malabat C, 2015, ELIFE, V4, DOI 10.7554/eLife.06722; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer A, 2016, NAT PROTOC, V11, P813, DOI 10.1038/nprot.2016.047; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Moura GR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-444; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Vera JM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2622-5; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wong K. H., 2001, CURR PROTOC MOL BIOL; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048	64	42	42	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					889	+	898.e10	10.1016/j.cell.2017.07.006	http://dx.doi.org/10.1016/j.cell.2017.07.006			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28803729	Bronze, Green Accepted			2022-12-28	WOS:000408372400009
J	Qin, EY; Cooper, DD; Abbott, KL; Lennon, J; Nagaraja, S; Mackay, A; Jones, C; Vogel, H; Jackson, PK; Monje, M				Qin, Elizabeth Y.; Cooper, Dominique D.; Abbott, Keene L.; Lennon, James; Nagaraja, Surya; Mackay, Alan; Jones, Chris; Vogel, Hannes; Jackson, Peter K.; Monje, Michelle			Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-ASSOCIATED MOLECULE; RECEPTOR-TYPE-Z; STEM-CELLS; HB-GAM; GLIOBLASTOMA-MULTIFORME; NEURITE OUTGROWTH; RADIATION-THERAPY; MIGRATION; BRAIN	The lateral ventricle subventricular zone (SVZ) is a frequent and consequential site of pediatric and adult glioma spread, but the cellular and molecular mechanisms mediating this are poorly understood. We demonstrate that neural precursor cell (NPC): glioma cell communication underpins this propensity of glioma to colonize the SVZ through secretion of chemoattractant signals toward which glioma cells home. Biochemical, proteomic, and functional analyses of SVZ NPC-secreted factors revealed the neurite outgrowth-promoting factor pleiotrophin, along with required binding partners SPARC/SPARCL1 and HSP90B, as key mediators of this chemoattractant effect. Pleiotrophin expression is strongly enriched in the SVZ, and pleiotrophin knock down starkly reduced glioma invasion of theSVZin themurine brain. Pleiotrophin, in complex with the binding partners, activated glioma Rho/ROCK signaling, and ROCK inhibition decreased invasion toward SVZ NPC-secreted factors. These findings demonstrate a pathogenic role for NPC: gliomainteractions and potential therapeutic targets to limit glioma invasion.	[Qin, Elizabeth Y.; Cooper, Dominique D.; Lennon, James; Nagaraja, Surya; Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Neurol, Palo Alto, CA 94305 USA; [Abbott, Keene L.; Jackson, Peter K.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab, Palo Alto, CA 94305 USA; [Vogel, Hannes; Jackson, Peter K.; Monje, Michelle] Stanford Univ, Dept Pathol, Palo Alto, CA 94305 USA; [Mackay, Alan; Jones, Chris] Inst Canc Res, Div Mol Pathol, London SM2 5NG, England; [Mackay, Alan; Jones, Chris] Inst Canc Res, Div Canc Therapeut, London SM2 5NG, England; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94305 USA; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Pediat, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Stanford University; Stanford University	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Palo Alto, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Pathol, Palo Alto, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Neurosurg, Palo Alto, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Pediat, Palo Alto, CA 94305 USA.	mmonje@stanford.edu	Jones, Chris/ABE-6059-2021	Jones, Chris/0000-0001-8118-2296; Abbott, Keene/0000-0002-6166-704X; Vogel, Otto Hannes/0000-0002-0960-3508; Jackson, Peter/0000-0002-1742-2539	Childhood Brain Tumor Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; National Institute of Neurological Disorders and Stroke [R01NS092597]; Liwei Wang Research Fund; Reller Family Research Fund; Department of Defense [W81XWH-151-0131]; McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; DIPG Collaborative; N8 Foundation; California Institute for Regenerative Medicine [RN3-06510]; V Foundation; Joey Fabus Childhood Cancer Foundation; Wayland Villars DIPG Foundation; Connor Johnson, Zoey Ganesh, and Declan Gloster Memorial Funds; Virginia and D.K. Ludwig Fund for Cancer Research; Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Cancer Research UK [C13468/A13982, C13468/A23536]; Cancer Research UK [13982, 23536] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092597] Funding Source: NIH RePORTER	Childhood Brain Tumor Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Liwei Wang Research Fund; Reller Family Research Fund; Department of Defense(United States Department of Defense); McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; DIPG Collaborative; N8 Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); V Foundation; Joey Fabus Childhood Cancer Foundation; Wayland Villars DIPG Foundation; Connor Johnson, Zoey Ganesh, and Declan Gloster Memorial Funds; Virginia and D.K. Ludwig Fund for Cancer Research; Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge support from the Childhood Brain Tumor Foundation, Lyla Nsouli Foundation, Unravel Pediatric Cancer, National Institute of Neurological Disorders and Stroke (R01NS092597), Liwei Wang Research Fund, Reller Family Research Fund, Department of Defense (W81XWH-151-0131), McKenna Claire Foundation, Alex's Lemonade Stand Foundation, The Cure Starts Now Foundation and DIPG Collaborative, N8 Foundation, California Institute for Regenerative Medicine (RN3-06510), V Foundation, Joey Fabus Childhood Cancer Foundation, Wayland Villars DIPG Foundation, Connor Johnson, Zoey Ganesh, and Declan Gloster Memorial Funds, Virginia and D.K. Ludwig Fund for Cancer Research, Child Health Research Institute at Stanford, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases, and Cancer Research UK (C13468/A13982 and C13468/A23536).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Adeberg S, 2014, INT J RADIAT ONCOL, V90, P886, DOI 10.1016/j.ijrobp.2014.07.027; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker SJ, 2016, GLIA, V64, P879, DOI 10.1002/glia.22945; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Caretti V, 2014, ACTA NEUROPATHOL, V128, P605, DOI 10.1007/s00401-014-1307-x; Chaichana KL, 2008, J NEURO-ONCOL, V89, P219, DOI 10.1007/s11060-008-9609-2; Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Evers P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-384; Furuta M, 2004, DEV BRAIN RES, V152, P189, DOI 10.1016/j.devbrainres.2004.06.014; Gonzalez-Castillo C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00443; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kinnunen A, 1999, EUR J NEUROSCI, V11, P491, DOI 10.1046/j.1460-9568.1999.00457.x; Krellman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100597; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Lauri SE, 1998, EUR J NEUROSCI, V10, P188; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Lee P, 2013, INT J RADIAT ONCOL, V86, P609, DOI 10.1016/j.ijrobp.2013.01.009; Li SY, 2007, CANCER LETT, V251, P220, DOI 10.1016/j.canlet.2006.11.024; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin CC, 2009, ONCOL REP, V22, P1033, DOI 10.3892/or_00000532; Lin GL, 2017, JOVE-J VIS EXP, DOI 10.3791/55360; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McClain CR, 2012, J NEUROSCI, V32, P15066, DOI 10.1523/JNEUROSCI.1320-12.2012; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Mistry AM, 2017, J NEURO-ONCOL, V132, P341, DOI 10.1007/s11060-017-2374-3; Mistry AM, 2017, J NEURO-ONCOL, V131, P125, DOI 10.1007/s11060-016-2278-7; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Nagaraja S, 2017, CANCER CELL, V31, P635, DOI 10.1016/j.ccell.2017.03.011; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Oellers P, 2009, GLIA, V57, P499, DOI 10.1002/glia.20777; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shimizu A, 2013, J BIOL CHEM, V288, P2210, DOI 10.1074/jbc.M112.397398; Sikkema AH, 2012, NEURO-ONCOLOGY, V14, P1125, DOI 10.1093/neuonc/nos130; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tsirmoula S, 2012, CANCER SCI, V103, P1826, DOI 10.1111/j.1349-7006.2012.02383.x; Ulbricht U, 2003, J NEUROPATH EXP NEUR, V62, P1265, DOI 10.1093/jnen/62.12.1265; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Walker TL, 2014, JOVE-J VIS EXP, DOI 10.3791/51225; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Wu H, 2005, J CUTAN PATHOL, V32, P125, DOI 10.1111/j.0303-6987.2005.00282.x; Zhang L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1690; Zhou XP, 2012, ONCOL REP, V28, P269, DOI 10.3892/or.2012.1796	73	100	100	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					845	+	859.e19	10.1016/j.cell.2017.07.016	http://dx.doi.org/10.1016/j.cell.2017.07.016			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28823557	Green Accepted, Bronze			2022-12-28	WOS:000408372400006
J	Komaroff, AL				Komaroff, Anthony L.			Gene Editing Using CRISPR Why the Excitement?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOME; IMMUNITY		[Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Komaroff, AL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Gen Med, 1620 Tremont St, Boston, MA 02120 USA.	anthony_komaroff@hms.harvard.edu						Chen ZH, 2017, NAT BIOTECHNOL, V35, P543, DOI 10.1038/nbt.3843; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna J., 2017, CRACK CREATION GENE; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	9	8	8	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					699	700		10.1001/jama.2017.10159	http://dx.doi.org/10.1001/jama.2017.10159			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28796848				2022-12-28	WOS:000408095800015
J	Uhlen, M; Zhang, C; Lee, S; Sjostedt, E; Fagerberg, L; Bidkhori, G; Benfeitas, R; Arif, M; Liu, ZT; Edfors, F; Sanli, K; von Feilitzen, K; Oksvold, P; Lundberg, E; Hober, S; Nilsson, P; Mattsson, J; Schwenk, JM; Brunnstrom, H; Glimelius, B; Sjoblom, T; Edqvist, PH; Djureinovic, D; Micke, P; Lindskog, C; Mardinoglu, A; Ponten, F				Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjostedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao; Edfors, Fredrik; Sanli, Kemal; von Feilitzen, Kalle; Oksvold, Per; Lundberg, Emma; Hober, Sophia; Nilsson, Peter; Mattsson, Johanna; Schwenk, Jochen M.; Brunnstrom, Hans; Glimelius, Bengt; Sjoblom, Tobias; Edqvist, Per-Henrik; Djureinovic, Dijana; Micke, Patrick; Lindskog, Cecilia; Mardinoglu, Adil; Ponten, Fredrik			A pathology atlas of the human cancer transcriptome	SCIENCE			English	Article							CARCINOMA; EXPRESSION; RNA; IMPACT; LIVER; KI-67; ANLN	Cancer is one of the leading causes of death, and there is great interest in understanding the underlying molecular mechanisms involved in the pathogenesis and progression of individual tumors. We used systems-level approaches to analyze the genome-wide transcriptome of the protein-coding genes of 17 major cancer types with respect to clinical outcome. A general pattern emerged: Shorter patient survival was associated with up-regulation of genes involved in cell growth and with down-regulation of genes involved in cellular differentiation. Using genome-scale metabolic models, we show that cancer patients have widespread metabolic heterogeneity, highlighting the need for precise and personalized medicine for cancer treatment. All data are presented in an interactive open-access database (www.proteinatlas.org/pathology) to allow genome-wide exploration of the impact of individual proteins on clinical outcomes.	[Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjostedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao; Edfors, Fredrik; Sanli, Kemal; von Feilitzen, Kalle; Oksvold, Per; Lundberg, Emma; Nilsson, Peter; Schwenk, Jochen M.; Mardinoglu, Adil] KTH, Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Danish Tech Univ, Ctr Biosustainabil, Copenhagen, Denmark; [Uhlen, Mathias; Hober, Sophia; Mardinoglu, Adil] Royal Inst Technol, AlbaNova Univ Ctr, KTH, Sch Biotechnol, Stockholm, Sweden; [Sjostedt, Evelina; Mattsson, Johanna; Glimelius, Bengt; Sjoblom, Tobias; Edqvist, Per-Henrik; Djureinovic, Dijana; Micke, Patrick; Lindskog, Cecilia; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Brunnstrom, Hans] Lund Univ, Skane Univ Hosp, Div Pathol, Lund, Sweden; [Mardinoglu, Adil] Chalmers Univ Technol, Dept Biol & Biol Engn, SE-41296 Gothenburg, Sweden	Royal Institute of Technology; Technical University of Denmark; Royal Institute of Technology; Uppsala University; Lund University; Skane University Hospital; Chalmers University of Technology	Uhlen, M (corresponding author), KTH, Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.; Uhlen, M (corresponding author), Danish Tech Univ, Ctr Biosustainabil, Copenhagen, Denmark.; Uhlen, M (corresponding author), Royal Inst Technol, AlbaNova Univ Ctr, KTH, Sch Biotechnol, Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Brunnström, Hans/AAZ-6803-2020; Arif, Muhammad/AFQ-6409-2022; Mardinoglu, Adil/AAS-6360-2021; Lundberg, Emma S K/F-3891-2010; Schwenk, Jochen M/F-1730-2010; Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021; Lee, Sunjae/H-9815-2019; Lindskog, Cecilia/AAO-2441-2021; Schwenk, Jochen/AAS-4164-2021; Sanli, Kemal/ABC-1517-2020; Nilsson, Peter/E-4547-2010; Lindskog, Cecilia/AAE-5462-2019; Arif, Muhammad/GSO-0267-2022; Benfeitas, Rui/G-1251-2016; Zhang, Cheng/L-7906-2016	Brunnström, Hans/0000-0001-7402-138X; Arif, Muhammad/0000-0003-2261-0881; Schwenk, Jochen M/0000-0001-8141-8449; Uhlen, Mathias/0000-0002-4858-8056; Lee, Sunjae/0000-0002-6428-5936; Schwenk, Jochen/0000-0001-8141-8449; Sanli, Kemal/0000-0001-7617-6537; Nilsson, Peter/0000-0002-4657-8532; Arif, Muhammad/0000-0003-2261-0881; Benfeitas, Rui/0000-0001-7972-0083; Zhang, Cheng/0000-0002-3721-8586; Kaller Lundberg, Emma/0000-0001-7034-0850; Lindskog, Cecilia/0000-0001-5611-1015	Swedish Cancer Foundation; Science for Life Laboratory; Erling Persson Foundation; Elixir (EU); Uppsala Lions Cancer Foundation; Knut and Alice Wallenberg Foundation; strategic research area "U-CAN" through Swedish Research Council grant CancerUU	Swedish Cancer Foundation; Science for Life Laboratory; Erling Persson Foundation; Elixir (EU); Uppsala Lions Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); strategic research area "U-CAN" through Swedish Research Council grant CancerUU	The data reported in this manuscript are tabulated in the main paper and the supplementary materials. We thank the entire staff of the Human Protein Atlas program and the Science for Life Laboratory, the National Genomics Infrastructure, and Swedish National Infrastructure for Computing at UPPMAX and C3SE for providing assistance in massive parallel sequencing and computational infrastructure. Supported by the Swedish Cancer Foundation (F.P.), Science for Life Laboratory infrastructure funding (C.L., E.L. and P.N.), the Erling Persson Foundation (M.U.), Elixir (EU infrastructure funding) (K.F. and M.U.), the Swedish Cancer Foundation and the Uppsala Lions Cancer Foundation (P.M.), the Knut and Alice Wallenberg Foundation, and the strategic research area "U-CAN" through Swedish Research Council grant CancerUU. We thank the Uppsala Biobank and Clinical Department of Pathology at the Uppsala University Hospital for providing specimens. We also thank The Cancer Genome Atlas for providing access to data. M.U. and F.P. are inventors on patents held by Atlas Antibodies that cover the analysis of RBM3 (U.S. patent 8728739) and PODXL (U.S. patent 8999656) as a prognostic marker in several cancers. The authors declare that they have no other conflict of interest. An interactive pathology atlas with gene-specific data for all human genes (including more than 900,000 Kaplan-Meier plots) is available at www.proteinatlas.org/pathology.	Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Bjornson E, 2015, CELL REP, V13, P2014, DOI 10.1016/j.celrep.2015.10.045; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Collado-Torres L, 2017, NAT BIOTECHNOL, V35, P319, DOI 10.1038/nbt.3838; Djureinovic D, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86837; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ghaffari P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00382; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hjelm B, 2011, PROTEOM CLIN APPL, V5, P624, DOI 10.1002/prca.201100020; Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121, DOI 10.1016/S0167-9473(02)00225-6; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Katono Ken, 2016, Asian Pac J Cancer Prev, V17, P289; Lee S, 2016, NUCLEIC ACIDS RES, V44, P5529, DOI 10.1093/nar/gkw462; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Magnusson K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2923-8; Mardinoglu A, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167422; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Mardinoglul A, 2015, CURR OPIN BIOTECH, V34, P91, DOI 10.1016/j.copbio.2014.12.013; Micke P, 2016, J THORAC ONCOL, V11, P862, DOI 10.1016/j.jtho.2016.01.020; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pawlik TM, 2007, ANN SURG, V245, P435, DOI 10.1097/01.sla.0000250420.73854.ad; Penault-Llorca F, 2017, PATHOLOGY, V49, P166, DOI 10.1016/j.pathol.2016.11.006; PENG L, 2015, SCI REP UK, V5; Saito Keita, 2015, Asian Pac J Cancer Prev, V16, P7039; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Tanaka T, 2016, BRIT J CANCER, V114, P1227, DOI 10.1038/bjc.2016.105; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang C, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00413	41	1633	1655	12	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					660	+		10.1126/science.aan2507	http://dx.doi.org/10.1126/science.aan2507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818916				2022-12-28	WOS:000407793600028
J	Robinson, JC; Whaley, CM; Brown, TT				Robinson, James C.; Whaley, Christopher M.; Brown, Timothy T.			Association of Reference Pricing with Drug Selection and Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTICANCER DRUGS; HEALTH-CARE; PRICES; CHOICES; COMPLICATIONS; CONSUMERS; SURGERY; MARKET; TESTS	BACKGROUND In the United States, prices for therapeutically similar drugs vary widely, which has prompted efforts by public and private insurers to steer patients toward the lower-priced options. Under reference pricing, the insurer or employer establishes a maximum contribution it will make toward the price of a drug or procedure, and the patient pays the remainder. METHODS We used difference-in-differences multivariable regression methods to analyze changes in prescriptions and pricing for 1302 drugs in 78 therapeutic classes in the United States, before and after implementation of reference pricing by an alliance of private employers. We assessed trends for the study group relative to those for an employee group that was not subject to reference pricing. The study included 1,122,741 prescriptions that were reimbursed during the period from 2010 through 2014. RESULTS Implementation of reference pricing was associated with a higher percentage of prescriptions that were filled for the lowest-priced reference drug within its therapeutic class (difference in probability, 7.0 percentage points; 95% confidence interval [CI], 4.0 to 9.9), a lower average price paid per prescription (-13.9%; 95% CI, -23.8 to -2.7), and a higher rate of copayment by patients (5.2%; 95% CI, 0.2 to 10.4) than in the comparison group. During the first 18 months after implementation, spending for employers was $1.34 million lower and the amount of copayments for employees was $0.12 million higher than in the comparison group. CONCLUSIONS Implementation of reference pricing was associated with significant changes in drug selection and spending for a population of patients covered by employment-based insurance in the United States.	[Robinson, James C.; Whaley, Christopher M.; Brown, Timothy T.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Whaley, Christopher M.] RAND, Santa Monica, CA USA	University of California System; University of California Berkeley; RAND Corporation	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	james.robinson@berkeley.edu		Robinson, James/0000-0003-0056-3017	Agency for Healthcare Research and Quality; Genentech Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022098] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Genentech Foundation(Roche HoldingGenentech); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Agency for Healthcare Research and Quality and the Genentech Foundation.	Acosta A, 2014, COCHRANE DB SYST REV, V10; Aitken M, 2016, HEALTH AFFAIR, V35, P1595, DOI 10.1377/hlthaff.2015.1636; [Anonymous], 2016, EST MED D; Bennette CS, 2016, HEALTH AFFAIR, V35, P805, DOI 10.1377/hlthaff.2015.1145; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Dafny LS, 2016, NEW ENGL J MED, V375, P2013, DOI 10.1056/NEJMp1607378; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Government Accountability Office, 2016, GEN DRUGS MED D; Hauptman PJ, 2017, JAMA INTERN MED, V177, P126, DOI 10.1001/jamainternmed.2016.6955; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Lee Joy Li-Yueh, 2012, Am J Manag Care, V18, pe429; Robinson JC, 2017, HEALTH AFFAIR, V36, P524, DOI 10.1377/hlthaff.2016.1256; Robinson JC, 2016, MED CARE, V55, P1050, DOI 10.1097/MLR.0000000000000605; Robinson JC, 2016, JAMA INTERN MED, V176, P1353, DOI 10.1001/jamainternmed.2016.2492; Robinson JC, 2015, JAMA INTERN MED, V175, P1783, DOI 10.1001/jamainternmed.2015.4588; Robinson JC, 2015, J BONE JOINT SURG AM, V97A, P1473, DOI 10.2106/JBJS.O.00240; Robinson JC, 2015, HEALTH AFFAIR, V34, P415, DOI 10.1377/hlthaff.2014.1198; Robinson JC, 2013, HEALTH AFFAIR, V32, P1392, DOI 10.1377/hlthaff.2013.0188; Ubel PA, 2016, ANN INTERN MED, V165, P878, DOI 10.7326/M16-1334	21	18	18	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					658	665		10.1056/NEJMsa1700087	http://dx.doi.org/10.1056/NEJMsa1700087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813219	Green Accepted, Bronze			2022-12-28	WOS:000407691400008
J	Leonard, MM; Sapone, A; Catassi, C; Fasano, A				Leonard, Maureen M.; Sapone, Anna; Catassi, Carlo; Fasano, Alessio			Celiac Disease and Nonceliac Gluten Sensitivity A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TASK-FORCE RECOMMENDATION; FOLLOW-UP; PEDIATRIC GASTROENTEROLOGY; GLIADIN PEPTIDES; MUCOSAL RECOVERY; VILLOUS ATROPHY; CHILDREN; RISK; MORTALITY; AUTOANTIBODIES	IMPORTANCE The prevalence of gluten-related disorders is rising, and increasing numbers of individuals are empirically trying a gluten-free diet for a variety of signs and symptoms. This review aims to present current evidence regarding screening, diagnosis, and treatment for celiac disease and nonceliac gluten sensitivity. OBSERVATIONS Celiac disease is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype (HLA-DQ2 and HLA-DQ8 genes) and autoantibodies (antitissue transglutaminase and antiendomysial). Although the inflammatory process specifically targets the intestinal mucosa, patients may present with gastrointestinal signs or symptoms, extraintestinal signs or symptoms, or both, suggesting that celiac disease is a systemic disease. Nonceliac gluten sensitivity is diagnosed in individuals who do not have celiac disease or wheat allergy but who have intestinal symptoms, extraintestinal symptoms, or both, related to ingestion of gluten-containing grains, with symptomatic improvement on their withdrawal. The clinical variability and the lack of validated biomarkers for nonceliac gluten sensitivity make establishing the prevalence, reaching a diagnosis, and further study of this condition difficult. Nevertheless, it is possible to differentiate specific gluten-related disorders from other conditions, based on currently available investigations and algorithms. Clinicians cannot distinguish between celiac disease and nonceliac gluten sensitivity by symptoms, as they are similar in both. Therefore, screening for celiac disease must occur before a gluten-free diet is implemented, since once a patient initiates a gluten-free diet, testing for celiac disease is no longer accurate. CONCLUSIONS AND RELEVANCE Celiac disease and nonceliac gluten sensitivity are common. Although both conditions are treated with a gluten-free diet, distinguishing between celiac disease and nonceliac gluten sensitivity is important for long-term therapy. Patients with celiac disease should be followed up closely for dietary adherence, nutritional deficiencies, and the development of possible comorbidities.	[Leonard, Maureen M.; Sapone, Anna; Catassi, Carlo; Fasano, Alessio] MassGen Hosp Children, Ctr Celiac Res & Treatment, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Leonard, Maureen M.; Sapone, Anna; Catassi, Carlo; Fasano, Alessio] Harvard Med Sch, Celiac Res Program, Boston, MA USA; [Sapone, Anna] Shire, Lexington, MA USA; [Catassi, Carlo; Fasano, Alessio] European Biomed Res Inst Salerno, Salerno, Italy; [Catassi, Carlo] Univ Politecn Marche, Dept Pediat, Ancona, Italy	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Shire Pharmaceuticals Limited; Marche Polytechnic University	Fasano, A (corresponding author), Massachusetts Gen Hosp East, Ctr Celiac Res, Bldg 114,16th St,Mail Stop 114-3503, Charlestown, MA 02129 USA.; Fasano, A (corresponding author), Massachusetts Gen Hosp East, Mucosal Immunol & Biol Res Ctr, Bldg 114,16th St,Mail Stop 114-3503, Charlestown, MA 02129 USA.	afasano@mgh.harvard.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261	Dr Schar Institute; INOVA Diagnostics; Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104344] Funding Source: NIH RePORTER	Dr Schar Institute; INOVA Diagnostics; Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Catassi reported receiving fees for scientific consultancy from Dr Schar Institute. Dr Fasano reported receiving a grant for sponsored research from INOVA Diagnostics; receiving speaking fees from Mead Johnson Nutrition; and that he is cofounder of, and a stockholder in, Alba Therapeutics, which makes products for the treatment of autoimmune and inflammatory diseases. No other authors reported disclosures.	ANDERSEN DH, 1947, J PEDIATR-US, V30, P564, DOI 10.1016/S0022-3476(47)80050-2; Anjum N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-16; Bai D, 2005, SCAND J GASTROENTERO, V40, P183, DOI 10.1080/00365520510011498; Barone MV, 2014, INT J MOL SCI, V15, P20518, DOI 10.3390/ijms151120518; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1252, DOI 10.1001/jama.2017.1462; Briani C, 2008, J NEUROIMMUNOL, V195, P171, DOI 10.1016/j.jneuroim.2008.01.008; Canavan C, 2011, ALIMENT PHARM THER, V34, P1012, DOI 10.1111/j.1365-2036.2011.04811.x; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Catassi G, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030292; Choung RS, 2017, JAMA-J AM MED ASSOC, V317, P1221, DOI 10.1001/jama.2017.1105; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Dicke W.K., 1941, NED TIJDSCHR GENEES, V85, P1715; Dickey W, 2000, AM J GASTROENTEROL, V95, P712, DOI 10.1111/j.1572-0241.2000.01838.x; Elfstrom P, 2012, CLIN GASTROENTEROL H, V10, P30, DOI 10.1016/j.cgh.2011.06.029; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2015, GASTROENTEROLOGY, V148, P1195, DOI 10.1053/j.gastro.2014.12.049; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Giersiepen K, 2012, J PEDIATR GASTR NUTR, V54, P229, DOI 10.1097/MPG.0b013e318216f2e5; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Green PHR, 2015, DIGEST DIS, V33, P137, DOI 10.1159/000370204; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Harper JW, 2007, AM J HEMATOL, V82, P996, DOI 10.1002/ajh.20996; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hill PG, 2008, ALIMENT PHARM THER, V27, P572, DOI 10.1111/j.1365-2036.2008.03609.x; Hollon JR, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-40; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Husby S, 2014, NAT REV GASTRO HEPAT, V11, P655, DOI 10.1038/nrgastro.2014.162; Jamma S, 2011, J CLIN GASTROENTEROL, V45, P30, DOI 10.1097/MCG.0b013e3181f42401; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Lammers KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138338; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; Lebwohl B, 2014, ALIMENT PHARM THER, V39, P488, DOI 10.1111/apt.12621; Leffler DA, 2015, NAT REV GASTRO HEPAT, V12, P561, DOI 10.1038/nrgastro.2015.131; Leonard MM, 2017, J PEDIATR GASTR NUTR, V64, P286, DOI 10.1097/MPG.0000000000001460; Leonard MM, 2015, EXPERT REV GASTROENT, V9, P209, DOI 10.1586/17474124.2014.945915; Lionetti E, 2014, DIGEST LIVER DIS, V46, P1057, DOI 10.1016/j.dld.2014.08.002; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Ludvigsson JF, 2004, J PEDIATR GASTR NUTR, V38, P181, DOI 10.1097/00005176-200402000-00015; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2011, J INVEST DERMATOL, V131, P2010, DOI 10.1038/jid.2011.162; Mahadev S, 2017, ALIMENT PHARM THER, V45, P1084, DOI 10.1111/apt.13988; Mansueto P, 2014, J AM COLL NUTR, V33, P39, DOI 10.1080/07315724.2014.869996; Martinelli P, 2000, GUT, V46, P332, DOI 10.1136/gut.46.3.332; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Michael S, 2015, BEST PRACT RES CL GA, V29, P425, DOI 10.1016/j.bpg.2015.05.001; Pagliari D, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/123653; Pantaleoni Stefano, 2014, ScientificWorldJournal, V2014, P173082, DOI 10.1155/2014/173082; Picarelli A, 1999, SCAND J GASTROENTERO, V34, P1099, DOI 10.1080/003655299750024896; Pietzak MM, 2005, GASTROENTEROLOGY, V128, pS135, DOI 10.1053/j.gastro.2005.02.025; Rashid Mohsin, 2011, J Mich Dent Assoc, V93, P42; Reilly NR, 2011, J PEDIATR GASTR NUTR, V53, P528, DOI 10.1097/MPG.0b013e3182276d5e; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2010, GUT, V59, P547, DOI 10.1136/gut.2009.195131; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Silano M, 2009, CURR MED CHEM, V16, P1489, DOI 10.2174/092986709787909613; Snyder J, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3147; Stamnaes J, 2015, SEMIN IMMUNOL, V27, P343, DOI 10.1016/j.smim.2015.11.001; Sturgeon C, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1251384; Tersigni C, 2014, HUM REPROD UPDATE, V20, P582, DOI 10.1093/humupd/dmu007; Thawani SP, 2015, JAMA NEUROL, V72, P806, DOI 10.1001/jamaneurol.2015.0475; Tio M, 2012, ALIMENT PHARM THER, V35, P540, DOI 10.1111/j.1365-2036.2011.04972.x; Toscano V, 2000, AM J GASTROENTEROL, V95, P1742, DOI 10.1111/j.1572-0241.2000.02187.x; Vecsei E, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-28; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; Vivas S, 2008, AM J GASTROENTEROL, V103, P2360, DOI 10.1111/j.1572-0241.2008.01977.x; Volta U, 2012, J CLIN GASTROENTEROL, V46, P680, DOI 10.1097/MCG.0b013e3182372541; Wessels MMS, 2016, J PEDIATR-US, V169, P55, DOI 10.1016/j.jpeds.2015.09.078; Wierdsma NJ, 2013, NUTRIENTS, V5, P3975, DOI 10.3390/nu5103975	77	173	180	6	94	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					647	656		10.1001/jama.2017.9730	http://dx.doi.org/10.1001/jama.2017.9730			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810029				2022-12-28	WOS:000407616000019
J	Madl, T				Madl, Tobias			BIOCHEMISTRY Patchy proteins form a perfect lens	SCIENCE			English	Editorial Material							CRYSTALLINS; EVOLUTION		[Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz	Madl, T (corresponding author), Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria.	tobias.madl@medunigraz.at	Madl, Tobias/B-1682-2012	Madl, Tobias/0000-0002-9725-5231	Integrative Metabolism Research Center Graz; Austrian infrastructure program; BioTechMed-Graz; Omics Center Graz; President's International Fellowship Initiative of the Chinese Academy of Sciences [2015VBB045]; National Natural Science Foundation of China [31450110423]; Austrian Science Fund [FWF: P28854, W1226-B18]	Integrative Metabolism Research Center Graz; Austrian infrastructure program; BioTechMed-Graz; Omics Center Graz; President's International Fellowship Initiative of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF))	The author thanks W. Graier for helpful discussions and critical comments. The author is supported by the Integrative Metabolism Research Center Graz, the Austrian infrastructure program 2016/2017, BioTechMed-Graz, Omics Center Graz, the President's International Fellowship Initiative of the Chinese Academy of Sciences (no. 2015VBB045), the National Natural Science Foundation of China (no. 31450110423), and the Austrian Science Fund (FWF: P28854 and W1226-B18).	Bianchi E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168301; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLOEMENDAL H, 1982, CRC CR REV BIOCH MOL, V12, P1, DOI 10.3109/10409238209105849; Cai J, 2017, SCIENCE, V357, P564, DOI 10.1126/science.aal2674; Gogelein C, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2951987; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; SCHURTENBERGER P, 1991, BIOPOLYMERS, V31, P1229, DOI 10.1002/bip.360311011; Sweeney AM, 2007, J R SOC INTERFACE, V4, P685, DOI 10.1098/rsif.2006.0210; TOMAREV SI, 1992, J BIOL CHEM, V267, P8604	11	4	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					546	547		10.1126/science.aao1456	http://dx.doi.org/10.1126/science.aao1456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798115	Green Accepted			2022-12-28	WOS:000407324800022
J	Meyer, MC; Hoffmann, DL; Aldenderfer, MS; Haas, WR; Dahl, JA; Wang, Z; Degering, D; Schlutz, F				Meyer, M. C.; Hoffmann, D. L.; Aldenderfer, M. S.; Haas, W. R.; Dahl, J. A.; Wang, Z.; Degering, D.; Schluetz, F.			Response to Comment on "Permanent human occupation of the central Tibetan Plateau in the early Holocene"	SCIENCE			English	Editorial Material							MULTIPLE GRAINS; SINGLE; DEPOSITS; QUARTZ; SEDIMENTS; MODELS	We show that Zhang and Li's sedimentological model for the Chusang travertine neglects the three-dimensional information from multiple outcrops and that their optically stimulated luminescence (OSL) age of about 20,000 years for the human imprints is untenable. We highlight the robustness of our chronology and explore reasons why Zhang and Li's OSL age is a gross overestimation of the real depositional age of the imprinted travertine.	[Meyer, M. C.; Wang, Z.] Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria; [Hoffmann, D. L.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Aldenderfer, M. S.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95343 USA; [Haas, W. R.] Univ Wyoming, Dept Anthropol, Laramie, WY 82071 USA; [Dahl, J. A.] Natl Isotope Ctr, Inst Geol & Nucl Sci GNS Sci, Lower Hutt 5040, New Zealand; [Degering, D.] ADD Ideas Albrecht & Detlev Degering, Zum Erzengel Michael 19, D-01723 Mohorn, Germany; [Schluetz, F.] Lower Saxony Inst Hist Coastal Res, D-26382 Wilhelmshaven, Germany	University of Innsbruck; Max Planck Society; University of California System; University of California Merced; University of Wyoming; GNS Science - New Zealand	Meyer, MC (corresponding author), Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria.	michael.meyer@uibk.ac.at	Meyer, Michael C/S-8214-2016	Meyer, Michael C/0000-0001-6677-7419; Schlutz, Frank/0000-0003-2114-8146; Hoffmann, Dirk/0000-0002-9245-2041; Haas, Randall/0000-0002-7742-2127				Arnold LJ, 2007, QUAT GEOCHRONOL, V2, P162, DOI 10.1016/j.quageo.2006.05.003; Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P306, DOI 10.1016/j.quageo.2009.02.017; Arnold LJ, 2011, BOREAS, V40, P417, DOI 10.1111/j.1502-3885.2010.00181.x; Demuro M, 2008, QUAT GEOCHRONOL, V3, P346, DOI 10.1016/j.quageo.2007.12.003; Duller GAT, 2008, BOREAS, V37, P589, DOI 10.1111/j.1502-3885.2008.00051.x; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Holmes A., 1965, PRINCIPLES PHYS GEOL; Meyer MC, 2017, SCIENCE, V355, P64, DOI 10.1126/science.aag0357; Olley JM, 2004, GEOMORPHOLOGY, V60, P337, DOI 10.1016/j.geomorph.2003.09.020; Rittenour TM, 2015, QUAT GEOCHRONOL, V30, P306, DOI 10.1016/j.quageo.2015.02.025; Rowe PJ, 1999, J QUATERNARY SCI, V14, P693; Shanahan TM, 2013, QUAT GEOCHRONOL, V15, P47, DOI 10.1016/j.quageo.2012.12.001; Stanley SM, 1999, EARTH SYSTEM HIST; Wang ZJ, 2016, SEDIMENT GEOL, V342, P218, DOI 10.1016/j.sedgeo.2016.07.002; Zhang DD, 2017, SCIENCE, V357, DOI 10.1126/science.aam9231; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749	16	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351								10.1126/science.aan8575	http://dx.doi.org/10.1126/science.aan8575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798103				2022-12-28	WOS:000407324800004
J	White, E				White, Emma			The art of triage	SCIENCE			English	Editorial Material								I was halfway through my Ph.D. coursework and struggling to define my nebulous research topic, with deadlines hurtling toward me and the MATLAB error beep propagating through my skull like a cluster bomb, when it all became too much. Smashing the keyboard in frustration and ripping incomprehensible pages from MATLAB for Beginners, I sank to the floor in defeat. "It's OK,Mama," whispered my 4-year-old daughter who, unbeknownst to me, had been watching from the doorway after creeping out of bed. As she stretched her tiny arms across my back, I realized that, although it is theoretically possible for me to publish prolifically in the best journals while making my kids animal-shaped sushi for lunch each day, it's about as sustainable as strip mining.	[White, Emma] Univ Melbourne, Melbourne, Vic, Australia	University of Melbourne	White, E (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.								0	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					618	618		10.1126/science.357.6351.618	http://dx.doi.org/10.1126/science.357.6351.618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798134				2022-12-28	WOS:000407324800046
J	Phillips, N				Phillips, Nicky			CONNECTING BIG IDEAS TO BENEFIT	NATURE			English	Editorial Material																			0	1	1	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S3	S3		10.1038/548S3a	http://dx.doi.org/10.1038/548S3a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792925	Bronze			2022-12-28	WOS:000407284300001
J	Solanas, G; Peixoto, FO; Perdiguero, E; Jardi, M; Ruiz-Bonilla, V; Datta, D; Symeonidi, A; Castellanos, A; Welz, PS; Caballero, JM; Sassone-Corsi, P; Munoz-Canoves, P; Benitah, SA				Solanas, Guiomar; Oliveira Peixoto, Francisca; Perdiguero, Eusebio; Jardi, Merce; Ruiz-Bonilla, Vanessa; Datta, Debayan; Symeonidi, Aikaterini; Castellanos, Andres; Welz, Patrick-Simon; Martin Caballero, Juan; Sassone-Corsi, Paolo; Munoz-Canoves, Pura; Aznar Benitah, Salvador			Aged Stem Cells Reprogram Their Daily Rhythmic Functions to Adapt to Stress	CELL			English	Article							CIRCADIAN CLOCK; SKELETAL-MUSCLE; SATELLITE CELL; REGENERATIVE CAPACITY; SKIN; ACTIVATION; SENESCENCE; AUTOPHAGY; NICHE; CYCLE	Normal homeostatic functions of adult stem cells have rhythmic daily oscillations that are believed to become arrhythmic during aging. Unexpectedly, we find that aged mice remain behaviorally circadian and that their epidermal and muscle stem cells retain a robustly rhythmic core circadian machinery. However, the oscillating transcriptome is extensively reprogrammed in aged stem cells, switching from genes involved in homeostasis to those involved in tissue-specific stresses, such as DNA damage or inefficient autophagy. Importantly, deletion of circadian clock components did not reproduce the hallmarks of this reprogramming, underscoring that rewiring, rather than arrhythmia, is associated with physiological aging. While age-associated rewiring of the oscillatory diurnal transcriptome is not recapitulated by a high-fat diet in young adult mice, it is significantly prevented by long-term caloric restriction in aged mice. Thus, stem cells rewire their diurnal timed functions to adapt to metabolic cues and to tissue-specific age-related traits.	[Solanas, Guiomar; Oliveira Peixoto, Francisca; Datta, Debayan; Symeonidi, Aikaterini; Castellanos, Andres; Welz, Patrick-Simon; Aznar Benitah, Salvador] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Munoz-Canoves, Pura; Aznar Benitah, Salvador] Catalan Inst Res & Adv Studies, ICREA, Barcelona 08010, Spain; [Perdiguero, Eusebio; Jardi, Merce; Ruiz-Bonilla, Vanessa; Munoz-Canoves, Pura] UPF, Dept Expt & Hlth Sci DCEXS, Barcelona 08003, Spain; [Perdiguero, Eusebio; Jardi, Merce; Ruiz-Bonilla, Vanessa; Munoz-Canoves, Pura] CIBER Neurodegenerat Dis, Barcelona 08003, Spain; [Munoz-Canoves, Pura] Spanish Natl Ctr Cardiovasc Res CNIC, Madrid 28029, Spain; [Martin Caballero, Juan] PCB PRBB Anim Facil, Barcelona 08028, Spain; [Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92607 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Pompeu Fabra University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of California System; University of California Irvine	Benitah, SA (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Munoz-Canoves, P; Benitah, SA (corresponding author), Catalan Inst Res & Adv Studies, ICREA, Barcelona 08010, Spain.; Munoz-Canoves, P (corresponding author), UPF, Dept Expt & Hlth Sci DCEXS, Barcelona 08003, Spain.; Munoz-Canoves, P (corresponding author), CIBER Neurodegenerat Dis, Barcelona 08003, Spain.; Munoz-Canoves, P (corresponding author), Spanish Natl Ctr Cardiovasc Res CNIC, Madrid 28029, Spain.	pura.munoz@upf.edu; salvador.aznar-benitah@irbbarcelona.org	Perdiguero, Eusebio/F-3178-2013; Welz, Patrick-Simon/F-3856-2016; Castellanos, Andres/F-3302-2016; Munoz-Canoves, Pura/B-3889-2015; Aznar-Benitah, Salvador/F-4761-2016	Perdiguero, Eusebio/0000-0003-3529-8989; Welz, Patrick-Simon/0000-0001-8370-625X; Castellanos, Andres/0000-0003-2864-7271; Aznar-Benitah, Salvador/0000-0002-9059-5049; Datta, Debayan/0000-0002-2347-0860; Solanas, Guiomar/0000-0001-8388-8647	European Research Council (ERC); Spanish Ministry of Economy and Development; Institute for Research in Biomedicine (IRB-Barcelona); La Caixa International Ph.D. fellowship; Juan de la Cierva postdoctoral fellowship; Spanish Ministry of Economy and Development [SAF2015-67369-R]; AFM; E-Rare/ERANET; Fundacio La Marato TV3; MDA; Convenio CNIC-UPF; MINECO (Government of Spain); Government of Spain [MDM-2014-0370]	European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Development; Institute for Research in Biomedicine (IRB-Barcelona); La Caixa International Ph.D. fellowship(La Caixa Foundation); Juan de la Cierva postdoctoral fellowship(Instituto de Salud Carlos III); Spanish Ministry of Economy and Development; AFM(Association Francaise contre les Myopathies); E-Rare/ERANET; Fundacio La Marato TV3; MDA(Muscular Dystrophy Association); Convenio CNIC-UPF; MINECO (Government of Spain)(Spanish Government); Government of Spain(Spanish Government)	Research for this project in the lab of S.A.B. was supported by the European Research Council (ERC), the Spanish Ministry of Economy and Development, and the Institute for Research in Biomedicine (IRB-Barcelona). F.O.P. is supported by a La Caixa International Ph.D. fellowship, and P-S.W. is supported by a Juan de la Cierva postdoctoral fellowship. Research in the lab of P.M.C. is supported by the Spanish Ministry of Economy and Development (SAF2015-67369-R), AFM, E-Rare/ERANET, Fundacio La Marato TV3, MDA, and Convenio CNIC-UPF. We are grateful for the excellent technical support from the IRB Functional Genomics Core Facility, the PCB (Scientific Park of Barcelona) Animal Unit and FACS Unit, the IRB Advanced Digital Microscopy Unit, and IRB Biostatistics/Bioinformatics Core Facility, the IRB FACS unit, the PCB (Scientific Park of Barcelona) Animal Unit, the IRB Imaging Unit, the IRB Histology Unit for technical assistance and support, the UPF/CRG FACS Unit, and the UPF Advanced Light Microscopy Unit (especially to Jaume Boix for microscopy advice and assistance). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). The DCESX/UPF is recipient of a "Maria de Maeztu" Programme for Units of Excellence in R&D MDM-2014-0370 (Government of Spain). We thank Veronica Raker for manuscript editing. We apologize to the authors whose work was not cited due to space limitations.	Amaral N, 2016, NAT CELL BIOL, V18, P516, DOI 10.1038/ncb3343; [Anonymous], TITLE ERROR; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Boada-Romero E, 2013, EMBO J, V32, P566, DOI 10.1038/emboj.2013.8; Bolstad B, 2005, BIOINFORMATICS COMPU; Bua S, 2015, CELL CYCLE, V14, P3897, DOI 10.1080/15384101.2015.1120919; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chakkalakal Jv, 2012, J Stem Cell Res Ther, VSuppl 11, P001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Goetsch KP, 2014, J CELL BIOCHEM, V115, P1299, DOI 10.1002/jcb.24784; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janich P, 2014, CURR OPIN CELL BIOL, V31, P8, DOI 10.1016/j.ceb.2014.06.010; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; Lipp H.-P., 2005, P MEAS BEH WAG NETH, P66; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Sada A, 2016, NAT CELL BIOL, V18, P619, DOI 10.1038/ncb3359; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shibukawa Y, 2013, EXP CELL RES, V319, P633, DOI 10.1016/j.yexcr.2012.12.022; Solanas G, 2013, NAT REV MOL CELL BIO, V14, P737, DOI 10.1038/nrm3675; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stringari C, 2015, CELL REP, V10, P1, DOI 10.1016/j.celrep.2014.12.007; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Team RC., 2022, LANG ENV STAT COMP; Tetteh PW, 2015, TRENDS CELL BIOL, V25, P100, DOI 10.1016/j.tcb.2014.09.003; Tierney MT, 2016, CELL REP, V14, P1940, DOI 10.1016/j.celrep.2016.01.072; Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	57	117	124	3	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					678	+		10.1016/j.cell.2017.07.035	http://dx.doi.org/10.1016/j.cell.2017.07.035			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802040	Bronze, Green Published			2022-12-28	WOS:000407445700009
J	Georgopoulos, AP; Georgopoulos, A				Georgopoulos, Apostolos P.; Georgopoulos, Angeliki			The Beautiful Brain and the Influence of Santiago Ramon y Cajal onMedicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORTEX		[Georgopoulos, Apostolos P.] Brain Sci Ctr, Dept Vet Affairs Med Ctr, Minneapolis, MN USA; [Georgopoulos, Apostolos P.] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Georgopoulos, Apostolos P.] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN USA; [Georgopoulos, Angeliki] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Georgopoulos, AP (corresponding author), Brain Sci Ctr 11B, Dept Vet Affairs Med Ctr, One Vet Dr, Minneapolis, MN 55417 USA.	omega@umn.edu						Cajal S., 1917, RAMON RECUERDOS DEMI; Georgopoulos AP, 2007, BRAIN RES REV, V55, P383, DOI 10.1016/j.brainresrev.2007.05.001; Jackson J H, 1898, Br Med J, V1, P65; Shepherd G.M., 2010, HDB BRAIN MICROCIRCU; Sherrington C., 1949, EXPLORER HUMAN BRAIN, pxiii; SLOPER JJ, 1978, PROC R SOC SER B-BIO, V203, P39, DOI 10.1098/rspb.1978.0089	6	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					502	504		10.1001/jama.2017.9858	http://dx.doi.org/10.1001/jama.2017.9858			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787487				2022-12-28	WOS:000407160100001
J	Moffatt, HK				Moffatt, H. Keith			Helicity-invariant even in a viscous fluid	SCIENCE			English	Editorial Material									[Moffatt, H. Keith] Univ Cambridge, Dept Appl Math & Theoret Phys, Wilberforce Rd, Cambridge CB3 0WA, England	University of Cambridge	Moffatt, HK (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Wilberforce Rd, Cambridge CB3 0WA, England.	hkm2@cam.ac.uk						Clugreanu G, 1961, CZECH MATH J, V11, P588, DOI 10.21136/CMJ.1961.100486; Kleckner D, 2013, NAT PHYS, V9, P253, DOI [10.1038/nphys2560, 10.1038/NPHYS2560]; MOFFATT HK, 1992, P ROY SOC LOND A MAT, V439, P411, DOI 10.1098/rspa.1992.0159; Scheeler MW, 2017, SCIENCE, V357, P487, DOI 10.1126/science.aam6897; Thomson W., 1869, EARTH ENV SCI T R SO, V25, P217; von Helmholtz H., 1858, J REINE ANGEW MATH, V55, P2555	6	18	19	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					448	449		10.1126/science.aao1428	http://dx.doi.org/10.1126/science.aao1428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774912				2022-12-28	WOS:000406840100017
J	Gibney, E				Gibney, Elizabeth			THE ANTIMATTER RACE	NATURE			English	Editorial Material							MASS-RATIO; ANTIHYDROGEN; ANTIPROTON; ELECTRON											Ahmadi M, 2017, NATURE, V548, P66, DOI 10.1038/nature23446; Ahmadi M, 2017, NATURE, V541, P506, DOI 10.1038/nature21040; Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; Andresen GB, 2011, NAT PHYS, V7, P558, DOI [10.1038/NPHYS2025, 10.1038/nphys2025]; Baur G, 1996, PHYS LETT B, V368, P251, DOI 10.1016/0370-2693(96)00005-6; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; Hori M, 2016, SCIENCE, V354, P610, DOI 10.1126/science.aaf6702; Nagahama H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14084; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861	9	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					20	23		10.1038/548020a	http://dx.doi.org/10.1038/548020a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770855	Bronze			2022-12-28	WOS:000406831700011
J	Shtaya, A; Dabbous, B				Shtaya, Anan; Dabbous, Bassam			SPOT DIAGNOSIS An incidental finding on computed tomography scan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shtaya, Anan] St Georges Univ Hosp NHS Trust, Neurosurg, London, England; St Georges Univ London, London, England	St Georges University London	Shtaya, A (corresponding author), St Georges Univ Hosp NHS Trust, Neurosurg, London, England.	ashtaya@sgul.ac.uk	Shtaya, Anan/AAX-2494-2020	Shtaya, Anan/0000-0001-7459-8437	National Institute for Health Research [CL-2015-16-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Couvreur T, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.04.053; Di Gaeta A, 2017, NEURORADIOL J, V30, P286, DOI 10.1177/1971400917697731; Helland CA, 2010, J NEUROSURG, V113, P934, DOI 10.3171/2009.11.JNS081663; Iaconetta G, 2006, NEUROL SCI, V26, P451, DOI 10.1007/s10072-006-0532-z; Yuksel MO, 2016, J CLIN DIAGN RES, V358	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2017	358								j3500	10.1136/bmj.j3500	http://dx.doi.org/10.1136/bmj.j3500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CI	28774875				2022-12-28	WOS:000407207000003
J	Burstin, H; Agrawal, S; Qaseem, A				Burstin, Helen; Agrawal, Shantanu; Qaseem, Amir			Moving to Measures That Matter and Motivate Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Burstin, Helen; Agrawal, Shantanu] Natl Qual Forum, 1030 15th St NW, Washington, DC 20005 USA; [Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	American College of Physicians	Burstin, H (corresponding author), Natl Qual Forum, 1030 15th St NW, Washington, DC 20005 USA.	hburstin@qualityforum.org						Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Baker DW, 2017, ANN INTERN MED, V167, P418, DOI 10.7326/M17-0691; Cella D, 2015, PATIENT REPORTED OUT; Department of Health and Human Services Office of the Assistant Secretary of Planning and Evaluation, REP C SOC RISK FACT; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; National Quality Forum, 2016, SUBM STAND 2016 MEAS; National Quality Forum, ATTR PRINC APPR	7	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					442	+		10.7326/M17-1855	http://dx.doi.org/10.7326/M17-1855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28806792				2022-12-28	WOS:000411009900025
J	Burr, ML; Sparbier, CE; Chan, YC; Williamson, JC; Woods, K; Beavis, PA; Lam, EYN; Henderson, MA; Bell, CC; Stolzenburg, S; Gilan, O; Bloor, S; Noori, T; Morgens, DW; Bassik, MC; Neeson, PJ; Behren, A; Darcy, PK; Dawson, SJ; Voskoboinik, I; Trapani, JA; Cebon, J; Lehner, PJ; Dawson, MA				Burr, Marian L.; Sparbier, Christina E.; Chan, Yih-Chih; Williamson, James C.; Woods, Katherine; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Stolzenburg, Sabine; Gilan, Omer; Bloor, Stuart; Noori, Tahereh; Morgens, David W.; Bassik, Michael C.; Neeson, Paul J.; Behren, Andreas; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Cebon, Jonathan; Lehner, Paul J.; Dawson, Mark A.			CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity	NATURE			English	Article							INFECTION; MEMBRANE	Cancer cells exploit the expression of the programmed death-1 (PD-1) ligand 1 (PD-L1) to subvert T-cell-mediated immunosurveillance(1,2). The success of therapies that disrupt PD-L1-mediated tumour tolerance has highlighted the need to understand the molecular regulation of PD-L1 expression(1). Here we identify the uncharacterized protein CMTM6 as a critical regulator of PD-L1 in a broad range of cancer cells, by using a genome-wide CRISPR-Cas9 screen. CMTM6 is a ubiquitously expressed protein that binds PD-L1 and maintains its cell surface expression. CMTM6 is not required for PD-L1 maturation but co-localizes with PD-L1 at the plasma membrane and in recycling endosomes, where it prevents PD-L1 from being targeted for lysosome-mediated degradation. Using a quantitative approach to profile the entire plasma membrane proteome, we find that CMTM6 displays specificity for PD-L1. Notably, CMTM6 depletion decreases PD-L1 without compromising cell surface expression of MHC class I. CMTM6 depletion, via the reduction of PD-L1, significantly alleviates the suppression of tumour-specific T cell activity in vitro and in vivo. These findings provide insights into the biology of PD-L1 regulation, identify a previously unrecognized master regulator of this critical immune checkpoint and highlight a potential therapeutic target to overcome immune evasion by tumour cells.	[Burr, Marian L.; Sparbier, Christina E.; Chan, Yih-Chih; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Stolzenburg, Sabine; Gilan, Omer; Noori, Tahereh; Neeson, Paul J.; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic 3000, Australia; [Burr, Marian L.; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Gilan, Omer; Neeson, Paul J.; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Burr, Marian L.; Williamson, James C.; Bloor, Stuart; Lehner, Paul J.] Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England; [Woods, Katherine; Behren, Andreas; Cebon, Jonathan] La Trobe Univ, Sch Canc Med, Melbourne, Vic 3086, Australia; [Woods, Katherine; Behren, Andreas; Cebon, Jonathan] Olivia Newton John Canc Res Inst, Heidelberg, Vic 3084, Australia; [Morgens, David W.; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Cambridge; La Trobe University; La Trobe University; Olivia Newton-John Cancer Research Institute; Stanford University; University of Melbourne; Peter Maccallum Cancer Center	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic 3000, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia.; Lehner, PJ (corresponding author), Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.; Dawson, MA (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.	marian.burr@petermac.org; pjl30@cam.ac.uk; mark.dawson@petermac.org	Neeson, Paul/ABD-4686-2020; Dawson, Mark A/B-9317-2017; Behren, Andreas/ABZ-2615-2022	Dawson, Mark A/0000-0002-5464-5029; Voskoboinik, Ilia/0000-0002-6410-009X; Gilan, Omer/0000-0003-4156-2619; Behren, Andreas/0000-0001-5329-280X; Williamson, James/0000-0002-2009-189X; Lehner, Paul Joseph/0000-0001-9383-1054; Neeson, Paul/0000-0002-2729-5887; Darcy, Phillip/0000-0002-5303-9561; Woods, Katherine/0000-0003-3474-3104; Burr, Marian/0000-0002-8995-3398; Sparbier, Christina/0000-0002-7482-0672; Trapani, Joseph/0000-0003-0983-1532; Bell, Charles/0000-0003-2194-8311; Dawson, Sarah-Jane/0000-0002-8276-0374; Cebon, Jonathan/0000-0002-3898-950X; Lam, Enid Yi Ni/0000-0001-5843-7836; Beavis, Paul/0000-0002-2116-013X	Cancer Research UK Fellowship; Addenbrooke's Charitable Trust award; NIHR fellowship; Senior Leukaemia Foundation Australia Fellowship; NHMRC [1085015, 1106444, 1106447]; Cancer Council Victoria; Leukaemia Foundation Australia; Wellcome Trust PRF [101835/Z/13/Z]; NHSBT; NIHR Cambridge BRC; Wellcome Trust Strategic Award; Addenbrooke's Charitable Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; Cancer Research UK [20097] Funding Source: researchfish; National Institute for Health Research [ACF-2012-14-003] Funding Source: researchfish; National Breast Cancer Foundation [PF-14-008] Funding Source: researchfish	Cancer Research UK Fellowship(Cancer Research UK); Addenbrooke's Charitable Trust award; NIHR fellowship; Senior Leukaemia Foundation Australia Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation Australia; Wellcome Trust PRF; NHSBT; NIHR Cambridge BRC; Wellcome Trust Strategic Award(Wellcome Trust); Addenbrooke's Charitable Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation	M.L.B. is supported by a Cancer Research UK Fellowship, Addenbrooke's Charitable Trust award and NIHR fellowship. M.A.D. is supported by a Senior Leukaemia Foundation Australia Fellowship and work in the Dawson laboratory is supported by the NHMRC (Grants 1085015, 1106444 and 1106447) Cancer Council Victoria and Leukaemia Foundation Australia. P.J.L. is supported by a Wellcome Trust PRF (101835/Z/13/Z) and work in the Lehner laboratory is supported by NHSBT, NIHR Cambridge BRC, a Wellcome Trust Strategic Award to CIMR, and the Addenbrooke's Charitable Trust.	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Behren A, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12097; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Moreno BH, 2015, SEMIN ONCOL, V42, P466, DOI 10.1053/j.seminoncol.2015.02.008; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Woods K, 2013, CLIN CANCER RES, V19, P4021, DOI 10.1158/1078-0432.CCR-13-1349	19	420	455	20	201	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					101	105		10.1038/nature23643	http://dx.doi.org/10.1038/nature23643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28813417	Green Accepted, Green Submitted			2022-12-28	WOS:000409388700041
J	Moreno, JD; Schmidt, U; Joffe, S				Moreno, Jonathan D.; Schmidt, Ulf; Joffe, Steve			The Nuremberg Code 70 Years Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moreno, Jonathan D.; Joffe, Steve] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,BH1415, Philadelphia, PA 19104 USA; [Moreno, Jonathan D.] Univ Penn, Dept Hist & Sociol Sci, Philadelphia, PA 19104 USA; [Schmidt, Ulf] Univ Kent, Rutherford Coll, Sch Hist, Canterbury, Kent, England; [Joffe, Steve] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Kent; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Moreno, JD (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,BH1415, Philadelphia, PA 19104 USA.	morenojd@mail.med.upenn.edu		Schmidt, Ulf/0000-0002-4539-1215	Wellcome Trust Seed Award [WT: 201441/Z/16/Z]	Wellcome Trust Seed Award(Wellcome Trust)	Drs Schmidt and Moreno acknowledge the support of a Wellcome Trust Seed Award 2016, "Cold War Bioethics: Human Research Ethics in Central Eastern Europe, 1945-present" (WT: 201441/Z/16/Z).	Dougherty S, 2017, NUREMBERG BETRAYED H; HEIMAN T, 1917, ETYKA LEKARSKA OBOWI; Moreno Jonathan D., 2001, UNDUE RISK SECRET ST; Polish Medical Association, 1967, SLUZBA ZDROWIA, V26, P3; Schmidt U, 2004, ST ANTONYS SER, P1, DOI 10.1057/9780230505247; Schmidt Ulf, 2015, SECRET SCI CENTURY P	6	16	16	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					795	796		10.1001/jama.2017.10265	http://dx.doi.org/10.1001/jama.2017.10265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28817743				2022-12-28	WOS:000409183700007
J	Holland, R; Bauer, B				Holland, Rebecca; Bauer, Brooke			Frontline: Support for breastfeeding in crisis	LANCET			English	Editorial Material									[Bauer, Brooke] Nurture Project Int, Buffalo, NY 52728 USA		Bauer, B (corresponding author), Nurture Project Int, Buffalo, NY 52728 USA.								0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					834	834		10.1016/S0140-6736(17)32098-6	http://dx.doi.org/10.1016/S0140-6736(17)32098-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28774420				2022-12-28	WOS:000408330700010
J	Houle, D; Bolstad, GH; van der Linde, K; Hansen, TF				Houle, David; Bolstad, Geir H.; van der Linde, Kim; Hansen, Thomas F.			Mutation predicts 40 million years of fly wing evolution	NATURE			English	Article							GENETIC PRINCIPAL COMPONENTS; DIVERGENCE TIMES; MOLECULAR PHYLOGENY; DROSOPHILA; COVARIANCE; EVOLVABILITY; CONSTRAINT; PATTERNS; SELECTION; RATES	Mutation enables evolution, but the idea that adaptation is also shaped by mutational variation is controversial(1-4). Simple evolutionary hypotheses predict such a relationship if the supply of mutations constrains evolution(5,6), but it is not clear that constraints exist, and, even if they do, they may be overcome by long-term natural selection(7). Quantification of the relationship between mutation and phenotypic divergence among species will help to resolve these issues. Here we use precise data on over 50,000 Drosophilid fly wings to demonstrate unexpectedly strong positive relationships between variation produced by mutation, standing genetic variation, and the rate of evolution over the last 40 million years. Our results are inconsistent with simple constraint hypotheses because the rate of evolution is very low relative to what both mutational and standing variation could allow. In principle, the constraint hypothesis could be rescued if the vast majority of mutations are so deleterious that they cannot contribute to evolution, but this also requires the implausible assumption that deleterious mutations have the same pattern of effects as potentially advantageous ones. Our evidence for a strong relationship between mutation and divergence in a slowly evolving structure challenges the existing models of mutation in evolution.	[Houle, David; Bolstad, Geir H.; van der Linde, Kim] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Bolstad, Geir H.] Norwegian Inst Nat Res NINA, NO-7485 Trondheim, Norway; [van der Linde, Kim] Anim Genet Inc, 1336 Timberlane Rd, Tallahassee, FL 32312 USA; [Hansen, Thomas F.] Univ Oslo, Dept Biol, CEES, N-0316 Oslo, Norway; [Hansen, Thomas F.] Univ Oslo, EVOGENE, N-0316 Oslo, Norway	State University System of Florida; Florida State University; Norwegian Institute Nature Research; University of Oslo; University of Oslo	Houle, D (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	dhoule@bio.fsu.edu	Hansen, Thomas/GWZ-2858-2022; Bolstad, Geir/K-3631-2014	Bolstad, Geir/0000-0003-1356-8239	US NSF DEB [0129219, 0950002]; NSERC	US NSF DEB; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank P. Galpern, J. Birdsley, F. S. Hollis, Y. Ng, and L. Carpenter for rearing and imaging Drosophilid species; C. Boake, J. David, G. Gilchrist, J. Hey, A. Hoikalla, L. Reed and J. True for contributing stocks, specimens or images; K. Meyer for assistance with Wombat; S. Steppan for help with r8s and phylogenetic analyses; J. Merila and M. Kirkpatrick for comments; and to the many students who measured fly wings. This work was supported by US NSF DEB grants 0129219 and 0950002, and NSERC grants to D.H.	[Anonymous], 2004, MVE MINIMUM VOLUME E; [Anonymous], 2004, WINGS AUTOMATED CAPT; [Anonymous], 2010, WOMB PROGR MIX MOD A; Arnold SJ, 2001, GENETICA, V112, P9, DOI 10.1023/A:1013373907708; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Bolstad GH, 2015, P NATL ACAD SCI USA, V112, P13284, DOI 10.1073/pnas.1505357112; Bolstad GH, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0255; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Draghi J, 2008, EVOLUTION, V62, P301, DOI 10.1111/j.1558-5646.2007.00303.x; Farhadifar R, 2016, GENETICS, V203, P1859, DOI 10.1534/genetics.115.185736; Fuller W.A., 2009, MEASUREMENT ERROR MO; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Grabowski MW, 2011, EVOLUTION, V65, P1336, DOI 10.1111/j.1558-5646.2011.01226.x; Grimaldi David, 2005, pi; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Hansen TF, 2003, J EXP ZOOL PART B, V296B, P23, DOI 10.1002/jez.b.00014; Hansen TF, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P130; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hansen TF, 2006, EVOLUTION, V60, P1523; Hansen TF, 2012, SYST BIOL, V61, P413, DOI 10.1093/sysbio/syr122; Hansen TF, 2011, EPIGENETICS: LINKING GENOTYPE AND PHENOTYPE IN DEVELOPMENT AND EVOLUTION, P357; HILL WG, 1982, P NATL ACAD SCI-BIOL, V79, P142, DOI 10.1073/pnas.79.1.142; Houle D, 1996, GENETICS, V143, P1467; Houle D, 2015, J EVOLUTION BIOL, V28, P1542, DOI 10.1111/jeb.12674; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; Houle D, 2013, EVOLUTION, V67, P1116, DOI 10.1111/j.1558-5646.2012.01838.x; Jones AG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4709; Kirkpatrick M, 2004, GENETICS, V168, P2295, DOI 10.1534/genetics.104.029181; Kristensen K, 2016, J STAT SOFTW, V70, P1; Le Rouzic A, 2013, EVOL BIOL, V40, P317, DOI 10.1007/s11692-012-9218-z; LYNCH M, 1991, EVOLUTION, V45, P1065, DOI [10.2307/2409716, 10.1111/j.1558-5646.1991.tb04375.x]; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; Lynch M, 1998, EVOLUTION, V52, P727, DOI 10.1111/j.1558-5646.1998.tb03697.x; Meyer K, 2005, GENET SEL EVOL, V37, P1, DOI [10.1051/gse:2004034, 10.1051/gse:2004030]; Meyer K, 2008, GENETICS, V180, P1153, DOI 10.1534/genetics.108.090159; Mezey JG, 2005, EVOLUTION, V59, P1027; Mitteroecker P, 2009, EVOLUTION, V63, P727, DOI 10.1111/j.1558-5646.2008.00587.x; O'Grady PM, 1999, MOL PHYLOGENET EVOL, V12, P124, DOI 10.1006/mpev.1998.0598; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Oliveira DCSG, 2012, MOL PHYLOGENET EVOL, V64, P533, DOI 10.1016/j.ympev.2012.05.012; Pavlicev M, 2015, ANNU REV ECOL EVOL S, V46, P413, DOI 10.1146/annurev-ecolsys-120213-091721; Pavlicev M, 2011, P ROY SOC B-BIOL SCI, V278, P1903, DOI 10.1098/rspb.2010.2113; R Core Team, 2016, R LANG ENV STAT COMP; Reed LK, 2007, MOL ECOL, V16, P1007, DOI 10.1111/j.1365-294X.2006.02941.x; RIEDL R, 1977, Q REV BIOL, V52, P351, DOI 10.1086/410123; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROUSSEEUW PJ, 1990, J AM STAT ASSOC, V85, P633, DOI 10.2307/2289995; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; SAS Institute, 2013, SAS SYSTEM WINDOWS R; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Stensmyr MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001942; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; van der Linde K, 2008, INSECT SYST EVOL, V39, P241, DOI 10.1163/187631208788784237; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; WEBER KE, 1992, GENETICS, V130, P345; WEBER KE, 1990, GENETICS, V126, P975; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	62	74	74	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					447	+		10.1038/nature23473	http://dx.doi.org/10.1038/nature23473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28792935				2022-12-28	WOS:000408279000037
J	Hirschtritt, ME; Kroenke, K				Hirschtritt, Matthew E.; Kroenke, Kurt			Screening for Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VALIDITY		[Hirschtritt, Matthew E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Kroenke, Kurt] VA HRS&D Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Kroenke, Kurt] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Kroenke, Kurt] Regenstrief Inst Inc, 1101 W 10th St,RF 221, Indianapolis, IN 46202 USA	University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kroenke, K (corresponding author), Regenstrief Inst Inc, 1101 W 10th St,RF 221, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org		Hirschtritt, Matthew/0000-0001-8654-1825; Kroenke, Kurt/0000-0002-0114-4669	National Institute of Mental Health [R25-MH060482]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr Hirschtritt received funding from the National Institute of Mental Health (R25-MH060482) to support this work.	Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Dube P, 2010, PRIM CARE COMPANION, V12; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Saliba D, 2012, J AM MED DIR ASSOC, V13, P618, DOI 10.1016/j.jamda.2012.06.003; Simon GE, 2006, PSYCHOL MED, V36, P27, DOI 10.1017/S0033291705006136; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Wahl I, 2014, J CLIN EPIDEMIOL, V67, P73, DOI 10.1016/j.jclinepi.2013.04.019; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x	10	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					745	746		10.1001/jama.2017.9820	http://dx.doi.org/10.1001/jama.2017.9820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE3DE	28829850	Green Published			2022-12-28	WOS:000408095800027
J	Clery, D				Clery, Daniel			ASTROPHYSICS Astrophysics missions vie for NASA money	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					634	634		10.1126/science.357.6352.634	http://dx.doi.org/10.1126/science.357.6352.634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818923				2022-12-28	WOS:000407793600011
J	Cohen, J				Cohen, Jon			INFECTIOUS DISEASES Where has all the Zika gone?	SCIENCE			English	News Item																			0	16	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					631	632		10.1126/science.357.6352.631	http://dx.doi.org/10.1126/science.357.6352.631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818921				2022-12-28	WOS:000407793600009
J	Shah, R				Shah, Reema			In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shah, Reema] McMaster Univ, Hamilton, ON, Canada	McMaster University	Shah, R (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; Pasqualetti G, 2015, J CLIN ENDOCR METAB, V100, P4240, DOI 10.1210/jc.2015-2046; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Villar HCCE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003419.pub2	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC14	JC14		10.7326/ACPJC-2017-167-4-014	http://dx.doi.org/10.7326/ACPJC-2017-167-4-014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806795				2022-12-28	WOS:000407797500002
J	Byrne, A				Byrne, Aidan			MEASURE FOR MEASURE	NATURE			English	Editorial Material									[Byrne, Aidan] Univ Queensland, Brisbane, Qld, Australia; [Byrne, Aidan] Australian Res Council, Canberra, ACT, Australia	University of Queensland	Byrne, A (corresponding author), Univ Queensland, Brisbane, Qld, Australia.; Byrne, A (corresponding author), Australian Res Council, Canberra, ACT, Australia.								0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S22	S22		10.1038/548S22a	http://dx.doi.org/10.1038/548S22a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792926	Bronze			2022-12-28	WOS:000407284300008
J	Trible, W; Olivos-Cisneros, L; McKenzie, SK; Saragosti, J; Chang, NC; Matthews, BJ; Oxley, PR; Kronauer, DJC				Trible, Waring; Olivos-Cisneros, Leonora; McKenzie, Sean K.; Saragosti, Jonathan; Chang, Ni-Chen; Matthews, Benjamin J.; Oxley, Peter R.; Kronauer, Daniel J. C.			orco Mutagenesis Causes Loss of Antennal Lobe Glomeruli and Impaired Social Behavior in Ants	CELL			English	Article							DRAFT GENOME; ODORANT; COMMUNICATION; RECEPTORS; EVOLUTION; GENE; RECONSTRUCTION; ESTABLISHMENT; SUPERFAMILY; CRISPR/CAS9	Life inside ant colonies is orchestrated with diverse pheromones, but it is not clear how ants perceive these social signals. It has been proposed that pheromone perception in ants evolved via expansions in the numbers of odorant receptors (ORs) and antennal lobe glomeruli. Here, we generate the first mutant lines in the clonal raider ant, Ooceraea biroi, by disrupting orco, a gene required for the function of all ORs. We find that orco mutants exhibit severe deficiencies in social behavior and fitness, suggesting they are unable to perceive pheromones. Surprisingly, unlike in Drosophila melanogaster, orco mutant ants also lack most of the similar to 500 antennal lobe glomeruli found in wild-type ants. These results illustrate that ORs are essential for ant social organization and raise the possibility that, similar to mammals, receptor function is required for the development and/or maintenance of the highly complex olfactory processing areas in the ant brain.	[Trible, Waring; Olivos-Cisneros, Leonora; McKenzie, Sean K.; Saragosti, Jonathan; Chang, Ni-Chen; Oxley, Peter R.; Kronauer, Daniel J. C.] Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA; [Matthews, Benjamin J.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Matthews, Benjamin J.] Howard Hughes Med Inst, Chevy Chase, MD 23930 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute	Trible, W; Kronauer, DJC (corresponding author), Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA.	wtrible@rockefeller.edu; dkronauer@rockefeller.edu	McKenzie, Sean K/AAD-8199-2020	McKenzie, Sean K/0000-0002-8238-4735; Matthews, Benjamin/0000-0002-8697-699X; Oxley, Peter/0000-0001-6170-1220	NIH [1DP2GM105454-01]; Searle Scholar Award; Klingenstein-Simons Fellowship Award in the Neurosciences; Pew Biomedical Scholar Award; Leon Levy Neuroscience Fellowship; Kravis Fellowship; NRSA Training Grant [GM066699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699, DP2GM105454] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; Klingenstein-Simons Fellowship Award in the Neurosciences; Pew Biomedical Scholar Award; Leon Levy Neuroscience Fellowship; Kravis Fellowship; NRSA Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Kronauer, Vosshall, and Ruta laboratories for reagents and critical insights. We are grateful to Ingrid Fetter-Pruneda for suggesting the Sharpie experiment, Yuko Ulrich for help with mixed-model statistics, Laura Seeholzer and Margaret Ebert, along with the Insect Genetic Technologies Research Coordination Network, for help in developing the injection protocol, Vanessa Ruta for providing flies, Leslie Vosshall for access to laboratory equipment, Zak Frentz and Asaf Gal for help in implementing the automated behavioral tracking, as well as Cori Bargmann, Claude Desplan, and Leslie Vosshall for comments on a previous version of this manuscript. This work was supported by grant 1DP2GM105454-01 from the NIH, a Searle Scholar Award, a Klingenstein-Simons Fellowship Award in the Neurosciences, and a Pew Biomedical Scholar Award to D.J.C.K. P.R.O. was supported by a Leon Levy Neuroscience Fellowship, and J.S. and S.K.M. were supported by a Kravis Fellowship and NRSA Training Grant GM066699, respectively. This is Clonal Raider Ant Project paper #6.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Engsontia Patamarerk, 2015, BMC Research Notes, V8, P380, DOI 10.1186/s13104-015-1371-x; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Fletcher M., 2011, 2011 IEEE WORKSH APP, P570, DOI DOI 10.1109/WACV.2011.5711555; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GASCUEL J, 1991, J NEUROBIOL, V22, P795, DOI 10.1002/neu.480220802; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Gruter C, 2016, CURR OPIN NEUROBIOL, V38, P6, DOI 10.1016/j.conb.2016.01.002; Holldobler B., 1982, Psyche (Cambridge), V89, P3, DOI 10.1155/1982/28390; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Jhaveri D, 2002, DEVELOPMENT, V129, P1251; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelber C, 2009, BRAIN BEHAV EVOLUT, V73, P273, DOI 10.1159/000230672; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kohl J, 2015, CURR OPIN NEUROBIOL, V34, P149, DOI 10.1016/j.conb.2015.06.009; Kohno H, 2016, ZOOL SCI, V33, P505, DOI 10.2108/zs160043; Kollmann M, 2011, CELL TISSUE RES, V343, P343, DOI 10.1007/s00441-010-1099-9; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Kronauer DJC, 2012, MOL ECOL, V21, P5221, DOI 10.1111/mec.12041; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; MALUN D, 1994, J COMP NEUROL, V350, P1, DOI 10.1002/cne.903500102; McKenzie SK, 2016, P NATL ACAD SCI USA, V113, P14091, DOI 10.1073/pnas.1610800113; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; Nakanishi A, 2010, J COMP NEUROL, V518, P2186, DOI 10.1002/cne.22326; Oxley PR, 2014, CURR BIOL, V24, P451, DOI 10.1016/j.cub.2014.01.018; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Reid W, 2016, CURR OPIN INSECT SCI, V13, P43, DOI 10.1016/j.cois.2015.11.001; Richard FJ, 2013, INSECT SOC, V60, P275, DOI 10.1007/s00040-013-0306-6; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Schulte C, 2014, P NATL ACAD SCI USA, V111, P9003, DOI 10.1073/pnas.1402341111; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Smith J. M., 1997, MAJOR TRANSITIONS EV; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Ulrich Y, 2015, INFECT GENET EVOL, V32, P348, DOI 10.1016/j.meegid.2015.04.002; Ulrich Y, 2012, P ROY SOC B-BIOL SCI, V279, P2982, DOI 10.1098/rspb.2012.0474; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	64	139	141	8	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					727	+		10.1016/j.cell.2017.07.001	http://dx.doi.org/10.1016/j.cell.2017.07.001			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802042	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000407445700013
J	Chertoff, J				Chertoff, Jason			Prisoner of My Preconceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; SYSTEM		[Chertoff, Jason] Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Gainesville, FL 32608 USA	State University System of Florida; University of Florida	Chertoff, J (corresponding author), Univ Florida, Coll Med, 1600 SW Archer Rd, Gainesville, FL 32608 USA.	jason.chertoff@medicine.ufl.edu						Kendig NE, 2016, JAMA-J AM MED ASSOC, V316, P387, DOI 10.1001/jama.2016.7651; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P423, DOI 10.1001/jama.292.4.423; Mueller KJ, 2008, JAMA-J AM MED ASSOC, V300, P2067, DOI [10.1001/jama.2008.545, DOI 10.1001/JAMA.2008.545]; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485	4	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					521	522		10.1001/jama.2017.5177	http://dx.doi.org/10.1001/jama.2017.5177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787510				2022-12-28	WOS:000407160100013
J	Kupferschmidt, K				Kupferschmidt, Kai			DISEASE ECOLOGY Anthrax cousin wreaks havoc in the rainforest	SCIENCE			English	News Item																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					438	439		10.1126/science.357.6350.438	http://dx.doi.org/10.1126/science.357.6350.438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774908				2022-12-28	WOS:000406840100013
J	Mramba, L; Ngari, M; Mwangome, M; Muchai, L; Bauni, E; Walker, AS; Gibb, DM; Fegan, G; Berkley, JA				Mramba, Lazarus; Ngari, Moses; Mwangome, Martha; Muchai, Lilian; Bauni, Evasius; Walker, A. Sarah; Gibb, Diana M.; Fegan, Gregory; Berkley, James A.			A growth reference for mid upper arm circumference for age among school age children and adolescents, and validation for mortality: growth curve construction and longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NUTRITIONAL-STATUS; RETROSPECTIVE COHORT; MUSCLE AREA; ANTHROPOMETRY; MALNUTRITION; HIV; OVERWEIGHT; MENARCHE; WEIGHT; HEIGHT	OBJECTIVES To construct growth curves for mid-upper-arm circumference (MUAC)-for-age z score for 5-19 year olds that accord with the World Health Organization growth standards, and to evaluate their discriminatory performance for subsequent mortality. DESIGN Growth curve construction and longitudinal cohort study. SETTING United States and international growth data, and cohorts in Kenya, Uganda, and Zimbabwe. PARTICIPANTS The Health Examination Survey (HES)/National Health and Nutrition Examination Survey (NHANES) US population datasets (age 5-25 years), which were used to construct the 2007 WHO growth reference for body mass index in this age group, were merged with an imputed dataset matching the distribution of the WHO 2006 growth standards age 2-6 years. Validation data were from 685 HIV infected children aged 5-17 years participating in the Antiretroviral Research for Watoto (ARROW) trial in Uganda and Zimbabwe; and 1741 children aged 5-13 years discharged from a rural Kenyan hospital (3.8% HIV infected). Both cohorts were followed-up for survival during one year. MAIN OUTCOME MEASURES Concordance with WHO 2006 growth standards at age 60 months and survival during one year according to MUAC-for-age and body mass index-for-age z scores. RESULTS The new growth curves transitioned smoothly with WHO growth standards at age 5 years. MUAC-forage z scores of -2 to -3 and less than-3, compared with -2 or more, was associated with hazard ratios for death within one year of 3.63 (95% confidence interval 0.90 to 14.7; P=0.07) and 11.1 (3.40 to 36.0; P<0.001), respectively, among ARROW trial participants; and 2.22 (1.01 to 4.9; P=0.04) and 5.15 (2.49 to 10.7; P<0.001), respectively, among Kenyan children after discharge from hospital. The AUCs for MUAC-for-age and body mass index-for-age z scores for discriminating subsequent mortality were 0.81 (95% confidence interval 0.70 to 0.92) and 0.75 (0.63 to 0.86) in the ARROW trial (absolute difference 0.06, 95% confidence interval -0.032 to 0.16; P=0.2) and 0.73 (0.65 to 0.80) and 0.58 (0.49 to 0.67), respectively, in Kenya (absolute difference in AUC 0.15, 0.07 to 0.23; P=0.0002). CONCLUSIONS The MUAC-for-age z score is at least as effective as the body mass index-for-age z score for assessing mortality risks associated with undernutrition among African school aged children and adolescents. MUAC can provide simplified screening and diagnosis within nutrition and HIV programmes, and in research.	[Mramba, Lazarus] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Ngari, Moses; Mwangome, Martha; Muchai, Lilian; Bauni, Evasius; Fegan, Gregory; Berkley, James A.] KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya; [Ngari, Moses; Berkley, James A.] Childhood Acute Illness & Nutr CHAIN Network, Nairobi, Kenya; [Muchai, Lilian] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Walker, A. Sarah; Gibb, Diana M.] UCL, MRC Clin Trials Unit, London, England; [Walker, A. Sarah; Berkley, James A.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Fegan, Gregory] Swansea Univ, Sch Med, Swansea Trials Unit, Swansea, W Glam, Wales	State University System of Florida; University of Florida; Jomo Kenyatta University of Agriculture & Technology; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Oxford; Swansea University	Berkley, JA (corresponding author), KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya.; Berkley, JA (corresponding author), Childhood Acute Illness & Nutr CHAIN Network, Nairobi, Kenya.; Berkley, JA (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	jberkley@kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Mwangome, Martha/AFO-0988-2022	Fegan, Greg W/0000-0002-2663-2765; Mwangome, Martha/0000-0003-4806-1307; Berkley, James/0000-0002-1236-849X; Ngari, Moses/0000-0001-7149-5491	Wellcome Trust; MRC; MRC [MC_UU_12023/26, MR/N021940/1, MR/M007367/1] Funding Source: UKRI; Medical Research Council [MR/M007367/1, MC_UU_12023/26, MR/N021940/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure. pdf and declare: JAB has received financial support from the Wellcome Trust for the submitted work; ASW and DMG have received financial support from the MRC. All authors have no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Abrhame T, 2014, J PUBLIC HLTH BANGK, V3, P19; Addo OY, 2017, AM J CLIN NUTR, V105, P111, DOI 10.3945/ajcn.116.142190; [Anonymous], 2015, R LANG ENV STAT COMP; Bahwere P., 2017, Field Exchange - Emergency Nutrition Network ENN, P44; Bassareo PP, 2013, J PEDIATR NEONATAL I, V2, DOI 10.7363/020207; Basu D, 2010, ASIA PAC J CLIN NUTR, V19, P283; Berheto Tezera M, 2015, Rural Remote Health, V15, P3012; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRIEND A, 1987, LANCET, V2, P725; Buckler JMH, 1990, LONGITUDINAL STUDY A, DOI [10.1007/978-1-4471-1721-6, DOI 10.1007/978-1-4471-1721-6]; Chaput J-P, 2017, PEDIATR OBES, V12, P439, DOI [10.1111/ijpo.12162, 10.1111/ijpo.12]; Chesire E J, 2008, East Afr Med J, V85, P471; Chomtho S, 2006, PEDIATR RES, V59, P860, DOI 10.1203/01.pdr.0000219395.83159.91; Cicek B, 2014, J CLIN RES PEDIATR E, V6, P216, DOI [10.4274/Jcrpe.1574, 10.4274/jcrpe.1574]; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Craig E, 2014, ARCH DIS CHILD, V99, P763, DOI 10.1136/archdischild-2013-305137; Dasgupta Aparajita, 2010, Indian J Community Med, V35, P276, DOI 10.4103/0970-0218.66892; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Freedman DS, 2015, AM J CLIN NUTR, V102, P1000, DOI 10.3945/ajcn.115.115576; Generalized Additive Models for Location, 2012, SCAL AND SHAP; Gibb DM, 2013, LANCET, V381, P1391, DOI 10.1016/S0140-6736(12)62198-9; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Irena AH, 2013, AM J CLIN NUTR, V98, P335, DOI 10.3945/ajcn.112.055095; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Kalanda BF, 2006, ACTA OBSTET GYN SCAN, V85, P33, DOI 10.1080/00016340500334869; Katz J, 2010, MATERN CHILD NUTR, V6, P287, DOI 10.1111/j.1740-8709.2009.00211.x; Kulathinal S, 2016, NUTR RES, V36, P835, DOI 10.1016/j.nutres.2016.04.007; Ledwaba KR, 2014, ANN PEDIAT CHILD HLT, V2, P1026; Leenstra T, 2005, EUR J CLIN NUTR, V59, P41, DOI 10.1038/sj.ejcn.1602031; Lu Q, 2014, PEDIATR NEONATOL, V55, P14, DOI 10.1016/j.pedneo.2013.05.004; Majaliwa ES, 2009, J ENDOCRINOL INVEST, V32, P85, DOI 10.1007/BF03345686; Malala Fund Blog, 2015, SYRIA CRISIS IS TAKI; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235; Mounir Gehan M, 2007, J Egypt Public Health Assoc, V82, P239; Musoke P, 2015, AIDS, V29, P1623, DOI [10.1097/QAD.0000000000000749, 10.1097/QAD.0000000000000590]; Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009; Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Neumann CG, 2013, BRIT J NUTR, V109, P1230, DOI 10.1017/S0007114512003121; NHANES I, 1971, CDC NAT CTR HLTH STA; PELLETIER DL, 1994, J NUTR, V124, pS2047; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; PROOS LA, 1993, HORM RES, V39, P18, DOI 10.1159/000182781; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rah JH, 2009, J HEALTH POPUL NUTR, V27, P802; Ramlal RT, 2012, NUTR CLIN PRACT, V27, P416, DOI 10.1177/0884533611435991; Ramoshaba N. E., 2015, Journal of Obesity & Weight Loss Therapy, V5, P243; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Simondon KB, 1997, ANN HUM BIOL, V24, P521, DOI 10.1080/03014469700005282; Sunguya BF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-869; Tang AM, 2013, USE CUTOFFS MID UPPE; Tong F, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0062-6; UNICEF, 2012, SCH DAD REF CAMPS; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Woodruff BA, 2002, EUR J CLIN NUTR, V56, P1108, DOI 10.1038/sj.ejcn.1601456	61	43	44	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2017	358								j3423	10.1136/bmj.j3423	http://dx.doi.org/10.1136/bmj.j3423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CI	28774873	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000407207000002
J	Humphreys, K				Humphreys, Keith			Avoiding globalisation of the prescription opioid epidemic	LANCET			English	Editorial Material							UNITED-STATES; DRUG		[Humphreys, Keith] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94550 USA; [Humphreys, Keith] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94035 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Humphreys, K (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94550 USA.; Humphreys, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94035 USA.	knh@stanford.edu			US Veterans Health Services Research and Development Service; Stanford Neurosciences Institute	US Veterans Health Services Research and Development Service; Stanford Neurosciences Institute	I have received grants from the US Veterans Health Services Research and Development Service and Stanford Neurosciences Institute. I declare no other competing interests. This Comment is an expression of personal opinion that does not necessarily reflect the official views of the funders. I am grateful to Benedikt Fischer, David Juurlink, Kristy Nielsen, and Peter Reuter for their suggestions on this Comment.	Balko R., 2012, HUFFINGTON POST; Clark K, 2017, COMMUNICATION; Fischer B, 2017, DRUG ALC REV; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Humphreys K, 2015, HEALTH AFFAIR, V34, P1624, DOI 10.1377/hlthaff.2015.0934; Lamas D, 2012, NEW ENGL J MED, V366, P199, DOI 10.1056/NEJMp1113622; Lembke A, 2016, DOCTORS WERE DUPED P; Lembke A, 2016, AM FAM PHYSICIAN, V93, P982; Lopez G., 2017, VOX             0420; Meier Barry, 2007, NY TIMES; National Institute on Drug Abuse, 2022, OV DEATH RAT; Ostrowksi J., 1989, THINKING DRUG LEGALI; Quinones S., 2015, DREAMLAND TRUE TALE; Robbins R., 2016, STAT NEWS       0309; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Ryan H., 2016, LOS ANGELES TIMES; United Nations International Narcotics Control Board, 2016, NARC DRUGS EST WORLD; US Centers for Disease Control and Prevention, 2016, PRESCR OP OV DAT; US Food and Drug Administration, 2017, FDA REQ REM OP ER RI; Whyte LE, 2016, ASSOCIATED PRES 1215; Zeller S., 2017, COMMONWEALTH	21	68	68	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					437	439		10.1016/S0140-6736(17)31918-9	http://dx.doi.org/10.1016/S0140-6736(17)31918-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB9MO	28792397				2022-12-28	WOS:000406463400008
J	Cardesa, JI; Vela-Martin, A; Jimenez, J				Cardesa, Jose I.; Vela-Martin, Alberto; Jimenez, Javier			The turbulent cascade in five dimensions	SCIENCE			English	Article							ISOTROPIC TURBULENCE; ENERGY-TRANSFER; STATISTICS	To the naked eye, turbulent flows exhibit whirls of many different sizes. To each size, or scale, corresponds a fraction of the total energy resulting from a cascade in five dimensions: scale, time, and three-dimensional space. Understanding this process is critical to strategies for modeling geophysical and industrial flows. By tracking the flow regions containing energy in different scales, we have detected the statistical predominance of a cross-scale link whereby fluid lumps of energy at scale D appear within lumps of scale 2D and die within those of scale Delta/2. Our approach uncovers the energy cascade in a simple water-like fluid, offering insights for turbulence models while paving the way for similar analyses in conducting fluids, quantum fluids, and plasmas.	[Cardesa, Jose I.; Vela-Martin, Alberto; Jimenez, Javier] Univ Politecn Madrid, Sch Aeronaut, Madrid 28040, Spain	Universidad Politecnica de Madrid	Cardesa, JI (corresponding author), Univ Politecn Madrid, Sch Aeronaut, Madrid 28040, Spain.	ji.cardesa@upm.es	jimenez, javier/A-6691-2008	jimenez, javier/0000-0003-0755-843X; Cardesa, Jose I./0000-0002-3863-5285; Vela-Martin, Alberto/0000-0003-4561-8683	project COTURB (Coherent Structures in Wall-bounded Turbulence) of the European Research Council	project COTURB (Coherent Structures in Wall-bounded Turbulence) of the European Research Council	We thank A. Lozano-Duran for providing the code for the tracking of flow structures. All authors acknowledge funding from project COTURB (Coherent Structures in Wall-bounded Turbulence) of the European Research Council. The data for this study were obtained using the DECI-PRACE (Distributed European Computing Initiative-Partnership for Advanced Computing in Europe) resource Minotauro, based in Spain at the Barcelona Supercomputing Centre. M. P. Encinar helped with making the data public. The flow fields are freely available from our online database at https://torroja.dmt.upm.es/turbdata/Isotropic.	Aluie H, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3266948; Aoyama T, 2005, J PHYS SOC JPN, V74, P3202, DOI 10.1143/JPSJ.74.3202; Benedict LH, 1996, EXP FLUIDS, V22, P129, DOI 10.1007/s003480050030; Cardesa JI, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4935812; Cerutti S, 1998, PHYS FLUIDS, V10, P928, DOI 10.1063/1.869615; Davidson PA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.214501; DOMARADZKI JA, 1993, PHYS FLUIDS A-FLUID, V5, P1747, DOI 10.1063/1.858850; Eyink GL, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3266883; HEISENBERG W, 1948, Z PHYS, V124, P628, DOI 10.1007/BF01668899; Hill RJ, 2002, J FLUID MECH, V468, P317, DOI 10.1017/S0022112002001696; Kolmogorov A.N., 1941, DOKL AKAD NAUK SSSR, V30, P299, DOI DOI 10.1098/RSPA.1991.0075; KRAICHNAN RH, 1959, J FLUID MECH, V5, P497, DOI 10.1017/S0022112059000362; KRAICHNAN RH, 1971, J FLUID MECH, V47, P525, DOI 10.1017/S0022112071001216; LEITH CE, 1967, PHYS FLUIDS, V10, P1409, DOI 10.1063/1.1762300; Lozano-Duran A, 2014, J FLUID MECH, V759, DOI 10.1017/jfm.2014.575; MENEVEAU C, 1994, PHYS FLUIDS, V6, P2820, DOI 10.1063/1.868170; Moisy F, 2004, J FLUID MECH, V513, P111, DOI 10.1017/S0022112004009802; Navon N, 2016, NATURE, V539, P72, DOI 10.1038/nature20114; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V32, P22; Onsager L., 1949, NUOVO CIM, V6, P279, DOI [DOI 10.1007/BF02780991, 10.1007/BF02780991]; Perez JC, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041005; PIOMELLI U, 1991, PHYS FLUIDS A-FLUID, V3, P1766, DOI 10.1063/1.857956; Proudman I., 1954, PHIL T R SOC LOND A, V247, P163, DOI DOI 10.1098/RSTA.1954.0016; Richardson L.F., 1922, WEATHER PREDICTION N, DOI DOI 10.1017/CBO9780511618291; Sagaut P., 2006, LARGE EDDY SIMULATIO, Vthird, P558, DOI [10.1007/b137536, DOI 10.1007/3-540-26403-5_3]; TATSUMI T, 1957, PROC R SOC LON SER-A, V239, P16, DOI 10.1098/rspa.1957.0020; Wan M, 2016, PHYS PLASMAS, V23, DOI 10.1063/1.4945631; Wan MP, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3447887; Weizsacker C. F., 1948, Z PHYS, V124, P614; YEUNG PK, 1991, PHYS FLUIDS A-FLUID, V3, P884, DOI 10.1063/1.857966	30	59	63	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					782	+		10.1126/science.aan7933	http://dx.doi.org/10.1126/science.aan7933			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28818968	Green Submitted			2022-12-28	WOS:000408327900038
J	Ma, H; Marti-Gutierrez, N; Park, SW; Wu, J; Lee, Y; Suzuki, K; Koski, A; Ji, DM; Hayama, T; Ahmed, R; Darby, H; Van Dyken, C; Li, Y; Kang, E; Park, AR; Kim, D; Kim, ST; Gong, JH; Gu, Y; Xu, X; Battaglia, D; Krieg, SA; Lee, DM; Wu, DH; Wolf, DP; Heitner, SB; Belmonte, JCI; Mato, PA; Kim, JS; Kaul, S; Mitalipov, S				Ma, Hong; Marti-Gutierrez, Nuria; Park, Sang-Wook; Wu, Jun; Lee, Yeonmi; Suzuki, Keiichiro; Koski, Amy; Ji, Dongmei; Hayama, Tomonari; Ahmed, Riffat; Darby, Hayley; Van Dyken, Crystal; Li, Ying; Kang, Eunju; Park, A. -Reum; Kim, Daesik; Kim, Sang-Tae; Gong, Jianhui; Gu, Ying; Xu, Xun; Battaglia, David; Krieg, Sacha A.; Lee, David M.; Wu, Diana H.; Wolf, Don P.; Heitner, Stephen B.; Belmonte, Juan Carlos Izpisua; Mato, Paula A.; Kim, Jin-Soo; Kaul, Sanjiv; Mitalipov, Shoukhrat			Correction of a pathogenic gene mutation in human embryos	NATURE			English	Article							RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; PRIMATE EMBRYOS; DIGENOME-SEQ; CAS9; CRISPR-CAS9; NUCLEASES; MOUSE; DNA; ZYGOTES	Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.	[Ma, Hong; Marti-Gutierrez, Nuria; Lee, Yeonmi; Koski, Amy; Ji, Dongmei; Hayama, Tomonari; Ahmed, Riffat; Darby, Hayley; Van Dyken, Crystal; Li, Ying; Kang, Eunju; Battaglia, David; Wolf, Don P.; Mato, Paula A.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest,Bond Ave, Portland, OR 97239 USA; [Park, Sang-Wook; Park, A. -Reum; Kim, Sang-Tae; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, 70 Yuseong Daero 1689 Gil, Daejeon 34047, South Korea; [Wu, Jun; Suzuki, Keiichiro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Kim, Daesik; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, 599 Gwanak Ro, Seoul 151747, South Korea; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Shenzhen, Bldg 11, Shenzhen 518083, Peoples R China; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Shenzhen, China Natl GeneBank, Jinsha Rd, Shenzhen 518210, Peoples R China; [Gong, Jianhui; Gu, Ying; Xu, Xun] BGI Qingdao, 2877 Tuanjie Rd,Sino German Ecopk, Qingdao 266000, Peoples R China; [Gong, Jianhui] BGI Shenzhen, Shenzhen Engn Lab Innovat Mol Diagnost, Bldg 11, Shenzhen 518083, Peoples R China; [Battaglia, David; Krieg, Sacha A.; Lee, David M.; Wu, Diana H.; Mato, Paula A.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 3303 Southwest,Bond Ave, Portland, OR 97239 USA; [Heitner, Stephen B.; Kaul, Sanjiv; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 Southwest,Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University; Institute for Basic Science - Korea (IBS); Salk Institute; Seoul National University (SNU); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Oregon Health & Science University; Oregon Health & Science University	Mato, PA; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest,Bond Ave, Portland, OR 97239 USA.; Kim, JS (corresponding author), Inst for Basic Sci Korea, Ctr Genome Engn, 70 Yuseong Daero 1689 Gil, Daejeon 34047, South Korea.; Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, 599 Gwanak Ro, Seoul 151747, South Korea.; Mato, PA (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 3303 Southwest,Bond Ave, Portland, OR 97239 USA.; Kaul, S; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 Southwest,Sam Jackson Pk Rd, Portland, OR 97239 USA.	belmonte@salk.edu; amatop@ohsu.edu; jskim01@snu.ac.kr; kauls@ohsu.edu; mitalipo@ohsu.edu	KIM, Jin-Soo/M-6918-2013; Kim, Daesik/AFH-7798-2022; Kim, Sang-Tae/U-9457-2018; Wu, Jun/AAF-1830-2019; Kim, Sang-Tae/X-8917-2019; Xu, Xun/AAI-6763-2020	KIM, Jin-Soo/0000-0003-4847-1306; Kim, Sang-Tae/0000-0003-1645-6021; Wu, Jun/0000-0001-9863-1668; Kim, Sang-Tae/0000-0003-1645-6021; Xu, Xun/0000-0002-5338-5173	OHSU institutional funds; Institute for Basic Science [IBS-R021-D1]; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Shenzhen Municipal Government of China [DRC-SZ [2016] 884]	OHSU institutional funds; Institute for Basic Science; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Shenzhen Municipal Government of China	We acknowledge the OHSU Institutional Review Board (IRB), Innovative Research Advisory Panel (IRAP), Scientific Review Committee (SRC) and Data Safety Monitoring Committee (DSMC) for oversight and guidance on this study. We thank all study participants for tissue donations; the Women's Health Research Unit staff, IVF laboratory staff, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology, OHSU for support and procurement of human gametes; S. Olson and Research Cytogenetics Laboratory at OHSU for cytogenetic analysis of ES cells; S. Cooper from the Wallace Division of Smiths Medical for donating ICSI and gamete manipulation micropipettes; Y. Wang, T. Wu and Y. Shen from BGI-Shenzhen for help with sample preparation, sequencing and data analyses; M. Ku from the H. A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core of the Salk Institute for next generation sequencing; and E. Aizawa and R. HernandezBenitez from the laboratory of JCIB for assistance. Studies conducted at OHSU were supported by OHSU institutional funds. Work in the laboratory of J.-S. K. was supported by the Institute for Basic Science (IBS-R021-D1). Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Moxie Foundation and the Leona M. and Harry B. Helmsley Charitable Trust. Work at BGI was supported by the Shenzhen Municipal Government of China (DRC-SZ [2016] 884).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Capmany G, 1996, MOL HUM REPROD, V2, P299, DOI 10.1093/molehr/2.5.299; Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guo XY, 2015, CELL RES, V25, P767, DOI 10.1038/cr.2015.64; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Luo Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004730; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlossarek S, 2011, J MOL CELL CARDIOL, V50, P613, DOI 10.1016/j.yjmcc.2011.01.014; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Tennakoon C, 2012, BIOINFORMATICS, V28, P2122, DOI 10.1093/bioinformatics/bts339; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016	48	562	596	16	763	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					413	+		10.1038/nature23305	http://dx.doi.org/10.1038/nature23305			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28783728	Bronze			2022-12-28	WOS:000408279000030
J	Pei, WK; Feyerabend, TB; Rossler, J; Wang, X; Postrach, D; Busch, K; Rode, I; Klapproth, K; Dietlein, N; Quedenau, C; Chen, W; Sauer, S; Wolf, S; Hofer, T; Rodewald, HR				Pei, Weike; Feyerabend, Thorsten B.; Rossler, Jens; Wang, Xi; Postrach, Daniel; Busch, Katrin; Rode, Immanuel; Klapproth, Kay; Dietlein, Nikolaus; Quedenau, Claudia; Chen, Wei; Sauer, Sascha; Wolf, Stephan; Hoefer, Thomas; Rodewald, Hans-Reimer			Polylox barcoding reveals haematopoietic stem cell fates realized in vivo	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; LINEAGE COMMITMENT; CLONAL ANALYSIS; EXPRESSION; GENE; PROGENITORS; SYSTEM; DIFFERENTIATION; PRECURSORS; RESOURCES	Developmental deconvolution of complex organs and tissues at the level of individual cells remains challenging. Non-invasive genetic fate mapping(1) has been widely used, but the low number of distinct fluorescent marker proteins limits its resolution. Much higher numbers of cell markers have been generated using viral integration sites(2), viral barcodes(3), and strategies based on transposons(4) and CRISPR-Cas9 genome editing(5); however, temporal and tissue-specific induction of barcodes in situ has not been achieved. Here we report the development of an artificial DNA recombination locus (termed Polylox) that enables broadly applicable endogenous barcoding based on the Cre-loxP recombination system(6,7). Polylox recombination in situ reaches a practical diversity of several hundred thousand barcodes, allowing tagging of single cells. We have used this experimental system, combined with fate mapping, to assess haematopoietic stem cell (HSC) fates in vivo. Classical models of haematopoietic lineage specification assume a tree with few major branches. More recently, driven in part by the development of more efficient single-cell assays and improved transplantation efficiencies, different models have been proposed, in which unilineage priming may occur in mice and humans at the level of HSCs8-10. We have introduced barcodes into HSC progenitors in embryonic mice, and found that the adult HSC compartment is a mosaic of embryo-derived HSC clones, some of which are unexpectedly large. Most HSC clones gave rise to multilineage or oligolineage fates, arguing against unilineage priming, and suggesting coherent usage of the potential of cells in a clone. The spreading of barcodes, both after induction in embryos and in adult mice, revealed a basic split between common myeloid-erythroid development and common lymphocyte development, supporting the long-held but contested view of a tree-like haematopoietic structure.	[Pei, Weike; Feyerabend, Thorsten B.; Postrach, Daniel; Busch, Katrin; Rode, Immanuel; Klapproth, Kay; Dietlein, Nikolaus; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Rossler, Jens; Wang, Xi; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Wang, Xi; Quedenau, Claudia; Chen, Wei; Sauer, Sascha] Max Delbruck Ctr, Sci Genom Platforms BIMSB BIH, D-13125 Berlin, Germany; [Wolf, Stephan] German Canc Res Ctr, Genom Facil, D-69120 Heidelberg, Germany; [Wolf, Stephan] German Canc Res Ctr, Prote Core Facil, D-69120 Heidelberg, Germany; [Hoefer, Thomas] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany.; Hofer, T (corresponding author), German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany.; Hofer, T (corresponding author), Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany.	t.hoefer@dkfz.de; hr.rodewald@dkfz.de	Wang, Xi/N-9527-2014; Höfer, Thomas/G-5665-2013; chen, wei/AFV-4999-2022	Wang, Xi/0000-0002-7572-6354; Höfer, Thomas/0000-0003-3560-8780; 	CellNetworks; DKFZ; e:Bio BMBF project [FKZ 0316182B]; ERC [742883];  [Transregio 156-A07];  [SFB 873-B11]	CellNetworks; DKFZ(Helmholtz Association); e:Bio BMBF project; ERC(European Research Council (ERC)European Commission); ; 	We thank J. Muehling, S. Oh, C. Heiner, P. Lobb, R. Lleras and C. Koenig (Pacific Biosciences), E. Hobeika (Ulm), S. Schafer, T. Grunzinger (DKFZ), K. Reifenberg, M. Socher, A. Frenznick (Animal Facility DKFZ), F. v. der Hoeven, U. Kloz (Transgenic Service DKFZ), and N. Diessl, C. Previti and S. Wiemann (Genomics & Proteomics Core Facilities DKFZ) for help, and R. Hoess, H. Glimm and K. Rajewsky for discussions. T. H. is supported by CellNetworks, DKFZ core funding and e:Bio BMBF project FKZ 0316182B (SB-Epo); T.B.F. and H.-R.R. are supported by Transregio 156-A07; H.-R.R. is supported by SFB 873-B11, ERC Advanced Grant 742883, and DKFZ core funding.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; HOESS R, 1985, GENE, V40, P325, DOI 10.1016/0378-1119(85)90056-3; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Junker J. P., 2017, MASSIVELY PARALLEL C; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Pei W., 2017, PROTOC EXCH; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rybtsov S, 2016, DEVELOPMENT, V143, P1284, DOI 10.1242/dev.131193; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schoedel KB, 2016, BLOOD, V128, P2285, DOI 10.1182/blood-2016-03-706010; Sheikh BN, 2016, BLOOD, V128, P2307, DOI 10.1182/blood-2015-10-676072; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weber TS, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0290-3; Weissman TA, 2015, GENETICS, V199, P293, DOI 10.1534/genetics.114.172510; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	33	213	215	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					456	+		10.1038/nature23653	http://dx.doi.org/10.1038/nature23653			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813413	Green Accepted			2022-12-28	WOS:000408279000039
J	Hay, AD; Little, P; Harnden, A; Thompson, M; Wang, K; Kendrick, D; Orton, E; Brookes, ST; Young, GJ; May, M; Hollinghurst, S; Carroll, FE; Downing, H; Timmins, D; Lafond, N; El-Gohary, M; Moore, M				Hay, Alastair D.; Little, Paul; Harnden, Anthony; Thompson, Matthew; Wang, Kay; Kendrick, Denise; Orton, Elizabeth; Brookes, Sara T.; Young, Grace J.; May, Margaret; Hollinghurst, Sandra; Carroll, Fran E.; Downing, Harriet; Timmins, David; Lafond, Natasher; El-Gohary, Magdy; Moore, Michael			Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; PRIMARY-CARE; ANTIBIOTIC USE; METAANALYSIS; CORTICOSTEROIDS; PNEUMONIA	IMPORTANCE Acute lower respiratory tract infection is common and often treated inappropriately in primary care with antibiotics. Corticosteroids are increasingly used but without sufficient evidence. OBJECTIVE To assess the effects of oral corticosteroids for acute lower respiratory tract infection in adults without asthma. DESIGN, SETTING, AND PARTICIPANTS Multicenter, placebo-controlled, randomized trial (July 2013 to final follow-up October 2014) conducted in 54 family practices in England among 401 adults with acute cough and at least 1 lower respiratory tract symptom not requiring immediate antibiotic treatment and with no history of chronic pulmonary disease or use of asthma medication in the past 5 years. INTERVENTIONS Two 20-mg prednisolone tablets (n = 199) or matched placebo (n = 202) once daily for 5 days. MAIN OUTCOMES AND MEASURES The primary outcomes were duration of moderately bad or worse cough (0 to 28 days; minimal clinically important difference, 3.79 days) and mean severity of symptoms on days 2 to 4 (scored from 0 [not affected] to 6 [as bad as it could be]; minimal clinically important difference, 1.66 units). Secondary outcomes were duration and severity of acute lower respiratory tract infection symptoms, duration of abnormal peak flow, antibiotic use, and adverse events. RESULTS Among 401 randomized patients, 2 withdrew immediately after randomization, and 1 duplicate patient was identified. Among the 398 patients with baseline data (mean age, 47 [SD, 16.0] years; 63% women; 17% smokers; 77% phlegm; 70% shortness of breath; 47% wheezing; 46% chest pain; 42% abnormal peak flow), 334 (84%) provided cough duration and 369 (93%) symptom severity data. Median cough duration was 5 days (interquartile range [IQR], 3-8 days) in the prednisolone group and 5 days (IQR, 3-10 days) in the placebo group (adjusted hazard ratio, 1.11; 95% CI, 0.89-1.39; P = .36 at an alpha = .05). Mean symptom severity was 1.99 points in the prednisolone group and 2.16 points in the placebo group (adjusted difference, -0.20; 95% CI, -0.40 to 0.00; P = .05 at an alpha= .001). No significant treatment effects were observed for duration or severity of other acute lower respiratory tract infection symptoms, duration of abnormal peak flow, antibiotic use, or nonserious adverse events. There were no serious adverse events. CONCLUSIONS AND RELEVANCE Oral corticosteroids should not be used for acute lower respiratory tract infection symptoms in adults without asthma because they do not reduce symptom duration or severity.	[Hay, Alastair D.; Hollinghurst, Sandra; Downing, Harriet] Univ Bristol, Ctr Acad Primary Care, NIHR Sch Primary Care Res, Populat Hlth Sci,Bristol Med Sch, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England; [Little, Paul; El-Gohary, Magdy; Moore, Michael] Univ Southampton, Aldermoor Hlth Ctr, Primary Care & Populat Sci, NIHR Sch Primary Care Res,Fac Med, Southampton, Hants, England; [Harnden, Anthony; Wang, Kay; Timmins, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, NIHR Sch Primary Care Res, Oxford, England; [Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Kendrick, Denise; Orton, Elizabeth; Lafond, Natasher] Univ Nottingham, Div Primary Care, NIHR Sch Primary Care Res, Sch Med, Nottingham, England; [Brookes, Sara T.; May, Margaret] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Young, Grace J.] Univ Bristol, Bristol Randomised Trials Collaborat, Populat Hlth Sci, Bristol Med Sch, Bristol, Avon, England; [Carroll, Fran E.] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Bristol, Avon, England	University of Bristol; University of Southampton; University of Oxford; University of Washington; University of Washington Seattle; University of Nottingham; University of Bristol; University of Bristol; University of Bristol	Hay, AD (corresponding author), Univ Bristol, Ctr Acad Primary Care, NIHR Sch Primary Care Res, Populat Hlth Sci,Bristol Med Sch, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.	alastair.hay@bristol.ac.uk	Moore, Michael/C-3447-2011; Orton, Elizabeth/AAI-1377-2021; Hay, Alastair/L-1818-2019	Moore, Michael/0000-0002-5127-4509; Orton, Elizabeth/0000-0002-2531-8846; Hay, Alastair/0000-0003-3012-375X; Kendrick, Denise/0000-0003-3603-6542; Little, Paul/0000-0003-3664-1873	National Institute for Health Research (NIHR) School for Primary Care Research [117a]; NIHR Research Professorship [NIHR-RP-02-12-012]; University of Bristol; National Institute for Health Research [NIHR-IPF-2013-07-08, CL-2012-13-002, CDF-2009-02-10, ACF-2010-26-003, RP-PG-0608-10018] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR)); NIHR Research Professorship; University of Bristol; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) School for Primary Care Research (grant reference 117a). Dr Hay is funded by an NIHR Research Professorship (NIHR-RP-02-12-012). The study sponsor was the University of Bristol.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 2013, STAT COMP PROGR VERS; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; BARDIN PG, 1995, INT ARCH ALLERGY IMM, V107, P127, DOI 10.1159/000236951; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Bjermer L, 2014, RESP MED, V108, P830, DOI 10.1016/j.rmed.2014.02.005; British Thoracic Network/Scottish Intercollegiate Guidelines Network, 2016, BRIT GUID MAN ASTHM; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; CDC, 2014, NAT STRAT COMB ANT R; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Department of Health, 2013, IL 5 YEAR ANT RES ST; Ebell MH, 2015, AM J MANAG CARE, V21, pE567; El-Gohary M, 2013, FAM PRACT, V30, P492, DOI 10.1093/fampra/cmt034; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 2000, ANN INTERN MED, V133, P981, DOI 10.7326/0003-4819-133-12-200012190-00014; Hayward G, 2012, ANN FAM MED, V10, P241, DOI 10.1370/afm.1338; Hayward G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2976; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; National Institute for Health and Clinical Excellence, 2008, RESP TRACT INF RESCR; Office for National Statistics, 2014, NAT STAT NAT POP PRO; Public Health England, 2015, ENGL SURV PROGR ANT; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; RUSSELL K, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001955.PUB2; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; Venekamp RP, 2012, CAN MED ASSOC J, V184, pE751, DOI 10.1503/cmaj.120430; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Welch C, 2014, STATA J, V14, P418, DOI 10.1177/1536867X1401400213; World Health Organization, 2016, ANTIMICROBIAL RESIST; Zalmanovici A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub2	35	25	25	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					721	730		10.1001/jama.2017.10572	http://dx.doi.org/10.1001/jama.2017.10572			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829884	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000408095800023
J	Slomski, A				Slomski, Anita			Exercise Therapy Offers Modest Benefits for Chronic Fatigue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					690	690		10.1001/jama.2017.10993	http://dx.doi.org/10.1001/jama.2017.10993			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829873				2022-12-28	WOS:000408095800008
J	Slomski, A				Slomski, Anita			Stereotactic Radiotherapy Is Superior for Benign Brain Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					690	690		10.1001/jama.2017.10995	http://dx.doi.org/10.1001/jama.2017.10995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829874				2022-12-28	WOS:000408095800009
J	Alfieri, O; Buzzatti, N				Alfieri, Ottavio; Buzzatti, Nicola			Expansion of the treatment toolbox for mitral regurgitation	LANCET			English	Editorial Material							REPAIR; OUTCOMES; REGISTRY; SURGERY		[Alfieri, Ottavio; Buzzatti, Nicola] Ist Sci San Raffaele, Dept Cardiac Surg, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Alfieri, O (corresponding author), Ist Sci San Raffaele, Dept Cardiac Surg, I-20132 Milan, Italy.	alfieri.ottavio@hsr.it						Alfieri O, 2015, EDGE TO EDGE MITRAL; Boekstegers P, 2014, CLIN RES CARDIOL, V103, P85, DOI 10.1007/s00392-013-0614-x; Buzzatti N, 2016, J THORAC CARDIOV SUR, V151, P88, DOI 10.1016/j.jtcvs.2015.09.099; d'Arcy JL, 2016, EUR HEART J, V37, P3515, DOI 10.1093/eurheartj/ehw229; Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018; Grasso C, 2013, AM J CARDIOL, V111, P1482, DOI 10.1016/j.amjcard.2013.01.300; Lesevic H, 2017, AM J CARDIOL, V119, P1255, DOI 10.1016/j.amjcard.2016.12.027; Maisano F, 2015, EUR HEART J, V36, P1651, DOI 10.1093/eurheartj/ehv123; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001; Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166; Praz F, 2017, LANCET, V390, P773, DOI 10.1016/S0140-6736(17)31600-8; Puls M, 2016, EUR HEART J, V37, P703, DOI 10.1093/eurheartj/ehv627; Sorajja P, 2016, J AM COLL CARDIOL, V67, P1129, DOI 10.1016/j.jacc.2015.12.054	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					722	724		10.1016/S0140-6736(17)31797-X	http://dx.doi.org/10.1016/S0140-6736(17)31797-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28831982				2022-12-28	WOS:000407858900007
J	Qiu, CW; Yang, YJ				Qiu, Cheng-Wei; Yang, Yuanjie			Vortex generation reaches a new plateau	SCIENCE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM; VORTICES; LIGHT		[Qiu, Cheng-Wei; Yang, Yuanjie] Natl Univ Singapore, Dept Elect & Comp Engn, 4 Engn Dr 3, Singapore 117583, Singapore	National University of Singapore	Qiu, CW (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, 4 Engn Dr 3, Singapore 117583, Singapore.	eleqc@nus.edu.sg	Qiu, Cheng-Wei/AAI-6274-2021		National Research Foundation, Prime Minister's Office, Singapore under Competitive Research Program (CRP) [NRF-CRP15-2015-03]	National Research Foundation, Prime Minister's Office, Singapore under Competitive Research Program (CRP)	The authors appreciate insightful discussions with E. Karimi, M. Padgett, Y. Kivshar, and F. Capasso and acknowledge support from the National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Program (CRP award NRF-CRP15-2015-03).	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Chong KE, 2015, NANO LETT, V15, P5369, DOI 10.1021/acs.nanolett.5b01752; Clark CW, 2015, NATURE, V525, P504, DOI 10.1038/nature15265; Harris J, 2015, NAT PHYS, V11, P629, DOI [10.1038/nphys3404, 10.1038/NPHYS3404]; Kim H, 2010, NANO LETT, V10, P529, DOI 10.1021/nl903380j; Maguid E, 2016, SCIENCE, V352, P1202, DOI 10.1126/science.aaf3417; Miao P, 2016, SCIENCE, V353, P464, DOI 10.1126/science.aaf8533; Spektor G, 2017, SCIENCE, V355, P1187, DOI 10.1126/science.aaj1699; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	11	42	42	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					645	645		10.1126/science.aan6359	http://dx.doi.org/10.1126/science.aan6359			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818929				2022-12-28	WOS:000407793600017
J	Bova, GS				Bova, G. Steven			CANCER GENOMICS Human metastases under scrutiny	NATURE			English	Editorial Material							PROSTATE-CANCER; EVOLUTION; HISTORY		[Bova, G. Steven] Univ Tampere, Prostate Canc Res Ctr, Fac Med & Life Sci, Tampere 33014, Finland; [Bova, G. Steven] Univ Tampere, BioMediTech Inst, Tampere 33014, Finland	Tampere University; Tampere University	Bova, GS (corresponding author), Univ Tampere, Prostate Canc Res Ctr, Fac Med & Life Sci, Tampere 33014, Finland.; Bova, GS (corresponding author), Univ Tampere, BioMediTech Inst, Tampere 33014, Finland.	g.steven.bova@uta.fi		Bova, George/0000-0003-1639-3104				Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Bova GS, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000752; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	13	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					287	288		10.1038/nature23535	http://dx.doi.org/10.1038/nature23535			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28783720				2022-12-28	WOS:000407748400021
J	Wellbery, C				Wellbery, Caroline			Signs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wellbery, Caroline] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA	Georgetown University	Wellbery, C (corresponding author), Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					609	611		10.1056/NEJMp1705387	http://dx.doi.org/10.1056/NEJMp1705387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813224				2022-12-28	WOS:000407691400003
J	Rowland, K				Rowland, Kate			Short-term use of oral corticosteroids was linked to increased risk for sepsis, VTE, and fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rowland, Kate] Rush Univ, Chicago, IL 60612 USA	Rush University	Rowland, K (corresponding author), Rush Univ, Chicago, IL 60612 USA.		Rowland, Kate/Q-6256-2019	Rowland, Kate/0000-0002-1383-0279				Kauh E, 2012, EUR J ENDOCRINOL, V166, P459, DOI 10.1530/EJE-11-0751	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC20	JC20		10.7326/ACPJC-2017-167-4-020	http://dx.doi.org/10.7326/ACPJC-2017-167-4-020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806801				2022-12-28	WOS:000407797500007
J	Struminger, B; Arora, S; Zalud-Cerrato, S; Lowrance, D; Ellerbrock, T				Struminger, Bruce; Arora, Sanjeev; Zalud-Cerrato, Sarah; Lowrance, David; Ellerbrock, Tedd			Building virtual communities of practice for health	LANCET			English	Editorial Material							CARE		[Struminger, Bruce; Arora, Sanjeev; Zalud-Cerrato, Sarah] Univ New Mexico, Hlth Sci Ctr, ECHO Inst, Albuquerque, NM 87102 USA; [Lowrance, David] US Ctr Dis Control & Prevent, Dar Es Salaam, Tanzania; [Ellerbrock, Tedd] US Ctr Dis Control & Prevent, Atlanta, GA USA	University of New Mexico; University of New Mexico's Health Sciences Center; Centers for Disease Control & Prevention - USA	Struminger, B (corresponding author), Univ New Mexico, Hlth Sci Ctr, ECHO Inst, Albuquerque, NM 87102 USA.	bstruminger@salud.unm.edu			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Arora S, 2011, HEALTH AFFAIR, V30, P1176, DOI 10.1377/hlthaff.2011.0278; Bramstedt KA, 2014, PROG TRANSPLANT, V24, P294, DOI 10.7182/pit2014289; Diaz-Chao A, 2014, INT J INTEGR CARE, V14; Grone O, 2001, Int J Integr Care, V1, pe21; Ikioda F, 2016, HEALTH POLICY TECHN, V5, P298, DOI 10.1016/j.hlpt.2016.02.006; Institute for Healthcare Improvement, 2003, IHI INNOVATION SERIE; Jimenez-Zarco AI, 2015, COMPUT HUM BEHAV, V51, P1303, DOI 10.1016/j.chb.2014.11.057; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Meins Alexa R., 2015, J PAIN RELIEF, V4, P177; Namibian Ministry of Health and Social Services, 2016, NAM COUNTR OP PLAN C; Portoghese I, 2014, NURSE EDUC PRACT, V14, P417, DOI 10.1016/j.nepr.2014.01.002; Poushter J, 2015, CELL PHONES AFRICA C; Sims J., 2016, TECHNOL FORECAST SOC; Wenger E, 2000, COMMUNITIES PRACTICE	15	37	37	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					632	634		10.1016/S0140-6736(17)31666-5	http://dx.doi.org/10.1016/S0140-6736(17)31666-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28816126	Green Accepted, Green Submitted			2022-12-28	WOS:000407456200007
J	Ahmadpoor, M; Jones, BF				Ahmadpoor, Mohammad; Jones, Benjamin F.			The dual frontier: Patented inventions and prior scientific advance	SCIENCE			English	Article							SCIENCE; TECHNOLOGY; INNOVATION; INDUSTRY; SEARCH; IMPACT; TEAMS; US	The extent to which scientific advances support marketplace inventions is largely unknown. We study 4.8 million U.S. patents and 32 million research articles to determine the minimum citation distance between patented inventions and prior scientific advances. We find that most cited research articles (80%) link forward to a future patent. Similarly, most patents (61%) link backward to a prior research article. Linked papers and patents typically stand 2 to 4 degrees distant from the other domain. Yet, advances directly along the patent-paper boundary are notably more impactful within their own domains. The distance metric further provides a typology of the fields, institutions, and individuals involved in science-to-technology linkages. Overall, the findings are consistent with theories that emphasize substantial and fruitful connections between patenting and prior scientific inquiry.	[Ahmadpoor, Mohammad; Jones, Benjamin F.] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Ahmadpoor, Mohammad; Jones, Benjamin F.] Northwestern Univ, Inst Complex Syst & Data Sci, Evanston, IL 60208 USA; [Jones, Benjamin F.] NBER, Cambridge, MA 02138 USA	Northwestern University; Northwestern University; National Bureau of Economic Research	Jones, BF (corresponding author), Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA.; Jones, BF (corresponding author), Northwestern Univ, Inst Complex Syst & Data Sci, Evanston, IL 60208 USA.; Jones, BF (corresponding author), NBER, Cambridge, MA 02138 USA.	bjones@kellogg.northwestern.edu		Jones, Benjamin/0000-0001-9697-9388	Alfred P. Sloan Foundation [G-2015-14014]; Northwestern Institute on Complex Systems	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Northwestern Institute on Complex Systems	We gratefully acknowledge support from the Alfred P. Sloan Foundation under award G-2015-14014 and support from the Northwestern Institute on Complex Systems. We thank workshop participants at the National Academy of Sciences, the European Policy for Intellectual Property Association, the Northwestern Institute for Complex Research, the Institute for Policy Research, P. Azoulay, A. Jaffe, A. Marco, M. Trajtenberg, and B. Uzzi for helpful comments. We are especially grateful to R. Gaetani for help with patent data. The Web of Science data are available via Thomson Reuters. The patent data sets are available publicly as discussed in the supplementary materials. The constructed D metric variables are available from the authors: bjones@kellogg.northwestern.edu (corresponding author) and mohammad.ahmadpoor@kellogg.northwestern.edu.	Arora A., 2015, 20902 NBER; Balconi M, 2010, RES POLICY, V39, P1, DOI 10.1016/j.respol.2009.09.013; BROOKS H, 1994, RES POLICY, V23, P477, DOI 10.1016/0048-7333(94)01001-3; Bryan K., 2016, IMPACT OPEN ACCESS M; Bush V., 1945, REPORT PRESIDENT U; Callaert J, 2014, SCIENTOMETRICS, V98, P1617, DOI 10.1007/s11192-013-1073-x; Carty J., 1916, REPRINT CIRCULAR SER; Cassiman B, 2008, IND CORP CHANGE, V17, P611, DOI 10.1093/icc/dtn023; Fleming L, 2004, STRATEGIC MANAGE J, V25, P909, DOI 10.1002/smj.384; Gaetani R., 2015, EC EFFECTS SCI SHOCK; Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Hicks D, 2001, RES POLICY, V30, P681, DOI 10.1016/S0048-7333(00)00147-5; Jaffe A. B., 2002, TRAJTENBERG PATENTS; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; KLEVORICK AK, 1995, RES POLICY, V24, P185, DOI 10.1016/0048-7333(93)00762-I; Landau R., 1986, POSITIVE SUM STRATEG, DOI DOI 10.1108/14601069810368485; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Maclaurin WR, 1953, Q J ECON, V67, P97, DOI 10.2307/1884150; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; Meyer M, 2000, RES POLICY, V29, P409, DOI 10.1016/S0048-7333(99)00040-2; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; National Academy of Sciences, 2010, MAN U INT PROP PUBL; National Science Foundation ( U.S.), 1957, BAS RES NAT RES; Nelson Richard R., 1962, RATE DIRECTION INVEN, P549; NELSON RR, 1959, J POLIT ECON, V67, P297, DOI 10.1086/258177; ROSENBERG N, 1994, RES POLICY, V23, P323, DOI 10.1016/0048-7333(94)90042-6; Rosenberg N., 1982, INSIDE BLACK BOX TEC, P141; SCHANKERMAN M, 1986, ECON J, V96, P1052, DOI 10.2307/2233173; Stokes D. E., 1997, PASTEURS QUADRANT BA; Thursby JG, 2003, SCIENCE, V301, P1052, DOI 10.1126/science.1087473; Tijssen RJW, 2000, SCIENTOMETRICS, V47, P389; US Department of Defense, 1969, PROJ HINDS FIN REP; von Hippel E., 1988, SOURCES INNOVATION; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	36	87	88	15	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					583	587		10.1126/science.aam9527	http://dx.doi.org/10.1126/science.aam9527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798128				2022-12-28	WOS:000407324800039
J	Clery, D				Clery, Daniel			COSMOLOGY Survey finds galaxy clumps stirred up by dark energy	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					537	538		10.1126/science.357.6351.537	http://dx.doi.org/10.1126/science.357.6351.537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798110				2022-12-28	WOS:000407324800017
J	Garcia-Seisdedos, H; Empereur-Mot, C; Elad, N; Levy, ED				Garcia-Seisdedos, Hector; Empereur-Mot, Charly; Elad, Nadav; Levy, Emmanuel D.			Proteins evolve on the edge of supramolecular self-assembly	NATURE			English	Article							ESCHERICHIA-COLI REVEALS; DE-NOVO DESIGN; CRYSTAL-STRUCTURE; ARGININE DECARBOXYLASE; COMPUTATIONAL DESIGN; AMYLOID STATE; PRINCIPLES; IMAGE; EVOLUTIONARY; INHIBITION	The self-association of proteins into symmetric complexes is ubiquitous in all kingdoms of life(1-6). Symmetric complexes possess unique geometric and functional properties, but their internal symmetry can pose a risk. In sickle-cell disease, the symmetry of haemoglobin exacerbates the effect of a mutation, triggering assembly into harmful fibrils(7). Here we examine the universality of this mechanism and its relation to protein structure geometry. We introduced point mutations solely designed to increase surface hydrophobicity among 12 distinct symmetric complexes from Escherichia coli. Notably, all responded by forming supramolecular assemblies in vitro, as well as in vivo upon heterologous expression in Saccharomyces cerevisiae. Remarkably, in four cases, micrometre-long fibrils formed in vivo in response to a single point mutation. Biophysical measurements and electron microscopy revealed that mutants self-assembled in their folded states and so were not amyloid-like. Structural examination of 73 mutants identified supramolecular assembly hot spots predictable by geometry. A subsequent structural analysis of 7,471 symmetric complexes showed that geometric hot spots were buffered chemically by hydrophilic residues, suggesting a mechanism preventing mis-assembly of these regions. Thus, point mutations can frequently trigger folded proteins to self-assemble into higher-order structures. This potential is counterbalanced by negative selection and can be exploited to design nanomaterials in living cells.	[Garcia-Seisdedos, Hector; Empereur-Mot, Charly; Levy, Emmanuel D.] Weizmann Inst Sci, Dept Biol Struct, IL-7610001 Rehovot, Israel; [Elad, Nadav] Weizmann Inst Sci, Dept Chem Res Support, IL-7610001 Rehovot, Israel; [Empereur-Mot, Charly] Conservatoire Natl Arts & Metiers, F-75003 Paris, France	Weizmann Institute of Science; Weizmann Institute of Science; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Levy, ED (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-7610001 Rehovot, Israel.	emmanuel.levy@weizmann.ac.il		Elad, Nadav/0000-0001-6222-2280; Empereur-mot, Charly/0000-0001-6972-8225; Garcia-Seisdedos, Hector/0000-0001-7722-2793	Israel Science Foundation; I-CORE Program of the Planning and Budgeting Committee [1775/12, 2179/14]; Marie Curie Career Integration Grants Program [711715]; Human Frontier Science Program [CDA00077/2015]; Koshland Foundation; McDonald-Leapman Grant; Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging	Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Marie Curie Career Integration Grants Program; Human Frontier Science Program(Human Frontier Science Program); Koshland Foundation; McDonald-Leapman Grant; Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging	We thank S. Wolf and E. Shimoni for help with electron microscopy experiments, and J. Georgeson for setting up the microscope time-lapse. We thank members of the laboratory, D. Fass and A. Horovitz for discussions throughout the realization of this work, H. Weissman for discussions about electron microscopy, and D. Fass for invaluable feedback on the manuscript. This work was supported by the Israel Science Foundation and the I-CORE Program of the Planning and Budgeting Committee (grants 1775/12 and 2179/14), by the Marie Curie Career Integration Grants Program (number 711715), by the Human Frontier Science Program Career Development Award (number CDA00077/2015), and by a research grant from A.-M. Boucher. H.G.S. received support from the Koshland Foundation and a McDonald-Leapman Grant. Electron microscopy studies were supported by the Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging. E.D.L. is incumbent of the Recanati Career Development Chair of Cancer Research.	Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; BOEKER EA, 1968, J BIOL CHEM, V243, P1678; Brodin JD, 2015, J AM CHEM SOC, V137, P10468, DOI 10.1021/jacs.5b05755; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CLAVERIE P, 1968, CR ACAD SCI D NAT, V266, P1616; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Colovos C, 1998, STRUCTURE, V6, P1329, DOI 10.1016/S0969-2126(98)00132-4; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; DeLano W.L, PYMOL MOL GRAPHICS S; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Doye JPK, 2004, PHYS BIOL, V1, pP9, DOI 10.1088/1478-3967/1/1/P02; DYKES GW, 1979, J MOL BIOL, V130, P451, DOI 10.1016/0022-2836(79)90434-0; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; Hindupur A, 2006, PROTEIN SCI, V15, P2605, DOI 10.1110/ps.062307706; Jaffe EK, 2002, J BIOL CHEM, V277, P19792, DOI 10.1074/jbc.M201486200; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jozic D, 2003, J MOL BIOL, V332, P243, DOI 10.1016/S0022-2836(03)00845-3; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lee KH, 2009, J MOL BIOL, V391, P178, DOI 10.1016/j.jmb.2009.06.022; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Levy ED, 2013, PROG MOL BIOL TRANSL, V117, P25, DOI 10.1016/B978-0-12-386931-9.00002-7; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lukatsky DB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178101; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mathews II, 1999, STRUCTURE, V7, P1395, DOI 10.1016/S0969-2126(00)80029-5; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thaw P, 2006, NUCLEIC ACIDS RES, V34, P1439, DOI 10.1093/nar/gkl009; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Totir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032498; von Delft F, 2003, STRUCTURE, V11, P985, DOI 10.1016/S0969-2126(03)00158-8; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9	72	119	120	8	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					244	+		10.1038/nature23320	http://dx.doi.org/10.1038/nature23320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783726				2022-12-28	WOS:000407284300050
J	Jefferson, R				Jefferson, Richard			TURNING SCIENCE INTO SOCIAL OUTCOMES	NATURE			English	Editorial Material									[Jefferson, Richard] Queensland Univ Technol, Biol Innovat, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Jefferson, R (corresponding author), Queensland Univ Technol, Biol Innovat, Brisbane, Qld, Australia.			Jefferson, Richard/0000-0001-5352-4498					0	4	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S8	S8		10.1038/548S8a	http://dx.doi.org/10.1038/548S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792924	Bronze			2022-12-28	WOS:000407284300003
J	Xu, T; Stewart, KM; Wang, XH; Liu, K; Xie, M; Ryu, JK; Li, K; Ma, TH; Wang, HX; Ni, L; Zhu, SY; Cao, N; Zhu, DW; Zhang, Y; Akassoglou, K; Dong, C; Driggers, EM; Ding, S				Xu, Tao; Stewart, Kelly M.; Wang, Xiaohu; Liu, Kai; Xie, Min; Ryu, Jae Kyu; Li, Ke; Ma, Tianhua; Wang, Haixia; Ni, Lu; Zhu, Saiyong; Cao, Nan; Zhu, Dongwei; Zhang, Yu; Akassoglou, Katerina; Dong, Chen; Driggers, Edward M.; Ding, Sheng			Metabolic control of T(H)17 and induced T-reg cell balance by an epigenetic mechanism	NATURE			English	Article							FATTY-ACID SYNTHESIS; REGULATORY T; GENE-EXPRESSION; DIFFERENTIATION; DEMETHYLATION; ACTIVATION; PATHWAY; PROTEIN; TARGET; GROWTH	Metabolism has been shown to integrate with epigenetics and transcription to modulate cell fate and function(1-3). Beyond meeting the bioenergetic and biosynthetic demands of T-cell differentiation(4-8), whether metabolism might control T-cell fate by an epigenetic mechanism is unclear. Here, through the discovery and mechanistic characterization of a small molecule, (aminooxy) acetic acid, that reprograms the differentiation of T helper 17 (T(H)17) cells towards induced regulatory T (iT(reg)) cells, we show that increased transamination, mainly catalysed by GOT1, leads to increased levels of 2-hydroxyglutarate in differentiating T(H)17 cells. The accumulation of 2-hydroxyglutarate resulted in hypermethylation of the Foxp3 gene locus and inhibited Foxp3 transcription, which is essential for fate determination towards T(H)17 cells. Inhibition of the conversion of glutamate to a-ketoglutaric acid prevented the production of 2-hydroxyglutarate, reduced methylation of the Foxp3 gene locus, and increased Foxp3 expression. This consequently blocked the differentiation of T(H)17 cells by antagonizing the function of transcription factor ROR gamma t and promoted polarization into iT(reg) cells. Selective inhibition of GOT1 with (aminooxy) acetic acid ameliorated experimental autoimmune encephalomyelitis in a therapeutic mouse model by regulating the balance between T(H)17 and iT(reg) cells. Targeting a glutamate-dependent metabolic pathway thus represents a new strategy for developing therapeutic agents against T(H)17-mediated autoimmune diseases.	[Xu, Tao; Liu, Kai; Xie, Min; Ryu, Jae Kyu; Li, Ke; Ma, Tianhua; Wang, Haixia; Zhu, Saiyong; Cao, Nan; Zhang, Yu; Akassoglou, Katerina; Ding, Sheng] J David Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA; [Stewart, Kelly M.; Zhu, Dongwei; Driggers, Edward M.] Agios Pharmaceut, 38 Sidney St, Cambridge, MA 02139 USA; [Wang, Xiaohu; Ni, Lu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Wang, Xiaohu; Ni, Lu; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ma, Tianhua; Ding, Sheng] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China; [Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Driggers, Edward M.] Gen Metabol LLC, 3 Huntington Rd, Arlington, MA 02474 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Agios Pharmaceuticals; Tsinghua University; Tsinghua University; Tsinghua University; University of California System; University of California San Francisco	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	chendong@tsinghua.edu.cn; edward.driggers@generalmetabolics.com; sheng.ding@gladstone.ucsf.edu	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Zhang, Yu/0000-0001-5512-9272; Akassoglou, Katerina/0000-0002-2632-1465; RYU, JAE KYU/0000-0002-3992-4011; Xu, Tao/0000-0002-4085-6191	Gladstone Institutes; Tsinghua University; NFSC [31570884]; Race to Erase MS Young Investigator Award; American Heart Association; NIH/NINDS [R35 NS097976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097976] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); Tsinghua University; NFSC(National Natural Science Foundation of China (NSFC)); Race to Erase MS Young Investigator Award; American Heart Association(American Heart Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.D. is supported by funding from the Gladstone Institutes and Tsinghua University. X.W. is supported by a grant from NFSC (31570884). A Race to Erase MS Young Investigator Award, and American Heart Association Scientist Development Grant were awarded to J.K.R. and NIH/NINDS R35 NS097976 was awarded to K.A. We thank G. Howard for help with editing the manuscript, and H. W. Lim for discussion.	Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	28	177	183	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					228	+		10.1038/nature23475	http://dx.doi.org/10.1038/nature23475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783731	Green Accepted			2022-12-28	WOS:000407284300047
J	Tollefson, J				Tollefson, Jeff			POLICY Fears rise over US climate report	NATURE			English	News Item																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					15	16		10.1038/548015a	http://dx.doi.org/10.1038/548015a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770853	Bronze			2022-12-28	WOS:000406831700008
J	Wells, JCK; Nesse, RM; Sear, R; Johnstone, RA; Stearns, SC				Wells, Jonathan C. K.; Nesse, Randolph M.; Sear, Rebecca; Johnstone, Rufus A.; Stearns, Stephen C.			Evolutionary public health: introducing the concept	LANCET			English	Article							HUMAN BEHAVIORAL ECOLOGY; CHILD UNDERNUTRITION; BIRTH-WEIGHT; ADULT HEALTH; REPRODUCTION; MORTALITY; RISK; MALNUTRITION; ASSOCIATION; FERTILITY	The emerging discipline of evolutionary medicine is breaking new ground in understanding why people become ill. However, the value of evolutionary analyses of human physiology and behaviour is only beginning to be recognised in the field of public health. Core principles come from life history theory, which analyses the allocation of finite amounts of energy between four competing functions-maintenance, growth, reproduction, and defence. A central tenet of evolutionary theory is that organisms are selected to allocate energy and time to maximise reproductive success, rather than health or longevity. Ecological interactions that influence mortality risk, nutrient availability, and pathogen burden shape energy allocation strategies throughout the life course, thereby affecting diverse health outcomes. Public health interventions could improve their own effectiveness by incorporating an evolutionary perspective. In particular, evolutionary approaches offer new opportunities to address the complex challenges of global health, in which populations are differentially exposed to the metabolic consequences of poverty, high fertility, infectious diseases, and rapid changes in nutrition and lifestyle. The effect of specific interventions is predicted to depend on broader factors shaping life expectancy. Among the important tools in this approach are mathematical models, which can explore probable benefits and limitations of interventions in silico, before their implementation in human populations.	[Wells, Jonathan C. K.] UCL Great Ormond St Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England; [Nesse, Randolph M.] Arizona State Univ, Ctr Evolut & Med, Phoenix, AZ USA; [Sear, Rebecca] London Sch Hyg & Trop Med, London, England; [Johnstone, Rufus A.] Univ Cambridge, Dept Zool, Cambridge, England; [Stearns, Stephen C.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of London; University College London; Arizona State University; Arizona State University-Downtown Phoenix; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Yale University	Wells, JCK (corresponding author), UCL Great Ormond St Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England.	jonathan.wells@ucl.ac.uk	Sear, Rebecca/K-9616-2019	Sear, Rebecca/0000-0002-4315-0223	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	Preparation of this manuscript was facilitated by support of the Arizona State University Centre for Evolution and Medicine provided for an authors' meeting. The model of growth was produced through a grant to RAJ and JCKW from the Leverhulme Trust.	Alvergne A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1733; [Anonymous], 2011, GLOBAL STATUS REPORT; [Anonymous], 1861, ORIGIN SPECIES MEANS; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Barker DJP, 1992, FETAL INFANT ORIGINS; Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018; Benhariz M, 1997, CLIN NUTR, V16, P251, DOI 10.1016/S0261-5614(97)80037-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Caudell MA, 2012, HUM BIOL, V84, P101, DOI 10.3378/027.084.0201; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Chisholm D., 1999, DEATH HOPE AND SEX; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Colleran H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2732; Collins FS, 2001, CANCER, V91, P221, DOI 10.1002/1097-0142(20010101)91:1+<221::AID-CNCR8>3.3.CO;2-0; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Darmasseelane Karthik, 2014, PLoS One, V9, pe87896, DOI 10.1371/journal.pone.0087896; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dobzhansky T, 1983, HUMAN CULTURE MOMENT; Doyal L, 1979, POLITICAL EC HLTH; Elder JP, 2003, PRINCIPLES PUBLIC HL, P253; FINCH CE, 1995, Q REV BIOL, V70, P1, DOI 10.1086/418864; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gale EAM, 2013, LANCET, V381, P1956, DOI 10.1016/S0140-6736(12)62207-7; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig David, 2014, Evolution Medicine and Public Health, P32, DOI 10.1093/emph/eou005; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hillhouse JJ, 2002, J BEHAV MED, V25, P395, DOI 10.1023/A:1015870516460; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jasienska G, 2017, LANCET, V390, P510, DOI [10.1016/S0140-6736(17)30573-1, 10.1016/s0140-6736(17)30573-1]; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Krieger N, 2004, EPIDEMIOL REV, V26, P92, DOI 10.1093/epirev/mxh009; Kuh D., 2004, LIFE COURSE APPROACH, DOI DOI 10.1093/ACPROF:OSO/9780198578154.003.0017; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; LASKER GW, 1969, SCIENCE, V166, P1480, DOI 10.1126/science.166.3912.1480; Lawson DW, 2008, INT J EPIDEMIOL, V37, P1408, DOI 10.1093/ije/dyn116; Lawson David W, 2012, Proc Biol Sci, V279, P4755, DOI 10.1098/rspb.2012.1635; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; Li J, 2006, DRUG DISCOV TODAY DI, V3, P387, DOI DOI 10.1016/J.DDMEC.2006.09.003; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lustig RH, 2006, NAT CLIN PRACT ENDOC, V2, P447, DOI 10.1038/ncpendmet0220; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McGregor G, 2015, MOL ENDOCRINOL, V29, P3, DOI 10.1210/me.2014-1328; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Nesse R.M., 1994, WHY WE GET SICK NEW; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Nettle D, 2013, BEHAV ECOL, V24, P1031, DOI 10.1093/beheco/ars222; .Office for National Statistics, 2014, STAT B IN HLTH LIF E; Omenn GS, 2010, P NATL ACAD SCI USA, V107, P1702, DOI 10.1073/pnas.0906198106; Ono C, 2013, PHARMACOGENOMICS, V14, P1745, DOI 10.2217/pgs.13.171; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Panter-Brick C, 2001, BRIT J NUTR, V85, P125, DOI 10.1079/BJN2000225; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Pepper GV, 2014, HUM NATURE-INT BIOS, V25, P378, DOI 10.1007/s12110-014-9204-5; Roff Derek A., 1992; Rook G, 2017, LANCET, V390, P521, DOI 10.1016/S0140-6736(17)30566-4; Schecter DE, 2010, HUM NATURE, V21; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Shukri NH, 2016, MATERN CHILD NUTR, V11, P110; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Stearns SC, 2016, EVOLUTIONARY MED; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; TRIVERS RL, 1974, AM ZOOL, V14, P249; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WADE N, 1974, SCIENCE, V186, P1093, DOI 10.1126/science.186.4169.1093; Watve M., 2013, DIPLOMATS DIABETES D; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Wells JCK, 2016, METABOLIC GHETTO: AN EVOLUTIONARY PERSPECTIVE ON NUTRITION, POWER RELATIONS AND CHRONIC DISEASE; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; Wells JCK, 2007, YEARB PHYS ANTHROPOL, V50, P191, DOI 10.1002/ajpa.20735; Wells JCK, 2016, EVOL MED PUBLIC HLTH, P133, DOI 10.1093/emph/eow011; Wells JCK, 2012, CURR ANTHROPOL, V53, pS466, DOI 10.1086/667606; Whitehead RD, 2014, HEALTH PSYCHOL, V33, P99, DOI 10.1037/a0032322; Wilson E. O., 1998, CONSILIENCE UNITY KN; Winslow CEA, 1920, MOD MED, V2, P183; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	99	117	120	0	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					500	509		10.1016/S0140-6736(17)30572-X	http://dx.doi.org/10.1016/S0140-6736(17)30572-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792412	Green Submitted, Green Accepted			2022-12-28	WOS:000406463400031
J	Agathocleous, M; Meacham, CE; Burgess, RJ; Piskounova, E; Zhao, ZY; Crane, GM; Cowin, BL; Bruner, E; Murphy, MM; Chen, WN; Spangrude, GJ; Hu, ZP; DeBerardinis, RJ; Morrison, SJ				Agathocleous, Michalis; Meacham, Corbin E.; Burgess, Rebecca J.; Piskounova, Elena; Zhao, Zhiyu; Crane, Genevieve M.; Cowin, Brianna L.; Bruner, Emily; Murphy, Malea M.; Chen, Weina; Spangrude, Gerald J.; Hu, Zeping; DeBerardinis, Ralph J.; Morrison, Sean J.			Ascorbate regulates haematopoietic stem cell function and leukaemogenesis	NATURE			English	Article							VITAMIN-C; CLONAL HEMATOPOIESIS; ALPHA-KETOGLUTARATE; DNA DEMETHYLATION; CANCER-CELLS; TET2; 5-METHYLCYTOSINE; ACID; DIFFERENTIATION; MUTATIONS	Stem-cell fate can be influenced by metabolite levels in culture, but it is not known whether physiological variations in metabolite levels in normal tissues regulate stem-cell function in vivo. Here we describe a metabolomics method for the analysis of rare cell populations isolated directly from tissues and use it to compare mouse haematopoietic stem cells (HSCs) to restricted haematopoietic progenitors. Each haematopoietic cell type had a distinct metabolic signature. Human and mouse HSCs had unusually high levels of ascorbate, which decreased with differentiation. Systemic ascorbate depletion in mice increased HSC frequency and function, in part by reducing the function of Tet2, a dioxygenase tumour suppressor. Ascorbate depletion cooperated with Flt3 internal tandem duplication (Flt3(ITD)) leukaemic mutations to accelerate leukaemogenesis, through cell-autonomous and possibly non-cell-autonomous mechanisms, in a manner that was reversed by dietary ascorbate. Ascorbate acted cell-autonomously to negatively regulate HSC function and myelopoiesis through Tet2-dependent and Tet2-independent mechanisms. Ascorbate therefore accumulates within HSCs to promote Tet activity in vivo, limiting HSC frequency and suppressing leukaemogenesis.	[Agathocleous, Michalis; Meacham, Corbin E.; Burgess, Rebecca J.; Piskounova, Elena; Zhao, Zhiyu; Crane, Genevieve M.; Cowin, Brianna L.; Bruner, Emily; Murphy, Malea M.; Hu, Zeping; DeBerardinis, Ralph J.; Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Agathocleous, Michalis; Meacham, Corbin E.; Burgess, Rebecca J.; Piskounova, Elena; Zhao, Zhiyu; Crane, Genevieve M.; Cowin, Brianna L.; Bruner, Emily; Murphy, Malea M.; Hu, Zeping; DeBerardinis, Ralph J.; Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Chen, Weina] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Spangrude, Gerald J.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [DeBerardinis, Ralph J.; Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA.; Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Sean.Morrison@UTSouthwestern.edu	Crane, Genevieve M/AAK-9224-2020; Morrison, Sean/ABD-5326-2021; Hu, Zeping/F-6205-2010	Crane, Genevieve M/0000-0001-9274-0214; Hu, Zeping/0000-0003-4146-7750; Murphy, Malea/0000-0001-7071-6862; Morrison, Sean/0000-0003-1587-8329; Piskounova, Elena/0000-0002-8554-8475	Cancer Prevention and Research Institute of Texas; National Institutes of Health [R37 AG024945, R01 DK100848]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024945] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.J.M. is a Howard Hughes Medical Institute (HHMI) Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, the Kathryn and Gene Bishop Distinguished Chair in Pediatric Research, the director of the Hamon Laboratory for Stem Cells and Cancer, and a Cancer Prevention and Research Institute of Texas Scholar. M. A. was a Royal Commission for the Exhibition of 1851 Research Fellow. We thank F. Harrison for sharing the Slc23a2<SUP>-/-</SUP> mice, N. Loof and the Moody Foundation Flow Cytometry Facility for flow cytometry, K. Correll, A. Leach and A. Gross for mouse colony management and BioHPC at UT Southwestern for providing high-performance computing. This work was supported by the Cancer Prevention and Research Institute of Texas and the National Institutes of Health (R37 AG024945 and R01 DK100848).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Huijskens Mirelle J A J, 2016, Results Immunol, V6, P8, DOI 10.1016/j.rinim.2016.01.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Knowles HJ, 2003, CANCER RES, V63, P1764; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Liu MM, 2016, P NATL ACAD SCI USA, V113, P10238, DOI 10.1073/pnas.1612262113; Loria CM, 2000, AM J CLIN NUTR, V72, P139; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Manning J, 2013, ANTIOXID REDOX SIGN, V19, P2054, DOI 10.1089/ars.2012.4988; May JM, 2011, BRIT J PHARMACOL, V164, P1793, DOI 10.1111/j.1476-5381.2011.01350.x; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Naka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9039; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Vukovic M, 2016, BLOOD, V127, P2841, DOI 10.1182/blood-2015-10-677138; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; WASHKO PW, 1992, ANAL BIOCHEM, V204, P1, DOI 10.1016/0003-2697(92)90131-P; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Young JI, 2015, ANNU REV NUTR, V35, P545, DOI 10.1146/annurev-nutr-071714-034228; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	58	290	299	13	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2017	549	7673					476	+		10.1038/nature23876	http://dx.doi.org/10.1038/nature23876			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4GT	28825709	Green Accepted			2022-12-28	WOS:000411930000041
J	Nichols, L; Brako, L; Rivera, SM; Tahmassian, A; Jones, MF; Pierce, HH; Bierer, BE				Nichols, Lisa; Brako, Lois; Rivera, Suzanne M.; Tahmassian, Ara; Jones, Martha F.; Pierce, Heather H.; Bierer, Barbara E.			What do revised US rules mean for human research?	SCIENCE			English	Editorial Material									[Nichols, Lisa] Council Govt Relat, Washington, DC 20005 USA; [Brako, Lois] Univ Michigan, Ann Arbor, MI 48109 USA; [Rivera, Suzanne M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Tahmassian, Ara; Bierer, Barbara E.] Harvard Univ, Cambridge, MA 02138 USA; [Jones, Martha F.] Washington Univ, St Louis, MO 63130 USA; [Pierce, Heather H.] Assoc Amer Med Coll, Washington, DC 20001 USA; [Bierer, Barbara E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Harvard University; Washington University (WUSTL); Association of American Medical Colleges; Harvard University; Brigham & Women's Hospital	Nichols, L (corresponding author), Council Govt Relat, Washington, DC 20005 USA.	lnichols@cogr.edu	Rivera, Suzanne M./AAF-2001-2020	Rivera, Suzanne/0000-0003-0240-6429; Pierce, Heather/0000-0002-2042-7664				[Anonymous], 2017, SECR ADV COMM HUM RE; [Anonymous], 2017, FED REGISTER, V82, P7149; [Anonymous], 2017, AM J MED GENET A, V173, P1462; Ervin AM, 2016, NEW ENGL J MED, V375, P2315, DOI 10.1056/NEJMp1608766; Ervin AM, 2015, SCIENCE, V350, P632, DOI 10.1126/science.aac4872; Joffe S, 2016, ANN INTERN MED, V165, P143, DOI 10.7326/M16-0119; Lynch HF, 2017, HASTINGS CENT REP, V47, P3, DOI 10.1002/hast.697; Menikoff J, 2017, NEW ENGL J MED, V376, P613, DOI 10.1056/NEJMp1700736; MENIKOFFF J, 2017, COMMUNICATION; NAT AC SCI, 2016, OPT NAT INV AC RES N; WHIT HOUS, 2017, REG FREEZ PEND REV; White House Office of Science and Technology Policy, 2013, INCR ACC RES FED FUN	12	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					650	651		10.1126/science.aan5855	http://dx.doi.org/10.1126/science.aan5855			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818933				2022-12-28	WOS:000407793600021
J	Bahat, G; Ilhan, B; Tufan, A; Karan, MA				Bahat, Gulistan; Ilhan, Birkan; Tufan, Asli; Karan, Mehmet Akif			Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Letter									[Bahat, Gulistan; Ilhan, Birkan; Karan, Mehmet Akif] Istanbul Univ, Istanbul, Turkey; [Tufan, Asli] Marmara Univ, Istanbul, Turkey	Istanbul University; Marmara University	Bahat, G (corresponding author), Istanbul Univ, Istanbul, Turkey.		Bahat, Gulistan/AAE-5508-2020; KARAN, Mehmet Akif/AAD-5304-2020					Bahat G, 2017, AM J MED, V130, pE319, DOI 10.1016/j.amjmed.2016.12.045; Benetos A, 2016, HYPERTENSION, V67, P820, DOI 10.1161/HYPERTENSIONAHA.115.07020; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050	5	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					288	288		10.7326/L17-0287	http://dx.doi.org/10.7326/L17-0287			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806808				2022-12-28	WOS:000407797500022
J	Chan, N; Weitz, J				Chan, Noel; Weitz, Jeffrey			In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chan, Noel; Weitz, Jeffrey] Thrombosis & Artherosclerosis Res Inst, Hamilton, ON, Canada		Chan, N (corresponding author), Thrombosis & Artherosclerosis Res Inst, Hamilton, ON, Canada.		Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550; Chan, Noel/0000-0001-9491-6172				Baigent C, 2003, ARTHRITIS RHEUM, V48, P12, DOI 10.1002/art.10738; *BAYER CORP, 2017, ASP COMPR PRESCR INF, P46564; Chan FKL, 2017, LANCET, V389, P2375, DOI 10.1016/S0140-6736(17)30981-9; *ROCHE LABS INC, 2017, ROCHE ECNAPROSYN, P46564	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC17	JC17		10.7326/ACPJC-2017-167-4-017	http://dx.doi.org/10.7326/ACPJC-2017-167-4-017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806798				2022-12-28	WOS:000407797500030
J	Hunter, BR				Hunter, Benton R.			In patients with chest pain, HEART score-guided and usual care did not differ for MACE or health care use	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT		[Hunter, Benton R.] Indiana Univ, Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis	Hunter, BR (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN USA.							Amsterdam EA, 2010, CIRCULATION, V122, P1756, DOI 10.1161/CIR.0b013e3181ec61df; Fanaroff AC, 2015, JAMA-J AM MED ASSOC, V314, P1955, DOI 10.1001/jama.2015.12735; Foy AJ, 2015, JAMA INTERN MED, V175, P428, DOI 10.1001/jamainternmed.2014.7657; Poldervaart JM, 2017, ANN INTERN MED, V166, P689, DOI 10.7326/M16-1600	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC22	JC22		10.7326/ACPJC-2017-167-4-022	http://dx.doi.org/10.7326/ACPJC-2017-167-4-022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806803				2022-12-28	WOS:000407797500031
J	O'Donoghue, F; McDonald, C				O'Donoghue, Fergal; McDonald, Christine			Review: CPAP improves QoL in obstructive sleep apnea; effects not as clear for mandibular advancement devices	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[O'Donoghue, Fergal; McDonald, Christine] Univ Melbourne, Melbourne, Vic, Australia	University of Melbourne	O'Donoghue, F (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.		McDonald, Christine Faye/AAU-9083-2021						0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC18	JC18		10.7326/ACPJC-2017-167-4-018	http://dx.doi.org/10.7326/ACPJC-2017-167-4-018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806799				2022-12-28	WOS:000407797500005
J	Cross, R				Cross, Ryan			NEUROSCIENCE Elderly chimps may get Alzheimer's disease	SCIENCE			English	News Item																			0	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					440	440		10.1126/science.357.6350.440	http://dx.doi.org/10.1126/science.357.6350.440			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774909				2022-12-28	WOS:000406840100014
J	Akimov, D; Albert, JB; An, P; Awe, C; Barbeau, PS; Becker, B; Belov, V; Brown, A; Bolozdynya, A; Cabrera-Palmer, B; Cervantes, M; Collar, JI; Cooper, RJ; Cooper, RL; Cuesta, C; Dean, DJ; Detwiler, JA; Eberhardt, A; Efremenko, Y; Elliott, SR; Erkela, EM; Fabris, L; Febbraro, M; Fields, NE; Fox, W; Fu, Z; Galindo-Uribarri, A; Green, MP; Hai, M; Heath, MR; Hedges, S; Hornback, D; Hossbach, TW; Iverson, EB; Kaufman, LJ; Ki, S; Klein, SR; Khromov, A; Konovalov, A; Kremer, M; Kumpan, A; Leadbetter, C; Li, L; Lu, W; Mann, K; Markoff, DM; Miller, K; Moreno, H; Mueller, PE; Newby, J; Orrell, JL; Overman, CT; Parno, DS; Penttila, S; Perumpilly, G; Ray, H; Raybern, J; Reyna, D; Rich, GC; Rimal, D; Rudik, D; Scholberg, K; Scholz, BJ; Sinev, G; Snow, WM; Sosnovtsev, V; Shakirov, A; Suchyta, S; Suh, B; Tayloe, R; Thornton, RT; Tolstukhin, I; Vanderwerp, J; Varner, RL; Virtue, CJ; Wan, Z; Yoo, J; Yu, CH; Zawada, A; Zettlemoyer, J; Zderic, AM				Akimov, D.; Albert, J. B.; An, P.; Awe, C.; Barbeau, P. S.; Becker, B.; Belov, V.; Brown, A.; Bolozdynya, A.; Cabrera-Palmer, B.; Cervantes, M.; Collar, J. I.; Cooper, R. J.; Cooper, R. L.; Cuesta, C.; Dean, D. J.; Detwiler, J. A.; Eberhardt, A.; Efremenko, Y.; Elliott, S. R.; Erkela, E. M.; Fabris, L.; Febbraro, M.; Fields, N. E.; Fox, W.; Fu, Z.; Galindo-Uribarri, A.; Green, M. P.; Hai, M.; Heath, M. R.; Hedges, S.; Hornback, D.; Hossbach, T. W.; Iverson, E. B.; Kaufman, L. J.; Ki, S.; Klein, S. R.; Khromov, A.; Konovalov, A.; Kremer, M.; Kumpan, A.; Leadbetter, C.; Li, L.; Lu, W.; Mann, K.; Markoff, D. M.; Miller, K.; Moreno, H.; Mueller, P. E.; Newby, J.; Orrell, J. L.; Overman, C. T.; Parno, D. S.; Penttila, S.; Perumpilly, G.; Ray, H.; Raybern, J.; Reyna, D.; Rich, G. C.; Rimal, D.; Rudik, D.; Scholberg, K.; Scholz, B. J.; Sinev, G.; Snow, W. M.; Sosnovtsev, V.; Shakirov, A.; Suchyta, S.; Suh, B.; Tayloe, R.; Thornton, R. T.; Tolstukhin, I.; Vanderwerp, J.; Varner, R. L.; Virtue, C. J.; Wan, Z.; Yoo, J.; Yu, C. -H.; Zawada, A.; Zettlemoyer, J.; Zderic, A. M.		COHERENT Collaboration	Observation of coherent elastic neutrino-nucleus scattering	SCIENCE			English	Article							STELLAR COLLAPSE; ELECTRON; DETECTOR; SILICON	The coherent elastic scattering of neutrinos off nuclei has eluded detection for four decades, even though its predicted cross section is by far the largest of all low-energy neutrino couplings. This mode of interaction offers new opportunities to study neutrino properties and leads to a miniaturization of detector size, with potential technological applications. We observed this process at a 6.7s confidence level, using a low-background, 14.6-kilogram CsI[Na] scintillator exposed to the neutrino emissions from the Spallation Neutron Source at Oak Ridge National Laboratory. Characteristic signatures in energy and time, predicted by the standard model for this process, were observed in high signal-to-background conditions. Improved constraints on nonstandard neutrino interactions with quarks are derived from this initial data set.	[Akimov, D.; Belov, V.; Konovalov, A.; Rudik, D.] AI Alikhanov Natl Res Ctr Kurchatov Inst, Inst Theoret & Expt Phys, Moscow 117218, Russia; [Akimov, D.; Belov, V.; Bolozdynya, A.; Khromov, A.; Konovalov, A.; Kumpan, A.; Rudik, D.; Sosnovtsev, V.; Shakirov, A.] Natl Res Nucl Univ MEPhI Moscow Engn Phys Inst, Moscow 115409, Russia; [Albert, J. B.; Fox, W.; Heath, M. R.; Kaufman, L. J.; Snow, W. M.; Tayloe, R.; Thornton, R. T.; Tolstukhin, I.; Vanderwerp, J.; Zettlemoyer, J.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [An, P.; Awe, C.; Barbeau, P. S.; Brown, A.; Green, M. P.; Hedges, S.; Ki, S.; Kremer, M.; Leadbetter, C.; Li, L.; Mann, K.; Markoff, D. M.; Miller, K.; Rich, G. C.; Suh, B.; Wan, Z.; Zawada, A.] Triangle Univ Nucl Lab, Durham, NC 27708 USA; [Awe, C.; Barbeau, P. S.; Cervantes, M.; Hedges, S.; Ki, S.; Li, L.; Miller, K.; Raybern, J.; Scholberg, K.; Sinev, G.; Suh, B.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Becker, B.; Efremenko, Y.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Brown, A.; Markoff, D. M.] North Carolina Cent Univ, Dept Math & Phys, Durham, NC 27707 USA; [Cabrera-Palmer, B.; Reyna, D.] Sandia Natl Labs, Livermore, CA 94550 USA; [Collar, J. I.; Fields, N. E.; Hai, M.; Perumpilly, G.; Scholz, B. J.] Univ Chicago, Enrico Fermi Inst, Kavli Inst Cosmol Phys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Collar, J. I.; Fields, N. E.; Hai, M.; Perumpilly, G.; Scholz, B. J.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Cooper, R. J.; Klein, S. R.; Suchyta, S.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Cooper, R. L.; Moreno, H.] New Mexico State Univ, Dept Phys, Las Cruces, NM 88003 USA; [Cooper, R. L.; Elliott, S. R.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Cuesta, C.; Detwiler, J. A.; Eberhardt, A.; Erkela, E. M.; Fu, Z.; Parno, D. S.; Zderic, A. M.] Univ Washington, Ctr Expt Nucl Phys & Astrophys, Seattle, WA 98195 USA; [Cuesta, C.; Detwiler, J. A.; Eberhardt, A.; Erkela, E. M.; Fu, Z.; Parno, D. S.; Zderic, A. M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Dean, D. J.; Efremenko, Y.; Fabris, L.; Febbraro, M.; Galindo-Uribarri, A.; Green, M. P.; Hornback, D.; Iverson, E. B.; Lu, W.; Mueller, P. E.; Newby, J.; Penttila, S.; Rich, G. C.; Suh, B.; Varner, R. L.; Yu, C. -H.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Green, M. P.; Mann, K.] North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Hossbach, T. W.; Orrell, J. L.; Overman, C. T.] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Konovalov, A.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Ray, H.; Rimal, D.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Rich, G. C.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Virtue, C. J.] Laurentian Univ, Dept Phys, Sudbury, ON P3E 2C6, Canada; [Yoo, J.] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon 34141, South Korea; [Yoo, J.] Inst for Basic Sci Korea, Ctr Axion & Precis Phys Res CAPP, Daejeon 34141, South Korea; [Cuesta, C.] Ctr Invest Energet Medioambientales & Tecnol, Madrid 28040, Spain; [Fields, N. E.] US Nucl Regulatory Commiss, Lisle, IL 60532 USA; [Hai, M.] SpaceX Rocket Dev Facil, Mcgregor, TX 76657 USA; [Kaufman, L. J.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94205 USA; [Parno, D. S.] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA	National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Indiana University System; Indiana University Bloomington; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; Duke University; Duke University; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina Central University; United States Department of Energy (DOE); Sandia National Laboratories; University of Chicago; University of Chicago; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; New Mexico State University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Moscow Institute of Physics & Technology; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; Laurentian University; Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Carnegie Mellon University	Collar, JI (corresponding author), Univ Chicago, Enrico Fermi Inst, Kavli Inst Cosmol Phys, 5640 S Ellis Ave, Chicago, IL 60637 USA.; Collar, JI (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	collar@uchicago.edu	Hossbach, Todd/HCH-8218-2022; Newby, Robert/AAK-5209-2021; Dean, David/AFZ-0605-2022; Cuesta, Clara/AAB-3448-2019; Rudik, Dmitry G/P-7121-2017; Khromov, Alexander/AAG-6967-2020; Orrell, John Laurence/E-9313-2015; Fast, James/AAA-4844-2019; Dean, David/AAI-2471-2021; Cuesta, Clara/L-5466-2014; Konovalov, Alexey/HGA-2909-2022; Green, Matthew/AAJ-7559-2020; Yoo, Jonghee/K-8394-2016; Varner, Robert Lindsay/AAE-7334-2022; Kumpan, Alexander V./CAA-0122-2022; , Erik/GRS-0110-2022; Khromov, Arkadiy/T-5821-2018; Parno, Diana/B-7546-2017	Newby, Robert/0000-0003-3571-1067; Cuesta, Clara/0000-0003-1190-7233; Rudik, Dmitry G/0000-0001-5585-7253; Orrell, John Laurence/0000-0001-7968-4051; Fast, James/0000-0003-2258-701X; Cuesta, Clara/0000-0003-1190-7233; Green, Matthew/0000-0002-1958-8030; Varner, Robert Lindsay/0000-0002-0477-7488; Zettlemoyer, Jacob/0000-0002-9222-7071; Kumpan, Alexander V./0000-0002-3947-7661; Thornton, Remington/0000-0001-9589-4606; Hedges, Samuel/0000-0001-6255-2933; Klein, Spencer/0000-0003-2841-6553; Detwiler, Jason/0000-0002-9050-4610; Yu, Chang-Hong/0000-0002-9849-842X; Tolstukhin, Ivan/0000-0002-6631-7479; Konovalov, Alexey/0000-0003-0647-9211; Barbeau, Phillip/0000-0002-8891-8988; Khromov, Arkadiy/0000-0002-6355-5615; Cooper, Reynold/0000-0002-5669-2961; Galindo-Uribarri, Alfredo/0000-0001-7450-404X; Tayloe, Rex/0000-0002-3732-6093; Parno, Diana/0000-0002-9363-0401; Heath, Matthew/0000-0002-4834-7025; Hossbach, Todd/0000-0001-5364-5337; Shakirov, Aleksey/0000-0003-1749-2251; Scholberg, Kate/0000-0002-7007-2021; Perumpilly, Gopakumar/0000-0003-2206-7524; An, Peibo/0000-0002-7632-0284; Scholz, Bjorn J./0000-0002-2657-3240	Alfred P. Sloan Foundation [BR2014-037]; Consortium for Nonproliferation Enabling Capabilities grant [DE-NA0002576]; Institute for Basic Science (Korea) [IBS-R017-G1-2017-a00]; NSF [PHY-1306942, PHY-1506357, PHY-1614545, HRD-1601174]; Lawrence Berkeley National Laboratory Directed Research and Development funds; Russian Foundation for Basic Research [17-02-01077_a]; Russian Science Foundation [02. a03.21.0005]; Sandia National Laboratories Directed Research and Development Exploratory Express Funds; Triangle Universities Nuclear Laboratory; U.S. Department of Energy (DOE) Office of Science [DE-SC0009824, DE-SC0010007, DE-SC0014249, DE-SC0014558]; DOE's National Nuclear Security Administration Office of Defense, Nuclear Nonproliferation Research, and Development; University of Washington Royalty Research Fund [FA124183]; DOE's National Nuclear Security Administration [DE-NA0003525]; DOE [DE-AC05-76RL01830]; National Consortium for Measurement and Signature Intelligence Research Program; Intelligence Community Postdoctoral Research Fellowship Program; Kavli Foundation; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; DOE Office of Science, Office of High Energy Physics;  [NSF PHY-1125897]; Division Of Physics [1461204, 1506357] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consortium for Nonproliferation Enabling Capabilities grant; Institute for Basic Science (Korea); NSF(National Science Foundation (NSF)); Lawrence Berkeley National Laboratory Directed Research and Development funds; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Sandia National Laboratories Directed Research and Development Exploratory Express Funds; Triangle Universities Nuclear Laboratory; U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); DOE's National Nuclear Security Administration Office of Defense, Nuclear Nonproliferation Research, and Development; University of Washington Royalty Research Fund(University of Washington); DOE's National Nuclear Security Administration(National Nuclear Security Administration); DOE(United States Department of Energy (DOE)); National Consortium for Measurement and Signature Intelligence Research Program; Intelligence Community Postdoctoral Research Fellowship Program; Kavli Foundation; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; DOE Office of Science, Office of High Energy Physics; ; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by Alfred P. Sloan Foundation grant BR2014-037; Consortium for Nonproliferation Enabling Capabilities grant DE-NA0002576; Institute for Basic Science (Korea) grant IBS-R017-G1-2017-a00; NSF grants PHY-1306942, PHY-1506357, PHY-1614545, and HRD-1601174; Lawrence Berkeley National Laboratory Directed Research and Development funds; Russian Foundation for Basic Research grant 17-02-01077_a; the Russian Science Foundation in the framework of MEPhI Academic Excellence Project (contract 02. a03.21.0005, 27.08.2013); Sandia National Laboratories Directed Research and Development Exploratory Express Funds; Triangle Universities Nuclear Laboratory; U.S. Department of Energy (DOE) Office of Science grants DE-SC0009824 and DE-SC0010007 and Early Career Awards DE-SC0014249 and DE-SC0014558; DOE's National Nuclear Security Administration Office of Defense, Nuclear Nonproliferation Research, and Development; and University of Washington Royalty Research Fund grant FA124183. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia LLC, a wholly owned subsidiary of Honeywell International Inc. for DOE's National Nuclear Security Administration under contract DE-NA0003525. Pacific Northwest National Laboratory is operated by Battelle for DOE under contract DE-AC05-76RL01830, where work was supported through awards from the National Consortium for Measurement and Signature Intelligence Research Program and from the Intelligence Community Postdoctoral Research Fellowship Program. This work was supported in part by the Kavli Institute for Cosmological Physics at the University of Chicago through grant NSF PHY-1125897, and an endowment from the Kavli Foundation and its founder Fred Kavli. This work was sponsored by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for DOE. It used resources of the Spallation Neutron Source, which is a DOE Office of Science User Facility. This material is based on work supported by the DOE Office of Science, Office of High Energy Physics. This research used resources of the Oak Ridge Leadership Computing Facility, which is a DOE Office of Science User Facility. Raw experimental data are archived at its High Performance Storage System, which provides 263 TB of COHERENT dedicated storage. We are grateful for additional resources provided by the research computing centers at the University of Chicago and Duke University.	Aguilar-Arevalo A, 2016, J PHYS CONF SER, V761, DOI 10.1088/1742-6596/761/1/012057; Akimov DY, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/10/P10023; Avignone FT, 2003, J PHYS G NUCL PARTIC, V29, P2615, DOI 10.1088/0954-3899/29/11/012; Barbeau PS, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/09/009; Billard J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.023524; Bondar A, 2007, NUCL INSTRUM METH A, V574, P493, DOI 10.1016/j.nima.2007.01.090; Braggio C, 2006, NUCL INSTRUM METH A, V568, P412, DOI 10.1016/j.nima.2006.06.008; Brice SJ, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.072004; CABRERA B, 1985, PHYS REV LETT, V55, P25, DOI 10.1103/PhysRevLett.55.25; Collar JI, 2015, NUCL INSTRUM METH A, V773, P56, DOI 10.1016/j.nima.2014.11.037; COWAN CL, 1956, SCIENCE, V124, P103, DOI 10.1126/science.124.3212.103; FREEDMAN DZ, 1974, PHYS REV D, V9, P1389, DOI 10.1103/PhysRevD.9.1389; FREEDMAN DZ, 1977, ANNU REV NUCL PART S, V27, P167, DOI 10.1146/annurev.ns.27.120177.001123; Golubkov SA, 2004, INSTRUM EXP TECH+, V47, P799, DOI 10.1023/B:INET.0000049703.01596.be; HASERT FJ, 1973, PHYS LETT B, VB 46, P138, DOI 10.1016/0370-2693(73)90499-1; Horowitz CJ, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.023005; Joshi TH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.171303; Kim Y, 2016, NUCL ENG TECHNOL, V48, P285, DOI 10.1016/j.net.2016.02.001; Kosmas T. S., 2017, PROBING LIGHT STERIL; KRAUSS LM, 1991, PHYS LETT B, V269, P407, DOI 10.1016/0370-2693(91)90192-S; SCHRAMM DN, 1975, PHYS REV LETT, V34, P113, DOI 10.1103/PhysRevLett.34.113; Stodolsky L., 1998, NEUTR ASTR RINGB CAS; WILSON JR, 1974, PHYS REV LETT, V32, P849, DOI 10.1103/PhysRevLett.32.849	34	365	367	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2017	357	6356					1123	+		10.1126/science.aao0990	http://dx.doi.org/10.1126/science.aao0990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7XX	28775215	Green Submitted			2022-12-28	WOS:000410639800037
J	Farooki, A; Scher, HI				Farooki, Azeez; Scher, Howard I.			Maintaining Bone Health During Hormonal Therapy for Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; MEN; FRACTURES		[Farooki, Azeez] Mem Sloan Kettering Canc Ctr, Dept Med, Endocrinol Oncol Serv, 1275 York Ave,Box 296, New York, NY 10065 USA; Weill Cornell Med Coll, New York, NY USA; [Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Scher, HI (corresponding author), Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	scherh@mskcc.org		Farooki, Azeez/0000-0003-4508-5186				Alibhai SMH, 2017, ANN INTERN MED, V167, P341, DOI 10.7326/M16-2577; Cianferotti L, 2017, ONCOTARGET; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Greenspan SL, 2013, J BONE MINER RES, V28, P325, DOI 10.1002/jbmr.1771; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; Lamy O, 2017, J CLIN ENDOCR METAB, V102, P354, DOI 10.1210/jc.2016-3170; Michaelson MD, 2007, J CLIN ONCOL, V25, P1038, DOI 10.1200/JCO.2006.07.3361; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908	10	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					357	+		10.7326/M17-1800	http://dx.doi.org/10.7326/M17-1800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28785765				2022-12-28	WOS:000409120400012
J	Okun, MS				Okun, Michael S.			Management of Parkinson Disease in 2017 Personalized Approaches for Patient-Specific Needs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LEVODOPA		[Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, POB 100236,Room L3-100, Gainesville, FL 32610 USA; [Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, POB 100236,Room L3-100, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, POB 100236,Room L3-100, Gainesville, FL 32610 USA.; Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, POB 100236,Room L3-100, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu			National Institutes of Health; Michael J. Fox Foundation; Tourette Association of America; Bachmann Strauss Foundation; National Parkinson Foundation; New England Journal of Medicine Journal Watch	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Tourette Association of America; Bachmann Strauss Foundation; National Parkinson Foundation; New England Journal of Medicine Journal Watch	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest Dr Okun reports receipt of grants from the National Institutes of Health, the Michael J. Fox Foundation, the Tourette Association of America, the Bachmann Strauss Foundation, and the National Parkinson Foundation; publication royalties from Books4Patients, Demos, Manson, Cambridge University Press, Smashwords, and Amazon/KDP; continuing medical education honoraria from WebMD-Medscape, QuantiaMD, the American Academy of Neurology, the Movement Disorders Society, and Mededicus; honoraria fora Vanderbilt University teaching course; and personal fees from the New England Journal of Medicine Journal Watch. He is the national medical director for the National Parkinson Foundation and oversees the foundation's question-and-answer website and blog.	Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fox SH, 2015, UPDATE TREATMENTS MO; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65	7	26	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					791	792		10.1001/jama.2017.7914	http://dx.doi.org/10.1001/jama.2017.7914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28828469				2022-12-28	WOS:000409183700005
J	Panigrahi, P; Parida, S; Nanda, NC; Satpathy, R; Pradhan, L; Chandel, DS; Baccaglini, L; Mohapatra, A; Mohapatra, SS; Misra, PR; Chaudhry, R; Chen, HGH; Johnson, JA; Morris, JG; Paneth, N; Gewolb, IH				Panigrahi, Pinaki; Parida, Sailajanandan; Nanda, Nimai C.; Satpathy, Radhanath; Pradhan, Lingaraj; Chandel, Dinesh S.; Baccaglini, Lorena; Mohapatra, Arjit; Mohapatra, Subhranshu S.; Misra, Pravas R.; Chaudhry, Rama; Chen, Hegang H.; Johnson, Judith A.; Morris, J. Glenn, Jr.; Paneth, Nigel; Gewolb, Ira H.			A randomized synbiotic trial to prevent sepsis among infants in rural India	NATURE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LATE-ONSET SEPSIS; NECROTIZING ENTEROCOLITIS; LACTOBACILLUS-PLANTARUM; PRETERM INFANTS; COLONIZATION; MICROFLORA; INFECTION; COUNTRIES; PLASMID	Sepsis in early infancy results in one million annual deaths worldwide, most of them in developing countries. No efficient means of prevention is currently available. Here we report on a randomized, double-blind, placebo-controlled trial of an oral synbiotic preparation (Lactobacillus plantarum plus fructooligosaccharide) in rural Indian newborns. We enrolled 4,556 infants that were at least 2,000 g at birth, at least 35 weeks of gestation, and with no signs of sepsis or other morbidity, and monitored them for 60 days. We show a significant reduction in the primary outcome (combination of sepsis and death) in the treatment arm (risk ratio 0.60, 95% confidence interval 0.48-0.74), with few deaths (4 placebo, 6 synbiotic). Significant reductions were also observed for culture-positive and culture-negative sepsis and lower respiratory tract infections. These findings suggest that a large proportion of neonatal sepsis in developing countries could be effectively prevented using a synbiotic containing L. plantarum ATCC-202195.	[Panigrahi, Pinaki; Baccaglini, Lorena] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Dept Epidemiol, Omaha, NE 68198 USA; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Dept Pediat, Omaha, NE 68198 USA; [Parida, Sailajanandan] SCB Med Coll, Dept Pediat, Cuttack, Odisha, India; [Nanda, Nimai C.] Ispat Gen Hosp, Dept Pediat, Rourkela, Odisha, India; [Satpathy, Radhanath; Mohapatra, Arjit; Mohapatra, Subhranshu S.; Misra, Pravas R.] Asian Inst Publ Hlth, Bhubaneswar, Odisha, India; [Pradhan, Lingaraj] Capital Hosp, Dept Pediat, Bhubaneswar, Odisha, India; [Chandel, Dinesh S.] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Dept Environm Agr & Occupat Hlth, Omaha, NE USA; [Chaudhry, Rama] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Chen, Hegang H.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Johnson, Judith A.; Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Epidemiol, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Pediat, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Human Dev, E Lansing, MI 48824 USA; [Gewolb, Ira H.] Michigan State Univ, Coll Human Med, Div Neonatol, E Lansing, MI 48824 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Srirama Chandra Bhanja Medical College & Hospital; University of Nebraska System; University of Nebraska Medical Center; All India Institute of Medical Sciences (AIIMS) New Delhi; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Panigrahi, P (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Dept Epidemiol, Omaha, NE 68198 USA.; Panigrahi, P (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Dept Pediat, Omaha, NE 68198 USA.	ppanigrahi@unmc.edu		Baccaglini, Lorena/0000-0003-3548-4802	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, USA [U01 HD 40574, R01 HD 53719]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053719, U01HD040574] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are thankful to the Indian Council of Medical Research and the Ministry of Health and Family Welfare Government of India for their review and timely clearance. The Government of Odisha, Department of Health and Family Welfare provided necessary approvals and directives at the block level for implementation of the project in the hospitals and the community setting. We are grateful to the Director of Capital Hospital, Bhubaneswar, and Ispat General Hospital for providing dedicated clinical research space and laboratory space to set up the Bactec blood culture, microbiology, and data management facilities. Our gratitude to Dayananda Das (now deceased) of Jana Sikshan Sansthan for his management skills and each of the > 200 members in the three-tier community intervention team. K. Pradhan and K. Mishra deserve thanks for managing the study in the two districts. Our thanks to the DSMB members for reviewing all serious adverse events and convening yearly in person for further review of compiled data and providing valuable insights. This study could not have been possible without the unconditional support of the parents of the newborns born in the study districts and the physicians, nurse-midwives, and Anganwadi workers of the government system who provided assistance throughout the conduct of the study. This study was funded by grants U01 HD 40574 and R01 HD 53719 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, USA.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Agarwal R, 2003, J PEDIATR GASTR NUTR, V36, P397, DOI 10.1097/00005176-200303000-00019; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Brocklehurst P, 2011, NEW ENGL J MED, V365, P1201, DOI 10.1056/NEJMoa1100441; Bujalance C, 2006, J MICROBIOL METH, V66, P572, DOI 10.1016/j.mimet.2006.02.005; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Das A, 2016, INDIAN PEDIATR, V53, P225, DOI 10.1007/s13312-016-0825-0; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dilli D, 2015, J PEDIATR-US, V166, P545, DOI 10.1016/j.jpeds.2014.12.004; Dilli D, 2013, PEDIATRICS, V132, pE932, DOI 10.1542/peds.2013-1262; Feld L, 2008, J ANTIMICROB CHEMOTH, V61, P845, DOI 10.1093/jac/dkn033; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; HENSEY OJ, 1985, J HYG-CAMBRIDGE, V95, P289, DOI 10.1017/S0022172400062719; Jacobs SE, 2013, PEDIATRICS, V132, P1055, DOI 10.1542/peds.2013-1339; Jacobsen L, 2007, FEMS MICROBIOL ECOL, V59, P158, DOI 10.1111/j.1574-6941.2006.00212.x; Jalilsood T, 2014, PLASMID, V73, P1, DOI 10.1016/j.plasmid.2014.04.004; Khailova L, 2013, SHOCK, V40, P496, DOI 10.1097/SHK.0000000000000066; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kiso M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01563; Lai EM, 2015, INDIAN J PEDIATR, V82, P439, DOI 10.1007/s12098-014-1565-6; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; McCulloh RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117462; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mullany LC, 2006, PEDIATR INFECT DIS J, V25, P665, DOI 10.1097/01.inf.0000223489.02791.70; Nandhini LP, 2016, J MATERN-FETAL NEO M, V29, P821, DOI 10.3109/14767058.2015.1019854; National Health Mission, 2011, HLTH STAT; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Panigrahi P, 1996, PEDIATR RES, V40, P415, DOI 10.1203/00006450-199609000-00009; Panigrahi P, 2017, J PERINATOL, V37, P911, DOI 10.1038/jp.2017.67; PANIGRAHI P, 1994, PEDIATR RES, V36, P115, DOI 10.1203/00006450-199407001-00021; Panigrahi P, 2008, J PEDIATR GASTR NUTR, V47, P45, DOI 10.1097/MPG.0b013e31815a5f2c; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Sinha A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006564; SPIGELBLATT L, 1985, PEDIATR INFECT DIS J, V4, P56, DOI 10.1097/00006454-198501000-00014; Tanaka A, 2011, LETT APPL MICROBIOL, V53, P35, DOI 10.1111/j.1472-765X.2011.03079.x; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Toomey N, 2010, RES MICROBIOL, V161, P127, DOI 10.1016/j.resmic.2009.12.010; UN Inter-Agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Waters Donald, 2011, J Glob Health, V1, P154; West PWJ, 1998, J MED MICROBIOL, V47, P923, DOI 10.1099/00222615-47-10-923	51	279	294	3	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					407	+		10.1038/nature23480	http://dx.doi.org/10.1038/nature23480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813414				2022-12-28	WOS:000408279000029
J	Zhou, QJ; Zhou, P; Wang, AL; Wu, D; Zhao, ML; Sudhof, TC; Brunger, AT				Zhou, Qiangjun; Zhou, Peng; Wang, Austin L.; Wu, Dick; Zhao, Minglei; Sudhof, Thomas C.; Brunger, Axel T.			The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis	NATURE			English	Article							CA2+ SENSOR; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; C2 DOMAIN; FUSION; MACHINERY; MOLECULE; MODEL	Synaptotagmin, complexin, and neuronal SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) proteins mediate evoked synchronous neurotransmitter release, but the molecular mechanisms mediating the cooperation between these molecules remain unclear. Here we determine crystal structures of the primed pre-fusion SNARE-complexin-synaptotagmin-1 complex. These structures reveal an unexpected tripartite interface between synaptotagmin-1 and both the SNARE complex and complexin. Simultaneously, a second synaptotagmin-1 molecule interacts with the other side of the SNARE complex via the previously identified primary interface. Mutations that disrupt either interface in solution also severely impair evoked synchronous release in neurons, suggesting that both interfaces are essential for the primed pre-fusion state. Ca2+ binding to the synaptotagmin-1 molecules unlocks the complex, allows full zippering of the SNARE complex, and triggers membrane fusion. The tripartite SNARE-complexin-synaptotagmin-1 complex at a synaptic vesicle docking site has to be unlocked for triggered fusion to start, explaining the cooperation between complexin and synaptotagmin-1 in synchronizing evoked release on the sub-millisecond timescale.	[Zhou, Qiangjun; Zhou, Peng; Wang, Austin L.; Wu, Dick; Zhao, Minglei; Sudhof, Thomas C.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zhou, Qiangjun; Wang, Austin L.; Zhao, Minglei; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Dept Biol Struct, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Zhao, Minglei] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Chicago	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Brunger, AT (corresponding author), Stanford Univ, Dept Photon Sci, Dept Biol Struct, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	brunger@stanford.edu	; Zhao, Minglei/J-4446-2015	Brunger, Axel/0000-0001-5121-2036; Zhou, Qiangjun/0000-0003-1789-9588; Zhao, Minglei/0000-0001-5832-6060	National Institutes of Health (NIH) [R37 MH63105, P50 MH086403]; Department of Energy (DOE) [DE-AC02-06CH11357, DE-AC02-76SF00515, DE-AC02-05CH11231]; National Institute of General Medical Sciences (NIGMS) from the NIH [P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; DOE Office of Biological and Environmental Research; NIH NIGMS [P41 GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105, P50MH086403, K99MH113764] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (DOE)(United States Department of Energy (DOE)); National Institute of General Medical Sciences (NIGMS) from the NIH; NIH-ORIP HEI; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Gipson, J. Leitz, A. Lyubimov, and W. I. Weis for discussions, S. Muennich and S. Pokutta for assistance with ITC, and the National Institutes of Health (NIH) for support (R37 MH63105 to A.T.B.; P50 MH086403 to T.C.S.). Crystal diffraction screening and data collection were performed at synchrotron facilities provided by the Advanced Photon Source at Argonne National Laboratory, the Stanford Synchrotron Radiation Lightsource, California, and the Advanced Light Source, Berkeley, California, funded by Department of Energy (DOE) under contracts DE-AC02-06CH11357 (Advanced Photon Source), DE-AC02-76SF00515 (Stanford Synchrotron Radiation Lightsource), and DE-AC02-05CH11231 (ALS). We thank the staff at these beamlines for help with diffraction data collection. The Northeastern Collaborative Access Team (NECAT) beamlines are funded by the National Institute of General Medical Sciences (NIGMS) from the NIH (P41 GM103403). The Pilatus 6M detector at the 24-ID-C beam line is funded by an NIH-ORIP HEI grant (S10 RR029205). The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program including beam line BL12-2 is supported by the DOE Office of Biological and Environmental Research, and by the NIH NIGMS (P41 GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Brewer KD, 2015, NAT STRUCT MOL BIOL, V22, P555, DOI 10.1038/nsmb.3035; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Cao P, 2013, J NEUROSCI, V33, P1714, DOI 10.1523/JNEUROSCI.4087-12.2013; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi UB, 2016, ELIFE, V5, DOI 10.7554/eLife.16886; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Dhara M, 2014, J CELL BIOL, V204, P1123, DOI 10.1083/jcb.201311085; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Evans CS, 2016, MOL BIOL CELL, V27, P979, DOI 10.1091/mbc.E15-07-0503; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gipson P., 2017, P NATL ACAD SCI US; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Lai Y, 2016, P NATL ACAD SCI USA, V113, pE4698, DOI 10.1073/pnas.1604348113; Lee J, 2013, J NEUROSCI, V33, P187, DOI 10.1523/JNEUROSCI.3214-12.2013; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohrmann R, 2015, CELL MOL LIFE SCI, V72, P4221, DOI 10.1007/s00018-015-1998-8; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Perez-Lara A, 2016, ELIFE, V5, DOI 10.7554/eLife.15886; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975	58	142	142	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					420	+		10.1038/nature23484	http://dx.doi.org/10.1038/nature23484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813412	Green Submitted, Green Accepted			2022-12-28	WOS:000408279000031
J	Zhou, SY				Zhou, Stephanie Y.			Underprivilege as Privilege	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zhou, Stephanie Y.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto	Zhou, SY (corresponding author), 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	steph.zhou@mail.utoronto.ca						Brosnan C, 2016, MED EDUC, V50, P842, DOI 10.1111/medu.12995; Frost HD, 2013, ACAD MED, V88, P1570, DOI 10.1097/ACM.0b013e3182a34b05	2	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					705	706		10.1001/jama.2017.9425	http://dx.doi.org/10.1001/jama.2017.9425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829880				2022-12-28	WOS:000408095800018
J	Liu, YS; Li, YH				Liu, Yansui; Li, Yuheng			Revitalize the world's countryside	NATURE			English	Editorial Material							CHINA		[Liu, Yansui] Chinese Acad Sci, IGSNRR, Ctr Reg Agr & Rural Dev, Beijing, Peoples R China; [Liu, Yansui] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China; [Li, Yuheng] Chinese Acad Sci, IGSNRR, Beijing, Peoples R China; [Li, Yuheng] Chinese Acad Sci, Ctr Assessment & Res Targeted Poverty Alleviat, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Normal University; Chinese Academy of Sciences; Chinese Academy of Sciences	Li, YH (corresponding author), Chinese Acad Sci, IGSNRR, Beijing, Peoples R China.; Li, YH (corresponding author), Chinese Acad Sci, Ctr Assessment & Res Targeted Poverty Alleviat, Beijing, Peoples R China.	liyuheng@igsnrr.ac.cn	Liu, Yansui/L-7289-2019; LIU, Yansui/T-6954-2019	Liu, Yansui/0000-0001-6636-7313; 				Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Carr Patrick J., 2009, HOLLOWING OUT MIDDLE; Li YH, 2016, J RURAL STUD, V47, P506, DOI 10.1016/j.jrurstud.2016.07.004; Li YH, 2012, GROWTH CHANGE, V43, P335, DOI 10.1111/j.1468-2257.2012.00588.x; Liu YS, 2014, LAND USE POLICY, V40, P6, DOI 10.1016/j.landusepol.2013.03.013; McLaughlin K, 2016, SCIENCE, V352, P283, DOI 10.1126/science.352.6283.283; Pierskalla JH, 2016, STUD COMP INT DEV, V51, P286, DOI 10.1007/s12116-015-9194-2; Wood R., 2008, SURVIVAL RURAL AM SM	8	528	757	132	568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					275	277		10.1038/548275a	http://dx.doi.org/10.1038/548275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8AU	28816262	Bronze			2022-12-28	WOS:000407748400011
J	Masood, E				Masood, Ehsan			A little democracy could go a long way	NATURE			English	Editorial Material												ehsan.masood@researchresearch.com							0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					261	261		10.1038/548261a	http://dx.doi.org/10.1038/548261a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8AU	28816266				2022-12-28	WOS:000407748400003
J	Cani, PD				Cani, Patrice D.			MICROBIOME Gut cell metabolism shapes the microbiome	SCIENCE			English	Editorial Material									[Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & Biotechnol, Metab & Nutr Res Grp, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO	Cani, PD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & Biotechnol, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	patrice.cani@uclouvain.be	D., Cani Patrice/M-8055-2016	D., Cani Patrice/0000-0003-2040-2448	Fonds de la Recherche Scientifique; European Research Council [336452-ENIGMO]; Fund for Strategic Fundamental Research-WELBIO; Funds Baillet Latour	Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); European Research Council(European Research Council (ERC)European Commission); Fund for Strategic Fundamental Research-WELBIO(WELBIO); Funds Baillet Latour	P.D.C. is a recipient of grants from Fonds de la Recherche Scientifique, European Research Council Starting grant 2013 (336452-ENIGMO), Fund for Strategic Fundamental Research-WELBIO, and the Funds Baillet Latour (Grant for Medical Research 2015).	Anhe FF, 2017, CAN J DIABETES, V41, P439, DOI 10.1016/j.jcjd.2017.02.002; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cabinian A, 2018, GUT, V67, P847, DOI 10.1136/gutjnl-2016-313214; Cani PD, 2017, NAT REV GASTRO HEPAT, V14, P321, DOI 10.1038/nrgastro.2017.54; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Everard A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6648; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rivera-Chavez F, 2017, FREE RADICAL BIO MED, V105, P93, DOI 10.1016/j.freeradbiomed.2016.09.022; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Spees A. M., 2013, MBIO, V4; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009	14	45	52	6	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					548	549		10.1126/science.aao2202	http://dx.doi.org/10.1126/science.aao2202			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798116				2022-12-28	WOS:000407324800023
J	Chen, WJ; Ozdemir, SK; Zhao, GM; Wiersig, J; Yang, L				Chen, Weijian; Ozdemir, Sahin Kaya; Zhao, Guangming; Wiersig, Jan; Yang, Lan			Exceptional points enhance sensing in an optical microcavity	NATURE			English	Article							NANOPARTICLES; CHIP; DEGENERACIES; LASERS	Sensors play an important part in many aspects of daily life such as infrared sensors in home security systems, particle sensors for environmental monitoring and motion sensors in mobile phones. High-quality optical microcavities are prime candidates for sensing applications because of their ability to enhance light-matter interactions in a very confined volume. Examples of such devices include mechanical transducers(1), magnetometers(2), single-particle absorption spectrometers(3), and microcavity sensors for sizing single particles(4) and detecting nanometre-scale objects such as single nanoparticles and atomic ions(5-7). Traditionally, a very small perturbation near an optical microcavity introduces either a change in the linewidth or a frequency shift or splitting of a resonance that is proportional to the strength of the perturbation. Here we demonstrate an alternative sensing scheme, by which the sensitivity of microcavities can be enhanced when operated at non-Hermitian spectral degeneracies known as exceptional points(8-16). In our experiments, we use two nanoscale scatterers to tune a whispering-gallery-mode micro-toroid cavity, in which light propagates along a concave surface by continuous total internal reflection, in a precise and controlled manner to exceptional points(12,13). A target nanoscale object that subsequently enters the evanescent field of the cavity perturbs the system from its exceptional point, leading to frequency splitting. Owing to the complex-square-root topology near an exceptional point, this frequency splitting scales as the square root of the perturbation strength and is therefore larger (for sufficiently small perturbations) than the splitting observed in traditional non-exceptional-point sensing schemes. Our demonstration of exceptional-point-enhanced sensitivity paves the way for sensors with unprecedented sensitivity.	[Chen, Weijian; Ozdemir, Sahin Kaya; Zhao, Guangming; Yang, Lan] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA; [Wiersig, Jan] Otto von Guericke Univ, Inst Theoret Phys, D-39016 Magdeburg, Germany	Washington University (WUSTL); Otto von Guericke University	Yang, L (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA.	yang@seas.wustl.edu	Yang, Lan/AAC-5390-2019; Ozdemir, Sahin Kaya/Y-9338-2019; Yang, Lan/AAC-5397-2019; Yang, Lan/B-5407-2018	Yang, Lan/0000-0002-9052-0450; Ozdemir, Sahin Kaya/0000-0002-2625-3992; Yang, Lan/0000-0002-9052-0450; Wiersig, Jan/0000-0003-2764-1660	National Science Foundation [EFMA1641109]; Army Research Office [W911NF1210026, W911NF1710189, W911NF1610339]; DFG [WI1986/6-1]	National Science Foundation(National Science Foundation (NSF)); Army Research Office; DFG(German Research Foundation (DFG))	This work was supported by the National Science Foundation (grant number EFMA1641109) and the Army Research Office (grant number s W911NF1210026, W911NF1710189 and W911NF1610339). J.W. acknowledges funding from the DFG (project number WI1986/6-1). We thank S. Rotter and X. F. Jiang for discussions.	Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Baaske MD, 2016, NAT PHOTONICS, V10, P733, DOI [10.1038/nphoton.2016.177, 10.1038/NPHOTON.2016.177]; Berry MV, 2004, CZECH J PHYS, V54, P1039, DOI 10.1023/B:CJOP.0000044002.05657.04; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Choi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153601; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; Ding K, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021007; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; Forstner S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120801; Gao T, 2015, NATURE, V526, P554, DOI 10.1038/nature15522; Gavartin E, 2012, NAT NANOTECHNOL, V7, P509, DOI [10.1038/nnano.2012.97, 10.1038/NNANO.2012.97]; He LN, 2013, LASER PHOTONICS REV, V7, P60, DOI 10.1002/lpor.201100032; He LN, 2011, NAT NANOTECHNOL, V6, P428, DOI [10.1038/nnano.2011.99, 10.1038/NNANO.2011.99]; Heiss WD, 2000, PHYS REV E, V61, P929, DOI 10.1103/PhysRevE.61.929; Heylman KD, 2016, NAT PHOTONICS, V10, P788, DOI [10.1038/nphoton.2016.217, 10.1038/NPHOTON.2016.217]; Lee SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.134101; Li BB, 2014, P NATL ACAD SCI USA, V111, P14657, DOI 10.1073/pnas.1408453111; Liu ZP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.110802; Lu T, 2011, IEEE J QUANTUM ELECT, V47, P320, DOI 10.1109/JQE.2010.2087742; Ozdemir SK, 2014, P NATL ACAD SCI USA, V111, pE3836, DOI 10.1073/pnas.1408283111; Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004; Peng B, 2016, P NATL ACAD SCI USA, V113, P6845, DOI 10.1073/pnas.1603318113; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Shao LB, 2013, ADV MATER, V25, P5616, DOI 10.1002/adma201302572; Vollmer F, 2012, NANOPHOTONICS-BERLIN, V1, P267, DOI 10.1515/nanoph-2012-0021; Wiersig J, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.033809; Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901; Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604; Zhen B, 2015, NATURE, V525, P354, DOI 10.1038/nature14889; Zhu JG, 2010, OPT EXPRESS, V18, P23535, DOI 10.1364/OE.18.023535; Zhu JG, 2010, NAT PHOTONICS, V4, P46, DOI 10.1038/NPHOTON.2009.237	33	851	857	49	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					192	+		10.1038/nature23281	http://dx.doi.org/10.1038/nature23281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796206				2022-12-28	WOS:000407284300039
J	Knop, E; Zoller, L; Ryser, R; Erpe, CG; Horler, M; Fontaine, C				Knop, Eva; Zoller, Leana; Ryser, Remo; Erpe, Christopher G.; Horler, Maurin; Fontaine, Colin			Artificial light at night as a new threat to pollination	NATURE			English	Article							ANIMAL MUTUALISTIC NETWORKS; NOCTURNAL POLLEN-TRANSPORT; PLANTS; COMMUNITIES; SYSTEMS	Pollinators are declining worldwide(1) and this has raised concerns for a parallel decline in the essential pollination service they provide to both crops and wild plants(2,3). Anthropogenic drivers linked to this decline include habitat changes, intensive agriculture, pesticides, invasive alien species, spread of pathogens and climate change(1). Recently, the rapid global increase in artificial light at night(4) has been proposed to be a new threat to terrestrial ecosystems; the consequences of this increase for ecosystem function are mostly unknown(5,6). Here we show that artificial light at night disrupts nocturnal pollination networks and has negative consequences for plant reproductive success. In artificially illuminated plant-pollinator communities, nocturnal visits to plants were reduced by 62% compared to dark areas. Notably, this resulted in an overall 13% reduction in fruit set of a focal plant even though the plant also received numerous visits by diurnal pollinators. Furthermore, by merging diurnal and nocturnal pollination sub-networks, we show that the structure of these combined networks tends to facilitate the spread of the negative consequences of disrupted nocturnal pollination to daytime pollinator communities. Our findings demonstrate that artificial light at night is a threat to pollination and that the negative effects of artificial light at night on nocturnal pollination are predicted to propagate to the diurnal community, thereby aggravating the decline of the diurnal community. We provide perspectives on the functioning of plant-pollinator communities, showing that nocturnal pollinators are not redundant to diurnal communities and increasing our understanding of the human-induced decline in pollinators and their ecosystem service.	[Knop, Eva; Zoller, Leana; Ryser, Remo; Erpe, Christopher G.; Horler, Maurin] Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland; [Fontaine, Colin] CNRS, UMR 7204, MNHN, Ctr Ecol & Sci Conservat, 61 Rue Buffon, F-75005 Paris, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Knop, E (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	evaknop@gmx.ch	Knop, Eva/D-2298-2018; Zoller, Leana/AAM-4525-2021	Knop, Eva/0000-0001-9402-2216; Zoller, Leana/0000-0002-7161-6529; Ryser, Remo/0000-0002-3771-8986	Swiss National Sciences Foundation	Swiss National Sciences Foundation(Swiss National Science Foundation (SNSF))	We thank all those who assisted with fieldwork, E. Thebault for discussions, M. Visser and M. Menz for comments that helped to improve this manuscript and D. Sanders for contributing to early ideas on the project. Furthermore, we are grateful to all experts who helped with identification of species: H.-P. Wymann (Lepidoptera), E. Obrecht (Diptera), S. Oertli (Hymenoptera) and C. Germann (Coleoptera). This study was supported by the Swiss National Sciences Foundation.	Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bennie J, 2016, J ECOL, V104, P611, DOI 10.1111/1365-2745.12551; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Clough Y, 2014, ECOL LETT, V17, P1168, DOI 10.1111/ele.12325; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Devoto M, 2011, ECOL ENTOMOL, V36, P25, DOI 10.1111/j.1365-2311.2010.01247.x; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Frank Kenneth D., 2006, P305; Gaston KJ, 2015, ENVIRON REV, V23, P14, DOI 10.1139/er-2014-0041; Gaston KJ, 2014, ENVIRON REV, V22, P323, DOI 10.1139/er-2014-0005; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Holker F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0130; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Macgregor CJ, 2017, GLOBAL CHANGE BIOL, V23, P697, DOI 10.1111/gcb.13371; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Rader R, 2016, P NATL ACAD SCI USA, V113, P146, DOI 10.1073/pnas.1517092112; Sauve AMC, 2016, ECOLOGY, V97, P908, DOI 10.1890/15-0132.1; Spoelstra K, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0129; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; Vanbergen AJ, 2014, FUNCT ECOL, V28, P178, DOI 10.1111/1365-2435.12191; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575	35	207	211	24	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					206	+		10.1038/nature23288	http://dx.doi.org/10.1038/nature23288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783730				2022-12-28	WOS:000407284300042
J	Tomasetti, C; Durrett, R; Kimmel, M; Lambert, A; Parmigiani, G; Zauber, A; Vogelstein, B				Tomasetti, Cristian; Durrett, Rick; Kimmel, Marek; Lambert, Amaury; Parmigiani, Giovanni; Zauber, Ann; Vogelstein, Bert			Role of stem-cell divisions in cancer risk	NATURE			English	Letter							RATES		[Tomasetti, Cristian] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat,Sidney Kimmel Canc Ctr, 550 North Broadway, Baltimore, MD 21205 USA; [Tomasetti, Cristian] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Durrett, Rick] Duke Univ, Dept Math, Durham, NC 27708 USA; [Kimmel, Marek] Rice Univ, Dept Stat, Houston, TX 77005 USA; [Lambert, Amaury] UMPC Univ Paris 06, Lab Probabilites & Modeles Aleatoires, F-75252 Paris, France; [Parmigiani, Giovanni] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Boston, MA 02115 USA; [Zauber, Ann] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr, 1650 Orleans St St, Baltimore, MD 21205 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, 1650 Orleans St St, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duke University; Rice University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Tomasetti, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat,Sidney Kimmel Canc Ctr, 550 North Broadway, Baltimore, MD 21205 USA.; Tomasetti, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	ctomasetti@jhu.edu						Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; GREINER TC, 1995, CANCER-AM CANCER SOC, V75, P370, DOI 10.1002/1097-0142(19950101)75:1+<370::AID-CNCR2820751319>3.0.CO;2-Q; Kort EJ, 2009, CANCER RES, V69, P6500, DOI 10.1158/0008-5472.CAN-09-0357; Lansdorp-Vogelaar I, 2012, CANCER EPIDEM BIOMAR, V21, P728, DOI 10.1158/1055-9965.EPI-12-0023; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Tomasetti C., 2015, PREPRINT; Tomasetti C, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6592; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	11	26	27	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					E13	E14		10.1038/nature23302	http://dx.doi.org/10.1038/nature23302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796214				2022-12-28	WOS:000407284300005
J	Scheeler, MW; van Rees, WM; Kedia, H; Kleckner, D; Irvine, WTM				Scheeler, Martin W.; van Rees, Wim M.; Kedia, Hridesh; Kleckner, Dustin; Irvine, William T. M.			Complete measurement of helicity and its dynamics in vortex tubes	SCIENCE			English	Article							BERRY TOPOLOGICAL PHASE; TURBULENCE; RECONNECTION; CONSERVATION; VORTICES	Helicity, a topological measure of the intertwining of vortices in a fluid flow, is a conserved quantity in inviscid fluids but can be dissipated by viscosity in real flows. Despite its relevance across a range of flows, helicity in real fluids remains poorly understood because the entire quantity is challenging to measure. We measured the total helicity of thin-core vortex tubes in water. For helical vortices that are stretched or compressed by a second vortex, we found conservation of total helicity. For an isolated helical vortex, we observed evolution toward and maintenance of a constant helicity state after the dissipation of twist helicity by viscosity. Our results show that helicity can remain constant even in a viscous fluid and provide an improved basis for understanding and manipulating helicity in real flows.	[Scheeler, Martin W.; Kedia, Hridesh; Kleckner, Dustin; Irvine, William T. M.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [van Rees, Wim M.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Irvine, William T. M.] Univ Chicago, James Franck Inst, 929 East 57th St, Chicago, IL 60637 USA; [Irvine, William T. M.] Univ Chicago, Enrico Fermi Inst, 929 East 57th St, Chicago, IL 60637 USA; [Irvine, William T. M.] Univ Calif Merced, 5200 Lake Rd, Merced, CA 95343 USA	University of Chicago; Harvard University; University of Chicago; University of Chicago; University of California System; University of California Merced	Irvine, WTM (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	wtmirvine@uchicago.edu		irvine, william/0000-0002-4925-2060; van Rees, Wim/0000-0001-6485-4804; Kleckner, Dustin/0000-0002-2043-1639	U.S. NSF [DMR-1351506]; Packard Foundation; Chicago MRSEC (U.S. NSF) [DMR 1420709]; Swiss National Science Foundation (SNF); Direct For Mathematical & Physical Scien [1351506] Funding Source: National Science Foundation	U.S. NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Chicago MRSEC (U.S. NSF); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded by U.S. NSF grant DMR-1351506 and the Packard Foundation. Additional support was provided by the Chicago MRSEC (U.S. NSF grant DMR 1420709), which is also gratefully acknowledged for access to its shared experimental facilities. W.M.v.R. thanks the Swiss National Science Foundation (SNF) for financial support.	ANDRE JC, 1977, J FLUID MECH, V81, P187, DOI 10.1017/S0022112077001979; AREF H, 1991, NATURE, V354, P50, DOI 10.1038/354050a0; BERGER MA, 1984, J FLUID MECH, V147, P133, DOI 10.1017/S0022112084002019; BERGER MA, 1984, GEOPHYS ASTRO FLUID, V30, P79, DOI 10.1080/03091928408210078; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; CHIAO RY, 1986, PHYS REV LETT, V57, P933, DOI 10.1103/PhysRevLett.57.933; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DOUADY S, 1991, PHYS REV LETT, V67, P983, DOI 10.1103/PhysRevLett.67.983; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; FRISCH U., 1995, TURBULENCE LEGACY AN; Gerz T, 2002, PROG AEROSP SCI, V38, P181, DOI 10.1016/S0376-0421(02)00004-0; Kadomtsev B. B., 1975, Fizika Plazmy, V1, P710; KIDA S, 1988, FLUID DYN RES, V4, P271, DOI 10.1016/0169-5983(88)90029-9; Kimura Y, 2014, J FLUID MECH, V751, P329, DOI 10.1017/jfm.2014.233; Kleckner D, 2016, NAT PHYS, V12, P650, DOI [10.1038/NPHYS3679, 10.1038/nphys3679]; Kleckner D, 2013, NAT PHYS, V9, P253, DOI [10.1038/nphys2560, 10.1038/NPHYS2560]; KRAICHNAN RH, 1973, J FLUID MECH, V59, P745, DOI 10.1017/S0022112073001837; LEVICH E, 1984, PHYS LETT A, V100, P53, DOI 10.1016/0375-9601(84)90354-2; Liang C. E., 2015, SCI REP, V5, P9224; LILLY DK, 1986, J ATMOS SCI, V43, P126, DOI 10.1175/1520-0469(1986)043<0126:TSEAPO>2.0.CO;2; Maggioni F, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026309; Melander M. V, 1988, P SUMM PROGR 1988, P257; Moffatt HK, 2014, P NATL ACAD SCI USA, V111, P3663, DOI 10.1073/pnas.1400277111; MOFFATT HK, 1992, ANNU REV FLUID MECH, V24, P281, DOI 10.1146/annurev.fl.24.010192.001433; MOFFATT HK, 1994, J FLUID MECH, V259, P241, DOI 10.1017/S002211209400011X; MOFFATT HK, 1992, P ROY SOC LOND A MAT, V439, P411, DOI 10.1098/rspa.1992.0159; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; PFISTER H, 1991, AM J PHYS, V59, P497, DOI 10.1119/1.16808; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Scheeler MW, 2014, P NATL ACAD SCI USA, V111, P15350, DOI 10.1073/pnas.1407232111; SONG Y, 1989, J GEOPHYS RES, V94, P5273, DOI 10.1029/JA094iA05p05273; Spalart PR, 1998, ANNU REV FLUID MECH, V30, P107, DOI 10.1146/annurev.fluid.30.1.107; TAYLOR JB, 1974, PHYS REV LETT, V33, P1139, DOI 10.1103/PhysRevLett.33.1139; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Thompson RL, 2007, WEATHER FORECAST, V22, P102, DOI 10.1175/WAF969.1; TOMITA A, 1986, PHYS REV LETT, V57, P937, DOI 10.1103/PhysRevLett.57.937; WAELBROECK FL, 1989, PHYS FLUIDS B-PLASMA, V1, P2372, DOI 10.1063/1.859172	38	74	75	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					487	490		10.1126/science.aam6897	http://dx.doi.org/10.1126/science.aam6897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774926				2022-12-28	WOS:000406840100034
J	Abderrahman, B; Jordan, VC				Abderrahman, Balkees; Jordan, V. Craig			Angela M. Hartley Brodie (1934-2017) OBITUARY	NATURE			English	Biographical-Item									[Abderrahman, Balkees] Univ Texas MD Anderson Canc Ctr, Breast Med Oncol, Houston, TX 77030 USA; [Jordan, V. Craig] Univ Texas MD Anderson Canc Ctr, Canc Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Abderrahman, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Breast Med Oncol, Houston, TX 77030 USA.	bhabderrahman@mdanderson.org; vcjordan@mdanderson.org	Abderrahman, Balkees/Z-2370-2019; JORDAN, V.Craig/AAX-3562-2020	Abderrahman, Balkees/0000-0001-9056-3453; 				BRODIE AH, PUBLICATION LIST	1	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					32	32		10.1038/548032a	http://dx.doi.org/10.1038/548032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770835	Bronze			2022-12-28	WOS:000406831700026
J	Niu, D; Wei, HJ; Lin, L; George, H; Wang, T; Lee, H; Zhao, HY; Wang, Y; Kan, YN; Shrock, E; Lesha, E; Wang, G; Luo, YL; Qing, YB; Jiao, DL; Zhao, H; Zhou, XY; Wang, SQ; Wei, H; Guell, M; Church, GM; Yang, LH				Niu, Dong; Wei, Hong-Jiang; Lin, Lin; George, Haydy; Wang, Tao; Lee, Hsiu; Zhao, Hong-Ye; Wang, Yong; Kan, Yinan; Shrock, Ellen; Lesha, Emal; Wang, Gang; Luo, Yonglun; Qing, Yubo; Jiao, Deling; Zhao, Heng; Zhou, Xiaoyang; Wang, Shouqi; Wei, Hong; Gueell, Marc; Church, George M.; Yang, Luhan			Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9	SCIENCE			English	Article							INFECTION; GENOMES; CELLS; PERVS	Xenotransplantation is a promising strategy to alleviate the shortage of organs for human transplantation. In addition to the concerns about pig-to-human immunological compatibility, the risk of cross-species transmission of porcine endogenous retroviruses (PERVs) has impeded the clinical application of this approach. We previously demonstrated the feasibility of inactivating PERV activity in an immortalized pig cell line. We now confirm that PERVs infect human cells, and we observe the horizontal transfer of PERVs among human cells. Using CRISPR-Cas9, we inactivated all of the PERVs in a porcine primary cell line and generated PERV-inactivated pigs via somatic cell nuclear transfer. Our study highlights the value of PERV inactivation to prevent cross-species viral transmission and demonstrates the successful production of PERV-inactivated animals to address the safety concern in clinical xenotransplantation.	[Niu, Dong; George, Haydy; Wang, Tao; Lee, Hsiu; Kan, Yinan; Lesha, Emal; Wang, Gang; Gueell, Marc; Church, George M.; Yang, Luhan] eGenesis, Cambridge, MA 02139 USA; [Niu, Dong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wei, Hong-Jiang; Zhao, Hong-Ye; Qing, Yubo; Jiao, Deling; Zhao, Heng] Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650201, Yunnan, Peoples R China; [Wei, Hong-Jiang; Qing, Yubo; Jiao, Deling; Zhao, Heng] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming 650201, Yunnan, Peoples R China; [Lin, Lin; Luo, Yonglun] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Wang, Yong; Zhou, Xiaoyang; Wei, Hong] Third Mil Med Univ, Dept Lab Anim Sci, Coll Basic Med Sci, Chongqing 400038, Peoples R China; [Shrock, Ellen; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Wang, Shouqi] Res Inst Shenzhen Jinxinnong Technol, Shenzhen 518106, Peoples R China; [Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Zhejiang University; Yunnan Agricultural University; Yunnan Agricultural University; Aarhus University; Army Medical University; Harvard University; Harvard Medical School; Harvard University	Yang, LH (corresponding author), eGenesis, Cambridge, MA 02139 USA.	luhan.yang@egenesisbio.com	Luo, Yonglun/C-4708-2013; Luo, Yonglun/AAG-9253-2020; Güell, Marc/AAB-3054-2021; Güell, Marc/J-2970-2017; Lesha, Emal/GXV-3245-2022	Luo, Yonglun/0000-0002-0007-7759; Güell, Marc/0000-0003-4000-7912; Güell, Marc/0000-0003-4000-7912; Shrock, Ellen/0000-0003-2484-4374; church, george/0000-0001-6232-9969; Lin, Lin/0000-0002-7546-4948	eGenesis; NIH [P50 HG005550]; Danish Research Council for Independent Research [DFF-1337-00128]; Sapere Aude Young Research Talent Prize [DFF-1335-00763]; Human Frontiers Science Program Long-Term Fellowship; Major Program on Basic Research Projects of Yunnan Province, China [2014FC006]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008525, P50HG005550] Funding Source: NIH RePORTER	eGenesis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Sapere Aude Young Research Talent Prize; Human Frontiers Science Program Long-Term Fellowship; Major Program on Basic Research Projects of Yunnan Province, China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Markmann from Massachusetts General Hospital and P. O'Connell from Sydney University for providing advice on xenotransplantation; J. Hu from the Alt lab at Boston Children's Hospital for assistance with junction capture sequencing; Y. Takeuchi from University College London for comments on virus interference; T. Ferrante from the Wyss Institute, Harvard University, for assistance with embryo imaging; and members of the Seidman lab at Harvard Medical School for advice regarding ddPCR. This study was mainly funded by eGenesis and was also funded by NIH grant P50 HG005550. Y.L. was funded by the Danish Research Council for Independent Research (grant DFF-1337-00128) and the Sapere Aude Young Research Talent Prize (grant DFF-1335-00763). M.G. was funded by a Human Frontiers Science Program Long-Term Fellowship. Some of the pig production was funded by the Major Program on Basic Research Projects of Yunnan Province, China (grant 2014FC006). PERV elements genotyping Illumina MiSeq data have been uploaded to the European Nucleotide Archive hosted by the European Bioinformatics Institute, with the submission reference PRJEB11222. L.Y. is the Chief Scientific Officer and board member of eGenesis. G.M.C. is the cofounder and scientific advisor of eGenesis. L.Y. is an inventor on provisional U.S. patent applications 62/487,898 and 62/527,702 that are submitted by eGenesis and cover PERV-inactivated pig production.	BENDINELLI M, 1985, ADV CANCER RES, V45, P125, DOI 10.1016/S0065-230X(08)60268-7; Denner J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080215; Deschamps JY, 2005, XENOTRANSPLANTATION, V12, P91, DOI 10.1111/j.1399-3089.2004.00199.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Shafran D, 2014, WORLD J SURG, V38, P1650, DOI 10.1007/s00268-014-2639-3; Wegman-Points LJ, 2014, REDOX BIOL, V2, P847, DOI 10.1016/j.redox.2014.06.006; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x	11	384	435	14	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357					1303	1307		10.1126/science.aan4187	http://dx.doi.org/10.1126/science.aan4187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7BX	28798043	Green Accepted			2022-12-28	WOS:000411337700048
J	Oberlander, J				Oberlander, Jonathan			Repeal, Replace, Repair, Retreat - Republicans' Health Care Quagmire	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.							Henry J., 2017, MED POCKET PRIMER; Malina D, 2017, NEW ENGL J MED, V377, DOI 10.1056/NEJMe1708506; Nather D, 2017, AXIOS           0707	3	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1001	1003		10.1056/NEJMp1710391	http://dx.doi.org/10.1056/NEJMp1710391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG6YC	28792847				2022-12-28	WOS:000410545200001
J	Wei, SC; Levine, JH; Cogdill, AP; Zhao, Y; Anang, NAAS; Andrews, MC; Sharma, P; Wang, J; Wargo, JA; Pe'er, D; Allison, JP				Wei, Spencer C.; Levine, Jacob H.; Cogdill, Alexandria P.; Zhao, Yang; Anang, Nana-Ama A. S.; Andrews, Miles C.; Sharma, Padmanee; Wang, Jing; Wargo, Jennifer A.; Pe'er, Dana; Allison, James P.			Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade	CELL			English	Article							REGULATORY T-CELLS; MASS CYTOMETRY; CANCER-IMMUNOTHERAPY; CTLA-4 BLOCKADE; COMBINATION IMMUNOTHERAPY; METASTATIC MELANOMA; PROGRAMMED DEATH-1; SOLID TUMORS; THERAPY; IMMUNE	Immune-checkpoint blockade is able to achieve durable responses in a subset of patients; however, we lack a satisfying comprehension of the underlying mechanisms of anti-CTLA-4- and anti-PD-1-induced tumor rejection. To address these issues, we utilized mass cytometry to comprehensively profile the effects of checkpoint blockade on tumor immune infiltrates in human melanoma and murine tumor models. These analyses reveal a spectrum of tumor-infiltrating T cell populations that are highly similar between tumor models and indicate that checkpoint blockade targets only specific subsets of tumor-infiltrating T cell populations. Anti-PD-1 predominantly induces the expansion of specific tumor-infiltrating exhausted-like CD8 T cell subsets. In contrast, anti-CTLA-4 induces the expansion of an ICOS+ Th1-like CD4 effector population in addition to engaging specific subsets of exhaustedlike CD8 T cells. Thus, our findings indicate that anti-CTLA-4 and anti-PD-1 checkpoint-blockade-induced immune responses are driven by distinct cellular mechanisms.	[Wei, Spencer C.; Cogdill, Alexandria P.; Anang, Nana-Ama A. S.; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Levine, Jacob H.; Pe'er, Dana] Sloan Kettering Inst, Computat & Syst Biol Program, New York, NY 10065 USA; [Cogdill, Alexandria P.; Andrews, Miles C.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Zhao, Yang; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Sharma, Padmanee; Wargo, Jennifer A.; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Parker Inst Canc Immunotherapy, Houston, TX 77030 USA; [Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wei, SC; Allison, JP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Allison, JP (corresponding author), Univ Texas MD Anderson Canc Ctr, Parker Inst Canc Immunotherapy, Houston, TX 77030 USA.	scwei@mdanderson.org; jallison@mdanderson.org		Pe'er, Dana/0000-0002-9259-8817; Andrews, Miles/0000-0003-1231-8641; Wei, Spencer/0000-0001-9673-9683; Anang, Nana-Ama/0000-0002-8495-2978; Allison, James/0000-0001-8980-5697; Cogdill, Alexandria/0000-0001-8917-9462	NCI Cancer Center Support Grant (CCSG) [P30CA016672]; Cancer Prevention and Research Institute of Texas (CPRIT) [R1203]; MDACC CCSG Bioinformatics Shared Resource [P30CA016672]; NIH [DP1-HD084071, R01CA164729, R01CA163793]; MSK Cancer Center Support Grant/Core Grant [P30CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA163793, P30CA008748, P30CA016672, K08CA160692, R01CA164729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant (CCSG); Cancer Prevention and Research Institute of Texas (CPRIT); MDACC CCSG Bioinformatics Shared Resource; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSK Cancer Center Support Grant/Core Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Duncan Mak for expert advice and technical assistance with mass cytometry analysis. Mass cytometry and cell sorting were performed at the MDACC Flow Cytometry and Cellular Imaging Core Facility, which is in part funded by NCI Cancer Center Support Grant (CCSG) P30CA016672. Sequencing was performed at the MDACC Sequencing and Microarray Facility, which is also in part funded by P30CA016672(SMF). This work was supported by a grant from Cancer Prevention and Research Institute of Texas (CPRIT) to J.P.A. (R1203), the MDACC CCSG Bioinformatics Shared Resource (P30CA016672 39), NIH grants to D.P. (DP1-HD084071 and R01CA164729), and a MSK Cancer Center Support Grant/Core Grant to D.P. (P30CA008748). S.C.W. is an MDACC Odyssey postdoctoral fellow. J.P.A. and P.S. are co-directors, and J.A.W. is a member of the Parker Institute for Cancer Immunotherapy. P.S. has consulted for AstraZeneca, Amgen, GlaxoSmithKline (GSK), and Bristol-Myers Squibb (BMS). P.S. serves on the scientific advisory boards for Jounce, Neon, Constellation, and Kite. P.S. is a co-founder of Jounce Therapeutics. P.S. received funding on NIH R01CA163793. M.C.A. has attended speakers' bureau with travel support from BMS and MSD. J.A.W. has received honoraria from speakers' bureau of Dava Oncology, BMS, and Illumina and is an advisory board member for GSK, Novartis, and Roche/Genentech. J.P.A. is a co-founder of Jounce and Neon Therapeutics, is an advisory board member for Jounce, Neon, Amgen, and Kite Pharmaceuticals, and has received royalties from intellectual property licensed to BMS and Merck.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Leelatian N, 2017, CYTOM PART B-CLIN CY, V92, P68, DOI 10.1002/cyto.b.21481; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Melchiotti R, 2017, CYTOM PART A, V91A, P73, DOI 10.1002/cyto.a.23001; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tanner SD, 2013, CANCER IMMUNOL IMMUN, V62, P955, DOI 10.1007/s00262-013-1416-8; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	54	692	722	15	263	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1120	1133		10.1016/j.cell.2017.07.024	http://dx.doi.org/10.1016/j.cell.2017.07.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28803728	Green Accepted, Bronze			2022-12-28	WOS:000409536000010
J	Ebmeier, S; Thayabaran, D; Braithwaite, I; Benamara, C; Weatherall, M; Beasley, R				Ebmeier, Stefan; Thayabaran, Darmiga; Braithwaite, Irene; Benamara, Clement; Weatherall, Mark; Beasley, Richard			Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012)	LANCET			English	Article							INHALED CORTICOSTEROIDS; NEW-ZEALAND; DEATHS; CERTIFICATION; CHILDHOOD; MORBIDITY; EPIDEMIC; RISK	Background International time trends in asthma mortality have been strongly affected by changes in management and in particular drug treatments. However, little is known about how asthma mortality has changed over the past decade. In this study, we assessed these international trends. Methods We collated age-standardised country-specific asthma mortality rates in the 5-34 year age group from the online WHO Mortality Database for 46 countries. To be included in the analysis, we specified that a country must have 10 years of complete data in the WHO Mortality Database between 1993 and 2012. In the absence of consistent and accurate asthma prevalence and prescribing data, we chose to use a locally weighted scatter plot smoother (LOESS) curve, weighted by the individual country population in the 5-34-year age group to show the global trends in asthma mortality rates with time. Findings Of the 46 countries included in the analysis of asthma mortality, 36 were high-income countries, and 10 were middle-income countries. The LOESS estimate of the global asthma mortality rate was 0.44 deaths per 100 000 people (90% CI 0.39-0.48) in 1993 and 0.19 deaths per 100 000 people (0.18-0.21) in 2006. Despite apparent further reductions in some countries and regions of the world, there was no appreciable change in global asthma mortality rates from 2006 through to 2012, when the LOESS estimate was also 0.19 deaths per 100 000 people (0.16-0.21). Interpretation The trend for reduction in global asthma mortality observed since the late 1980s might have stalled, with no appreciable difference in a smoothed LOESS curve of asthma mortality from 2006 to 2012. Although better implementation of established management strategies that have been shown to reduce mortality risk is needed, to achieve a further substantive reduction in global asthma mortality novel strategies will also be required.	[Ebmeier, Stefan; Thayabaran, Darmiga; Braithwaite, Irene; Benamara, Clement; Beasley, Richard] Med Res Inst New Zealand, Private Bag 7902, Wellington 6242, New Zealand; [Weatherall, Mark] Univ Otago Wellington, Dept Med, Wellington, New Zealand	Medical Research Institute Of New Zealand; University of Otago	Beasley, R (corresponding author), Med Res Inst New Zealand, Private Bag 7902, Wellington 6242, New Zealand.	richard.beasley@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019	Weatherall, Mark/0000-0002-0051-9107; Ebmeier, Stefan/0000-0001-7570-7172	Health Research Council of New Zealand Independent Research Organisation	Health Research Council of New Zealand Independent Research Organisation	The Medical Research Institute of New Zealand, which is supported by Health Research Council of New Zealand Independent Research Organisation.	Abramson MJ, 2001, AM J RESP CRIT CARE, V163, P12, DOI 10.1164/ajrccm.163.1.9910042; Agusti A, 2016, EUR RESPIR J, V47, P359; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; AIHW Australian Centre for Asthma Monitoring, 2005, AIHW ASTHM SER, V2; BEASLEY R, 1991, AUST NZ J MED, V21, P753, DOI 10.1111/j.1445-5994.1991.tb01385.x; Beasley R, 2001, AM J RESP CRIT CARE, V163, P3, DOI 10.1164/ajrccm.163.1.ed1400c; Beasley R, 1997, CIBA F SYMP, V206, P140; Beasley R, 1999, J ALLERGY CLIN IMMUN, V104, pS18, DOI 10.1016/S0091-6749(99)70270-8; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Burney P, 1996, EUR RESPIR J, V9, P687; Centers for Disease Control and Prevention, 2015, CDC WOND; CRANE J, 1989, LANCET, V1, P917; CRANE J, 1995, THORAX, V50, pS5, DOI 10.1136/thx.50.Suppl_1.S5; DiSantostefano RL, 2008, ANN ALLERG ASTHMA IM, V100, P558, DOI 10.1016/S1081-1206(10)60048-8; Freund RJ, 2000, SAS SYSTEM REGRESSIO, P150; Goeman DP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002539; Goldman M, 2000, J ALLERGY CLIN IMMUN, V105, P71, DOI 10.1016/S0091-6749(00)90180-5; Haahtela T, 2006, THORAX, V61, P663, DOI 10.1136/thx.2005.055699; JACKSON RT, 1982, BRIT MED J, V285, P771, DOI 10.1136/bmj.285.6344.771; Kumana CR, 2001, J ASTHMA, V38, P161, DOI 10.1081/JAS-100000035; Lim DL, 2006, THORAX, V61, P362, DOI 10.1136/thx.2005.050435; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; MELISSINOS CG, 1995, CHEST, V107, P1771, DOI 10.1378/chest.107.6.1771-b; MITCHELL EA, 1989, THORAX, V44, P81, DOI 10.1136/thx.44.2.81; Neffen H, 2006, RESP MED, V100, P1431, DOI 10.1016/j.rmed.2005.11.004; PEARCE N, 1995, LANCET, V345, P41, DOI 10.1016/S0140-6736(95)91159-6; Pearce N, 2000, ASTHMA RHINITIS, P58; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Reid DWEC, 1998, EUR RESPIR J, V12, P1079, DOI 10.1183/09031936.98.12051079; Royal College of Physicians, 2015, WHY ASTH STILL KILLS; SEARS MR, 1986, AM J EPIDEMIOL, V124, P1004, DOI 10.1093/oxfordjournals.aje.a114470; SO SY, 1990, RESP MED, V84, P457, DOI 10.1016/S0954-6111(08)80109-6; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; SPEIZER FE, 1968, BRIT MED J, V3, P245, DOI 10.1136/bmj.3.5612.245; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; Suissa S, 2001, J ALLERGY CLIN IMMUN, V107, P937, DOI 10.1067/mai.2001.115653; Suissa S, 2003, EUR RESPIR J, V21, P101, DOI 10.1183/09031936.03.00058503; Wijesinghe M, 2009, CHEST, V135, P1045, DOI 10.1378/chest.08-2082; World Health Organization (WHO), 2015, MORT DAT	39	153	162	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					935	945		10.1016/S0140-6736(17)31448-4	http://dx.doi.org/10.1016/S0140-6736(17)31448-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28797514				2022-12-28	WOS:000408746300023
J	Cheverud, J				Cheverud, James			GENETICS Role of mutation in fly-wing evolution	NATURE			English	Editorial Material							DROSOPHILA-MELANOGASTER; CONSTRAINTS; COVARIANCE; CHARACTERS; SELECTION; SHAPE; SIZE	Analysis of wing variation within and between fly species reveals an unexpectedly slow evolutionary rate. Variations due to mutation and interspecific differences are similar, perhaps as a result of complex genetic interactions. SEE LETTER P.447	[Cheverud, James] Loyola Univ, Dept Biol, Chicago, IL 60660 USA	Loyola University Chicago	Cheverud, J (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60660 USA.	jcheverud@luc.edu						CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Draghi J, 2008, EVOLUTION, V62, P301, DOI 10.1111/j.1558-5646.2007.00303.x; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Futuyma DJ, 2015, INTERDISC EVOL RES, V2, P29, DOI 10.1007/978-3-319-15045-1_2; GOULD SJ, 1982, SCIENCE, V216, P380, DOI 10.1126/science.7041256; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; Houle D, 2017, NATURE, V548, P447, DOI 10.1038/nature23473; Houle D, 2013, EVOLUTION, V67, P1116, DOI 10.1111/j.1558-5646.2012.01838.x; Jones AG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4709; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1980, GENETICS, V94, P203; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Melo D, 2015, P NATL ACAD SCI USA, V112, P470, DOI 10.1073/pnas.1322632112; Mezey JG, 2005, EVOLUTION, V59, P1027; Pavlicev M, 2015, ANNU REV ECOL EVOL S, V46, P413, DOI 10.1146/annurev-ecolsys-120213-091721	16	2	2	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					401	403		10.1038/nature23536	http://dx.doi.org/10.1038/nature23536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28792936				2022-12-28	WOS:000408279000026
J	Lyon, J				Lyon, Jeff			Open Access Data Tool for Cancer Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					689	689		10.1001/jama.2017.11202	http://dx.doi.org/10.1001/jama.2017.11202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829858				2022-12-28	WOS:000408095800005
J	Lyon, J				Lyon, Jeff			Vaccines Protect Fetus From Zika	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					689	689		10.1001/jama.2017.11200	http://dx.doi.org/10.1001/jama.2017.11200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829857				2022-12-28	WOS:000408095800004
J	Amini, S; Kolle, S; Petrone, L; Ahanotu, O; Sunny, S; Sutanto, CN; Hoon, S; Cohen, L; Weaver, JC; Aizenberg, J; Vogel, N; Miserez, A				Amini, Shahrouz; Kolle, Stefan; Petrone, Luigi; Ahanotu, Onyemaechi; Sunny, Steffi; Sutanto, Clarinda N.; Hoon, Shawn; Cohen, Lucas; Weaver, James C.; Aizenberg, Joanna; Vogel, Nicolas; Miserez, Ali			Preventing mussel adhesion using lubricant-infused materials	SCIENCE			English	Article							FOULING RELEASE COATINGS; ANTIFOULING COATINGS; FOOT PROTEIN; SURFACES; DESIGN; FRACTURE; DOPA	Mussels are opportunistic macrofouling organisms that can attach to most immersed solid surfaces, leading to serious economic and ecological consequences for the maritime and aquaculture industries. We demonstrate that lubricant-infused coatings exhibit very low preferential mussel attachment and ultralow adhesive strengths under both controlled laboratory conditions and in marine field studies. Detailed investigations across multiple length scales-from the molecular-scale characterization of deposited adhesive proteins to nanoscale contact mechanics to macroscale live observations-suggest that lubricant infusion considerably reduces fouling by deceiving the mechanosensing ability of mussels, deterring secretion of adhesive threads, and decreasing the molecular work of adhesion. Our study demonstrates that lubricant infusion represents an effective strategy to mitigate marine biofouling and provides insights into the physical mechanisms underlying adhesion prevention.	[Amini, Shahrouz; Petrone, Luigi; Sutanto, Clarinda N.; Miserez, Ali] Nanyang Technol Univ, Sch Mat Sci & Engn, Ctr Biomimet Sensor Sci, 50 Nanyang Ave, Singapore 639798, Singapore; [Amini, Shahrouz] NTU ERI N, Energy Res Inst, Singapore 637553, Singapore; [Kolle, Stefan; Ahanotu, Onyemaechi; Cohen, Lucas; Weaver, James C.; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, 60 Oxford St, Cambridge, MA 02138 USA; [Kolle, Stefan; Sunny, Steffi; Cohen, Lucas; Aizenberg, Joanna] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hoon, Shawn] Biomed Sci Inst, Mol Engn Lab, Agcy Sci Technol & Res, Singapore, Singapore; [Vogel, Nicolas] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Particle Technol, Haberstr 9A, D-91058 Erlangen, Germany; [Miserez, Ali] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Harvard University; Agency for Science Technology & Research (A*STAR); University of Erlangen Nuremberg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Miserez, A (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Ctr Biomimet Sensor Sci, 50 Nanyang Ave, Singapore 639798, Singapore.; Aizenberg, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, 60 Oxford St, Cambridge, MA 02138 USA.; Aizenberg, J (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Vogel, N (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Particle Technol, Haberstr 9A, D-91058 Erlangen, Germany.; Miserez, A (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	jaiz@seas.harvard.edu; nicolas.vogel@fau.de; ali.miserez@ntu.edu.sg	Weaver, James C./AAE-7870-2019; Miserez, Ali/CAF-2662-2022; Miserez, Ali/D-1074-2010	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170; Aizenberg, Joanna/0000-0002-2343-8705; Cohen, Lucas/0000-0001-5819-1872; Petrone, Luigi/0000-0002-3315-3981; Amini, Shahrouz/0000-0002-1928-2760	Singapore Maritime Institute (SMI) [SMI-2013-MA-03]; Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy [DE-AR0000326]; Office of Naval Research (ONR), U.S. Department of Defense [N00014-16-1-3169]; Deutsche Forschungsgemeinschaft (DFG) through the Cluster of Excellence Engineering of Advanced Materials [EXC 315]; Interdisciplinary Center for Functional Particle Systems (FPS); Stellwagen Bank National Marine Sanctuary	Singapore Maritime Institute (SMI); Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy(United States Department of Energy (DOE)); Office of Naval Research (ONR), U.S. Department of Defense; Deutsche Forschungsgemeinschaft (DFG) through the Cluster of Excellence Engineering of Advanced Materials(German Research Foundation (DFG)); Interdisciplinary Center for Functional Particle Systems (FPS); Stellwagen Bank National Marine Sanctuary	This study was funded by the Singapore Maritime Institute (SMI), grant SMI-2013-MA-03 (A.M.). This work was also funded by the Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy, under award DE-AR0000326, and by the Office of Naval Research (ONR), U.S. Department of Defense, under award N00014-16-1-3169. N.V. acknowledges funding of the Deutsche Forschungsgemeinschaft (DFG) through the Cluster of Excellence Engineering of Advanced Materials (EXC 315) and the Interdisciplinary Center for Functional Particle Systems (FPS). We thank A. Tesler for providing i-WO samples, D. Daniel for discussion on interfacial energies, E. Maldonado for help with the field study, and Stellwagen Bank National Marine Sanctuary for providing the field site and field site support. The transcriptome of P. viridis foot used to identify TRP channels is available at https://www.ncbi.nlm.nih.gov/nuccore/GEKL00000000. S.S., N.V., and J.A. are inventors on a patent application (US20150210951A1) submitted by Harvard University that covers LBL slippery liquid-infused porous surfaces (SLIPS). J.A. is an inventor on a U.S. Patent Application (#14/414,291) submitted by Harvard University that covers 3D SLIPS. J.A. is the founder of the start-up company SLIPS Technologies, Inc.	Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299; Bruchmann J, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601082; Burkett JR, 2009, J ADHESION, V85, P601, DOI 10.1080/00218460902996903; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Chapman JW, 2003, CONSERV BIOL, V17, P1386, DOI 10.1046/j.1523-1739.2003.01016.x; CHAUDHURY MK, 1993, J ADHES SCI TECHNOL, V7, P669, DOI 10.1163/156856193X00907; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Chung JY, 2005, J ADHESION, V81, P1119, DOI 10.1080/00218460500310887; Cui JX, 2015, NAT MATER, V14, P790, DOI [10.1038/NMAT4325, 10.1038/nmat4325]; Danner EW, 2012, BIOCHEMISTRY-US, V51, P6511, DOI 10.1021/bi3002538; Desmond KW, 2015, SOFT MATTER, V11, P6832, DOI 10.1039/c5sm01072a; Drr S., 2010, BIOFOULING; Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109; Flemming H.C., 2009, MARINE IND BIOFOULIN; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kinloch A.J., 1987, ADHESION ADHESIVES S; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v; Li JS, 2013, ACS APPL MATER INTER, V5, P6704, DOI 10.1021/am401532z; Lipkin DM, 1996, ACTA MATER, V44, P1287, DOI 10.1016/1359-6454(95)00300-2; MacCallum N, 2015, ACS BIOMATER SCI ENG, V1, P43, DOI 10.1021/ab5000578; Maier GP, 2015, SCIENCE, V349, P628, DOI 10.1126/science.aab0556; Manna U, 2016, ADV FUNCT MATER, V26, P3599, DOI 10.1002/adfm.201505522; Miserez A, 2004, ACTA MATER, V52, P1337, DOI 10.1016/j.actamat.2003.11.019; Petrone L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9737; Qin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3187; Railkin AI, 2004, MARINE BIOFOULING CO; RICE JR, 1989, MAT SCI ENG A-STRUCT, V107, P23, DOI 10.1016/0921-5093(89)90372-9; Rodriguez NRM, 2015, BIOFOULING, V31, P221, DOI 10.1080/08927014.2015.1026337; Salta M, 2010, PHILOS T R SOC A, V368, P4729, DOI 10.1098/rsta.2010.0195; Schellenberger F, 2015, SOFT MATTER, V11, P7617, DOI 10.1039/c5sm01809a; Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809; Smith JD, 2013, SOFT MATTER, V9, P1772, DOI 10.1039/c2sm27032c; Sunny S, 2016, P NATL ACAD SCI USA, V113, P11676, DOI 10.1073/pnas.1605272113; Sunny S, 2014, ADV FUNCT MATER, V24, P6658, DOI 10.1002/adfm.201401289; SUO Z, 1993, ACTA METALL MATER, V41, P1551, DOI 10.1016/0956-7151(93)90263-R; Tesler AB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9649; Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Wang ST, 2015, CHEM REV, V115, P8230, DOI 10.1021/cr400083y; Wei W, 2014, ACTA BIOMATER, V10, P1663, DOI 10.1016/j.actbio.2013.09.007; Wei W, 2013, J AM CHEM SOC, V135, P377, DOI 10.1021/ja309590f; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Xiao LL, 2013, ACS APPL MATER INTER, V5, P10074, DOI 10.1021/am402635p; Yu J, 2013, P NATL ACAD SCI USA, V110, P15680, DOI 10.1073/pnas.1315015110	48	272	280	52	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					668	+		10.1126/science.aai8977	http://dx.doi.org/10.1126/science.aai8977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818939				2022-12-28	WOS:000407793600030
J	Cole, TJ; Altman, DG				Cole, Tim J.; Altman, Douglas G.			Statistics Notes: Percentage differences, symmetry, and natural logarithms	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Cole, Tim J.] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England	University of London; University College London; University of Oxford	Cole, TJ (corresponding author), UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England.	tim.cole@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/M012069/1] Funding Source: researchfish; MRC [MR/M012069/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bland JM, 1996, BRIT MED J, V312, P700; Bland JM, 1996, BRIT MED J, V312, P1079; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Bland JM, 1996, BRIT MED J, V312, P770; Cole TJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3663; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x	7	24	25	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3683	10.1136/bmj.j3683	http://dx.doi.org/10.1136/bmj.j3683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814563	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000408228300004
J	Landi, SM; Freiwald, WA				Landi, Sofia M.; Freiwald, Winrich A.			Two areas for familiar face recognition in the primate brain	SCIENCE			English	Article							RESPONSE PATTERNS; UNFAMILIAR FACES; MACAQUE; OBJECTS; CORTEX; IDENTITY; NEURONS; SYSTEM; MONKEY; REPRESENTATIONS	Familiarity alters face recognition: Familiar faces are recognized more accurately than unfamiliar ones and under difficult viewing conditions when unfamiliar face recognition fails. The neural basis for this fundamental difference remains unknown. Using whole-brain functional magnetic resonance imaging, we found that personally familiar faces engage the macaque face-processing network more than unfamiliar faces. Familiar faces also recruited two hitherto unknown face areas at anatomically conserved locations within the perirhinal cortex and the temporal pole. These two areas, but not the core face-processing network, responded to familiar faces emerging from a blur with a characteristic nonlinear surge, akin to the abruptness of familiar face recognition. In contrast, responses to unfamiliar faces and objects remained linear. Thus, two temporal lobe areas extend the core face-processing network into a familiar face-recognition system.	[Landi, Sofia M.; Freiwald, Winrich A.] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA	Rockefeller University	Landi, SM; Freiwald, WA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	slandi@rockefeller.edu; wfreiwald@rockefeller.edu		Freiwald, Winrich/0000-0001-8456-5030	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Howard Hughes Medical Institute International Student Research Fellowship; Center for Brains, Minds, and Machines - National Science Foundation STC award [CCF-1231216]; National Eye Institute of the National Institutes of Health [R01 EY021594]; National Institute of Mental Health of the National Institutes of Health [R01 MH105397]; Human Frontier Science Program [RGP0015/2013]; McKnight Foundation; Pew Charitable Trust; The New York Stem Cell Foundation; NATIONAL EYE INSTITUTE [R01EY021594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105397] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Center for Brains, Minds, and Machines - National Science Foundation STC award; National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Human Frontier Science Program(Human Frontier Science Program); McKnight Foundation; Pew Charitable Trust; The New York Stem Cell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Gonzalez, M. Cano-Vinas, I. Sani, and S. Shepherd for help with animal training and data collection; J. Sliwa for discussion of methods; veterinary services and animal husbandry staff of The Rockefeller University for care of the subjects; and C. Jiang from the Biostatistics Team of The Rockefeller University for her assistance with statistics. Unfamiliar face stimuli were obtained from the PrimFace database (http://visiome.neuroinf.jp/primface), funded by a Grant-in-Aid for Scientific Research on Innovative Areas, "Face Perception and Recognition" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was supported by the Howard Hughes Medical Institute International Student Research Fellowship (to S.M.L.), the Center for Brains, Minds, and Machines funded by National Science Foundation STC award CCF-1231216, the National Eye Institute of the National Institutes of Health (R01 EY021594 to W.A.F.), the National Institute of Mental Health of the National Institutes of Health (R01 MH105397, to W.A.F.), Human Frontier Science Program (RGP0015/2013 to W.A.F.), the McKnight Foundation (to W.A.F.), the Pew Charitable Trust (to W.A.F.), and The New York Stem Cell Foundation (to W.A.F.). W.A.F. is a New York Stem Cell Foundation Robertson Investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Data are available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.10g45.	Axelrod V, 2013, NEUROIMAGE, V81, P371, DOI 10.1016/j.neuroimage.2013.05.015; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUCE V, 1982, BRIT J PSYCHOL, V73, P105, DOI 10.1111/j.2044-8295.1982.tb01795.x; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Carbon CC, 2008, PERCEPTION, V37, P801, DOI 10.1068/p5789; Collins JA, 2014, NEUROPSYCHOLOGIA, V61, P65, DOI 10.1016/j.neuropsychologia.2014.06.005; Conway CA, 2008, J VISION, V8, DOI 10.1167/8.3.17; Eifuku S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018913; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Fisher C, 2015, P NATL ACAD SCI USA, V112, P14717, DOI 10.1073/pnas.1512378112; Fisher C, 2015, CURR BIOL, V25, P261, DOI 10.1016/j.cub.2014.11.038; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Furl N, 2012, J NEUROSCI, V32, P15952, DOI 10.1523/JNEUROSCI.1992-12.2012; Gentileschi V, 2001, COGN NEUROPSYCHOL, V18, P439, DOI 10.1080/02643290125835; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kondo H, 2003, J COMP NEUROL, V465, P499, DOI 10.1002/cne.10842; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moss HE, 2005, CEREB CORTEX, V15, P616, DOI 10.1093/cercor/bhh163; Mur M, 2010, CEREB CORTEX, V20, P2027, DOI 10.1093/cercor/bhp272; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Natu V, 2011, BRIT J PSYCHOL, V102, P726, DOI 10.1111/j.2044-8295.2011.02053.x; Natu VS, 2015, NEUROIMAGE, V108, P151, DOI 10.1016/j.neuroimage.2014.12.027; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ramon M, 2015, P NATL ACAD SCI USA, V112, pE4835, DOI 10.1073/pnas.1414929112; Schwartz L, 2016, J EXP PSYCHOL GEN, V145, P1493, DOI 10.1037/xge0000220; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; Sliwa J, 2011, P NATL ACAD SCI USA, V108, P1735, DOI 10.1073/pnas.1008169108; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Tyler LK, 2013, J COGNITIVE NEUROSCI, V25, P1723, DOI 10.1162/jocn_a_00419; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	47	60	61	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					591	595		10.1126/science.aan1139	http://dx.doi.org/10.1126/science.aan1139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798130	Green Accepted			2022-12-28	WOS:000407324800041
J	Lee, P				Lee, Peter			Terence John Cain OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		CAIN TJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2017	358								j3851	10.1136/bmj.j3851	http://dx.doi.org/10.1136/bmj.j3851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7YF	28801342				2022-12-28	WOS:000407741300001
J	Nguyen, AT; Prado, MA; Schmidt, PJ; Sendamarai, AK; Wilson-Grady, JT; Min, MW; Campagna, DR; Tian, G; Shi, Y; Dederer, V; Kawan, M; Kuehnle, N; Paulo, JA; Yao, Y; Weiss, MJ; Justice, MJ; Gygi, SP; Fleming, MD; Finley, D				Nguyen, Anthony T.; Prado, Miguel A.; Schmidt, Paul J.; Sendamarai, Anoop K.; Wilson-Grady, Joshua T.; Min, Mingwei; Campagna, Dean R.; Tian, Geng; Shi, Yuan; Dederer, Verena; Kawan, Mona; Kuehnle, Nathalie; Paulo, Joao A.; Yao, Yu; Weiss, Mitchell J.; Justice, Monica J.; Gygi, Steven P.; Fleming, Mark D.; Finley, Daniel			UBE2O remodels the proteome during terminal erythroid differentiation	SCIENCE			English	Article							RETICULOCYTE MATURATION; UBIQUITIN PROTEASE; RIBOSOMES; AUTOPHAGY; MONOUBIQUITINATION; ERYTHROPOIESIS; UBIQUITYLATION; ACTIVATION; INHIBITION; STARVATION	During terminal differentiation, the global protein complement is remodeled, as epitomized by erythrocytes, whose cytosol is similar to 98% globin. The erythroid proteome undergoes a rapid transition at the reticulocyte stage; however, the mechanisms driving programmed elimination of preexisting cytosolic proteins are unclear. We found that a mutation in the murine Ube2o gene, which encodes a ubiquitin-conjugating enzyme induced during erythropoiesis, results in anemia. Proteomic analysis suggested that UBE2O is a broad-spectrum ubiquitinating enzyme that remodels the erythroid proteome. In particular, ribosome elimination, a hallmark of reticulocyte differentiation, was defective in Ube2o(-/-) mutants. UBE2O recognized ribosomal proteins and other substrates directly, targeting them to proteasomes for degradation. Thus, in reticulocytes, the induction of ubiquitinating factors may drive the transition from a complex to a simple proteome.	[Nguyen, Anthony T.; Prado, Miguel A.; Wilson-Grady, Joshua T.; Min, Mingwei; Tian, Geng; Shi, Yuan; Dederer, Verena; Kawan, Mona; Kuehnle, Nathalie; Paulo, Joao A.; Gygi, Steven P.; Finley, Daniel] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Schmidt, Paul J.; Sendamarai, Anoop K.; Campagna, Dean R.; Fleming, Mark D.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Schmidt, Paul J.; Sendamarai, Anoop K.; Campagna, Dean R.; Fleming, Mark D.] Harvard Med Sch, Boston, MA 02115 USA; [Yao, Yu; Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Justice, Monica J.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Genet & Genome Biol Program, Toronto, ON M5G 0A4, Canada; [Min, Mingwei] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Shi, Yuan] Univ Calif Los Angeles, Dept Mol & Clin Pharmacol, Los Angeles, CA 90095 USA; [Dederer, Verena; Kawan, Mona; Kuehnle, Nathalie] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; Ruprecht Karls University Heidelberg	Finley, D (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Fleming, MD (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.; Fleming, MD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mark.fleming@childrens.harvard.edu; daniel_finley@hms.harvard.edu	MIN, MINGWEI/Y-8296-2019; Paulo, Joao/AAO-3981-2020; Prado, Miguel A/P-3922-2017; Weiss, Mitchell J/W-9814-2018; Knapp, Stefan/AAG-2347-2019	MIN, MINGWEI/0000-0002-9050-5330; Paulo, Joao/0000-0002-4291-413X; Prado, Miguel A/0000-0002-4914-1619; Weiss, Mitchell J/0000-0003-2460-3036; Knapp, Stefan/0000-0001-5995-6494; Nguyen, Anthony/0000-0003-0181-4623; Sendamarai, Anoop/0000-0002-0476-5428; Fleming, Mark/0000-0003-0948-4024	NIH [5R21HL116210, 5R01HL125710, T32GM007753, HL124980, DK098285, U01 HD39372, R01 CA115503]; Biogen-Idec [6780680-01]; Diamond Blackfan Anemia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL124980, R21HL116210, R01HL125710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen-Idec(Biogen); Diamond Blackfan Anemia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Special thanks to S. Elsasser for bioinformatics analysis of Ube2o, and to B. Wadas for characterizing autophagy inhibitors. We thank M. Hegde for communicating results prior to publication. Supported by NIH grants 5R21HL116210 and 5R01HL125710, Biogen-Idec grant 6780680-01, and the Diamond Blackfan Anemia Foundation (D.F. and M.D.F.); NIH Medical Scientist Training Program grant T32GM007753 and NIH F30 grant HL124980 (A.T.N.); NIH K01 grant DK098285 (J.A.P.); and NIH grants U01 HD39372 and R01 CA115503 (M.J.J.). We thank R. King, C. Widmaier, S. de Poot, K. Y. Hung, and D. Brown for advice and assistance. Hem9 mice are available from M.J.J. under a material transfer agreement with Baylor College of Medicine. The data presented in this paper are tabulated in the main paper and the supplementary materials.	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; BENDEROFF S, 1978, MEMBRANE BIOCHEM, V1, P89, DOI 10.3109/09687687809064161; Berleth ES, 1996, BIOCHEMISTRY-US, V35, P1664, DOI 10.1021/bi952105y; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Braten O, 2016, P NATL ACAD SCI USA, V113, pE4639, DOI 10.1073/pnas.1608644113; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Geminard C, 2002, BIOCELL, V26, P205; GLOWACKI ER, 1965, J MOL BIOL, V11, P116, DOI 10.1016/S0022-2836(65)80177-2; HALDEMAN MT, 1995, J BIOL CHEM, V270, P9507, DOI 10.1074/jbc.270.16.9507; Hass A. L., 1991, RED BLOOD CELL AGING, P191; Higgins R, 2015, MOL CELL, V59, P35, DOI 10.1016/j.molcel.2015.04.026; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kozlowski LP, 2017, NUCLEIC ACIDS RES, V45, pD1112, DOI 10.1093/nar/gkw978; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Liang K., 2017, CELL, V168, DOI [10.1016/j.cell.2016.12.011, DOI 10.1016/J.CELL.2016.12.011;PMID:28065413]; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Pestov DG, 2012, MOL CELL BIOL, V32, P2135, DOI 10.1128/MCB.06763-11; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; SHAEFFER JR, 1988, J BIOL CHEM, V263, P13663; Silva GM, 2015, NAT STRUCT MOL BIOL, V22, P116, DOI 10.1038/nsmb.2955; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; WEFES I, 1995, P NATL ACAD SCI USA, V92, P4982, DOI 10.1073/pnas.92.11.4982; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Zhang T, 2016, CELL REP, V14, P2426, DOI 10.1016/j.celrep.2016.02.040; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38	46	87	89	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350							eaan0218	10.1126/science.aan0218	http://dx.doi.org/10.1126/science.aan0218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774900	Green Accepted			2022-12-28	WOS:000406840100029
J	Chawla, DS				Chawla, Dalmeet Singh			Big names in statistics want to shake up much-maligned P value	NATURE			English	News Item																			0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					16	+		10.1038/nature.2017.22375	http://dx.doi.org/10.1038/nature.2017.22375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770857	Bronze			2022-12-28	WOS:000406831700009
J	Enriquez, P				Enriquez, Paul			GM-food regulations: engage the public	NATURE			English	Letter									[Enriquez, Paul] North Carolina State Univ, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Enriquez, P (corresponding author), North Carolina State Univ, Raleigh, NC 27695 USA.	penriqu@ncsu.edu		Enriquez, Paul/0000-0002-1987-0183				JUSKEVICH JC, 1990, SCIENCE, V249, P875, DOI 10.1126/science.2203142; Nature Editorial, 2017, NATURE, V546, P327	2	0	0	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					31	31		10.1038/548031b	http://dx.doi.org/10.1038/548031b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770832	Bronze			2022-12-28	WOS:000406831700022
J	Lane, R				Lane, Richard			Profile Fowzan Alkuraya: leading light in Saudi Human Genome Program	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					446	446		10.1016/S0140-6736(17)31908-6	http://dx.doi.org/10.1016/S0140-6736(17)31908-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792402				2022-12-28	WOS:000406463400014
J	Swartz, AW; Eberth, JM; Josey, MJ; Strayer, SM				Swartz, Andrew W.; Eberth, Jan M.; Josey, Michele J.; Strayer, Scott M.			Reanalysis of All-Cause Mortality in the US Preventive Services Task Force 2016 Evidence Report on Colorectal Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Letter									[Swartz, Andrew W.] Yukon Kuskokwim Delta Reg Hosp, Bethel, AK 99559 USA; [Eberth, Jan M.; Josey, Michele J.; Strayer, Scott M.] Univ South Carolina, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia	Swartz, AW (corresponding author), Yukon Kuskokwim Delta Reg Hosp, Bethel, AK 99559 USA.		Eberth, Jan M./A-1335-2014	Eberth, Jan M./0000-0001-9500-4212; Swartz, Andrew/0000-0001-9267-9820	American Cancer Society [MRSG-15-148-01-CPHPS]; National Institutes of Health, National Institute of General Medical Sciences [T32-GM081740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081740] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Eberth is supported in part by a Mentored Research Scholar Grant from the American Cancer Society (MRSG-15-148-01-CPHPS). Ms. Josey is supported in part by grant T32-GM081740 from the National Institutes of Health, National Institute of General Medical Sciences.	[Anonymous], 2010, R LANG ENV STAT COMP; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P2411, DOI 10.1001/jama.2014.14695; JULIOUS SA, 1994, BRIT MED J, V309, P1480, DOI 10.1136/bmj.309.6967.1480; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332	5	20	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2017	167	8					602	603		10.7326/M17-0859	http://dx.doi.org/10.7326/M17-0859			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ9JM	28828493	Green Accepted			2022-12-28	WOS:000413092700027
J	Ory, DS; Ottinger, EA; Farhat, NY; King, KA; Jiang, XT; Weissfeld, L; Berry-Kravis, E; Davidson, CD; Bianconi, S; Keener, LA; Rao, R; Soldatos, A; Sidhu, R; Walters, KA; Xu, X; Thurm, A; Solomon, B; Pavan, WJ; Machielse, BN; Kao, M; Silber, SA; Mckew, JC; Brewer, CC; Vite, CH; Walkley, SU; Austin, CP; Porter, FD				Ory, Daniel S.; Ottinger, Elizabeth A.; Farhat, Nicole Yanjanin; King, Kelly A.; Jiang, Xuntian; Weissfeld, Lisa; Berry-Kravis, Elizabeth; Davidson, Cristin D.; Bianconi, Simona; Keener, Lee Ann; Rao, Ravichandran; Soldatos, Ariane; Sidhu, Rohini; Walters, Kimberly A.; Xu, Xin; Thurm, Audrey; Solomon, Beth; Pavan, William J.; Machielse, Bernardus N.; Kao, Mark; Silber, Steven A.; Mckew, John C.; Brewer, Carmen C.; Vite, Charles H.; Walkley, Steven U.; Austin, Christopher P.; Porter, Forbes D.			Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial	LANCET			English	Article							HEPATOCELLULAR-CARCINOMA; MIGLUSTAT THERAPY; CALBINDIN-D; CYCLODEXTRIN; CHOLESTEROL; PATIENT; BIOMARKER; CHILDREN; STORAGE; BRAIN	Background Niemann-Pick disease, type C1 (NPC1) is a lysosomal storage disorder characterised by progressive neurodegeneration. In preclinical testing, 2-hydroxypropyl-beta-cyclodextrins (HP beta CD) significantly delayed cerebellar Purkinje cell loss, slowed progression of neurological manifestations, and increased lifespan in mouse and cat models of NPC1. The aim of this study was to assess the safety and efficacy of lumbar intrathecal HP beta CD. Methods In this open-label, dose-escalation phase 1-2a study, we gave monthly intrathecal HP beta CD to participants with NPC1 with neurological manifestation at the National Institutes of Health (NIH), Bethesda, MD, USA. To explore the potential effect of 2-week dosing, three additional participants were enrolled in a parallel study at Rush University Medical Center (RUMC), Chicago, IL, USA. Participants from the NIH were non-randomly, sequentially assigned in cohorts of three to receive monthly initial intrathecal HP beta CD at doses of 50, 200, 300, or 400 mg per month. A fifth cohort of two participants received initial doses of 900 mg. Participants from RUMC initially received 200 or 400 mg every 2 weeks. The dose was escalated based on tolerance or safety data from higher dose cohorts. Serum and CSF 24(S)-hydroxycholesterol (24[S]-HC), which serves as a biomarker of target engagement, and CSF protein biomarkers were evaluated. NPC Neurological Severity Scores (NNSS) were used to compare disease progression in HP beta CD-treated participants relative to a historical comparison cohort of 21 NPC1 participants of similar age range. Findings Between Sept 21, 2013, and Jan 19, 2015, 32 participants with NPC1 were assessed for eligibility at the National Institutes of Health. 18 patients were excluded due to inclusion criteria not met (six patients), declined to participate (three patients), pursued independent expanded access and obtained the drug outside of the study (three patients), enrolled in the RUMC cohort (one patient), or too late for the trial enrolment (five patients). 14 patients were enrolled and sequentially assigned to receive intrathecal HP beta CD at a starting dose of 50 mg per month (three patients), 200 mg per month (three patients), 300 mg per month (three patients), 400 mg per month (three patients), or 900 had treatment interrupted at 17 months due to hepatocellular carcinoma, one patient had dose interruption for 2 doses based on caregiver hardship and one patient had treatment interrupted for 1 dose for mastoiditis. 11 patients were assessed at 18 months. Between Dec 11, 2013, and June 25, 2014, three participants were assessed for eligibility and enrolled at RUMC, and were assigned to receive intrathecal HP beta CD at a starting dose of 200 mg every 2 weeks (two patients), or 400 mg every two weeks (one patient). There were no dropouts in this group and all 3 patients were assessed at 18 months. Biomarker studies were consistent with improved neuronal cholesterol homoeostasis and decreased neuronal pathology. Post-drug plasma 24(S)-HC area under the curve (AUC 8-72) values, an indicator of neuronal cholesterol homoeostasis, were significantly higher than post-saline plasma 24(S)-HC AUC 8-72 after doses of 900 mg (p=0.0063) and 1200 mg (p=0.0037). CSF 24(S)-HC concentrations in three participants given either 600 or 900 mg of HP beta CD were increased about two fold (p=0.0032) after drug administration. No drug-related serious adverse events were observed. Mid-frequency to high-frequency hearing loss, an expected adverse event, was documented in all participants. When managed with hearing aids, this did not have an appreciable effect on daily communication. The NNSS for the 14 participants treated monthly increased at a rate of 1.22, SEM 0.34 points per year compared with 2.92, SEM 0.27 points per year (p=0.0002) for the 21 patient comparison group. Decreased progression was observed for NNSS domains of ambulation (p=0.0622), cognition (p=0.0040) and speech (p=0.0423). Interpretation Patients with NPC1 treated with intrathecal HP beta CD had slowed disease progression with an acceptable safety profile. These data support the initiation of a multinational, randomised, controlled trial of intrathecal HP beta CD. Funding National Institutes of Health, Dana's Angels Research Trust, Ara Parseghian Medical Research Foundation, Hope for Haley, Samantha's Search for the Cure Foundation, National Niemann-Pick Disease Foundation, Support of Accelerated Research for NPC Disease, Vtesse, Janssen Research and Development, a Johnson & Johnson company, and Johnson & Johnson.	[Ory, Daniel S.; Jiang, Xuntian; Sidhu, Rohini] Washington Univ, Sch Med, St Louis, MO USA; [Ottinger, Elizabeth A.; Mckew, John C.; Austin, Christopher P.] NIH, Natl Ctr Adv Translat Sci, Dept Hlth & Human Serv, Bldg 10, Bethesda, MD 20892 USA; [Farhat, Nicole Yanjanin; Bianconi, Simona; Keener, Lee Ann; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [King, Kelly A.; Brewer, Carmen C.] Natl Inst Deafness & Other Commun Disorders, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Weissfeld, Lisa; Walters, Kimberly A.] Stat Collaborat, Washington, DC USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Davidson, Cristin D.; Walkley, Steven U.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Rao, Ravichandran; Machielse, Bernardus N.] Vtesse Inc, Gaithersburg, MD USA; [Soldatos, Ariane] NINDS, NIH, Dept Hlth & Human Serv, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Thurm, Audrey] NIMH, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Solomon, Beth] NIH, Mark O Hatfield Clin Res Ctr, Dept Hlth & Human Serv, Bldg 10, Bethesda, MD 20892 USA; [Pavan, William J.] NHGRI, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kao, Mark] Janssen R&D, Preclin Dev & Safety, Raritan, NJ USA; [Silber, Steven A.] Johnson & Johnson, Global Publ Hlth, Philadelphia, PA USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Rush University; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johnson & Johnson; Johnson & Johnson USA; University of Pennsylvania	Porter, FD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Translat Med, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	fdporter@mail.nih.gov	Davidson, Cristin/AAA-2733-2020; Sidhu, Rohini/G-3547-2012; Davidson, Cristin/F-4889-2017	Davidson, Cristin/0000-0002-5508-8113; Sidhu, Rohini/0000-0003-1703-2167; Davidson, Cristin/0000-0002-5508-8113; Pavan, William/0000-0001-8281-5120; soldatos, ariane/0000-0003-3570-5230	National Institutes of Health; Dana's Angels Research Trust; Ara Parseghian Medical Research Foundation; Samantha's Search for the Cure Foundation; National Niemann-Pick Disease Foundation; Accelerated Research for NPC Disease; Vtesse; Janssen Research and Development; Johnson & Johnson company; Johnson Johnson; Hadley Hope Fund; Hope for Hayley; Hide & Seek Foundation; International Niemann-Pick Disease Alliance; Niemann-Pick UK; Samantha's Search for the Cure; Support Of Accelerated Research for NPC Disease; Addi Cassi Fund; Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; National Institute on Deafness and Other Communication Disorders, NIH; National Center for Advancing Translational Sciences, NIH; Department of Health and Human Services; Clinical Center Bench-to-Bedside award program; NIH [R01 N5081985, R01 N5073661]; NCATS/NCI [HHSN261200800001E]; Hope for Hayley Foundation; NICHD Clinical Trials Database Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZIAHD008825] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000369] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073661, R01NS081985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIDDC000075, ZIADC000064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana's Angels Research Trust; Ara Parseghian Medical Research Foundation; Samantha's Search for the Cure Foundation; National Niemann-Pick Disease Foundation; Accelerated Research for NPC Disease; Vtesse; Janssen Research and Development; Johnson & Johnson company(Johnson & JohnsonJohnson & Johnson USA); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Hadley Hope Fund; Hope for Hayley; Hide & Seek Foundation; International Niemann-Pick Disease Alliance; Niemann-Pick UK; Samantha's Search for the Cure; Support Of Accelerated Research for NPC Disease; Addi Cassi Fund; Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; National Institute on Deafness and Other Communication Disorders, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences, NIH; Department of Health and Human Services; Clinical Center Bench-to-Bedside award program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS/NCI; Hope for Hayley Foundation; NICHD Clinical Trials Database Team; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institutes of Health, Dana's Angels Research Trust, Ara Parseghian Medical Research Foundation, Hope for Haley, Samantha's Search for the Cure Foundation, National Niemann-Pick Disease Foundation, Support of Accelerated Research for NPC Disease, Vtesse, Janssen Research and Development, a Johnson & Johnson company, and Johnson & Johnson.; The authors express their appreciation to the caregivers and patients who participated in this study, to all the members of the NPC1 community who contributed to this effort, and to the family organisations that provided support: Ara Parseghian Medical Research Foundation, Dana's Angels Research Trust, Hadley Hope Fund, Hope for Hayley, Hide & Seek Foundation, International Niemann-Pick Disease Alliance, National Niemann-Pick Disease Foundation, Niemann-Pick UK, Samantha's Search for the Cure, Support Of Accelerated Research for NPC Disease, and The Addi & Cassi Fund. This work was supported by funding from the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (FDP), the National Institute on Deafness and Other Communication Disorders (CCB), and the National Center for Advancing Translational Sciences (EAO, CPA, XX and JM), NIH, Department of Health and Human Services, the Clinical Center Bench-to-Bedside award program (FDP, DSO, WJP), and by NIH Grants R01 N5081985 (DSO) and R01 N5073661 (CHV) and by contract HHSN261200800001E from NCATS/NCI (DSO). Support was provided by grants from the Dana's Angels Research Trust (DSO and FDP), Ara Parseghian Medical Research Foundation (FDP, CHV), Hope for Hayley and Samantha's Search for the Cure Foundations (EBK), National Niemann-Pick Disease Foundation (CHV) and Support Of Accelerated Research for NPC Disease (DSO, SUW, CDD and CHV). Data management was supported by the NICHD Clinical Trials Database Team. The authors are deeply appreciative for the assistance provided by numerous individuals who contributed to the successful completion of this study. These include Marcus Brewster, Karim Calis, Jamie Chin, Stephanie Cologna, James Cradock, Nuria Carrillo, Cristina Csimma, Hope Decederfelt, Marc DeMeulder, Cristan Farmer, George Grimes, Alan Hubbs, Marjo Janssen, Roopa Kanakatti Shankar, Kristen Lewis, Aiyi Liu, Leonza Machielse, Juan Marugan, Lili Portilla, Ilona Scott, Judith Starling, Sury Vepa, Chris Zalewski, and Wei Zheng. HP beta CD was provided by Janssen Research & Development, a Johnson & Johnson company. The authors and the NPC community are indebted to Johnson & Johnson for their support in helping to move the initial development of this drug forward. To Dillon, a kid who showed us how to live life in spite of a devastating disease.	Garcia-Robles AA, 2016, J NEUROL SCI, V366, P65, DOI 10.1016/j.jns.2016.04.048; Birch NC, 2003, J PEDIATR GASTR NUTR, V37, P624, DOI 10.1097/00005176-200311000-00023; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bradbury A, 2016, J PHARMACOL EXP THER, V358, P254, DOI 10.1124/jpet.116.232975; Chien YH, 2013, MOL GENET METAB, V109, P231, DOI 10.1016/j.ymgme.2013.04.003; Clark J G, 1981, ASHA, V23, P493; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Desikan RS, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-39; GARTNER JC, 1986, PEDIATRICS, V77, P104; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Harari O, 2014, BIOL PSYCHIAT, V75, P723, DOI 10.1016/j.biopsych.2013.11.032; Imrie J, 2007, J INHERIT METAB DIS, V30, P51, DOI 10.1007/s10545-006-0384-7; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; King KA, 2014, EAR HEARING, V35, P110, DOI 10.1097/AUD.0b013e3182a362b8; KIYOSAWA K, 1993, J NEUROL SCI, V118, P29, DOI 10.1016/0022-510X(93)90241-P; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Matsuo M, 2014, MOL GENET METAB REP, V1, P391, DOI 10.1016/j.ymgmr.2014.08.004; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0284-z; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; Pennington DJ, 1996, PEDIATR RADIOL, V26, P220, DOI 10.1007/BF01405304; PIKUS A, 1991, ANN NY ACAD SCI, V630, P313, DOI 10.1111/j.1749-6632.1991.tb19618.x; Pontikis CC, 2013, J INHERIT METAB DIS, V36, P491, DOI 10.1007/s10545-012-9583-x; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023666; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Tortelli B, 2014, HUM MOL GENET, V23, P6022, DOI 10.1093/hmg/ddu331; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vite C.H., 2015, SCI TRANSL MED, V7, p276ra26, DOI DOI 10.1126/SCI; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969	37	185	189	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1758	1768		10.1016/S0140-6736(17)31465-4	http://dx.doi.org/10.1016/S0140-6736(17)31465-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ6GB	28803710	Green Accepted, Bronze			2022-12-28	WOS:000412853100028
J	Beck, RW; Riddlesworth, TD; Ruedy, K; Ahmann, A; Haller, S; Kruger, D; McGill, JB; Polonsky, W; Price, D; Aronoff, S; Aronson, R; Toschi, E; Kollman, C; Bergenstal, R				Beck, R. W.; Riddlesworth, T. D.; Ruedy, K.; Ahmann, A.; Haller, S.; Kruger, D.; McGill, J. B.; Polonsky, W.; Price, D.; Aronoff, S.; Aronson, R.; Toschi, E.; Kollman, C.; Bergenstal, R.		DIAMOND Study Grp	Continuous Glucose Monitoring in Patients With Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					I20	I20		10.7326/P17-9044	http://dx.doi.org/10.7326/P17-9044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828488				2022-12-28	WOS:000411009900002
J	Sopko, NA; Burnett, AL				Sopko, Nikolai A.; Burnett, Arthur L.			Penile transplantation is here	LANCET			English	Editorial Material							PHALLOPLASTY; MICROPENIS		[Burnett, Arthur L.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Burnett, AL (corresponding author), Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA.	aburnet1@jhmi.edu	Sopko, Nikolai/AAL-2036-2020	Sopko, Nikolai/0000-0003-4913-0570				Callens N, 2013, J SEX MED, V10, P2890, DOI 10.1111/jsm.12298; El-Bahnasawy MS, 2004, INT J IMPOT RES, V16, P521, DOI 10.1038/sj.ijir.3901222; Kayes O, 2012, NAT REV UROL, V9, P499, DOI 10.1038/nrurol.2012.150; Kepe T, 2010, SOC SCI MED, V70, P729, DOI 10.1016/j.socscimed.2009.11.016; Leonard DA, 2013, TRANSPLANTATION, V95, P403, DOI 10.1097/TP.0b013e31826d886d; Massanyi EZ, 2013, J UROLOGY, V190, P1577, DOI 10.1016/j.juro.2012.12.050; Rodrigue JR, 2017, AM J TRANSPLANT, V17, P2687, DOI 10.1111/ajt.14302; Sopko NA, 2017, J UROLOGY, V198, P274, DOI 10.1016/j.juro.2016.10.134; Sopko NA, 2017, EUR UROL, V71, P584, DOI 10.1016/j.eururo.2016.07.006; Tuffaha SH, 2017, TRANSPL INT, V30, P441, DOI 10.1111/tri.12928; van der Merwe A, 2017, LANCET	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1008	1010		10.1016/S0140-6736(17)31933-5	http://dx.doi.org/10.1016/S0140-6736(17)31933-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28823495				2022-12-28	WOS:000409528600006
J	Cimmino, L; Dolgalev, I; Wang, YB; Yoshimi, A; Martin, GH; Wang, JJ; Ng, V; Xia, B; Witkowski, MT; Mitchell-Flack, M; Grillo, I; Bakogianni, S; Ndiaye-Lobry, D; Martin, MT; Guillamot, M; Banh, RS; Xu, MJ; Figueroa, ME; Dickins, RA; Abdel-Wahab, O; Park, CY; Tsirigos, A; Neel, BG; Aifantis, I				Cimmino, Luisa; Dolgalev, Igor; Wang, Yubao; Yoshimi, Akihide; Martin, Gaelle H.; Wang, Jingjing; Ng, Victor; Xia, Bo; Witkowski, Matthew T.; Mitchell-Flack, Marisa; Grillo, Isabella; Bakogianni, Sofia; Ndiaye-Lobry, Delphine; Martin, Miguel Torres; Guillamot, Maria; Banh, Robert S.; Xu, Mingjiang; Figueroa, Maria E.; Dickins, Ross A.; Abdel-Wahab, Omar; Park, Christopher Y.; Tsirigos, Aristotelis; Neel, Benjamin G.; Aifantis, Iannis			Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; VITAMIN-C; DNA DEMETHYLATION; ASCORBIC-ACID; HYPOMETHYLATING AGENTS; STEM-CELLS; LOSS LEADS; CANCER; METHYLATION; HYPERMETHYLATION	Loss-of-function mutations in TET2 occur frequently in patients with clonal hematopoiesis, myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML) and are associated with a DNA hypermethylation phenotype. To determine the role of TET2 deficiency in leukemia stem cell maintenance, we generated a reversible transgenic RNAi mouse to model restoration of endogenous Tet2 expression. Tet2 restoration reverses aberrant hematopoietic stem and progenitor cell (HSPC) self-renewal in vitro and in vivo. Treatment with vitamin C, a cofactor of Fe2+ and alpha-KG-dependent dioxygenases, mimics TET2 restoration by enhancing 5-hydroxymethylcytosine formation in Tet2-deficient mouse HSPCs and suppresses human leukemic colony formation and leukemia progression of primary human leukemia PDXs. Vitamin C also drives DNA hypomethylation and expression of a TET2-dependent gene signature in human leukemia cell lines. Furthermore, TET-mediated DNA oxidation induced by vitamin C treatment in leukemia cells enhances their sensitivity to PARP inhibition and could provide a safe and effective combination strategy to selectively target TET deficiency in cancer.	[Cimmino, Luisa; Dolgalev, Igor; Martin, Gaelle H.; Wang, Jingjing; Ng, Victor; Xia, Bo; Witkowski, Matthew T.; Mitchell-Flack, Marisa; Grillo, Isabella; Bakogianni, Sofia; Ndiaye-Lobry, Delphine; Guillamot, Maria; Park, Christopher Y.; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Cimmino, Luisa; Dolgalev, Igor; Wang, Yubao; Wang, Jingjing; Witkowski, Matthew T.; Mitchell-Flack, Marisa; Grillo, Isabella; Bakogianni, Sofia; Ndiaye-Lobry, Delphine; Guillamot, Maria; Banh, Robert S.; Tsirigos, Aristotelis; Neel, Benjamin G.; Aifantis, Iannis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Dolgalev, Igor; Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10016 USA; [Yoshimi, Akihide; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Yoshimi, Akihide; Abdel-Wahab, Omar] Weill Cornell Med Coll, New York, NY 10065 USA; [Martin, Miguel Torres; Figueroa, Maria E.] Univ Miami, Dept Human Genet, Miller Sch Med, Miami, FL 33136 USA; [Xu, Mingjiang] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Dickins, Ross A.] Monash Univ, Australian Ctr Blood Dis, Clayton, Vic 3004, Australia	New York University; New York University; New York University; Memorial Sloan Kettering Cancer Center; Cornell University; University of Miami; University of Miami; Monash University	Cimmino, L; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Cimmino, L; Neel, BG; Aifantis, I (corresponding author), NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	luisa.cimmino@nyumc.org; benjamin.neel@nyumc.org; iannis.aifantis@nyumc.org	Xia, Bo/AAD-7499-2020; Figueroa, Maria/AAE-8662-2019; wang, jing/GRS-7509-2022; Dolgalev, Igor/AAY-6406-2020; wang, jing/GVT-8700-2022; Yoshimi, Akihide/I-3792-2019; Dickins, Ross A/K-2852-2012; WANG, JINGYI/GSJ-1241-2022	Xia, Bo/0000-0003-0929-7253; Dolgalev, Igor/0000-0003-4451-126X; Yoshimi, Akihide/0000-0002-0664-7281; Dickins, Ross A/0000-0003-4112-5304; Torres Martin, Miguel/0000-0003-1589-8936; Figueroa, Maria Eugenia/0000-0003-4887-4981; Witkowski, Matthew/0000-0003-1434-4288; Tsirigos, Aristotelis/0000-0002-7512-8477; Martin, Gaelle/0000-0001-8849-9413	Cancer Center Support Grant [P30 CA016887]; US NIH [RO1 CA216421, R01 CA194923, R01 CA169784, R01 CA133379, R01CA149655, 5R01CA173636, R01 CA49132]; Leukemia & Lymphoma Society [6340-11, 6373-13]; Feinberg Lymphoma Pilot Grant; Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; Howard Hughes Medical Institute; New York State Department of Health [CO030132]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA216421, R01CA133379, R01CA149655, R01CA049152, R01CA194923, R01CA202025, R01CA173636, R01CA169784] Funding Source: NIH RePORTER	Cancer Center Support Grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Feinberg Lymphoma Pilot Grant; Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York State Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Mark. D. Minden from the Princess Margaret Cancer Center (Toronto, Canada) for providing primary AML patient samples. We would like to thank Mirimus Inc for expertise in generation and analysis of the ShTet2 animals. We also thank the NYU School of Medicine core facilities including High Performance Computing, Flow Cytometry the Genome Technology Center, Experimental Pathology and Microscopy. The New York University Langone Medical Center Experimental Pathology Research Laboratory (New York, NY, USA) and Microscopy Laboratory (New York, NY, USA) are supported by Cancer Center Support Grant P30 CA016887. This research was supported by the US NIH (RO1 CA216421, R01 CA194923, R01 CA169784, R01 CA133379, R01CA149655, 5R01CA173636, and R01 CA49132), the Leukemia & Lymphoma Society (TRP#6340-11 and LLS#6373-13), Feinberg Lymphoma Pilot Grant (to L.C.), The Chemotherapy Foundation, The V Foundation for Cancer Research, Alex's Lemonade Stand Foundation for Childhood Cancer, St. Baldrick's Cancer Research Foundation (to L.C. and I.A.), and the Howard Hughes Medical Institute (to I.A.). The work was also supported by the New York State Department of Health (CO030132).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; CAMERON E, 1979, CANCER RES, V39, P663; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Ciccarone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046927; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Fritz H, 2014, INTEGR CANCER THER, V13, P280, DOI 10.1177/1534735414534463; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guillamot M, 2016, TRENDS CANCER, V2, P70, DOI 10.1016/j.trecan.2015.12.006; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kawada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062717; Kim WI, 2007, EXP HEMATOL, V35, P1231, DOI 10.1016/j.exphem.2007.04.012; Kosmider O, 2009, HAEMATOL-HEMATOL J, V94, P1676, DOI 10.3324/haematol.2009.011205; Liu MM, 2016, P NATL ACAD SCI USA, V113, P10238, DOI 10.1073/pnas.1612262113; Morales JC, 2014, CRIT REV EUKAR GENE, V24, P15, DOI 10.1615/CritRevEukaryotGeneExpr.2013006875; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Padayatty SJ, 2016, ORAL DIS, V22, P463, DOI 10.1111/odi.12446; Pan F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15102; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rasmussen KD, 2015, GENE DEV, V29, P910, DOI 10.1101/gad.260174.115; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Young JI, 2015, ANNU REV NUTR, V35, P545, DOI 10.1146/annurev-nutr-071714-034228; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zeidan AM, 2014, CURR OPIN HEMATOL, V21, P123, DOI 10.1097/MOH.0000000000000016	44	389	401	8	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1079	1095		10.1016/j.cell.2017.07.032	http://dx.doi.org/10.1016/j.cell.2017.07.032			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28823558	Bronze, Green Accepted			2022-12-28	WOS:000409536000007
J	Driscoll, LN; Pettit, NL; Minderer, M; Chettih, SN; Harvey, CD				Driscoll, Laura N.; Pettit, Noah L.; Minderer, Matthias; Chettih, Selmaan N.; Harvey, Christopher D.			Dynamic Reorganization of Neuronal Activity Patterns in Parietal Cortex	CELL			English	Article							VISUAL-CORTEX; VIRTUAL-NAVIGATION; SPATIAL NAVIGATION; DECISION-MAKING; NEURAL CIRCUITS; REPRESENTATIONS; MULTIPLE; MEMORY; DEPRIVATION; STABILITY	Neuronal representations change as associations are learned between sensory stimuli and behavioral actions. However, it is poorly understood whether representations for learned associations stabilize in cortical association areas or continue to change following learning. We tracked the activity of posterior parietal cortex neurons for a month as mice stably performed a virtual-navigation task. The relationship between cells' activity and task features was mostly stable on single days but underwent major reorganization over weeks. The neurons informative about task features (trial type and maze locations) changed across days. Despite changes in individual cells, the population activity had statistically similar properties each day and stable information for over a week. As mice learned additional associations, new activity patterns emerged in the neurons used for existing representations without greatly affecting the rate of change of these representations. We propose that dynamic neuronal activity patterns could balance plasticity for learning and stability for memory.	[Driscoll, Laura N.; Pettit, Noah L.; Minderer, Matthias; Chettih, Selmaan N.; Harvey, Christopher D.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harvey, CD (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	harvey@hms.harvard.edu			Burroughs-Wellcome Fund Career Award at the Scientific Interface; Searle Scholars Program; New York Stem Cell Foundation; Alfred P. Sloan Research Foundation; NARSAD Brain and Behavior Research Young Investigator Award; NIH grant from the NIMH BRAINS program [R01MH107620]; NIH grant from NINDS [R01NS089521]; Armenise-Harvard Foundation Junior Faculty Grant; Edward R. and Anne G. Lefler Center Predoctoral Fellowship; Junior Faculty Award; Albert J. Ryan Fellowship; Stuart H.Q. and Victoria Quan Fellowship; Boehringer Ingelheim Fonds Fellowship; Herchel Smith Graduate Fellowship; NSF Graduate Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089521] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; New York Stem Cell Foundation; Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); NARSAD Brain and Behavior Research Young Investigator Award; NIH grant from the NIMH BRAINS program; NIH grant from NINDS; Armenise-Harvard Foundation Junior Faculty Grant; Edward R. and Anne G. Lefler Center Predoctoral Fellowship; Junior Faculty Award; Albert J. Ryan Fellowship; Stuart H.Q. and Victoria Quan Fellowship; Boehringer Ingelheim Fonds Fellowship(Boehringer Ingelheim); Herchel Smith Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Tim O'Leary, Ofer Mazor, and the Harvey lab for comments on the manuscript; Paola Patella for contributing to the setup of the optogenetics experiments; and the Research Instrumentation Core at Harvard Medical School. This work was supported by a Burroughs-Wellcome Fund Career Award at the Scientific Interface, the Searle Scholars Program, the New York Stem Cell Foundation, the Alfred P. Sloan Research Foundation, a NARSAD Brain and Behavior Research Young Investigator Award, NIH grants from the NIMH BRAINS program (R01MH107620) and NINDS (R01NS089521), an Armenise-Harvard Foundation Junior Faculty Grant, an Edward R. and Anne G. Lefler Center Predoctoral Fellowship (L.N.D.) and Junior Faculty Award, the Albert J. Ryan Fellowship (L.N.D.), the Stuart H.Q. and Victoria Quan Fellowship (L.N.D. and N.L.P.), a Boehringer Ingelheim Fonds Fellowship (M.M.), a Herchel Smith Graduate Fellowship (M.M.), and a NSF Graduate Research Fellowship (S.N.C.). C.D.H. is a New York Stem Cell Foundation Robertson Neuroscience Investigator.	Ajemian R, 2013, P NATL ACAD SCI USA, V110, pE5078, DOI 10.1073/pnas.1320116110; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Goard MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.13764; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kappel D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004485; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Liberti WA, 2016, NAT NEUROSCI, V19, P1665, DOI 10.1038/nn.4405; Licata AM, 2017, J NEUROSCI, V37, P4954, DOI 10.1523/JNEUROSCI.0105-17.2017; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Morcos AS, 2016, NAT NEUROSCI, V19, P1672, DOI 10.1038/nn.4403; Mouse A., 2016, ALLEN MOUSE COMMON C; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; Padoa-Schioppa C, 2004, J NEUROPHYSIOL, V91, P449, DOI 10.1152/jn.00876.2002; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Rose T, 2016, SCIENCE, V352, P1319, DOI 10.1126/science.aad3358; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Stevenson IH, 2011, J NEUROPHYSIOL, V106, P764, DOI 10.1152/jn.00626.2010; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	47	136	137	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					986	+	999.e16	10.1016/j.cell.2017.07.021	http://dx.doi.org/10.1016/j.cell.2017.07.021			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28823559	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000408372400016
J	Lyon, J				Lyon, Jeff			Even the Eye Has a Microbiome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					689	689		10.1001/jama.2017.10599	http://dx.doi.org/10.1001/jama.2017.10599			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829856				2022-12-28	WOS:000408095800003
J	Cornwall, W				Cornwall, Warren			RIVER RESTORATION U.S.-Mexico water pact aims for a greener Colorado delta	SCIENCE			English	News Item																			0	0	0	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					635	635		10.1126/science.357.6352.635	http://dx.doi.org/10.1126/science.357.6352.635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818924				2022-12-28	WOS:000407793600012
J	Leykum, LK; O'Leary, K				Leykum, Luci K.; O'Leary, Kevin			Inpatient Notes: Sensemaking-Fostering a Shared Understanding in Clinical Teams	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTCOMES; ROUNDS		South Texas Vet Hlth Care Syst, San Antonio, TX USA; UT Sch Med San Antonio, San Antonio, TX USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Northwestern University; Feinberg School of Medicine	Leykum, LK (corresponding author), UT Hlth San Antonio, Dept Med, Div Gen & Hosp Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Leykum@uthscsa.edu		O'Leary, Kevin/0000-0003-4715-5790				Leykum LK, 2015, J GEN INTERN MED, V30, P1821, DOI 10.1007/s11606-015-3377-4; O'Leary KJ, 2016, J HOSP MED, V11, P524, DOI 10.1002/jhm.2587; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Weick K.E., 1995, SENSEMAKING ORG	5	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					HO2	HO3		10.7326/M17-1829	http://dx.doi.org/10.7326/M17-1829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806812				2022-12-28	WOS:000407797500001
J	Savage, B				Savage, Brian			GEOPHYSICS A seismic shift in continental tectonic plates	SCIENCE			English	Editorial Material							MANTLE CONVECTION; LITHOSPHERE		[Savage, Brian] Univ Rhode Isl, Dept Geosci, 9 East Alumni Ave,317 Woodward Hall, Kingston, RI 02881 USA	University of Rhode Island	Savage, B (corresponding author), Univ Rhode Isl, Dept Geosci, 9 East Alumni Ave,317 Woodward Hall, Kingston, RI 02881 USA.	savage@uri.edu						Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Fischer KM, 2010, ANNU REV EARTH PL SC, V38, P551, DOI 10.1146/annurev-earth-040809-152438; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; JORDAN TH, 1978, NATURE, V274, P544, DOI 10.1038/274544a0; Lenardic A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001859; Miller MS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044366; Rader E, 2015, GEOCHEM GEOPHY GEOSY, V16, P3484, DOI 10.1002/2015GC005943; Savage B, 2017, EARTH PLANET SC LETT, V459, P394, DOI 10.1016/j.epsl.2016.11.028; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; Tharimena S, 2017, SCIENCE, V357, P580, DOI 10.1126/science.aan0741; Yuan HY, 2010, NATURE, V466, P1063, DOI 10.1038/nature09332; Zhu HJ, 2012, NAT GEOSCI, V5, P493, DOI 10.1038/ngeo1501	12	0	0	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					549	550		10.1126/science.aao1285	http://dx.doi.org/10.1126/science.aao1285			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798117				2022-12-28	WOS:000407324800024
J	Tharimena, S; Rychert, C; Harmon, N				Tharimena, Saikiran; Rychert, Catherine; Harmon, Nicholas			A unified continental thickness from seismology and diamonds suggests a melt-defined plate	SCIENCE			English	Article							LITHOSPHERIC MANTLE BENEATH; MOLTEN UPPER-MANTLE; THERMAL STRUCTURE; BOUNDARY; VELOCITY; TOMOGRAPHY; EVOLUTION; CRATON; MODEL; SR	Thick, rigid continents move over the weaker underlying mantle, although geophysical and geochemical constraints on the exact thickness and defining mechanism of the continental plates are widely discrepant. Xenoliths suggest a chemical continental lithosphere similar to 175 kilometers thick, whereas seismic tomography supports a much thicker root (>250 kilometers) and a gradual lithosphere-asthenosphere transition, consistent with a thermal definition. We modeled SS precursor waveforms from continental interiors and found a 7 to 9% velocity drop at depths of 130 to 190 kilometers. The discontinuity depth is well correlated with the origin depths of diamond-bearing xenoliths and corresponds to the transition from coarse to deformed xenoliths. At this depth, the xenolith-derived geotherm also intersects the carbonate-silicate solidus, suggesting that partial melt defines the plate boundaries beneath the continental interior.	[Tharimena, Saikiran; Rychert, Catherine; Harmon, Nicholas] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Tharimena, S (corresponding author), Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England.	s.tharimena@noc.soton.ac.uk		Rychert, Catherine/0000-0001-5071-793X; Tharimena, Saikiran/0000-0002-1841-1911; Harmon, Nicholas/0000-0002-0731-768X	Natural Environment Research Council [NE/M003507/1]; European Research Council [GA 638665]; NERC [NE/M003507/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank H. Grutter for providing data sources from his extended abstract from the 8th International Kimberlite Conference, T. Gernon and M. De Wit for their comments on an earlier version of the manuscript, and the anonymous reviewers for their insightful comments. The seismic data used in this study are available at the Incorporated Research Institutions for Seismology (IRIS) data management center (http://ds.iris.edu/ds/nodes/dmc) and were downloaded using the Standing Order for Data (SOD) package (http://seis.sc.edu/sod). Supported by Natural Environment Research Council grant NE/M003507/1 and European Research Council grant GA 638665.	Abt DL, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006914; Artemieva IM, 2009, LITHOS, V109, P23, DOI 10.1016/j.lithos.2008.09.015; Bostock MG, 1998, J GEOPHYS RES-SOL EA, V103, P21183, DOI 10.1029/98JB01069; BOYD FR, 1985, NATURE, V315, P387, DOI 10.1038/315387a0; Cooper CM, 2004, EARTH PLANET SC LETT, V222, P807, DOI 10.1016/j.epsl.2004.04.008; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Faul UH, 1997, J GEOPHYS RES-SOL EA, V102, P10299, DOI 10.1029/96JB03460; Ford HA, 2010, EARTH PLANET SC LETT, V300, P299, DOI 10.1016/j.epsl.2010.10.007; French S, 2013, SCIENCE, V342, P227, DOI 10.1126/science.1241514; Geissler WH, 2010, GEOPHYS J INT, V181, P604, DOI 10.1111/j.1365-246X.2010.04548.x; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; HIRTH G, 1995, J GEOPHYS RES-SOL EA, V100, P1981, DOI 10.1029/94JB02128; Karato SI, 2015, NAT GEOSCI, V8, P509, DOI 10.1038/NGEO2462; KENNEDY CS, 1976, J GEOPHYS RES, V81, P2467, DOI 10.1029/JB081i014p02467; King SD, 2005, EARTH PLANET SC LETT, V234, P1, DOI 10.1016/j.epsl.2005.03.007; Kumar P, 2007, NATURE, V449, P894, DOI 10.1038/nature06214; Lee CTA, 2005, EARTH PLANET SC LETT, V230, P379, DOI 10.1016/j.epsl.2004.11.019; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; Nataf HC, 1996, PHYS EARTH PLANET IN, V95, P101, DOI 10.1016/0031-9201(95)03105-7; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; PEARSON DG, 1995, GEOCHIM COSMOCHIM AC, V59, P959, DOI 10.1016/00167-0379(50)00143-; Pedersen HA, 2009, LITHOS, V109, P81, DOI 10.1016/j.lithos.2008.09.016; Rudnick RL, 1998, CHEM GEOL, V145, P395, DOI 10.1016/S0009-2541(97)00151-4; Rychert CA, 2005, NATURE, V436, P542, DOI 10.1038/nature03904; Rychert CA, 2014, GEOPHYS J INT, V196, P1694, DOI 10.1093/gji/ggt474; Rychert CA, 2010, LITHOS, V120, P173, DOI 10.1016/j.lithos.2009.12.006; Rychert CA, 2010, GEOPHYS J INT, V180, P1128, DOI 10.1111/j.1365-246X.2009.04497.x; Rychert CA, 2009, SCIENCE, V324, P495, DOI 10.1126/science.1169754; Savage B, 2008, EARTH PLANET SC LETT, V272, P600, DOI 10.1016/j.epsl.2008.05.026; Schaeffer AJ, 2015, SPRINGER GEOPHYS, P3, DOI 10.1007/978-3-319-15627-9_1; Schutt DL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2003JB002950; Skemer P., 2008, J GEOPHYS RES, V113, P113; Tharimena S, 2017, J GEOPHYS RES-SOL EA, V122, P2131, DOI 10.1002/2016JB013526; WALKER RJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1583, DOI 10.1016/0016-7037(89)90240-8; Walter M.J., 1999, SPEC PUBL GEOCHEM SO, V6, P225; Wittlinger G, 2007, EARTH PLANET SC LETT, V254, P404, DOI 10.1016/j.epsl.2006.11.048; Wolbern I, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004167	37	37	38	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					580	+		10.1126/science.aan0741	http://dx.doi.org/10.1126/science.aan0741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798127	Green Accepted			2022-12-28	WOS:000407324800038
J	Bausewein, T; Mills, DJ; Langer, JD; Nitschke, B; Nussberger, S; Kuhlbrandt, W				Bausewein, Thomas; Mills, Deryck J.; Langer, Julian D.; Nitschke, Beate; Nussberger, Stephan; Kuehlbrandt, Werner			Cryo-EM Structure of the TOM Core Complex from Neurospora crassa	CELL			English	Article							MITOCHONDRIAL RECEPTOR COMPLEX; OUTER-MEMBRANE PROTEINS; IMPORT PORE; MASS-SPECTROMETRY; TRANSLOCATION; PREPROTEINS; CHANNEL; BIOGENESIS; PREDICTION; DYNAMICS	The TOM complex is the main entry gate for protein precursors from the cytosol into mitochondria. We have determined the structure of the TOM core complex by cryoelectron microscopy (cryo-EM). The complex is a 148 kDa symmetrical dimer of ten membrane protein subunits that create a shallow funnel on the cytoplasmic membrane surface. In the core of the dimer, the beta-barrels of the Tom40 pore form two identical preprotein conduits. Each Tom40 pore is surrounded by the transmembrane segments of the alpha-helical subunits Tom5, Tom6, and Tom7. Tom22, the central preprotein receptor, connects the two Tom40 pores at the dimer interface. Our structure offers detailed insights into the molecular architecture of the mitochondrial preprotein import machinery.	[Bausewein, Thomas; Mills, Deryck J.; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany; [Nitschke, Beate; Nussberger, Stephan] Univ Stuttgart, Abt Biophys, Inst Biomat & Biomol Syst, Pfaffenwaldring 57, D-70550 Stuttgart, Germany	Max Planck Society; Max Planck Society; University of Stuttgart	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	werner.kuehlbrandt@biophys.mpg.de		Mills, Deryck/0000-0003-0904-1119; Kuhlbrandt, Werner/0000-0002-2013-4810; Nussberger, Stephan/0000-0003-3619-4452; Langer, Julian David/0000-0002-5190-577X	Max Planck Society; University of Stuttgart	Max Planck Society(Max Planck Society); University of Stuttgart	We thank Simone Prinz for help with specimen preparation and Janet Vonck and Edoardo D'Imprima for advice on single-particle processing. We thank Manuela Zoonens, IBPC, Paris, for providing non-ionic amphipols. This work was supported by the Max Planck Society (W.K.) and the University of Stuttgart (S.N.).	Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; [Anonymous], 2000, ACTA CRYSTALLOGR D, V56, P1341; [Anonymous], 2007, ANN REV PHYSL; [Anonymous], 2012, J STRUCT BIOL, V180, P519; [Anonymous], 2003, MICROBIOL MOL BIOL R, V67, P593; [Anonymous], 2015, J MOL BIOL, V427, P1075; [Anonymous], 2010, NAT REV MOL CELL BIO; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Dembowski M, 2001, J BIOL CHEM, V276, P17679, DOI 10.1074/jbc.M009653200; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Ellenrieder L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13021; Flinner N, 2013, BBA-MOL CELL RES, V1833, P3314, DOI 10.1016/j.bbamcr.2013.10.006; Gessmann D, 2011, BBA-BIOENERGETICS, V1807, P1647, DOI 10.1016/j.bbabio.2011.08.006; Go N. E., 2005, MOL BIOL CELL, V16; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N., 2015, J STRUCT BIOL, V192, P216; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; HONLINGER A, 1995, MOL CELL BIOL, V15, P3382; Honlinger A, 1996, EMBO J, V15, P2125, DOI 10.1002/j.1460-2075.1996.tb00566.x; Inska M, 2015, CURR OPIN CELL BIOL, V33, P42; Jackups Jr R., 2009, P NATL ACAD SCI, V106; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KEIL P, 1996, ADV MOL CEL, V17, P81; Kohlstaedt M, 2016, MBIO, V7, DOI 10.1128/mBio.01921-15; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Lackey SWK, 2014, J BIOL CHEM, V289, P21640, DOI 10.1074/jbc.M114.578765; Lesnik C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6711; Meisinger C., 2008, J MOL BIOL; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Nargang FE, 1998, MOL CELL BIOL, V18, P3173, DOI 10.1128/MCB.18.6.3173; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Sokolova L., 2010, MASS SPECTROMETRY MI; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; uller-Spath S, 2010, P ACAD SCI US, V107, P14609; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Watkinson TG, 2015, INT J MASS SPECTROM, V391, P54, DOI 10.1016/j.ijms.2015.06.017; Wenz LS, 2015, J CELL BIOL, V210, P1047, DOI 10.1083/jcb.201504119; Xie H, 2014, J BACTERIOL, V196, P472, DOI 10.1128/JB.01072-13; Yamano K, 2010, J BIOL CHEM, V285, P41222, DOI 10.1074/jbc.M110.163238; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	55	104	104	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					693	+		10.1016/j.cell.2017.07.012	http://dx.doi.org/10.1016/j.cell.2017.07.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802041	Bronze			2022-12-28	WOS:000407445700010
J	Loomis, I				Loomis, Ilima			HOUSE OF THE SUN	SCIENCE			English	Editorial Material								How astronomers built the world's largest solar telescope on Maui even as protesters derailed a larger telescope one island away											0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					444	447		10.1126/science.357.6350.444	http://dx.doi.org/10.1126/science.357.6350.444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774911				2022-12-28	WOS:000406840100016
J	Khoury, A; Porte, F; Haq, M				Khoury, Alexandra; Porte, Francois; Haq, Masud			CASE REVIEW Epstein Barr virus, abdominal pain, and jaundice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khoury, Alexandra] Conquest Hosp, Hastings, England; [Porte, Francois] Tunbridge Wells Hosp, Tunbridge Wells, England; [Haq, Masud] Tunbridge Wells Hosp, Diabet & Endocrinol, Tunbridge Wells, England		Khoury, A (corresponding author), Conquest Hosp, Hastings, England.	aakhoury@doctors.org.uk						Anderson S, 2007, RSNA RADIOL, V358; Asgari MM, 1997, YALE J BIOL MED, V70, P175; Chak A, 1999, GASTROINTEST ENDOSC, V49, P599, DOI 10.1016/S0016-5107(99)70388-3; Dolan JP, 2009, J GASTROINTEST SURG, V13, P2292, DOI 10.1007/s11605-009-0988-2; Garrow D, 2007, CLIN GASTROENTEROL H, V5, P616, DOI 10.1016/j.cgh.2007.02.027; Gutt CN, 2013, ANN SURG, V258, P385, DOI 10.1097/SLA.0b013e3182a1599b; Hurt C, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.12.011; Kaltenthaler Eva C, 2006, BMC Med Imaging, V6, P9, DOI 10.1186/1471-2342-6-9; Keus F, 2010, COCHRANE DB SYST REV, V358; Kottanattu L, 2016, J CLIN VIROL, V82, P51, DOI 10.1016/j.jcv.2016.06.017; Poddighe D, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/459608; Rinderknecht AS, 2012, PEDIATR EMERG CARE, V28, P1377, DOI 10.1097/PEC.0b013e318276c78a; Shah S, 2015, J PEDIAT SURG CASE R, V3, P285, DOI 10.1016/j.epsc.2015.05.002; Simorov A, 2013, AM J SURG, V206, P935, DOI 10.1016/j.amjsurg.2013.08.019; Torre D, 1999, SCAND J INFECT DIS, V31, P543, DOI 10.1080/00365549950164409; Williams E, 2017, GUT, V66, P765, DOI 10.1136/gutjnl-2016-312317	16	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2017	358								j3386	10.1136/bmj.j3386	http://dx.doi.org/10.1136/bmj.j3386			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CI	28774939				2022-12-28	WOS:000407207000001
J	Delbo, M; Walsh, K; Bolin, B; Avdellidou, C; Morbidelli, A				Delbo, Marco; Walsh, Kevin; Bolin, Bryce; Avdellidou, Chrysa; Morbidelli, Alessandro			Identification of a primordial asteroid family constrains the original planetesimal population	SCIENCE			English	Article							EULALIA	A quarter of known asteroids is associated with more than 100 distinct asteroid families, meaning that these asteroids originate as impact fragments from the family parent bodies. The determination of which asteroids of the remaining population are members of undiscovered families, or accreted as planetesimals from the protoplanetary disk, would constrain a critical phase of planetary formation by unveiling the unknown planetesimal size distribution. We discovered a 4-billion-year-old asteroid family extending across the entire inner part of the main belt whose members include most of the dark asteroids previously unlinked to families. This allows us to identify some original planetesimals, which are all larger than 35 kilometers, supporting the view of asteroids being born big. Their number matches the known distinct meteorite parent bodies.	[Delbo, Marco; Bolin, Bryce; Morbidelli, Alessandro] Univ Cote Azur, CNRS Lagrange, Observ Cote Azur, CS 34229, F-06304 Nice 4, France; [Walsh, Kevin] Southwest Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA; [Avdellidou, Chrysa] European Space Agcy, Directorate Sci, Sci Support Off, Keplerlaan 1, NL-2201 AZ Noordwijk, ZH, Netherlands	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Southwest Research Institute; European Space Agency	Delbo, M (corresponding author), Univ Cote Azur, CNRS Lagrange, Observ Cote Azur, CS 34229, F-06304 Nice 4, France.	delbo@oca.eu		Avdellidou, Chrysa/0000-0001-8228-8789; Walsh, Kevin/0000-0002-0906-1761	French National Program of Planetology; National Science Foundation [1518127]; Bonus Qualite Recherche of the Observatoire de la Cote d'Azur (OCA); French National Research Agency [ANR-13-BS06-0003]; Division Of Astronomical Sciences [1518127] Funding Source: National Science Foundation	French National Program of Planetology; National Science Foundation(National Science Foundation (NSF)); Bonus Qualite Recherche of the Observatoire de la Cote d'Azur (OCA); French National Research Agency(French National Research Agency (ANR)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	M.D. and B.B. acknowledge support from the French National Program of Planetology. M.D. carried out part of this work while visiting the European Space Agency/European Space Research and Technology Centre and the Leiden Observatory (Netherlands). K.W. was supported by the National Science Foundation, grant 1518127, and by the Bonus Qualite Recherche of the Observatoire de la Cote d'Azur (OCA). A.M. acknowledges support from the French National Research Agency, grant ANR-13-BS06-0003. Our asteroid database, including family assignments, is released as supplementary data S1. The software used for this work, the relevant input files, and our modified version of SWIFT_RMVS3, used for the dynamical analysis, are available at https://dataverse.harvard.edu/dataverse/PrimordialFamily (doi:10.7910/DVN/MNA7QG, Harvard Dataverse). Comments of anonymous reviewers substantially improved this work.	Bolin BT, 2017, ICARUS, V282, P290, DOI 10.1016/j.icarus.2016.09.029; Bottke W. F., 2015, ASTEROIDS, VIV, P701, DOI [10.2458/azuuapress9780816532131-ch036, DOI 10.2458/AZUUAPRESS9780816532131-CH036]; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Brasil PIO, 2016, ICARUS, V266, P142, DOI 10.1016/j.icarus.2015.11.015; Broz M, 2011, MON NOT R ASTRON SOC, V414, P2716, DOI 10.1111/j.1365-2966.2011.18587.x; Burbine T. H., 2002, ASTEROIDS, VIII, P653, DOI DOI 10.2307/J.CTV1V7ZDN4.50; Carruba V, 2016, MON NOT R ASTRON SOC, V458, P3731, DOI 10.1093/mnras/stw533; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; de Leon J, 2016, ICARUS, V266, P57, DOI 10.1016/j.icarus.2015.11.014; DeMeo FE, 2013, ICARUS, V226, P723, DOI 10.1016/j.icarus.2013.06.027; Johansen A., 2015, ASTEROIDS, V4, P471, DOI [10.2458/azu_uapress_9780816532131-ch025, DOI 10.2458/AZU_UAPRESS_9780816532131-CH025]; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Johansen A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500109; Johnson BC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601658; Klahr H., 2016, P INT ASTRON UNION, V318, P1; Masiero JR, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/7; Milani A, 2014, ICARUS, V239, P46, DOI 10.1016/j.icarus.2014.05.039; Minton DA, 2010, ICARUS, V207, P744, DOI 10.1016/j.icarus.2009.12.008; Morbidelli A., 2015, ASTEROIDS, VIV, P493; Nesvorny D., 2015, IDENTIFICATION DYNAM, P297, DOI [10.2458/azuuapress9780816532131-ch016, DOI 10.2458/AZU_UAPRESS_9780816532131-CH016]; Parker A, 2008, ICARUS, V198, P138, DOI 10.1016/j.icarus.2008.07.002; Pinilla-Alonso N, 2016, ICARUS, V274, P231, DOI 10.1016/j.icarus.2016.03.022; Simon JB, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/1/55; Spoto F, 2015, ICARUS, V257, P275, DOI 10.1016/j.icarus.2015.04.041; The Minor Planet Center of the International Astronomical Union, AST ID ORB EL AR OBT; Vokrouhlicky D, 2006, ICARUS, V182, P118, DOI 10.1016/j.icarus.2005.12.010; Walsh KJ, 2013, ICARUS, V225, P283, DOI 10.1016/j.icarus.2013.03.005; Youdin AN, 2005, ASTROPHYS J, V620, P459, DOI 10.1086/426895	28	62	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1026	+		10.1126/science.aam6036	http://dx.doi.org/10.1126/science.aam6036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28775212				2022-12-28	WOS:000409455700041
J	Zhang, ZW; Chen, P; Duan, XD; Zang, KT; Luo, J; Duan, XF				Zhang, Zhengwei; Chen, Peng; Duan, Xidong; Zang, Ketao; Luo, Jun; Duan, Xiangfeng			Robust epitaxial growth of two-dimensional heterostructures, multiheterostructures, and superlattices	SCIENCE			English	Article							LARGE-AREA; MONOLAYER; MOS2; TRANSISTORS; LAYERS; WS2; HETEROJUNCTIONS; DYNAMICS; FILMS; MONO	We report a general synthetic strategy for highly robust growth of diverse lateral heterostructures, multiheterostructures, and superlattices from two-dimensional (2D) atomic crystals. A reverse flow during the temperature-swing stage in the sequential vapor deposition growth process allowed us to cool the existing 2D crystals to prevent undesired thermal degradation and uncontrolled homogeneous nucleation, thus enabling highly robust block-by-block epitaxial growth. Raman and photoluminescence mapping studies showed that a wide range of 2D heterostructures (such as WS2-WSe2 and WS2-MoSe2), multiheterostructures (such as WS2-WSe2-MoS2 and WS2-MoSe2-WSe2), and superlattices (such as WS2-WSe2-WS2-WSe2-WS2) were readily prepared with precisely controlled spatial modulation. Transmission electron microscope studies showed clear chemical modulation with atomically sharp interfaces. Electrical transport studies of WSe2-WS2 lateral junctions showed well-defined diode characteristics with a rectification ratio up to 10(5).	[Zhang, Zhengwei; Chen, Peng; Duan, Xidong; Duan, Xiangfeng] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Zang, Ketao; Luo, Jun] Tianjin Univ Technol, Sch Mat, Inst New Energy Mat & Low Carbon Technol, Ctr Electron Microscopy, Tianjin 300384, Peoples R China; [Chen, Peng; Duan, Xidong; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Chen, Peng; Duan, Xiangfeng] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	Hunan University; Tianjin University of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Duan, XD; Duan, XF (corresponding author), Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China.; Duan, XD; Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Duan, XF (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.	xidongduan@hnu.edu.cn; xduan@chem.ucla.edu	Duan, Xiangfeng/E-7522-2011; Duan, Xiangfeng/AAQ-9674-2020; Luo, Jun/CAG-4333-2022	Duan, Xiangfeng/0000-0002-4321-6288; Duan, Xiangfeng/0000-0002-4321-6288; Luo, Jun/0000-0001-5084-2087; Duan, Xidong/0000-0002-4951-901X; Chen, Peng/0000-0001-8527-1210	National Natural Science Foundation of China [61528403]; National Program for Thousand Young Talents of China; Tianjin Municipal Science and Technology Commission [15JCYBJC52600]; Tianjin Municipal Education Commission; National Science Foundation [DMR1508144]; Direct For Mathematical & Physical Scien [1508144] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Thousand Young Talents of China; Tianjin Municipal Science and Technology Commission; Tianjin Municipal Education Commission; National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from the National Natural Science Foundation of China (no. 61528403). J.L. acknowledges support from the National Program for Thousand Young Talents of China, Tianjin Municipal Science and Technology Commission (15JCYBJC52600), and Tianjin Municipal Education Commission. X.F.D. acknowledges support from the National Science Foundation DMR1508144. All data are reported in the main text and supplementary materials.	Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Chen JY, 2016, CHEM MATER, V28, P7194, DOI 10.1021/acs.chemmater.6b03639; Chen K, 2015, ACS NANO, V9, P9868, DOI 10.1021/acsnano.5b03188; COEHOORN R, 1987, PHYS REV B, V35, P6195, DOI 10.1103/PhysRevB.35.6195; Desai SB, 2016, SCIENCE, V354, P99, DOI 10.1126/science.aah4698; Duan XD, 2014, NAT NANOTECHNOL, V9, P1024, DOI [10.1038/NNANO.2014.222, 10.1038/nnano.2014.222]; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Jones AM, 2014, NAT PHYS, V10, P130, DOI [10.1038/NPHYS2848, 10.1038/nphys2848]; Kang K, 2015, NATURE, V520, P656, DOI 10.1038/nature14417; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/NNANO.2014.150, 10.1038/nnano.2014.150]; Lee YH, 2013, NANO LETT, V13, P1852, DOI 10.1021/nl400687n; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Li HL, 2014, J AM CHEM SOC, V136, P3756, DOI 10.1021/ja500069b; Li MY, 2015, SCIENCE, V349, P524, DOI 10.1126/science.aab4097; Liu KK, 2012, NANO LETT, V12, P1538, DOI 10.1021/nl2043612; Lu X, 2014, NANO LETT, V14, P2419, DOI 10.1021/nl5000906; Mahjouri-Samani M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8749; Mann J, 2014, ADV MATER, V26, P1399, DOI 10.1002/adma.201304389; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Rivera P, 2016, SCIENCE, V351, P688, DOI 10.1126/science.aac7820; Sahin H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165409; Tan CL, 2015, J AM CHEM SOC, V137, P12162, DOI 10.1021/jacs.5b03590; Tongay S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4834358; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang XL, 2014, ACS NANO, V8, P5125, DOI 10.1021/nn501175k; Wu SF, 2015, NATURE, V520, P69, DOI 10.1038/nature14290; Yoo YD, 2015, J AM CHEM SOC, V137, P14281, DOI 10.1021/jacs.5b06643; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Yu WJ, 2013, NAT MATER, V12, P246, DOI [10.1038/NMAT3518, 10.1038/nmat3518]; Zhang XQ, 2015, NANO LETT, V15, P410, DOI 10.1021/nl503744f; Zhang Y, 2013, ACS NANO, V7, P8963, DOI 10.1021/nn403454e; Zhao MV, 2016, NAT NANOTECHNOL, V11, P954, DOI 10.1038/nnano.2016.115; Zhao WJ, 2013, NANOSCALE, V5, P9677, DOI 10.1039/c3nr03052k; Zhou YB, 2014, ACS NANO, V8, P1485, DOI 10.1021/nn405529r	38	415	420	83	863	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					788	+		10.1126/science.aan6814	http://dx.doi.org/10.1126/science.aan6814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28775210				2022-12-28	WOS:000408327900040
J	Liu, XY; Ahn, S; Kahsai, AW; Meng, KC; Latorraca, NR; Pani, B; Venkatakrishnan, AJ; Masoudi, A; Weis, WI; Dror, RO; Chen, X; Lefkowitz, RJ; Kobilka, BK				Liu, Xiangyu; Ahn, Seungkirl; Kahsai, Alem W.; Meng, Kai-Cheng; Latorraca, Naomi R.; Pani, Biswaranjan; Venkatakrishnan, A. J.; Masoudi, Ali; Weis, William I.; Dror, Ron O.; Chen, Xin; Lefkowitz, Robert J.; Kobilka, Brian K.			Mechanism of intracellular allosteric beta(2)AR antagonist revealed by X-ray crystal structure	NATURE			English	Article							GENERAL FORCE-FIELD; MOLECULAR-DYNAMICS; VALIDATION; AUTOMATION; ACTIVATION; PROTEINS; INSIGHTS	G-protein-coupled receptors (GPCRs) pose challenges for drug discovery efforts because of the high degree of structural homology in the orthosteric pocket, particularly for GPCRs within a single subfamily, such as the nine adrenergic receptors. Allosteric ligands may bind to less-conserved regions of these receptors and therefore are more likely to be selective. Unlike orthosteric ligands, which tonically activate or inhibit signalling, allosteric ligands modulate physiologic responses to hormones and neurotransmitters, and may therefore have fewer adverse effects. The majority of GPCR crystal structures published to date were obtained with receptors bound to orthosteric antagonists, and only a few structures bound to allosteric ligands have been reported. Compound 15 (Cmpd-15) is an allosteric modulator of the beta(2) adrenergic receptor (beta(2)AR) that was recently isolated from a DNA-encoded small-molecule library(1). Orthosteric beta-adrenergic receptor antagonists, known as beta-blockers, are amongst the most prescribed drugs in the world and Cmpd-15 is the first allosteric beta-blocker. Cmpd-15 exhibits negative cooperativity with agonists and positive cooperativity with inverse agonists. Here we present the structure of the beta(2)AR bound to a polyethylene glycol-carboxylic acid derivative (Cmpd-15PA) of this modulator. Cmpd-15PA binds to a pocket formed primarily by the cytoplasmic ends of transmembrane segments 1, 2, 6 and 7 as well as intracellular loop 1 and helix 8. A comparison of this structure with inactive-and active-state structures of the beta(2)AR reveals the mechanism by which Cmpd-15 modulates agonist binding affinity and signalling.	[Liu, Xiangyu; Kobilka, Brian K.] Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Ahn, Seungkirl; Kahsai, Alem W.; Pani, Biswaranjan; Masoudi, Ali; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Meng, Kai-Cheng; Chen, Xin] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Dept Med Chem, Changzhou 213164, Jiangsu, Peoples R China; [Latorraca, Naomi R.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Tsinghua University; Duke University; Changzhou University; Stanford University; Stanford University; Stanford University; Stanford University; Duke University; Duke University; Howard Hughes Medical Institute	Kobilka, BK (corresponding author), Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu; kobilka@stanford.edu	Pani, Biswaranjan/GLT-9217-2022; Lefkowitz, Robert/AAW-2649-2021; Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990	National Institute of Health [NS028471, GM106990, HL16037, T32HL007101]; Amgen-China Postdoc fellowship; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM106990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen-China Postdoc fellowship; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Hirata at Beamline BL32XU of Spring-8 for assistance in data collection. A. Wall and T. Xu provided technical assistance. NuEvolution for constructive discussions in the course of the work. We acknowledge support from the National Institute of Health grants NS028471 and GM106990 (B.K.K.), HL16037 (R.J.L.) and T32HL007101 (A.W.K. and A.M.), Amgen-China Postdoc fellowship (X.L.) and the Mathers Foundation (B.K.K. and W.I.W.). R.J.L. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn S, 2017, P NATL ACAD SCI USA, V114, P1708, DOI 10.1073/pnas.1620645114; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Case D. A., 2016, AMBER 2016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang W., 2015, NATURE, V524, P315, DOI DOI 10.1038/NATURE14886; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Ranganathan A, 2014, BIOCHEMISTRY-US, V53, P7283, DOI 10.1021/bi5008723; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TENEYCK LF, 1985, METHOD ENZYMOL, V115, P324; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605	40	103	101	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					480	+		10.1038/nature23652	http://dx.doi.org/10.1038/nature23652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813418	Green Accepted			2022-12-28	WOS:000408279000044
J	Relhan, N; Schwartz, SG; Flynn, HW				Relhan, Nidhi; Schwartz, Stephen G.; Flynn, Harry W., Jr.			Endogenous Fungal Endophthalmitis An Increasing Problem Among Intravenous Drug Users	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANDIDA ENDOPHTHALMITIS; MANAGEMENT; AGENTS	JAMA OPHTHALMOLOGY An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in NewEngland Aubrey R. Tirpack, MD; Jay S. Duker, MD; Caroline R. Baumal, MD IMPORTANCE Intravenous drug abuse (IVDA) is a known risk factor for endogenous fungal endophthalmitis (EFE), a severe intraocular infection caused by hematogenous seeding of mycotic organisms to the eye. Reporting significant increases in heroin-related deaths since 2014, the New England region is in the midst of an opioid crisis that has led to a substantial increase in patients at risk for this vision-threatening disease. OBJECTIVE To present an update on characteristics, management, and visual outcomes in patients with EFE. DESIGN, SETTING, AND PARTICIPANTS Medical records review was initiated on July 1, 2016, evaluating all patients with EFE referred to New England Eye Center at Tufts Medical Center, a tertiary care ophthalmology practice distributed throughout Massachusetts, from May 1, 2014, to May 1, 2016. Patients with a history of IVDA and culture-proven or clinical evidence of fungal endophthalmitis were included. EXPOSURES Intravenous drug use. MAIN OUTCOMES AND MEASURES Patient demographics, comorbidities, presenting symptoms and vision, vitreoretinal findings, treatment regimens, culture data, and final visual acuities. RESULTS Ten patients (5 women) with IVDA-related EFE were identified between May 1, 2014, and May 1, 2016-an increase from 3 patients treated from May 2012 to April 2014. The mean (SD) patient age was 34 (11) years (range, 24-60 years). Presenting visual acuities ranged from 20/25 to hand motion. The most common presenting symptoms were floaters (n = 8), reduced vision (n = 6), and pain (n = 5). Initial treatment included systemic antifungals in all patients and intravitreal antifungals in 9 eyes. Five patients required pars plana vitrectomy for worsening vitritis. The most commonly isolated pathogen was Candida albicans in 20% of the patients. Final visual acuity ranged from 20/40 to 20/300. CONCLUSIONS AND RELEVANCE The data provided in this report suggest that EFE represents severe end organ damage associated with IVDA and portends poor visual outcomes. Health care professionals must maintain a high suspicion for EFE, as patients are typically ambulatory on presentation without systemic signs of infection.	[Relhan, Nidhi; Schwartz, Stephen G.; Flynn, Harry W., Jr.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Flynn, HW (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA.	hflynn@med.miami.edu			National Institutes of Health center core grant [P30EY014801]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health center core grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health center core grant P30EY014801 and an unrestricted grant from Research to Prevent Blindness.	BROD RD, 1990, OPHTHALMOLOGY, V97, P666, DOI 10.1016/S0161-6420(90)32547-2; Ghoraba Hammouda H, 2017, Retin Cases Brief Rep, V11, P171, DOI 10.1097/ICB.0000000000000321; Lingappan A, 2012, AM J OPHTHALMOL, V153, P162, DOI 10.1016/j.ajo.2011.06.020; Relhan N, 2017, RETINA-J RET VIT DIS, V37, P811, DOI 10.1097/IAE.0000000000001603; Sallam A, 2012, RETINA-J RET VIT DIS, V32, P1129, DOI 10.1097/IAE.0b013e31822d3a34; Silva RA, 2015, AM J OPHTHALMOL, V159, P257, DOI 10.1016/j.ajo.2014.10.027; Sridhar J, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-60; Tirpack AR, 2017, JAMA OPHTHALMOL, V135, P534, DOI 10.1001/jamaophthalmol.2017.0650	8	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					741	+		10.1001/jama.2017.10585	http://dx.doi.org/10.1001/jama.2017.10585			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829854				2022-12-28	WOS:000408095800025
J	Li, HB; Tong, JY; Zhu, S; Batista, PJ; Duffy, EE; Zhao, J; Bailis, W; Cao, GC; Kroehling, L; Chen, YY; Wang, G; Broughton, JP; Chen, YG; Kluger, Y; Simon, MD; Chang, HY; Yin, ZN; Flavell, RA				Li, Hua-Bing; Tong, Jiyu; Zhu, Shu; Batista, Pedro J.; Duffy, Erin E.; Zhao, Jun; Bailis, Will; Cao, Guangchao; Kroehling, Lina; Chen, Yuanyuan; Wang, Geng; Broughton, James P.; Chen, Y. Grace; Kluger, Yuval; Simon, Matthew D.; Chang, Howard Y.; Yin, Zhinan; Flavell, Richard A.			m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways	NATURE			English	Article							GENE-EXPRESSION REGULATION; DEGRADATION DYNAMICS; N-6-METHYLADENOSINE; NAIVE; RESOLUTION; UPDATE; MODEL	N-6-methyladenosine (m(6)A) is the most common and abundant messenger RNA modification, modulated by 'writers', 'erasers' and 'readers' of this mark(1,2). In vitro data have shown that m(6)A influences all fundamental aspects of mRNA metabolism, mainly mRNA stability, to determine stem cell fates(3,4). However, its in vivo physiological function in mammals and adult mammalian cells is still unknown. Here we show that the deletion of m(6)A 'writer' protein METTL3 in mouse T cells disrupts T cell homeostasis and differentiation. In a lymphopaenic mouse adoptive transfer model, naive Mettl3-deficient T cells failed to undergo homeostatic expansion and remained in the naive state for up to 12 weeks, thereby preventing colitis. Consistent with these observations, the mRNAs of SOCS family genes encoding the STAT signalling inhibitory proteins SOCS1, SOCS3 and CISH were marked by m(6)A, exhibited slower mRNA decay and showed increased mRNAs and levels of protein expression in Mettl3-deficient naive T cells. This increased SOCS family activity consequently inhibited IL-7-mediated STAT5 activation and T cell homeostatic proliferation and differentiation. We also found that m(6)A has important roles for inducible degradation of Socs mRNAs in response to IL-7 signalling in order to reprogram naive T cells for proliferation and differentiation. Our study elucidates for the first time, to our knowledge, the in vivo biological role of m(6)A modification in T-cell-mediated pathogenesis and reveals a novel mechanism of T cell homeostasis and signal-dependent induction of mRNA degradation.	[Li, Hua-Bing; Tong, Jiyu; Zhu, Shu; Zhao, Jun; Bailis, Will; Cao, Guangchao; Kroehling, Lina; Chen, Yuanyuan; Wang, Geng; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Tong, Jiyu; Cao, Guangchao; Yin, Zhinan] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China; [Tong, Jiyu; Cao, Guangchao; Yin, Zhinan] Jinan Univ, Guangdong Prov Key Lab Mol Immunol & Antibody Eng, Guangzhou 510632, Guangdong, Peoples R China; [Batista, Pedro J.; Broughton, James P.; Chen, Y. Grace; Chang, Howard Y.] Stanford Univ, Ctr Dynam Regulomes, Stanford, CA 94305 USA; [Duffy, Erin E.; Simon, Matthew D.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; [Duffy, Erin E.; Simon, Matthew D.] Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA; [Zhao, Jun; Kluger, Yuval] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Chen, Yuanyuan] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Chongqing 400038, Peoples R China; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Jinan University; Jinan University; Stanford University; Yale University; Yale University; Yale University; Army Medical University; Howard Hughes Medical Institute	Li, HB; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Yin, ZN (corresponding author), Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.; Yin, ZN (corresponding author), Jinan Univ, Guangdong Prov Key Lab Mol Immunol & Antibody Eng, Guangzhou 510632, Guangdong, Peoples R China.; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	huabing.li@yale.edu; zhinan.yin@yale.edu; richard.flavell@yale.edu	Li, Huabing/M-5390-2013; Cao, Guangchao/AAB-1263-2020; Zhao, Jun/AAT-2086-2021; Chen, Yuanyuan/GXG-2130-2022; Simon, Matthew/ABF-9127-2020; Zhu, Shu/P-6163-2018	Li, Huabing/0000-0003-3573-6803; Cao, Guangchao/0000-0003-2069-3396; Zhu, Shu/0000-0002-8163-0869; Duffy Lacy, Erin/0000-0002-7519-5098; Simon, Matthew/0000-0001-7423-5265; Broughton, James/0000-0001-5852-9546	NIH [T32 2T32DK007356]; Helen Hay Whitney Foundation-Howard Hughes Medical Institute; Howard Hughes Medical Institute; NSF Major International Joint Research Program of China [31420103901]; '111' project [R01-HG004361]; NIH New Innovator Award [DP2 HD083992-01]; Searle scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD083992] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation-Howard Hughes Medical Institute(Howard Hughes Medical Institute); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Major International Joint Research Program of China; '111' project(Ministry of Education, China - 111 Project); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Flynn, R. Jackson, Y. Yang, M. Vesely, R. Paiva, N. Palm and all the other members of the Flavell laboratory for discussions and comments. We thank J. Alderman, C. Lieber, C. Hughes and J. Stein for technical support. H.-B.L. was supported by NIH T32 2T32DK007356. S.Z was supported by a fellowship from Helen Hay Whitney Foundation-Howard Hughes Medical Institute. This work was supported by the Howard Hughes Medical Institute (R.A.F.), NSF Major International Joint Research Program of China - 31420103901 (Z.Y. and R.A.F.) and '111' project (Z.Y.), R01-HG004361 (H.Y.C.), NIH New Innovator Award DP2 HD083992-01 (M.D.S.), and a Searle scholarship (M.D.S.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Chong M. M., IMMUNITY, V18, P475; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Collins A, 2005, IMMUNITY, V23, P4, DOI 10.1016/j.immuni.2005.07.003; de Pretis S, 2015, BIOINFORMATICS, V31, P2829, DOI 10.1093/bioinformatics/btv288; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Duffy Erin E, 2016, Curr Protoc Chem Biol, V8, P234, DOI 10.1002/cpch.12; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Henao-Mejia J., 2016, COLD SPRING HARB PRO; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin Christopher E, 2013, Methods Mol Biol, V979, P81, DOI 10.1007/978-1-62703-290-2_9; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 2003, J EXP MED, V197, P425, DOI 10.1084/jem.20020939; Nueda MJ, 2014, BIOINFORMATICS, V30, P2598, DOI 10.1093/bioinformatics/btu333; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	435	467	11	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					338	+		10.1038/nature23450	http://dx.doi.org/10.1038/nature23450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792938	Green Accepted			2022-12-28	WOS:000407748400034
J	Ronning, F; Helm, T; Hirer, KRS; Bachmann, MD; Balicas, L; Chan, MK; Ramshaw, BJ; McDonald, RD; Balakirev, FF; Jaime, M; Bauer, ED; Moll, PJW				Ronning, F.; Helm, T.; Hirer, K. R. S.; Bachmann, M. D.; Balicas, L.; Chan, M. K.; Ramshaw, B. J.; McDonald, R. D.; Balakirev, F. F.; Jaime, M.; Bauer, E. D.; Moll, P. J. W.			Electronic in-plane symmetry breaking at field-tuned quantum criticality in CeRhIn5	NATURE			English	Article							DENSITY-WAVE; FERMI-SURFACE; SUPERCONDUCTIVITY; MAGNETOSTRICTION; TRANSPORT; PRESSURE; PHASES; ORDER	Electronic nematic materials are characterized by a lowered symmetry of the electronic system compared to the underlying lattice, in analogy to the directional alignment without translational order in nematic liquid crystals(1). Such nematic phases appear in the copper-and iron-based high-temperature superconductors(2-4), and their role in establishing superconductivity remains an open question. Nematicity may take an active part, cooperating or competing with superconductivity, or may appear accidentally in such systems. Here we present experimental evidence for a phase of fluctuating nematic character in a heavy-fermion superconductor, CeRhIn5 (ref. 5). We observe a magnetic-field-induced state in the vicinity of a field-tuned antiferromagnetic quantum critical point at H-c approximate to 50 tesla. This phase appears above an out-of-plane critical field H* approximate to 28 tesla and is characterized by a substantial in-plane resistivity anisotropy in the presence of a small in-plane field component. The in-plane symmetry breaking has little apparent connection to the underlying lattice, as evidenced by the small magnitude of the magnetostriction anomaly at H*. Furthermore, no anomalies appear in the magnetic torque, suggesting the absence of metamagnetism in this field range. The appearance of nematic behaviour in a prototypical heavy-fermion superconductor highlights the interrelation of nematicity and unconventional superconductivity, suggesting nematicity to be common among correlated materials.	[Ronning, F.; Bauer, E. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Helm, T.; Hirer, K. R. S.; Bachmann, M. D.; Moll, P. J. W.] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Balicas, L.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Chan, M. K.; Ramshaw, B. J.; McDonald, R. D.; Balakirev, F. F.; Jaime, M.] LANL, Natl High Magnet Field Lab, MS E536, Los Alamos, NM 87545 USA; [Ramshaw, B. J.] Cornell Univ, Lab Atom & Solid State Phys, 142 Sci Dr, Ithaca, NY 14853 USA; [Jaime, M.] Inst Mat Sci Agh, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Max Planck Society; State University System of Florida; Florida State University; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University	Moll, PJW (corresponding author), Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany.	Philip.moll@cpfs.mpg.de	Ramshaw, Brad/AAU-5603-2020; Helm, Toni/K-7515-2018; Balakirev, Fedor/AAY-2860-2020; Jaime, Marcelo/F-3791-2015; Balakirev, Fedor/AAS-6827-2020; Balicas, Luis/A-3110-2008; Ramshaw, Brad/J-3121-2013	Helm, Toni/0000-0002-0938-8537; Balakirev, Fedor/0000-0003-4887-5140; Jaime, Marcelo/0000-0001-5360-5220; Balakirev, Fedor/0000-0003-4887-5140; Ramshaw, Brad/0000-0002-3222-5007; Shirer, Kent/0000-0003-4570-0361	DOE-BES [DE-SC0002613]; Max Planck Society; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [MO 3077/1-1]; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering; National Science Foundation [DMR-1157490]; State of Florida; US DOE; IMS Rapid Response program at LANL; US DOE BES 'Science at 100T'; Engineering and Physical Sciences Research Council [1657076] Funding Source: researchfish	DOE-BES(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); State of Florida; US DOE(United States Department of Energy (DOE)); IMS Rapid Response program at LANL; US DOE BES 'Science at 100T'(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Mackenzie, B. Batlogg, S. Kivelson, E. Fradkin, C. Geibel and J. Thompson for discussions. We also thank B. Zeng for supporting the torque measurements. L.B. is supported by DOE-BES through award DE-SC0002613. The project was supported by the Max Planck Society and funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - MO 3077/1-1. Work at Los Alamos National Laboratory was performed under the auspices of the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering. Work at the National High Magnetic Field Laboratory was supported by National Science Foundation Cooperative Agreement no. DMR-1157490, the State of Florida, and the US DOE. M.J. acknowledges support from the IMS Rapid Response program at LANL. M.K.C. was supported by funds from US DOE BES 'Science at 100T'.	Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Bao W, 2000, PHYS REV B, V62, P14621, DOI 10.1103/PhysRevB.62.R14621; Bauer ED, 2006, PHYSICA B, V378-80, P142, DOI 10.1016/j.physb.2006.01.053; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Capriotti L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257206; Christianson AD, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054410; COPPERSMITH SN, 1987, PHYS REV B, V36, P311, DOI 10.1103/PhysRevB.36.311; Cornelius AL, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144411; Daou R, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3356980; Das P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.246403; DUMAS J, 1985, LECT NOTES PHYS, V217, P439; Eisenstein JP, 2001, SOLID STATE COMMUN, V117, P123, DOI 10.1016/S0038-1098(00)00435-X; Fernandes RM, 2014, NAT PHYS, V10, P97, DOI 10.1038/nphys2877; Fil DV, 2000, LOW TEMP PHYS+, V26, P581, DOI 10.1063/1.1289128; Fisher RA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224509; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Gegenwart P, 2006, PHYSICA B, V378-80, P117, DOI 10.1016/j.physb.2006.01.047; Gerber S, 2015, SCIENCE, V350, P949, DOI 10.1126/science.aac6257; GILL JC, 1986, J PHYS C SOLID STATE, V19, P6589, DOI 10.1088/0022-3719/19/33/009; Grachtrup DS, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.134422; Graf D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076406; GRUNER G, 1994, REV MOD PHYS, V66, P1, DOI 10.1103/RevModPhys.66.1; Gruner G., 1988, REV MOD PHYS, V32, P11; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Jaime M, 2012, P NATL ACAD SCI USA, V109, P12404, DOI 10.1073/pnas.1200743109; Jiao L, 2015, P NATL ACAD SCI USA, V112, P673, DOI 10.1073/pnas.1413932112; Kasahara S, 2012, NATURE, V486, P382, DOI 10.1038/nature11178; Kim JW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.137201; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lester C, 2015, NAT MATER, V14, P373, DOI [10.1038/nmat4181, 10.1038/NMAT4181]; Moll PJW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7663; Pan W, 1999, PHYS REV LETT, V83, P820, DOI 10.1103/PhysRevLett.83.820; Park T, 2008, NATURE, V456, P366, DOI 10.1038/nature07431; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Park T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.077003; Park T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055062; POMERANCHUK II, 1959, SOV PHYS JETP-USSR, V8, P361; Raymond S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/24/242204; Rost AW, 2011, P NATL ACAD SCI USA, V108, P16549, DOI 10.1073/pnas.1112775108; Rotter M, 2008, ANGEW CHEM INT EDIT, V47, P7949, DOI 10.1002/anie.200803641; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Shishido H, 2002, J PHYS SOC JPN, V71, P162, DOI 10.1143/JPSJ.71.162; Takeuchi T, 2001, J PHYS SOC JPN, V70, P877, DOI 10.1143/JPSJ.70.877; Zhong RD, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.177601	47	70	70	3	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					313	+		10.1038/nature23315	http://dx.doi.org/10.1038/nature23315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28783723	Green Submitted			2022-12-28	WOS:000407748400028
J	Vecchi, GA; Delworth, TL				Vecchi, Gabriel A.; Delworth, Thomas L.			Integrate the whole system	NATURE			English	Editorial Material									[Vecchi, Gabriel A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Vecchi, Gabriel A.] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Delworth, Thomas L.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	Princeton University; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA	Vecchi, GA (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.; Vecchi, GA (corresponding author), Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA.	gvecchi@princeton.edu; tom.delworth@noaa.gov	Delworth, Thomas L/C-5191-2014; Vecchi, Gabriel/A-2413-2008	Delworth, Thomas L/0000-0003-4865-5391; Vecchi, Gabriel/0000-0002-5085-224X					0	22	22	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					284	284		10.1038/nature23538	http://dx.doi.org/10.1038/nature23538			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792930				2022-12-28	WOS:000407748400018
J	Stacey, D; Legare, F; Lewis, KB				Stacey, Dawn; Legare, France; Lewis, Krystina B.			Patient Decision Aids to Engage Adults in Treatment or Screening Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stacey, Dawn; Lewis, Krystina B.] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada; [Stacey, Dawn] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Legare, France] Univ Laval, Fac Med, Quebec City, PQ, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Laval University	Stacey, D (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dstacey@uottawa.ca		Legare, France/0000-0002-2296-6696; Stacey, Dawn/0000-0002-2681-741X				Centers for Medicare & Medicaid Services, MED COV LING CANC LO; National Institute for Health and Care Excellence, PAT EXP AD NHS SERV; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5	4	67	69	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					657	658		10.1001/jama.2017.10289	http://dx.doi.org/10.1001/jama.2017.10289			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810006				2022-12-28	WOS:000407616000020
J	Loewenberg, S				Loewenberg, Sam			Treating and preventing cholera in Bangladesh	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					637	638		10.1016/S0140-6736(17)32208-0	http://dx.doi.org/10.1016/S0140-6736(17)32208-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28816128				2022-12-28	WOS:000407456200009
J	Charles, A				Charles, Andrew			Migraine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; SOCIETY EVIDENCE ASSESSMENT; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CLINICAL-FEATURES; CANADIAN HEADACHE; AMERICAN ACADEMY; PARALLEL-GROUP; ADULTS REPORT; GUIDELINE	A 23-year-old woman presents with five episodes of headache during the past 2 months. Each episode began with yawning, sensitivity to light, and a depressed mood that was followed by the gradual onset of neck pain that spread to the occipital region and eventually to the retro-orbital region on the right side. The pain became incapacitating over a period of 1 to 2 hours and was associated with nausea and sensitivity to light and sound. With two of the episodes, she had jagged lines in her vision for 15 minutes as the neck pain was beginning; with all the episodes, she had severe fatigue and difficulty concentrating and finding words. The headache lasted approximately 24 hours, and, after resolution, she had several hours of residual neck soreness, fatigue, and depressed mood. How would you evaluate and treat this patient?	[Charles, Andrew] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, UCLA Goldberg Migraine Program, 635 Charles Young Dr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Charles, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, UCLA Goldberg Migraine Program, 635 Charles Young Dr, Los Angeles, CA 90095 USA.	acharles@ucla.edu			Amgen; Biohaven Pharmaceutical; Eli Lilly; Takeda Pharmaceuticals	Amgen(Amgen); Biohaven Pharmaceutical(Johnson & Johnson); Eli Lilly(Eli Lilly); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Dr. Charles reports receiving consulting fees from Amgen, receiving fees for serving on a medical advisory board from Alder BioPharmaceuticals and eNeura, receiving fees for serving on a scientific advisory board from Biohaven Pharmaceutical, receiving consulting fees and fees for serving on a scientific advisory board from Eli Lilly, receiving grant support from Takeda Pharmaceuticals, and serving as Secretary of the American Headache Society. No other potential conflict of interest relevant to this article was reported.	Abu Bakar N, 2016, CEPHALALGIA, V36, P67, DOI 10.1177/0333102415580099; Ahn AH, 2010, HEADACHE, V50, P1507, DOI 10.1111/j.1526-4610.2010.01765.x; Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; Ashina M, 2013, CEPHALALGIA, V33, P540, DOI 10.1177/0333102412475234; Ashina S, 2015, CEPHALALGIA, V35, P211, DOI 10.1177/0333102414535110; Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Bigal ME, 2008, NEUROLOGY, V71, P1821, DOI 10.1212/01.wnl.0000335946.53860.1d; Cameron C, 2015, HEADACHE, V55, P221, DOI 10.1111/head.12601; Charles A, 2013, CURR OPIN NEUROL, V26, P235, DOI 10.1097/WCO.0b013e32836085f4; Chong CD, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0662-5; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008040.pub3; Diener HC, 2016, NAT REV NEUROL, V12, P575, DOI 10.1038/nrneurol.2016.124; Eller M, 2016, NEUROLOGY, V86, P856, DOI 10.1212/WNL.0000000000002406; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Giffin NJ, 2016, NEUROLOGY, V87, P309, DOI 10.1212/WNL.0000000000002789; Giffin NJ, 2003, NEUROLOGY, V60, P935, DOI 10.1212/01.WNL.0000052998.58526.A9; Gil-Gouveia R, 2016, CEPHALALGIA, V36, P422, DOI 10.1177/0333102415604471; Goadsby PJ, 2008, CEPHALALGIA, V28, P383, DOI 10.1111/j.1468-2982.2008.01546.x; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goldstein J, 2014, CEPHALALGIA, V34, P1070, DOI 10.1177/0333102414530527; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hansen JM, 2016, CEPHALALGIA, V36, P216, DOI 10.1177/0333102415584601; Hepp Z, 2015, CEPHALALGIA, V35, P478, DOI 10.1177/0333102414547138; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Hou M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0750-1; Kirthi V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008041.pub3; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Law S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008541.pub3; Linde K, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003225.PUB2; Linde M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010610; Linde M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010611; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lipton RB, 2013, HEADACHE, V53, P1300, DOI 10.1111/head.12154; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; Magis D, 2013, CEPHALALGIA, V33, P526, DOI 10.1177/0333102413477739; Marcus R, 2014, CEPHALALGIA, V34, P114, DOI 10.1177/0333102413500727; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; Minen MT, 2016, J NEUROL NEUROSUR PS, V87, P741, DOI 10.1136/jnnp-2015-312233; Nagy AJ, 2011, NEUROLOGY, V77, P1827, DOI 10.1212/WNL.0b013e3182377dbb; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Orr SL, 2016, HEADACHE, V56, P911, DOI 10.1111/head.12835; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; Schoenen J, 2013, NEUROLOGY, V80, P697, DOI 10.1212/WNL.0b013e3182825055; Seng EK, 2016, CEPHALALGIA; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Stovner LJ, 2014, CEPHALALGIA, V34, P523, DOI 10.1177/0333102413515348; Tepper S, 2017, LANCET NEUROL, V16, P425, DOI 10.1016/S1474-4422(17)30083-2; Tepper Stewart J, 2015, Continuum (Minneap Minn), V21, P1018, DOI 10.1212/CON.0000000000000211; Timm FP, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6635; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vetvik KG, 2017, LANCET NEUROL, V16, P76, DOI 10.1016/S1474-4422(16)30293-9; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233; Worthington I, 2013, CAN J NEUROL SCI, V40, pS1; Zagami AS, 2014, ANN CLIN TRANSL NEUR, V1, P1036, DOI 10.1002/acn3.113	55	64	66	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					553	561		10.1056/NEJMcp1605502	http://dx.doi.org/10.1056/NEJMcp1605502			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28792865				2022-12-28	WOS:000407212600008
J	Lazaridis, I; Mittnik, A; Patterson, N; Mallick, S; Rohland, N; Pfrengle, S; Furtwangler, A; Peltzer, A; Posth, C; Vasilakis, A; McGeorge, PJP; Konsolaki-Yannopoulou, E; Korres, G; Martlew, H; Michalodimitrakis, M; Ozsait, M; Ozsait, N; Papathanasiou, A; Richards, M; Roodenberg, SA; Tzedakis, Y; Arnott, R; Fernandes, DM; Hughey, JR; Lotakis, DM; Navas, PA; Maniatis, Y; Tamatoyannopoulos, JAS; Stewardson, K; Stockhammer, P; Pinhasi, R; Reich, D; Krause, J; Stamatoyannopoulos, G				Lazaridis, Iosif; Mittnik, Alissa; Patterson, Nick; Mallick, Swapan; Rohland, Nadin; Pfrengle, Saskia; Furtweangler, Anja; Peltzer, Alexander; Posth, Cosimo; Vasilakis, Andonis; McGeorge, P. J. P.; Konsolaki-Yannopoulou, Eleni; Korres, George; Martlew, Holley; Michalodimitrakis, Manolis; Ozsait, Mehmet; Ozsait, Nesrin; Papathanasiou, Anastasia; Richards, Michael; Roodenberg, Songul Alpaslan; Tzedakis, Yannis; Arnott, Robert; Fernandes, Daniel M.; Hughey, Jeffery R.; Lotakis, Dimitra M.; Navas, Patrick A.; Maniatis, Yannis; Tamatoyannopoulos, John A. S.; Stewardson, Kristin; Stockhammer, Philipp; Pinhasi, Ron; Reich, David; Krause, Johannes; Stamatoyannopoulos, George			Genetic origins of the Minoans and Mycenaeans	NATURE			English	Article							EARLY FARMERS; GENOME SEQUENCE; ANCIENT DNA; MIGRATION; HISTORY; ADMIXTURE; AGE; CONTAMINATION; POPULATIONS; EURASIANS	The origins of the Bronze Age Minoan and Mycenaean cultures have puzzled archaeologists for more than a century. We have assembled genome-wide data from 19 ancient individuals, including Minoans from Crete, Mycenaeans from mainland Greece, and their eastern neighbours from southwestern Anatolia. Here we show that Minoans and Mycenaeans were genetically similar, having at least three-quarters of their ancestry from the first Neolithic farmers of western Anatolia and the Aegean(1,2), and most of the remainder from ancient populations related to those of the Caucasus(3) and Iran(4,5). However, the Mycenaeans differed from Minoans in deriving additional ancestry from an ultimate source related to the hunter-gatherers of eastern Europe and Siberia(6-8), introduced via a proximal source related to the inhabitants of either the Eurasian steppe(1,6,9) or Armenia(4,9). Modern Greeks resemble the Mycenaeans, but with some additional dilution of the Early Neolithic ancestry. Our results support the idea of continuity but not isolation in the history of populations of the Aegean, before and after the time of its earliest civilizations.	[Lazaridis, Iosif; Mallick, Swapan; Rohland, Nadin; Roodenberg, Songul Alpaslan; Stewardson, Kristin; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Lazaridis, Iosif; Patterson, Nick; Mallick, Swapan; Reich, David] Broad Inst Harvard, Cambridge, MA 02142 USA; [Lazaridis, Iosif; Patterson, Nick; Mallick, Swapan; Reich, David] MIT, Cambridge, MA 02142 USA; [Mittnik, Alissa; Peltzer, Alexander; Posth, Cosimo; Stockhammer, Philipp; Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Mittnik, Alissa; Pfrengle, Saskia; Furtweangler, Anja; Posth, Cosimo; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72074 Tubingen, Germany; [Patterson, Nick] Radcliffe Inst, Cambridge, MA 02138 USA; [Mallick, Swapan; Stewardson, Kristin; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Peltzer, Alexander] Univ Tubingen, Integrat Transcript Ctr Bioinformat, D-72076 Tubingen, Germany; [Vasilakis, Andonis] 23rd Ephorate Prehistor & Class Antiqu, Crete, NE USA; [McGeorge, P. J. P.] British Sch Athens, Athens 10676, Greece; [Konsolaki-Yannopoulou, Eleni] Greek Minist Culture, 26th Ephorate Prehistor & Class Antiqu, Piraeus 13536, Greece; [Korres, George] Univ Athens, Dept Archaeol, Athens 17584, Greece; [Martlew, Holley] Hellen Archaeol Fdn, Holley Martlew Archaeol Fdn, Tivoli House,Tivoli Rd, Cheltenham GL50 2TD, Glos, England; [Michalodimitrakis, Manolis] Univ Crete, Med Sch, Iraklion 71113, NE, Greece; [Ozsait, Mehmet; Ozsait, Nesrin] Bayar caddesi, Erenkoy, Eser Apt 7,Daire 24, Istanbul, Turkey; [Papathanasiou, Anastasia] Greek Minist Culture, Ephorate Paleoantropol & Speleol, Athens 11636, Greece; [Richards, Michael] Simon Fraser Univ, Dept Archaeol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Tzedakis, Yannis] Hellen Archaeol Serv, Samara 27,Paleo Psychico, Athens 15452, Greece; [Arnott, Robert] Univ Oxford, Green Templeton Coll, Woodstock Rd, Oxford OX2 6HG, England; [Fernandes, Daniel M.; Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Fernandes, Daniel M.; Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 4, Ireland; [Fernandes, Daniel M.] Univ Coimbra, Dept Life Sci, CIAS, P-3000456 Coimbra, Portugal; [Hughey, Jeffery R.] Hartnell Coll, Div Math Sci & Engn, 411 Cent Ave, Salinas, CA 93901 USA; [Lotakis, Dimitra M.; Navas, Patrick A.] Univ Washington, Div Med Gen, Washington, DC 98195 USA; [Maniatis, Yannis] Natl Ctr Sci Res Demokritos Aghia Paraskevi, Lab Archaeometry, Athens 15310, Greece; [Tamatoyannopoulos, John A. S.] Univ Washington, Dept Med, Washington, DC 98195 USA; [Tamatoyannopoulos, John A. S.; Stamatoyannopoulos, George] Univ Washington, Dept Genome Sci, Washington, DC 98195 USA; [Tamatoyannopoulos, John A. S.] Altius Inst Biomed Sci, Washington, DC 98121 USA; [Stockhammer, Philipp] Ludwig Maximilians Univ Munchen, Inst Vor & Fruhgeschichtliche Archaol & Provinzia, D-80799 Munich, Germany; [Pinhasi, Ron] Univ Vienna, Dept Anthropol, Althanstr 14, A-1090 Vienna, Austria	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Eberhard Karls University of Tubingen; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Eberhard Karls University of Tubingen; National & Kapodistrian University of Athens; University of Crete; Simon Fraser University; University of Oxford; University College Dublin; University College Dublin; Universidade de Coimbra; University of Washington; National Centre of Scientific Research "Demokritos"; University of Washington; University of Washington; University of Munich; University of Vienna	Lazaridis, I (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	lazaridis@genetics.med.harvard.edu; reich@genetics.med.harvard.edu; krause@shh.mpg.de; gstam@u.washington.edu	Posth, Cosimo/AAL-6219-2021; Richards, Michael/O-3717-2016; Krause, Johannes/AFP-2642-2022; Peltzer, Alexander/I-4064-2019; Pinhasi, Ron/AAT-1531-2020	Richards, Michael/0000-0001-5274-8887; Krause, Johannes/0000-0001-9144-3920; Peltzer, Alexander/0000-0002-6503-2180; Pinhasi, Ron/0000-0003-1629-8131; M Fernandes, Daniel/0000-0002-7434-6552	Royal Society; Institute for Aegean Prehistory (INSTAP); Irish Research Council [GOIPG/2013/36]; Deutsche Forschungsgemeinschaft [KR 4015/1-1]; Max Planck Society; National Institutes of Health [GM100233]; National Science Foundation [HOMINID BCS-1032255]; Howard Hughes Medical Institute; Lucille P. Markey Charitable Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Royal Society(Royal Society of London); Institute for Aegean Prehistory (INSTAP); Irish Research Council(Irish Research Council for Science, Engineering and Technology); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Lucille P. Markey Charitable Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. McCormick for comments and critiques, F. Gohringer, I. Kucukkalipci, and G. Brandt for wet laboratory support, and S. Paabo for providing access to the clean room facilities at the MPI-EVA, Leipzig. We thank the Hellenic Ministry of Culture, the Hellenic Archaeological Service, and the Turkish Ministry of Culture and Tourism for approval of our studies, and the personnel of the Hagios Nikolaos, Herakleion, Pireas, Olympia, Chora (Trifylia), and Isparta Museums for facilitating sample collection. All maps were plotted in R using the worldHiRes map of the 'mapdata' package (using data in the public domain from the CIA World Data Bank II). Research on Hagios Charalambos cave by P.J.P.McG. was supported by the Royal Society and the Institute for Aegean Prehistory (INSTAP). D.M.F. was supported by an Irish Research Council grant (GOIPG/2013/36). J.K. and A.M. were funded by Deutsche Forschungsgemeinschaft grant KR 4015/1-1 and the Max Planck Society. D.R. was supported by National Institutes of Health grant GM100233, by National Science Foundation HOMINID BCS-1032255, and is a Howard Hughes Medical Institute investigator. The study of the ancient Minoans and Mycenaeans was supported by the Lucille P. Markey Charitable Trust to G.S.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Angel JL, 1946, AM ANTHROPOL, V48, P493, DOI 10.1525/aa.1946.48.4.02a00020; Behar DM, 2013, HUM BIOL, V85, P859, DOI 10.3378/027.085.0604; Bernal M., 1987, BLACK ATHENA AFROASI, V1; Bouwrnan AS, 2008, J ARCHAEOL SCI, V35, P2580, DOI 10.1016/j.jas.2008.04.010; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Busby GBJ, 2015, CURR BIOL, V25, P2518, DOI 10.1016/j.cub.2015.08.007; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Chadwick J., 1967, DECIPHERMENT LINEAR; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dickinson O., 1994, AEGEAN BRONZE AGE; Evans A., 1921, PALACE MINOS COMP AC; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hughey JR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2871; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Kilinc GM, 2016, CURR BIOL, V26, P2659, DOI 10.1016/j.cub.2016.07.057; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kretschmer P., 1896, EINLEITUNG GESCH GRI; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martiniano R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10326; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Myres J. L, 1930, WHO WERE THE GREEKS; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Sakellariou M. B, 1980, PROTO GRECS PEUPLEME; Schiffels S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10408; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Willetts R. F., 1992, CIVILIZATION ANCIENT	57	121	122	6	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					214	+		10.1038/nature23310	http://dx.doi.org/10.1038/nature23310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783727	Green Accepted, Green Submitted			2022-12-28	WOS:000407284300044
J	Piazza, A; Wright, WD; Heyer, WD				Piazza, Aurele; Wright, William Douglass; Heyer, Wolf-Dietrich			Multi-invasions Are Recombination Byproducts that Induce Chromosomal Rearrangements	CELL			English	Article							BREAK-INDUCED REPLICATION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; GENOMIC DISORDERS; DNA-REPLICATION; CANCER GENOMES; MPH1 HELICASE; D-LOOPS	Inaccurate repair of broken chromosomes generates structural variants that can fuel evolution and inflict pathology. We describe a novel rearrangement mechanism in which translocation between intact chromosomes is induced by a lesion on a third chromosome. This multi-invasion-induced rearrangement (MIR) stems from a homologous recombination byproduct, where a broken DNA end simultaneously invades two intact donors. No homology is required between the donors, and the intervening sequence from the invading molecule is inserted at the translocation site. MIR is stimulated by increasing homology length and spatial proximity of the donors and depends on the overlapping activities of the structure-selective endonucleases Mus81-Mms4, Slx1-Slx4, and Yen1. Conversely, the 3'-flap nuclease Rad1-Rad10 and enzymes known to disrupt recombination intermediates (Sgs1-Top3-Rmi1, Srs2, and Mph1) inhibit MIR. Resolution of MIR intermediates propagates secondary chromosome breaks that frequently cause additional rearrangements. MIR features have implications for the formation of simple and complex rearrangements underlying human pathologies.	[Piazza, Aurele; Wright, William Douglass; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Microbiol & Mol Genet, 1 Shields Ave, Davis, CA 95616 USA; [Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Heyer, WD (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, 1 Shields Ave, Davis, CA 95616 USA.; Heyer, WD (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	wdheyer@ucdavis.edu	Piazza, Aurele/ABA-8549-2021	Piazza, Aurele/0000-0002-7722-0955	Fondation ARC pour la Recherche sur le Cancer; EMBO [ALTF-238-2013]; European Union [628355]; Philippe Foundation; NIH [GM58015, CA92276]; France-Berkeley Fund [FBF 2015-32]; NATIONAL CANCER INSTITUTE [R01CA092276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058015] Funding Source: NIH RePORTER	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); EMBO(European Molecular Biology Organization (EMBO)); European Union(European Commission); Philippe Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); France-Berkeley Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Heyer laboratory as well as Jim Haber and Martin Kupiec for helpful discussions. We are particularly thankful to Rodney Rothstein, Lorraine Symington, and Neil Hunter for their critical comments. We thank Abou Ibrahim-Biangoro and Noelle Cabral for help with strains construction. We are grateful to Adam Bailis, Lorraine Symington, Ian Hickson, Patrick Sung, Steve Kowalczykowski, Neil Hunter, and Marc Wold for strains and protein expression vectors. A.P. was supported by fellowships from the Fondation ARC pour la Recherche sur le Cancer, the EMBO (ALTF-238-2013), the Framework Project 7 of the European Union (Marie Curie International Outgoing Fellowship 628355) administered by the Institut Pasteur, France, and received financial support from the Philippe Foundation. This research was supported by NIH grants GM58015 and CA92276 and award FBF 2015-32 from the France-Berkeley Fund to W.-D.H.	Anand RP, 2014, GENE DEV, V28, P2394, DOI 10.1101/gad.250258.114; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Bondurand N, 2012, EUR J HUM GENET, V20, P990, DOI 10.1038/ejhg.2012.29; Bosco G, 1998, GENETICS, V150, P1037; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Coic E, 2011, GENETICS, V189, P1225, DOI 10.1534/genetics.111.132738; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fasching CL, 2015, MOL CELL, V57, P595, DOI 10.1016/j.molcel.2015.01.022; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Forget A. L., 2012, COLD SPRING HARB PER, V7; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; HEUDE M, 1993, GENETICS, V133, P489; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; Inbar O, 2000, J BIOL CHEM, V275, P30833, DOI 10.1074/jbc.C000133200; Inbar O, 1999, MOL CELL BIOL, V19, P4134; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Kaur H, 2015, MOL CELL, V57, P583, DOI 10.1016/j.molcel.2015.01.020; Kim Songmi, 2016, Genomics & Informatics, V14, P70, DOI 10.5808/GI.2016.14.3.70; Kloosterman WP, 2013, CURR OPIN CELL BIOL, V25, P341, DOI 10.1016/j.ceb.2013.02.008; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Liu J., 2017, THESIS, V6; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mazon G, 2013, MOL CELL, V52, P63, DOI 10.1016/j.molcel.2013.09.007; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Munoz-Galvan S, 2012, MOL CELL BIOL, V32, P1592, DOI 10.1128/MCB.00111-12; Nazaryan-Petersen L, 2016, HUM MUTAT, V37, P385, DOI 10.1002/humu.22953; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Oakley TJ, 2002, DNA REPAIR, V1, P463, DOI 10.1016/S1568-7864(02)00032-0; Pardo B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002979; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rossi B, 2010, GENETICS, V186, P775, DOI 10.1534/genetics.110.120683; Ruiz JF, 2009, MOL CELL BIOL, V29, P5441, DOI 10.1128/MCB.00256-09; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sneeden JL, 2013, NUCLEIC ACIDS RES, V41, P4913, DOI 10.1093/nar/gkt192; Spies J, 2016, MOL CELL, V62, P903, DOI 10.1016/j.molcel.2016.04.032; Stafa A, 2014, GENETICS, V196, P1017, DOI 10.1534/genetics.114.162297; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tang SM, 2015, MOL CELL, V57, P607, DOI 10.1016/j.molcel.2015.01.021; Thierry A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7154; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	66	63	63	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					760	+		10.1016/j.cell.2017.06.052	http://dx.doi.org/10.1016/j.cell.2017.06.052			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28781165	Green Accepted, Bronze			2022-12-28	WOS:000407445700016
J	Shah, U; Goldstein, AM; Gee, MS; Deshpande, V				Shah, Uzma; Goldstein, Allan M.; Gee, Michael S.; Deshpande, Vikram			Case 24-2017: An 8-Month-Old Girl with Fever and an Abdominal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANCREATIC HAMARTOMA; CLASSIFICATION; LESION; TUMOR		[Shah, Uzma] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Goldstein, Allan M.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Gee, Michael S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Deshpande, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shah, Uzma] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Goldstein, Allan M.] Harvard Med Sch, Dept Surg, Boston, MA USA; [Gee, Michael S.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Deshpande, Vikram] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shah, U (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Shah, U (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.							Adsay NV, 2004, SEMIN DIAGN PATHOL, V21, P260, DOI 10.1053/j.semdp.2005.07.003; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Benifla M, 2003, J CLIN GASTROENTEROL, V37, P169, DOI 10.1097/00004836-200308000-00015; BURT TB, 1983, PEDIATR RADIOL, V13, P287, DOI 10.1007/BF00973350; FLAHERTY MJ, 1992, HUM PATHOL, V23, P1309, DOI 10.1016/0046-8177(92)90301-I; Goske MJ, 2011, PEDIATR RADIOL, V41, P611, DOI [10.1007/s00247-010-1957-3, 10.1007/s00247-011-2133-0]; Jiao YC, 2015, PANCREATOLOGY, V15, P194, DOI 10.1016/j.pan.2014.10.009; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; McFaul CD, 2004, PANCREATOLOGY, V4, P533, DOI 10.1159/000080528; Nagata S, 2007, PATHOL INT, V57, P276, DOI 10.1111/j.1440-1827.2007.02090.x; Pauser U, 2005, AM J SURG PATHOL, V29, P797, DOI 10.1097/01.pas.0000157748.18591.d7; Pauser U, 2005, MODERN PATHOL, V18, P1211, DOI 10.1038/modpathol.3800406; Ranganath SH, 2012, AM J ROENTGENOL, V199, pW1, DOI 10.2214/AJR.11.6642; Rockacy M, 2013, ANN GASTROENTEROL, V26, P122; Sueyoshi R, 2013, INT J SURG CASE REP, V4, P98, DOI 10.1016/j.ijscr.2012.10.001; Teoh AYB, 2016, WORLD J GASTRO ENDOS, V8, P310, DOI 10.4253/wjge.v8.i6.310; Thrall M, 2008, PEDIATR DEVEL PATHOL, V11, P314, DOI 10.2350/07-04-0260.1; Yamaguchi H, 2013, AM J SURG PATHOL, V37, P1006, DOI 10.1097/PAS.0b013e318283ce4c; Zhang JW, 2016, ONCOL LETT, V11, P3925, DOI 10.3892/ol.2016.4535	20	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					574	582		10.1056/NEJMcpc1616393	http://dx.doi.org/10.1056/NEJMcpc1616393			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28792868				2022-12-28	WOS:000407212600012
J	Silberberg, SD; Crawford, DC; Finkelstein, R; Koroshetz, WJ; Blank, RD; Freeze, HH; Garrison, HH; Seger, YR				Silberberg, Shai D.; Crawford, Devon C.; Finkelstein, Robert; Koroshetz, Walter J.; Blank, Robert D.; Freeze, Hudson H.; Garrison, Howard H.; Seger, Yvette R.			Shake up conferences	NATURE			English	Editorial Material									[Silberberg, Shai D.] NINDS, Res Qual, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Crawford, Devon C.; Koroshetz, Walter J.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Finkelstein, Robert] NINDS, Div Extramural Act, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Blank, Robert D.] Federat Amer Soc Expt Biol, SRC Advisory Comm, Bethesda, MD USA; [Freeze, Hudson H.] Federat Amer Soc Expt Biol, Bethesda, MD USA; [Garrison, Howard H.] Federat Amer Soc Expt Biol, Policy, Bethesda, MD USA; [Seger, Yvette R.] Federat Amer Soc Expt Biol, Sci Policy, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Silberberg, SD (corresponding author), NINDS, Res Qual, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	silberbs@ninds.nih.gov	Silberberg, Shai/ABA-2778-2020; Blank, Robert D./V-5995-2019; Seger, Yvette/A-5423-2010	Blank, Robert D./0000-0003-2950-1944; Seger, Yvette/0000-0003-2099-4244; Crawford, Devon/0000-0002-9354-4976; Garrison, Howard/0000-0001-9455-3527					0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					153	154		10.1038/548153a	http://dx.doi.org/10.1038/548153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28796229	Bronze			2022-12-28	WOS:000407284300022
J	Mack, MJ; Acker, MA; Gelijns, AC; Overbey, JR; Parides, MK; Browndyke, JN; Groh, MA; Moskowitz, AJ; Jeffries, NO; Ailawadi, G; Thourani, VH; Moquete, EG; Iribarne, A; Voisine, P; Perrault, LP; Bowdish, ME; Bilello, M; Davatzikos, C; Mangusan, RF; Winkle, RA; Smith, PK; Michler, RE; Miller, MA; O'Sullivan, KL; Taddei-Peters, WC; Rose, EA; Weisel, RD; Furie, KL; Bagiella, E; Moy, CS; O'Gara, PT; Messe, SR				Mack, Michael J.; Acker, Michael A.; Gelijns, Annetine C.; Overbey, Jessica R.; Parides, Michael K.; Browndyke, Jeffrey N.; Groh, Mark A.; Moskowitz, Alan J.; Jeffries, Neal O.; Ailawadi, Gorav; Thourani, Vinod H.; Moquete, Ellen G.; Iribarne, Alexander; Voisine, Pierre; Perrault, Louis P.; Bowdish, Michael E.; Bilello, Michel; Davatzikos, Christos; Mangusan, Ralph F.; Winkle, Rachelle A.; Smith, Peter K.; Michler, Robert E.; Miller, Marissa A.; O'Sullivan, Karen L.; Taddei-Peters, Wendy C.; Rose, Eric A.; Weisel, Richard D.; Furie, Karen L.; Bagiella, Emilia; Moy, Claudia Scala; O'Gara, Patrick T.; Messe, Steven R.		Cardiothoracic Surgical Trials Net	Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC-SURGERY; THORACIC-SURGEONS; BRAIN-LESIONS; STROKE; DELIRIUM; SOCIETY; BYPASS; RISK; DECLINE; IMPACT	IMPORTANCE Stroke is a major complication of surgical aortic valve replacement (SAVR). OBJECTIVE To determine the efficacy and adverse effects of cerebral embolic protection devices in reducing ischemic central nervous system (CNS) injury during SAVR. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial of patients with calcific aortic stenosis undergoing SAVR at 18 North American centers between March 2015 and July 2016. The end of follow-up was December 2016. INTERVENTIONS Use of 1 of 2 cerebral embolic protection devices (n = 118 for suction-based extraction and n = 133 for intra-aortic filtration device) vs a standard aortic cannula (control; n = 132) at the time of SAVR. MAIN OUTCOMES AND MEASURES The primary end pointwas freedom from clinical or radiographic CNS infarction at 7 days (+/- 3 days) after the procedure. Secondary end points included a composite of mortality, clinical ischemic stroke, and acute kidney injury within 30 days after surgery; delirium; mortality; serious adverse events; and neurocognition. RESULTS Among 383 randomized patients (mean age, 73.9 years; 38.4% women; 368 [96.1%] completed the trial), the rate of freedom from CNS infarction at 7 days was 32.0% with suction-based extraction vs 33.3% with control (between-group difference, -1.3%; 95% CI, -13.8% to 11.2%) and 25.6% with intra-aortic filtration vs 32.4% with control (between-group difference, -6.9%; 95% CI, -17.9% to 4.2%). The 30-day composite end point was not significantly different between suction-based extraction and control (21.4% vs 24.2%, respectively; between-group difference, -2.8%[95% CI, -13.5% to 7.9%]) nor between intra-aortic filtration and control (33.3% vs 23.7%; between-group difference, 9.7% [95% CI, -1.2% to 20.5%]). There were no significant differences in mortality (3.4% for suction-based extraction vs 1.7% for control; and 2.3% for intra-aortic filtration vs 1.5% for control) or clinical stroke (5.1% for suction-based extraction vs 5.8% for control; and 8.3% for intra-aortic filtration vs 6.1% for control). Delirium at postoperative day 7 was 6.3% for suction-based extraction vs 15.3% for control (between-group difference, -9.1%; 95% CI, -17.1% to -1.0%) and 8.1% for intra-aortic filtration vs 15.6% for control (between-group difference, -7.4%; 95% CI, -15.5% to 0.6%). Mortality and overall serious adverse events at 90 days were not significantly different across groups. Patients in the intra-aortic filtration group vs patients in the control group experienced significantly more acute kidney injury events (14 vs 4, respectively; P = .02) and cardiac arrhythmias (57 vs 30; P = .004). CONCLUSIONS AND RELEVANCE Among patients undergoing SAVR, cerebral embolic protection devices compared with a standard aortic cannula did not significantly reduce the risk of CNS infarction at 7 days. Potential benefits for reduction in delirium, cognition, and symptomatic stroke merit larger trials with longer follow-up.	[Gelijns, Annetine C.] Icahn Sch Med Mt Sinai, One Gustave L Levy Pl,POB 1077, New York, NY 10029 USA; [Mack, Michael J.; Winkle, Rachelle A.] Baylor Scott & White Hlth, Baylor Res Inst, Dept Cardiothorac Surg, Plano, TX USA; [Acker, Michael A.] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Gelijns, Annetine C.; Overbey, Jessica R.; Parides, Michael K.; Moskowitz, Alan J.; Moquete, Ellen G.; O'Sullivan, Karen L.; Bagiella, Emilia] Icahn Sch Med Mt Sinai, Int Ctr Hlth Outcomes & Innovat Res, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Browndyke, Jeffrey N.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Div Geriatr Behav Hlth, Durham, NC USA; [Groh, Mark A.; Mangusan, Ralph F.] Mission Hlth & Hosp, Cardiovasc & Thorac Surg, Asheville, NC USA; [Jeffries, Neal O.] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA; [Ailawadi, Gorav] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Thourani, Vinod H.] Emory Univ, Sch Med, Div Cardiothorac Surg, Clin Res Unit, Atlanta, GA 30322 USA; [Iribarne, Alexander] Dartmouth Hitchcock Med Ctr, Cardiac Surg, Lebanon, NH 03766 USA; [Voisine, Pierre] Inst Univ Cardiol Quebec, Hop Laval, Quebec City, PQ, Canada; [Perrault, Louis P.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Bowdish, Michael E.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA USA; [Bilello, Michel; Davatzikos, Christos] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Smith, Peter K.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA; [Michler, Robert E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Cardiothorac Surg, New York, NY USA; [Miller, Marissa A.; Taddei-Peters, Wendy C.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Rose, Eric A.] Mt Sinai Hlth Syst, Dept Cardiac Surg, New York, NY USA; [Weisel, Richard D.] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Weisel, Richard D.] Univ Hlth Network, Toronto Gen Hosp, Div Cardiovasc Surg, Toronto, ON, Canada; [Weisel, Richard D.] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada; [Furie, Karen L.] Brown Univ, Rhode Isl Hosp, Dept Neurol, Miriam Hosp, Providence, RI 02903 USA; [Furie, Karen L.] Brown Univ, Bradley Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA; [Moy, Claudia Scala] NINDS, Div Clin Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Messe, Steven R.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Virginia; Emory University; Dartmouth College; Laval University; Universite de Montreal; University of Southern California; University of Pennsylvania; Duke University; Montefiore Medical Center; Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Rhode Island Hospital; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Brigham & Women's Hospital; University of Pennsylvania	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, One Gustave L Levy Pl,POB 1077, New York, NY 10029 USA.	annetine.gelijns@mssm.edu	Davatzikos, Christos/ABE-2057-2021; Parides, Michael/GON-8474-2022; Carrera, Joseph/U-7401-2019; Browndyke, Jeffrey/AAE-7292-2021; Rose, Eric/AAJ-2281-2020; thourani, vinod/AAP-5968-2020	Carrera, Joseph/0000-0003-2487-4506; Davatzikos, Christos/0000-0002-1025-8561; Mangusan, Ralph/0000-0003-4775-8655; Douglas, Pamela/0000-0001-9876-4049; Overbey, Jessica/0000-0001-7283-1661	National Institute of Neurological Disorders and Stroke [U01 HL088942]; National Heart, Lung, and Blood Institute [U01 HL088942]; Canadian Institutes for Health Research [U01 HL088942]; National Institutes of Health [R01 AG014971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL088963, UM1HL118007, UM1HL117924, UM1HL117922, U01HL088942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014971] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The trial was supported by cooperative agreement U01 HL088942 funded by the National Institute of Neurological Disorders and Stroke, the National Heart, Lung, and Blood Institute, and the Canadian Institutes for Health Research. Additional support was provided by grant R01 AG014971 from the National Institutes of Health (Dr Davatzikos). Training in use of the Embol-X (Edwards Lifesciences) and CardioGard (CardioGard) devices was provided by the companies but they did not provide financial support for the study.	Alassar A, 2015, ANN THORAC SURG, V99, P802, DOI 10.1016/j.athoracsur.2014.09.054; Banbury MK, 2003, ANN THORAC SURG, V76, P508, DOI 10.1016/S0003-4975(03)00530-7; Barber PA, 2008, STROKE, V39, P1427, DOI 10.1161/STROKEAHA.107.502989; Bolotin G, 2014, ANN THORAC SURG, V98, P1627, DOI 10.1016/j.athoracsur.2014.06.061; Cook DJ, 2007, ANN THORAC SURG, V83, P1389, DOI 10.1016/j.athoracsur.2006.11.089; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Doganci S, 2013, PERFUSION-UK, V28, P256, DOI 10.1177/0267659112470693; Floyd TF, 2006, ANN THORAC SURG, V81, P2160, DOI 10.1016/j.athoracsur.2006.01.080; Franco K, 2001, PSYCHOSOMATICS, V42, P68, DOI 10.1176/appi.psy.42.1.68; Glas KE, 2007, J AM SOC ECHOCARDIOG, V20, P1227, DOI 10.1016/j.echo.2007.09.001; Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899; Grover FL, 2017, ANN THORAC SURG, V103, P1021, DOI 10.1016/j.athoracsur.2016.12.001; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Kapadia SR, 2017, J AM COLL CARDIOL, V69, P367, DOI 10.1016/j.jacc.2016.10.023; Knipp SC, 2005, EUR J CARDIO-THORAC, V28, P88, DOI 10.1016/j.ejcts.2005.02.043; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Lansky AJ, 2017, J AM COLL CARDIOL, V69, P679, DOI 10.1016/j.jacc.2016.11.045; Meller SM, 2014, CATHETER CARDIO INTE, V83, P502, DOI 10.1002/ccd.24904; Messe SR, 2014, CIRCULATION, V129, P2253, DOI 10.1161/CIRCULATIONAHA.113.005084; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Patel N, 2015, CARDIOVASC PSYCHIAT, V2015; Patel N, 2015, J CARDIAC SURG, V30, P808, DOI 10.1111/jocs.12643; Patel N, 2015, STROKE, V46, P680, DOI 10.1161/STROKEAHA.114.007533; Puskas JD, 2000, ANN THORAC SURG, V69, P1053, DOI 10.1016/S0003-4975(99)01569-6; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Stolz E, 2004, STROKE, V35, P888, DOI 10.1161/01.STR.0000120306.82787.5A; Uddin A, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001913; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2	32	43	44	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					536	547		10.1001/jama.2017.9479	http://dx.doi.org/10.1001/jama.2017.9479			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787505	Green Accepted, Green Published			2022-12-28	WOS:000407160100016
J	Martin, SK; Cifu, AS				Martin, Shannon K.; Cifu, Adam S.			Routine Preoperative Laboratory Tests for Elective Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Martin, Shannon K.] Univ Chicago, Sect Hosp Med, 5841 S Maryland Ave,MC5000, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Martin, SK (corresponding author), Univ Chicago, Sect Hosp Med, 5841 S Maryland Ave,MC5000, Chicago, IL 60637 USA.	smartin1@medicine.bsd.uchicago.edu						Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; [Anonymous], 2016, ROUT PREOP TESTS EL; Balk EM, 2014, 14EHC009EF AG HEALTH; Bock Matthias, 2016, Anesthesiol Clin, V34, P43, DOI 10.1016/j.anclin.2015.10.005; Card R, I CLIN SYSTEMS IMPRO; Czoski-Murray C, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16500	6	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					567	568		10.1001/jama.2017.7508	http://dx.doi.org/10.1001/jama.2017.7508			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787493				2022-12-28	WOS:000407160100019
J	[Anonymous]				[Anonymous]			Newborn Infection Linked With Placenta Consumption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					511	511		10.1001/jama.2017.9720	http://dx.doi.org/10.1001/jama.2017.9720			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787512				2022-12-28	WOS:000407160100007
J	Taher, AT; Weatherall, DJ; Cappellini, MD				Taher, Ali T.; Weatherall, David J.; Cappellini, Maria Domenica			Thalassaemia	LANCET			English	Review							TRANSFUSION-DEPENDENT THALASSEMIA; HEPATIC IRON CONCENTRATION; MAGNETIC-RESONANCE EVALUATION; RANDOMIZED CONTROLLED-TRIAL; MEDICALLY TREATED PATIENTS; ERYTHROID MARROW FUNCTION; SERUM FERRITIN LEVELS; QUALITY-OF-LIFE; BETA-THALASSEMIA; MYOCARDIAL IRON	Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the most common monogenic diseases worldwide. Several clinical forms of alpha-thalassaemia and beta-thalassaemia, including the co-inheritance of beta-thalassaemia with haemoglobin E resulting in haemoglobin E/beta-thalassaemia, have been described. The disease hallmarks include imbalance in the alpha/beta-globin chain ratio, ineffective erythropoiesis, chronic haemolytic anaemia, compensatory haemopoietic expansion, hypercoagulability, and increased intestinal iron absorption. The complications of iron overload, arising from transfusions that represent the basis of disease management in most patients with severe thalassaemia, might further complicate the clinical phenotype. These pathophysiological mechanisms lead to an array of clinical manifestations involving numerous organ systems. Conventional management primarily relies on transfusion and iron-chelation therapy, as well as splenectomy in specific cases. An increased understanding of the molecular and pathogenic factors that govern the disease process have suggested routes for the development of new therapeutic approaches that address the underlying chain imbalance, ineffective erythropoiesis, and iron dysregulation, with several agents being evaluated in preclinical models and clinical trials.	[Taher, Ali T.] Amer Univ Beirut, Med Ctr, Dept Internal Med, POB 11-0236, Beirut 11072020, Lebanon; [Weatherall, David J.] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Cappellini, Maria Domenica] Univ Milan, IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Dept Clin Sci & Commun, Milan, Italy	American University of Beirut; University of Oxford; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Taher, AT (corresponding author), Amer Univ Beirut, Med Ctr, Dept Internal Med, POB 11-0236, Beirut 11072020, Lebanon.	ataher@aub.edu.lb	CAPPELLINI, MARIA DOMENICA/B-4475-2017	CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864	Medical Research Council [MC_UU_00016/12, MC_UU_12009/13] Funding Source: researchfish; MRC [MC_UU_12009/13, MC_UU_00016/12] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aessopos A, 2007, HAEMATOL-HEMATOL J, V92, P131, DOI 10.3324/haematol.10455; Allen A, 2010, BLOOD, V116, P5368, DOI 10.1182/blood-2010-06-289488; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503; Angelucci E, 2002, BLOOD, V100, P17, DOI 10.1182/blood.V100.1.17; Angelucci E, 2014, HAEMATOLOGICA; Angelucci E, 2010, HEMATOL-AM SOC HEMAT, P456, DOI 10.1182/asheducation-2010.1.456; Aydinok Y, 2015, EUR J HAEMATOL, V95, P244, DOI 10.1111/ejh.12487; Belhoul KM, 2012, ANN HEMATOL, V91, P1107, DOI 10.1007/s00277-012-1412-7; Berdoukas V, 2013, AM J HEMATOL, V88, pE283, DOI 10.1002/ajh.23543; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Borgna-Pignatti C, 2014, BRIT J HAEMATOL, V164, P579, DOI 10.1111/bjh.12643; Brittenham GM, 2011, NEW ENGL J MED, V364, P146, DOI 10.1056/NEJMct1004810; Bunn HF, 2011, PATHOPHYSIOLOGY BLOO, P93; Camaschella C, 2016, BRIT J HAEMATOL, V172, P512, DOI 10.1111/bjh.13820; Cao A, 2004, HAEMATOLOGICA, V89, P1157; Cappellini MD, 2011, BLOOD, V118, P884, DOI 10.1182/blood-2010-11-316646; Cappellini MD, 2012, EXPERT REV HEMATOL, V5, P505, DOI [10.1586/ehm.12.42, 10.1586/EHM.12.42]; Cappellini MD., 2014, GUIDELINES MANAGEMEN, V3; Carpenter JP, 2013, HAEMATOLOGICA, V98, P1368, DOI 10.3324/haematol.2013.083634; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; Casale M, 2014, AM J HEMATOL, V89, P1102, DOI 10.1002/ajh.23844; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; CAZZOLA M, 1995, BRIT J HAEMATOL, V89, P473, DOI 10.1111/j.1365-2141.1995.tb08351.x; CAZZOLA M, 1987, BLOOD, V69, P296; CAZZOLA M, 1987, HAEMATOLOGICA, V72, P195; Christianson A., 2006, GLOBAL REPORT BIRTH; Cohen Alan R, 2004, Hematology Am Soc Hematol Educ Program, P14; Cooley TB, 1927, AM J DIS CHILD, V34, P347, DOI 10.1001/archpedi.1927.04130210022002; Danjou F, 2011, HAEMATOL-HEMATOL J, V96, P1573, DOI 10.3324/haematol.2011.055962; Davis BA, 2000, BLOOD, V95, P1229, DOI 10.1182/blood.V95.4.1229.004k32_1229_1236; Delea TE, 2007, TRANSFUSION, V47, P1919, DOI 10.1111/j.1537-2995.2007.01416.x; Deugnier Y, 2011, GASTROENTEROLOGY, V141, P1202, DOI 10.1053/j.gastro.2011.06.065; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Farmaki K, 2011, BLOOD CELL MOL DIS, V47, P33, DOI 10.1016/j.bcmd.2011.03.007; Farmaki K, 2010, BRIT J HAEMATOL, V148, P466, DOI 10.1111/j.1365-2141.2009.07970.x; Fischer R, 2005, ANN NY ACAD SCI, V1054, P350, DOI 10.1196/annals.1345.043; Fisher SA, 2013, COCHRANE DB SYST REV, V8; Fucharoen S, 2012, COLD SPRING HARB PER, V2, P8, DOI [10.1101/cshperspect.a01173428., DOI 10.1101/CSHPERSPECT.A01173428, DOI 10.1101/CSHPERSPECT.A011734]; Gabutti V, 1996, ACTA HAEMATOL-BASEL, V95, P26, DOI 10.1159/000203853; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Haidar R, 2010, EUR SPINE J, V19, P871, DOI 10.1007/s00586-010-1357-2; Haines D, 2013, BRIT J HAEMATOL, V160, P680, DOI 10.1111/bjh.12177; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Kirk P, 2009, Circulation, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kirk P, 2010, J MAGN RESON IMAGING, V32, P315, DOI 10.1002/jmri.22245; Lal A, 2011, NEW ENGL J MED, V364, P710, DOI 10.1056/NEJMoa1010174; Lorey F, 2001, GENET TEST, V5, P93, DOI 10.1089/109065701753145538; Lorey F, 2000, J PEDIAT HEMATOL ONC, V22, P564, DOI 10.1097/00043426-200011000-00024; Maakaron JE, 2013, ANN HEPATOL, V12, P142, DOI 10.1016/S1665-2681(19)31397-3; Mamtani M, 2008, BRIT J HAEMATOL, V141, P882, DOI 10.1111/j.1365-2141.2008.07122.x; Mavrogeni S, 2008, INT J CARDIOVAS IMAG, V24, P849, DOI 10.1007/s10554-008-9332-2; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Musallam KM, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2013.097220; Musallam KM, 2013, ACTA HAEMATOL-BASEL, V130, P64, DOI 10.1159/000345734; Musallam KM, 2013, HAEMATOLOGICA, V98, P833, DOI 10.3324/haematol.2012.066845; Musallam KM, 2013, BLOOD CELL MOL DIS, V51, P35, DOI 10.1016/j.bcmd.2013.01.015; Musallam KM, 2013, BLOOD, V121, P2199, DOI 10.1182/blood-2012-10-408021; Musallam KM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a013482; Musallam KM, 2012, THROMB RES, V130, P695, DOI 10.1016/j.thromres.2012.07.013; Musallam KM, 2012, BLOOD CELL MOL DIS, V49, P136, DOI 10.1016/j.bcmd.2012.06.001; Musallam KM, 2012, BLOOD REV, V26, pS16, DOI 10.1016/S0268-960X(12)70006-1; Musallam KM, 2012, ANN HEMATOL, V91, P235, DOI 10.1007/s00277-011-1291-3; Musallam KM, 2011, BLOOD CELL MOL DIS, V47, P232, DOI 10.1016/j.bcmd.2011.07.005; Musallam KM, 2011, EUR J HAEMATOL, V87, P539, DOI 10.1111/j.1600-0609.2011.01706.x; Musallam KM, 2011, HAEMATOL-HEMATOL J, V96, P1605, DOI 10.3324/haematol.2011.047852; Musallam KM, 2011, EUR J HAEMATOL, V87, P73, DOI 10.1111/j.1600-0609.2011.01623.x; Nai A, 2012, BLOOD; Noetzli LJ, 2012, AM J HEMATOL, V87, P155, DOI 10.1002/ajh.22223; Noetzli LJ, 2012, AM J HEMATOL, V87, P167, DOI 10.1002/ajh.22247; O'Donnell A, 2007, P NATL ACAD SCI USA, V104, P9440, DOI 10.1073/pnas.0703424104; Olivieri NF, 2008, BRIT J HAEMATOL, V141, P388, DOI 10.1111/j.1365-2141.2008.07126.x; Olivieri NF, 2012, BLOOD REV, V26, pS28, DOI 10.1016/S0268-960X(12)70009-7; Olivieri Nancy F, 2011, Indian J Med Res, V134, P522; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Origa R, 2008, HAEMATOL-HEMATOL J, V93, P1095, DOI 10.3324/haematol.12484; Pathare A, 2010, ANN HEMATOL, V89, P405, DOI 10.1007/s00277-009-0838-z; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pennell DJ, 2014, BLOOD, V123, P1447, DOI 10.1182/blood-2013-04-497842; Pennell DJ, 2012, HAEMATOL-HEMATOL J, V97, P842, DOI 10.3324/haematol.2011.049957; Piel FB, 2014, NEW ENGL J MED, V371, P1908, DOI 10.1056/NEJMra1404415; Porter JB, 2001, BRIT J HAEMATOL, V115, P239, DOI 10.1046/j.1365-2141.2001.03195.x; Porter JB, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-38; Premawardhena A, 2005, LANCET, V366, P1467, DOI 10.1016/S0140-6736(05)67396-5; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; Rivella S, 2015, HAEMATOLOGICA, V100, P421, DOI 10.3324/haematol.2014.114827; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Rivella S, 2009, CURR OPIN HEMATOL, V16, P187, DOI 10.1097/MOH.0b013e32832990a4; Roghi A, 2010, ANN HEMATOL, V89, P585, DOI 10.1007/s00277-009-0879-3; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Rund D, 2016, AM J HEMATOL, V91, P15, DOI 10.1002/ajh.24231; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2010, HEMATOL ONCOL CLIN N, V24, P1005, DOI 10.1016/j.hoc.2010.08.009; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Siegel CA, 2005, CLEV CLIN J MED, V72, P199, DOI 10.3949/ccjm.72.3.199; Sripichai O, 2008, AM J HEMATOL, V83, P482, DOI 10.1002/ajh.21130; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; St Pierre TG, 2014, MAGN RESON MED, V71, P2215, DOI 10.1002/mrm.24854; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Taher A., 2013, GUIDELINES MANAGEMEN; Taher AT, 2010, J THROMB HAEMOST, V8, P2152, DOI 10.1111/j.1538-7836.2010.03940.x; Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324/haematol.13098; Taher A, 2006, THROMB HAEMOSTASIS, V96, P488, DOI 10.1160/TH06-05-0267; Taher A, 2006, BLOOD CELL MOL DIS, V37, P12, DOI 10.1016/j.bcmd.2006.04.005; Taher A, 2009, BRIT J HAEMATOL, V147, P752, DOI 10.1111/j.1365-2141.2009.07908.x; Taher AT, 2015, BLOOD CELL MOL DIS, V55, P108, DOI 10.1016/j.bcmd.2015.05.011; Taher AT, 2013, ANN HEMATOL, V92, P1485, DOI 10.1007/s00277-013-1808-z; Taher AT, 2011, BRIT J HAEMATOL, V152, P512, DOI 10.1111/j.1365-2141.2010.08486.x; Taher AT, 2010, BRIT J HAEMATOL, V150, P486, DOI 10.1111/j.1365-2141.2010.08220.x; Taher AT, 2010, AM J HEMATOL, V85, P288, DOI 10.1002/ajh.21626; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Tanner MA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-12; Telfer PT, 2000, BRIT J HAEMATOL, V110, P971, DOI 10.1046/j.1365-2141.2000.02298.x; Vichinsky E, 2012, BLOOD REV, V26, pS31, DOI 10.1016/S0268-960X(12)70010-3; Vichinsky E, 2010, ANN NY ACAD SCI, V1202, P180, DOI 10.1111/j.1749-6632.2010.05572.x; Viprakasit V, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0131-7; Voskaridou E, 2012, ANN HEMATOL, V91, P1451, DOI 10.1007/s00277-012-1465-7; Weatherall D, 2004, AM J HUM GENET, V74, P385, DOI 10.1086/381402; Weatherall DJ, 2010, HEMATOL ONCOL CLIN N, V24, P1021, DOI 10.1016/j.hoc.2010.08.010; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Wood JC, 2008, HAEMATOLOGICA, V93, P917, DOI 10.3324/haematol.12513; Wood JC, 2014, AM J HEMATOL, V89, P505, DOI 10.1002/ajh.23673; Wood JC, 2011, HEMATOL-AM SOC HEMAT, P443, DOI 10.1182/asheducation-2011.1.443; WORWOOD M, 1980, BRIT J HAEMATOL, V46, P409, DOI 10.1111/j.1365-2141.1980.tb05987.x; Yang GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085379; Ziyadeh FN, 2012, NEPHRON CLIN PRACT, V121, pC136, DOI 10.1159/000339787	139	334	364	19	171	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					155	167		10.1016/S0140-6736(17)31822-6	http://dx.doi.org/10.1016/S0140-6736(17)31822-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT0EG	28774421				2022-12-28	WOS:000422793400030
J	Cifu, AS				Cifu, Adam S.			Diagnostic Errors and Diagnostic Calibration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT		[Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081; National Academies of Sciences Engineering and Medicine, IMPR DIAGN HLTH CAR; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944	7	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					905	906		10.1001/jama.2017.11030	http://dx.doi.org/10.1001/jama.2017.11030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28828468				2022-12-28	WOS:000410487100007
J	Alibhai, SMH; Zukotynski, K; Walker-Dilks, C; Emmenegger, U; Finelli, A; Morgan, SC; Hotte, SJ; Tomlinson, GA; Winquist, E				Alibhai, Shabbir M. H.; Zukotynski, Katherine; Walker-Dilks, Cindy; Emmenegger, Urban; Finelli, Antonio; Morgan, Scott C.; Hotte, Sebastien J.; Tomlinson, George A.; Winquist, Eric			Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ANDROGEN-DEPRIVATION-THERAPY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ZOLEDRONIC ACID; MINERAL DENSITY; VERTEBRAL FRACTURES; MEN; OSTEOPOROSIS; PREVENT; ALENDRONATE	Background: Bone health is a significant concern in men with prostate cancer. Purpose: To evaluate the effectiveness of drug, supplement, and lifestyle interventions aimed at preventing fracture, improving bone mineral density (BMD), or preventing or delaying osteoporosis in men with nonmetastatic prostate cancer. Data Sources: Ovid MEDLINE (1946 to 19 January 2017), EMBASE (1980 to 18 January 2017), and the Cochrane Database of Systematic Reviews (19 January 2017). Study Selection: Randomized trials and systematic reviews of trials that were published in English; involved men with nonmetastatic prostate cancer; and compared bone-targeted therapies with placebo, usual care, or other active treatments. Data Extraction: Two reviewers independently extracted study characteristics and assessed study risk of bias for each outcome. Data Synthesis: Two systematic reviews and 28 reports of 27 trials met inclusion criteria. All trials focused on men with nonmetastatic prostate cancer who were initiating or continuing androgen deprivation therapy (ADT). Bisphosphonates were effective in increasing BMD, but no trial was sufficiently powered to detect reduction in fractures. Denosumab improved BMD and reduced the incidence of new radiographic vertebral fractures in 1 high-quality trial. No trials compared calcium or vitamin D versus placebo. Three lifestyle intervention trials did not show a statistically significant difference in change in BMD between exercise and usual care. Limitations: Most trials were of moderate quality. Only 2 randomized controlled trials were designed to examine fracture outcomes. Potential harms of treatments were not evaluated. Conclusion: Both bisphosphonates and denosumab improve BMD in men with nonmetastatic prostate cancer who are receiving ADT. Denosumab also reduces risk for radiographic vertebral fractures, based on 1 trial. More trials studying fracture outcomes are needed in this population.	Univ Toronto, Univ Hlth Network, Odette Canc Ctr, Toronto, ON, Canada; Princess Margaret Hosp, Toronto, ON, Canada; [Zukotynski, Katherine] McMaster Univ, Dept Med, 1200 Main St West,Room 1P11, Hamilton, ON L8N 3Z5, Canada; [Zukotynski, Katherine] McMaster Univ, Dept Radiol, 1200 Main St West,Room 1P11, Hamilton, ON L8N 3Z5, Canada; [Walker-Dilks, Cindy] McMaster Univ, Canc Care Ontario, Program Evidence Based Care, Dept Oncol,Juravinski Hosp, G Wing,2nd Floor,Room 202,711 Concess St, Hamilton, ON L8V 1C3, Canada; [Hotte, Sebastien J.] McMaster Univ, Dept Oncol, Div Med Oncol, 699 Concess St, Hamilton, ON L8V 5C2, Canada; Juravinski Canc Ctr, Hamilton, ON, Canada; [Morgan, Scott C.] Univ Ottawa, Dept Radiol, Div Radiat Oncol, 501 Smyth Rd,Box 903, Ottawa, ON K1H 8L6, Canada; Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada; [Winquist, Eric] Western Univ, Dept Oncol, Div Med Oncol, 790 Commissioners Rd E, London, ON N6A 4L6, Canada; London Hlth Sci Ctr, London, ON, Canada; [Alibhai, Shabbir M. H.] Univ Toronto, Div Geriatr Med, Dept Med, 200 Elizabeth St,Room EN14-214, Toronto, ON M5G 2C4, Canada; [Emmenegger, Urban] Univ Toronto, Div Med Oncol, Dept Med, 190 Elizabeth St,R Fraser Elliott Bldg 3-805, Toronto, ON M5G 2C4, Canada; [Finelli, Antonio] Univ Toronto, Div Urol, Dept Surg, 700 Univ Ave, Toronto, ON M5G 1Z5, Canada; [Tomlinson, George A.] Univ Toronto, Dept Med, Dept Publ Hlth Sci, EN-10,Room 235,200 Elizabeth St, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McMaster University; McMaster University; Cancer Care Ontario; McMaster University; McMaster University; McMaster University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Western University (University of Western Ontario); London Health Sciences Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Alibhai, SMH; Zukotynski, K (corresponding author), McMaster Univ, Canc Care Ontario, Program Evidence Based Care, Dept Oncol,Juravinski Hosp, G Wing,2nd Floor,Room 202,711 Concess St, Hamilton, ON L8V 1C3, Canada.	ccopgi@mcmaster.ca	Tomlinson, George/L-5432-2016	Tomlinson, George/0000-0002-9328-6399; Alibhai, Shabbir/0000-0001-7815-6046; Hotte, Sebastien/0000-0001-9286-1972; Morgan, Scott/0000-0002-6568-3346	Program in Evidence-Based Care	Program in Evidence-Based Care	Program in Evidence-Based Care.	Al-Shamsi HO, 2012, J ONCOL, V2012, DOI 10.1155/2012/958596; Alibhai S, 2016, BONE HLTH BONE TARGE; Alibhai SMH, 2012, JAMA-J AM MED ASSOC, V307, P255, DOI 10.1001/jama.2011.2022; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; [Anonymous], 2021, LANG ENV STAT COMP; Bhoopalam N, 2009, J UROLOGY, V182, P2257, DOI 10.1016/j.juro.2009.07.046; Casey R, 2010, CAN J UROL, V17, P5170; Choo R, 2013, INT J RADIAT ONCOL, V85, P1239, DOI 10.1016/j.ijrobp.2012.11.007; Cormie P, 2015, BJU INT, V115, P256, DOI 10.1111/bju.12646; Cosman F, 2017, NEW ENGL J MED, V376, P396, DOI 10.1056/NEJMc1615367; Datta M, 2012, ONCOLOGIST, V17, P1171, DOI 10.1634/theoncologist.2012-0051; Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214; Denham JW, 2014, BJU INT, V114, P344, DOI 10.1111/bju.12497; Denham JW, 2012, LANCET ONCOL, V13, P1260, DOI 10.1016/S1470-2045(12)70423-0; Ding H, 2013, ASIAN PAC J CANCER P, V14, P3337, DOI 10.7314/APJCP.2013.14.5.3337; Gilbert SM, 2011, UROL ONCOL-SEMIN ORI, V29, P647, DOI 10.1016/j.urolonc.2009.09.004; Gralow JR, 2009, J NATL COMPR CANC NE, V7, pS1, DOI 10.6004/jnccn.2009.0076; Greenspan SL, 2005, J CLIN ENDOCR METAB, V90, P6410, DOI 10.1210/jc.2005-0183; Greenspan SL, 2008, J CLIN ONCOL, V26, P4426, DOI 10.1200/JCO.2007.15.1233; Greenspan SL, 2007, ANN INTERN MED, V146, P416, DOI 10.7326/0003-4819-146-6-200703200-00006; Griffith JF, 2010, RADIOL CLIN N AM, V48, P519, DOI 10.1016/j.rcl.2010.02.012; Gulamhusein H, 2014, JAMA-J AM MED ASSOC, V312, P2285, DOI 10.1001/jama.2014.14038; Hasenoehrl T, 2015, SUPPORT CARE CANCER, V23, P2479, DOI 10.1007/s00520-015-2782-x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Israeli RS, 2007, CLIN GENITOURIN CANC, V5, P271, DOI 10.3816/CGC.2007.n.003; Kachnic LA, 2013, PROSTATE CANCER P D, V16, P382, DOI 10.1038/pcan.2013.35; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kapoor A, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/176164; Kearns AE, 2010, SUPPORT CARE CANCER, V18, P321, DOI 10.1007/s00520-009-0655-x; Klotz LH, 2013, EUR UROL, V63, P927, DOI 10.1016/j.eururo.2012.09.007; Leslie WD, 2016, ANN INTERN MED, V165, P465, DOI 10.7326/M15-2937; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Michaelson MD, 2007, J CLIN ONCOL, V25, P1038, DOI 10.1200/JCO.2006.07.3361; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Morabito N, 2004, J BONE MINER RES, V19, P1766, DOI 10.1359/JBMR.040813; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Nilsen TS, 2015, ACTA ONCOL, V54, P1805, DOI 10.3109/0284186X.2015.1037008; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Panju AH, 2009, BJU INT, V103, P753, DOI 10.1111/j.1464-410X.2008.08156.x; Parmar MK, 2004, STAT MED, V23, DOI DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.C0;2-8; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Rao MP, 2008, CURR UROL, V2, P79; Rodrigues P, 2007, INT J UROL, V14, P317, DOI 10.1111/j.1442-2042.2006.01721.x; Ryan CW, 2007, BJU INT, V100, P70, DOI 10.1111/j.1464-410X.2007.06853.x; Ryan CW, 2006, J UROLOGY, V176, P972, DOI 10.1016/j.juro.2006.04.078; SantaMina D, 2012, J CANC THER, V3, P146, DOI DOI 10.4236/JCT.2012.32020; Schwarzer G., 2007, R NEWS, V7, P40; Neto AS, 2012, PROSTATE CANCER P D, V15, P36, DOI 10.1038/pcan.2011.4; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith MR, 2010, J UROLOGY, V184, P1316, DOI 10.1016/j.juro.2010.06.022; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Tanvetyanon T, 2005, CANCER-AM CANCER SOC, V103, P237, DOI 10.1002/cncr.20766; Taxel P, 2010, BJU INT, V106, P1473, DOI 10.1111/j.1464-410X.2010.09329.x; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0657-x; Winters-Stone KM, 2014, MED SCI SPORT EXER, V46, P1482, DOI 10.1249/MSS.0000000000000265	61	30	30	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					341	+		10.7326/M16-2577	http://dx.doi.org/10.7326/M16-2577			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28785760				2022-12-28	WOS:000409120400008
J	Damman, P; de Winter, RJ				Damman, Peter; de Winter, Robbert J.			Timing of revascularisation for acute coronary syndrome	LANCET			English	Editorial Material							ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; INTERVENTION; IMMEDIATE; TRIAL; ANGIOPLASTY		[Damman, Peter; de Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Damman, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands.	p.damman@amc.uva.nl	Damman, Peter/D-9469-2018		AstraZeneca; OrbusNeich Medical; Abbott Vascular; Stentys; Tryton	AstraZeneca(AstraZeneca); OrbusNeich Medical; Abbott Vascular(Abbott Laboratories); Stentys; Tryton	PD has received a research grant from AstraZeneca related to adherence to pharmacological therapy after acute coronary syndrome. RJdW has received research grants from OrbusNeich Medical, Abbott Vascular, AstraZeneca, Stentys, and Tryton for stent research and pharmacological therapy with P2Y12-receptor inhibition before STEMI.	Badings EA, 2013, EUROINTERVENTION, V9, P54, DOI 10.4244/EIJV9I1A9; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Jobs A, 2017, LANCET; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418	12	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					717	718		10.1016/S0140-6736(17)31632-X	http://dx.doi.org/10.1016/S0140-6736(17)31632-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28778542				2022-12-28	WOS:000407858900004
J	Cole, TJ; Altman, DG				Cole, Tim J.; Altman, Douglas G.			Statistics Notes: What is a percentage difference?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Cole, Tim J.] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	University of London; University College London; University of Oxford	Cole, TJ (corresponding author), UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England.	tim.cole@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	MRC [MR/M012069/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/M012069/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2016, GUINNESS BOOK RECORD; Cole TJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3683; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17	3	17	17	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3663	10.1136/bmj.j3663	http://dx.doi.org/10.1136/bmj.j3663			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814561	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000408228300003
J	Copp, T; Jansen, J; Doust, J; Mol, BWJ; Dokras, A; McCaffery, K				Copp, Tessa; Jansen, Jesse; Doust, Jenny; Mol, Ben W. J.; Dokras, Anuja; McCaffery, Kirsten			TOO MUCH MEDICINE Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-STYLE MODIFICATION; ANDROGEN EXCESS; ROTTERDAM CRITERIA; PREVALENCE; DIAGNOSIS; ANXIETY; METFORMIN; CONSENSUS; COMMON; RISK		[Copp, Tessa; Jansen, Jesse; McCaffery, Kirsten] Univ Sydney, Sydney Sch Publ Hlth, Wiser Healthcare, Sydney, NSW 2006, Australia; [Copp, Tessa; Jansen, Jesse; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW 2006, Australia; [Doust, Jenny] Bond Univ, Wiser Healthcare, Southport, Qld 4229, Australia; [Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Mol, Ben W. J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5005, Australia; [Mol, Ben W. J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Dokras, Anuja] Univ Penn, Dept Obstet & Gynecol, Penn PCOS Ctr, Philadelphia, PA 19104 USA	University of Sydney; University of Sydney; Bond University; Bond University; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); University of Pennsylvania	Jansen, J (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Wiser Healthcare, Sydney, NSW 2006, Australia.; Jansen, J (corresponding author), Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW 2006, Australia.	jesse.jansen@sydney.edu.au	Copp, Tessa/AAL-5109-2020; McCaffery, Kirsten/K-7945-2019; Doust, Jenny/AGI-8773-2022	Copp, Tessa/0000-0001-7801-5884; McCaffery, Kirsten/0000-0003-2696-5006; Doust, Jenny/0000-0002-4024-9308				[Anonymous], 2016, Nat Rev Dis Primers, V2, P16058, DOI 10.1038/nrdp.2016.58; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Bazarganipour F, 2013, IRAN J REPROD MED, V11, P829; Bhagavath B, 2012, AM J OBSTET GYNECOL, V206, P195, DOI 10.1016/j.ajog.2011.06.007; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Boyle JA, 2012, MED J AUSTRALIA, V196, P62, DOI 10.5694/mja11.10553; Carmina E, 2005, J CLIN ENDOCR METAB, V90, P2545, DOI 10.1210/jc.2004-2279; Carmina E, 2010, AM J OBSTET GYNECOL, V358, P201, DOI [10.1016/j.ajog.2010.03, DOI 10.1016/J.AJ0G.2010.03.008]; Cooney LG, 2017, HUM REPROD, V32, P1075, DOI 10.1093/humrep/dex044; Copp T, 2017, HUM REPROD, V32, P876, DOI 10.1093/humrep/dex029; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; Deeks AA, 2011, HUM REPROD, V26, P1399, DOI 10.1093/humrep/der071; Deeks AA, 2010, FERTIL STERIL, V93, P2421, DOI 10.1016/j.fertnstert.2009.09.018; Dewailly D, 2016, BEST PRACT RES CL OB, V37, P5, DOI 10.1016/j.bpobgyn.2016.03.009; Dewailly D, 2014, HUM REPROD UPDATE, V20, P334, DOI 10.1093/humupd/dmt061; Dhesi AS, 2016, AM J OBSTET GYNECOL, V215, P579, DOI 10.1016/j.ajog.2016.07.043; Dokras A, 2014, J CLIN ENDOCR METAB, V99, P1583, DOI 10.1210/jc.2013-4190; Dokras A, 2012, FERTIL STERIL, V97, P225, DOI 10.1016/j.fertnstert.2011.10.022; Dokras A, 2011, OBSTET GYNECOL, V117, P145, DOI 10.1097/AOG.0b013e318202b0a4; Doust J, 2017, JAMA INTERN MED, V177, P1020, DOI 10.1001/jamainternmed.2017.1302; Duijkers IJM, 2010, GYNECOL ENDOCRINOL, V26, P152, DOI [10.3109/09513590903247824, 10.1080/09513590903247824]; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; French DP, 2017, ANN BEHAV MED, V51, P718, DOI 10.1007/s12160-017-9895-z; Goodarzi MO, 2005, FERTIL STERIL, V84, P766, DOI 10.1016/j.fertnstert.2005.03.051; Jean Hailes for Women's Health on behalf of the PCOS Australian Alliance, 2015, EV BAS GUID ASS MAN; Johnstone EB, 2010, J CLIN ENDOCR METAB, V95, P4965, DOI 10.1210/jc.2010-0202; Jones GL, 2011, JOGNN-J OBST GYN NEO, V40, P577, DOI 10.1111/j.1552-6909.2011.01279.x; Jorgensen P, 2015, FAM PRACT, V32, P492, DOI 10.1093/fampra/cmv065; Joshi Beena, 2014, Indian J Endocrinol Metab, V18, P317, DOI 10.4103/2230-8210.131162; Kitzinger C, 2002, SOC SCI MED, V54, P349, DOI 10.1016/S0277-9536(01)00034-X; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lauritsen MP, 2014, HUM REPROD, V29, P791, DOI 10.1093/humrep/det469; Legro RS, 2016, J CLIN ENDOCR METAB, V101, P2658, DOI 10.1210/jc.2016-1659; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Lizneva D, 2016, FERTIL STERIL, V106, P1510, DOI 10.1016/j.fertnstert.2016.07.1121; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Mehrabian F, 2011, ENDOKRYNOL POL, V62, P238; Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub3; Morris S, 2016, CLIN OBES, V6, P1, DOI 10.1111/cob.12123; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Naderpoor N, 2015, HUM REPROD UPDATE, V21, P560, DOI 10.1093/humupd/dmv025; National Institute of Health, 2012, EV BAS METH WORKSH P; Ogedegbe G, 2010, HYPERTENSION, V56, P344, DOI 10.1161/HYPERTENSIONAHA.110.156257; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Rashidi H, 2014, EUR J OBSTET GYN R B, V174, P100, DOI 10.1016/j.ejogrb.2013.12.018; Roe Andrea Hsu, 2011, Rev Obstet Gynecol, V4, P45; Rowlands IJ, 2016, HUM REPROD, V31, P2072, DOI 10.1093/humrep/dew174; Royal College of Obstetricians and Gynaecologists Greentop Guidelines, 2014, LONG TERM CONS POL O; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311; Tang T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub4; Teede HJ, 2013, OBESITY, V21, P1526, DOI 10.1002/oby.20213; Teede HJ, 2011, MED J AUSTRALIA, V195, pS69, DOI 10.5694/mja11.10915; Tehrani FR, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-89; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-39; Witchel SF, 2015, HORM RES PAEDIAT, V83, P376, DOI 10.1159/000375530; Yildiz BO, 2012, HUM REPROD, V27, P3067, DOI 10.1093/humrep/des232; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377; Zhuang J, 2014, GYNECOL OBSTET INVES, V77, P217, DOI 10.1159/000358485	66	29	30	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3694	10.1136/bmj.j3694	http://dx.doi.org/10.1136/bmj.j3694			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814559	Green Published			2022-12-28	WOS:000408228300005
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... baby boxes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Imperial College Healthcare NHS Trust, 2016, TRUST 1 UK PIL FINN; Lee H., 2013, BBC NEWS; Powell T., 2017, EVENING STANDARD; Scottish Government, 2017, REG BAB BOX WILL BEG; Temple Health, 2017, NEWS ANN; Trust Lullaby, 2017, AR CARDB BAB BOX SAF	6	0	0	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2017	358								j3873	10.1136/bmj.j3873	http://dx.doi.org/10.1136/bmj.j3873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BX	28811288				2022-12-28	WOS:000408228100005
J	Amitai, G; Sorek, R				Amitai, Gil; Sorek, Rotem			MICROBIOLOGY Intracellular signaling in CRISPR-Cas defense	SCIENCE			English	Editorial Material							DNA CLEAVAGE; IMMUNITY; RECOGNITION; PROKARYOTES; DEGRADATION; COMPLEX		[Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rotem.sorek@weizmann.ac.il						Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467	13	6	6	5	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					550	551		10.1126/science.aao2210	http://dx.doi.org/10.1126/science.aao2210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798118				2022-12-28	WOS:000407324800025
J	Bernard, G				Bernard, Gordon			HISTORY OF MEDICINE Acute Lung Failure - Our Evolving Understanding of ARDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OUTCOMES		[Bernard, Gordon] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Bernard, G (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.							BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; The ARDS Definition Task Force, 2012, JAMA, V307, P2526	5	14	14	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					507	509		10.1056/NEJMp1706595	http://dx.doi.org/10.1056/NEJMp1706595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28792872				2022-12-28	WOS:000407212600002
J	Marris, E				Marris, Emma			PEST CONTROL Mosquitoes meet their match in Tahiti	NATURE			English	News Item																			0	12	14	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					17	18		10.1038/548017a	http://dx.doi.org/10.1038/548017a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770863	Bronze			2022-12-28	WOS:000406831700010
J	Salomon, WE; Jolly, SM; Moore, MJ; Zamore, PD; Serebrov, V				Salomon, William E.; Jolly, Samson M.; Moore, Melissa J.; Zamore, Phillip D.; Serebrov, Victor			Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides	CELL			English	Correction												phillip.zamore@umassmed.edu; victor.serebrov@umassmed.edu		Zamore, Phillip/0000-0002-4505-9618; Serebrov, Victor/0000-0002-5800-3103				Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029	1	8	8	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					517	520		10.1016/j.cell.2016.06.048	http://dx.doi.org/10.1016/j.cell.2016.06.048			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	28777949	Bronze			2022-12-28	WOS:000380255400026
J	Bradley, DJ; Goodman, SN; Powe, NR				Bradley, DJ; Goodman, SN; Powe, NR			Cardiac resynchronization for progressive heart failure - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Bradley, DJ (corresponding author), Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA.							Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 1999, AM J CARDIOL, V83, p130D; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; BRISTOW MR, 2003, AM COLL CARD 52 ANN; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2002, J CARDIOVASC ELECTR, V13, pS73, DOI 10.1111/j.1540-8167.2002.tb01958.x; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Walker S, 2000, AM J CARDIOL, V86, P231, DOI 10.1016/S0002-9149(00)00865-1	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					37	38		10.1001/jama.290.1.37	http://dx.doi.org/10.1001/jama.290.1.37			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	28828472				2022-12-28	WOS:000183868600014
J	Benowitz, NL				Benowitz, Neal L.			Comprehensive Nicotine Regulation to End the Combustible Tobacco Epidemic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CIGARETTES		[Benowitz, Neal L.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Benowitz, NL (corresponding author), Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Box 1220, San Francisco, CA 94143 USA.	Neal.Benowitz@ucsf.edu						Beard E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4645; Benowitz NL, 2012, CANCER EPIDEM BIOMAR, V21, P761, DOI 10.1158/1055-9965.EPI-11-0644; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Donny EC, 2015, NEW ENGL J MED, V373, P1340, DOI 10.1056/NEJMsa1502403; Food and Drug Administration HHS, 2016, Fed Regist, V81, P28973; Tengs TO, 2005, PREV MED, V40, P170, DOI 10.1016/j.ypmed.2004.05.017; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262	8	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2017	167	10					736	+		10.7326/M17-2071	http://dx.doi.org/10.7326/M17-2071			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO2DP	28806818				2022-12-28	WOS:000416584200017
J	Chiba, K; Lorbeer, FK; Shain, AH; McSwiggen, DT; Schruf, E; Oh, A; Ryu, J; Darzacq, X; Bastian, BC; Hockemeyer, D				Chiba, Kunitoshi; Lorbeer, Franziska K.; Shain, A. Hunter; McSwiggen, David T.; Schruf, Eva; Oh, Areum; Ryu, Jekwan; Darzacq, Xavier; Bastian, Boris C.; Hockemeyer, Dirk			Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism	SCIENCE			English	Article							TERMINAL TRANSFERASE; GENOME INSTABILITY; HUMAN-CELLS; CANCER; MELANOMA; LENGTH; DYSFUNCTION; RISK; TETRAHYMENA	TERT promoter mutations (TPMs) are the most common noncoding mutations in cancer. The timing and consequences of TPMs have not been fully established. Here, we show that TPMs acquired at the transition from benign nevus to malignant melanoma do not support telomere maintenance. In vitro experiments revealed that TPMs do not prevent telomere attrition, resulting in cells with critically short and unprotected telomeres. Immortalization by TPMs requires a gradual up-regulation of telomerase, coinciding with telomere fusions. These data suggest that TPMs contribute to tumorigenesis by promoting immortalization and genomic instability in two phases. In an initial phase, TPMs do not prevent bulk telomere shortening but extend cellular life span by healing the shortest telomeres. In the second phase, the critically short telomeres lead to genome instability and telomerase is further up-regulated to sustain cell proliferation.	[Chiba, Kunitoshi; Lorbeer, Franziska K.; McSwiggen, David T.; Schruf, Eva; Darzacq, Xavier; Hockemeyer, Dirk] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shain, A. Hunter; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Shain, A. Hunter; Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Oh, Areum; Ryu, Jekwan] Opt Biosyst, Santa Clara, CA 95050 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Hockemeyer, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	hockemeyer@berkeley.edu		Lorbeer, Franziska/0000-0002-3152-6852; Chiba, Kunitoshi/0000-0003-3385-9308; Shain, Alan/0000-0002-2999-9706; Darzacq, Xavier/0000-0003-2537-8395	Nakajima foundation fellowship; Pew Charitable Trusts; Alexander and Margaret Stewart Trust; Siebel Stem Cell Institute; NIH [R01-CA196884, 5T32 CA177555, 1R35CA22048]; Melanoma Research Alliance individual investigator award; Terry Patters Memorial Foundation; California Institute for Regenerative Medicine grant [LA1-08013]; NATIONAL CANCER INSTITUTE [R01CA142873, T32CA177555, R01CA196884, R35CA220481] Funding Source: NIH RePORTER	Nakajima foundation fellowship; Pew Charitable Trusts; Alexander and Margaret Stewart Trust; Siebel Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance individual investigator award; Terry Patters Memorial Foundation; California Institute for Regenerative Medicine grant(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. S. Martin, R. Tjian, and the members of the Hockemeyer laboratory for critical comments on the manuscript. K.C. is supported by a Nakajima foundation fellowship. D.H. is a Pew-Stewart Scholar for Cancer Research supported by the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust. D.H. is supported by the Siebel Stem Cell Institute and NIH R01-CA196884. A.H.S is supported by NIH 5T32 CA177555. B.C.B. is supported by NIH 1R35CA22048, a Melanoma Research Alliance individual investigator award, and the Terry Patters Memorial Foundation. X.D. is supported by the California Institute for Regenerative Medicine grant LA1-08013. StellarVision is an imaging instrument developed by Optical Biosystems, and A.O. and J.R. are full-time employees of this company. MATLAB code used for image analysis is available at https://gitlab.com/tjian-darzacq-lab. Patient sequencing data are available within the Sequence Read Archive with accession number SRP113411.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Cancer Genome Atlas N., 2015, CELL, V161, P1681, DOI [10.1016/j.cell.2015.05.044, DOI 10.1016/J.CELL.2015.05.044]; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iles MM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju267; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lin TT, 2014, BRIT J HAEMATOL, V167, P214, DOI 10.1111/bjh.13023; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171; Min J, 2016, CANCER DISCOV, V6, P1212, DOI 10.1158/2159-8290.CD-16-1050; Nagore E, 2016, INT J CANCER, V139, P75, DOI 10.1002/ijc.30042; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Rode L, 2016, INT J EPIDEMIOL, V45, P1634, DOI 10.1093/ije/dyw179; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Stanley SE, 2015, CURR OPIN GENET DEV, V33, P1, DOI 10.1016/j.gde.2015.06.004	30	150	151	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2017	357	6358					1416	+		10.1126/science.aao0535	http://dx.doi.org/10.1126/science.aao0535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI3QH	28818973	Green Accepted			2022-12-28	WOS:000411880800051
J	McIntyre, A; Joseph, AM; Bagley, N				McIntyre, Adrianna; Joseph, Allan M.; Bagley, Nicholas			Small Change, Big Consequences - Partial Medicaid Expansions under the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McIntyre, Adrianna] Harvard Univ, Cambridge, MA 02138 USA; [Joseph, Allan M.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Joseph, Allan M.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Bagley, Nicholas] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McIntyre, A (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Joseph, Allan/0000-0003-2768-0889				Centers for Medicare & Medicaid Services, 2012, FREQ ASK QUEST EXCH; Keehan SP, 2017, HEALTH AFFAIR, V36, P553, DOI 10.1377/hlthaff.2016.1627; Scott D., 2013, GOVERNING; Sommers BD, 2016, HEALTH AFFAIR, V35, P96, DOI 10.1377/hlthaff.2015.0917	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1004	1006		10.1056/NEJMp1710265	http://dx.doi.org/10.1056/NEJMp1710265			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG6YC	28792848	Green Published			2022-12-28	WOS:000410545200002
J	Kattakuzhy, S; Gross, C; Emmanuel, B; Teferi, G; Jenkins, V; Silk, R; Akoth, E; Thomas, A; Ahmed, C; Espinosa, M; Price, A; Rosenthal, E; Tang, L; Wilson, E; Bentzen, S; Masur, H; Kottilil, S				Kattakuzhy, Sarah; Gross, Chloe; Emmanuel, Benjamin; Teferi, Gebeyehu; Jenkins, Veronica; Silk, Rachel; Akoth, Elizabeth; Thomas, Aurielle; Ahmed, Charisse; Espinosa, Michelle; Price, Angie; Rosenthal, Elana; Tang, Lydia; Wilson, Eleanor; Bentzen, Soren; Masur, Henry; Kottilil, Shyam		Ascend Providers	Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers A Nonrandomized Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NATIONAL-HEALTH; UNITED-STATES; OUTCOMES; REGIMENS	Background: Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has resulted in high rates of disease cure; however, not enough specialists currently are available to provide care. Objective: To determine the efficacy of HCV treatment independently provided by nurse practitioners (NPs), primary care physicians (PCPs), or specialist physicians using DAA therapy. Design: Nonrandomized, open-label clinical trial initiated in 2015. (ClinicalTrials.gov: NCT02339038) Setting: 13 urban, federally qualified health centers (FQHCs) in the District of Columbia. Patients: A referred sample of 600 patients, of whom 96% were black, 69% were male, 82% were treatment naive, and 20% had cirrhosis. Seventy-two percent of the patients had HCV genotype 1a infection. The baseline characteristics of patients seen by each provider type were similar. Intervention: Patients were assigned in a nonrandomized but specified manner to receive treatment from 1 of 5 NPs, 5 PCPs, or 6 specialists. All providers underwent an identical 3-hour training session based on guidelines. Patients received treatment with ledipasvir-sofosbuvir, which was provided on site, according to U.S. Food and Drug Administration labeling requirements. Measurements: Sustained virologic response (SVR). Results: 516 patients achieved SVR, a response rate of 86% (95% CI, 83.0% to 88.7%), with no major safety signals. Response rates were consistent across the 3 provider types: NPs, 89.3% (CI, 83.3% to 93.8%); PCPs, 86.9% (CI, 80.6% to 91.7%); and specialists, 83.8% (CI, 79.0% to 87.8%). Patient loss to follow-up was the major cause of non-SVR. Limitation: Nonrandomized patient distribution; possible referral bias. Conclusion: In a real-world cohort of patients at urban FQHCs, HCV treatment administered by nonspecialist providers was as safe and effective as that provided by specialists. Nurse practitioners and PCPs with compact didactic training could substantially expand the availability of community-based providers to escalate HCV therapy, bridging existing gaps in the continuum of care for patients with HCV infection.	[Kattakuzhy, Sarah; Gross, Chloe; Emmanuel, Benjamin; Silk, Rachel; Akoth, Elizabeth; Espinosa, Michelle; Price, Angie; Rosenthal, Elana; Tang, Lydia; Wilson, Eleanor; Kottilil, Shyam] Univ Maryland, Sch Med, Div Clin Care & Res, Inst Human Virol, Room S222,725 West Lombard St, Baltimore, MD 21201 USA; Unity Hlth Care & Family & Med Counseling Serv, Washington, DC USA; NIH, Bldg 10, Bethesda, MD 20892 USA; [Teferi, Gebeyehu] Unity Hlth Care Walker Jones, 40 Patterson St Northeast, Washington, DC 20002 USA; [Jenkins, Veronica] Family Med Counseling Serv Med Clin, 2041 Martin Luther King Jr Ave SE,Suite 300, Washington, DC 20020 USA; [Bentzen, Soren] 600 West Redwood St,Howard Hall 109D, Baltimore, MD 21201 USA; [Thomas, Aurielle; Ahmed, Charisse; Masur, Henry] Bldg 10,Room 2C145,10 Ctr Dr, Bethesda, MD 20814 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA	Kottilil, S (corresponding author), Univ Maryland, Sch Med, Div Clin Care & Res, Inst Human Virol, Room S222,725 West Lombard St, Baltimore, MD 21201 USA.	skottilil@ihv.umaryland.edu	Kottilil, Shyam/ABF-7605-2021; Bentzen, Soren M/O-7787-2019	Bentzen, Soren M/0000-0002-7444-7564; Rosenthal, Elana/0000-0001-7234-4871; Wilson, Eleanor/0000-0002-4855-514X	National Institutes of Health; Gilead Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL009021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	National Institutes of Health and Gilead Sciences.	Afdhal NH, 2013, J VIRAL HEPATITIS, V20, P745, DOI 10.1111/jvh.12173; American Association for the Study of Liver Disease; Infectious Dis- eases Society of America, 2017, HCV GUID REC TEST MA; American Association for the Study of Liver Diseases; Infectious Diseases Society of America, 2017, HCV TEST LINK CAR; American Association of American Medical Colleges, 2015, 2015 STAT PHYS WORKF; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Backus LI, 2015, J CLIN GASTROENTEROL, V49, P329, DOI 10.1097/MCG.0000000000000124; Centers for Disease Control and Prevention, 2015, VIR HEP HEP C; Cheng W, 2015, J GASTROEN HEPATOL, V30, P1, DOI 10.1111/jgh.12863; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; District of Columbia Department of Health; HIV/AIDS Hepatitis STD and TB Administration, 2013, ANN EP SURV REP 2013; Gilead Sciences, 2016, HARVONI US FULL PRES; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Kottilil S, 2014, ANN INTERN MED, V161, P443, DOI 10.7326/M14-0741; National Institute of Allergy and Infectious Diseases; National Institutes of Health; U.S. Department of Health and Human Services, 2013, DIV AIDS DAIDS TABL; Rossaro L, 2013, DIGEST DIS SCI, V58, P3620, DOI 10.1007/s10620-013-2810-y; Tazawa Junichi, 2011, J Rural Med, V6, P54, DOI 10.2185/jrm.6.54; Terrault Z. S., 2015, 66 ANN M AM ASS STUD; U.S. Preventive Services Task Force, 2015, HEP C SCREEN; Weiss JJ, 2012, INT C VIR HEP 2012 N; Woodrell C, 2015, J ADDICT MED, V9, P405, DOI 10.1097/ADM.0000000000000147; World Health Organisation, 2007, TASK SHIFT RAT RED T; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	23	148	149	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					311	+		10.7326/M17-0118	http://dx.doi.org/10.7326/M17-0118			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28785771	Green Accepted			2022-12-28	WOS:000409120400005
J	Wiesenfeldt, MP; Nairoukh, Z; Li, W; Glorius, F				Wiesenfeldt, Mario P.; Nairoukh, Zackaria; Li, Wei; Glorius, Frank			Hydrogenation of fluoroarenes: Direct access to all-cis-(multi)fluorinated cycloalkanes	SCIENCE			English	Article							ASYMMETRIC HYDROGENATION; ARENE HYDROGENATION; COMPLEXES; FLUORINATION; HYDRODEFLUORINATION; CHEMISTRY; CATALYST; ACIDS	All-cis-multifluorinated cycloalkanes exhibit intriguing electronic properties. In particular, they display extremely high dipole moments perpendicular to the aliphatic ring, making them highly desired motifs in material science. Very few such motifs have been prepared, as their syntheses require multistep sequences from diastereoselectively prefunctionalized precursors. Herein we report a synthetic strategy to access these valuable materials via the rhodium-cyclic (alkyl)(amino)carbene (CAAC)-catalyzed hydrogenation of readily available fluorinated arenes in hexane. This route enables the scalable single-step preparation of an abundance of multisubstituted and multifluorinated cycloalkanes, including all-cis-1,2,3,4,5,6-hexafluorocyclohexane as well as cis-configured fluorinated aliphatic heterocycles.	[Wiesenfeldt, Mario P.; Nairoukh, Zackaria; Li, Wei; Glorius, Frank] Westfal Wilhelms Univ Munster, Organisch Chem Inst, Corrensstr 40, D-48149 Munster, Germany	University of Munster	Glorius, F (corresponding author), Westfal Wilhelms Univ Munster, Organisch Chem Inst, Corrensstr 40, D-48149 Munster, Germany.	glorius@uni-muenster.de	Nairoukh, Zackaria/AAE-4554-2021; Glorius, Frank/K-6385-2015	Glorius, Frank/0000-0002-0648-956X; Nairoukh, Zackaria/0000-0001-8443-4292; Wiesenfeldt, Mario Patrick/0000-0002-7142-9336	Studienstiftung des Deutschen Volkes; Hans-Jensen-Minerva Foundation; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft	Studienstiftung des Deutschen Volkes; Hans-Jensen-Minerva Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge the Studienstiftung des Deutschen Volkes (M.P.W.), the Hans-Jensen-Minerva Foundation (Z.N.), the Alexander von Humboldt Foundation (W.L.), and the Deutsche Forschungsgemeinschaft (F.G.) for generous financial support. We thank C. Schlepphorst, L. Candish, M. van Gemmeren, and R. Honeker for helpful discussions. We thank K. Bergander for NMR measurements and helpful discussions and C. G. Daniliuc for x-ray crystallographic analysis. Crystallographic data for 8e and 9e are available free of charge from the Cambridge Crystallographic Data Centre under CCDC-1561951 and CCDC-155388, respectively. Additional data are available in the supplementary materials. M.P.W., Z.N., and F.G. are inventors on German patent application 10 2017 106 467.2, held and submitted by Westfalische Wilhelms-Universitat Munster, which covers a method for the synthesis of fluorinated cyclic aliphatic compounds.	AIZENBERG M, 1994, SCIENCE, V265, P359, DOI 10.1126/science.265.5170.359; Augustine R. L., 1996, HETEROGENEOUS CATALY, P403; Bloom S, 2012, ANGEW CHEM INT EDIT, V51, P10580, DOI 10.1002/anie.201203642; Durie AJ, 2012, CHEM COMMUN, V48, P9643, DOI 10.1039/c2cc34679f; Durie AJ, 2011, CHEM COMMUN, V47, P8265, DOI 10.1039/c1cc13016a; Dyson PJ, 2003, DALTON T, P2964, DOI 10.1039/b303250g; Engman M, 2007, J AM CHEM SOC, V129, P4536, DOI 10.1021/ja0686763; FACHE F, 1995, TETRAHEDRON LETT, V36, P885, DOI 10.1016/0040-4039(94)02386-P; Haufe G, 2003, EUR J ORG CHEM, V2003, P2166, DOI 10.1002/ejoc.200200648; Hird M, 2007, CHEM SOC REV, V36, P2070, DOI 10.1039/b610738a; Keddie NS, 2015, NAT CHEM, V7, P483, DOI [10.1038/NCHEM.2232, 10.1038/nchem.2232]; Kirsch P, 2000, ANGEW CHEM INT EDIT, V39, P4217, DOI 10.1002/1521-3773(20001201)39:23<4216::AID-ANIE4216>3.0.CO;2-K; Li W, 2017, J AM CHEM SOC, V139, P2585, DOI 10.1021/jacs.6b13124; Liu W, 2012, SCIENCE, V337, P1322, DOI 10.1126/science.1222327; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; NELSON TD, 2006, Patent No. 2006069287; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Ortega N, 2012, ANGEW CHEM INT EDIT, V51, P1710, DOI 10.1002/anie.201107811; Pitts CR, 2017, J AM CHEM SOC, V139, P2208, DOI 10.1021/jacs.7b00335; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; SABURI M, 1992, TETRAHEDRON LETT, V33, P7877, DOI 10.1016/S0040-4039(00)74767-8; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Soleilhavoup M, 2015, ACCOUNTS CHEM RES, V48, P256, DOI 10.1021/ar5003494; Stalzer MM, 2016, ANGEW CHEM INT EDIT, V55, P5263, DOI 10.1002/anie.201600345; Urban S, 2011, ANGEW CHEM INT EDIT, V50, P3803, DOI 10.1002/anie.201100008; Ventre S, 2015, J AM CHEM SOC, V137, P5654, DOI 10.1021/jacs.5b02244; Wei Y, 2015, J AM CHEM SOC, V137, P9250, DOI 10.1021/jacs.5b05868; Whittlesey MK, 2014, ACS CATAL, V4, P3152, DOI 10.1021/cs500887p; Yang H, 1999, ORGANOMETALLICS, V18, P2285, DOI 10.1021/om990151e	29	123	123	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					908	912		10.1126/science.aao0270	http://dx.doi.org/10.1126/science.aao0270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28798044				2022-12-28	WOS:000408734900040
J	Tancredi, DJ				Tancredi, Daniel J.			GLOBAL HEALTH Probiotic prevents infections in newborns	NATURE			English	Editorial Material							METAANALYSIS; MICROBIOTA; INFANTS; GUT	A major cause of death and disease in babies is the failure of their developing immune systems to block life-threatening infections. A clinical trial reports that the use of a probiotic can help to prevent such infections. SEE ARTICLE P.407	[Tancredi, Daniel J.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Tancredi, Daniel J.] Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Tancredi, DJ (corresponding author), Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA.; Tancredi, DJ (corresponding author), Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA.	djtancredi@ucdavis.edu	Tancredi, Daniel J/O-3381-2013	Tancredi, Daniel J/0000-0002-3884-7907				Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Dermyshi E, 2017, NEONATOLOGY, V112, P9, DOI 10.1159/000454668; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Goenka A, 2015, J INFECTION, V71, pS112, DOI 10.1016/j.jinf.2015.04.027; Panigrahi P, 2008, J PEDIATR GASTR NUTR, V47, P45, DOI 10.1097/MPG.0b013e31815a5f2c; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Rao SC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3684; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shane A. L., 2017, J LANCET; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	12	8	8	4	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					404	405		10.1038/nature23540	http://dx.doi.org/10.1038/nature23540			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28813407				2022-12-28	WOS:000408279000028
J	Winblad, N; Lanner, F				Winblad, Nerges; Lanner, Fredrik			BIOTECHNOLOGY At the heart of gene edits in human embryos	NATURE			English	Editorial Material							PROTEIN; ZYGOTES	The gene-editing technology CRISPR-Cas has been used in human embryos grown in vitro to correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. SEE ARTICLE P.413	[Lanner, Fredrik] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden; Karolinska Univ Sjukhuset, Stockholm, Sweden	Karolinska Institutet	Lanner, F (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden.	fredrik.lanner@ki.se		Lanner, Fredrik/0000-0002-2771-7445				Carrier L, 2015, GENE, V573, P188, DOI 10.1016/j.gene.2015.09.008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; National Academies of Sciences Engineering and Medicine; National Academy of Medicine; National Academy of Sciences; Committee on Human Gene Editing: Scientific Medical and Ethical Considerations, 2017, HUM GEN ED SCI ETH G; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z	10	7	7	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					398	400		10.1038/nature23533	http://dx.doi.org/10.1038/nature23533			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28783721	Bronze			2022-12-28	WOS:000408279000024
J	Swain, A				Swain, Amanda			Ductal sex determination	SCIENCE			English	Editorial Material									[Swain, Amanda] Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Swain, A (corresponding author), Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	amanda.swain@icr.ac.uk		Swain, Amanda/0000-0001-8666-1608				CUNHA GR, 1992, J ANDROL, V13, P465; JOST A, 1953, RECENT PROG HORM RES, V8, P379; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wu SP, 2016, J STEROID BIOCHEM, V157, P7, DOI 10.1016/j.jsbmb.2015.11.011; Zhao F, 2017, SCIENCE, V357, P717, DOI 10.1126/science.aai9136	6	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					648	648		10.1126/science.aao2630	http://dx.doi.org/10.1126/science.aao2630			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818931				2022-12-28	WOS:000407793600019
J	Tamura, K; Takeda, M; Setsuie, R; Tsubota, T; Hirabayashi, T; Miyamoto, K; Miyashita, Y				Tamura, Keita; Takeda, Masaki; Setsuie, Rieko; Tsubota, Tadashi; Hirabayashi, Toshiyuki; Miyamoto, Kentaro; Miyashita, Yasushi			Conversion of object identity to object-general semantic value in the primate temporal cortex	SCIENCE			English	Article							CORTICAL MICROSTIMULATION; INFEROTEMPORAL CORTEX; PERIRHINAL CORTEX; MEMORY; OPTOGENETICS; RECOGNITION; PERCEPTION; BRAIN	At the final stage of the ventral visual stream, perirhinal neurons encode the identity of memorized objects through learning. However, it remains elusive whether and how object percepts alone, or concomitantly a nonphysical attribute of the objects ("learned"), are decoded from perirhinal activities. By combining monkey psychophysics with optogenetic and electrical stimulations, we found a focal spot of memory neurons where both stimulations led monkeys to preferentially judge presented objects as "already seen." In an adjacent fringe area, where neurons did not exhibit selective responses to the learned objects, electrical stimulation induced the opposite behavioral bias toward "never seen before," whereas optogenetic stimulation still induced bias toward "already seen." These results suggest that mnemonic judgment of objects emerges via the decoding of their nonphysical attributes encoded by perirhinal neurons.	[Tamura, Keita; Takeda, Masaki; Setsuie, Rieko; Tsubota, Tadashi; Hirabayashi, Toshiyuki; Miyamoto, Kentaro; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Takeda, Masaki; Miyashita, Yasushi] Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan	University of Tokyo; Juntendo University	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Miyashita, Y (corresponding author), Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Core, Vector/CAF-4832-2022; Miyashita, Yasushi/B-7171-2019; Tamura, Keita/I-2931-2012	Miyashita, Yasushi/0000-0003-3496-8637; Tamura, Keita/0000-0003-2697-1510; Miyamoto, Kentaro/0000-0003-1386-0045; Takeda, Masaki/0000-0002-2235-1624	MEXT; Japan Society for the Promotion of Science (JSPS) KAKENHI [17H06161, 24220008, 16H01281, 17K07062, 26890007, 15H01419, 17H02219]; CREST, Japan Science and Technology Agency; AMED-CREST, Japan Agency for Medical Research and Development; Brain Sciences Project of the Center for Novel Science Initiative, National Institutes of Natural Sciences [BS271006]; Brain/MINDS from AMED; Strategic Research Program for Brain Sciences from AMED; JSPS [265926]; Grants-in-Aid for Scientific Research [16H01281] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED-CREST, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Brain Sciences Project of the Center for Novel Science Initiative, National Institutes of Natural Sciences; Brain/MINDS from AMED; Strategic Research Program for Brain Sciences from AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Deisseroth for optogenetic constructs; R. J. Samulski and the University of North Carolina Vector Core for virus vectors; K. Jimura and T. Matsui for helpful discussions; Y. Ohashi for management of the virus experiment facility; K. W. Koyano for the MR imaging protocol; and A. Fukuda, T. Watanabe, K. Kakizawa, and K. Date for experimental assistance. Macaques used in this research were provided by NBRP "Japanese Monkeys" through the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Supported by MEXT and Japan Society for the Promotion of Science (JSPS) KAKENHI grants 17H06161 and 24220008 (Y.M.), 16H01281 and 17K07062 (M.T.), 26890007 (R.S.), and 15H01419 and 17H02219 (T.H.); CREST, Japan Science and Technology Agency (Y.M.); AMED-CREST, Japan Agency for Medical Research and Development (Y. M.); Brain Sciences Project of the Center for Novel Science Initiative, National Institutes of Natural Sciences, grant BS271006 (M.T.); Brain/MINDS from AMED (T.H.); the Strategic Research Program for Brain Sciences from AMED (T.H.); and JSPS Research Fellowships for Young Scientists grant 265926 (K.M.). All data necessary to support this paper's conclusions are available in the supplementary materials.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Buckley MJ, 1998, J NEUROSCI, V18, P2268; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dai J, 2014, CURR BIOL, V24, P63, DOI 10.1016/j.cub.2013.11.011; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; Fetsch CR, 2014, NEURON, V83, P797, DOI 10.1016/j.neuron.2014.07.011; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; Gerits A, 2013, TRENDS GENET, V29, P403, DOI 10.1016/j.tig.2013.03.004; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Klein C, 2016, NEURON, V90, P143, DOI 10.1016/j.neuron.2016.02.036; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moeller S, 2017, NAT NEUROSCI, V20, P743, DOI 10.1038/nn.4527; Mogami T, 2006, J NEUROSCI, V26, P6761, DOI 10.1523/JNEUROSCI.4924-05.2006; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Naya Y, 2003, J NEUROSCI, V23, P2861; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Reid RC, 2012, NEURON, V75, P209, DOI 10.1016/j.neuron.2012.06.031; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tamura K, 2012, J NEUROSCI METH, V211, P49, DOI 10.1016/j.jneumeth.2012.08.004; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	30	31	31	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					687	+		10.1126/science.aan4800	http://dx.doi.org/10.1126/science.aan4800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818944				2022-12-28	WOS:000407793600035
J	Roberts, L				Roberts, Leslie			PUBLIC HEALTH Revolutionary malaria tests have unexpected downsides	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					536	537		10.1126/science.357.6351.536	http://dx.doi.org/10.1126/science.357.6351.536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798109				2022-12-28	WOS:000407324800016
J	Gupta, S				Gupta, Sujata			TRIALS AND TRIBULATIONS	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S28	S31		10.1038/548S28a	http://dx.doi.org/10.1038/548S28a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792921	Bronze			2022-12-28	WOS:000407284300010
J	Heng, K				Heng, Kevin			ASTRONOMY Ozone-like layer in an exoplanet atmosphere	NATURE			English	Editorial Material							HD 209458B; HOT-JUPITER; TEMPERATURE INVERSION; EMISSION-SPECTRUM; THERMAL INVERSION; PLANET		[Heng, Kevin] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland	University of Bern	Heng, K (corresponding author), Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland.	kevin.heng@csh.unibe.ch						Burrows A, 2007, ASTROPHYS J, V668, pL171, DOI 10.1086/522834; Charbonneau D, 2008, ASTROPHYS J, V686, P1341, DOI 10.1086/591635; Deming LD, 2017, J GEOPHYS RES-PLANET, V122, P53, DOI 10.1002/2016JE005155; Desert JM, 2008, ASTRON ASTROPHYS, V492, P585, DOI 10.1051/0004-6361:200810355; Diamond-Lowe H, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/66; Evans TM, 2017, NATURE, V548, P58, DOI 10.1038/nature23266; Evans TM, 2016, ASTROPHYS J LETT, V822, DOI 10.3847/2041-8205/822/1/L4; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Harrington J, 2007, NATURE, V447, P691, DOI 10.1038/nature05863; Haynes K, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/146; Kirkpatrick JD, 2005, ANNU REV ASTRON ASTR, V43, P195, DOI 10.1146/annurev.astro.42.053102.134017; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Madhusudhan N, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/36; Mancini L, 2016, MON NOT R ASTRON SOC, V461, P1053, DOI 10.1093/mnras/stw1386; Seager S, 2014, P NATL ACAD SCI USA, V111, P12634, DOI 10.1073/pnas.1304213111; Sharp CM, 2007, ASTROPHYS J SUPPL S, V168, P140, DOI 10.1086/508708; Showman AP, 2002, ASTRON ASTROPHYS, V385, P166, DOI 10.1051/0004-6361:20020101; Stevenson KB, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/136	20	0	0	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					38	40		10.1038/548038b	http://dx.doi.org/10.1038/548038b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770834				2022-12-28	WOS:000406831700031
J	Owens, B				Owens, Brian			CYBERSECURITY FOR THE TRAVELLING SCIENTIST	NATURE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					123	124		10.1038/548123a	http://dx.doi.org/10.1038/548123a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770861	Bronze			2022-12-28	WOS:000406831700051
J	Petersen, H				Petersen, Hannah			NUCLEAR PHYSICS The fastest-rotating fluid	NATURE			English	Editorial Material									[Petersen, Hannah] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; [Petersen, Hannah] GSI Helmholtz Ctr Heavy Ion Res, Darmstadt, Germany	Goethe University Frankfurt; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Petersen, H (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany.; Petersen, H (corresponding author), GSI Helmholtz Ctr Heavy Ion Res, Darmstadt, Germany.	petersen@fias.uni-frankfurt.de		Elfner, Hannah/0000-0002-6213-3613				Abelev BI, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.024915; Adamczyk L, 2017, NATURE, V548, P62, DOI 10.1038/nature23004; Becattini F, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.054902; Friman B., 2011, CBM PHYS BOOK; Kharzeev DE, 2016, PROG PART NUCL PHYS, V88, P1, DOI 10.1016/j.ppnp.2016.01.001; Liang ZT, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.102301; Skokov VV, 2009, INT J MOD PHYS A, V24, P5925, DOI 10.1142/S0217751X09047570	7	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					34	35		10.1038/548034a	http://dx.doi.org/10.1038/548034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770844				2022-12-28	WOS:000406831700027
J	[Anonymous]				[Anonymous]			Continuing debate about method of delivery and pregnancy outcomes: a 2010 Lancet Article	LANCET			English	Editorial Material																		Hull PM, 2017, LANCET, V390, P455, DOI 10.1016/S0140-6736(17)31820-2; Lumbiganon P, 2017, LANCET, V390, P456, DOI 10.1016/S0140-6736(17)31819-6; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5	3	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					439	439						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792398				2022-12-28	WOS:000406463400009
J	Jiang, DH; Berger, F				Jiang, Danhua; Berger, Frederic			DNA replication-coupled histone modification maintains Polycomb gene silencing in plants	SCIENCE			English	Article							CELL-CYCLE; CHROMATIN; ARABIDOPSIS; PROPAGATION; HETEROCHROMATIN; TRIMETHYLATION; RECRUITMENT; LYSINE-27; MARKS; H3.1	Propagation of patterns of gene expression through the cell cycle requires prompt restoration of epigenetic marks after the twofold dilution caused by DNA replication. Here we show that the transcriptional repressive mark H3K27me3 (histone H3 lysine 27 trimethylation) is restored in replicating plant cells through DNA replication-coupled modification of histone variant H3.1. Plants evolved a mechanism for efficient K27 trimethylation on H3.1, which is essential for inheritance of the silencing memory from mother to daughter cells. We illustrate how this mechanism establishes H3K27me3-mediated silencing during the developmental transition to flowering. Our study reveals a mechanism responsible for transmission of H3K27me3 in plant cells through cell divisions, enabling H3K27me3 to function as an epigenetic mark.	[Jiang, Danhua; Berger, Frederic] Austrian Acad Sci, Vienna Bioctr, Gregor Mendel Inst, Dr Bohr Gasse 3, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Berger, F (corresponding author), Austrian Acad Sci, Vienna Bioctr, Gregor Mendel Inst, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	frederic.berger@gmi.oeaw.ac.at		JIANG, DANHUA/0000-0003-0892-8842; Berger, Frederic/0000-0002-3609-8260	European Molecular Biology Organization [ALTF 1129-2013]; Austrian Science Fund (FWF) [P28320-B21]; Gregor Mendel Institute; Vienna Biocenter Core Facilities for Next Generation Sequencing and Plant Science; IMP/IMBA BioOptics Facility	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Gregor Mendel Institute; Vienna Biocenter Core Facilities for Next Generation Sequencing and Plant Science; IMP/IMBA BioOptics Facility	We thank S. Akimcheva for assistance with BY-2 cell culture; B. Lei for providing HEK293 cells; M. Goiser for help with bioinformatics; and O. Bell, I. Drinnenberg, M. Borg, and J. M. Watson for critical reading of the manuscript. D. J. was supported by the European Molecular Biology Organization long-term fellowship (ALTF 1129-2013). This work was supported by grant P28320-B21 from the Austrian Science Fund (FWF), core funding from the Gregor Mendel Institute, the Vienna Biocenter Core Facilities for Next Generation Sequencing and Plant Science, and the IMP/IMBA BioOptics Facility. The supplementary materials contain additional data. The sequencing data generated in this study are deposited at the Gene Expression Omnibus (accession number GSE101221).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Coleman RT, 2017, SCIENCE, V356, DOI 10.1126/science.aai8236; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02723; Jacob Y, 2014, SCIENCE, V343, P1249, DOI 10.1126/science.1248357; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Laprell F, 2017, SCIENCE, V356, P85, DOI 10.1126/science.aai8266; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; MacAlpine DM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010207; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Scofield S, 2006, PLANT MOL BIOL, V60, P929, DOI 10.1007/s11103-005-4478-y; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Song J, 2013, CURR BIOL, V23, pR807, DOI 10.1016/j.cub.2013.07.027; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Xiao J, 2015, CURR OPIN PLANT BIOL, V23, P15, DOI 10.1016/j.pbi.2014.10.003; Xu M, 2012, EMBO REP, V13, P60, DOI 10.1038/embor.2011.206; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	28	88	92	30	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2017	357	6356					1146	+		10.1126/science.aan4965	http://dx.doi.org/10.1126/science.aan4965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7XX	28818970				2022-12-28	WOS:000410639800043
J	Kim, CK; Ye, L; Jennings, JH; Pichamoorthy, N; Tang, DD; Yoo, ACW; Ramakrishnan, C; Deisseroth, K				Kim, Christina K.; Ye, Li; Jennings, Joshua H.; Pichamoorthy, Nandini; Tang, Daniel D.; Yoo, Ai-Chi W.; Ramakrishnan, Charu; Deisseroth, Karl			Molecular and Circuit-Dynamical Identification of Top-Down Neural Mechanisms for Restraint of Reward Seeking	CELL			English	Article							DEEP BRAIN-STIMULATION; PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; SELECTIVE INACTIVATION; INDUCED REINSTATEMENT; GLUTAMATERGIC INPUTS; DECISION-MAKING; DRIVE AVERSION; NEURONS; PROJECTIONS	Reward-seeking behavior is fundamental to survival, but suppression of this behavior can be essential as well, even for rewards of high value. In humans and rodents, the medial prefrontal cortex (mPFC) has been implicated in suppressing reward seeking; however, despite vital significance in health and disease, the neural circuitry through which mPFC regulates reward seeking remains incompletely understood. Here, we show that a specific subset of superficial mPFC projections to a subfield of nucleus accumbens (NAc) neurons naturally encodes the decision to initiate or suppress reward seeking when faced with risk of punishment. A highly resolved sub-population of these top-down projecting neurons, identified by 2-photon Ca2+ imaging and activity-dependent labeling to recruit the relevant neurons, was found capable of suppressing reward seeking. This natural activity-resolved mPFC-to-NAc projection displayed unique molecular-genetic and micro-circuit-level features concordant with a conserved role in the regulation of reward-seeking behavior, providing cellular and anatomical identifiers of behavioral and possible therapeutic significance.	[Kim, Christina K.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Ye, Li; Deisseroth, Karl] Stanford Univ, HHMI, Stanford, CA 94305 USA; [Ye, Li; Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Jennings, Joshua H.; Pichamoorthy, Nandini; Tang, Daniel D.; Yoo, Ai-Chi W.; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, HHMI, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu		Tang, Daniel/0000-0002-0286-713X; Kim, Christina/0000-0002-1466-7098	NIDA [F31DA041795, R01DA03537701]; NIDDK [K01DK114165]; HHWF [F-1052]; NIMH [R01MH075957, R01MH086373]; DARPA/ARL Neuro-FAST program [W911NF-14-2-0013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK114165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA041795] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HHWF; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DARPA/ARL Neuro-FAST program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Bito (University of Tokyo, Tokyo, Japan) for the E-SARE plasmid. We thank M. J. Wagner (Stanford University, California) for detailed comments on the manuscript. This work was supported by NIDA (F31DA041795 to C.K.K.; R01DA03537701 to K.D.), NIDDK (K01DK114165 to L.Y.), HHWF (F-1052 to J.H.J.), NIMH (R01MH075957 and R01MH086373 K.D.), and the DARPA/ARL Neuro-FAST program (Cooperative Agreement W911NF-14-2-0013 to K.D.).	Al-Hasani R, 2015, NEURON, V87, P1063, DOI 10.1016/j.neuron.2015.08.019; Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Bossert JM, 2012, J NEUROSCI, V32, P4982, DOI 10.1523/JNEUROSCI.0005-12.2012; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Calipari ES, 2016, P NATL ACAD SCI USA, V113, P2726, DOI 10.1073/pnas.1521238113; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DeNardo LA, 2015, NAT NEUROSCI, V18, P1687, DOI 10.1038/nn.4131; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hayes DJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00049; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Jonkman S, 2009, BEHAV NEUROSCI, V123, P875, DOI 10.1037/a0016330; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levesque M, 1996, BRAIN RES, V709, P311, DOI 10.1016/0006-8993(95)01333-4; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Orsini CA, 2015, NEUROSCI BIOBEHAV R, V58, P147, DOI 10.1016/j.neubiorev.2015.04.009; Orsini CA, 2015, J NEUROSCI, V35, P1368, DOI 10.1523/JNEUROSCI.3586-14.2015; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Pfarr S, 2015, J NEUROSCI, V35, P10750, DOI 10.1523/JNEUROSCI.0684-15.2015; Pinto L, 2015, NEURON, V87, P437, DOI 10.1016/j.neuron.2015.06.021; Qi J, 2016, NAT NEUROSCI, V19, P725, DOI 10.1038/nn.4281; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Saunders BT, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0210; Sorensen AT, 2016, ELIFE, V5, DOI 10.7554/eLife.13918; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; St Onge JR, 2012, J NEUROSCI, V32, P2886, DOI 10.1523/JNEUROSCI.5625-11.2012; St Onge JR, 2010, CEREB CORTEX, V20, P1816, DOI 10.1093/cercor/bhp250; Stopper CM, 2014, NAT NEUROSCI, V17, P33, DOI 10.1038/nn.3587; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Warren BL, 2016, J NEUROSCI, V36, P6691, DOI 10.1523/JNEUROSCI.0140-16.2016; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010; Zalocusky KA, 2016, NATURE, V531, P642, DOI 10.1038/nature17400	62	73	75	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					1013	+	1027.e14	10.1016/j.cell.2017.07.020	http://dx.doi.org/10.1016/j.cell.2017.07.020			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28823561	Green Accepted, Bronze			2022-12-28	WOS:000408372400018
J	Kazi, DS; Penko, J; Coxson, PG; Moran, AE; Ollendorf, DA; Tice, JA; Bibbins-Domingo, K				Kazi, Dhruv S.; Penko, Joanne; Coxson, Pamela G.; Moran, Andrew E.; Ollendorf, Daniel A.; Tice, Jeffrey A.; Bibbins-Domingo, Kirsten			Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kazi, Dhruv S.] Zuckerberg San Francisco Gen Hosp, Div Cardiol, San Francisco, CA USA; [Penko, Joanne; Coxson, Pamela G.] Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA USA; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Internal Med, New York, NY USA; [Ollendorf, Daniel A.] Inst Clin & Econ Review, Boston, MA USA; [Tice, Jeffrey A.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Columbia University; University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, Zuckerberg San Francisco Gen Hosp, POB 1364, San Francisco, CA 94143 USA.	kirsten.bibbins-domingo@ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	University of California, San Francisco	University of California, San Francisco(University of California System)	This work was supported by the University of California, San Francisco.	Beasley D, UPDATE 1 AMGEN DISCO; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]	3	111	112	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					748	750		10.1001/jama.2017.9924	http://dx.doi.org/10.1001/jama.2017.9924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829863	Green Published			2022-12-28	WOS:000408095800028
J	Slomski, A				Slomski, Anita			Olaparib Increased Survival in Metastatic Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					690	690		10.1001/jama.2017.9824	http://dx.doi.org/10.1001/jama.2017.9824			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829871				2022-12-28	WOS:000408095800006
J	Slomski, A				Slomski, Anita			Recombinant Influenza Vaccine More Effective in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					690	690		10.1001/jama.2017.10997	http://dx.doi.org/10.1001/jama.2017.10997			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829875				2022-12-28	WOS:000408095800010
J	Meng, QJ; Grossnickle, DM; Liu, D; Zhang, YG; Neander, AI; Ji, Q; Luo, ZX				Meng, Qing-Jin; Grossnickle, David M.; Liu, Di; Zhang, Yu-Guang; Neander, April I.; Ji, Qiang; Luo, Zhe-Xi			New gliding mammaliaforms from the Jurassic	NATURE			English	Article							MULTITUBERCULATE MAMMALS; ADAPTIVE RADIATION; ANATOMY; DIVERSIFICATION; TRANSFORMATION; PROPORTIONS; ADAPTATIONS; EVOLUTION	Stem mammaliaforms are Mesozoic forerunners to mammals, and they offer critical evidence for the anatomical evolution and ecological diversification during the earliest mammalian history. Two new eleutherodonts from the Late Jurassic period have skin membranes and skeletal features that are adapted for gliding. Characteristics of their digits provide evidence of roosting behaviour, as in dermopterans and bats, and their feet have a calcaneal calcar to support the uropagatium as in bats. The new volant taxa are phylogenetically nested with arboreal eleutherodonts. Together, they show an evolutionary experimentation similar to the iterative evolutions of gliders within arboreal groups of marsupial and placental mammals. However, gliding eleutherodonts possess rigid interclavicle-clavicle structures, convergent to the avian furculum, and they retain shoulder girdle plesiomorphies of mammaliaforms and monotremes. Forelimb mobility required by gliding occurs at the acromion-clavicle and glenohumeral joints, is different from and convergent to the shoulder mobility at the pivotal clavicle-sternal joint in marsupial and placental gliders.	[Meng, Qing-Jin; Liu, Di; Zhang, Yu-Guang] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Grossnickle, David M.; Luo, Zhe-Xi] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Neander, April I.; Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Ji, Qiang] Hebei GEO Univ, Shijiazhuang 050031, Hebei, Peoples R China	University of Chicago; University of Chicago; Hebei GEO University	Luo, ZX (corresponding author), Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA.; Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021; Meng, Q./GSI-6185-2022	Neander, April/0000-0001-6816-2872	Beijing Scientific Commission; UChicago-BSD; UChicago Fellowship; FMNH Fellowship	Beijing Scientific Commission; UChicago-BSD; UChicago Fellowship; FMNH Fellowship	We thank A. Shinya for fossil preparation; S. Bi, S. Gatesy, L. Heaney, H.-J. Li, Z.-J. Gao, T. Martin, B. Patterson, P. Sereno, N. Shubin, X.-T. Zheng and C.-F. Zhou for access to comparative specimens; staff of BMNH and FMNH for assistance. Research supported by funding for Q.-J.M. (Beijing Scientific Commission), Z.-X.L. (UChicago-BSD) and D.M.G. (UChicago and FMNH Fellowships). Full acknowledgments are provided in the Supplementary Information.	Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Byrnes G, 2011, INTEGR COMP BIOL, V51, P991, DOI 10.1093/icb/icr069; Chen M, 2015, PALEOBIOLOGY, V41, P280, DOI 10.1017/pab.2014.14; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Giannini NP, 2006, B AM MUS NAT HIST, P4; Grossnickle DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2110; Hammer O., 2020, PALEONTOLOGICAL STAT, P1; Huang Di-ying, 2015, Acta Palaeontologica Sinica, V54, P501; Jackson S., 2012, GLIDING MAMMALS WORL; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; JENKINS FA, 1979, J ZOOL, V188, P379; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; JOHNSONMURRAY JL, 1987, AUST J ZOOL, V35, P101, DOI 10.1071/ZO9870101; Kawashima T, 2012, FOLIA MORPHOL, V71, P228; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Lessertisseur J., 1967, TRAITE ZOOLOGIE, P709; Liu YQ, 2012, PALAEOGEOGR PALAEOCL, V323, P1, DOI 10.1016/j.palaeo.2012.01.017; Luo Z.-X., 2017, NATURE; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo Zhe-Xi, 2015, P167; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2015, SCIENCE, V347, P760, DOI 10.1126/science.1260880; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schutt William A. Jr., 1998, Journal of Mammalian Evolution, V5, P1; Sereno Paul C., 2006, P315; Simmons Nancy B., 1994, Journal of Mammalian Evolution, V2, P231, DOI 10.1007/BF01464276; Socha JJ, 2015, CAN J ZOOL, V93, P901, DOI 10.1139/cjz-2014-0013; Stanchak K. E., 2016, ANAT REC, V299, P244; Sues Hans-Dieter, 2006, P114; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Thorington Richard W. Jr., 2001, Mammal Study, V26, P61; Thorington RW, 2007, J MAMMAL, V88, P882, DOI 10.1644/06-MAMM-S-325R2.1; THORINGTON RW, 1981, J MAMMAL, V62, P101, DOI 10.2307/1380481; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	50	54	58	6	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					291	+		10.1038/nature23476	http://dx.doi.org/10.1038/nature23476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792929				2022-12-28	WOS:000407748400024
J	Shroyer, AL; Hattler, B; Wagner, TH; Collins, JF; Baltz, JH; Quin, JA; Almassi, GH; Kozora, E; Bakaeen, F; Cleveland, JC; Bishawi, M; Grover, FL				Shroyer, A. Laurie; Hattler, Brack; Wagner, Todd H.; Collins, Joseph F.; Baltz, Janet H.; Quin, Jacquelyn A.; Almassi, G. Hossein; Kozora, Elizabeth; Bakaeen, Faisal; Cleveland, Joseph C., Jr.; Bishawi, Muath; Grover, Frederick L.		Vet Affairs ROOBY-FS Grp	Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; TERM-FOLLOW-UP; VETERANS-AFFAIRS; GRAFT PATENCY; CLINICAL-OUTCOMES; ROOBY TRIAL; SURGERY; REVASCULARIZATION; EXPERIENCE; SURVIVAL	BACKGROUND Coronary-artery bypass grafting (CABG) surgery may be performed either with cardiopulmonary bypass (on pump) or without cardiopulmonary bypass (off pump). We report the 5-year clinical outcomes in patients who had been included in the Veterans Affairs trial of on-pump versus off-pump CABG. METHODS From February 2002 through June 2007, we randomly assigned 2203 patients at 18 medical centers to undergo either on-pump or off-pump CABG, with 1-year assessments completed by May 2008. The two primary 5-year outcomes were death from any cause and a composite outcome of major adverse cardiovascular events, defined as death from any cause, repeat revascularization (CABG or percutaneous coronary intervention), or nonfatal myocardial infarction. Secondary 5-year outcomes included death from cardiac causes, repeat revascularization, and nonfatal myocardial infarction. Primary outcomes were assessed at a P value of 0.05 or less, and secondary outcomes at a P value of 0.01 or less. RESULTS The rate of death at 5 years was 15.2% in the off-pump group versus 11.9% in the on-pump group (relative risk, 1.28; 95% confidence interval [CI], 1.03 to 1.58; P = 0.02). The rate of major adverse cardiovascular events at 5 years was 31.0% in the off-pump group versus 27.1% in the on-pump group (relative risk, 1.14; 95% CI, 1.00 to 1.30; P = 0.046). For the 5-year secondary outcomes, no significant differences were observed: for nonfatal myocardial infarction, the rate was 12.1% in the off-pump group and 9.6% in the on-pump group (P = 0.05); for death from cardiac causes, the rate was 6.3% and 5.3%, respectively (P = 0.29); for repeat revascularization, the rate was 13.1% and 11.9%, respectively (P = 0.39); and for repeat CABG, the rate was 1.4% and 0.5%, respectively (P = 0.02). CONCLUSIONS In this randomized trial, off-pump CABG led to lower rates of 5-year survival and event-free survival than on-pump CABG.	[Shroyer, A. Laurie; Bishawi, Muath] Northport Vet Affairs, VA Med Ctr, Northport, NY USA; [Shroyer, A. Laurie; Hattler, Brack; Baltz, Janet H.; Cleveland, Joseph C., Jr.; Grover, Frederick L.] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Denver, CO USA; [Kozora, Elizabeth] Natl Jewish Hlth, Denver, CO USA; [Hattler, Brack; Cleveland, Joseph C., Jr.; Grover, Frederick L.] Univ Colorado, Sch Med, Aurora, CO USA; [Wagner, Todd H.] Stanford Univ, VA Hlth Econ Resource Ctr, Palo Alto, CA 94304 USA; [Wagner, Todd H.] Stanford Univ, Dept Surg, Palo Alto, CA 94304 USA; [Collins, Joseph F.] VA Med Ctr, Cooperat Studies Program, Coordinating Ctr, Perry Point, MD USA; [Quin, Jacquelyn A.] VA Boston Healthcare Syst, West Roxbury, MA USA; [Almassi, G. Hossein] Zablocki VA Med Ctr, Milwaukee, WI USA; [Almassi, G. Hossein] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bakaeen, Faisal] Cleveland Clin, Cleveland, OH 44106 USA; [Bakaeen, Faisal] VA Pittsburgh Hlth Care Syst, Pittsburgh, PA USA; [Bishawi, Muath] Duke Univ, Med Ctr, Durham, NC USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Medical College of Wisconsin; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Duke University	Shroyer, AL (corresponding author), Northport VA Med Ctr, Res & Dev Off 151, Bldg 62,Rm 125, Northport, NY 11768 USA.	shroyer@va.gov		Wagner, Todd/0000-0001-7625-3504	Department of Veterans Affairs Office of Research and Development Cooperative Studies Program; Department of Veterans Affairs (VA) Office of Research and Development Co-operative Studies Program (CSP) [517-FS]; Offices of Research and Development at the Northport VA Medical Center; Eastern Colorado Health Care System Denver VA Medical Center	Department of Veterans Affairs Office of Research and Development Cooperative Studies Program(US Department of Veterans Affairs); Department of Veterans Affairs (VA) Office of Research and Development Co-operative Studies Program (CSP)(US Department of Veterans Affairs); Offices of Research and Development at the Northport VA Medical Center; Eastern Colorado Health Care System Denver VA Medical Center	Funded by the Department of Veterans Affairs Office of Research and Development Cooperative Studies Program and others; ROOBY-FS ClinicalTrials.gov number, NCT01924442.; Supported by a grant (CSP#517-FS) from the Department of Veterans Affairs (VA) Office of Research and Development Co-operative Studies Program (CSP) and, in part, by the Offices of Research and Development at the Northport VA Medical Center and the Eastern Colorado Health Care System Denver VA Medical Center.	Almassi GH, 2016, J THORAC CARDIOV SUR, V151, P1215, DOI 10.1016/j.jtcvs.2015.12.038; Almassi GH, 2015, J THORAC CARDIOV SUR, V150, P1428, DOI 10.1016/j.jtcvs.2015.08.124; Almassi GH, 2013, ANN THORAC SURG, V96, P1302, DOI 10.1016/j.athoracsur.2013.05.055; Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8; Angelini GD, 2009, J THORAC CARDIOV SUR, V137, P295, DOI 10.1016/j.jtcvs.2008.09.046; [Anonymous], 2017, SOC THOR SURG AD CAR; Bakaeen FG, 2014, J THORAC CARDIOV SUR, V148, P856, DOI 10.1016/j.jtcvs.2013.12.047; BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312; Bishawi M, 2013, ANN THORAC SURG, V95, P1946, DOI 10.1016/j.athoracsur.2012.12.014; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; Diegeler A, 2013, NEW ENGL J MED, V368, P1189, DOI 10.1056/NEJMoa1211666; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006; Hattler B, 2012, CIRCULATION, V125, P2827, DOI 10.1161/CIRCULATIONAHA.111.069260; Houlind K, 2014, J THORAC CARDIOV SUR, V148, P1812, DOI 10.1016/j.jtcvs.2014.02.024; Hueb W, 2010, CIRCULATION, V122, pS48, DOI 10.1161/CIRCULATIONAHA.109.924258; Karolak W, 2007, AM HEART J, V153, P689, DOI 10.1016/j.ahj.2007.01.033; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kozora E, 2010, ANN THORAC SURG, V90, P1134, DOI 10.1016/j.athoracsur.2010.05.076; Lamy A, 2016, NEW ENGL J MED, V375, P2359, DOI 10.1056/NEJMoa1601564; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Moller CH, 2012, COCHRANE DB SYST REV, V14; Moller CH, 2011, HEART, V97, P907, DOI 10.1136/hrt.2010.211680; Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859; Novitzky D, 2011, ANN THORAC SURG, V92, P2147, DOI 10.1016/j.athoracsur.2011.05.122; Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4; Puskas JD, 2011, ANN THORAC SURG, V91, P1836, DOI 10.1016/j.athoracsur.2010.12.043; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Shroyer ALW, 2014, ANN THORAC SURG, V98, P38, DOI 10.1016/j.athoracsur.2014.03.042; Shroyer ALW, 2008, SEMIN CARDIOTHORAC V, V12, P140, DOI 10.1177/1089253208323060; Synnergren MJ, 2008, J THORAC CARDIOV SUR, V136, P29, DOI 10.1016/j.jtcvs.2007.07.059; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X; WOOD J, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2215	35	176	190	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					623	632		10.1056/NEJMoa1614341	http://dx.doi.org/10.1056/NEJMoa1614341			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7FG	28813218	Bronze			2022-12-28	WOS:000407691400005
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium Difficile Infection (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 59, pg 49, 2017)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							TRANSPLANTATION; VANCOMYCIN						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2011, MED LETT DRUGS THER, V53, P73; First Databank Inc, APPR WHOL ACQ COST M; Gerding DN, 2008, CLIN INFECT DIS, V46, pS32, DOI 10.1086/521860; Goldenberg SD, 2016, EUR J CLIN MICROBIOL, V35, P251, DOI 10.1007/s10096-015-2538-z; Hota SS, 2017, CLIN INFECT DIS, V64, P265, DOI 10.1093/cid/ciw731; Prabhu V, 2016, EUR C CLIN MICR INF; Rao K, 2016, J HOSP MED, V11, P56, DOI 10.1002/jhm.2449; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Stevens VW, 2017, JAMA INTERN MED, V177, P546, DOI 10.1001/jamainternmed.2016.9045; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; 2017, MED LETT DRUGS THERA, V59, P49	12	7	7	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					659	660		10.1001/jama.2017.10092	http://dx.doi.org/10.1001/jama.2017.10092			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810021				2022-12-28	WOS:000407616000021
J	Friedrich, MJ				Friedrich, M. J.			Global Obesity Epidemic Worsening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	90	95	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					603	603		10.1001/jama.2017.10693	http://dx.doi.org/10.1001/jama.2017.10693			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810033				2022-12-28	WOS:000407616000005
J	Johansen, MY; MacDonald, CS; Hansen, KB; Karstoft, K; Christensen, R; Pedersen, M; Hansen, LS; Zacho, M; Wedell-Neergaard, AS; Nielsen, ST; Iepsen, UW; Langberg, H; Vaag, AA; Pedersen, BK; Ried-Larsen, M				Johansen, Mette Yun; MacDonald, Christopher Scott; Hansen, Katrine Bagge; Karstoft, Kristian; Christensen, Robin; Pedersen, Maria; Hansen, Louise Seier; Zacho, Morten; Wedell-Neergaard, Anne-Sophie; Nielsen, Signe Tellerup; Iepsen, Ulrik Wining; Langberg, Henning; Vaag, Allan Arthur; Pedersen, Bente Klarlund; Ried-Larsen, Mathias			Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OPEN-LABEL; PHYSICAL-ACTIVITY; INSULIN GLARGINE; RISK-FACTORS; EXERCISE; NONINFERIORITY; ASSOCIATION; PHASE-3; COST	IMPORTANCE It is unclear whether a lifestyle intervention can maintain glycemic control in patients with type 2 diabetes. OBJECTIVE To test whether an intensive lifestyle intervention results in equivalent glycemic control compared with standard care and, secondarily, leads to a reduction in glucose-lowering medication in participants with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS Randomized, assessor-blinded, single-center study within Region Zealand and the Capital Region of Denmark (April 2015-August 2016). Ninety-eight adult participants with non-insulin-dependent type 2 diabetes who were diagnosed for less than 10 years were included. Participants were randomly assigned (2: 1; stratified by sex) to the lifestyle group (n = 64) or the standard care group (n = 34). INTERVENTIONS All participants received standard care with individual counseling and standardized, blinded, target-driven medical therapy. Additionally, the lifestyle intervention included 5 to 6 weekly aerobic training sessions (duration 30-60 minutes), of which 2 to 3 sessions were combined with resistance training. The lifestyle participants received dietary plans aiming for a body mass index of 25 or less. Participants were followed up for 12 months. MAIN OUTCOMES AND MEASURES Primary outcome was change in hemoglobin A(1c) (HbA(1c)) from baseline to 12-month follow-up, and equivalence was prespecified by a CI margin of +/- 0.4% based on the intention-to-treat population. Superiority analysis was performed on the secondary outcome reductions in glucose-lowering medication. RESULTS Among 98 randomized participants (mean age, 54.6 years [SD, 8.9]; women, 47 [48%]; mean baseline HbA(1c), 6.7%), 93 participants completed the trial. From baseline to 12-month follow-up, the mean HbA(1c) level changed from 6.65% to 6.34% in the lifestyle group and from 6.74% to 6.66% in the standard care group (mean between-group difference in change of -0.26%[95% CI, -0.52% to -0.01%]), not meeting the criteria for equivalence (P = .15). Reduction in glucose-lowering medications occurred in 47 participants (73.5%) in the lifestyle group and 9 participants (26.4%) in the standard care group (difference, 47.1 percentage points [95% CI, 28.6-65.3]). There were 32 adverse events (most commonly musculoskeletal pain or discomfort and mild hypoglycemia) in the lifestyle group and 5 in the standard care group. CONCLUSIONS AND RELEVANCE Among adults with type 2 diabetes diagnosed for less than 10 years, a lifestyle intervention compared with standard care resulted in a change in glycemic control that did not reach the criterion for equivalence, but was in a direction consistent with benefit. Further research is needed to assess superiority, as well as generalizability and durability of findings.	[Johansen, Mette Yun; MacDonald, Christopher Scott; Hansen, Katrine Bagge; Karstoft, Kristian; Pedersen, Maria; Hansen, Louise Seier; Zacho, Morten; Wedell-Neergaard, Anne-Sophie; Nielsen, Signe Tellerup; Iepsen, Ulrik Wining; Langberg, Henning; Vaag, Allan Arthur; Pedersen, Bente Klarlund; Ried-Larsen, Mathias] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Johansen, Mette Yun; MacDonald, Christopher Scott; Hansen, Katrine Bagge; Karstoft, Kristian; Pedersen, Maria; Hansen, Louise Seier; Zacho, Morten; Wedell-Neergaard, Anne-Sophie; Nielsen, Signe Tellerup; Iepsen, Ulrik Wining; Langberg, Henning; Vaag, Allan Arthur; Pedersen, Bente Klarlund; Ried-Larsen, Mathias] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [MacDonald, Christopher Scott; Langberg, Henning] Univ Copenhagen, CopenRehab, Copenhagen, Denmark; [Christensen, Robin] Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark; [Christensen, Robin] Frederiksberg Univ Hosp, Copenhagen, Denmark; [Pedersen, Maria] Herlev Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark; [Vaag, Allan Arthur] AstraZeneca, Translat Res & Early Clin Dev, Cardiovasc & Metab Res, Molndal, Sweden; [Ried-Larsen, Mathias] Odense Univ Hosp, Danish Diabet Acad, Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; AstraZeneca; University of Southern Denmark; Odense University Hospital	Ried-Larsen, M (corresponding author), Rigshosp 7641, Ctr Inflammat & Metab, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.; Ried-Larsen, M (corresponding author), Rigshosp 7641, Ctr Phys Act Res, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	mathias.ried-larsen@regionh.dk	Ried-Larsen, Mathias/GPX-7640-2022; Pedersen, Bente Klarlund/AGR-3217-2022; Iepsen, Ulrik Winning/AGZ-2144-2022; Johansen, Mette Yun/AAD-9067-2021	Ried-Larsen, Mathias/0000-0002-8388-5291; Pedersen, Bente Klarlund/0000-0001-6508-6288; Iepsen, Ulrik Winning/0000-0002-8140-2583; Yun Johansen, Mette/0000-0001-5517-1454; Vaag, Allan Arthur/0000-0002-3690-2191; Christensen, Robin/0000-0002-6600-0631; Hansen, Katrine Bagge/0000-0002-2587-5589; Karstoft, Kristian/0000-0002-6596-4199	TrygFonden; Danish Council for Strategic Research [09-067009, 09-075724]; Danish Diabetes Academy; Novo Nordisk Foundation	TrygFonden; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This project was funded by TrygFonden. The Centre for Physical Activity Research (CFAS) is supported by a grant from TrygFonden. Centre for Inflammation and Metabolism/CFAS is a member of the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grants 09-067009 and 09-075724). The Contour Next glucose monitors were provided by Bayer A/S, Copenhagen, Denmark. This work was also supported by a grant from the Danish Diabetes Academy, which is supported by the Novo Nordisk Foundation (Dr Ried-Larsen).	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS47, DOI 10.2337/dc16-S009; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bland JM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3985; Blonde L, 2015, LANCET, V385, P2057, DOI 10.1016/S0140-6736(15)60936-9; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Coppell KJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3337; Delahanty LM, 2015, OBESITY, V23, P1792, DOI 10.1002/oby.21172; Espeland M, 2007, DIABETES CARE, V30, P1374; Espeland MA, 2014, DIABETES CARE, V37, P2548, DOI 10.2337/dc14-0093; Gorter KJ, DIABETES GLYCAEMIC C; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Inagaki N, 2015, LANCET DIABETES ENDO, V3, P191, DOI 10.1016/S2213-8587(14)70251-7; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; KOSKINEN PJ, 1993, DIABETES CARE, V16, P1049, DOI 10.2337/diacare.16.7.1049b; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Prasad-Reddy Lalita, 2015, Drugs Context, V4, P212283, DOI 10.7573/dic.212283; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Redmon JB, 2010, DIABETES CARE, V33, P1153, DOI 10.2337/dc09-2090; Ried-Larsen M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009764; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; US Department of Health and Human Services FaDA Center for Drug Evaluation and Research, GUID IND DIAB MELL D; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Zinman B, 2013, LANCET DIABETES ENDO, V1, P123, DOI 10.1016/S2213-8587(13)70013-5	35	93	100	2	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					637	646		10.1001/jama.2017.10169	http://dx.doi.org/10.1001/jama.2017.10169			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810024	Green Published			2022-12-28	WOS:000407616000018
J	Naci, H; Smalley, KR; Kesselheim, AS				Naci, Huseyin; Smalley, Katelyn R.; Kesselheim, Aaron S.			Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPEUTIC AGENTS; END-POINTS; TRIAL; FDA; ONCOLOGY	IMPORTANCE Drugs treating serious or life-threatening conditions can receive US Food and Drug Administration (FDA) accelerated approval based on showing an effect in surrogate measures that are only reasonably likely to predict clinical benefit. Confirmatory trials are then required to determine whether these effects translate to clinical improvements. OBJECTIVE To characterize preapproval and confirmatory clinical trials of drugs granted accelerated approval. DESIGN AND SETTING Publicly available FDA documents were reviewed to identify the preapproval trials leading to accelerated approval between 2009 and 2013. Information on the status and findings of required confirmatory studies was extracted from the FDA's database of postmarketing requirements and commitments, ClinicalTrials.gov, and matched peer-reviewed publications. Follow-up ended on April 7, 2017. EXPOSURES Granting of accelerated approval. MAIN OUTCOMES AND MEASURES Characteristics of preapproval and confirmatory studies were compared in terms of study design features (randomization, blinding, comparator, primary end point). Subsequent regulatory decisions and estimated time between accelerated approval and fulfillment of regulatory requirements were summarized. RESULTS The FDA granted accelerated approval to 22 drugs for 24 indications (19 for indications involving cancer treatment) between 2009 and 2013. A total of 30 preapproval studies supported the 24 indications. The median number of participants enrolled in the preapproval studies was 132 (interquartile range, 89-224). Eight studies (27%) included fewer than 100 participants and 20 (67%) included fewer than 200. At a minimum 3 years of follow-up, 19 of 38 (50%) required confirmatory studies were completed, including 18 published reports. Twenty-five of the 38 (66%) examined clinical efficacy, 7 (18%) evaluated longer follow-up, and 6 (16%) focused on safety The proportion of studies with randomized designs did not differ before and after accelerated approval (12/30 [40%] vs 10/18 [56%]; difference, 16%; 95% CI, -15% to 46%; P = .31). Postapproval requirements were completed and demonstrated efficacy in 10 of 24 indications (42%) on the basis of trials that evaluated surrogate measures. Among the 14 of 24 indications (58%) that had not yet completed all requirements, at least 1 of the confirmatory studies failed to demonstrate clinical benefit in 2 (8%), were terminated in 2 (8%), and were delayed by more than 1 year in 3 (13%). Studies were progressing according to target timelines for the remaining 7 indications (29%). Clinical benefit had not yet been confirmed for 8 indications that had been initially approved 5 or more years prior. CONCLUSIONS AND RELEVANCE Among 22 drugs with 24 indications granted accelerated approval by the FDA in 2009-2013, efficacy was often confirmed in postapproval trials a minimum of 3 years after approval, although confirmatory trials and preapproval trials had similar design elements, including reliance on surrogate measures as outcomes.	[Naci, Huseyin; Smalley, Katelyn R.] London Sch Econ & Polit Sci, Dept Hlth Policy, LSE Hlth, 20 Houghton St, London WC2A 2AE, England; [Kesselheim, Aaron S.] Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA USA	University of London; London School Economics & Political Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Naci, H (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, LSE Hlth, 20 Houghton St, London WC2A 2AE, England.	h.naci@lse.ac.uk	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Smalley, Katelyn/0000-0002-9997-2453	Higher Education Funding Council of England; Engelberg Foundation; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science	Higher Education Funding Council of England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Engelberg Foundation; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science	Dr Naci is supported by the Higher Education Funding Council of England. Dr Kesselheim's work is supported by the Engelberg Foundation and the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science.	[Anonymous], 1992, Fed Regist, V57, P58942; [Anonymous], POSTM REQ COMM; [Anonymous], GUID IND EXP PROGR S; Carpenter D, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1107201, 10.1056/nejmp1107201]; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Darrow Jonathan J, 2014, N Engl J Med, V370, pe39, DOI 10.1056/NEJMp1402114; Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150; Downing NS, 2017, NEW ENGL J MED, V376, P1386, DOI 10.1056/NEJMc1700103; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Kim C, 2015, JAMA INTERN MED, V175, P1992, DOI 10.1001/jamainternmed.2015.5868; Lipton JH, 2016, LANCET ONCOL, V17, P612, DOI 10.1016/S1470-2045(16)00080-2; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; Naci H, 2017, MILBANK Q, V95, P261, DOI 10.1111/1468-0009.12261; Pease AM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1680; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; U.S. Government Accounting Office, 2009, NEW DRUG APPR FDA NE; United States Government Accountability Office, 2016, FDA EXP MAN APPL DAT; US Food and Drug Administration, 2007, GUID IND CLIN TRAIL; US Food and Drug Administration, 2011, GUID IND POSTM STUD; US Food and Drug Administration, ACC APPR; US Food and Drug Administration, DRUGS FDA FDA APPR D; US Food and Drug Administration, 2006, GUID IND CLIN STUD S; US Food and Drug Administration, ACC RESTR APPR SUBP	30	103	103	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					626	636		10.1001/jama.2017.9415	http://dx.doi.org/10.1001/jama.2017.9415			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810023	Green Published, Green Accepted			2022-12-28	WOS:000407616000017
J	Sato, S; Solanas, G; Peixoto, FO; Bee, L; Symeonidi, A; Schmidt, MS; Brenner, C; Masri, S; Benitah, SA; Sassone-Corsi, P				Sato, Shogo; Solanas, Guiomar; Oliveira Peixoto, Francisca; Bee, Leonardo; Symeonidi, Aikaterini; Schmidt, Mark S.; Brenner, Charles; Masri, Selma; Aznar Benitah, Salvador; Sassone-Corsi, Paolo			Circadian Reprogramming in the Liver Identifies Metabolic Pathways of Aging	CELL			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; NICOTINAMIDE RIBOSIDE; ACETYL-COENZYME; GENE-EXPRESSION; CLOCK; MITOCHONDRIAL; NAD(+); SIRTUINS; EXTENDS	The process of aging and circadian rhythms are intimately intertwined, but how peripheral clocks involved in metabolic homeostasis contribute to aging remains unknown. Importantly, caloric restriction (CR) extends lifespan in several organisms and rewires circadian metabolism. Using young versus old mice, fed ad libitum or under CR, we reveal reprogramming of the circadian transcriptome in the liver. These age-dependent changes occur in a highly tissue-specific manner, as demonstrated by comparing circadian gene expression in the liver versus epidermal and skeletal muscle stem cells. Moreover, de novo oscillating genes under CR show an enrichment in SIRT1 targets in the liver. This is accompanied by distinct circadian hepatic signatures in NAD(+)-related metabolites and cyclic global protein acetylation. Strikingly, this oscillation in acetylation is absent in old mice while CR robustly rescues global protein acetylation. Our findings indicate that the clock operates at the crossroad between protein acetylation, liver metabolism, and aging.	[Sato, Shogo; Bee, Leonardo; Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, INSERM U1233, Ctr Epigenet & Metab, Irvine, CA 92607 USA; [Solanas, Guiomar; Oliveira Peixoto, Francisca; Symeonidi, Aikaterini; Aznar Benitah, Salvador] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain; [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Aznar Benitah, Salvador] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain	University of California System; University of California Irvine; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Iowa; ICREA	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, INSERM U1233, Ctr Epigenet & Metab, Irvine, CA 92607 USA.; Benitah, SA (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain.; Benitah, SA (corresponding author), Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain.	salvador.aznar-benitah@irbbarcelona.org; psc@uci.edu	Aznar-Benitah, Salvador/F-4761-2016; Brenner, Charles/D-6339-2014	Aznar-Benitah, Salvador/0000-0002-9059-5049; Brenner, Charles/0000-0002-4955-3226; Schmidt, Mark/0000-0003-4593-4096; Sato, Shogo/0000-0002-2874-7072; Solanas, Guiomar/0000-0001-8388-8647; Masri, Selma/0000-0002-8619-8331	Della Martin Foundation; Italian Association for Cancer Research; National Institutes of Health; INSERM (Institut National de la Sante et Recherche Medicale, France); Roy J. Carver Trust; Novo Nordisk Foundation; European Research Council (ERC); Spanish Ministry of Economy and Development; Institute for Research in Biomedicine (IRB-Barcelona); La Caixa International PhD fellowship; MINECO (Government of Spain); NATIONAL INSTITUTE ON AGING [R21AG041504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036408] Funding Source: NIH RePORTER	Della Martin Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM (Institut National de la Sante et Recherche Medicale, France); Roy J. Carver Trust; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Development; Institute for Research in Biomedicine (IRB-Barcelona); La Caixa International PhD fellowship(La Caixa Foundation); MINECO (Government of Spain); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Sassone-Corsi laboratory for help and critical discussions. S.S. is supported by the Della Martin Foundation; L. B. by Italian Association for Cancer Research; this work was possible through support by the National Institutes of Health, INSERM (Institut National de la Sante et Recherche Medicale, France), the Roy J. Carver Trust, and a Novo Nordisk Foundation Challenge Grant. Research for this project in the lab of S.A.B. was supported by the European Research Council (ERC), the Spanish Ministry of Economy and Development, and the Institute for Research in Biomedicine (IRB-Barcelona). F.O.P. is supported by a La Caixa International PhD fellowship. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain).	[Anonymous], SCIENCE, V350, P1208; [Anonymous], TITLE ERROR; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039; Masri S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005685; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Masri S, 2013, P NATL ACAD SCI USA, V110, P3339, DOI 10.1073/pnas.1217632110; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Ocampo A, 2016, TRENDS MOL MED, V22, P725, DOI 10.1016/j.molmed.2016.06.005; Orozco-Solis R, 2014, CURR OPIN GENET DEV, V26, P66, DOI 10.1016/j.gde.2014.06.003; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970; Patel SA, 2016, FASEB J, V30, P1634, DOI 10.1096/fj.15-282475; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Peleg S, 2016, TRENDS BIOCHEM SCI, V41, P700, DOI 10.1016/j.tibs.2016.05.008; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012; SEUFERT CD, 1974, BIOCHEM BIOPH RES CO, V57, P901, DOI 10.1016/0006-291X(74)90631-7; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Ulgherait M, 2016, CELL METAB, V24, P763, DOI 10.1016/j.cmet.2016.11.002; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	69	174	184	5	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					664	+		10.1016/j.cell.2017.07.042	http://dx.doi.org/10.1016/j.cell.2017.07.042			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802039	Bronze, Green Accepted			2022-12-28	WOS:000407445700008
J	Cohen, JM; Femia, AN; Ho, RS				Cohen, Jeffrey M.; Femia, Alisa N.; Ho, Roger S.			A Woman With Purple Macules on the Legs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMALL-VESSEL VASCULITIS; ANTIBODIES; MANAGEMENT; DIAGNOSIS; HEPATITIS		[Cohen, Jeffrey M.; Femia, Alisa N.; Ho, Roger S.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, 240 E 28th St,11th Floor, New York, NY 10016 USA	New York University	Ho, RS (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, 240 E 28th St,11th Floor, New York, NY 10016 USA.	Roger.Ho@nyumc.org						Carlson JA, 2006, CLIN DERMATOL, V24, P414, DOI 10.1016/j.clindermatol.2006.07.007; DAVIS P, 1975, GUT, V16, P413, DOI 10.1136/gut.16.6.413; Goeser MR, 2014, AM J CLIN DERMATOL, V15, P299, DOI 10.1007/s40257-014-0076-6; Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iglesias-Gamarra Antonio, 2007, Curr Rheumatol Rep, V9, P304, DOI 10.1007/s11926-007-0049-3; Lei Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162241; Lotti T, 1998, J AM ACAD DERMATOL, V39, P667, DOI 10.1016/S0190-9622(98)70039-8; Pop TL, 2014, CLIN LAB, V60, P931, DOI 10.7754/Clin.Lab.2013.130222; Sais G, 1998, ARCH DERMATOL, V134, P309, DOI 10.1001/archderm.134.3.309	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					569	570		10.1001/jama.2017.9227	http://dx.doi.org/10.1001/jama.2017.9227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787491				2022-12-28	WOS:000407160100020
J	Bower, DS; Lips, KR; Schwarzkopf, L; Georges, A; Clulow, S				Bower, Deborah S.; Lips, Karen R.; Schwarzkopf, Lin; Georges, Arthur; Clulow, Simon			Amphibians on the brink	SCIENCE			English	Editorial Material							BATRACHOCHYTRIUM-SALAMANDRIVORANS; CHYTRIDIOMYCOSIS; DENDROBATIDIS; MANAGEMENT; AUSTRALIA; DECLINES; FROGS		[Bower, Deborah S.; Schwarzkopf, Lin] James Cook Univ, Townsville, Qld 4811, Australia; [Lips, Karen R.] Univ Maryland, College Pk, MD 20742 USA; [Georges, Arthur] Univ Canberra, Canberra, ACT 2601, Australia; [Clulow, Simon] Univ Newcastle, Callaghan, NSW 2308, Australia	James Cook University; University System of Maryland; University of Maryland College Park; University of Canberra; University of Newcastle	Bower, DS (corresponding author), James Cook Univ, Townsville, Qld 4811, Australia.	deborah.bower@jcu.edu.au	Bower, Deborah/P-2605-2017; Schwarzkopf, Lin/C-1242-2012; Georges, Arthur/D-2153-2009	Bower, Deborah/0000-0003-0188-3290; Schwarzkopf, Lin/0000-0002-1009-670X; Georges, Arthur/0000-0003-2428-0361; Lips, Karen/0000-0002-2719-1551; Clulow, Simon/0000-0002-5700-6345				BARINAGA M, 1990, SCIENCE, V247, P1033, DOI 10.1126/science.247.4946.1033; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Dahl C, 2012, HERPETOL J, V22, P183; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Grant EHC, 2017, FRONT ECOL ENVIRON, V15, P214, DOI 10.1002/fee.1481; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Knapp RA, 2016, P NATL ACAD SCI USA, V113, P11889, DOI 10.1073/pnas.1600983113; Lips KR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0465; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Phillips BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052502; Skerratt LF, 2016, WILDLIFE RES, V43, P105, DOI 10.1071/WR15071; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Stockwell MP, 2015, BIODIVERS CONSERV, V24, P2583, DOI 10.1007/s10531-015-0946-0; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Weldon C, 2013, ECOHEALTH, V10, P234, DOI 10.1007/s10393-013-0869-8	15	30	30	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					454	455		10.1126/science.aao0500	http://dx.doi.org/10.1126/science.aao0500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774916				2022-12-28	WOS:000406840100021
J	Gomez, JL; Bonaventura, J; Lesniak, W; Mathews, WB; Sysa-Shah, P; Rodriguez, LA; Ellis, RJ; Richie, CT; Harvey, BK; Dannals, RF; Pomper, MG; Bonci, A; Michaelides, M				Gomez, Juan L.; Bonaventura, Jordi; Lesniak, Wojciech; Mathews, William B.; Sysa-Shah, Polina; Rodriguez, Lionel A.; Ellis, Randall J.; Richie, Christopher T.; Harvey, Brandon K.; Dannals, Robert F.; Pomper, Martin G.; Bonci, Antonello; Michaelides, Michael			Chemogenetics revealed: DREADD occupancy and activation via converted clozapine	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER; N-OXIDE; IN-VIVO; METABOLISM; DRUGS; MICE; RAT	The chemogenetic technology DREADD (designer receptors exclusively activated by designer drugs) is widely used for remote manipulation of neuronal activity in freely moving animals. DREADD technology posits the use of "designer receptors," which are exclusively activated by the "designer drug" clozapine N-oxide (CNO). Nevertheless, the in vivo mechanism of action of CNO at DREADDs has never been confirmed. CNO does not enter the brain after systemic drug injections and shows low affinity for DREADDs. Clozapine, to which CNO rapidly converts in vivo, shows high DREADD affinity and potency. Upon systemic CNO injections, converted clozapine readily enters the brain and occupies central nervous system-expressed DREADDs, whereas systemic subthreshold clozapine injections induce preferential DREADD-mediated behaviors.	[Gomez, Juan L.; Bonaventura, Jordi; Rodriguez, Lionel A.; Ellis, Randall J.; Michaelides, Michael] NIDA, Biobehav Imaging & Mol Neuropsychopharmacol, Intramural Res Program, Baltimore, MD 21224 USA; [Lesniak, Wojciech; Mathews, William B.; Sysa-Shah, Polina; Dannals, Robert F.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Richie, Christopher T.; Harvey, Brandon K.] NIDA, Intramural Res Program, Optogenet & Transgen Technol Core, Baltimore, MD 21224 USA; [Bonci, Antonello] NIDA, Synapt Plast Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Michaelides, Michael] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine	Michaelides, M (corresponding author), NIDA, Biobehav Imaging & Mol Neuropsychopharmacol, Intramural Res Program, Baltimore, MD 21224 USA.; Michaelides, M (corresponding author), Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	mike.michaelides@nih.gov	Harvey, Brandon K/A-5559-2010; Michaelides, Mike/V-5199-2019; Bonaventura, Jordi/A-5229-2019; Gomez, Juan/O-7541-2017; Harvey, Brandon Keith/AAY-4080-2021; Michaelides, Michael/K-4736-2013	Bonaventura, Jordi/0000-0002-4745-0151; Gomez, Juan/0000-0003-3170-9904; Harvey, Brandon Keith/0000-0002-4036-1383; Ellis, Randall/0000-0003-3862-0881; Michaelides, Michel/0000-0002-1552-7046; Dannals, Robert/0000-0002-5483-5914; Michaelides, Michael/0000-0003-0398-4917; Mathews, William/0000-0001-8001-416X	NIDA [ZIA000069, ZIA000526]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000069, ZIADA000526] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIDA Intramural Research Program (ZIA000069 and ZIA000526). We thank M. Higuchi, B. Ji, and T. Minamimoto for providing access to WT and hM4Di transgenic mouse tissue. We thank M. Sanchez-Soto and D. Howard for assisting with in vitro studies. Last, we thank G. Smith, H. Davis, N. Ator, D. Jacob, J. Engles, B. Liu, and M. Morales for research and administrative support and Y. Shaham, A. Newman, and C. Bradberry for their comments on the manuscript. M.M. is a cofounder and owns stock in Metis Laboratories. All other authors declare no conflicts of interest. All data are stored in our laboratory and freely available upon request. J.L.G., J.B., and M.M. designed experiments, performed experiments, and wrote the manuscript. W.L., P.S.-S., C.T.R., W.B.M., L.A.R., and R.J.E. performed experiments. B.K.H., R.F.D., M.G.P., and A.B. provided access to administrative/research support, reagents, and/or equipment. All coauthors reviewed the manuscript and provided comments.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BENDER D, 1994, NUCL MED BIOL, V21, P921, DOI 10.1016/0969-8051(94)90080-9; Chang WH, 1998, PROG NEURO-PSYCHOPH, V22, P723, DOI 10.1016/S0278-5846(98)00035-9; Eldridge MAG, 2016, NAT NEUROSCI, V19, P37, DOI 10.1038/nn.4192; English JG, 2015, JAMA NEUROL, V72, P1361, DOI 10.1001/jamaneurol.2015.1921; Fang J, 2000, EUR J DRUG METAB PH, V25, P109, DOI 10.1007/BF03190076; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; JANN MW, 1994, ARCH INT PHARMACOD T, V328, P243; Ji B, 2016, J NEUROSCI, V36, P11544, DOI 10.1523/JNEUROSCI.1279-16.2016; Lin G, 1996, J PHARMACEUT BIOMED, V14, P1561, DOI 10.1016/0731-7085(96)01738-4; MacLaren D. A., 2016, ENEURO, DOI [10.1126/science.aan2475, DOI 10.1523/ENEUR0.0219-16.2016]; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; Michaelides M, 2013, J CLIN INVEST, V123, P5342, DOI 10.1172/JCI72117; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Raper J, 2017, ACS CHEM NEUROSCI, V8, P1570, DOI 10.1021/acschemneuro.7b00079; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803	18	522	524	11	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					503	+		10.1126/science.aan2475	http://dx.doi.org/10.1126/science.aan2475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774929	Green Accepted			2022-12-28	WOS:000406840100038
J	Hilker, TA; Salomon, G; Grusdt, F; Omran, A; Boll, M; Demler, E; Bloch, I; Gross, C				Hilker, Timon A.; Salomon, Guillaume; Grusdt, Fabian; Omran, Ahmed; Boll, Martin; Demler, Eugene; Bloch, Immanuel; Gross, Christian			Revealing hidden antiferromagnetic correlations in doped Hubbard chains via string correlators	SCIENCE			English	Article							SPIN-CHARGE SEPARATION; ONE-DIMENSIONAL SRCUO2; LUTTINGER LIQUID; MODEL; ORDER; SUPERCONDUCTIVITY; FERMIONS; STRIPES; STATES	Topological phases, like the Haldane phase in spin-1 chains, defy characterization through local order parameters. Instead, nonlocal string order parameters can be employed to reveal their hidden order. Similar dilutedmagnetic correlations appear in doped one-dimensional lattice systems owing to the phenomenon of spin-charge separation. Here we report on the direct observation of such hidden magnetic correlations via quantum gas microscopy of hole-doped ultracold Fermi-Hubbard chains. The measurement of nonlocal spin-density correlation functions reveals a hidden finite-range antiferromagnetic order, a direct consequence of spin-charge separation. Our technique, which measures nonlocal order directly, can be readily extended to higher dimensions to study the complex interplay between magnetic order and density fluctuations.	[Hilker, Timon A.; Salomon, Guillaume; Omran, Ahmed; Boll, Martin; Bloch, Immanuel; Gross, Christian] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Grusdt, Fabian; Omran, Ahmed; Demler, Eugene] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Bloch, Immanuel] Ludwig Maximilians Univ Munchen, Fak Phys, D-80799 Munich, Germany	Max Planck Society; Harvard University; University of Munich	Hilker, TA (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	timon.hilker@mpq.mpg.de	Bloch, Immanuel/G-3174-2010; Bloch, Immanuel/N-9169-2019; Salomon, guillaume/ABB-1056-2021; Salomon, Guillaume/T-1081-2018; Demler, Eugene/ABG-1933-2021; Boll, Martin/AAN-7034-2020; Omran, Ahmed/AHH-4541-2022; Gross, Christian/P-5475-2014	Bloch, Immanuel/0000-0002-0679-4759; Salomon, guillaume/0000-0003-2349-0869; Salomon, Guillaume/0000-0003-2349-0869; Demler, Eugene/0000-0002-2499-632X; Omran, Ahmed/0000-0002-2253-0278; Gross, Christian/0000-0003-2292-5234; Hilker, Timon/0000-0002-1012-5750; Boll, Martin/0000-0002-9778-4280; Grusdt, Fabian/0000-0003-3531-8089	Max Planck Society (MPG); European Union (UQUAM); Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms (CUA), NSF [DMR-1308435]; Moore Foundation; Air Force Office of Scientific Research (AFOSR) Quantum Simulation MURI; AFOSR MURI Photonic Quantum Matter; Direct For Mathematical & Physical Scien [1308435] Funding Source: National Science Foundation	Max Planck Society (MPG)(Max Planck Society); European Union (UQUAM); Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms (CUA), NSF; Moore Foundation(Gordon and Betty Moore Foundation); Air Force Office of Scientific Research (AFOSR) Quantum Simulation MURI; AFOSR MURI Photonic Quantum Matter; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge J. Koepsell and J. Vijayan for a critical reading of the manuscript and A. Sterdyniak and M. Zvonarev for useful discussions. Financial support was provided by the Max Planck Society (MPG) and European Union (UQUAM). F.G. and E.D. acknowledge support from Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms (CUA), NSF grant DMR-1308435, the Moore Foundation, Air Force Office of Scientific Research (AFOSR) Quantum Simulation MURI, and AFOSR MURI Photonic Quantum Matter. The data that support the plots presented in this paper and other findings of this study are available from the corresponding author upon reasonable request.	Auerbach A., 1994, INTERACTING ELECT QU; Auslaender OM, 2005, SCIENCE, V308, P88, DOI 10.1126/science.1107821; Boll M, 2016, SCIENCE, V353, P1257, DOI 10.1126/science.aag1635; Brown P. T., 2016, ARXIV161207746CONDMA; Carlson E W, 2004, CONCEPTS HIGH TEMPER, P275; Cheuk LW, 2016, SCIENCE, V353, P1260, DOI 10.1126/science.aag3349; DENNIJS M, 1989, PHYS REV B, V40, P4709, DOI 10.1103/PhysRevB.40.4709; Edge GJA, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063406; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; GIAMARCHI T., 2004, INT SERIES MONOGRAPH; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Haller E, 2015, NAT PHYS, V11, P738, DOI [10.1038/nphys3403, 10.1038/NPHYS3403]; Imambekov A, 2012, REV MOD PHYS, V84, P1253, DOI 10.1103/RevModPhys.84.1253; KENNEDY T, 1992, PHYS REV B, V45, P304, DOI 10.1103/PhysRevB.45.304; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Knap M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.147205; Kollath C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.176401; Kruis HV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075109; Kruis HV, 2004, EUROPHYS LETT, V65, P512, DOI 10.1209/epl/i2003-10114-3; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; OGATA M, 1990, PHYS REV B, V41, P2326, DOI 10.1103/PhysRevB.41.2326; Omran A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.263001; Parsons MF, 2016, SCIENCE, V353, P1253, DOI 10.1126/science.aag1430; Recati A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.020401; REN Y, 1993, PHYS REV B, V48, P16662, DOI 10.1103/PhysRevB.48.16662; Rigol M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130403; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Wen X.G., 2004, QUANTUM FIELD THEORY; WOYNAROVICH F, 1982, J PHYS C SOLID STATE, V15, P85, DOI 10.1088/0022-3719/15/1/007; Zaanen J, 1998, J PHYS CHEM SOLIDS, V59, P1769, DOI 10.1016/S0022-3697(98)00106-1; Zaanen J, 2001, PHILOS MAG B, V81, P1485, DOI 10.1080/13642810110051791; Zhang Y, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094501	37	109	109	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					484	+		10.1126/science.aam8990	http://dx.doi.org/10.1126/science.aam8990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774925	Green Submitted			2022-12-28	WOS:000406840100033
J	Arguello, V; Freeby, M				Arguello, Vanessa; Freeby, Matthew			Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections: Does This Mean Continuous Glucose Monitoring for Everyone?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIAL		[Arguello, Vanessa; Freeby, Matthew] UCLA, David Geffen Sch Med, 200 Med Plaza Driveway,Suite 530, Los Angeles, CA 90095 USA; [Arguello, Vanessa] UCLA, David Geffen Sch Med, 1245 16th St,Suite 307, Santa Monica, CA 90404 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Arguello, V (corresponding author), UCLA, David Geffen Sch Med, 1245 16th St,Suite 307, Santa Monica, CA 90404 USA.	varguello@mednet.ucla.edu						Allen NA, 2008, DIABETES RES CLIN PR, V80, P371, DOI 10.1016/j.diabres.2008.01.006; Bailey TS, 2016, ENDOCR PRACT, V22, P231, DOI 10.4158/EP151124.CS; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Beck RW, 2017, ANN INTERN MED, V167, P365, DOI 10.7326/M16-2855; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Haak T, 2017, DIABETES THER, V8, P55, DOI 10.1007/s13300-016-0223-6; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Ryder JR, 2013, NEW ENGL J MED, V369, P287, DOI 10.1056/NEJMc1306652; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Vigersky RA, 2012, DIABETES CARE, V35, P32, DOI 10.2337/dc11-1438	10	2	2	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					436	+		10.7326/M17-2121	http://dx.doi.org/10.7326/M17-2121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828490				2022-12-28	WOS:000411009900022
J	Baker, DW; Chassin, MR				Baker, David W.; Chassin, Mark R.			Holding Providers Accountable for Health Care Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY IMPROVEMENT; ASSOCIATION; NONRESPONSE; MANAGEMENT; PNEUMONIA; RATES	Federal public reporting and payment programs have increasingly emphasized the measurement of outcomes (such as readmission, health care- associated infections, and mortality). Yet, the criteria for assessing whether outcome measures are accurate and valid enough to use for public reporting, payment, and accreditation are not well- defined. An outcome measure should be used only if the outcome can be influenced substantially by providers (that is, a strong process- outcome link exists) and statistical adjustment can be made for differences in patient populations across providers so that differences in outcomes are truly attributable to differences in the care provided. Validly distinguishing differences in quality of care across providers requires precision in both the design of the outcome measure and the actual recording of all the measure's elements. Four criteria are proposed to assess outcome measures. First, strong evidence should exist that good medical care leads to improvement in the outcome within the time period for the measure. Second, the outcome should be measurable with a high degree of precision. Third, the risk-adjustment methodology should include and accurately measure the risk factors most strongly associated with the outcome. Fourth, implementation of the outcome measure must have little chance of inducing unintended adverse consequences. These criteria were applied to 10 outcome measures currently used or proposed for accountability programs. Three measures met all 4 criteria; 5, including all 4 claims-based 30-day mortality measures, failed to meet 1 or more criteria. Patient-reported outcome measures are problematic, because low response rates may cause bias. These findings raise concerns and suggest the need for a national dialogue about how to judge outcome measures currently in use or proposed for the future.	[Baker, David W.; Chassin, Mark R.] Joint Commiss, One Renaissance Blvd, Oak Brook Terrace, IL 60181 USA		Baker, DW (corresponding author), Joint Commiss, One Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.; Baker, DW (corresponding author), Joint Commiss, Healthcare Qual Evaluat, One Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	dbaker@jointcommission.org						ACS, 2017, ACS NAT SURG QUAL IM; Bell BP, 2016, CTR DIS CONTR PREV; Bilimoria KY, 2015, JAMA-J AM MED ASSOC, V314, P1333, DOI 10.1001/jama.2015.12470; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Centers for Disease Control and Prevention, 2017, BLOODSTR INV EV CENT; Centers for Medicare & Medicaid Services, 2013, CMS FIN RUL IMPR QUA; Centers for Medicare & Medicaid Services, 2017, MED HOSP COMP; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; Chong WF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-105; Elliott MN, 2009, HEALTH SERV RES, V44, P501, DOI 10.1111/j.1475-6773.2008.00914.x; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; New York State Department of Health, 2016, CARD SURG PCI ANG RE; Rothberg MB, 2014, ANN INTERN MED, V160, P380, DOI 10.7326/M13-1419; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Tefera L, 2016, JAMA-J AM MED ASSOC, V315, P2167, DOI 10.1001/jama.2016.1652; The Society of Thoracic Surgeons. STS National Database, 2017, STS NAT DAT; Winters BD, 2016, MED CARE, V55, P1105, DOI 10.1097/MLR.0000000000000550; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zheng Hua, 2014, EGEMS (Wash DC), V2, P1130, DOI 10.13063/2327-9214.1130	24	13	13	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					418	+		10.7326/M17-0691	http://dx.doi.org/10.7326/M17-0691			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28806793				2022-12-28	WOS:000411009900018
J	Mattiroli, F; Bhattacharyya, S; Dyer, PN; White, AE; Sandman, K; Burkhart, BW; Byrne, KR; Lee, T; Ahn, NG; Santangelo, TJ; Reeve, JN; Luger, K				Mattiroli, Francesca; Bhattacharyya, Sudipta; Dyer, Pamela N.; White, Alison E.; Sandman, Kathleen; Burkhart, Brett W.; Byrne, Kyle R.; Lee, Thomas; Ahn, Natalie G.; Santangelo, Thomas J.; Reeve, John N.; Luger, Karolin			Structure of histone-based chromatin in Archaea	SCIENCE			English	Article							THERMOCOCCUS-KODAKARENSIS; CRYSTAL-STRUCTURE; NUCLEOSOME; ORIGIN; DNA; FOLD	Small basic proteins present in most Archaea share a common ancestor with the eukaryotic core histones. We report the crystal structure of an archaeal histone-DNA complex. DNA wraps around an extended polymer, formed by archaeal histone homodimers, in a quasi-continuous superhelix with the same geometry as DNA in the eukaryotic nucleosome. Substitutions of a conserved glycine at the interface of adjacent protein layers destabilize archaeal chromatin, reduce growth rate, and impair transcription regulation, confirming the biological importance of the polymeric structure. Our data establish that the histone-based mechanism of DNA compaction predates the nucleosome, illuminating the origin of the nucleosome.	[Mattiroli, Francesca; Dyer, Pamela N.; White, Alison E.; Lee, Thomas; Ahn, Natalie G.; Luger, Karolin] Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA; [Bhattacharyya, Sudipta; Burkhart, Brett W.; Byrne, Kyle R.; Santangelo, Thomas J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Sandman, Kathleen; Reeve, John N.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Santangelo, Thomas J.; Luger, Karolin] Colorado State Univ, Inst Genome Architecture & Funct, Ft Collins, CO 80523 USA; [Luger, Karolin] Univ Colorado Boulder, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Bhattacharyya, Sudipta] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Colorado System; University of Colorado Boulder; Colorado State University; University System of Ohio; Ohio State University; Colorado State University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Austin	Luger, K (corresponding author), Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA.; Luger, K (corresponding author), Colorado State Univ, Inst Genome Architecture & Funct, Ft Collins, CO 80523 USA.; Luger, K (corresponding author), Univ Colorado Boulder, Howard Hughes Med Inst, Boulder, CO 80309 USA.	karolin.luger@colorado.edu	Mattiroli, Francesca/AAT-1489-2020; Santangelo, Tom/L-8206-2019	Mattiroli, Francesca/0000-0002-1574-7217; Santangelo, Tom/0000-0003-4559-3244; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; DYER, PAMELA/0000-0002-0142-5073; LEE, THOMAS/0000-0001-9283-4659; AHN, NATALIE/0000-0002-2690-2630; Bhattacharyya, Sudipta/0000-0001-8777-3353	NIH [GM 067777, GM53185, GM100329, GM114594]; European Molecular Biology Organization [ALTF 1267-2013]; Dutch Cancer Society [KWF 2014-6649]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053185, R01GM100329, R01GM114594, R01GM067777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dutch Cancer Society(KWF Kankerbestrijding); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Colorado BioFrontiers Institute Next-Generation Sequencing Core Facility for performing BioAnalzyer runs and the Protein Expression and Purification Facility at Colorado State University for reagents. This work was supported by NIH grants GM 067777 (to K.L.), GM53185 (to J.N.R.), GM100329 (to T.J.S.), and GM114594 (to N.G.A.). F.M. is funded by the European Molecular Biology Organization (ALTF 1267-2013) and the Dutch Cancer Society (KWF 2014-6649). K.L. is supported by the Howard Hughes Medical Institute. F.M. finalized the structure, designed mutants, performed the analytical ultracentrifugation and qRT-PCR experiments, and contributed to structure analysis, the MNase experiments, and manuscript preparation. S.B. processed and phased the x-ray data, built and refined the model, and helped analyze the structure. P.N.D. and K.S. prepared complexes, obtained crystals, and collected data. P.N.D. performed in vitro complex analysis, and A.E.W. performed the MNase and histone-extraction experiments. T.J.S., B.W.B., and K.R.B. constructed and characterized the T. kodakarensis strains and grew biomass. T.L. and N.G.A. performed mass spectrometry. T.J.S. assisted in manuscript preparation. J.N.R. and K.L. conceived and directed the project, wrote the manuscript, analyzed the structure, and prepared figures. The structure has been deposited in the Protein Data Bank (PDB accession code 5T5K).	Aravind L, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016063; Bailey KA, 2000, J MOL BIOL, V303, P25, DOI 10.1006/jmbi.2000.4128; Decanniere K, 2000, J MOL BIOL, V303, P35, DOI 10.1006/jmbi.2000.4104; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Hileman TH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00195; Kato D, 2017, SCIENCE, V356, P205, DOI 10.1126/science.aak9867; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Maruyama H, 2013, EMBO REP, V14, P711, DOI 10.1038/embor.2013.94; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Nishida H, 2017, J GEN APPL MICROBIOL, V63, P28, DOI 10.2323/jgam.2016.07.003; Sandman K, 2001, BIOCHIMIE, V83, P277, DOI 10.1016/S0300-9084(00)01208-6; Sandman K, 2008, EXTREMOPHILES, V12, P811, DOI 10.1007/s00792-008-0185-3; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Santangelo TJ, 2011, MOL MICROBIOL, V81, P897, DOI 10.1111/j.1365-2958.2011.07734.x; Soares DJ, 2000, J MOL BIOL, V297, P39, DOI 10.1006/jmbi.2000.3546; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Tomschik M, 2001, STRUCTURE, V9, P1201, DOI 10.1016/S0969-2126(01)00682-7; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031	22	86	88	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					609	611		10.1126/science.aaj1849	http://dx.doi.org/10.1126/science.aaj1849			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798133	Green Accepted			2022-12-28	WOS:000407324800045
J	Voosen, P				Voosen, Paul			PLANETARY SCIENCE Fear of microbial taint curbs Mars explorers	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					535	536		10.1126/science.357.6351.535	http://dx.doi.org/10.1126/science.357.6351.535			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798108				2022-12-28	WOS:000407324800015
J	Zhang, DD; Li, SH				Zhang, David D.; Li, Sheng-Hua			Comment on "Permanent human occupation of the central Tibetan Plateau in the early Holocene"	SCIENCE			English	Editorial Material							SINGLE GRAINS; MULTIPLE GRAINS; SEDIMENTS; DEPOSITS	Meyer et al. (Reports, 6 January 2017, p. 64) suggest a new chronology for permanent human occupation of Tibet based on their dating of the travertine and colluvium deposits that contain or are deposited near fossil human handprints and footprints. However, misinterpretations in both stratigraphic reconstruction and dating data may have caused the newly proposed age of these human imprints to have been seriously underestimated.	[Zhang, David D.] Guangzhou Univ, Sch Geog Sci, Guangzhou 510006, Guangdong, Peoples R China; [Zhang, David D.] Univ Hong Kong, Dept Geog, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Li, Sheng-Hua] Univ Hong Kong, Dept Earth Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	Guangzhou University; University of Hong Kong; University of Hong Kong	Zhang, DD (corresponding author), Guangzhou Univ, Sch Geog Sci, Guangzhou 510006, Guangdong, Peoples R China.; Zhang, DD (corresponding author), Univ Hong Kong, Dept Geog, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	zhangd@hku.hk			Research Grant Council of the Hong Kong Special Administrative Region, China [7033/12P, 17303014]	Research Grant Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	Most of the comments on <SUP>230</SUP>Th/U dating were originally made by H. Cheng at the Institute of Global Environmental Change, Xi'an Jiaotong University. We thank him for permission to quote his idea. This study was financially supported by grants to S.-H.L. from the Research Grant Council of the Hong Kong Special Administrative Region, China (7033/12P and 17303014).	Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P204, DOI 10.1016/j.quageo.2008.12.001; BISCHOFF JL, 1991, GEOCHIM COSMOCHIM AC, V55, P543, DOI 10.1016/0016-7037(91)90011-S; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Garnett ER, 2004, QUATERNARY SCI REV, V23, P947, DOI 10.1016/j.quascirev.2003.06.018; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; LUO SD, 1991, GEOCHIM COSMOCHIM AC, V55, P555, DOI 10.1016/0016-7037(91)90012-T; Meyer MC, 2017, SCIENCE, V355, P64, DOI 10.1126/science.aag0357; Olley JM, 1999, RADIAT MEAS, V30, P207, DOI 10.1016/S1350-4487(99)00040-2; Olley JM, 2004, GEOMORPHOLOGY, V60, P337, DOI 10.1016/j.geomorph.2003.09.020; Roberts RG, 2000, RADIAT MEAS, V32, P459, DOI 10.1016/S1350-4487(00)00104-9; Thomsen KJ, 2005, RADIAT MEAS, V39, P47, DOI 10.1016/j.radmeas.2004.01.039; Wang ZJ, 2016, SEDIMENT GEOL, V342, P218, DOI 10.1016/j.sedgeo.2016.07.002; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749	14	6	8	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351							eaam9231	10.1126/science.aam9231	http://dx.doi.org/10.1126/science.aam9231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798104				2022-12-28	WOS:000407324800002
J	Hampton, RY; Dargemont, C				Hampton, Randolph Y.; Dargemont, Catherine			New developments for protein quality control	SCIENCE			English	Editorial Material							DEGRADATION		[Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Dargemont, Catherine] Univ Paris Diderot Sorbonne Paris Cite, Hop St Louis, CNRS, INSERM UMR944,UMR7212, F-75475 Paris 10, France	University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	rhampton@ucsd.edu; catherine.dargemont@inserm.fr						Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Shao S, 2016, TRENDS BIOCHEM SCI, V41, P124, DOI 10.1016/j.tibs.2015.10.007; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; WEFES I, 1995, P NATL ACAD SCI USA, V92, P4982, DOI 10.1073/pnas.92.11.4982; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178	9	2	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					450	451		10.1126/science.aao1896	http://dx.doi.org/10.1126/science.aao1896			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774913				2022-12-28	WOS:000406840100018
J	Pearson, M; Metcalfe, C; Jayamanne, S; Gunnell, D; Weerasinghe, M; Pieris, R; Priyadarshana, C; Knipe, DW; Hawton, K; Dawson, AH; Bandara, P; Desilva, D; Gawarammana, I; Eddleston, M; Konradsen, F				Pearson, Melissa; Metcalfe, Chris; Jayamanne, Shaluka; Gunnell, David; Weerasinghe, Manjula; Pieris, Ravi; Priyadarshana, Chamil; Knipe, Duleeka W.; Hawton, Keith; Dawson, Andrew H.; Bandara, Palitha; Desilva, Dhammika; Gawarammana, Indika; Eddleston, Michael; Konradsen, Flemming			Effectiveness of household lockable pesticide storage to reduce pesticide self-poisoning in rural Asia: a community-based, cluster-randomised controlled trial	LANCET			English	Article							SUICIDE-PREVENTION STRATEGIES; SRI-LANKA; DEVELOPING-COUNTRIES; INGESTION; DEATHS; IMPACT	Background Agricultural pesticide self-poisoning is a major public health problem in rural Asia. The use of safer household pesticide storage has been promoted to prevent deaths, but there is no evidence of effectiveness. We aimed to test the effectiveness of lockable household containers for prevention of pesticide self-poisoning. Methods We did a community-based, cluster-randomised controlled trial in a rural area of North Central Province, Sri Lanka. Clusters of households were randomly assigned (1: 1), with a sequence computer-generated by a minimisation process, to intervention or usual practice (control) groups. Intervention households that had farmed or had used or stored pesticide in the preceding agricultural season were given a lockable storage container. Further promotion of use of the containers was restricted to community posters and 6-monthly reminders during routine community meetings. The primary outcome was incidence of pesticide self-poisoning in people aged 14 years or older during 3 years of follow-up. Identification of outcome events was done by staff who were unaware of group allocation. Analysis was by intention to treat. This trial is registered with ClinicalTrials. gov, number NCT1146496. Findings Between Dec 31, 2010, and Feb 2, 2013, we randomly assigned 90 rural villages to the intervention group and 90 to the control group. 27 091 households (114 168 individuals) in the intervention group and 26 291 households (109 693 individuals) in the control group consented to participate. 20 457 household pesticide storage containers were distributed. In individuals aged 14 years or older, 611 cases of pesticide self-poisoning had occurred by 3 years in the intervention group compared with 641 cases in the control group; incidence of pesticide self-poisoning did not differ between groups (293.3 per 100 000 person-years of follow-up in the intervention group vs 318.0 per 100 000 in the control group; rate ratio [RR] 0.93, 95% CI 0.80-1.08; p=0.33). We found no evidence of switching from pesticide self-poisoning to other forms of self-harm, with no significant difference in the number of fatal (82 in the intervention group vs 67 in the control group; RR 1.22, 0.88-1.68]) or non-fatal (1135 vs 1153; RR 0.97, 0.86-1.08) self-harm events involving all methods. Interpretation We found no evidence that means reduction through improved household pesticide storage reduces pesticide self-poisoning. Other approaches, particularly removal of highly hazardous pesticides from agricultural practice, are likely to be more effective for suicide prevention in rural Asia.	[Pearson, Melissa; Eddleston, Michael] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Pharmacol Toxicol & Therapeut, Edinburgh EH16 4TJ, Midlothian, Scotland; [Pearson, Melissa; Eddleston, Michael] Univ Edinburgh, Ctr Pesticide Suicide Prevent, Edinburgh, Midlothian, Scotland; [Pearson, Melissa; Jayamanne, Shaluka; Gunnell, David; Weerasinghe, Manjula; Pieris, Ravi; Priyadarshana, Chamil; Knipe, Duleeka W.; Dawson, Andrew H.; Gawarammana, Indika; Eddleston, Michael; Konradsen, Flemming] Univ Peradeniya, Fac Med, SACTRC, Peradeniya, Sri Lanka; [Metcalfe, Chris; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Jayamanne, Shaluka] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Weerasinghe, Manjula] Rajarata Univ Sri Lanka, Dept Community Med, Anuradhapura, Sri Lanka; [Hawton, Keith] Univ Oxford, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Dawson, Andrew H.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Bandara, Palitha; Desilva, Dhammika] Prov Dept Hlth Serv, Anuradhapura, North Central P, Sri Lanka; [Gawarammana, Indika] Univ Peradeniya, Dept Med, Fac Med, Peradeniya, Sri Lanka; [Konradsen, Flemming] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark	University of Edinburgh; University of Edinburgh; University of Peradeniya; University of Bristol; University Kelaniya; Rajarata University of Sri Lanka; University of Oxford; University of Sydney; University of Peradeniya; University of Copenhagen	Eddleston, M (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Pharmacol Toxicol & Therapeut, Edinburgh EH16 4TJ, Midlothian, Scotland.	m.eddleston@ed.ac.uk	Dawson, Andrew H/U-8041-2019; Gunnell, David/ABE-6653-2020; Pearson, Melissa/M-5250-2014	Dawson, Andrew H/0000-0002-8047-397X; Gunnell, David/0000-0002-0829-6470; Konradsen, Flemming/0000-0003-1036-6949; Knipe, Duleeka/0000-0002-1040-7635; Metcalfe, Chris/0000-0001-8318-8907; Pearson, Melissa/0000-0001-6683-3628	Wellcome Trust; American Foundation for Suicide Prevention; Lister Institute of Preventive Medicine; Chief Scientist Office of Scotland; University of Copenhagen; NHMRC Australia; MRC [MR/K025643/1] Funding Source: UKRI; Medical Research Council [MR/K025643/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); American Foundation for Suicide Prevention; Lister Institute of Preventive Medicine; Chief Scientist Office of Scotland; University of Copenhagen; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Wellcome Trust, with additional support from the American Foundation for Suicide Prevention, Lister Institute of Preventive Medicine, Chief Scientist Office of Scotland, University of Copenhagen, and NHMRC Australia.	Bateman DN, 2008, PLOS MED, V5, P185, DOI 10.1371/journal.pmed.0050058; Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304; Chowdhury FR, INT J EPIDE IN PRESS; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Eddleston M, 2006, CLIN TOXICOL, V44, P283, DOI 10.1080/15563650600584444; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; Eddleston M, 2016, BRIT J CLIN PHARMACO, V81, P462, DOI 10.1111/bcp.12784; FAO WHO, 2016, INT COD COND PEST MA; Fleischmann A, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2015.27; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Gunnell D, 2017, LANCET GLOB HEALTH, V5, pe924; Hawton K, 2007, CRISIS, V28, P4, DOI 10.1027/0227-5910.28.S1.4; Hawton K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-69; Knipe DW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014006; Knipe DW, 2017, LANCET GLOB HEALTH, V5, pE651, DOI 10.1016/S2214-109X(17)30208-5; Knipe DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172893; Knipe DW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-839; Knipe Duleeka W, 2014, BMC Res Notes, V7, P452, DOI 10.1186/1756-0500-7-452; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; Konradsen F, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-13; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Liu S, 2015, PSYCHOL MED, V45, P3259, DOI 10.1017/S0033291715001269; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Manuweera G, 2008, ENVIRON HEALTH PERSP, V116, P492, DOI 10.1289/ehp.11029; Mew EJ, 2017, J AFFECT DISORDERS, V219, P93, DOI 10.1016/j.jad.2017.05.002; Mohamed F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-405; Pearson M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-879; Senarathna L, 2012, B WORLD HEALTH ORGAN, V90, P436, DOI 10.2471/BLT.11.092114; Van der Hoek W, 1998, SOC SCI MED, V46, P495, DOI 10.1016/S0277-9536(97)00193-7; Vijayakumar L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-850; Weerasinghe M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-276; WHO, SAF ACC PEST SUIC PR; WHO, 2015, COUNTR HLTH PROF WHO; Wickramasinghe K, 2009, B WORLD HEALTH ORGAN, V87, P180, DOI 10.2471/BLT.08.051920; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; World Health Organization, 2014, PREV SUIC PREV SUIC; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X	41	50	51	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1863	1872		10.1016/S0140-6736(17)31961-X	http://dx.doi.org/10.1016/S0140-6736(17)31961-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK1LY	28807536	Green Published, hybrid			2022-12-28	WOS:000413244500027
J	Yip, P				Yip, Paul			Learning from a negative trial of lockable pesticide storage	LANCET			English	Editorial Material							SUICIDE-PREVENTION; STRATEGIES		[Yip, Paul] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yip, P (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk						Chen YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133809; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Knox KL, 2004, AM J PUBLIC HEALTH, V94, P37, DOI 10.2105/AJPH.94.1.37; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Law CK, 2009, J AFFECT DISORDERS, V114, P254, DOI 10.1016/j.jad.2008.07.021; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Pearson M, 2017, LANCET; World Health Organization, 2014, WORLD SUIC REP; Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Yip PSF, 2010, BRIT J PSYCHIAT, V196, P241, DOI 10.1192/bjp.bp.109.065185	12	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1817	1819		10.1016/S0140-6736(17)32207-9	http://dx.doi.org/10.1016/S0140-6736(17)32207-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK1LY	28807537	hybrid			2022-12-28	WOS:000413244500010
J	Nugent, SM; Morasco, BJ; O'Neil, ME; Freeman, M; Low, A; Kondo, K; Elven, C; Zakher, B; Motu'apuaka, M; Paynter, R; Kansagara, D				Nugent, Shannon M.; Morasco, Benjamin J.; O'Neil, Maya E.; Freeman, Michele; Low, Allison; Kondo, Karli; Elven, Camille; Zakher, Bernadette; Motu'apuaka, Makalapua; Paynter, Robin; Kansagara, Devan			The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CENTRAL NEUROPATHIC PAIN; MARIJUANA USE; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; PULMONARY ASPERGILLOSIS; HYPEREMESIS SYNDROME; MEDICINAL EXTRACTS; MEDICAL CANNABIS; SUBSTANCE USE; VAPORIZED CANNABIS	Background: Cannabis is increasingly available for the treatment of chronic pain, yet its efficacy remains uncertain. Purpose: To review the benefits of plant-based cannabis preparations for treating chronic pain in adults and the harms of cannabis use in chronic pain and general adult populations. Data Sources: MEDLINE, Cochrane Database of Systematic Reviews, and several other sources from database inception to March 2017. Study Selection: Intervention trials and observational studies, published in English, involving adults using plant-based cannabis preparations that reported pain, quality of life, or adverse effect outcomes. Data Extraction: Two investigators independently abstracted study characteristics and assessed study quality, and the investigator group graded the overall strength of evidence using standard criteria. Data Synthesis: From 27 chronic pain trials, there is low-strength evidence that cannabis alleviates neuropathic pain but insufficient evidence in other pain populations. According to 11 systematic reviews and 32 primary studies, harms in general population studies include increased risk for motor vehicle accidents, psychotic symptoms, and short-term cognitive impairment. Although adverse pulmonary effects were not seen in younger populations, evidence on most other long-term physical harms, in heavy or long-term cannabis users, or in older populations is insufficient. Limitation: Few methodologically rigorous trials; the cannabis formulations studied may not reflect commercially available products; and limited applicability to older, chronically ill populations and patients who use cannabis heavily. Conclusion: Limited evidence suggests that cannabis may alleviate neuropathic pain in some patients, but insufficient evidence exists for other types of chronic pain. Among general populations, limited evidence suggests that cannabis is associated with an increased risk for adverse mental health effects.	[Nugent, Shannon M.; O'Neil, Maya E.] VA Portland Hlth Care Syst, Mail Code R&D66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Morasco, Benjamin J.] VA Portland Hlth Care Syst, Mail Code R&D99,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Freeman, Michele; Low, Allison; Kondo, Karli; Motu'apuaka, Makalapua; Paynter, Robin; Kansagara, Devan] VA Portland Hlth Care Syst, Mail Code R&D71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Elven, Camille] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Zakher, Bernadette] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Nugent, SM (corresponding author), VA Portland Hlth Care Syst, Mail Code R&D66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Shannon.Nugent@va.gov; kansagar@ohsu.edu	Kondo, Karli/R-3994-2019	Kondo, Karli/0000-0002-4635-5056; Paynter, Robin/0000-0002-6969-4261	U.S. Department of Veterans Affairs [PROSPERO: CRD42016033623]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs. (PROSPERO: CRD42016033623)	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Abrams DI, 2011, CLIN PHARMACOL THER, V90, P844, DOI 10.1038/clpt.2011.188; Adler JN, 2013, NEW ENGL J MED, V368, pE30, DOI 10.1056/NEJMclde1305159; Ashrafioun L, 2015, ADDICT BEHAV, V42, P185, DOI 10.1016/j.addbeh.2014.11.024; Atkins D, 2013, AHRQ PUBLICATION; Berkman ND, 2013, METHODS GUIDE EFFECT; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Bonn-Miller MO, 2014, AM J DRUG ALCOHOL AB, V40, P23, DOI 10.3109/00952990.2013.821477; Borges G, 2016, J AFFECT DISORDERS, V195, P63, DOI 10.1016/j.jad.2016.02.007; Butler M, MED CANNABIS NONCANC; Callaghan RC, 2013, CANCER CAUSE CONTROL, V24, P1811, DOI 10.1007/s10552-013-0259-0; Carabellese F, 2013, RIV PSICHIATR, V48, P43, DOI 10.1708/1228.13614; Cescon DW, 2008, J CLIN ONCOL, V26, P2214, DOI 10.1200/JCO.2007.15.2777; Chacko JA, 2006, UROLOGY, V67, P100, DOI 10.1016/j.urology.2005.07.005; CHUSID MJ, 1975, ANN INTERN MED, V82, P682, DOI 10.7326/0003-4819-82-5-682; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; de Carvalho MFF, 2015, ARCH ORAL BIOL, V60, P1750, DOI 10.1016/j.archoralbio.2015.09.009; de Vries M, 2016, CLIN GASTROENTEROL H, DOI [10.1016/j.cgh.2016.09, DOI 10.1016/J.CGH.2016.09]; Degenhardt L, 2015, DRUG ALCOHOL DEPEN, V147, P144, DOI 10.1016/j.drugalcdep.2014.11.031; DeGeorge M, 2017, P 2013 ANN M AM AC P; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Ellis RJ, 2009, NEUROPSYCHOPHARMACOL, V34, P672, DOI 10.1038/npp.2008.120; Englund A, 2013, J PSYCHOPHARMACOL, V27, P19, DOI 10.1177/0269881112460109; Fiz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018440; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Frost L, 2013, AM HEART J, V165, P170, DOI 10.1016/j.ahj.2012.11.007; Ganzer F, 2016, NEUROPSYCHOL REV, V26, P186, DOI 10.1007/s11065-016-9316-2; Gibbs M, 2015, J AFFECT DISORDERS, V171, P39, DOI 10.1016/j.jad.2014.09.016; Gurney J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1905-6; Hancox RJ, 2010, EUR RESPIR J, V35, P42, DOI 10.1183/09031936.00065009; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Hefner K, 2015, AM J ADDICTION, V24, P538, DOI 10.1111/ajad.12260; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ilgen MA, 2013, DRUG ALCOHOL DEPEN, V132, P654, DOI 10.1016/j.drugalcdep.2013.04.019; Institute of Medicine Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Kansagara D, CANNABIS MANAGEMENT; Kansagara D, 2016, BENEFITS HARMS CANNA; Kaufmann RM, 2010, PHARMACOPSYCHIATRY, V43, P24, DOI 10.1055/s-0029-1237397; Kuepper R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d738; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Lynch ME, 2014, J PAIN SYMPTOM MANAG, V47, P166, DOI 10.1016/j.jpainsymman.2013.02.018; Marks WH, 1996, TRANSPLANTATION, V61, P1771, DOI 10.1097/00007890-199606270-00018; Mason O, 2009, PSYCHOL MED, V39, P951, DOI 10.1017/S0033291708004741; Mittleman MA, 2001, CIRCULATION, V103, P2805; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Munckhof WJ, 2003, INT J TUBERC LUNG D, V7, P860; MYERSCOUGH R, 1985, J PERS SOC PSYCHOL, V49, P1541; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; National Conference of State Legislatures, 2017, MAR OV; Notcutt W, 2004, ANAESTHESIA, V59, P440, DOI 10.1111/j.1365-2044.2004.03674.x; NOYES R, 1975, CLIN PHARMACOL THER, V18, P84; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Pletcher MJ, 2012, JAMA-J AM MED ASSOC, V307, P173, DOI 10.1001/jama.2011.1961; Portenoy RK, 2012, J PAIN, V13, P438, DOI 10.1016/j.jpain.2012.01.003; Ramos S, 2013, PSYCHOTHER PSYCHOSOM, V82, P90; Reisfield GM, 2009, PAIN MED, V10, P1434, DOI 10.1111/j.1526-4637.2009.00726.x; Rossler W, 2012, ADDICTION, V107, P1174, DOI 10.1111/j.1360-0443.2011.03760.x; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Rogeberg O, 2016, ADDICTION, V111, P1348, DOI 10.1111/add.13347; Ryan-Ibarra S, 2015, DRUG ALCOHOL REV, V34, P141, DOI 10.1111/dar.12207; Sadiq M., 2013, J ADDICT MED S, V7, pE3, DOI [10.1097/ADM.0b013e3182a3b16f, DOI 10.1097/ADM.0B013E3182A3B16F]; Schreiner AM, 2012, EXP CLIN PSYCHOPHARM, V20, P420, DOI 10.1037/a0029117; Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029; Serpell M, 2014, EUR J PAIN, V18, P999, DOI 10.1002/j.1532-2149.2013.00445.x; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sorensen CJ, 2017, J MED TOXICOL, V13, P71, DOI 10.1007/s13181-016-0595-z; Soriano-Co M, 2010, DIGEST DIS SCI, V55, P3113, DOI 10.1007/s10620-010-1131-7; Storr M, 2014, INFLAMM BOWEL DIS, V20, P472, DOI 10.1097/01.MIB.0000440982.79036.d6; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; van Amerongen G, 2018, CLIN THER, V40, P1467, DOI 10.1016/j.clinthera.2017.01.016; van Nierop M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076690; Vandrey R, 2015, JAMA-J AM MED ASSOC, V313, P2491, DOI 10.1001/jama.2015.6613; Velasco A, 2012, J HOSP MED S2, V7; Viswanathan M, 2012, AHRQ PUBLICATION; Vujasinovic M, 2012, ZDR VESTN, V81, P159; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Wallace MS, 2015, J PAIN, V16, P616, DOI 10.1016/j.jpain.2015.03.008; Ware MA, 2010, CAN MED ASSOC J, V182, pE694, DOI 10.1503/cmaj.091414; Ware MA, 2015, J PAIN, V16, P1233, DOI 10.1016/j.jpain.2015.07.014; Welder JD, 2012, J GEN INTERN MED, V27, pS480; Wells G., NEWCASTLE OTTAWA SCA; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wilsey B, 2008, J PAIN, V9, P506, DOI 10.1016/j.jpain.2007.12.010; Wilsey B, 2016, J PAIN, V17, P982, DOI 10.1016/j.jpain.2016.05.010; Wilsey B, 2013, J PAIN, V14, P136, DOI 10.1016/j.jpain.2012.10.009; Woods JA, 2016, AM J THER, V23, pE601, DOI 10.1097/MJT.0000000000000034; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zhang LR, 2015, INT J CANCER, V136, P894, DOI 10.1002/ijc.29036	99	179	180	3	76	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					319	+		10.7326/M17-0155	http://dx.doi.org/10.7326/M17-0155			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF6LC	28806817				2022-12-28	WOS:000409120400006
J	Ehara, H; Yokoyama, T; Shigematsu, H; Yokoyama, S; Shirouzu, M; Sekine, S				Ehara, Haruhiko; Yokoyama, Takeshi; Shigematsu, Hideki; Yokoyama, Shigeyuki; Shirouzu, Mikako; Sekine, Shun-ichi			Structure of the complete elongation complex of RNA polymerase II with basal factors	SCIENCE			English	Article							SENSITIVITY-INDUCING FACTOR; TRANSCRIPTION ELONGATION; FACTOR SPT5; DOMAINS; CLAMP; DSIF; PHOSPHORYLATION; IDENTIFICATION; PROCESSIVITY; INITIATION	In the early stage of transcription, eukaryotic RNA polymerase II (Pol II) exchanges initiation factors with elongation factors to form an elongation complex for processive transcription. Here we report the structure of the Pol II elongation complex bound with the basal elongation factors Spt4/5, Elf1, and TFIIS. Spt4/5 (the Spt4/Spt5 complex) and Elf1 modify a wide area of the Pol II surface. Elf1 bridges the Pol II central cleft, completing a "DNA entry tunnel" for downstream DNA. Spt4 and the Spt5 NGN and KOW1 domains encircle the upstream DNA, constituting a "DNA exit tunnel." The Spt5 KOW4 and KOW5 domains augment the "RNA exit tunnel," directing the exiting nascent RNA. Thus, the elongation complex establishes a completely different transcription and regulation platform from that of the initiation complexes.	[Ehara, Haruhiko; Yokoyama, Takeshi; Shigematsu, Hideki; Shirouzu, Mikako; Sekine, Shun-ichi] RIKEN, Ctr Life Sci Technol, Tsuzuki Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsuzuki Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN; RIKEN	Sekine, S (corresponding author), RIKEN, Ctr Life Sci Technol, Tsuzuki Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	shunichi.sekine@riken.jp	Sekine, Shun-ichi/N-5450-2015; Shirouzu, Mikako/A-6521-2016; Shigematsu, Hideki/E-1052-2017; Yokoyama, Shigeyuki/N-6911-2015; Ehara, Haruhiko/C-3643-2017	Sekine, Shun-ichi/0000-0001-8174-8704; Shigematsu, Hideki/0000-0003-3951-8651; Yokoyama, Shigeyuki/0000-0003-3133-7338; Ehara, Haruhiko/0000-0002-7420-145X	Photon Factory Program Advisory Committee [2015G520]; Japan Society for the Promotion of Science KAKENHI grant [JP15H04344, JP15H01656]; Platform Project for Supporting Drug Discovery and Life Science Research - Japan Agency for Medical Research and Development; RIKEN Pioneering Project, Dynamic Structural Biology	Photon Factory Program Advisory Committee(High Energy Accelerator Research Organization (KEK)); Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research - Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); RIKEN Pioneering Project, Dynamic Structural Biology	We thank Y. Tomabechi, T. Uchikubo-Kamo, and T. Osanai for technical assistance. The synchrotron radiation experiments were performed at BL41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (proposal nos. 2014B1265, 2015B2040, 2016A2526, and 2016B2526) and at NE3A of the Photon Factory with the approval of the Photon Factory Program Advisory Committee (proposal no. 2015G520). We thank H. Okumura and K. Hasegawa for assistance with data collection at SPring-8. This work was supported in part by the Japan Society for the Promotion of Science KAKENHI grant numbers JP15H04344 (to S.S.) and JP15H01656 (to H.S.), the Platform Project for Supporting Drug Discovery and Life Science Research funded by the Japan Agency for Medical Research and Development, and the RIKEN Pioneering Project, Dynamic Structural Biology. The atomic coordinates and structure factors for the EC bound with Elf1 and Spt5 KOW5 have been deposited in the Protein Data Bank (PDB ID 5XOG). The cryo-EM density map and the atomic coordinates for the EC bound with Spt4/5 and TFIIS were deposited in the Electron Microscopy (EM) Data Bank (accession code EMD-6747) and the Protein Data Bank (PDB ID 5XON), respectively.	Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Crickard JB, 2016, J BIOL CHEM, V291, P9853, DOI 10.1074/jbc.M116.716001; Daniels JP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-24; Ehara H, 2017, BIOCHEM BIOPH RES CO, V487, P230, DOI 10.1016/j.bbrc.2017.04.039; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meyer PA, 2015, MOL CELL BIOL, V35, P3354, DOI 10.1128/MCB.00520-15; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Qiu YJ, 2017, J BIOL CHEM, V292, P5555, DOI 10.1074/jbc.M116.760751; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; Sekine S, 2015, MOL CELL, V57, P408, DOI 10.1016/j.molcel.2014.12.014; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	30	99	99	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					921	924		10.1126/science.aan8552	http://dx.doi.org/10.1126/science.aan8552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28775211				2022-12-28	WOS:000408734900043
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			Public Opinion about the Future of the Affordable Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELECTION; VOTERS		[Blendon, Robert J.; Benson, John M.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] John F Kennedy Sch Govt, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,4th Fl, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu						Abramowitz A. I., 2014, STATE PARTIES CHANGI, P21; [Anonymous], 2017, ABC NEWS POLL   0417; [Anonymous], 2013, MAJ US SAY HEALTHC N; [Anonymous], 2017, NBC NEWS        0617; [Anonymous], 2017, CNN ORC POLL; [Anonymous], 2017, CNN ORC POLL    0301; [Anonymous], 2015, US 51 SAY GOV SHOULD; [Anonymous], 2017, FOX NEWS POLL   0719; [Anonymous], 2017, CBS NEWS POLL   0615; [Anonymous], 2017, PBS NEWSHOUR MA 0621; [Anonymous], 2017, FOX NEWS POLL   0628; Blendon RJ, 2016, NEW ENGL J MED, V375, DOI 10.1056/NEJMsr1606159; Blendon RJ, 2014, NEW ENGL J MED, V371, DOI 10.1056/NEJMsr1412118; Campbell J., 2016, POLARIZED MAKING SEN; Gallup- Institute for International Social Research Poll, 1964, IPOLL DAT; Kaiser Family Foundation, 2016, KAISER HLTH TRACKING; Kaiser Family Foundation, 2017, KAISER HLTH TRACKING; Monmouth University Polling Institute Poll, 2017, NOT MUCH SWAMP DRAIN; Monmouth University Polling Institute Poll, 2017, COST DRIV OP HLTH CA; Pew Research Center, 2014, 2014 POL POL TYP SUR; Pew Research Center, 2017, SHAR SAYING GOV RESP; Pew Research Center, 2016, MARCH 2016 POL SURV; Politico-Harvard T. H., 2017, CHAN SCH PUBL HLTH P; Politico-Harvard T. H., 2016, CHAN SCH PUBL HLRH P; Quinnipiac University Poll, 2017, MERK CHALL TRUMP LEA; Quinnipiac University Poll, 2017, 21 US VOT APPR REV H; Quinnipiac University Poll, 2017, TRUMP DROPS NEW LOW; Quinnipiac University Poll, 2017, US VOT REJ GOP HLTH	28	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9								10.1056/NEJMsr1710032	http://dx.doi.org/10.1056/NEJMsr1710032			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28813210	Bronze			2022-12-28	WOS:000408626400015
J	Wenthur, CJ; Zhou, B; Janda, KD				Wenthur, Cody J.; Zhou, Bin; Janda, Kim D.			Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity	NATURE			English	Article							METABOLIC-FATE; DESIGNER DRUGS; METHAMPHETAMINE; AMPHETAMINE; FENETYLLINE; ABUSE; DERIVATIVES; RAT	Fenethylline, also known by the trade name Captagon, is a synthetic psychoactive stimulant that has recently been linked to a substanceuse disorder and 'pharmacoterrorism' in the Middle East(1-4). Although fenethylline shares a common phenethylamine core with other amphetamine-type stimulants, it also incorporates a covalently linked xanthine moiety into its parent structure(5,6). These independently active pharmacophores are liberated during metabolism, resulting in the release of a structurally diverse chemical mixture into the central nervous system(7-9). Although the psychoactive properties of fenethylline have been reported to differ from those of other synthetic stimulants, the in vivo chemical complexity it manifests upon ingestion has impeded efforts to unambiguously identify the specific species responsible for these effects(10,11). Here we develop a 'dissection through vaccination' approach, called DISSECTIV, to mitigate the psychoactive effects of fenethylline and show that its rapid-onset and distinct psychoactive properties are facilitated by functional synergy between theophylline and amphetamine. Our results demonstrate that incremental vaccination against a single chemical species within a multi-component mixture can be used to uncover emergent properties arising from polypharmacological activity. We anticipate that DISSECTIV will be used to expose unidentified active chemical species and resolve pharmacodynamic interactions within other chemically complex systems, such as those found in counterfeit or illegal drug preparations, post-metabolic tissue samples and natural product extracts.	[Wenthur, Cody J.; Zhou, Bin; Janda, Kim D.] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wenthur, Cody J.; Zhou, Bin; Janda, Kim D.] Scripps Res Inst, Dept Immunol, WIRM Inst Res & Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Janda, KD (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.; Janda, KD (corresponding author), Scripps Res Inst, Dept Immunol, WIRM Inst Res & Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kdjanda@scripps.edu	Wenthur, Cody J/J-5502-2019	Wenthur, Cody J/0000-0001-6043-3842	NIH [DA024705-06]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the NIH (DA024705-06). We thank M. Gooyit for supplying reagents, B. Ellis for assistance with tissue collection and M. Taffe for providing DEA licensing (RT0485537). This is manuscript 29481 from The Scripps Research Institute.	Al-Hemiary NJ, 2014, SUBST USE MISUSE, V49, P1759, DOI 10.3109/10826084.2014.913633; AL-Imam A, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2548; Alabdalla MA, 2005, FORENSIC SCI INT, V152, P185, DOI 10.1016/j.forsciint.2004.08.004; Biata G, 2007, PHARMACOL REP, V59, P636; Christophersen AS, 2000, TOXICOL LETT, V112, P127, DOI 10.1016/S0378-4274(99)00205-2; DIMPFEL W, 1986, NEUROPSYCHOBIOLOGY, V15, P101, DOI 10.1159/000118250; ELLISON T, 1970, EUR J PHARMACOL, V13, P123, DOI 10.1016/0014-2999(70)90192-5; Fond G, 2016, PSYCHOPHARMACOLOGY, V233, P933, DOI 10.1007/s00213-016-4204-2; Franco R, 2000, NEUROPSYCHOPHARMACOL, V23, pS50, DOI 10.1016/S0893-133X(00)00144-5; Gooyit M, 2017, ACS CHEM NEUROSCI, V8, P468, DOI 10.1021/acschemneuro.6b00389; Haile CN, 2015, AM J ADDICTION, V24, P748, DOI 10.1111/ajad.12307; Heller AR, 2015, ANAESTHESIST, V64, P190, DOI 10.1007/s00101-015-0005-y; Justinova Z, 2003, J PHARMACOL EXP THER, V307, P977, DOI 10.1124/jpet.103.056762; Katselou M, 2016, BASIC CLIN PHARMACOL, V119, P133, DOI 10.1111/bcpt.12584; KEUP W, 1986, DRUG ALCOHOL DEPEN, V17, P169, DOI 10.1016/0376-8716(86)90007-4; Kimishima A, 2017, ACS CHEM BIOL, V12, P36, DOI 10.1021/acschembio.6b00977; Kinsey Berma, 2014, Ther Adv Vaccines, V2, P106, DOI 10.1177/2051013614537818; Klingler K. H., 1966, US patent, Patent No. 3245994; Kraemer T, 2002, THER DRUG MONIT, V24, P277, DOI 10.1097/00007691-200204000-00009; KRISTEN G, 1986, DRUG ALCOHOL DEPEN, V17, P259, DOI 10.1016/0376-8716(86)90012-8; Nelson ME, 2014, EMERG MED CLIN N AM, V32, P1, DOI 10.1016/j.emc.2013.09.001; NICKEL B, 1986, DRUG ALCOHOL DEPEN, V17, P235, DOI 10.1016/0376-8716(86)90011-6; Rasmussen N, 2011, J INTERDISCIPL HIST, V42, P205, DOI 10.1162/JINH_a_00212; Richards HJ, 2014, CLIN PSYCHOL REV, V34, P1, DOI 10.1016/j.cpr.2013.10.006; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Shufman E, 1999, ISRAEL J PSYCHIAT, V36, P129; U. N. I. D. C. Programme, 1997, TRENDS ORGAN CRIME, V3, P11; Van Hout MC, 2016, ADDICTION, V111, P748, DOI 10.1111/add.13262; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; YOSHIMURA H, 1988, XENOBIOTICA, V18, P929, DOI 10.3109/00498258809167516	30	4	4	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					476	+		10.1038/nature23464	http://dx.doi.org/10.1038/nature23464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28813419	Green Accepted			2022-12-28	WOS:000408279000043
J	Sun, XN; Velez, S; Atxabal, A; Bedoya-Pinto, A; Parui, S; Zhu, XW; Llopis, R; Casanova, F; Hueso, LE				Sun, Xiangnan; Velez, Saul; Atxabal, Ainhoa; Bedoya-Pinto, Amilcar; Parui, Subir; Zhu, Xiangwei; Llopis, Roger; Casanova, Felix; Hueso, Luis E.			A molecular spin-photovoltaic device	SCIENCE			English	Article							OPEN-CIRCUIT VOLTAGE; HETEROJUNCTION SOLAR-CELLS; GIANT MAGNETORESISTANCE; ORGANIC SEMICONDUCTORS; VALVES; SPINTRONICS; TRANSPORT; ORIGIN; LIGHT; C60	We fabricated a C-60 fullerene-based molecular spin-photovoltaic device that integrates a photovoltaic response with the spin transport across the molecular layer. The photovoltaic response can be modified under the application of a small magnetic field, with a magnetophotovoltage of up to 5% at room temperature. Device functionalities include a magnetic current inverter and the presence of diverging magnetocurrent at certain illumination levels that could be useful for sensing. Completely spin-polarized currents can be created by balancing the external partially spin-polarized injection with the photogenerated carriers.	[Sun, Xiangnan; Zhu, Xiangwei] Chinese Acad Sci, Ctr Excellence Nanosci, Natl Ctr Nanosci & Technol, Key Lab Nanosyst & Hierarch Fabricat, Beijing 100190, Peoples R China; [Sun, Xiangnan; Zhu, Xiangwei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Velez, Saul; Atxabal, Ainhoa; Parui, Subir; Llopis, Roger; Casanova, Felix; Hueso, Luis E.] CIC nanoGUNE Nanosci Cooperat Res Ctr, Donostia San Sebastian 20018, Spain; [Bedoya-Pinto, Amilcar] Max Planck Inst Microstruct Phys, Halle An Der Saale, Sachsen Anhalt, Germany; [Casanova, Felix; Hueso, Luis E.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Max Planck Society; Basque Foundation for Science	Hueso, LE (corresponding author), CIC nanoGUNE Nanosci Cooperat Res Ctr, Donostia San Sebastian 20018, Spain.; Hueso, LE (corresponding author), Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain.	l.hueso@nanogune.eu	Bedoya-Pinto, Amilcar/GVS-2231-2022; sun, xiangnan/I-4713-2015; Bedoya-Pinto, Amilcar/AAK-7312-2020; Bedoya-Pinto, Amilcar/P-3245-2014; PARUI, SUBIR/K-1987-2014; Atxabal Arrasate, Ainhoa/Q-4793-2018; Llorens, Roger Llopis/S-1403-2019; Casanova, Felix/B-4639-2013; Hueso, Luis E/C-8713-2009; Velez, Saul/I-4826-2015	Bedoya-Pinto, Amilcar/0000-0001-5449-3179; sun, xiangnan/0000-0002-5461-9699; Bedoya-Pinto, Amilcar/0000-0001-5449-3179; PARUI, SUBIR/0000-0002-9722-2552; Atxabal Arrasate, Ainhoa/0000-0003-2661-6252; Llorens, Roger Llopis/0000-0002-5172-2690; Casanova, Felix/0000-0003-0316-2163; Hueso, Luis E/0000-0002-7918-8047; Velez, Saul/0000-0002-0019-2271	Ministry of Science and Technology of China [2016YFA0200700, 2017YFA0206600]; European Union [256470-ITAMOSCINOM]; European Research Council [257654-SPINTROS]; NMP project [263104-HINTS]; Spanish Ministry of Economy [MAT2015-65159-R]; Basque Government [PRE_2016_2_0025]; National Natural Science Foundation of China [21673059]; CAS Pioneer Hundred Talents Program	Ministry of Science and Technology of China(Ministry of Science and Technology, China); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); NMP project; Spanish Ministry of Economy(Spanish Government); Basque Government(Basque Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Pioneer Hundred Talents Program	The authors acknowledge financial support from the Ministry of Science and Technology of China (grants 2016YFA0200700 and 2017YFA0206600); the European Union 7th Framework Programme under the Marie Curie Actions (256470-ITAMOSCINOM), the European Research Council (257654-SPINTROS), and the NMP project (263104-HINTS); the Spanish Ministry of Economy (project no. MAT2015-65159-R); the Basque Government (project no. PRE_2016_2_0025); the National Natural Science Foundation of China (grant 21673059); and the CAS Pioneer Hundred Talents Program. All data are reported in the main paper and supplementary materials.	Al Ma'Mari F, 2015, NATURE, V524, P69, DOI 10.1038/nature14621; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Barraud C, 2010, NAT PHYS, V6, P615, DOI 10.1038/NPHYS1688; Bobbert PA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156604; Bottegoni F, 2014, NAT MATER, V13, P790, DOI [10.1038/nmat4015, 10.1038/NMAT4015]; Cinchetti M, 2017, NAT MATER, V16, P507, DOI [10.1038/NMAT4902, 10.1038/nmat4902]; Dediu VA, 2009, NAT MATER, V8, P707, DOI [10.1038/NMAT2510, 10.1038/nmat2510]; Devir-Wolfman AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5529; Endres B, 2013, NAT COMMUN, V4, P1, DOI 10.1038/ncomms3068; Gobbi M, 2011, ADV MATER, V23, P1609, DOI 10.1002/adma.201004672; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Jang HJ, 2017, ADV MATER, V29, DOI 10.1002/adma.201602739; Jansen R, 2013, NAT MATER, V12, P779, DOI 10.1038/nmat3745; Moodera JS, 2014, MRS BULL, V39, P578, DOI 10.1557/mrs.2014.128; Nguyen TD, 2012, SCIENCE, V337, P204, DOI 10.1126/science.1223444; O'Malley KM, 2012, ADV ENERGY MATER, V2, P82, DOI 10.1002/aenm.201100522; Pandey R, 2012, ADV FUNCT MATER, V22, P617, DOI 10.1002/adfm.201101948; Ramsdale CM, 2002, J APPL PHYS, V92, P4266, DOI 10.1063/1.1506385; Rao A, 2013, NATURE, V500, P435, DOI 10.1038/nature12339; Sanvito S, 2011, CHEM SOC REV, V40, P3336, DOI 10.1039/c1cs15047b; Sun XN, 2016, ADV MATER, V28, P2609, DOI 10.1002/adma.201503831; Sun XN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3794; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Tran TLA, 2012, ADV FUNCT MATER, V22, P1180, DOI 10.1002/adfm.201102584; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; Xin H, 2012, CHEM MATER, V24, P1995, DOI 10.1021/cm300355e; Xiong ZH, 2004, NATURE, V427, P821, DOI 10.1038/nature02325; Yu ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5842; Zhang C, 2015, NAT PHYS, V11, P428, DOI [10.1038/NPHYS3277, 10.1038/nphys3277]; Zhang XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2929; Zhang YB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1654	31	104	107	17	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					677	+		10.1126/science.aan5348	http://dx.doi.org/10.1126/science.aan5348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818941				2022-12-28	WOS:000407793600032
J	Voosen, P				Voosen, Paul			CLIMATE SCIENCE 2.7-million-year-old ice opens window on past	SCIENCE			English	News Item																			0	6	6	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					630	631		10.1126/science.357.6352.630	http://dx.doi.org/10.1126/science.357.6352.630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818920				2022-12-28	WOS:000407793600008
J	Taniguchi, R; Inoue, A; Sayama, M; Uwamizu, A; Yamashita, K; Hirata, K; Yoshida, M; Tanaka, Y; Kato, HE; Nakada-Nakura, Y; Otani, Y; Nishizawa, T; Doi, T; Ohwada, T; Ishitani, R; Aoki, J; Nureki, O				Taniguchi, Reiya; Inoue, Asuka; Sayama, Misa; Uwamizu, Akiharu; Yamashita, Keitaro; Hirata, Kunio; Yoshida, Masahito; Tanaka, Yoshiki; Kato, Hideaki E.; Nakada-Nakura, Yoshiko; Otani, Yuko; Nishizawa, Tomohiro; Doi, Takayuki; Ohwada, Tomohiko; Ishitani, Ryuichiro; Aoki, Junken; Nureki, Osamu			Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA(6)	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; RESOLUTION CRYSTAL-STRUCTURE; ACCURATE DOCKING; ACTIVATION; ASSAY; IDENTIFICATION; SYSTEM; FAMILY; GLIDE; P2Y5	Lysophosphatidic acid (LPA) is a bioactive lipid composed of a phosphate group, a glycerol backbone, and a single acyl chain that varies in length and saturation. LPA activates six class A G-proteincoupled receptors to provoke various cellular reactions(1). Because LPA signalling has been implicated in cancer(2) and fibrosis(3), the LPA receptors are regarded as promising drug targets. The six LPA receptors are subdivided into the endothelial differentiation gene (EDG) family (LPA(1)-LPA(3))(1) and the phylogenetically distant nonEDG family (LPA(4)-LPA(6))(4). The structure of LPA(1) has enhanced our understanding of the EDG family of LPA receptors(5). By contrast, the functional and pharmacological characteristics of the non-EDG family of LPA receptors have remained unknown, owing to the lack of structural information. Although the non-EDG LPA receptors share sequence similarity with the P2Y family of nucleotide receptors(4), the LPA recognition mechanism cannot be deduced from the P2Y(1) and P2Y(12) structures(6-8) because of the large differences in the chemical structures of their ligands. Here we determine the 3.2 angstrom crystal structure of LPA(6), the gene deletion of which is responsible for congenital hair loss(9,10), to clarify the ligand recognition mechanism of the non-EDG family of LPA receptors. Notably, the ligand-binding pocket of LPA(6) is laterally open towards the membrane, and the acyl chain of the lipid used for the crystallization is bound within this pocket, indicating the binding mode of the LPA acyl chain. Docking and mutagenesis analyses also indicated that the conserved positively charged residues within the central cavity recognize the phosphate head group of LPA by inducing an inward shift of transmembrane helices 6 and 7, suggesting that the receptor activation is triggered by this conformational rearrangement.	[Taniguchi, Reiya; Kato, Hideaki E.; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Taniguchi, Reiya; Kato, Hideaki E.; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Inoue, Asuka; Uwamizu, Akiharu; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka; Hirata, Kunio; Nishizawa, Tomohiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sayama, Misa; Otani, Yuko; Ohwada, Tomohiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Organ & Med Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Yamashita, Keitaro; Hirata, Kunio] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Yoshida, Masahito; Doi, Takayuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Heterocycl Chem, Sendai, Miyagi 9808578, Japan; [Tanaka, Yoshiki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Syst Biol, Ikoma, Nara 6300192, Japan; [Nakada-Nakura, Yoshiko] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Kato, Hideaki E.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Tokyo; RIKEN; Tohoku University; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN; Tohoku University; Nara Institute of Science & Technology; Kyoto University; Stanford University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan.; Nureki, O (corresponding author), RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan.; Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 9808578, Japan.; Aoki, J (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan.	jaoki@m.tohoku.ac.jp; nureki@bs.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Doi, Takayuki/U-1009-2019; Kato, Hideaki/AAQ-4323-2020; Yoshida, Masahito/K-6636-2019	Kato, Hideaki/0000-0002-1941-5535; Yoshida, Masahito/0000-0002-0252-7637; Yamashita, Keitaro/0000-0002-5442-7582; Hirata, Kunio/0000-0002-1491-6509; Tanaka, Yoshiki/0000-0001-6960-5276	AMED-CREST; Platform for Drug Discovery, Informatics and Structural Life Science from AMED; MEXT [16H06294, 15H05897]; JSPS KAKENHI [16J07583, 15H06862, 17H05000, 16H06574]; JST, PRESTO [JPMJPR1331, JPMJPR14L9, JPMJPR14L8]; PRIME from AMED; AMED; Grants-in-Aid for Scientific Research [17H03640] Funding Source: KAKEN	AMED-CREST; Platform for Drug Discovery, Informatics and Structural Life Science from AMED; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST, PRESTO(Japan Science & Technology Agency (JST)); PRIME from AMED; AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Nishimasu for critical comments on the manuscript; T. Nakane for assistance in the diffraction data analyses; K. Ohgomori for technical assistance; A. Inoue for flow cytometry analyses; F. M. N. Kadji for the TGF alpha shedding assay; Y. Nakamura for the LPA mass spectrometry analysis; and the beamline staff at BL32XU of SPring-8 (Hyogo, Japan) for assistance with data collection. The diffraction experiments were performed at SPring-8 BL32XU (proposals 2015A1024, 2015A1057, 2015B2024, 2015B2057 and 2016A2527), with the approval of RIKEN. This work was supported by grants from the AMED-CREST, by the Platform for Drug Discovery, Informatics and Structural Life Science from AMED, and by a MEXT Grant-in-Aid for Specially Promoted Research (grant 16H06294) to O.N. This work was also supported by JSPS KAKENHI (grant 16J07583 to R.T.; 15H06862 to K. Y.; 17H05000 to T. N.; 16H06574 to R.I.). A. I. was funded by JST, PRESTO (grant JPMJPR1331), and the PRIME from AMED. H. K. and T. N. were funded by JST, PRESTO (grants JPMJPR14L9 and JPMJPR14L8, respectively). J.A. received funding from the AMED-CREST, AMED, and a MEXT Grant-in-Aid for Scientific Research on Innovative Areas (grant 15H05897).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; Devost D, 2017, J BIOL CHEM, V292, P5443, DOI 10.1074/jbc.M116.763854; Dranoff JA, 2000, J BIOL CHEM, V275, P30701, DOI 10.1074/jbc.M003366200; Ehlert FJ, 1999, J PHARMACOL EXP THER, V289, P981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hayashi R, 2015, J DERMATOL SCI, V78, P197, DOI 10.1016/j.jdermsci.2015.03.006; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Igarashi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11410; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jiang GW, 2013, BIOORG MED CHEM LETT, V23, P1865, DOI 10.1016/j.bmcl.2013.01.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Ketscher A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.34; Khandoga AL, 2011, CARDIOVASC RES, V90, P157, DOI 10.1093/cvr/cvq369; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lee M, 2009, AM J PHYSIOL-GASTR L, V297, pG641, DOI 10.1152/ajpgi.00191.2009; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shihoya W, 2016, NATURE, V537, P363, DOI 10.1038/nature19319; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Ueno G, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952941; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	50	68	73	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					356	+		10.1038/nature23448	http://dx.doi.org/10.1038/nature23448			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792932				2022-12-28	WOS:000407748400038
J	Carter, SM				Carter, Stacy M.			ESSAY Overdiagnosis, ethics, and trolley problems: why factors other than outcomes matter-an essay by Stacy Carter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carter, Stacy M.] Univ Sydney, Sydney Hlth Eth, K25 Med Fdn Bldg, Sydney, NSW 2006, Australia	University of Sydney	Carter, SM (corresponding author), Univ Sydney, Sydney Hlth Eth, K25 Med Fdn Bldg, Sydney, NSW 2006, Australia.	stacy.carter@sydney.edu.au	Carter, Stacy/A-6544-2011	Carter, Stacy/0000-0003-2617-8694	National Health and Medical Research Council of Australia [1104136]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia (grant 1104136).	Armstrong BK, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp2731721; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Brand C, 2015, P 37 ANN M COGN SCI, P268; Bruers S, 2014, PHILOSOPHIA, V42, P251, DOI 10.1007/s11406-013-9507-5; Carter SM, 2016, J MED ETHICS, V42, P705, DOI 10.1136/medethics-2015-102928; Carter SM, 2015, AM J PREV MED, V49, P274, DOI 10.1016/j.amepre.2015.01.009; Driver J., 2014, STANFORD ENCY PHILOS; Fried BH, 2012, PHILOS QUART, V62, P505, DOI 10.1111/j.1467-9213.2012.00061.x; Fried Barbara H., 2012, J ETHICS, V16, P39, DOI DOI 10.1007/S10892-011-9113-3; GODLEE F., 2013, BRIT MED J, V346, pf477, DOI DOI 10.1136/BMJ.F477; Grady D., 2016, NY TIMES; GREENHALGH T, 2015, BMC MED, V13; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Johansson M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h825; Kamm F, 2016, TROLLEY PROBLEM MYST, DOI DOI 10.1093/ACPROF:OSO/9780190247157.001.0001; Kelman M, 2014, J EMPIR LEGAL STUD, V11, P197, DOI 10.1111/jels.12039; McCaffery KJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i348; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Rakowski E., 2016, TROLLEY PROBLEM MYST; Rasmussen Kristine, 2013, Evid Based Med, V18, P83, DOI 10.1136/eb-2012-101216; Shiffrin SV, 2012, LEG THEOR, V18, P357, DOI 10.1017/S1352325212000080; Sohn E, 2015, NATURE, V527, pS118, DOI 10.1038/527S118a; STRATTONLAKE P, 2016, STANFORD ENCY PHILOS; Thomas R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6172; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Thomson JJ, 2008, PHILOS PUBLIC AFF, V36, P359, DOI 10.1111/j.1088-4963.2008.00144.x	28	12	12	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3872	10.1136/bmj.j3872	http://dx.doi.org/10.1136/bmj.j3872			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE5BZ	28814560				2022-12-28	WOS:000408228300010
J	Nieto, P; Ambrogio, C; Esteban-Burgos, L; Gomez-Lopez, G; Blasco, MT; Yao, Z; Marais, R; Rosen, N; Chiarle, R; Pisano, DG; Barbacid, M; Santamaria, D				Nieto, Patricia; Ambrogio, Chiara; Esteban-Burgos, Laura; Gomez-Lopez, Gonzalo; Teresa Blasco, Maria; Yao, Zhan; Marais, Richard; Rosen, Neal; Chiarle, Roberto; Pisano, David G.; Barbacid, Mariano; Santamaria, David			A Braf kinase-inactive mutant induces lung adenocarcinoma	NATURE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; K-RAS ONCOGENE; MOUSE MODEL; C-RAF; B-RAF; CANCER; CELLS; PROTEIN; PROGRESSION; INHIBITORS	The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours harbour a number of alterations without obvious oncogenic function including BRAF-inactivating mutations. Inactivating BRAF mutants in lung predominate over the activating V600E mutant that is frequently observed in other tumour types(1). Here we demonstrate that the expression of an endogenous Braf(D631A) kinase-inactive isoform in mice (corresponding to the human BRAF(D594A) mutation) triggers lung adenocarcinoma in vivo, indicating that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf(D631A) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity(2,3), and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report a key role for the wild-type Braf kinase in sustaining Kras(G12V)/Braf(D631A)-driven tumours. Ablation of the wild-type Braf allele prevents the development of lung adenocarcinoma by inducing a further increase in MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also induces transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not only in tumour development, but also in dictating the nature of the cancer-initiating cell and ultimately the resulting tumour phenotype.	[Nieto, Patricia; Ambrogio, Chiara; Esteban-Burgos, Laura; Teresa Blasco, Maria; Barbacid, Mariano; Santamaria, David] CNIO, Expt Oncol Mol Oncol Programme, Madrid 28029, Spain; [Gomez-Lopez, Gonzalo] CNIO, Bioinformat Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Yao, Zhan; Rosen, Neal; Pisano, David G.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA; [Marais, Richard] Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester M20 4BX, Lancs, England; [Chiarle, Roberto] Harvard Med Sch, Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Ambrogio, Chiara] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Santamaria, David] Univ Bordeaux, INSERM, U1218, ACT Lab,IECB, F-33600 Pessac, France	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Memorial Sloan Kettering Cancer Center; Cancer Research UK; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Barbacid, M (corresponding author), CNIO, Expt Oncol Mol Oncol Programme, Madrid 28029, Spain.	mbarbacid@cnio.es; d.santamaria@iecb.u-bordeaux.fr	Rosen, Neal/ABF-2677-2020; Gomez-Lopez, Gonzalo/D-9123-2016; Yao, Zhan/AAK-6756-2020; Santamaria, David/D-3930-2011	Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Santamaria, David/0000-0002-4711-3569; YAO, ZHAN/0000-0001-5391-5691; Esteban-Burgos, Laura/0000-0002-4881-9803; Blasco, Teresa/0000-0001-9531-2522	European Research Council [ERC-AG/250297-RAS AHEAD]; EU [HEALTH-F2-2010-259770/LUNGTARGET, HEALTH-2010-260791/EUROCANPLATFORM]; Spanish Ministry of Economy and Competitiveness [SAF2011-30173, SAF2014-59864-R]; AXA Research Fund; National Institutes of Health [P01 CA129243, R35 CA210085]; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]; NIH MSKCC Cancer Center Support Grant [P30 CA008748]; FP7 ERC-StG [242965-Lunely]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-12023]; FPU fellowship from Spanish Ministry of Education; Spanish Association Against Cancer (AECC); Cancer Research UK [22902] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, R35CA210085, P01CA129243] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); AXA Research Fund(AXA Research Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant; NIH MSKCC Cancer Center Support Grant; FP7 ERC-StG; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); FPU fellowship from Spanish Ministry of Education(German Research Foundation (DFG)); Spanish Association Against Cancer (AECC); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. de Martino for histopathological evaluation of murine lung tumours. This work was supported by grants to M.B. from the European Research Council (ERC-AG/250297-RAS AHEAD), EU-Framework Programme (HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010-260791/EUROCANPLATFORM) and Spanish Ministry of Economy and Competitiveness (SAF2011-30173 and SAF2014-59864-R). M.B. is the recipient of an Endowed Chair from the AXA Research Fund. Funding was also provided by grants to N.R. from the National Institutes of Health (P01 CA129243; R35 CA210085); the Commonwealth Foundation for Cancer Research, the Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center and the Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT17-15). Support was also received from the NIH MSKCC Cancer Center Support Grant P30 CA008748. Work in the laboratory of R.C. was supported by grants FP7 ERC-2009-StG (242965-Lunely) and Associazione Italiana per la Ricerca sul Cancro (AIRC) grant IG-12023. P.N. was the recipient of an FPU fellowship from the Spanish Ministry of Education. C.A. was the recipient of a postdoctoral fellowship from the Spanish Association Against Cancer (AECC).	Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Carter J, 2015, AM J CLIN PATHOL, V144, P620, DOI 10.1309/AJCP85ATMJOZOUDJ; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Cheung WKC, 2015, ONCOGENE, V34, P5771, DOI 10.1038/onc.2015.85; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dietlein F, 2015, CELL, V162, P146, DOI 10.1016/j.cell.2015.05.053; Doma E, 2013, CANCER RES, V73, P6926, DOI 10.1158/0008-5472.CAN-13-0748; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kamata T, 2010, CANCER RES, V70, P8475, DOI 10.1158/0008-5472.CAN-10-0603; Kammouni W, 2002, CELL GROWTH DIFFER, V13, P441; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yao Z., 2017, NATURE	31	60	63	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					239	+		10.1038/nature23297	http://dx.doi.org/10.1038/nature23297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783725	Green Accepted			2022-12-28	WOS:000407284300049
J	Cuthill, IC; Allen, WL; Arbuckle, K; Caspers, B; Chaplin, G; Hauber, ME; Hill, GE; Jablonski, NG; Jiggins, CD; Kelber, A; Mappes, J; Marshall, J; Merrill, R; Osorio, D; Prum, R; Roberts, NW; Roulin, A; Rowland, HM; Sherratt, TN; Skelhorn, J; Speed, MP; Stevens, M; Stoddard, MC; Stuart-Fox, D; Talas, L; Tibbetts, E; Caro, T				Cuthill, Innes C.; Allen, William L.; Arbuckle, Kevin; Caspers, Barbara; Chaplin, George; Hauber, Mark E.; Hill, Geoffrey E.; Jablonski, Nina G.; Jiggins, Chris D.; Kelber, Almut; Mappes, Johanna; Marshall, Justin; Merrill, Richard; Osorio, Daniel; Prum, Richard; Roberts, Nicholas W.; Roulin, Alexandre; Rowland, Hannah M.; Sherratt, Thomas N.; Skelhorn, John; Speed, Michael P.; Stevens, Martin; Stoddard, Mary Caswell; Stuart-Fox, Devi; Talas, Laszlo; Tibbetts, Elizabeth; Caro, Tim			The biology of color	SCIENCE			English	Review							POLARIZATION VISION; EVOLUTION; PATTERNS; RECOGNITION; CAMOUFLAGE; SELECTION; SIGNALS; PREDICT; MECHANISMS; PLEIOTROPY	Coloration mediates the relationship between an organism and its environment in important ways, including social signaling, antipredator defenses, parasitic exploitation, thermoregulation, and protection from ultraviolet light, microbes, and abrasion. Methodological breakthroughs are accelerating knowledge of the processes underlying both the production of animal coloration and its perception, experiments are advancing understanding of mechanism and function, and measurements of color collected noninvasively and at a global scale are opening windows to evolutionary dynamics more generally. Here we provide a roadmap of these advances and identify hitherto unrecognized challenges for this multi-and interdisciplinary field.	[Cuthill, Innes C.; Roberts, Nicholas W.; Talas, Laszlo] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Allen, William L.; Arbuckle, Kevin] Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales; [Caspers, Barbara] Univ Bielefeld, Dept Anim Behav, POB 100131, D-33501 Bielefeld, Germany; [Chaplin, George; Jablonski, Nina G.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Hauber, Mark E.] CUNY, Hunter Coll & Grad Ctr, Dept Psychol, New York, NY 10065 USA; [Hauber, Mark E.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3DT, England; [Kelber, Almut] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Mappes, Johanna] Univ Jyvaskyla, Ctr Excellence Biol Interact Res, Jyvaskyla 40014, Finland; [Marshall, Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Merrill, Richard] Ludwig Maximilians Univ t, Dept Evolutionary Biol, Munich, Germany; [Osorio, Daniel] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Prum, Richard] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; [Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Rowland, Hannah M.] Univ Cambridge, Dept Zool, Cambridge CB2 3DT, England; [Rowland, Hannah M.] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Skelhorn, John] Newcastle Univ, Inst Neurosci, Newcastle, NSW NE2 4HH, Australia; [Speed, Michael P.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZX, Merseyside, England; [Stevens, Martin] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9FE, Cornwall, England; [Stoddard, Mary Caswell] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Stuart-Fox, Devi] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Tibbetts, Elizabeth] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Caro, Tim] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Rowland, Hannah M.] Max Planck Inst Chem Ecol, Hans Knoll Str 8, D-07745 Jena, Germany	University of Bristol; Swansea University; University of Bielefeld; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; City University of New York (CUNY) System; Hunter College (CUNY); University of Illinois System; University of Illinois Urbana-Champaign; Auburn University System; Auburn University; University of Cambridge; Lund University; University of Jyvaskyla; University of Queensland; University of Munich; University of Sussex; Yale University; University of Lausanne; University of Cambridge; Zoological Society of London; Carleton University; University of Newcastle; University of Liverpool; University of Exeter; Princeton University; University of Melbourne; University of Michigan System; University of Michigan; University of California System; University of California Davis; University of California System; University of California Davis; Max Planck Society	Caro, T (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	tmcaro@ucdavis.edu	Mappes, Johanna/AAZ-3627-2021; Allen, Will/T-9816-2019; Hill, Geoffrey E./R-7354-2019; Jiggins, Chris/T-4296-2019; Rowland, Hannah/D-8114-2012; Jiggins, Chris D/B-9960-2008; Kelber, Almut/H-6216-2014	Allen, Will/0000-0003-2654-0438; Hill, Geoffrey E./0000-0001-8864-6495; Jiggins, Chris/0000-0002-7809-062X; Rowland, Hannah/0000-0002-1040-555X; Jiggins, Chris D/0000-0002-7809-062X; Talas, Laszlo/0000-0001-5731-3890; Kelber, Almut/0000-0003-3937-2808; Tibbetts, Elizabeth/0000-0002-5625-892X; Stuart-Fox, Devi/0000-0003-3362-1412; Prum, Richard/0000-0002-4741-7132; Jablonski, Nina/0000-0001-7644-874X; Osorio, Daniel/0000-0002-5856-527X; Arbuckle, Kevin/0000-0002-9171-5874; Cuthill, Innes/0000-0002-5007-8856; Marshall, Justin/0000-0001-9006-6713; Mappes, Johanna/0000-0002-1117-5629; Roberts, Nicholas/0000-0002-4540-6683	Wissenschaftskolleg zu Berlin; Engineering and Physical Sciences Research Council [EP/M006905/1]; Biotechnology and Biological Sciences Research Council [BB/M002780/1, BB/N006569/1]; Biotechnology and Biological Sciences Research Council [BB/J000272/1] Funding Source: researchfish; BBSRC [BB/M002780/1, BB/J000272/1, BB/N006569/1] Funding Source: UKRI; EPSRC [EP/M006905/1] Funding Source: UKRI	Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Wissenschaftskolleg zu Berlin for financial and logistical support in hosting the workshop where these ideas were formulated; we also thank two reviewers. I.C.C. and L.T. were funded by the Engineering and Physical Sciences Research Council (grant EP/M006905/1), and I.C.C. and J.S. were funded by the Biotechnology and Biological Sciences Research Council (grants BB/M002780/1 and BB/N006569/1). With the exception of the first and last authors, who organized the workshop and coordinated the manuscript preparation, all authors contributed equally and are listed alphabetically.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Allen CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-94; Allen William L, 2013, Am J Primatol, V75, P664, DOI 10.1002/ajp.22129; Arbuckle K, 2015, P NATL ACAD SCI USA, V112, P13597, DOI 10.1073/pnas.1509811112; Azofeifa DE, 2015, J QUANT SPECTROSC RA, V160, P63, DOI 10.1016/j.jqsrt.2015.03.014; Barnett JB, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.11.015; Bates H.W., 1862, T LINN SOC LOND, V23, P495; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Brandley NC, 2013, EVOL ECOL, V27, P1045, DOI 10.1007/s10682-013-9656-9; Caro T, 2017, TRENDS ECOL EVOL, V32, P23, DOI 10.1016/j.tree.2016.10.003; Caro T, 2016, EVOL ECOL, V30, P797, DOI 10.1007/s10682-016-9854-3; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; COOK SE, 1994, ANIM BEHAV, V47, P389, DOI 10.1006/anbe.1994.1053; Cummings ME, 2007, EVOLUTION, V61, P530, DOI 10.1111/j.1558-5646.2007.00047.x; Daly IM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12140; Delhey K, 2017, CONSERV BIOL, V31, P30, DOI 10.1111/cobi.12834; Douglas RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39395; Duarte RC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0342; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Dufresne ER, 2009, SOFT MATTER, V5, P1792, DOI 10.1039/b902775k; el Jundi B, 2014, J COMP PHYSIOL A, V200, P575, DOI 10.1007/s00359-014-0890-6; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Endler JA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0352; Feller KD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0336; Garamszegi, 2014, MODERN PHYLOGENETIC, P553; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Higham JP, 2014, BEHAV ECOL, V25, P8, DOI 10.1093/beheco/art097; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Jablonski NG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0349; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Johnsen S, 2011, OPTICS LIFE BIOL GUI; Jones Richard Anthony Lewis, 2002, SOFT CONDENSED MATTE; Jordan TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21744; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kawasaki M, 2015, J COMP PHYSIOL A, V201, P1115, DOI 10.1007/s00359-015-1039-y; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2016, CURR OPIN NEUROBIOL, V41, P106, DOI 10.1016/j.conb.2016.09.007; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Lahti DC, 2016, AM NAT, V187, P547, DOI 10.1086/685780; Langridge KV, 2007, CURR BIOL, V17, pR1044, DOI 10.1016/j.cub.2007.10.028; Ligon RA, 2016, CURR ZOOL, V62, P237, DOI 10.1093/cz/zow051; Lind O, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0338; Lopes RJ, 2016, CURR BIOL, V26, P1427, DOI 10.1016/j.cub.2016.03.076; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Mallarino R, 2016, NATURE, V539, P518, DOI 10.1038/nature20109; Manukyan L, 2017, NATURE, V544, P173, DOI 10.1038/nature22031; Marshall Justin, 2014, Curr Biol, V24, pR1150, DOI 10.1016/j.cub.2014.10.025; Marshall KLA, 2014, BEHAV ECOL, V25, P1325, DOI 10.1093/beheco/aru126; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Martin PR, 2015, AM NAT, V185, P443, DOI 10.1086/680206; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Merilaita S, 2006, J EVOLUTION BIOL, V19, P2022, DOI 10.1111/j.1420-9101.2006.01137.x; Merilaita S, 2003, EVOLUTION, V57, P1248; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Mundy NI, 2016, CURR BIOL, V26, P1435, DOI 10.1016/j.cub.2016.04.047; New STD, 2010, CURR ZOOL, V56, P327; Nokelainen O, 2012, P ROY SOC B-BIOL SCI, V279, P257, DOI 10.1098/rspb.2011.0880; Peters RA, 2007, CURR BIOL, V17, P1231, DOI 10.1016/j.cub.2007.06.035; Rabosky ARD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11484; Renoult JP, 2017, BIOL REV, V92, P292, DOI 10.1111/brv.12230; Roulin A, 2016, BIOL REV, V91, P328, DOI 10.1111/brv.12171; San-Jose LM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0337; Sandkam BA, 2016, J COMP PHYSIOL A, V202, P527, DOI 10.1007/s00359-016-1097-9; Schultz TD, 2009, FUNCT ECOL, V23, P724, DOI 10.1111/j.1365-2435.2009.01584.x; Shawkey MD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0536; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Skelhorn J, 2016, BEHAV ECOL, V27, P955, DOI 10.1093/beheco/arw009; Skelhorn J, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2890; Smucny J, 2013, BRAIN COGNITION, V81, P263, DOI 10.1016/j.bandc.2012.11.008; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stoddard MC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0339; Stoddard MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5117; Stoddard MC, 2013, ANIM BEHAV, V85, P693, DOI 10.1016/j.anbehav.2013.01.005; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Stoner CJ, 2003, BEHAV ECOL, V14, P823, DOI 10.1093/beheco/arg072; Thompson MJ, 2014, HEREDITY, V113, P1, DOI 10.1038/hdy.2014.20; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Umbers KDL, 2016, ANIM BEHAV, V113, pE5, DOI 10.1016/j.anbehav.2016.01.002; Valkonen JK, 2014, CURR ZOOL, V60, P114, DOI 10.1093/czoolo/60.1.114; Van Ruijssevelt L, 2013, J PHYSIOL-PARIS, V107, P156, DOI 10.1016/j.jphysparis.2012.08.005; Vinther J, 2016, CURR BIOL, V26, P2456, DOI 10.1016/j.cub.2016.06.065; Vinther J, 2015, BIOESSAYS, V37, P643, DOI 10.1002/bies.201500018; Wallace AR, 1889, DARWINISM; Wallace AR, 1877, AM NAT, V11, P641; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353; Weaver RJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0343; Xiao F, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1527; Yoshida M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0390	92	329	336	32	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350							eaan0221	10.1126/science.aan0221	http://dx.doi.org/10.1126/science.aan0221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774901	Green Submitted, Green Accepted			2022-12-28	WOS:000406840100028
J	McGartland, A; Revesz, R; Axelrad, DA; Dockins, C; Sutton, P; Woodruff, TJ				McGartland, Al; Revesz, Richard; Axelrad, Daniel A.; Dockins, Chris; Sutton, Patrice; Woodruff, Tracey J.			Estimating the health benefits of environmental regulations	SCIENCE			English	Editorial Material									[McGartland, Al; Axelrad, Daniel A.; Dockins, Chris] US EPA, Washington, DC 20460 USA; [Revesz, Richard] NYU, New York, NY 10012 USA; [Sutton, Patrice; Woodruff, Tracey J.] Univ Calif San Francisco, San Francisco, CA 94143 USA	United States Environmental Protection Agency; New York University; University of California System; University of California San Francisco	Woodruff, TJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	tracey.woodruff@ucsf.edu		Axelrad, Daniel/0000-0003-2814-2601; Woodruff, Tracey/0000-0003-3622-1297	U.S. Environmental Protection Agency; JPB Foundation; Tides Foundation; Institute for Policy Integrity at New York University School of Law; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022841] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); JPB Foundation; Tides Foundation; Institute for Policy Integrity at New York University School of Law; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This article is based on discussions at a 2016 symposium organized by the authors at JPB Foundation in New York, NY. Support for the symposium and this paper were provided to the UCSF Program on Reproductive Health and the Environment by the U.S. Environmental Protection Agency, the JPB Foundation, the Tides Foundation, and the Institute for Policy Integrity at New York University School of Law. The views articulated here are those of the authors and should not be ascribed to any supporting or affiliated organizations.	[Anonymous], 2009, SCI DEC ADV RISK ASS; Clewell HJ, 2005, RISK ANAL, V25, P285, DOI 10.1111/j.1539-6924.2005.00589.x; Judson Richard, 2009, Environ Health Perspect, V117, P685, DOI 10.1289/ehp.0800168; Kivi PA, 2010, J AGR RESOUR ECON, V35, P443; Morgenstern Richard D., 2015, RFF REGULATORY PERFO; National Research Council, 2014, REV EPAS INT RISK IN; National Toxicology Program, 2015, HDB COND LIT BAS HLT; U. S. Environmental Protection Agency, 2010, EPA240R10001; U. S. Environmental Protection Agency, 2014, EPA420R14005; US Office of Management and Budget, 2015, 2015 REP C BEN COSTS; World Health Organization, 2014, WHO GUID DOC EV EXPR	11	20	20	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					457	458		10.1126/science.aam8204	http://dx.doi.org/10.1126/science.aam8204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774918	Green Accepted			2022-12-28	WOS:000406840100023
J	Wistuba-Hamprecht, K; Pawelec, G				Wistuba-Hamprecht, Kilian; Pawelec, Graham			KEYNOTE-006: a success in melanoma, but a long way to go	LANCET			English	Editorial Material							IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB		[Wistuba-Hamprecht, Kilian] Univ Med Ctr Tuebingen, Med Res Ctr, Dept Dermatol, D-72074 Tubingen, Germany; [Pawelec, Graham] Univ Med Ctr Tuebingen, Med Res Ctr, Dept Internal Med 2, D-72074 Tubingen, Germany; [Pawelec, Graham] Hlth Sci North Res Inst, Sudbury, ON, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Health Sciences North; Northern Ontario School of Medicine	Wistuba-Hamprecht, K (corresponding author), Univ Med Ctr Tuebingen, Med Res Ctr, Dept Dermatol, D-72074 Tubingen, Germany.	kilian.wistuba-hamprecht@uni-tuebingen.de	Wistuba-Hamprecht, Kilian/AAH-6961-2020; Pawelec, Graham/H-2713-2019	Wistuba-Hamprecht, Kilian/0000-0002-3104-8512; Pawelec, Graham/0000-0002-3600-0163				Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Long B, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS5609; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schachter J, 2017, LANCET; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1816	1817		10.1016/S0140-6736(17)31816-0	http://dx.doi.org/10.1016/S0140-6736(17)31816-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK1LY	28822577				2022-12-28	WOS:000413244500009
J	Ren, JG; Xu, P; Yong, HL; Zhang, L; Liao, SK; Yin, J; Liu, WY; Cai, WQ; Yang, M; Li, L; Yang, KX; Han, X; Yao, YQ; Li, J; Wu, HY; Wan, S; Liu, L; Liu, DQ; Kuang, YW; He, ZP; Shang, P; Guo, C; Zheng, RH; Tian, K; Zhu, ZC; Liu, NL; Lu, CY; Shu, R; Chen, YA; Peng, CZ; Wang, JY; Pan, JW				Ren, Ji-Gang; Xu, Ping; Yong, Hai-Lin; Zhang, Liang; Liao, Sheng-Kai; Yin, Juan; Liu, Wei-Yue; Cai, Wen-Qi; Yang, Meng; Li, Li; Yang, Kui-Xing; Han, Xuan; Yao, Yong-Qiang; Li, Ji; Wu, Hai-Yan; Wan, Song; Liu, Lei; Liu, Ding-Quan; Kuang, Yao-Wu; He, Zhi-Ping; Shang, Peng; Guo, Cheng; Zheng, Ru-Hua; Tian, Kai; Zhu, Zhen-Cai; Liu, Nai-Le; Lu, Chao-Yang; Shu, Rong; Chen, Yu-Ao; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei			Ground-to-satellite quantum teleportation	NATURE			English	Article							ENTANGLEMENT DISTRIBUTION; STATE; LIGHT; SPINS	An arbitrary unknown quantum state cannot be measured precisely or replicated perfectly(1). However, quantum teleportation enables unknown quantum states to be transferred reliably from one object to another over long distances(2), without physical travelling of the object itself. Long-distance teleportation is a fundamental element of protocols such as large-scale quantum networks(3,4) and distributed quantum computation(5,6). But the distances over which transmission was achieved in previous teleportation experiments, which used optical fibres and terrestrial free-space channels(7-12), were limited to about 100 kilometres, owing to the photon loss of these channels. To realize a global-scale 'quantum internet'(13) the range of quantum teleportation needs to be greatly extended. A promising way of doing so involves using satellite platforms and space-based links, which can connect two remote points on Earth with greatly reduced channel loss because most of the propagation path of the photons is in empty space. Here we report quantum teleportation of independent single-photon qubits from a ground observatory to a low-Earth-orbit satellite, through an uplink channel, over distances of up to 1,400 kilometres. To optimize the efficiency of the link and to counter the atmospheric turbulence in the uplink, we use a compact ultra-bright source of entangled photons, a narrow beam divergence and high-bandwidth and high-accuracy acquiring, pointing and tracking. We demonstrate successful quantum teleportation of six input states in mutually unbiased bases with an average fidelity of 0.80 +/- 0.01, well above the optimal state-estimation fidelity on a single copy of a qubit (the classical limit)(14). Our demonstration of a ground-to-satellite uplink for reliable and ultra-long-distance quantum teleportation is an essential step towards a global-scale quantum internet.	[Ren, Ji-Gang; Xu, Ping; Yong, Hai-Lin; Liao, Sheng-Kai; Yin, Juan; Liu, Wei-Yue; Cai, Wen-Qi; Yang, Meng; Li, Li; Yang, Kui-Xing; Han, Xuan; Shang, Peng; Guo, Cheng; Liu, Nai-Le; Lu, Chao-Yang; Chen, Yu-Ao; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Ren, Ji-Gang; Xu, Ping; Yong, Hai-Lin; Liao, Sheng-Kai; Yin, Juan; Liu, Wei-Yue; Cai, Wen-Qi; Yang, Meng; Li, Li; Yang, Kui-Xing; Han, Xuan; Shang, Peng; Guo, Cheng; Liu, Nai-Le; Lu, Chao-Yang; Chen, Yu-Ao; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Ren, Ji-Gang; Xu, Ping; Yong, Hai-Lin; Zhang, Liang; Liao, Sheng-Kai; Yin, Juan; Liu, Wei-Yue; Cai, Wen-Qi; Yang, Meng; Li, Li; Yang, Kui-Xing; Han, Xuan; Shang, Peng; Guo, Cheng; Liu, Nai-Le; Lu, Chao-Yang; Shu, Rong; Chen, Yu-Ao; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei] Univ Sci & Technol China, CAS, Ctr Excellence & Synerget Innovat Ctr Quantum Inf, Shanghai 201315, Peoples R China; [Zhang, Liang; Liu, Ding-Quan; Kuang, Yao-Wu; He, Zhi-Ping; Shu, Rong; Wang, Jian-Yu] Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China; [Yao, Yong-Qiang] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Li, Ji; Wu, Hai-Yan] Chinese Acad Sci, Nanjing Astron Instruments Co Ltd, Nanjing 210042, Jiangsu, Peoples R China; [Wan, Song; Liu, Lei; Zhu, Zhen-Cai] Shanghai Engn Ctr Microsatellites, Shanghai 201203, Peoples R China; [Zheng, Ru-Hua] Beijing Inst Tracking & Telecommun Technol, Beijing 100094, Peoples R China; [Tian, Kai] Xian Satellite Control Ctr, State Key Lab Astronaut Dynam, Xian 710061, Shaanxi, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences	Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China.; Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.; Peng, CZ; Wang, JY; Pan, JW (corresponding author), Univ Sci & Technol China, CAS, Ctr Excellence & Synerget Innovat Ctr Quantum Inf, Shanghai 201315, Peoples R China.; Wang, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China.	pcz@ustc.edu.cn; jywang@mail.sitp.ac.cn; pan@ustc.edu.cn	Lu, Chao-Yang/D-8481-2011; Chen, Yu-Ao/B-2057-2013; Pan, Jian-Wei/A-2332-2010; Yong, Hai-Lin/AAD-3818-2019; yin, juan/AAG-3315-2021; liao, shengkai/L-7149-2019	Lu, Chao-Yang/0000-0002-8227-9177; Chen, Yu-Ao/0000-0002-2309-2281; Pan, Jian-Wei/0000-0002-6100-5142; Yong, Hai-Lin/0000-0002-9074-5617; Han, Xuan/0000-0001-6251-403X; Yang, Kui-Xing/0000-0001-5073-8378	Strategic Priority Research Program on Space Science; Chinese Academy of Sciences; National Natural Science Foundation of China	Strategic Priority Research Program on Space Science; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank many colleagues at the National Space Science Center, National Astronomical Observatories and Xi'an Satellite Control Centre, especially B.-M. Xu, J. Li, J.-C. Gong, B. Chen, X.-J. Jiang and T. Xi, for their management and coordination. We thank T. Chen and Y.-H. Zhou from Ngari Observatory for their support during the experiment. This work was supported by the Strategic Priority Research Program on Space Science, the Chinese Academy of Sciences and National Natural Science Foundation of China.	BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Bussieres F, 2014, NAT PHOTONICS, V8, DOI [10.1038/nphoton.2014.215, 10.1038/NPHOTON.2014.215]; Chen LK, 2017, OPTICA, V4, P77, DOI 10.1364/OPTICA.4.000077; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Landry O, 2007, J OPT SOC AM B, V24, P398, DOI 10.1364/JOSAB.24.000398; Liao SK, 2017, NATURE, V549, P43, DOI 10.1038/nature23655; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Pan JW, 1998, PHYS REV A, V57, P2208, DOI 10.1103/PhysRevA.57.2208; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Stone R, 2012, SCIENCE, V337, P1156, DOI 10.1126/science.337.6099.1156; Sun QC, 2016, NAT PHOTONICS, V10, P671, DOI [10.1038/NPHOTON.2016.179, 10.1038/nphoton.2016.179]; Valivarthi R, 2016, NAT PHOTONICS, V10, P676, DOI [10.1038/nphoton.2016.180, 10.1038/NPHOTON.2016.180]; Wang HS, 2015, J PHYS CONF SER, V595, DOI 10.1088/1742-6596/595/1/012037; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Yang SJ, 2016, NAT PHOTONICS, V10, P381, DOI [10.1038/nphoton.2016.51, 10.1038/NPHOTON.2016.51]; Yao YQ, 2012, PROC SPIE, V8444, DOI 10.1117/12.925917; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241; Zhong MJ, 2015, NATURE, V517, P177, DOI 10.1038/nature14025; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	30	361	380	9	243	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					70	+		10.1038/nature23675	http://dx.doi.org/10.1038/nature23675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28825708	Green Submitted			2022-12-28	WOS:000409388700034
J	Paolucci, C; Khurana, I; Parekh, AA; Li, SC; Shih, AJ; Li, H; Di Iorio, JR; Albarracin-Caballero, JD; Yezerets, A; Miller, JT; Delgass, WN; Ribeiro, FH; Schneider, WF; Gounder, R				Paolucci, Christopher; Khurana, Ishant; Parekh, Atish A.; Li, Sichi; Shih, Arthur J.; Li, Hui; Di Iorio, John R.; Albarracin-Caballero, Jonatan D.; Yezerets, Aleksey; Miller, Jeffrey T.; Delgass, W. Nicholas; Ribeiro, Fabio H.; Schneider, William F.; Gounder, Rajamani			Dynamic multinuclear sites formed by mobilized copper ions in NOx selective catalytic reduction	SCIENCE			English	Article							WATER-GAS SHIFT; ACTIVE-SITES; HETEROGENEOUS CATALYSIS; SINGLE-ATOM; CU-SSZ-13; MECHANISM; OXIDATION; CU-ZSM-5; AMMONIA; OXYGEN	Copper ions exchanged into zeolites are active for the selective catalytic reduction (SCR) of nitrogen oxides (NOx) with ammonia (NH3), but the low-temperature rate dependence on copper (Cu) volumetric density is inconsistent with reaction at single sites. We combine steady-state and transient kinetic measurements, x-ray absorption spectroscopy, and first-principles calculations to demonstrate that under reaction conditions, mobilized Cu ions can travel through zeolite windows and form transient ion pairs that participate in an oxygen (O-2)-mediated Cu-I -> Cu-II redox step integral to SCR. Electrostatic tethering to framework aluminum centers limits the volume that each ion can explore and thus its capacity to form an ion pair. The dynamic, reversible formation of multinuclear sites from mobilized single atoms represents a distinct phenomenon that falls outside the conventional boundaries of a heterogeneous or homogeneous catalyst.	[Paolucci, Christopher; Li, Sichi; Li, Hui; Schneider, William F.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Khurana, Ishant; Parekh, Atish A.; Shih, Arthur J.; Di Iorio, John R.; Albarracin-Caballero, Jonatan D.; Miller, Jeffrey T.; Delgass, W. Nicholas; Ribeiro, Fabio H.; Gounder, Rajamani] Purdue Univ, Charles D Davidson Sch Chem Engn, 480 Stadium Mall Dr, W Lafayette, IN 47907 USA; [Yezerets, Aleksey] Cummins Inc, 1900 McKinley Ave,MC 50183, Columbus, IN 47201 USA	University of Notre Dame; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cummins	Schneider, WF (corresponding author), Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA.; Gounder, R (corresponding author), Purdue Univ, Charles D Davidson Sch Chem Engn, 480 Stadium Mall Dr, W Lafayette, IN 47907 USA.	wschneider@nd.edu; rgounder@purdue.edu	Schneider, William F/D-4240-2013; Khurana, Ishant/N-4371-2019; Li, Sichi/W-4588-2018; Di Iorio, John/AAN-6386-2020; Schneider, William F./ABH-6170-2020	Khurana, Ishant/0000-0002-5444-0103; Li, Sichi/0000-0002-2565-5906; Di Iorio, John/0000-0002-7519-5100; Schneider, William F./0000-0003-0664-2138; Shih, Arthur/0000-0002-2414-0644	National Science Foundation GOALI program [1258715-CBET, 1258690-CBET]; National Science Foundation Faculty Early Career Development Program [1552517-CBET]; Cummins, Inc.; Patrick and Jane Eilers Graduate Student Fellowship for Energy Related Research; U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences [DE-AC02-06CH11357]; Office of Biological and Environmental Research; Directorate For Engineering [1258690] Funding Source: National Science Foundation	National Science Foundation GOALI program(National Science Foundation (NSF)); National Science Foundation Faculty Early Career Development Program(National Science Foundation (NSF)); Cummins, Inc.; Patrick and Jane Eilers Graduate Student Fellowship for Energy Related Research; U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Full details of experiments and computational models are provided in the supplementary materials. Financial support was provided by the National Science Foundation GOALI program under award numbers 1258715-CBET (Purdue) and 1258690-CBET (Notre Dame), the National Science Foundation Faculty Early Career Development Program under award number 1552517-CBET (R.G.), Cummins, Inc. (I.K., A.J.S., A.A.P., J.D.A.-C.). and The Patrick and Jane Eilers Graduate Student Fellowship for Energy Related Research (C.P.). Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. We thank the Center for Research Computing at Notre Dame, and EMSL, a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory, for computational resources.	Baerlocher C, 2017, DATABASE ZEOLITE STR; Bates SA, 2014, J CATAL, V312, P87, DOI 10.1016/j.jcat.2014.01.004; Borfecchia E, 2015, CHEM SCI, V6, P548, DOI 10.1039/c4sc02907k; BOUDART M, 1995, CHEM REV, V95, P661, DOI 10.1021/cr00035a009; Chen L, 2016, J PHYS CHEM C, V120, P29182, DOI 10.1021/acs.jpcc.6b09553; Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101; Ding K, 2015, SCIENCE, V350, P189, DOI 10.1126/science.aac6368; Falsig H, 2016, TOP CATAL, V59, P861, DOI 10.1007/s11244-016-0560-8; Gao F, 2017, J AM CHEM SOC, V139, P4935, DOI 10.1021/jacs.7b01128; Gao F, 2014, J CATAL, V319, P1, DOI 10.1016/j.jcat.2014.08.010; Goodman BR, 1999, J PHYS CHEM B, V103, P10452, DOI 10.1021/jp9922110; Gunter T, 2015, CHEM COMMUN, V51, P9227, DOI 10.1039/c5cc01758k; Janssens TVW, 2015, ACS CATAL, V5, P2832, DOI 10.1021/cs501673g; Jones J, 2016, SCIENCE, V353, P150, DOI 10.1126/science.aaf8800; Korhonen ST, 2011, CHEM COMMUN, V47, P800, DOI 10.1039/c0cc04218h; Kwak JH, 2010, J CATAL, V275, P187, DOI 10.1016/j.jcat.2010.07.031; Kyriakou G, 2012, SCIENCE, V335, P1209, DOI 10.1126/science.1215864; LOEWENSTEIN W, 1954, AM MINERAL, V39, P92; Lomachenko KA, 2016, J AM CHEM SOC, V138, P12025, DOI 10.1021/jacs.6b06809; McCann SD, 2015, ACCOUNTS CHEM RES, V48, P1756, DOI 10.1021/acs.accounts.5b00060; Metz M, 2001, J AM CHEM SOC, V123, P4938, DOI 10.1021/ja004166b; Mirica LM, 2005, SCIENCE, V308, P1890, DOI 10.1126/science.1112081; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Paolucci C, 2016, ADV CATAL, V59, P1, DOI 10.1016/bs.acat.2016.10.002; Paolucci C, 2016, J AM CHEM SOC, V138, P6028, DOI 10.1021/jacs.6b02651; Paolucci C, 2014, ANGEW CHEM INT EDIT, V53, P11828, DOI 10.1002/anie.201407030; Peterson EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5885; Smeets PJ, 2010, J AM CHEM SOC, V132, P14736, DOI 10.1021/ja106283u; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P6456, DOI 10.1002/anie.200462473; Thomas JM, 2012, P ROY SOC A-MATH PHY, V468, P1884, DOI 10.1098/rspa.2012.0196; Vanelderen P, 2015, J AM CHEM SOC, V137, P6383, DOI 10.1021/jacs.5b02817; Wei HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6634; Woertink JS, 2009, P NATL ACAD SCI USA, V106, P18908, DOI 10.1073/pnas.0910461106; Yang M, 2015, J AM CHEM SOC, V137, P3470, DOI 10.1021/ja513292k; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526	36	403	404	72	919	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					898	+		10.1126/science.aan5630	http://dx.doi.org/10.1126/science.aan5630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28818971				2022-12-28	WOS:000408734900038
J	Roy, DS; Kitamura, T; Okuyama, T; Ogawa, SK; Sun, C; Obata, Y; Yoshiki, A; Tonegawa, S				Roy, Dheeraj S.; Kitamura, Takashi; Okuyama, Teruhiro; Ogawa, Sachie K.; Sun, Chen; Obata, Yuichi; Yoshiki, Atsushi; Tonegawa, Susumu			Distinct Neural Circuits for the Formation and Retrieval of Episodic Memories	CELL			English	Article							ENGRAM CELLS; OCEAN CELLS; SUBICULUM; RAT; HIPPOCAMPUS; NEURONS; EXPRESSION; RESPONSES; DYNAMICS; STRESS	The formation and retrieval of a memory is thought to be accomplished by activation and reactivation, respectively, of the memory-holding cells (engram cells) by a common set of neural circuits, but this hypothesis has not been established. The medial temporal-lobe system is essential for the formation and retrieval of episodic memory for which individual hippocampal subfields and entorhinal cortex layers contribute by carrying out specific functions. One subfield whose function is poorly known is the subiculum. Here, we show that dorsal subiculum and the circuit, CA1 to dorsal subiculum to medial entorhinal cortex layer 5, play a crucial role selectively in the retrieval of episodic memories. Conversely, the direct CA1 to medial entorhinal cortex layer 5 circuit is essential specifically for memory formation. Our data suggest that the subiculum-containing detour loop is dedicated to meet the requirements associated with recall such as rapid memory updating and retrieval-driven instinctive fear responses.	[Roy, Dheeraj S.; Kitamura, Takashi; Okuyama, Teruhiro; Ogawa, Sachie K.; Sun, Chen; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Cambridge, MA 02139 USA; [Roy, Dheeraj S.; Kitamura, Takashi; Okuyama, Teruhiro; Ogawa, Sachie K.; Sun, Chen; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Obata, Yuichi; Yoshiki, Atsushi] RIKEN, BioResource Ctr, 3-1-1 Koyadai, Ibaraki 3050074, Japan; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tonegawa, Susumu] RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tonegawa@mit.edu	Core, Vector/CAF-4832-2022; Yoshiki, Atsushi/O-6162-2019; Kitamura, Takashi/AAR-7837-2021	Yoshiki, Atsushi/0000-0002-9450-5151; Kitamura, Takashi/0000-0001-5597-859X; Sun, Chen/0000-0002-2419-794X; Okuyama, Teruhiro/0000-0003-1566-0063	RIKEN Brain Science Institute; Howard Hughes Medical Institute; JPB Foundation	RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation	We thank S. LeBlanc, S. Huang, A. Arons, J. Martin, L. Smith, F. Bushard, A. Hamalian, W. Yu, and C. Lovett for help with experiments; N. Mise and Y. Koga for help with generating the dorsal subiculum mouse line; M. Morrissey for comments; L. Brenner for proofreading; and all members of the Tonegawa laboratory for their support. We thank Ian Wickersham for providing rabies virus, Ki Goosens for sharing a microplate reader, and the Harvard Center for Biological Imaging for access to a light sheet fluorescence microscope. This work was supported by the RIKEN Brain Science Institute, the Howard Hughes Medical Institute, and the JPB Foundation (to S.T.).	BOURQUE CW, 1993, ANN NY ACAD SCI, V689, P512, DOI 10.1111/j.1749-6632.1993.tb55581.x; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ding SL, 2013, J COMP NEUROL, V521, P4145, DOI 10.1002/cne.23416; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Geva-Sagiv M, 2016, NAT NEUROSCI, V19, P952, DOI 10.1038/nn.4310; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Herman JP, 1998, NEUROSCIENCE, V86, P449, DOI 10.1016/S0306-4522(98)00055-4; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Jin X, 2016, CELL, V164, P632, DOI 10.1016/j.cell.2016.01.007; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kelley JB, 2009, LEARN MEMORY, V16, P371, DOI 10.1101/lm.1329209; Kishi T, 2000, J COMP NEUROL, V419, P205, DOI 10.1002/(SICI)1096-9861(20000403)419:2<205::AID-CNE5>3.0.CO;2-0; Kitamura T, 2015, NEURON, V87, P1317, DOI 10.1016/j.neuron.2015.08.036; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Kondoh K, 2016, NATURE, V532, P103, DOI 10.1038/nature17156; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nakazawa Y, 2016, HIPPOCAMPUS, V26, P1140, DOI 10.1002/hipo.22596; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Raybuck JD, 2014, NEUROSCI LETT, V569, P1, DOI 10.1016/j.neulet.2014.02.063; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; SHARP PE, 1994, J NEUROSCI, V14, P2339; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Sun C, 2015, P NATL ACAD SCI USA, V112, P9466, DOI 10.1073/pnas.1511668112; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WITTER MP, 1990, EUR J NEUROSCI, V2, P718, DOI 10.1111/j.1460-9568.1990.tb00462.x; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	45	127	128	4	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					1000	+	1012.e19	10.1016/j.cell.2017.07.013	http://dx.doi.org/10.1016/j.cell.2017.07.013			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28823555	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000408372400017
J	Jagadeesh, KA; Wu, DJ; Birgmeier, JA; Boneh, D; Bejerano, G				Jagadeesh, Karthik A.; Wu, David J.; Birgmeier, Johannes A.; Boneh, Dan; Bejerano, Gill			Deriving genomic diagnoses without revealing patient genomes	SCIENCE			English	Article							MUTATIONS; ENCRYPTION	Patient genomes are interpretable only in the context of other genomes; however, genome sharing enables discrimination. Thousands of monogenic diseases have yielded definitive genomic diagnoses and potential gene therapy targets. Here we show how to provide such diagnoses while preserving participant privacy through the use of secure multiparty computation. In multiple real scenarios (small patient cohorts, trio analysis, two-hospital collaboration), we used our methods to identify the causal variant and discover previously unrecognized disease genes and variants while keeping up to 99.7% of all participants' most sensitive genomic information private.	[Jagadeesh, Karthik A.; Wu, David J.; Birgmeier, Johannes A.; Boneh, Dan; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Boneh, Dan] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Bejerano, Gill] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Bejerano, Gill] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Boneh, D; Bejerano, G (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Boneh, D (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA.	dabo@cs.stanford.edu; bejerano@stanford.edu			Stanford Graduate and Computational and Evolutionary Human Genomics Fellowships; NSF Graduate Research Fellowship; Stanford Interdisciplinary Graduate Fellowship; Simons Fellowship; National Science Foundation; Stanford Pediatrics Department, Defense Advanced Research Projects Agency; Packard Foundation; Microsoft Faculty Fellowships	Stanford Graduate and Computational and Evolutionary Human Genomics Fellowships; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Interdisciplinary Graduate Fellowship; Simons Fellowship; National Science Foundation(National Science Foundation (NSF)); Stanford Pediatrics Department, Defense Advanced Research Projects Agency; Packard Foundation(The David & Lucile Packard Foundation); Microsoft Faculty Fellowships(Microsoft)	We thank J. Bernstein and members of the Boneh and Bejerano labs for valuable discussions, tools, and project feedback. We also thank Stanford patients and clinicians, as well as the patients and professionals involved in the deposition of the dbGaP (Database of Genotype and Phenotype) sets that we used. This work was supported in part by Stanford Graduate and Computational and Evolutionary Human Genomics Fellowships (K.A.J.), an NSF Graduate Research Fellowship (D.J.W.), a Stanford Interdisciplinary Graduate Fellowship (J.A.B.), Simons and National Science Foundation Fellowships (D.B.), the Stanford Pediatrics Department, Defense Advanced Research Projects Agency, the Packard Foundation, and Microsoft Faculty Fellowships (G.B.). We declare no conflicts of interest. All patient studies were performed in compliance with the Stanford Institutional Review Board. Code is available at https://github.com/dwu4/genome-privacy.	Chen F, 2017, BIOINFORMATICS, V33, P871, DOI 10.1093/bioinformatics/btw758; Chillotti I, 2016, LECT NOTES COMPUT SC, V10031, P3, DOI 10.1007/978-3-662-53887-6_1; Dowlin N, 2017, P IEEE, V105, P552, DOI 10.1109/JPROC.2016.2622218; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Gazzo AM, 2016, NUCLEIC ACIDS RES, V44, pD900, DOI 10.1093/nar/gkv1068; Gentry C, 2009, ACM S THEORY COMPUT, P169, DOI 10.1145/1536414.1536440; Hazay C, 2010, INFORM SEC CRYPT TEX, P3, DOI 10.1007/978-3-642-14303-8; Huang YF, 2017, NAT GENET, V49, P618, DOI 10.1038/ng.3810; Kaiser J, 2016, SCIENCE, V354, P398, DOI 10.1126/science.354.6311.398; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindell Y, 2009, J CRYPTOL, V22, P161, DOI 10.1007/s00145-008-9036-8; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nolte IM, 2017, EUR J HUM GENET, V25, P877, DOI 10.1038/ejhg.2017.50; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Regalado Antonio, 2015, MIT TECHNOL REV; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Riazi MS, 2016, PROCEEDINGS OF THE 2016 IEEE INTERNATIONAL SYMPOSIUM ON HARDWARE ORIENTED SECURITY AND TRUST (HOST), P248, DOI 10.1109/HST.2016.7495590; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Shringarpure SS, 2015, AM J HUM GENET, V97, P631, DOI 10.1016/j.ajhg.2015.09.010; Simmons S, 2016, CELL SYST, V3, P54, DOI 10.1016/j.cels.2016.04.013; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Siu LL, 2016, NAT MED, V22, P464, DOI 10.1038/nm.4089; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88	30	69	74	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					692	+		10.1126/science.aam9710	http://dx.doi.org/10.1126/science.aam9710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818945	Green Submitted			2022-12-28	WOS:000407793600036
J	Conroy, K				Conroy, Kevin			SPOT DIAGNOSIS An unusual cause of chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Conroy, Kevin] Queen Elizabeth Hosp, Gateshead, England		Conroy, K (corresponding author), Queen Elizabeth Hosp, Gateshead, England.	kevin.conroy@nhs.net						Baral D, 2015, AM J RESP CRIT CARE, V358, pA6029; Bruce DM, 1996, J ROY COLL SURG EDIN, V41, P7; JOHKOH T, 1992, AM J ROENTGENOL, V158, P1217, DOI 10.2214/ajr.158.6.1590110; Naidich DP, 2007, COMPUTED TOMOGRAPHY; Raja A, 2010, INDIA J SURG ONCOL, V1, P274, DOI 10.1007/s13193-011-0047-9	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2017	358								j3438	10.1136/bmj.j3438	http://dx.doi.org/10.1136/bmj.j3438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5CB	28818967				2022-12-28	WOS:000408228500001
J	Kumar, S; Strachan, JP; Williams, RST				Kumar, Suhas; Strachan, John Paul; Williams, R. S. Tanley			Chaotic dynamics in nanoscale NbO2 Mott memristors for analogue computing	NATURE			English	Article							RECURRENT NEURAL-NETWORKS; COMPUTATION; ORDER; EDGE	At present, machine learning systems use simplified neuron models that lack the rich nonlinear phenomena observed in biological systems, which display spatio-temporal cooperative dynamics. There is evidence that neurons operate in a regime called the edge of chaos(1) that may be central to complexity, learning efficiency, adaptability and analogue (non-Boolean) computation in brains(2-7). Neural networks have exhibited enhanced computational complexity when operated at the edge of chaos(2), and networks of chaotic elements have been proposed for solving combinatorial or global optimization problems(8). Thus, a source of controllable chaotic behaviour that can be incorporated into a neural-inspired circuit may be an essential component of future computational systems. Such chaotic elements have been simulated using elaborate transistor circuits that simulate known equations of chaos(9-12), but an experimental realization of chaotic dynamics from a single scalable electronic device has been lacking(5,6,13). Here we describe niobium dioxide (NbO2) Mott memristors each less than 100 nanometres across that exhibit both a nonlinear-transport-driven current-controlled negative differential resistance and a Mott-transition-driven temperature-controlled negative differential resistance. Mott materials have a temperature-dependent metal-insulator transition that acts as an electronic switch, which introduces a history-dependent resistance into the device. We incorporate these memristors into a relaxation oscillator(14) and observe a tunable range of periodic and chaotic self-oscillations(15). We show that the nonlinear current transport coupled with thermal fluctuations at the nanoscale generates chaotic oscillations. Such memristors could be useful in certain types of neural-inspired computation by introducing a pseudo-random signal that prevents global synchronization and could also assist in finding a global minimum during a constrained search. We specifically demonstrate that incorporating such memristors into the hardware of a Hopfield computing network can greatly improve the efficiency and accuracy of converging to a solution for computationally difficult problems.	[Kumar, Suhas; Strachan, John Paul; Williams, R. S. Tanley] Hewlett Packard Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA	Hewlett-Packard	Kumar, S; Williams, RST (corresponding author), Hewlett Packard Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA.	suhas.kumar@hpe.com; stan.williams@hpe.com	Kumar, Suhas/C-8061-2017; Williams, R. Stanley/A-8281-2009; Strachan, John Paul/AAD-1240-2020	Kumar, Suhas/0000-0002-6772-7250; Williams, R. Stanley/0000-0003-0213-4259; Strachan, John Paul/0000-0002-1382-3677	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) [2017-17013000002]	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA)	The research is in part based on work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via contract number 2017-17013000002. We thank L. O. Chua for reviewing the manuscript, discussions and data analysis. We also thank G. Gibson for discussions and insights.	Ascoli A, 2015, IEEE T CIRCUITS-I, V62, P1165, DOI 10.1109/TCSI.2015.2413152; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; CHEN LN, 1995, NEURAL NETWORKS, V8, P915, DOI 10.1016/0893-6080(95)00033-V; Chua L, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/383001; Chua L, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412500988; Chua LO, 2005, INT J BIFURCAT CHAOS, V15, P3435, DOI 10.1142/S0218127405014337; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; Ditto WL, 2008, PHILOS T R SOC A, V366, P653, DOI 10.1098/rsta.2007.2116; Driscoll T, 2011, APPL PHYS A-MATER, V102, P885, DOI 10.1007/s00339-011-6318-z; Gibson GA, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4939913; Guckenheimer J, 1983, NONLINEAR OSCILLATIO, P117; HOPFIELD JJ, 1985, BIOL CYBERN, V52, P141; Hu M., IEEE C DES AUT; Hu X., 2013, MEMRISTOR NETWORKS, P351; KAUFFMAN SA, 1990, PHYSICA D, V42, P135, DOI 10.1016/0167-2789(90)90071-V; Kruse R., 2016, COMPUTATIONAL INTELL, V8, P131; Kumar S, 2017, NANOSCALE, V9, P1793, DOI 10.1039/c6nr07671h; Mainzer K., 2013, LOC ACT PRINC; Mannan ZI, 2016, INT J BIFURCAT CHAOS, V26, DOI 10.1142/S0218127416300093; Muthuswamy B, 2010, INT J BIFURCAT CHAOS, V20, P1567, DOI 10.1142/S0218127410027076; Ott E, 2002, CHAOS DYNAMICAL SYST; Pickett MD, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/384002; Pickett MD, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/21/215202; Pickett MD, 2011, ADV MATER, V23, P1730, DOI 10.1002/adma.201004497; Seifter J, 2015, ARTIF LIFE, V21, P55, DOI 10.1162/ARTL_a_00152; Shafiee A, 2016, CONF PROC INT SYMP C, P14, DOI 10.1109/ISCA.2016.12; Suzuki H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01610; Wang G., 2015, MATH PROB ENG, V2015; Whitfield J, 2005, NATURE, V436, P905, DOI 10.1038/436905a	29	286	287	27	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					318	321		10.1038/nature23307	http://dx.doi.org/10.1038/nature23307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792931				2022-12-28	WOS:000407748400029
J	Quinonez, RA; Coon, ER; Schroeder, AR; Moyer, VA				Quinonez, Ricardo A.; Coon, Eric R.; Schroeder, Alan R.; Moyer, Virginia A.			TOO MUCH MEDICINE When technology creates uncertainty: pulse oximetry and overdiagnosis of hypoxaemia in bronchiolitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFANTS; INTERMITTENT; CHILDHOOD; DIAGNOSIS; CHILDREN		[Quinonez, Ricardo A.] Baylor Coll Med, Dept Pediat, Sect Pediat Hosp Med, Houston, TX 77030 USA; [Coon, Eric R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Schroeder, Alan R.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Moyer, Virginia A.] Amer Board Pediat Inc, Chapel Hill, NC USA	Baylor College of Medicine; Utah System of Higher Education; University of Utah; Stanford University	Quinonez, RA (corresponding author), Baylor Coll Med, Dept Pediat, Sect Pediat Hosp Med, Houston, TX 77030 USA.	raquinon@texaschildrens.org		Coon, Eric/0000-0001-7297-8348				[Anonymous], 2014, THORAX, V69, P1; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bass JL, 2007, PEDIATRICS, V119, P611, DOI 10.1542/peds.2006-3002; Coon ER, 2014, PEDIATRICS, V134, P1013, DOI 10.1542/peds.2014-1778; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Cunningham S, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19710; Cunningham S, 2012, ARCH DIS CHILD, V97, P361, DOI 10.1136/adc.2010.205211; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Enoch AJ, 2016, ARCH DIS CHILD, V101, P694, DOI 10.1136/archdischild-2015-309638; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Hunt CE, 1999, J PEDIATR-US, V135, P580, DOI 10.1016/S0022-3476(99)70056-9; Joint Commission, 2013, JT COMM PERSPECT, V358, P1; Mallory MD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e45; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; MATTHES K., 1935, ARCH EXP PATH U PHARMAKOL, V179, P698; McBride SC, 2005, PEDIATRICS, V116, P603, DOI 10.1542/peds.2004-2387; McCulloh R, 2015, JAMA PEDIATR, V169, P898, DOI 10.1001/jamapediatrics.2015.1746; MOK JYQ, 1986, J PEDIATR-US, V108, P365; Mower WR, 1997, PEDIATRICS, V99, P681, DOI 10.1542/peds.99.5.681; MOWER WR, 1995, CHEST, V108, P1297, DOI 10.1378/chest.108.5.1297; NEFF TA, 1988, CHEST, V94, P227, DOI 10.1378/chest.94.2.227a; Paramore LC, 2004, PHARMACOECONOMICS, V22, P275, DOI 10.2165/00019053-200422050-00001; Principi T, 2016, JAMA PEDIATR, V170, P602, DOI 10.1001/jamapediatrics.2016.0114; Quinonez RA, 2013, J HOSP MED, V8, P479, DOI 10.1002/jhm.2064; Ralston SL, 2015, PEDIATRICS, V136, P782, DOI 10.1542/peds.2015-2862; Ricci V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2305; Rietveld S, 1999, J ASTHMA, V36, P409, DOI 10.3109/02770909909087283; Schondelmeyer Amanda C, 2016, Hosp Pediatr, V6, P243, DOI 10.1542/hpeds.2015-0198; Schondelmeyer AC, 2015, PEDIATRICS, V135, pE1044, DOI 10.1542/peds.2014-2295; Schroeder AR, 2004, ARCH PEDIAT ADOL MED, V158, P527, DOI 10.1001/archpedi.158.6.527; Schuh S, 2014, JAMA-J AM MED ASSOC, V312, P712, DOI 10.1001/jama.2014.8637; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; TAYLOR MB, 1986, ANAESTHESIA, V41, P943, DOI 10.1111/j.1365-2044.1986.tb12922.x; Thomson L, 2014, PAEDIATR RESPIR REV, V15, P120, DOI 10.1016/j.prrv.2014.03.003; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Unger S, 2008, PEDIATRICS, V121, P470, DOI 10.1542/peds.2007-1135; Walsh P, 2015, WEST J EMERG MED, V16, P85, DOI 10.5811/westjem.2015.1.24930; Wehby GL, 2013, J PEDIATR-US, V162, P606, DOI 10.1016/j.jpeds.2012.09.011; Welch H, 2011, OVERDIAGNOSED MAKING; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	45	23	24	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3850	10.1136/bmj.j3850	http://dx.doi.org/10.1136/bmj.j3850			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814557				2022-12-28	WOS:000408228300008
J	Koretz, RL				Koretz, Ronald L.			In nonvalvular AF, DOAC-related risk for GI bleeding was lower with apixaban than dabigatran or rivaroxaban	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SAFETY		[Koretz, Ronald L.] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, Sylmar, CA 91342 USA.							Noseworthy P, 2016, J AM COLL CARDIOL, V67, P692, DOI 10.1016/S0735-1097(16)30693-3; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC21	JC21		10.7326/ACPJC-2017-167-4-021	http://dx.doi.org/10.7326/ACPJC-2017-167-4-021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806802				2022-12-28	WOS:000407797500008
J	Johnston, J; Farrell, RM; Parens, E				Johnston, Josephine; Farrell, Ruth M.; Parens, Erik			Supporting Women's Autonomy in Prenatal Testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Johnston, Josephine; Parens, Erik] Hastings Ctr, Garrison, NY 10524 USA; [Farrell, Ruth M.] Cleveland Clin, Ob Gyn & Womens Hlth Inst, Cleveland, OH 44106 USA; [Farrell, Ruth M.] Cleveland Clin, Dept Bioeth, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Johnston, J (corresponding author), Hastings Ctr, Garrison, NY 10524 USA.			Johnston, Josephine/0000-0002-7411-6992	NHGRI NIH HHS [R01 HG008805, RM1 HG007257, P50 HG007257] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008805, P50HG007257] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ackerman JP, 2016, MAYO CLIN PROC, V91, P1606, DOI 10.1016/j.mayocp.2016.08.008; Bernhardt BA, 2013, GENET MED, V15, P139, DOI 10.1038/gim.2012.113; Kolvraa S, 2016, PRENATAL DIAG, V36, P1127, DOI 10.1002/pd.4948; Kuppermann M, 2014, JAMA-J AM MED ASSOC, V312, P1210, DOI 10.1001/jama.2014.11479; Parham Lindsey, 2017, CURR GENET MED REP, V5, P44	5	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					505	507		10.1056/NEJMp1703425	http://dx.doi.org/10.1056/NEJMp1703425			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28792882	Green Accepted			2022-12-28	WOS:000407212600001
J	Yao, Z; Yaeger, R; Rodrik-Outmezguine, VS; Tao, A; Torres, NM; Chang, MT; Drosten, M; Zhao, HY; Cecchi, F; Hembrough, T; Michels, J; Baumert, H; Miles, L; Campbell, NM; de Stanchina, E; Solit, DB; Barbacid, M; Taylor, BS; Rosen, N				Yao, Zhan; Yaeger, Rona; Rodrik-Outmezguine, Vanessa S.; Tao, Anthony; Torres, Neilawattie M.; Chang, Matthew T.; Drosten, Matthias; Zhao, Huiyong; Cecchi, Fabiola; Hembrough, Todd; Michels, Judith; Baumert, Herve; Miles, Linde; Campbell, Naomi M.; de Stanchina, Elisa; Solit, David B.; Barbacid, Mariano; Taylor, Barry S.; Rosen, Neal			Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS	NATURE			English	Article							WILD-TYPE; MUTATIONS; MECHANISMS	Approximately 200 BRAF mutant alleles have been identified in human tumours. Activating BRAF mutants cause feedback inhibition of GTP-bound RAS, are RAS-independent and signal either as active monomers (class 1) or constitutively active dimers (class 2)(1). Here we characterize a third class of BRAF mutants-those that have impaired kinase activity or are kinase-dead. These mutants are sensitive to ERK-mediated feedback and their activation of signalling is RAS-dependent. The mutants bind more tightly than wild-type BRAF to RAS-GTP, and their binding to and activation of wild-type CRAF is enhanced, leading to increased ERK signalling. The model suggests that dysregulation of signalling by these mutants in tumours requires coexistent mechanisms for maintaining RAS activation despite ERK-dependent feedback. Consistent with this hypothesis, melanomas with these class 3 BRAF mutations also harbour RAS mutations or NF1 deletions. By contrast, in lung and colorectal cancers with class 3 BRAF mutants, RAS is typically activated by receptor tyrosine kinase signalling. These tumours are sensitive to the inhibition of RAS activation by inhibitors of receptor tyrosine kinases. We have thus defined three distinct functional classes of BRAF mutants in human tumours. The mutants activate ERK signalling by different mechanisms that dictate their sensitivity to therapeutic inhibitors of the pathway.	[Yao, Zhan; Rodrik-Outmezguine, Vanessa S.; Torres, Neilawattie M.; Zhao, Huiyong; Miles, Linde; de Stanchina, Elisa; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA; [Yaeger, Rona; Solit, David B.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Tao, Anthony] New York Univ, Coll Arts & Sci, Ctr Neural Sci, New York, NY 10012 USA; [Chang, Matthew T.; Solit, David B.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Chang, Matthew T.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Drosten, Matthias; Barbacid, Mariano] CNIO, Mol Oncol Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Cecchi, Fabiola; Hembrough, Todd] NantOmics LLC, Mol Oncol Grp, 9600 Med Ctr Dr,Suite 300, Rockville, MD 20854 USA; [Michels, Judith] Dept Med Oncol, Gustave Roussy Canc Campus, Villejuif, France; [Michels, Judith] Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Baumert, Herve] St Joseph Hosp, Urol Dept, Paris, France; [Miles, Linde] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Anti Canc Drug Dev Grad Training Program, Baltimore, MD 21205 USA; [Campbell, Naomi M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Solit, David B.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Ctr Mech Based Therapeut, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Centro Nacional de Investigaciones Oncologicas (CNIO); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Mech Based Therapeut, New York, NY 10065 USA.	rosenn@mskcc.org	Solit, David B./AAC-5309-2019; Yao, Zhan/AAK-6756-2020; Michels, Judith/Q-5693-2018; Rosen, Neal/ABF-2677-2020	Michels, Judith/0000-0002-9640-0222; Solit, David/0000-0002-6614-802X; Miles, Linde/0000-0003-3578-2842; YAO, ZHAN/0000-0001-5391-5691; Drosten, Matthias/0000-0002-3205-456X	National Institutes of Health (NIH) [P01 CA129243, R35 CA210085]; Melanoma Research Alliance [237059, 348724]; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]; NIH MSKCC Cancer Center Support Grant [P30 CA008748]; Conquer Cancer Foundation of the American Society of Clinical Oncology; NIH [R01 CA204749, R01 CA180037, U54 ODSS020355, T32 GM007175]; Sontag Foundation; Josie Robertson Foundation; Cycle For Survival; Arlene and Joseph Taub Foundation; European Research Council [ERC-AG/250297-RAS AHEAD]; EU [HEALTH-F2-2010-259770/LUNGTARGET, HEALTH-2010-260791/ EUROCANPLATFORM]; Spanish Ministry of Economy and Competitiveness [SAF2011-30173, SAF2014-59864-R]; AXA Research Fund; NATIONAL CANCER INSTITUTE [R35CA210085, R01CA180037, P30CA008748, R01CA169351, P01CA129243, R01CA204749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant; NIH MSKCC Cancer Center Support Grant; Conquer Cancer Foundation of the American Society of Clinical Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Josie Robertson Foundation; Cycle For Survival; Arlene and Joseph Taub Foundation; European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); AXA Research Fund(AXA Research Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to P. Lito, Y. Gao, W. Su, L. Desrochers, D. Santamaria and O. Abdel-Wahab for useful discussions. We thank S. Lowe for the vectors of the retrovirus-based inducible expression system and M. Baccarini for the Raf1-knockout MEFs. We thank Novartis for supplying INC280. We also thank I. Maruani Ryan for her help on this work. This research was supported by grants to N.R. from the National Institutes of Health (NIH) (P01 CA129243; R35 CA210085); the Melanoma Research Alliance (237059 and 348724); The Commonwealth Foundation for Cancer Research and The Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; and the Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT17-15). Support was also received from the NIH MSKCC Cancer Center Support Grant P30 CA008748. Additional funding was provided by a Career Development Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (R.Y.); and from the NIH (R01 CA204749 and R01 CA180037), the Sontag and Josie Robertson Foundations and the Cycle For Survival (B.S.T.). Additional NIH funding was received by E.d.S. (U54 ODSS020355). We would like to acknowledge the support of the Arlene and Joseph Taub Foundation and of Paula and Thomas McInerney, without which this work would not have been possible. M.T.C. was supported in part by the NIH training grant T32 GM007175. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by grants from the European Research Council (ERC-AG/250297-RAS AHEAD), EU-Framework Programme (HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010-260791/ EUROCANPLATFORM) and Spanish Ministry of Economy and Competitiveness (SAF2011-30173 and SAF2014-59864-R) to M.B. M.B. is the recipient of an Endowed Chair from the AXA Research Fund.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Catenacci DVT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100586; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hall RD, 2014, CANCER CONTROL, V21, P221, DOI 10.1177/107327481402100307; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hembrough T, 2013, J MOL DIAGN, V15, P454, DOI 10.1016/j.jmoldx.2013.03.002; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Nieto P., 2017, NATURE; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	18	266	274	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					234	+		10.1038/nature23291	http://dx.doi.org/10.1038/nature23291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28783719	Green Accepted			2022-12-28	WOS:000407284300048
J	Yanagitani, K; Juszkiewicz, S; Hegde, RS				Yanagitani, Kota; Juszkiewicz, Szymon; Hegde, Ramanujan S.			UBE2O is a quality control factor for orphans of multiprotein complexes	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MISLOCALIZED PROTEINS; MEMBRANE-PROTEINS; ALPHA-HEMOGLOBIN; DEGRADATION; THERAPY; CELLS	Many nascent proteins are assembled into multiprotein complexes of defined stoichiometry. Imbalances in the synthesis of individual subunits result in orphans. How orphans are selectively eliminated to maintain protein homeostasis is poorly understood. Here, we found that the conserved ubiquitin-conjugating enzyme UBE2O directly recognized juxtaposed basic and hydrophobic patches on unassembled proteins to mediate ubiquitination without a separate ubiquitin ligase. In reticulocytes, where UBE2O is highly up-regulated, unassembled a-globin molecules that failed to assemble with beta-globin were selectively ubiquitinated by UBE2O. In nonreticulocytes, ribosomal proteins that did not engage nuclear import factors were targets for UBE2O. Thus, UBE2O is a self-contained quality control factor that comprises substrate recognition and ubiquitin transfer activities within a single protein to efficiently target orphans of multiprotein complexes for degradation.	[Yanagitani, Kota; Juszkiewicz, Szymon; Hegde, Ramanujan S.] MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Yanagitani, Kota] Thomas N Sato BioMEC X Labs, Adv Telecommun Res Inst Int ATR, Hikaridai 2-2-2, Kyoto 6190288, Japan	MRC Laboratory Molecular Biology; Advanced Telecommunications Research Institute International	Hegde, RS (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk	Yanagitani, Kota/N-4106-2018	Yanagitani, Kota/0000-0002-5905-9950; Hegde, Ramanujan/0000-0001-8338-852X; Juszkiewicz, Szymon/0000-0002-3361-7264	U.K. MRC [MC_UP_A022_1007]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; MRC; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007, 1662869] Funding Source: researchfish	U.K. MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Skehel and his team for mass spectrometry analysis; V. Bittl, M. Daly, and E. Zavodszky for initial help with flow cytometry assays; M. Rodrigo-Brenni for useful discussions about ubiquitination; S. Shao for useful discussions about preparing complexes in the PURE system; S. Elsasser for bioinformatics advice; and D. Finley for sharing results before publication. This work was supported by the U.K. MRC (MC_UP_A022_1007 to R.S.H.). K.Y. was supported by an Overseas Research fellowship from the Japan Society for the Promotion of Science, a fellowship from the Uehara Memorial Foundation, and a MRC postdoctoral fellowship. Additional data can be found in the supplementary materials.	Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Dodgson SE, 2016, GENETICS, V202, P1395, DOI 10.1534/genetics.115.185660; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guimaraes JC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1104-z; Harper JW, 2016, NATURE, V537, P328, DOI 10.1038/nature19947; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liang K., 2017, CELL, V168, DOI [10.1016/j.cell.2016.12.011, DOI 10.1016/J.CELL.2016.12.011;PMID:28065413]; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Miyazaki Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07687; Nguyen AT, 2017, SCIENCE, V357, DOI 10.1126/science.aan0218; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Shimizu Y, 2010, METHODS MOL BIOL, V607, P11, DOI 10.1007/978-1-60327-331-2_2; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; WEFES I, 1995, P NATL ACAD SCI USA, V92, P4982, DOI 10.1073/pnas.92.11.4982; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Xu Y, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.40; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38	29	61	61	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					472	+		10.1126/science.aan0178	http://dx.doi.org/10.1126/science.aan0178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774922	Green Accepted			2022-12-28	WOS:000406840100030
J	Gonzalez-Gay, MA; Matteson, EL; Castaneda, S				Gonzalez-Gay, Miguel A.; Matteson, Eric L.; Castaneda, Santos			Polymyalgia rheumatica	LANCET			English	Review							GIANT-CELL ARTERITIS; PROSPECTIVE FOLLOW-UP; PROVISIONAL CLASSIFICATION CRITERIA; SERONEGATIVE SYMMETRICAL SYNOVITIS; ERYTHROCYTE SEDIMENTATION-RATE; CERVICAL INTERSPINAL BURSITIS; POSITRON-EMISSION-TOMOGRAPHY; DOUBLE-BLIND; RHEUMATISM/AMERICAN COLLEGE; TEMPORAL ARTERITIS	Polymyalgia rheumatica is an inflammatory disease that affects the shoulder, the pelvic girdles, and the neck, usually in individuals older than 50 years. Increases in acute phase reactants are typical of polymyalgia rheumatica. The disorder might present as an isolated condition or in association with giant cell arteritis. Several diseases, including inflammatory rheumatic and autoimmune diseases, infections, and malignancies can mimic polymyalgia rheumatica. Imaging techniques have identified the presence of bursitis in more than half of patients with active disease. Vascular uptake on PET scans is seen in some patients. A dose of 12.5-25.0 mg prednisolone daily or equivalent leads to rapid improvement of symptoms in most patients with isolated disease. However, relapses are common when prednisolone is tapered. Methotrexate might be used in patients who relapse. The effectiveness of biological therapies, such as anti-interleukin 6, in patients with polymyalgia rheumatica that is refractory to glucocorticoids requires further investigation. Most population-based studies indicate that mortality is not increased in patients with isolated disease.	[Gonzalez-Gay, Miguel A.] Univ Cantabria, Div Rheumatol & Epidemiol, Genet & Atherosclerosis Res Grp Syst Inflammatory, Hosp Univ Marques de Valdecilla,Inst Invest Marqu, Santander 39011, Spain; [Gonzalez-Gay, Miguel A.] Univ Witwatersrand, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Matteson, Eric L.] Mayo Clin, Coll Med & Sci, Div Rheumatol, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA; [Castaneda, Santos] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp La Princesa, Rheumatol Div, Madrid, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Witwatersrand; Mayo Clinic; Mayo Clinic; Autonomous University of Madrid; Hospital de La Princesa	Gonzalez-Gay, MA (corresponding author), Univ Cantabria, Div Rheumatol & Epidemiol, Genet & Atherosclerosis Res Grp Syst Inflammatory, Hosp Univ Marques de Valdecilla,Inst Invest Marqu, Santander 39011, Spain.	miguelaggay@hotmail.com			Instituto de Salud Carlos III [PI06/0024, PS09/00748, PI12/00060, PI15/00525]; RETICS from Instituto de Salud Carlos III [RD12/0009]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); RETICS from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	We thank Isabel Martinez-Rodriguez and Ignacio Banzo from Hospital Universitario Marques de Valdecilla (Santander, Spain) for providing the PET and CT images for figure 1 and 2 of this Seminar; and Pierluigi Macchioni from Arcispedale Santa Maria Nuova (Reggio-Emilia, Italy) for kindly providing the ultrasound images for figure 3 of this Seminar. This study was funded by the Instituto de Salud Carlos III (grants PI06/0024, PS09/00748, PI12/00060, and PI15/00525), and was partially funded by RETICS Programs RD12/0009 from Instituto de Salud Carlos III.	Aikawa NE, 2012, CLIN RHEUMATOL, V31, P575, DOI 10.1007/s10067-011-1914-z; Baerlecken NT, 2012, ANN RHEUM DIS, V71, P943, DOI 10.1136/annrheumdis-2011-200413; Bahlas S, 1998, J RHEUMATOL, V25, P99; BEHN AR, 1983, ANN RHEUM DIS, V42, P374, DOI 10.1136/ard.42.4.374; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; BOESEN P, 1987, ARTHRITIS RHEUM, V30, P294, DOI 10.1002/art.1780300308; Boiardi L, 2006, J RHEUMATOL, V33, P703; Camellino D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0492-2; Cantini F, 2005, CLIN EXP RHEUMATOL, V23, P462; Cantini F, 2004, J RHEUMATOL, V31, P120; Cantini F, 1999, ANN RHEUM DIS, V58, P230, DOI 10.1136/ard.58.4.230; Cantini F, 2001, J RHEUMATOL, V28, P1049; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Ceccato F, 2006, CLIN RHEUMATOL, V25, P854, DOI 10.1007/s10067-005-0188-8; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Crowson CS, 2017, SEMIN ARTHRITIS RHEU, V47, P253, DOI 10.1016/j.semarthrit.2017.04.001; Cutolo M, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000426; Dababneh A, 1998, J RHEUMATOL, V25, P2140; Dasgupta B, 1998, BRIT J RHEUMATOL, V37, P189; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; Dejaco C, 2015, ANN RHEUM DIS, V74, P1799, DOI 10.1136/annrheumdis-2015-207492; Dejaco C, 2015, ARTHRITIS RHEUMATOL, V67, P2569, DOI 10.1002/art.39333; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; Devauchelle-Pensec V, 2016, ANN RHEUM DIS, V75, P1506, DOI 10.1136/annrheumdis-2015-208742; Doran MF, 2002, J RHEUMATOL, V29, P1694; Elling P, 1996, J RHEUMATOL, V23, P112; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Gonzalez-Gay MA, 1999, J RHEUMATOL, V26, P1326; Gonzalez-Gay MA, 1999, CLIN EXP RHEUMATOL, V17, P276; Gonzalez-Gay MA, 1998, J RHEUMATOL, V25, P1750; Gonzalez-Gay MA, 2000, J RHEUMATOL, V27, P2179; Gonzalez-Gay MA, 2000, CLIN EXP RHEUMATOL, V18, P755; Gonzalez-Gay MA, 2004, ARTHRIT RHEUM-ARTHR, V51, P652, DOI 10.1002/art.20523; Gonzalez-Gay MA, 2004, SEMIN ARTHRITIS RHEU, V33, P289, DOI 10.1016/j.semarthrit.2003.09.007; Gonzalez-Gay MA, 2004, ARTHRIT RHEUM-ARTHR, V51, P274, DOI 10.1002/art.20231; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay MA, 2002, CLIN EXP RHEUMATOL, V20, P179; Gonzalez-Gay MA, 2008, ANN RHEUM DIS, V67, P733, DOI 10.1136/ard.2008.087999; Gonzalez-Gay MA, 2007, MEDICINE, V86, P61, DOI 10.1097/md.0b013e31803d1764; Gonzalez-Gay MA, 2006, DRUG AGING, V23, P627, DOI 10.2165/00002512-200623080-00002; Gonzalez-Gay MA, 2016, EXPERT OPIN ORPHAN D, V4, P1133, DOI 10.1080/21678707.2016.1244480; Gonzalez-Gay MA, 2016, NAT REV RHEUMATOL, V12, P3, DOI 10.1038/nrrheum.2015.142; Gonzalez-Gay MA, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-014-0480-1; Gonzalez-Gay MA, 2010, EXPERT OPIN PHARMACO, V11, P1077, DOI 10.1517/14656561003724739; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P317, DOI 10.1001/archinte.157.3.317; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P2016, DOI 10.1001/archinte.1997.00440380126014; Gran JT, 2001, RHEUMATOLOGY, V40, P1238, DOI 10.1093/rheumatology/40.11.1238; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; HEALEY LA, 1992, J RHEUMATOL, V19, P270; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Helliwell T, 2016, J RHEUMATOL, V43, P182, DOI 10.3899/jrheum.141179; Hernandez-Rodriguez J, 2009, ARCH INTERN MED, V169, P1839, DOI 10.1001/archinternmed.2009.352; Hunder GG, 2006, MAYO CLIN PROC, V81, P1071, DOI 10.4065/81.8.1071; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; Kang JH, 2011, CEREBROVASC DIS, V32, P497, DOI 10.1159/000332031; Kermani TA, 2013, LANCET, V381, P63, DOI 10.1016/S0140-6736(12)60680-1; Kreiner F, 2010, ARTHRITIS RHEUM-US, V62, P3768, DOI 10.1002/art.27728; Kremers HM, 2007, ARTHRIT RHEUM-ARTHR, V57, P279, DOI 10.1002/art.22548; Kremers HM, 2005, J RHEUMATOL, V32, P65; KYLE V, 1993, ANN RHEUM DIS, V52, P847, DOI 10.1136/ard.52.12.847; Lally L, 2016, ARTHRITIS RHEUMATOL, V68, P2550, DOI 10.1002/art.39740; Langford CA, 2017, ARTHRITIS RHEUMATOL, V69, P837, DOI 10.1002/art.40044; Lavado-Perez C, 2015, REV ESP MED NUCL IMA, V34, P275, DOI [10.1016/j.remnie.2015.07.005, 10.1016/j.remn.2015.05.011]; Loricera J, 2015, REV ESP MED NUCL IMA, V34, P372, DOI 10.1016/j.remn.2015.07.002; Loricera J, 2015, CLIN EXP RHEUMATOL, V33, pS19; Loricera J, 2014, CLIN EXP RHEUMATOL, V32, pS79; Loricera J, 2015, SEMIN ARTHRITIS RHEU, V44, P717, DOI 10.1016/j.semarthrit.2014.12.005; Macchioni P, 2014, ANN RHEUM DIS, V73, P1190, DOI 10.1136/annrheumdis-2013-204167; Macchioni P, 2013, SEMIN ARTHRITIS RHEU, V43, P113, DOI 10.1016/j.semarthrit.2013.01.003; Macchioni P, 2009, RHEUMATOLOGY, V48, P1566, DOI 10.1093/rheumatology/kep286; Mackie SL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6937; Mackie SL, 2015, ANN RHEUM DIS, V74, P2188, DOI 10.1136/annrheumdis-2015-207395; Martinez-Rodriguez I, 2014, EUR J NUCL MED MOL I, V41, P2319, DOI 10.1007/s00259-014-2863-y; Masson C, 2015, EULAR TXB RHEUMATIC, P754; Matsui K, 2018, INT J RHEUM DIS, V21, P497, DOI 10.1111/1756-185X.13006; Matteson EL, 2016, RHEUM DIS CLIN N AM, V42, P75, DOI 10.1016/j.rdc.2015.08.009; Matteson EL, 2012, J RHEUMATOL, V39, P795, DOI 10.3899/jrheum.110977; Mattey DL, 2000, ARTHRITIS RHEUM, V43, P1749, DOI 10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K; MCCARTY DJ, 1985, JAMA-J AM MED ASSOC, V254, P2763, DOI 10.1001/jama.254.19.2763; Meliconi R, 1996, ARTHRITIS RHEUM-US, V39, P1199, DOI 10.1002/art.1780390719; Mok CC, 2015, BONE, V75, P222, DOI 10.1016/j.bone.2015.03.002; Mori S, 2016, CLIN RHEUMATOL, V35, P1367, DOI 10.1007/s10067-014-2650-y; Myklebust G, 2003, SCAND J RHEUMATOL, V32, P38, DOI 10.1080/03009740310000382; Narvaez J, 2015, SEMIN ARTHRITIS RHEU, V45, P328, DOI 10.1016/j.semarthrit.2015.06.009; Nesher G, 2016, RAMBAM MAIMONIDES ME, V7, DOI 10.5041/RMMJ.10262; Olivieri I, 2007, RHEUMATOL INT, V27, P927, DOI 10.1007/s00296-007-0331-8; Olivieri I, 2012, J RHEUMATOL, V39, P1110, DOI 10.3899/jrheum.120184; Ortego-Jurado M, 2015, J OSTEOPOROS, V2015, DOI 10.1155/2015/729451; Owen CE, 2015, INTERN MED J, V45, P1102, DOI 10.1111/imj.12823; Ozen G, 2016, J RHEUMATOL, V43, P893, DOI 10.3899/jrheum.151103; Pease CT, 2009, RHEUMATOLOGY, V48, P123, DOI 10.1093/rheumatology/ken343; Pease CT, 2005, J RHEUMATOL, V32, P1043; Pego-Reigosa JM, 2005, ARTHRIT RHEUM-ARTHR, V53, P931, DOI 10.1002/art.21585; Peris P, 2003, J RHEUMATOL, V30, P2624; Pipitone N, 2013, EUR J INTERN MED, V24, P583, DOI 10.1016/j.ejim.2013.03.003; Proven A, 1999, J RHEUMATOL, V26, P1333; Pujades-Rodriguez M, 2016, HEART, V102, P383, DOI 10.1136/heartjnl-2015-308514; Raheel S, 2016, ARTHRITIS CARE RES, DOI [10.1002/, DOI 10.1002/]; Regent A, 2016, J RHEUMATOL, V43, P1547, DOI 10.3899/jrheum.151252; Rhee RL, 2017, ANN RHEUM DIS, V76, P1031, DOI 10.1136/annrheumdis-2016-210152; Rizzoli R, 2012, CALCIFIED TISSUE INT, V91, P225, DOI 10.1007/s00223-012-9630-5; Rizzoli R, 2015, NAT REV RHEUMATOL, V11, P98, DOI 10.1038/nrrheum.2014.188; Sakellariou G, 2013, CLIN EXP RHEUMATOL, V31, P1; Salvarani C, 2008, ANN RHEUM DIS, V67, P758, DOI 10.1136/ard.2007.084723; SALVARANI C, 1994, ARTHRITIS RHEUM, V37, P1621, DOI 10.1002/art.1780371111; Salvarani C, 1997, ANN INTERN MED, V127, P27, DOI 10.7326/0003-4819-127-1-199707010-00005; Salvarani C, 2000, J RHEUMATOL, V27, P1470; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Salvarani C, 2013, CLIN EXP RHEUMATOL, V31, P526; Salvarani C, 2003, CLIN EXP RHEUMATOL, V21, pS23; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 1999, J RHEUMATOL, V26, P517; Salvarani C, 1996, ARTHRITIS RHEUM, V39, P73, DOI 10.1002/art.1780390110; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; SALVARANI C, 1991, ARTHRITIS RHEUM, V34, P351, DOI 10.1002/art.1780340313; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P3788, DOI 10.1002/art.34647; SCHAUFELBERGER C, 1995, BRIT J RHEUMATOL, V34, P261; Singh YP, 2015, ANN RHEUM DIS, V74, P1808, DOI 10.1136/annrheumdis-2015-207578; van der Geest KSM, 2015, RHEUMATOLOGY, V54, P1397, DOI 10.1093/rheumatology/keu526; van der Geest KSM, 2014, ARTHRITIS RHEUMATOL, V66, P1927, DOI 10.1002/art.38625; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; Villiger PM, 2016, LANCET, V387, P1921, DOI 10.1016/S0140-6736(16)00560-2; Wakura D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158509; Warrington KJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2664; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]; Yates M, 2017, CLIN EXP RHEUMATOL, V35, P1; Yates M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1127-3	134	126	134	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1700	1712		10.1016/S0140-6736(17)31825-1	http://dx.doi.org/10.1016/S0140-6736(17)31825-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI9TS	28774422				2022-12-28	WOS:000412352800029
J	Kingston, A; Wohland, P; Wittenberg, R; Robinson, L; Brayne, C; Matthews, FE; Jagger, C				Kingston, Andrew; Wohland, Pia; Wittenberg, Raphael; Robinson, Louise; Brayne, Carol; Matthews, Fiona E.; Jagger, Carol		Cognitive Function Ageing Studies	Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)	LANCET			English	Article							ENGLAND; EXPECTANCY; HEALTH; OLDER	Background Little is known about how the proportions of dependency states have changed between generational cohorts of older people. We aimed to estimate years lived in different dependency states at age 65 years in 1991 and 2011, and new projections of future demand for care. Methods In this population-based study, we compared two Cognitive Function and Ageing Studies (CFAS I and CFAS II) of older people (aged >= 65 years) who were permanently registered with a general practice in three defined geographical areas (Cambridgeshire, Newcastle, and Nottingham; UK). These studies were done two decades apart (1991 and 2011). General practices provided lists of individuals to be contacted and were asked to exclude those who had died or might die over the next month. Baseline interviews were done in the community and care homes. Participants were stratified by age, and interviews occurred only after written informed consent was obtained. Information collected included basic sociodemographics, cognitive status, urinary incontinence, and self-reported ability to do activities of daily living. CFAS I was assigned as the 1991 cohort and CFAS II as the 2011 cohort, and both studies provided prevalence estimates of dependency in four states: high dependency (24-h care), medium dependency (daily care), low dependency (less than daily), and independent. Years in each dependency state were calculated by Sullivan's method. To project future demands for social care, the proportions in each dependency state (by age group and sex) were applied to the 2014 England population projections. Findings Between 1991 and 2011, there were significant increases in years lived from age 65 years with low dependency (1.7 years [95% CI 1.0-2.4] for men and 2.4 years [1.8-3.1] for women) and increases with high dependency (0.9 years [0.2-1.7] for men and 1.3 years [0.5-2.1] for women). The majority of men's extra years of life were spent independent (36.3%) or with low dependency (36.3%) whereas for women the majority were spent with low dependency (58.0%), and only 4.8% were independent. There were substantial reductions in the proportions with medium and high dependency who lived in care homes, although, if these dependency and care home proportions remain constant in the future, further population ageing will require an extra 71 215 care home places by 2025. Interpretation On average older men now spend 2.4 years and women 3.0 years with substantial care needs, and most will live in the community. These findings have considerable implications for families of older people who provide the majority of unpaid care, but the findings also provide valuable new information for governments and care providers planning the resources and funding required for the care of their future ageing populations. Funding Medical Research Council (G9901400) and (G06010220), with support from the National Institute for Health Research Comprehensive Local research networks in West Anglia and Trent, UK, and Neurodegenerative Disease Research Network in Newcastle, UK. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under CC BY 4.0 license.	[Kingston, Andrew; Robinson, Louise; Matthews, Fiona E.; Jagger, Carol] Newcastle Univ, Fac Med, Inst Hlth & Soc, Newcastle NE4 5PL, England; [Kingston, Andrew; Robinson, Louise; Matthews, Fiona E.; Jagger, Carol] Newcastle Univ, Fac Med, Inst Ageing, Newcastle, England; [Wohland, Pia] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Wittenberg, Raphael] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London, England; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Matthews, Fiona E.] Univ Cambridge, Cambridge Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	Newcastle University - UK; Newcastle University - UK; University of Hull; University of York - UK; University of London; London School Economics & Political Science; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Jagger, C (corresponding author), Newcastle Univ, Fac Med, Inst Hlth & Soc, Newcastle NE4 5PL, England.	carol.jagger@newcastle.ac.uk	Matthews, Fiona/O-6932-2015; Comas-Herrera, Adelina/A-2325-2011; Comas-Herrera, Adelina/Q-7107-2019; Brayne, Carol/AAA-4285-2020; Wohland, Pia/AAV-8877-2020; Wohland, Pia/H-3096-2016; Dening, Tom/E-1335-2013	Matthews, Fiona/0000-0002-1728-2388; Comas-Herrera, Adelina/0000-0002-9860-9062; Comas-Herrera, Adelina/0000-0002-9860-9062; Brayne, Carol/0000-0001-5307-663X; McKeith, Ian/0000-0002-9250-0568; Wohland, Pia/0000-0002-6893-5852; Wharton, Stephen B/0000-0003-2785-333X; Kingston, Andrew/0000-0003-4211-7007; Pickett, James/0000-0002-2657-0795; Jagger, Carol/0000-0002-6377-9926; Dening, Tom/0000-0003-3387-4241	Medical Research Council [G9901400, G06010220]; National Institute for Health Research Comprehensive Local research network in West Anglia; National Institute for Health Research Comprehensive Local research network in Trent, UK; Neurodegenerative Disease Research Network in Newcastle, UK; ESRC [ES/I017399/1] Funding Source: UKRI; MRC [MC_U105292687, G9901400, G0601022, MC_UU_00002/12] Funding Source: UKRI; Economic and Social Research Council [ES/I017399/1] Funding Source: researchfish; Medical Research Council [G0601022, MC_U105292687, MC_UU_00002/12] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-043, NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Local research network in West Anglia; National Institute for Health Research Comprehensive Local research network in Trent, UK; Neurodegenerative Disease Research Network in Newcastle, UK; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Medical Research Council (G9901400) and (G06010220), with support from the National Institute for Health Research Comprehensive Local research networks in West Anglia and Trent, UK, and Neurodegenerative Disease Research Network in Newcastle, UK.	Appleby J, 2015, Q MONITORING REPORT; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Brayne C, 1999, BMJ; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; De Brauwer I, 2014, ARCH GERONTOL GERIAT, V59, P175, DOI 10.1016/j.archger.2014.03.005; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Fernandez J-L, 2010, AGEING SOC CHALLENGE; Folstein M, 1975, J PSYCHIAT RES; Freedman VA, 2016, AM J PUBLIC HEALTH, V106, P1079, DOI 10.2105/AJPH.2016.303089; Gerada C, 2012, PREPARING FUTURE GP; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; ISAACS B, 1976, BRIT J PREV SOC MED, V30, P79; Jagger C, CAPABILITY DEPENDENC; Jagger C., HLTH EXPECTANCY CALC; Jagger C, 2016, LANCET, V387, P779, DOI 10.1016/S0140-6736(15)00947-2; Jagger C, 2011, INT HANDB POPUL, V2, P551, DOI 10.1007/978-90-481-9996-9_26; Kingston A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031665; Koopmans RTCM, 2013, J AM MED DIR ASSOC, V14, P781, DOI 10.1016/j.jamda.2013.08.004; Kreft D, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0093-1; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Malley Juliette, 2011, Health Stat Q, P33, DOI 10.1057/hsq.2011.17; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mathers CD, CAUSES INT INCREASES; Matthews FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161705; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McGee MA, 1998, AGE AGEING, V27, P605, DOI 10.1093/ageing/27.5.605; Mortimer J, 2015, HLTH CARE OLDER PEOP; Nadash P, 2017, GERONTOLOGIST, DOI [10.1093/geront/, DOI 10.1093/geront/]; Robinson L., 2015, PRESENT FUTURE CONFI; Seko R, 2012, J EPIDEMIOL, V22, P238, DOI 10.2188/jea.JE20110069; Stineman MG, 2014, PM&R, V6, P976, DOI 10.1016/j.pmrj.2014.05.001; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; UN Department of Economic and Social Affairs, 2009, WORLD POP AG 2009	34	81	81	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1676	1684		10.1016/S0140-6736(17)31575-1	http://dx.doi.org/10.1016/S0140-6736(17)31575-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI9TS	28821408	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000412352800027
J	Gottlieb, S; Zeller, M				Gottlieb, Scott; Zeller, Mitchell			A Nicotine-Focused Framework for Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STANDARDS		[Gottlieb, Scott] US FDA, Off Commissioner, Silver Spring, MD 20993 USA; [Zeller, Mitchell] US FDA, Ctr Tobacco Prod, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP)	Gottlieb, S (corresponding author), US FDA, Off Commissioner, Silver Spring, MD 20993 USA.							[Anonymous], 2004, HLTH CONS SMOK REP S; Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Donny EC, 2015, NEW ENGL J MED, V373, P1340, DOI 10.1056/NEJMsa1502403; Donny EC, 2014, PREV MED, V68, P17, DOI 10.1016/j.ypmed.2014.06.020	5	181	184	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2017	377	12					1111	1114		10.1056/NEJMp1707409	http://dx.doi.org/10.1056/NEJMp1707409			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7FF	28813211	Bronze			2022-12-28	WOS:000411348500004
J	Patel, S				Patel, Sachin			Cannabis for Pain and Posttraumatic Stress Disorder: More Consensus Than Controversy or Vice Versa?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Patel, Sachin] Vanderbilt Psychiat Hosp, 1601 23rd Ave South, Nashville, TN 37232 USA	Vanderbilt University	Patel, S (corresponding author), Vanderbilt Psychiat Hosp, 1601 23rd Ave South, Nashville, TN 37232 USA.	Sachin.patel@vanderbilt.edu	Patel, Sachin/E-5608-2012		NIMH NIH HHS [R01 MH107435] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107435] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C, DOI [10.17226/24625, DOI 10.17226/24625]; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; O'Neil ME, 2017, ANN INTERN MED, V167, P332, DOI 10.7326/M17-0477; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Serpell M, 2014, EUR J PAIN, V18, P999, DOI 10.1002/j.1532-2149.2013.00445.x	5	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					355	356		10.7326/M17-1713	http://dx.doi.org/10.7326/M17-1713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28806789				2022-12-28	WOS:000409120400011
J	Hirota, T; Ohta, H; Powell, BE; Mahadevaiah, SK; Ojarikre, OA; Saitou, M; Turner, JMA				Hirota, Takayuki; Ohta, Hiroshi; Powell, Benjamin E.; Mahadevaiah, Shantha K.; Ojarikre, Obah A.; Saitou, Mitinori; Turner, James M. A.			Fertile offspring from sterile sex chromosome trisomic mice	SCIENCE			English	Article							PLURIPOTENT STEM-CELLS; DOWN-SYNDROME; GERM-CELLS; MOUSE; FATE	Having the correct number of chromosomes is vital for normal development and health. Sex chromosome trisomy affects 0.1% of the human population and is associated with infertility. We show that during reprogramming to induced pluripotent stem cells (iPSCs), fibroblasts from sterile trisomic XXYand XYYmice lose the extra sex chromosome through a phenomenon we term trisomy-biased chromosome loss (TCL). Resulting euploid XY iPSCs can be differentiated into the male germ cell lineage and functional sperm that can be used in intracytoplasmic sperm injection to produce chromosomally normal, fertile offspring. Sex chromosome loss is comparatively infrequent during mouse XX and XY iPSC generation. TCL also applies to other chromosomes, generating euploid iPSCs from cells of a Down syndrome mouse model. It can also create euploid iPSCs from human trisomic patient fibroblasts. The findings have relevance to overcoming infertility and other trisomic phenotypes.	[Hirota, Takayuki; Powell, Benjamin E.; Mahadevaiah, Shantha K.; Ojarikre, Obah A.; Turner, James M. A.] Francis Crick Inst, Sex Chromosome Biol Lab, London NW1 1AT, England; [Ohta, Hiroshi; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Kyoto 6068501, Japan; [Ohta, Hiroshi; Saitou, Mitinori] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Kyoto, Japan; [Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068501, Japan	Francis Crick Institute; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Turner, JMA (corresponding author), Francis Crick Inst, Sex Chromosome Biol Lab, London NW1 1AT, England.; Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Kyoto 6068501, Japan.; Saitou, M (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Kyoto, Japan.; Saitou, M (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.; Saitou, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp; james.turner@crick.ac.uk		Hirota, Takayuki/0000-0002-8145-3225; Powell, Benjamin/0000-0003-2533-8262	Francis Crick Institute; Cancer Research UK [FC001193]; UK Medical Research Council [FC001193]; Wellcome Trust [FC001193]; European Research Council [CoG 647971]; Japan Science and Technology Agency [JPMJER1104]; Japan Society for the Promotion of Science [17H06098]; The Francis Crick Institute [10193] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001193), UK Medical Research Council (FC001193), and Wellcome Trust (FC001193); European Research Council (CoG 647971); Japan Science and Technology Agency (JPMJER1104); and Japan Society for the Promotion of Science (17H06098). We thank the Francis Crick Institute Biological Research, Light Microscopy, and Experimental Histopathology facilities; M. Sangrithi and I. Okamoto for technical advice; V. Tybulewicz for Tc1 mice; and K. Niakan, R. Lovell-Badge, and Turner laboratory members for comments.	Amano T, 2015, DNA RES, V22, P331, DOI 10.1093/dnares/dsv016; Arnold Arthur P, 2012, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-30726-3_4; Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Greco E, 2013, HUM REPROD, V28, P1155, DOI 10.1093/humrep/det046; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heard E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002675; Hughes JF, 2015, ANNU REV GENET, V49, P507, DOI 10.1146/annurev-genet-112414-055311; Hunt PA, 1998, MOL REPROD DEV, V49, P101, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;101::AID-MRD1&gt;3.0.CO;2-T; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishii T, 2013, CELL STEM CELL, V13, P145, DOI 10.1016/j.stem.2013.07.005; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Mahadevaiah SK, 2000, CYTOGENET CELL GENET, V89, P29, DOI 10.1159/000015585; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ramasamy R, 2009, J UROLOGY, V182, P1108, DOI 10.1016/j.juro.2009.05.019; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Sheppard O, 2012, SCI WORLD J, DOI 10.1100/2012/214078; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	25	33	34	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					932	934		10.1126/science.aam9046	http://dx.doi.org/10.1126/science.aam9046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28818972	Green Submitted, Green Accepted			2022-12-28	WOS:000408734900046
J	Patel, SJ; Sanjana, NE; Kishton, RJ; Eidizadeh, A; Vodnala, SK; Cam, M; Gartner, JJ; Jia, L; Steinberg, SM; Yamamoto, TN; Merchant, AS; Mehta, GU; Chichura, A; Shalem, O; Tran, E; Eil, R; Sukumar, M; Guijarro, EP; Day, CP; Robbins, P; Feldman, S; Merlino, G; Zhang, F; Restifo, NP				Patel, Shashank J.; Sanjana, Neville E.; Kishton, Rigel J.; Eidizadeh, Arash; Vodnala, Suman K.; Cam, Maggie; Gartner, Jared J.; Jia, Li; Steinberg, Seth M.; Yamamoto, Tori N.; Merchant, Anand S.; Mehta, Gautam U.; Chichura, Anna; Shalem, Ophir; Tran, Eric; Eil, Robert; Sukumar, Madhusudhanan; Guijarro, Eva Perez; Day, Chi-Ping; Robbins, Paul; Feldman, Steve; Merlino, Glenn; Zhang, Feng; Restifo, Nicholas P.			Identification of essential genes for cancer immunotherapy	NATURE			English	Article							CELL LUNG-CANCER; METASTATIC MELANOMA; DIFFERENTIAL GENE; ENDOTHELIAL-CELLS; CTLA-4 BLOCKADE; PD-1 BLOCKADE; T-CELLS; GENOME; RECEPTOR; LYMPHOCYTES	Somatic gene mutations can alter the vulnerability of cancer cells to T-cell-based immunotherapies. Here we perturbed genes in human melanoma cells to mimic loss-of-function mutations involved in resistance to these therapies, by using a genome-scale CRISPR-Cas9 library that consisted of around 123,000 single-guide RNAs, and profiled genes whose loss in tumour cells impaired the effector function of CD8(+) T cells. The genes that were most enriched in the screen have key roles in antigen presentation and interferon-gamma signalling, and correlate with cytolytic activity in patient tumours from The Cancer Genome Atlas. Among the genes validated using different cancer cell lines and antigens, we identified multiple loss-of-function mutations in APLNR, encoding the apelin receptor, in patient tumours that were refractory to immunotherapy. We show that APLNR interacts with JAK1, modulating interferon-gamma responses in tumours, and that its functional loss reduces the efficacy of adoptive cell transfer and checkpoint blockade immunotherapies in mouse models. Our results link the loss of essential genes for the effector function of CD8(+) T cells with the resistance or non-responsiveness of cancer to immunotherapies.	[Patel, Shashank J.; Kishton, Rigel J.; Eidizadeh, Arash; Vodnala, Suman K.; Cam, Maggie; Gartner, Jared J.; Jia, Li; Steinberg, Seth M.; Yamamoto, Tori N.; Merchant, Anand S.; Mehta, Gautam U.; Chichura, Anna; Tran, Eric; Eil, Robert; Sukumar, Madhusudhanan; Guijarro, Eva Perez; Day, Chi-Ping; Robbins, Paul; Feldman, Steve; Merlino, Glenn; Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA; [Patel, Shashank J.] Georgetown Univ, Sch Med, NIH Georgetown Univ Grad Partnership Program, Washington, DC 20057 USA; [Sanjana, Neville E.] New York Genome Ctr, New York, NY 10013 USA; [Sanjana, Neville E.] NYU, Dept Biol, 550 1St Ave, New York, NY 10012 USA; [Yamamoto, Tori N.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Shalem, Ophir] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Shalem, Ophir] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Restifo, Nicholas P.] NIH, Ctr Cell Based Therapy, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; New York University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Patel, SJ; Restifo, NP (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.; Patel, SJ (corresponding author), Georgetown Univ, Sch Med, NIH Georgetown Univ Grad Partnership Program, Washington, DC 20057 USA.; Sanjana, NE (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Sanjana, NE (corresponding author), NYU, Dept Biol, 550 1St Ave, New York, NY 10012 USA.; Restifo, NP (corresponding author), NIH, Ctr Cell Based Therapy, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	patelsj@mail.nih.gov; nsanjana@nygenome.org; restifon@mail.nih.gov	Restifo, Nicholas Phillip/Z-1614-2019; Macrae, Rhiannon/AAX-1536-2020; wang, edwin/G-5372-2010; Restifo, Nicholas Phillip/M-6549-2019; Mehta, Gautam/AAP-6600-2020; Feldman, Steven R./AAH-6971-2021	Mehta, Gautam/0000-0002-8009-6430; Feldman, Steven R./0000-0002-0090-6289; Patel, Shashank/0000-0001-6973-6997; Restifo, Nicholas P./0000-0003-4229-4580; Shalem, Ophir/0000-0002-2267-0801	Intramural Research Program of the NCI; Cancer Moonshot program for the Center for Cell-based Therapy at the NCI, NIH; Milstein Family Foundation; NIH through NHGRI [R00-HG008171]; Sidney Kimmel Scholar Award; NATIONAL CANCER INSTITUTE [ZIABC011167] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG008171] Funding Source: NIH RePORTER	Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Moonshot program for the Center for Cell-based Therapy at the NCI, NIH; Milstein Family Foundation; NIH through NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Sidney Kimmel Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The research was supported by the Intramural Research Program of the NCI, and by the Cancer Moonshot program for the Center for Cell-based Therapy at the NCI, NIH. The work was also supported by the Milstein Family Foundation. We thank S.A. Rosenberg, K. Hanada, A. Wellstein, C. Hurley and L. M. Weiner for their valuable discussions and intellectual input, M. Kruhlak, Z. Yu, C. Subramaniam, C. Kariya, A. J. Leonardi, N. Ha, H. Xu, M. A. Black and H. Chinnasamy for technical assistance in this project. This work used the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov). The results here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This study was done in partial fulfilment of a PhD in Tumor Biology to S.J.P. N.E.S. is supported by the NIH through NHGRI (R00-HG008171) and a Sidney Kimmel Scholar Award.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan TA, 2015, NEW ENGL J MED, V373, P1984, DOI 10.1056/NEJMc1508163; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kammertoens T, 2017, NATURE, V545, P98, DOI 10.1038/nature22311; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le D. T., 2017, SCI AAN, V6733; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nathanson T, 2017, CANCER IMMUNOL RES, V5, P84, DOI 10.1158/2326-6066.CIR-16-0019; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Roh W., 2017, SCI TRANSL MED, V9; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Wang LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062924; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	49	463	481	4	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					537	+		10.1038/nature23477	http://dx.doi.org/10.1038/nature23477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28783722	Green Accepted, Green Published			2022-12-28	WOS:000408703100028
J	Sigal, M; Logan, CY; Kapalczynska, M; Mollenkopf, HJ; Berger, H; Wiedenmann, B; Nusse, R; Amieva, MR; Meyer, TF				Sigal, Michael; Logan, Catriona Y.; Kapalczynska, Marta; Mollenkopf, Hans-Joachim; Berger, Hilmar; Wiedenmann, Bertram; Nusse, Roeland; Amieva, Manuel R.; Meyer, Thomas F.			Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis	NATURE			English	Article							SMALL-INTESTINE; WNT RECEPTORS; LGR5; STOMACH; MOUSE; CANCER; IDENTIFICATION; POPULATIONS; EXPRESSION; REVEALS	The constant regeneration of stomach epithelium is driven by long-lived stem cells(1-3), but the mechanism that regulates their turnover is not well understood. We have recently found that the gastric pathogen Helicobacter pylori can activate gastric stem cells and increase epithelial turnover(4), while Wnt signalling is known to be important for stem cell identity and epithelial regeneration in several tissues(5). Here we find that antral Wnt signalling, marked by the classic Wnt target gene Axin2, is limited to the base and lower isthmus of gastric glands, where the stem cells reside. Axin2 is expressed by Lgr5(+) cells, as well as adjacent, highly proliferative Lgr(5-) cells that are able to repopulate entire glands, including the base, upon depletion of the Lgr5(+) population. Expression of both Axin2 and Lgr5 requires stroma-derived R-spondin 3 produced by gastric myofibroblasts proximal to the stem cell compartment. Exogenous R-spondin administration expands and accelerates proliferation of Axin2(+)/Lgr5(-) but not Lgr5(+) cells. Consistent with these observations, H. pylori infection increases stromal R-spondin 3 expression and expands the Axin2(+) cell pool to cause hyperproliferation and gland hyperplasia. The ability of stromal niche cells to control and adapt epithelial stem cell dynamics constitutes a sophisticated mechanism that orchestrates epithelial regeneration and maintenance of tissue integrity.	[Sigal, Michael; Kapalczynska, Marta; Berger, Hilmar; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Sigal, Michael; Kapalczynska, Marta; Wiedenmann, Bertram] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Sigal, Michael] Berlin Inst Hlth, D-10117 Berlin, Germany; [Logan, Catriona Y.; Nusse, Roeland] Stanford Univ, Dept Dev Biol, Howard Hughes Med Inst, Stanford Inst Stem Cell Biol & Regenerat Med,Sch, Stanford, CA 94305 USA; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Microarray Genom, D-10117 Berlin, Germany; [Amieva, Manuel R.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Amieva, Manuel R.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Meyer, Thomas F.] Ctr Syst Biomed, Steinbeis Innovat, D-14612 Falkensee, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Howard Hughes Medical Institute; Stanford University; Max Planck Society; Stanford University; Stanford University	Sigal, M; Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany.; Sigal, M (corresponding author), Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.; Sigal, M (corresponding author), Berlin Inst Hlth, D-10117 Berlin, Germany.; Meyer, TF (corresponding author), Ctr Syst Biomed, Steinbeis Innovat, D-14612 Falkensee, Germany.	michael.sigal@charite.de; meyer@mpiib-berlin.mpg.de	Amieva, Manuel/U-2581-2017; Mollenkopf, Hans-Joachim/AAH-2500-2019; Meyer, Thomas F./J-2485-2013	Amieva, Manuel/0000-0002-5601-4490; Berger, Hilmar/0000-0002-6304-4946; Wiedenmann, Bertram/0000-0002-7890-2552; Meyer, Thomas F./0000-0002-6120-8679; Sigal, Michael/0000-0003-4772-0761	Deutsche Forschungsgemeinschaft [SI 1983/2-1, SI 1983/3-1, ME 705/18-1]; Innovation Fund of the Max Planck Society; WILL Foundation; Charite University Medicine Berlin; Berlin Institute of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovation Fund of the Max Planck Society; WILL Foundation; Charite University Medicine Berlin; Berlin Institute of Health	We thank K. Hoffmann, S. Jackisch, D. Frahm, S. Mullerke, C. Fung, and R. Cooper for technical assistance, R. Zietlow for editing the manuscript, and D. Zhao for comments. Financial support for this work was provided by the Deutsche Forschungsgemeinschaft to M. S. (SI 1983/2-1 and SI 1983/3-1) and T.F.M. (ME 705/18-1) and the Innovation Fund of the Max Planck Society to T.F.M. M. S. was supported by the WILL Foundation and is a participant in the Berlin Institute of Health Charite Clinician Scientist Program funded by the Charite University Medicine Berlin and the Berlin Institute of Health.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Hayakawa Y, 2015, GUT, V64, P544, DOI 10.1136/gutjnl-2014-307190; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; LEE ER, 1985, AM J ANAT, V172, P205, DOI 10.1002/aja.1001720304; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Matsuo J, 2017, GASTROENTEROLOGY, V152, P218, DOI 10.1053/j.gastro.2016.09.018; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neufeld S, 2012, GENESIS, V50, P741, DOI 10.1002/dvg.22040; Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sigal M, 2015, GASTROENTEROLOGY, V148, P1392, DOI 10.1053/j.gastro.2015.02.049; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Wilhelm F, 2017, MOL CANCER RES, V15, P776, DOI 10.1158/1541-7786.MCR-16-0472; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	26	117	122	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					451	+		10.1038/nature23642	http://dx.doi.org/10.1038/nature23642			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813421				2022-12-28	WOS:000408279000038
J	Jobs, A; Mehta, SR; Montalescot, G; Vicaut, E; van't Hof, AWJ; Badings, EA; Neumann, FJ; Kastrati, A; Sciahbasi, A; Reuter, PG; Lapostolle, F; Milosevic, A; Stankovic, G; Milasinovic, D; Vonthein, R; Desch, S; Thiele, H				Jobs, Alexander; Mehta, Shamir R.; Montalescot, Gilles; Vicaut, Eric; van't Hof, Arnoud W. J.; Badings, Erik A.; Neumann, Franz-Josef; Kastrati, Adnan; Sciahbasi, Alessandro; Reuter, Paul-Georges; Lapostolle, Frederic; Milosevic, Aleksandra; Stankovic, Goran; Milasinovic, Dejan; Vonthein, Reinhard; Desch, Steffen; Thiele, Holger			Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials	LANCET			English	Article							ELDERLY-PATIENTS; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; DIABETES-MELLITUS; UNSTABLE ANGINA; COLLABORATIVE METAANALYSIS; LATE INTERVENTION; IMMEDIATE; ROUTINE; ANGIOGRAPHY	Background A routine invasive strategy is recommended for patients with non-ST-elevation acute coronary syndromes (NSTE-ACS). However, optimal timing of invasive strategy is less clearly defined. Individual clinical trials were underpowered to detect a mortality benefit; we therefore did a meta-analysis to assess the effect of timing on mortality. Methods We identified randomised controlled trials comparing an early versus a delayed invasive strategy in patients presenting with NSTE-ACS by searching MEDLINE, Cochrane Central Register of Controlled Trials, and Embase. We included trials that reported all-cause mortality at least 30 days after in-hospital randomisation and for which the trial investigators agreed to collaborate (ie, providing individual patient data or standardised tabulated data). We pooled hazard ratios (HRs) using random-effects models. This meta-analysis is registered at PROSPERO (CRD42015018988). Findings We included eight trials (n = 5324 patients) with a median follow-up of 180 days (IQR 180-360). Overall, there was no significant mortality reduction in the early invasive group compared with the delayed invasive group HR 0.81, 95% CI 0.64-1.03; p = 0.0879). In pre-specified analyses of high-risk patients, we found lower mortality with an early invasive strategy in patients with elevated cardiac biomarkers at baseline (HR 0.761, 95% CI 0.581-0.996), diabetes (0.67, 0.45-0.99), a GRACE risk score more than 140 (0.70, 0.52-0.95), and aged 75 years older (0.65, 0.46-0.93), although tests for interaction were inconclusive. Interpretation An early invasive strategy does not reduce mortality compared with a delayed invasive strategy in all patients with NSTE-ACS. However, an early invasive strategy might reduce mortality in high-risk patients.	[Thiele, Holger] Univ Leipzig, Heart Ctr Leipzig, Strumpellstr 39, D-04289 Leipzig, Germany; [Jobs, Alexander; Desch, Steffen] Univ Heart Ctr Lubeck, Med Clin 2, Dept Cardiol Angiol & Intens Med, Lubeck, Germany; [Jobs, Alexander; Desch, Steffen; Thiele, Holger] German Ctr Cardiovasc Res, Lubeck, Germany; [Mehta, Shamir R.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mehta, Shamir R.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Montalescot, Gilles; Vicaut, Eric] Sorbonne Univ Paris 6, ACTION Study Grp, CHU Pitie Salpetriere, Inst Cardiol, Paris, France; [van't Hof, Arnoud W. J.] Isala Klin, Dept Cardiol, Zwolle, Netherlands; [van't Hof, Arnoud W. J.; Badings, Erik A.] Deventer Hosp, Dept Cardiol Res, Deventer, Netherlands; [Neumann, Franz-Josef] Univ Freiburg, Klin Kardiol & Angiol 2, Univ Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany; [Kastrati, Adnan] Deutsch Herzzentrum Munich, Kardiol Klin, Munich, Germany; [Sciahbasi, Alessandro] ASL RM 2, Sandro Pertini Hosp, Intervent Cardiol, Rome, Italy; [Reuter, Paul-Georges; Lapostolle, Frederic] Univ Paris 13, Hop Avicenne, AP HP, Urgences Samu 93, F-93000 Bobigny, France; [Reuter, Paul-Georges; Lapostolle, Frederic] Univ Paris 07, INSERM, U942, Paris, France; [Milosevic, Aleksandra; Stankovic, Goran; Milasinovic, Dejan] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia; [Stankovic, Goran] Univ Belgrade, Fac Med, Belgrade, Serbia; [Vonthein, Reinhard] Univ Lubeck, Inst Med Biometrie & Stat, Lubeck, Germany; [Vonthein, Reinhard] Univ Lubeck, ZKS Lubeck, Lubeck, Germany	Heart Center Leipzig GMBH; Leipzig University; German Centre for Cardiovascular Research; McMaster University; Population Health Research Institute; McMaster University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Isala Clinics; Deventer Hospital; Universitats Herzzentrum Freiburg; University of Freiburg; German Heart Centre Munich; Ospedale Sandro Pertini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Clinical Centre of Serbia; University of Belgrade; University of Lubeck; University of Lubeck	Thiele, H (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Strumpellstr 39, D-04289 Leipzig, Germany.	holger.thiele@medizin.uni-leipzig.de	, Kastrati/Y-2389-2019; Sciahbasi, Alessandro/W-8635-2019; Stankovic, Goran/Q-8507-2019; Thiele, Holger/ABE-6792-2020; Reuter, Paul-Georges/C-1347-2016	Sciahbasi, Alessandro/0000-0002-7964-4479; Stankovic, Goran/0000-0002-9414-0885; Thiele, Holger/0000-0002-0169-998X; Reuter, Paul-Georges/0000-0001-9022-5876; Vonthein, Reinhard/0000-0002-0057-777X				Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Badings EA, 2013, EUROINTERVENTION, V9, P54, DOI 10.4244/EIJV9I1A9; Bauer T, 2007, EUR HEART J, V28, P2873, DOI 10.1093/eurheartj/ehm464; Bonello L, 2016, JACC-CARDIOVASC INTE, V9, P2267, DOI 10.1016/j.jcin.2016.09.017; Brush JE, 2016, J AM COLL CARDIOL, V68, P2365, DOI 10.1016/j.jacc.2016.08.066; Devlin G, 2008, EUR HEART J, V29, P1275, DOI 10.1093/eurheartj/ehn124; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Duchateau L, 2001, CONTROL CLIN TRIALS, V22, P538, DOI 10.1016/S0197-2456(01)00152-0; Ekerstad N, 2011, CIRCULATION, V124, P2397, DOI 10.1161/CIRCULATIONAHA.111.025452; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Giraldez RR, 2013, AM HEART J, V165, P918, DOI 10.1016/j.ahj.2013.01.005; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Katritsis DG, 2011, EUR HEART J, V32, P32, DOI 10.1093/eurheartj/ehq276; Malkin CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000540; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Meune C, 2011, HEART, V97, P1479, DOI 10.1136/hrt.2010.220988; Milasinovic D, 2015, ATHEROSCLEROSIS, V241, P48, DOI 10.1016/j.atherosclerosis.2015.04.808; Milosevic A, 2016, JACC-CARDIOVASC INTE, V9, P541, DOI 10.1016/j.jcin.2015.11.018; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Navarese EP, 2013, ANN INTERN MED, V158, P261, DOI 10.7326/0003-4819-158-4-201302190-00006; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; O'Donoghue ML, 2012, J AM COLL CARDIOL, V60, P106, DOI 10.1016/j.jacc.2012.02.059; Rajpurohit N, 2013, CATHETER CARDIO INTE, V81, P223, DOI 10.1002/ccd.24439; Reuter PG, 2015, INT J CARDIOL, V182, P414, DOI 10.1016/j.ijcard.2014.12.089; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rosengren A, 2006, EUR HEART J, V27, P789, DOI 10.1093/eurheartj/ehi774; Sciahbasi A, 2010, CLIN CARDIOL, V33, P650, DOI 10.1002/clc.20785; Shen WF, 2001, CHINESE MED J-PEKING, V114, P59; Stengaard C, 2016, EUR HEART J ACUTE CA; Tekin K, 2013, KOREAN CIRC J, V43, P725, DOI 10.4070/kcj.2013.43.11.725; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418; van't Hof AWJ, 2003, EUR HEART J, V24, P1401, DOI 10.1016/S0195-668X(03)00259-8; Zhang Jun, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P865	40	117	122	2	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					737	746		10.1016/S0140-6736(17)31490-3	http://dx.doi.org/10.1016/S0140-6736(17)31490-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28778541				2022-12-28	WOS:000407858900018
J	Navarro, M; Monge-Maillo, B; Flores-Chavez, MD; Lopez-Velez, R				Navarro, Miriam; Monge-Maillo, Begona; Flores-Chavez, Maria D.; Lopez-Velez, Rogelio			Hunting hidden parasites: Trypanosoma cruzi	LANCET			English	Editorial Material							CHAGAS-DISEASE		[Navarro, Miriam] Spanish Soc Trop Med & Int Hlth, Madrid 28010, Spain; [Monge-Maillo, Begona; Lopez-Velez, Rogelio] Ramon y Cajal Univ Hosp, Natl Referral Unit Trop Dis, Madrid, Spain; [Monge-Maillo, Begona; Lopez-Velez, Rogelio] Salud Entre Culturas, Madrid, Spain; [Flores-Chavez, Maria D.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Leishmaniasis & Enfermedad Chagas, Madrid, Spain	Hospital Universitario Ramon y Cajal; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Navarro, M (corresponding author), Spanish Soc Trop Med & Int Hlth, Madrid 28010, Spain.	miriamtropical@gmail.com	Lopez-Velez, Rogelio/AAV-1782-2021; Flores, Maria/HHD-2216-2022; Flores-Chavez, Maria/M-5918-2015	Navarro, Miriam/0000-0001-7727-1587; Flores-Chavez, Maria/0000-0003-2597-3100				[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Ansede M., 2015, PARASITO ACECHO TRES; Basile L, 2011, EUROSURVEILLANCE, V16, P14, DOI 10.2807/ese.16.37.19968-en; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Fundacion Mundo Sano, 2016, CAMP DIAGN MADR 2016; Imaz-Iglesia I, 2015, ACTA TROP, V148, P77, DOI 10.1016/j.actatropica.2015.04.014; Legido-Quigley H, 2013, LANCET, V382, P1977, DOI 10.1016/S0140-6736(13)62649-5; Merino FJ, 2013, REV ESP QUIM, V26, P253; Navarro M., 2016, CAZA PARASITOS SILEN; Navarro M, 2013, J IMMIGR MINOR HEALT, V15, P1009, DOI 10.1007/s10903-012-9707-2; Navarro M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001962; Pecoul B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004343; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003245; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Torres G., 2014, BBC NEWS; Ventura-Garcia L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002410; World Health Organization, 2009, REP WHO INF CONS	18	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					724	726		10.1016/S0140-6736(17)31536-2	http://dx.doi.org/10.1016/S0140-6736(17)31536-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28831983				2022-12-28	WOS:000407858900008
J	Bodin, O				Bodin, Orjan			Collaborative environmental governance: Achieving collective action in social-ecological systems	SCIENCE			English	Review							SCALE MISMATCHES; POLICY NETWORKS; COMMUNICATION-NETWORKS; RESOURCE-MANAGEMENT; URBAN-DEVELOPMENT; CLIMATE POLICY; OUTCOMES; INFORMATION; COOPERATION; PERFORMANCE	Managing ecosystems is challenging because of the high number of stakeholders, the permeability of man-made political and jurisdictional demarcations in relation to the temporal and spatial extent of biophysical processes, and a limited understanding of complex ecosystem and societal dynamics. Given these conditions, collaborative governance is commonly put forward as the preferred means of addressing environmental problems. Under this paradigm, a deeper understanding of if, when, and how collaboration is effective, and when other means of addressing environmental problems are better suited, is needed. Interdisciplinary research on collaborative networks demonstrates that which actors get involved, with whom they collaborate, and in what ways they are tied to the structures of the ecosystems have profound implications on actors' abilities to address different types of environmental problems.	[Bodin, Orjan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Stockholm University	Bodin, O (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	orjan.bodin@su.se	Lobo, Diele/I-9106-2012; Bodin, Örjan/A-5098-2010	Bodin, Örjan/0000-0002-8218-1153	Swedish Foundation for Strategic Environmental Research (Mistra); Swedish Research Council; Formas [2016-04263, 2016-01137]	Swedish Foundation for Strategic Environmental Research (Mistra)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas)	This work was financially supported by the Swedish Foundation for Strategic Environmental Research (Mistra) through a core grant to the Stockholm Resilience Centre at Stockholm University. The Swedish Research Council and Formas contributed with additional support through project grants 2016-04263 and 2016-01137.	Alexander SM, 2017, AQUAT CONSERV, V27, P1209, DOI 10.1002/aqc.2775; Alexander SM, 2015, GLOBAL ENVIRON CHANG, V35, P213, DOI 10.1016/j.gloenvcha.2015.09.001; Ansell C, 2008, J PUBL ADM RES THEOR, V18, P543, DOI 10.1093/jopart/mum032; Barnes M, 2016, SOC NETWORKS, V45, P55, DOI 10.1016/j.socnet.2015.11.004; Barnes ML, 2016, P NATL ACAD SCI USA, V113, P6466, DOI 10.1073/pnas.1523245113; Berardo R, 2016, PUBLIC ADMIN REV, V76, P738, DOI 10.1111/puar.12532; Berardo R, 2014, INT J COMMONS, V8, P236, DOI 10.18352/ijc.463; Berardo R, 2010, AM J POLIT SCI, V54, P632, DOI 10.1111/j.1540-5907.2010.00451.x; Bergsten A, 2014, ECOL SOC, V19, DOI 10.5751/ES-06931-190406; Bergsten A, 2013, LANDSCAPE URBAN PLAN, V119, P35, DOI 10.1016/j.landurbplan.2013.06.009; Biggs R., 2014, PRINCIPLES BUILDING; Bodin O, 2016, GLOBAL ENVIRON CHANG, V41, P183, DOI 10.1016/j.gloenvcha.2016.10.004; Bodin O, 2017, POLICY STUD J, V45, P289, DOI 10.1111/psj.12146; Bodin O, 2016, ECOL SOC, V21, DOI 10.5751/ES-08368-210140; Bodin O, 2014, CONSERV BIOL, V28, P1371, DOI 10.1111/cobi.12306; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Boin A, 2010, AUST J PUBL ADMIN, V69, P357, DOI 10.1111/j.1467-8500.2010.00694.x; Brummel RF, 2012, GLOBAL ENVIRON CHANG, V22, P516, DOI 10.1016/j.gloenvcha.2011.12.004; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Castro A. P., 2001, ENVIRON SCI POLICY, V4, P229, DOI DOI 10.1016/S1462-9011(01)00022-3; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cosens BA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05093-180103; Crona B, 2017, WORLD DEV, V91, P70, DOI 10.1016/j.worlddev.2016.10.006; Cumming GS, 2006, ECOL SOC, V11; Dallimer M, 2015, TRENDS ECOL EVOL, V30, P132, DOI 10.1016/j.tree.2014.12.004; Dee LE, 2017, TRENDS ECOL EVOL, V32, P118, DOI 10.1016/j.tree.2016.10.011; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dowd AM, 2014, NAT CLIM CHANGE, V4, P558, DOI [10.1038/nclimate2275, 10.1038/NCLIMATE2275]; Edelenbos J, 2015, CURR OPIN ENV SUST, V12, P25, DOI 10.1016/j.cosust.2014.08.009; Ekstrom JA, 2009, ECOL SOC, V14; Epstein G, 2015, CURR OPIN ENV SUST, V14, P34, DOI 10.1016/j.cosust.2015.03.005; Fischer M, 2014, POLICY STUD J, V42, P344, DOI 10.1111/psj.12064; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Folke C, 2007, ECOL SOC, V12; Galaz V, 2008, INSTITUTIONS AND ENVIRONMENTAL CHANGE: PRINCIPAL FINDINGS, APPLICATIONS, AND RESEARCH FRONTIERS, P147; Gallemore CT, 2014, ECOL SOC, V19, DOI 10.5751/ES-06418-190218; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Grundmann R, 2016, NAT GEOSCI, V9, P562, DOI 10.1038/ngeo2780; Guerrero AM, 2015, ECOL SOC, V20, DOI 10.5751/ES-08035-200441; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henry AD, 2014, ANNU REV ENV RESOUR, V39, P583, DOI 10.1146/annurev-environ-101813-013246; Henry AD, 2011, J PUBL ADM RES THEOR, V21, P419, DOI 10.1093/jopart/muq042; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Ingold K, 2014, GLOBAL ENVIRON CHANG, V24, P88, DOI 10.1016/j.gloenvcha.2013.11.021; Ingold K, 2011, POLICY STUD J, V39, P435, DOI 10.1111/j.1541-0072.2011.00416.x; Isaac ME, 2012, AGR SYST, V109, P9, DOI 10.1016/j.agsy.2012.01.011; Jasny L, 2015, NAT CLIM CHANGE, V5, P782, DOI [10.1038/NCLIMATE2666, 10.1038/nclimate2666]; Kininmonth S, 2015, AMBIO, V44, pS138, DOI 10.1007/s13280-014-0605-9; Klijn EH, 2007, PUBLIC ADMIN, V85, P587, DOI 10.1111/j.1467-9299.2007.00662.x; Klijn EH, 2010, PUBLIC ADMIN, V88, P1063, DOI 10.1111/j.1467-9299.2010.01826.x; Koontz TM, 2006, PUBLIC ADMIN REV, V66, P111, DOI 10.1111/j.1540-6210.2006.00671.x; LANSING JS, 1993, AM ANTHROPOL, V95, P97, DOI 10.1525/aa.1993.95.1.02a00050; Lubell M, 2017, CONSERV LETT, V10, P699, DOI 10.1111/conl.12311; Lubell M, 2017, PUBLIC ADMIN REV, V77, P668, DOI 10.1111/puar.12622; Lubell M, 2014, ECOL SOC, V19, DOI 10.5751/ES-06880-190423; Lubell M, 2013, POLICY STUD J, V41, P537, DOI 10.1111/psj.12028; Maciejewski K, 2015, ECOL APPL, V25, P11, DOI 10.1890/13-2240.1; Matous P, 2015, ECOL SOC, V20, DOI 10.5751/ES-07602-200236; Matous P, 2013, INT J AGR SUSTAIN, V11, P301, DOI 10.1080/14735903.2012.751701; McAllister RRJ, 2017, INT J COMMONS, V11, P330, DOI 10.18352/ijc.701; McAllister RRJ, 2015, POLICY STUD J, V43, P379, DOI 10.1111/psj.12103; McAllister RRJ, 2014, REG ENVIRON CHANGE, V14, P527, DOI 10.1007/s10113-013-0489-4; McGinnis MD, 2011, POLICY STUD J, V39, P51, DOI 10.1111/j.1541-0072.2010.00396.x; Meek CL, 2013, GLOBAL ENVIRON CHANG, V23, P217, DOI 10.1016/j.gloenvcha.2012.10.003; Munck af Rosenschold J., 2014, ECOL SOC, V19, P30, DOI DOI 10.5751/ES-07033-190430J.1467-9299.2010.01826.X; Munoz-Erickson TA, 2010, ECOL SOC, V15; Nelson KC, 2014, AGR HUM VALUES, V31, P245, DOI 10.1007/s10460-013-9462-6; Nohrstedt D, 2014, RISK HAZARDS CRISIS, V5, P134, DOI 10.1002/rhc3.12055; Nykvist B, 2014, SOC NATUR RESOUR, V27, P436, DOI 10.1080/08941920.2013.861562; Olsson P, 2014, ECOL SOC, V19, DOI 10.5751/ES-06799-190401; Osterblom H, 2012, CONSERV BIOL, V26, P638, DOI 10.1111/j.1523-1739.2012.01850.x; Ostrom, 1990, GOVERNING COMMONS, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2010, GLOBAL ENVIRON CHANG, V20, P550, DOI 10.1016/j.gloenvcha.2010.07.004; Plummer R, 2017, ECOL ECON, V140, P79, DOI 10.1016/j.ecolecon.2017.04.028; Prell C, 2010, ECOL SOC, V15; Provan KG, 2008, J PUBL ADM RES THEOR, V18, P229, DOI 10.1093/jopart/mum015; Raab J, 2015, J PUBL ADM RES THEOR, V25, P479, DOI 10.1093/jopart/mut039; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; SABATIER PA, 1988, POLICY SCI, V21, P129, DOI 10.1007/BF00136406; Sandstrom A, 2010, ECOL SOC, V15; Sayles JS, 2017, P NATL ACAD SCI USA, V114, pE1776, DOI 10.1073/pnas.1604405114; Scott TA, 2017, J PUBL ADM RES THEOR, V27, P647, DOI 10.1093/jopart/mux009; Scott TA, 2017, POLICY STUD J, V45, P191, DOI 10.1111/psj.12162; Shellenberger M., 2009, GEOPOLITICS HIST INT, V1, P121; Shore J, 2015, ORGAN SCI, V26, P1432, DOI 10.1287/orsc.2015.0980; Tengo M, 2014, AMBIO, V43, P579, DOI 10.1007/s13280-014-0501-3; Treml EA, 2015, GLOBAL ENVIRON CHANG, V31, P263, DOI 10.1016/j.gloenvcha.2015.01.012; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; van Meerkerk I, 2014, POLICY SCI, V47, P3, DOI 10.1007/s11077-013-9181-2; Vance-Borland K, 2011, CONSERV LETT, V4, P278, DOI 10.1111/j.1755-263X.2011.00176.x; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325; Walker PA, 2004, SOC NATUR RESOUR, V17, P735, DOI 10.1080/08941920490480723; Wang P, 2013, SOC NETWORKS, V35, P96, DOI 10.1016/j.socnet.2013.01.004; Westley F, 2011, AMBIO, V40, P762, DOI 10.1007/s13280-011-0186-9; Westley FR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05072-180327; Wyborn C, 2013, J ENVIRON MANAGE, V123, P58, DOI 10.1016/j.jenvman.2013.03.014; Young O.R., 2002, I DIMENSIONS ENV CHA, V1st ed., DOI DOI 10.7551/MITPRESS/3807.001.0001; Zachrisson A, 2013, FOREST POLICY ECON, V33, P39, DOI 10.1016/j.forpol.2013.04.008	100	413	418	104	577	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					659	+		10.1126/science.aan1114	http://dx.doi.org/10.1126/science.aan1114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818915	Green Submitted			2022-12-28	WOS:000407793600027
J	Cao, JY; Packer, JS; Ramani, V; Cusanovich, DA; Huynh, C; Daza, R; Qiu, X; Lee, C; Furlan, SN; Steemers, FJ; Adey, A; Waterston, RH; Trapnell, C; Shendure, J				Cao, Junyue; Packer, Jonathan S.; Ramani, Vijay; Cusanovich, Darren A.; Huynh, Chau; Daza, Riza; Qiu, Xiaojie; Lee, Choli; Furlan, Scott N.; Steemers, Frank J.; Adey, Andrew; Waterston, Robert H.; Trapnell, Cole; Shendure, Jay			Comprehensive single-cell transcriptional profiling of a multicellular organism	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MESSENGER-RNA-SEQ; GENE-EXPRESSION; NERVOUS-SYSTEM; GENOME; CONTIGUITY; PATHWAYS; CORTEX	To resolve cellular heterogeneity, we developed a combinatorial indexing strategy to profile the transcriptomes of single cells or nuclei, termed sci-RNA-seq (single-cell combinatorial indexing RNA sequencing). We applied sci-RNA-seq to profile nearly 50,000 cells from the nematode Caenorhabditis elegans at the L2 larval stage, which provided >50-fold "shotgun" cellular coverage of its somatic cell composition. From these data, we defined consensus expression profiles for 27 cell types and recovered rare neuronal cell types corresponding to as few as one or two cells in the L2 worm. We integrated these profiles with whole-animal chromatin immunoprecipitation sequencing data to deconvolve the cell type-specific effects of transcription factors. The data generated by sci-RNA-seq constitute a powerful resource for nematode biology and foreshadow similar atlases for other organisms.	[Cao, Junyue; Packer, Jonathan S.; Ramani, Vijay; Cusanovich, Darren A.; Huynh, Chau; Daza, Riza; Qiu, Xiaojie; Lee, Choli; Waterston, Robert H.; Trapnell, Cole; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cao, Junyue; Qiu, Xiaojie] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Furlan, Scott N.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA; [Furlan, Scott N.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Furlan, Scott N.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Steemers, Frank J.] Adv Res Grp, San Diego, CA USA; [Adey, Andrew] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Adey, Andrew] Knight Cardiovasc Inst, Portland, OR USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Oregon Health & Science University; Howard Hughes Medical Institute	Waterston, RH; Trapnell, C; Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 02115 USA.	watersto@uw.edu; coletrap@uw.edu; shendure@uw.edu	Daza, Riza M./HCH-4047-2022; , 周一珉/AAQ-9453-2020; Horwitz, Marshall/AAE-8376-2021; Shendure, Jay/AAU-3684-2021	Cusanovich, Darren/0000-0001-6889-0095; Cao, Junyue/0000-0003-4097-489X; Packer, Jonathan/0000-0003-4025-0007; Furlan, Scott/0000-0003-3007-9840	NIH [DP1HG007811, R01HG006283, U41HG007355, R01GM072675, DP2 HD088158]; Paul G. Allen Family Foundation; W. M. Keck Foundation; Dale F. Frey Award for Breakthrough Scientists; Alfred P. Sloan Foundation; William Gates III Endowed Chair in Biomedical Sciences; National Heart, Lung, and Blood Institute [T32HL007828]; Illumina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD088158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007355, DP1HG007811, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675, R35GM124704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Dale F. Frey Award for Breakthrough Scientists; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); William Gates III Endowed Chair in Biomedical Sciences; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Illumina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The raw data have been deposited with the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession code GSE98561. We thank members of the Shendure, Trapnell, and Waterston laboratories for helpful discussions and feedback, particularly A. Hill, V. Agarwal, M. Gasperini, L. Starita, Y. Yin, and B. Martin; S. Zimmerman and C. Berg for helpful technique suggestions; the modERN consortium for allowing us to use their ChIP-seq data; D. Prunkard and L. Gitari in the Pathology Flow Cytometry Core Facility for their exceptional assistance in flow sorting; the T. Reh laboratory for sharing the NIH/3T3 cell line; and H. Hutter for adding our tissue-specific expression profiles to gExplore. HeLa S3 cells were used as part of this study. Henrietta Lacks, and the HeLa cell line that was established from her tumor cells in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. This work was funded by grants from the NIH (DP1HG007811 and R01HG006283 to J.S., U41HG007355 and R01GM072675 to R.H.W, and DP2 HD088158 to C.T.), the Paul G. Allen Family Foundation (to J.S.), the W. M. Keck Foundation (to C. T. and J.S.), the Dale F. Frey Award for Breakthrough Scientists (to C. T.), the Alfred P. Sloan Foundation Research Fellowship (to C. T.), and the William Gates III Endowed Chair in Biomedical Sciences (to R.H.W.). D. A. C. was supported in part by T32HL007828 from the National Heart, Lung, and Blood Institute. J.S. is an investigator of the Howard Hughes Medical Institute. F.J.S. declares competing financial interests in the form of stock ownership and paid employment by Illumina. One or more embodiments of one or more patents and patent applications filed by Illumina may encompass the methods, reagents, and data disclosed in this manuscript.	Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Altun ZF, 2002, WORMATLAS; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Boeck ME, 2016, GENOME RES, V26, P1441, DOI 10.1101/gr.202663.115; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2016, CURR BIOL, V26, pR1197, DOI 10.1016/j.cub.2016.10.027; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kudron M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r5; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Liu Serena, 2016, F1000Res, V5, DOI 10.12688/f1000research.7223.1; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mainpal R, 2015, DEVELOPMENT, V142, P3571, DOI 10.1242/dev.125732; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Mulqueen R. M., 2017, 157230 BIORXIV; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ruksana R, 2005, GENES CELLS, V10, P261, DOI 10.1111/j.1365-2443.2005.00829.x; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takayama J, 2010, NUCLEIC ACIDS RES, V38, P131, DOI 10.1093/nar/gkp868; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tung PY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39921; Vitak SA, 2017, NAT METHODS, V14, P302, DOI [10.1038/NMETH.4154, 10.1038/nmeth.4154]; Wagner CR, 2010, NATURE, V467, P839, DOI 10.1038/nature09429; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills QF, 2013, NAT BIOTECHNOL, V31, P748, DOI 10.1038/nbt.2642; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng WH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw739; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	54	587	612	10	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					661	667		10.1126/science.aam8940	http://dx.doi.org/10.1126/science.aam8940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818938	Green Accepted, Green Submitted			2022-12-28	WOS:000407793600029
J	Cyranoski, D				Cyranoski, David			NEUROSCIENCE China launches imaging factory	NATURE			English	News Item																		2017, NATURE, V543, P14; 2017, NATURE, V548, P150	2	5	6	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					268	269		10.1038/548268a	http://dx.doi.org/10.1038/548268a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816258	Bronze			2022-12-28	WOS:000407748400005
J	Luo, ZX; Meng, QJ; Grossnickle, DM; Liu, D; Neander, AI; Zhang, YG; Ji, Q				Luo, Zhe-Xi; Meng, Qing-Jin; Grossnickle, David M.; Liu, Di; Neander, April I.; Zhang, Yu-Guang; Ji, Qiang			New evidence for mammaliaform ear evolution and feeding adaptation in a Jurassic ecosystem	NATURE			English	Article							MULTITUBERCULATE MAMMALS; DIVERSIFICATION; FOSSIL	Stem mammaliaforms are forerunners to modern mammals(1), and they achieved considerable ecomorphological diversity in their own right(2). Recent discoveries suggest that eleutherodontids, a subclade of Haramiyida, were more species-rich during the Jurassic period in Asia than previously recognized(3-12). Here we report a new Jurassic eleutherodontid mammaliaform with an unusual mosaic of highly specialized characteristics(1-6), and the results of phylogenetic analyses that support the hypothesis that haramiyidans are stem mammaliaforms. The new fossil shows fossilized skin membranes that are interpreted to be for gliding and a mandibular middle ear with a unique character combination previously unknown in mammaliaforms. Incisor replacement is prolonged until well after molars are fully erupted, a timing pattern unique to most other mammaliaforms. In situ molar occlusion and a functional analysis reveal a new mode of dental occlusion: dual mortar-pestle occlusion of opposing upper and lower molars, probably for dual crushing and grinding. This suggests that eleutherodontids are herbivorous, and probably specialized for granivory or feeding on soft plant tissues. The inferred dietary adaptation of eleutherodontid gliders represents a remarkable evolutionary convergence with herbivorous gliders in Theria. These Jurassic fossils represent volant, herbivorous stem mammaliaforms associated with pre-angiosperm plants that appear long before the later, iterative associations between angiosperm plants and volant herbivores in various therian clades.	[Luo, Zhe-Xi; Neander, April I.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Luo, Zhe-Xi; Grossnickle, David M.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Meng, Qing-Jin; Liu, Di; Zhang, Yu-Guang] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Ji, Qiang] Hebei GEO Univ, Shijiazhuang 050031, Hebei, Peoples R China	University of Chicago; University of Chicago; Hebei GEO University	Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.; Luo, ZX (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.; Meng, QJ (corresponding author), Beijing Museum Nat Hist, Beijing 100050, Peoples R China.	zxluo@uchicago.edu; mengqingjin18@163.com	Meng, Q./GSI-6185-2022; Luo, Zhe-XI/AAU-2263-2021	Neander, April/0000-0001-6816-2872	Beijing Scientific Commission; UChicago-BSD	Beijing Scientific Commission; UChicago-BSD	We thank A. Shinya for fossil preparation; S. Bi, S. Gatesy, L. Heaney, H.-J. Li, Z.-J. Gao, T. Martin, B. Patterson, N. Shubin, X.-T. Zheng and C.-F. Zhou for access to comparative specimens. Funding supported Q.-J.M. (Beijing Scientific Commission) and Z.-X.L. (UChicago-BSD). Full acknowledgments are provided in the Supplementary Information.	Anders U, 2011, PALAEONTOL Z, V85, P321, DOI 10.1007/s12542-011-0098-9; Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Jackson S., 2012, GLIDING MAMMALS WORL; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Liao H. - Y., 2014, ACTA PALAEONTOLOGICA, V53, P201; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo Zhe-Xi, 2004, Bulletin of Carnegie Museum of Natural History, V36, P159, DOI 10.2992/0145-9058(2004)36[159:EODRIM]2.0.CO;2; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2015, SCIENCE, V347, P760, DOI 10.1126/science.1260880; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meng J, 2016, J MORPHOL; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Meng Q. - J., 2017, NATURE; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; O'Meara RN, 2016, PALEOBIOLOGY, V42, P439, DOI 10.1017/pab.2015.51; RADINSKY LB, 1968, J MORPHOL, V124, P167, DOI 10.1002/jmor.1051240204; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Thorington RW, 2005, J VERTEBR PALEONTOL, V25, P950, DOI 10.1671/0272-4634(2005)025[0950:TDOIFS]2.0.CO;2; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	30	67	73	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					326	+		10.1038/nature23483	http://dx.doi.org/10.1038/nature23483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792934				2022-12-28	WOS:000407748400031
J	Pierrat, V; Marchand-Martin, L; Arnaud, C; Kaminski, M; Resche-Rigon, M; Lebeaux, C; Bodeau-Livinec, F; Morgan, AS; Goffinet, F; Marret, S; Ancel, PY				Pierrat, Veronique; Marchand-Martin, Laetitia; Arnaud, Catherine; Kaminski, Monique; Resche-Rigon, Matthieu; Lebeaux, Cecile; Bodeau-Livinec, Florence; Morgan, Andrei S.; Goffinet, Francois; Marret, Stephane; Ancel, Pierre-Yves			Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVE PERINATAL-CARE; AGE 5 YEARS; STAGES QUESTIONNAIRES; CEREBRAL-PALSY; INFANTS; SURVIVAL; BIRTH; TERM; PERFORMANCE; DISABILITY	OBJECTIVES To describe neurodevelopmental outcomes at 2 years corrected age for children born alive at 22-26, 27-31, and 32-34 weeks' gestation in 2011, and to evaluate changes since 1997. DESIGN Population based cohort studies, EPIPAGE and EPIPAGE-2. SETTING FRANCE. PARTICIPANTS 5567 neonates born alive in 2011 at 22-34 completed weeks' gestation, with 4199 survivors at 2 years corrected age included in follow-up. Comparison of outcomes reported for 3334 (1997) and 2418 (2011) neonates born alive in the nine regions participating in both studies. MAIN OUTCOME MEASURES Survival; cerebral palsy (2000 European consensus definition); scores below threshold on the neurodevelopmental Ages and Stages Questionnaire (ASQ; at least one of five domains below threshold) if completed between 22 and 26 months corrected age, in children without cerebral palsy, blindness, or deafness; and survival without severe or moderate neuromotor or sensory disabilities (cerebral palsy with Gross Motor Function Classification System levels 2-5, unilateral or bilateral blindness or deafness). Results are given as percentage of outcome measures with 95% confidence intervals. RESULTS Among 5170 liveborn neonates with parental consent, survival at 2 years corrected age was 51.7% (95% confidence interval 48.6% to 54.7%) at 22-26 weeks' gestation, 93.1% (92.1% to 94.0%) at 27-31 weeks' gestation, and 98.6% (97.8% to 99.2%) at 32-34 weeks' gestation. Only one infant born at 22-23 weeks survived. Data on cerebral palsy were available for 3599 infants (81.0% of the eligible population). The overall rate of cerebral palsy at 24-26, 27-31, and 32-34 weeks' gestation was 6.9% (4.7% to 9.6%), 4.3% (3.5% to 5.2%), and 1.0% (0.5% to 1.9%), respectively. Responses to the ASQ were analysed for 2506 children (56.4% of the eligible population). The proportion of children with an ASQ result below threshold at 24-26, 27-31, and 32-34 weeks' gestation were 50.2% (44.5% to 55.8%), 40.7% (38.3% to 43.2%), and 36.2% (32.4% to 40.1%), respectively. Survival without severe or moderate neuromotor or sensory disabilities among live births increased between 1997 and 2011, from 45.5% (39.2% to 51.8%) to 62.3% (57.1% to 67.5%) at 25-26 weeks' gestation, but no change was observed at 22-24 weeks' gestation. At 32-34 weeks' gestation, there was a non-statistically significant increase in survival without severe or moderate neuromotor or sensory disabilities (P= 0.61), but the proportion of survivors with cerebral palsy declined (P= 0.01). CONCLUSIONS In this large cohort of preterm infants, rates of survival and survival without severe or moderate neuromotor or sensory disabilities have increased during the past two decades, but these children remain at high risk of developmental delay.	[Pierrat, Veronique; Marchand-Martin, Laetitia; Kaminski, Monique; Lebeaux, Cecile; Bodeau-Livinec, Florence; Morgan, Andrei S.; Goffinet, Francois; Ancel, Pierre-Yves] INSERM, Obstet Perinatal & Pediat Epidemiol Team, Sorbonne Paris Cite, Epidemiol & Biostat,Res Ctr,U1153, Paris, France; [Pierrat, Veronique; Marchand-Martin, Laetitia; Kaminski, Monique; Lebeaux, Cecile; Bodeau-Livinec, Florence; Morgan, Andrei S.; Goffinet, Francois; Ancel, Pierre-Yves] Paris Descartes Univ, Paris, France; [Pierrat, Veronique] Jeanne de Flandre Hosp, Dept Neonatal Med, CHU Lille, F-59000 Lille, France; [Arnaud, Catherine] Univ Toulouse III Paul Sabatier, UMR 1027, INSERM, Toulouse, France; [Resche-Rigon, Matthieu] St Louis Hosp, AP HP, Biostat & Med Informat Dept, Paris, France; [Bodeau-Livinec, Florence] EHESP, Rennes, France; [Goffinet, Francois] Univ Paris 05, Grp Hosp Cochin Broca, AP HP, Hotel Dieu,DHU Risques & Grossesse,Matern Port Ro, Paris, France; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Pediat Intens Care & Neuropediat, Rouen, France; [Marret, Stephane] Inst Res & Innovat Biomed, U1245, Res Unit, Rouen, France; [Ancel, Pierre-Yves] Cochin Broca Hotel Dieu Hosp, Clin Res Unit, Ctr Clin Invest P1419, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Ecole des Hautes Etudes en Sante Publique (EHESP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Pierrat, V (corresponding author), INSERM, Obstet Perinatal & Pediat Epidemiol Team, Sorbonne Paris Cite, Epidemiol & Biostat,Res Ctr,U1153, Paris, France.	veronique.pierrat@inserm.fr	Boileau, Pascal/AAG-9683-2021; Resche-Rigon, Matthieu/ABA-5374-2021; Bodeau-Livinec, Florence/U-9053-2017; ARNAUD, Catherine/AAC-5646-2019; Boileau, Pascal/H-7508-2015	Boileau, Pascal/0000-0001-9755-6467; Bodeau-Livinec, Florence/0000-0002-4266-6287; ARNAUD, Catherine/0000-0002-4002-802X; Boileau, Pascal/0000-0001-9755-6467; Marret, Stephane/0000-0002-2858-148X; LORON, Gauthier/0000-0001-9536-9510; Morgan, Andrei/0000-0003-4143-1977; Boubred, Farid/0000-0003-3039-2036; ANCEL, pierre-yves/0000-0001-9632-7494; Marchand-Martin, Laetitia/0000-0002-8036-8387; resche-rigon, matthieu/0000-0003-2220-5085	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future [ANR-11-EQPX-0038]; PREMUP Foundation; Fondation de France [00050329]; Fondation pour la Recherche Medicale [SPF20160936356]	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX program of investments in the future; PREMUP Foundation; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This project has been funded with support from the following organisations: The French Institute of Public Health Research/Institute of Public Health and its partners: the French Health Ministry, the National Institute of Health and Medical Research (INSERM), the National Institute of Cancer, and the National Solidarity Fund for Autonomy (CNSA); The National Research Agency through the French EQUIPEX program of investments in the future (reference ANR-11-EQPX-0038); the PREMUP Foundation; Fondation de France (reference 00050329); and Fondation pour la Recherche Medicale (reference SPF20160936356). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2017, DEV MED CHILD NEUROL, V59, P484, DOI 10.1111/dmcn.13307; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Blaggan S, 2014, PEDIATRICS, V134, pE55, DOI 10.1542/peds.2014-0266; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Charkaluk ML, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2798; Cheong JL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4805; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; de Waal CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041302; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Doyle LW, 2010, PEDIATRICS, V126, P342, DOI 10.1542/peds.2010-0710; Doyle LW, 2004, EARLY HUM DEV, V80, P103, DOI 10.1016/j.earlhumdev.2004.05.009; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Durrmeyer X, 2017, ARCH DIS CHILD-FETAL, V102, pF98, DOI 10.1136/archdischild-2016-310718; Ego A, 2016, J GYNECOL OBST BIO R, V45, P155, DOI 10.1016/j.jgyn.2015.08.009; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Gallagher K, 2014, ARCH DIS CHILD-FETAL, V99, pF245, DOI 10.1136/archdischild-2013-305191; Ghassabian A, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4372; Glascoe FP, 2001, ARCH PEDIAT ADOL MED, V155, P54, DOI 10.1001/archpedi.155.1.54; Guillen U, 2015, PEDIATRICS, V136, P343, DOI 10.1542/peds.2015-0542; Hellgren KM, 2016, JAMA OPHTHALMOL, V134, P555, DOI 10.1001/jamaophthalmol.2016.0391; Himmelmann K, 2015, DEV MED CHILD NEUROL, V57, P762, DOI 10.1111/dmcn.12718; Janson H, 2004, ACTA PAEDIATR, V93, P1525, DOI 10.1080/08035250410033051; Janvier A, 2016, ARCH DIS CHILD-FETAL, V101, pF375, DOI 10.1136/archdischild-2016-310466; Johnson S, 2015, ARCH DIS CHILD-FETAL, V100, pF301, DOI 10.1136/archdischild-2014-307684; Kerstjens JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133087; Larroque B., 2000, ARCH PEDIAT S2, V7, P339, DOI DOI 10.1016/S0929-693X(00)80094-9; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Larroque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021361; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Moore Tamanna, 2012, BMJ, V345, pe7961, DOI 10.1136/bmj.e7961; Moriette G, 2010, ARCH PEDIATRIE, V17, P527, DOI 10.1016/j.arcped.2009.09.024; Moriette G, 2010, ARCH PEDIATRIE, V17, P518, DOI 10.1016/j.arcped.2009.09.025; Perlbarg J, 2016, ARCH DIS CHILD-FETAL, V101, pF384, DOI 10.1136/archdischild-2015-308728; Putnick DL, 2017, J PEDIATR-US, V181, P74, DOI 10.1016/j.jpeds.2016.09.006; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Reid SM, 2016, DEV MED CHILD NEUROL, V58, P25, DOI 10.1111/dmcn.13001; Reid SM, 2014, DEV MED CHILD NEUROL, V56, P222, DOI 10.1111/dmcn.12228; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Rysavy MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0689; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Saigal S, 2016, JAMA PEDIATR, V170, P678, DOI 10.1001/jamapediatrics.2016.0289; Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Sellier E, 2016, DEV MED CHILD NEUROL, V58, P85, DOI 10.1111/dmcn.12865; Serenius F, 2016, JAMA PEDIATR, V170, P954, DOI 10.1001/jamapediatrics.2016.1210; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Spittle Alicia, 2015, Cochrane Database Syst Rev, pCD005495, DOI 10.1002/14651858.CD005495.pub4; Spittle AJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1363; Squire J, 2009, ASQ 3 USERS GUIDE; Steenis LJP, 2015, EARLY HUM DEV, V91, P217, DOI 10.1016/j.earlhumdev.2015.01.008; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; van Wassenaer-Leemhuis AG, 2016, DEV MED CHILD NEUROL, V58, P67, DOI 10.1111/dmcn.13049; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Veldhuizen S, 2015, ACAD PEDIATR, V15, P231, DOI 10.1016/j.acap.2014.08.002; Velikonja T, 2017, CHILD CARE HLTH DEV, V43, P1, DOI 10.1111/cch.12397; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5; Younge N, 2017, NEW ENGL J MED, V376, P617, DOI 10.1056/NEJMoa1605566; Zeitlin J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i2976	64	208	213	4	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3448	10.1136/bmj.j3448	http://dx.doi.org/10.1136/bmj.j3448			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814566	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000408228300001
J	Ott, SM				Ott, Susan M.			Review: Osteoporosis drugs may improve BMD and reduce fractures in some patients with CKD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE		[Ott, Susan M.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ott, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Dave V, 2015, AM J NEPHROL, V41, P129, DOI 10.1159/000380960; Hruska KA, 2017, BONE, V100, P80, DOI 10.1016/j.bone.2017.01.023; Ott SM, 2013, NAT REV NEPHROL, V9, P681, DOI 10.1038/nrneph.2013.182; West SL, 2012, NEPHROL DIAL TRANSPL, V27, P2384, DOI 10.1093/ndt/gfr620	4	7	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC19	JC19		10.7326/ACPJC-2017-167-4-019	http://dx.doi.org/10.7326/ACPJC-2017-167-4-019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806800				2022-12-28	WOS:000407797500006
J	[Anonymous]				[Anonymous]			Effect of Malaria Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					603	603		10.1001/jama.2017.10691	http://dx.doi.org/10.1001/jama.2017.10691			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810032				2022-12-28	WOS:000407616000004
J	Nengo, I; Tafforeau, P; Gilbert, CC; Fleagle, JG; Miller, ER; Feibel, C; Fox, DL; Feinberg, J; Pugh, KD; Berruyer, C; Mana, S; Engle, Z; Spoor, F				Nengo, Isaiah; Tafforeau, Paul; Gilbert, Christopher C.; Fleagle, John G.; Miller, Ellen R.; Feibel, Craig; Fox, David L.; Feinberg, Josh; Pugh, Kelsey D.; Berruyer, Camille; Mana, Sara; Engle, Zachary; Spoor, Fred			New infant cranium from the African Miocene sheds light on ape evolution	NATURE			English	Article							OLD-WORLD MONKEYS; MIDDLE-MIOCENE; TUGEN HILLS; ORIGIN; GEOCHRONOLOGY; KIPSARAMON; HOMINIDS; HISTORY; BEARING; SIZE	The evolutionary history of extant hominoids (humans and apes) remains poorly understood. The African fossil record during the crucial time period, the Miocene epoch, largely comprises isolated jaws and teeth, and little is known about ape cranial evolution. Here we report on the, to our knowledge, most complete fossil ape cranium yet described, recovered from the 13 million-year-old Middle Miocene site of Napudet, Kenya. The infant specimen, KNM-NP 59050, is assigned to a new species of Nyanzapithecus on the basis of its unerupted permanent teeth, visualized by synchrotron imaging. Its ear canal has a fully ossified tubular ectotympanic, a derived feature linking the species with crown catarrhines. Although it resembles some hylobatids in aspects of its morphology and dental development, it possesses no definitive hylobatid synapomorphies. The combined evidence suggests that nyanzapithecines were stem hominoids close to the origin of extant apes, and that hylobatid-like facial features evolved multiple times during catarrhine evolution.	[Nengo, Isaiah] De Anza Coll, Dept Anthropol, Cupertino, CA 95104 USA; [Nengo, Isaiah] SUNY Stony Brook, Turkana Basin Inst, Social & Behav Sci Bldg N-507, Stony Brook, NY 11794 USA; [Tafforeau, Paul; Berruyer, Camille] European Synchrotron Radiat Facil, CS-40220, F-38043 Grenoble 09, France; [Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, 695 Pk Ave, New York, NY 10065 USA; [Gilbert, Christopher C.; Pugh, Kelsey D.] CUNY, Grad Ctr, 365 5th Ave, New York, NY 10016 USA; [Gilbert, Christopher C.; Pugh, Kelsey D.] New York Consortium Evolutionary Primatol, New York, NY USA; [Fleagle, John G.] SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [Miller, Ellen R.] Wake Forest Univ, Dept Anthropol, Winston Salem, NC 27109 USA; [Feibel, Craig] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Feibel, Craig; Engle, Zachary] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Fox, David L.; Feinberg, Josh] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Mana, Sara] Salem State Univ, Dept Geol Sci, Salem, MA 01970 USA; [Spoor, Fred] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Spoor, Fred] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; European Synchrotron Radiation Facility (ESRF); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wake Forest University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Minnesota System; University of Minnesota Twin Cities; Massachusetts System of Public Higher Education; Salem State University; University of London; University College London; Max Planck Society	Nengo, I (corresponding author), De Anza Coll, Dept Anthropol, Cupertino, CA 95104 USA.; Nengo, I (corresponding author), SUNY Stony Brook, Turkana Basin Inst, Social & Behav Sci Bldg N-507, Stony Brook, NY 11794 USA.	Isaiah.Nengo@stonybrook.edu		Fox, David L/0000-0002-2291-6146; Berruyer, Camille/0000-0002-0046-2972; Feinberg, Joshua/0000-0002-5845-9848; nengo, isaiah/0000-0002-1898-8788; Engle, Zachary/0000-0002-6412-7727; Tafforeau, Paul/0000-0002-5962-1683	Leakey Foundation; Foothill-De Anza Foundation; De Anza College Design and Manufacturing Technologies Department; National Geographic Society; European Synchrotron Radiation Facility; Max Planck Society	Leakey Foundation; Foothill-De Anza Foundation; De Anza College Design and Manufacturing Technologies Department; National Geographic Society(National Geographic Society); European Synchrotron Radiation Facility; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the Government of Kenya for permission to do this research, the National Museums of Kenya, the American Museum of Natural History, Harvard Museum of Comparative Zoology, the Musee des Confluences of Lyon, and the Digital Morphology Museum (KUPRI) for access to specimens in their care, and the Turkana Basin Institute for field support. The Leakey Foundation and trustee G. Getty, the Foothill-De Anza Foundation, De Anza College Design and Manufacturing Technologies Department, the National Geographic Society, the European Synchrotron Radiation Facility (beamlines ID 19 and BM5), and the Max Planck Society funded fieldwork or laboratory studies. We are grateful to M. Kibunjia and F. Manthi for facilitating permission to transport the specimen to Grenoble for scanning, and to D. Berthet, E. Delson, M. Hill, J.-J. Hublin, D. Plotzki, and H. Temming for facilitating computed tomography scans of comparative specimens. We are grateful to R. David, M. Gilleland, L. Gonzales, T. Harrison, J. Kelley, Y. Kunimatsu, L. Martin, M. Leakey, K. O'Maley, M. Pickford, C. Rendiger, B. Sokhi, and A. Stoessel for help with this research. We thank the field crew, A. Ekes, B. Ewoi, J. Ekusi, A. Ekuon, C. Nyete, and T. Ngundo, for their tireless efforts in the field that led to the discovery of the specimen, C. Kiarie for preparing the fossil, and B. Monroy for preparing some of the graphics. We particularly thank J. Ekusi for discovering KNM-NP 59050.	Alba DM, 2015, SCIENCE, V350, DOI 10.1126/science.aab2625; Begun D., 2015, HDB PALEOANTHROPOLOG, P1261; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun David R., 1997, P389; Begun DR, 2001, HOM EVOLUT CLIMAT CH, V2, P231; Behrensmeyer AK, 2002, J HUM EVOL, V42, P11, DOI 10.1006/jhev.2001.0519; BENEFIT BR, 1993, FOLIA PRIMATOL, V60, P133, DOI 10.1159/000156682; BENEFIT BR, 1993, AM J PHYS ANTHROPOL, V92, P329, DOI 10.1002/ajpa.1330920307; Bernor RL, 2007, P NATL ACAD SCI USA, V104, P19661, DOI 10.1073/pnas.0710109105; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Cameron DW, 1997, J HUM EVOL, V33, P449, DOI 10.1006/jhev.1997.0145; Chamberlain A. T., 1987, THESIS; Dalrymple G.B., 1981, 1176 US GEOL SURV; DALRYMPLE GB, 1993, J GEOPHYS RES-PLANET, V98, P13085, DOI 10.1029/93JE01222; Dirks W, 2007, J HUM EVOL, V53, P309, DOI 10.1016/j.jhevol.2007.04.007; Dodson R. G., 1971, 87 GEOL SURV KEN; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Gilbert CC, 2011, J HUM EVOL, V60, P731, DOI 10.1016/j.jhevol.2011.01.005; Gilbert CC, 2010, J HUM EVOL, V59, P465, DOI 10.1016/j.jhevol.2010.05.005; Gitau S. N., 1998, AM J PHYS ANTHR S, V26, P109; Gonzales LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8580; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison T, 2002, CAM S BIO EVOL ANTHR, V33, P311; HARRISON T, 1986, AM J PHYS ANTHROPOL, V71, P265, DOI 10.1002/ajpa.1330710303; Harrison Terry, 1997, P327; Harrison Terry, 2010, P429; Hilgen FJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P923, DOI 10.1016/B978-0-444-59425-9.00029-9; HILL A, 1988, YEARB PHYS ANTHROPOL, V31, P49; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Kelley J, 2002, J HUM EVOL, V42, P39, DOI 10.1006/jhev.2001.0504; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; MCCROSSIN ML, 1992, INT J PRIMATOL, V13, P659, DOI 10.1007/BF02551258; Morley C.K., 1999, AAPG BULL, V44, P19, DOI DOI 10.1306/ST44623C2; OLEJNICZAK AJ, 2006, THESIS; Pickford M, 2005, ANTHROPOL SCI, V113, P189, DOI 10.1537/ase.113.189; Rae TC, 1999, FOLIA PRIMATOL, V70, P125, DOI 10.1159/000021685; RAFFERTY KL, 1995, AM J PHYS ANTHROPOL, V97, P391, DOI 10.1002/ajpa.1330970406; Rossie JB, 2006, J HUM EVOL, V50, P568, DOI 10.1016/j.jhevol.2005.12.007; Ryan TM, 2012, P ROY SOC B-BIOL SCI, V279, P3467, DOI 10.1098/rspb.2012.0939; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; SOLA SM, 1995, J HUM EVOL, V29, P101, DOI 10.1006/jhev.1995.1049; Spoor CF, 1993, THESIS; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Ward SC, 2002, CAM S BIO EVOL ANTHR, V33, P385; Wiens JJ, 2000, SM S COMP E, P115	54	29	30	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					169	+		10.1038/nature23456	http://dx.doi.org/10.1038/nature23456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28796200	Green Submitted			2022-12-28	WOS:000407284300035
J	Savage, N				Savage, Neil			ON THE RIGHT TRACK	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S23	S25		10.1038/548S23a	http://dx.doi.org/10.1038/548S23a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792923	Bronze			2022-12-28	WOS:000407284300009
J	Ulland, TK; Song, WM; Huang, SCC; Ulrich, JD; Sergushichev, A; Beatty, WL; Loboda, AA; Zhou, YY; Caims, NJ; Kambal, A; Loginicheva, E; Gilfillan, S; Cella, M; Virgin, HW; Unanue, ER; Wang, YM; Artyomov, MN; Holtzman, DM; Colonna, M				Ulland, Tyler K.; Song, Wilbur M.; Huang, Stanley Ching-Cheng; Ulrich, Jason D.; Sergushichev, Alexey; Beatty, Wandy L.; Loboda, Alexander A.; Zhou, Yingyue; Caims, Nigel J.; Kambal, Amal; Loginicheva, Ekaterina; Gilfillan, Susan; Cella, Marina; Virgin, Herbert W.; Unanue, Emil R.; Wang, Yaming; Artyomov, Maxim N.; Holtzman, David M.; Colonna, Marco			TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease	CELL			English	Article							MYELOID CELLS; NEURODEGENERATIVE DISEASE; CREATINE TRANSPORTER; APOLIPOPROTEIN-E; TRANSGENIC MICE; MOUSE MODEL; AUTOPHAGY; BETA; INFLAMMATION; GROWTH	Elevated risk of developing Alzheimer's disease (AD) is associated with hypomorphic variants of TREM2, a surface receptor required for microglial responses to neurodegeneration, including proliferation, survival, clustering, and phagocytosis. How TREM2 promotes such diverse responses is unknown. Here, we find that microglia in AD patients carrying TREM2 risk variants and TREM2-deficient mice with AD-like pathology have abundant autophagic vesicles, as do TREM2-deficient macrophages under growth-factor limitation or endoplasmic reticulum (ER) stress. Combined metabolomics and RNA sequencing (RNA-seq) linked this anomalous autophagy to defective mammalian target of rapamycin (mTOR) signaling, which affects ATP levels and biosynthetic pathways. Metabolic derailment and autophagy were offset in vitro through Dectin-1, a receptor that elicits TREM2-like intracellular signals, and cyclocreatine, a creatine analog that can supply ATP. Dietary cyclocreatine tempered autophagy, restored microglial clustering around plaques, and decreased plaque-adjacent neuronal dystrophy in TREM2-deficient mice with amyloid-beta pathology. Thus, TREM2 enables microglial responses during AD by sustaining cellular energetic and biosynthetic metabolism.	[Ulland, Tyler K.; Song, Wilbur M.; Huang, Stanley Ching-Cheng; Zhou, Yingyue; Kambal, Amal; Loginicheva, Ekaterina; Gilfillan, Susan; Cella, Marina; Virgin, Herbert W.; Unanue, Emil R.; Wang, Yaming; Artyomov, Maxim N.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ulrich, Jason D.; Caims, Nigel J.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Ulrich, Jason D.; Caims, Nigel J.; Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Ulrich, Jason D.; Caims, Nigel J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Sergushichev, Alexey; Loboda, Alexander A.] ITMO Univ, Comp Technol Dept, St Petersburg 197101, Russia; [Beatty, Wandy L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); ITMO University; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Cella, Marina/ABA-8564-2020; Wang, Yaming/GNW-3745-2022; Sergushichev, Alexey A/J-8756-2015; Loboda, Alexander A/N-2502-2016	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Sergushichev, Alexey A/0000-0003-1159-7220; Virgin, Herbert/0000-0001-8580-7628; Ulland, Tyler/0000-0002-6507-4989; Cella, Marina/0000-0003-1230-1313; Zhou, Yingyue/0000-0002-0923-1046	NIH [RF1AG05148501, 5T32CA009547-30, DK058177, P01 AG03991, P01 AG026276]; Knight ADRC [P50 AG0568 1]; Cure Alzheimer's Fund; National Multiple Sclerosis Society [RG4687A1/1]; Government of Russian Federation [074-U01]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114551, U19AI109725, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK058177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026276, RF1AG051485, P50AG005681, P01AG003991] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knight ADRC; Cure Alzheimer's Fund; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Government of Russian Federation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Dr. Edward Driggers at General Metabolomics for providing metabolite analysis services. We also would like to thank Drs. Edward J. Pearce and David E. Sanin at the Max Planck Institute of Immunobiology and Epigenetics for discussions and experimental assistance. Finally, we would like to thank Dr. Robert E. Schmidt for assistance in interpreting TEM images. Confocal imaging was performed at the Washington University Center for Cellular Imaging. This work was funded by the NIH (RF1AG05148501 to M.Co., 5T32CA009547-30 to T.K.U., DK058177 to E.R.U., and P01 AG03991 and P01 AG026276 to D.M.H.), Knight ADRC (P50 AG0568 1 to M.Co.), the Cure Alzheimer's Fund (to M.Co.), the National Multiple Sclerosis Society (RG4687A1/1 to M.Ce.), and the Government of Russian Federation (074-U01 to A.S. and A.A.L.). Y.W. is currently employed by Eli Lilly and Company.	Ara G, 1998, IN VIVO, V12, P223; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gold M, 2015, SEMIN IMMUNOPATHOL, V37, P607, DOI 10.1007/s00281-015-0518-0; Guerreiro R, 2014, NEUROTHERAPEUTICS, V11, P732, DOI 10.1007/s13311-014-0295-9; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Kurosawa Y, 2012, J CLIN INVEST, V122, P2837, DOI 10.1172/JCI59373; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Masliah E, 1996, J NEUROSCI, V16, P5795; MCLAUGHLIN AC, 1972, J BIOL CHEM, V247, P4382; Meyer-Luehmann M, 2015, TRENDS NEUROSCI, V38, P659, DOI 10.1016/j.tins.2015.08.011; Netea-Maier RT, 2016, AUTOPHAGY, V12, P245, DOI 10.1080/15548627.2015.1071759; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sergushichev AA, 2016, NUCLEIC ACIDS RES, V44, pW194, DOI 10.1093/nar/gkw266; Shibuya Y, 2014, J NEUROSCI, V34, P14484, DOI 10.1523/JNEUROSCI.2567-14.2014; Snow RJ, 2001, MOL CELL BIOCHEM, V224, P169, DOI 10.1023/A:1011908606819; Tanzi RE, 2012, COLD SPRING HARB PER; Tejera D, 2016, CURR ALZHEIMER RES, V13, P370, DOI 10.2174/1567205013666151116125012; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Werner M, 2010, IMMUNOL REV, V237, P55, DOI 10.1111/j.1600-065X.2010.00934.x; WOZNICKI DT, 1979, J NEUROCHEM, V33, P75, DOI 10.1111/j.1471-4159.1979.tb11708.x; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003	55	490	508	7	233	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					649	+		10.1016/j.cell.2017.07.023	http://dx.doi.org/10.1016/j.cell.2017.07.023			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802038	Green Accepted, Bronze			2022-12-28	WOS:000407445700007
J	Bieleninik, L; Geretsegger, M; Mossler, K; Assmus, J; Thompson, G; Gattino, G; Elefant, C; Gottfried, T; Igliozzi, R; Muratori, F; Suvini, F; Kim, J; Crawford, MJ; Odell-Miller, H; Oldfield, A; Casey, O; Finnemann, J; Carpente, J; Park, AL; Grossi, E; Gold, C				Bieleninik, Lucja; Geretsegger, Monika; Mossler, Karin; Assmus, Jorg; Thompson, Grace; Gattino, Gustavo; Elefant, Cochavit; Gottfried, Tali; Igliozzi, Roberta; Muratori, Filippo; Suvini, Ferdinando; Kim, Jinah; Crawford, Mike J.; Odell-Miller, Helen; Oldfield, Amelia; Casey, Orla; Finnemann, Johanna; Carpente, John; Park, A-La; Grossi, Enzo; Gold, Christian		TIME-A Study Team	Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder The TIME-A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVENTION	IMPORTANCE Music therapymay facilitate skills in areas affected by autism spectrum disorder (ASD), such as social interaction and communication. OBJECTIVE To evaluate effects of improvisational music therapy on generalized social communication skills of children with ASD. DESIGN, SETTING, AND PARTICIPANTS Assessor-blinded, randomized clinical trial, conducted in 9 countries and enrolling children aged 4 to 7 years with ASD. Childrenwere recruited from November 2011 to November 2015, with follow-up between January 2012 and November 2016. INTERVENTIONS Enhanced standard care (n=182) vs enhanced standard care plus improvisational music therapy (n=182), allocated in a 1: 1 ratio. Enhanced standard care consisted of usual care as locally available plus parent counseling to discuss parents' concerns and provide information about ASD. In improvisational music therapy, trained music therapists sang or played music with each child, attuned and adapted to the child's focus of attention, to help children develop affect sharing and joint attention. MAIN OUTCOMES AND MEASURES The primary outcome was symptom severity over 5 months, based on the Autism Diagnostic Observation Schedule (ADOS), social affect domain (range, 0-27; higher scores indicate greater severity; minimal clinically important difference, 1). Prespecified secondary outcomes included parent-rated social responsiveness. All outcomes were also assessed at 2 and 12 months. RESULTS Among 364 participants randomized (mean age, 5.4 years; 83% boys), 314 (86%) completed the primary end point and 290 (80%) completed the last end point. Over 5 months, participants assigned to music therapy received a median of 19 music therapy, 3 parent counseling, and 36 other therapy sessions, compared with 3 parent counseling and 45 other therapy sessions for those assigned to enhanced standard care. From baseline to 5 months, mean ADOS social affect scores estimated by linear mixed-effects models decreased from 14.08 to 13.23 in the music therapy group and from 13.49 to 12.58 in the standard care group (mean difference, 0.06 [95% CI, - 0.70 to 0.81]; P = .88), with no significant difference in improvement. Of 20 exploratory secondary outcomes, 17 showed no significant difference. CONCLUSIONS AND RELEVANCE Among children with autism spectrum disorder, improvisational music therapy, compared with enhanced standard care, resulted in no significant difference in symptom severity based on the ADOS social affect domain over 5 months. These findings do not support the use of improvisational music therapy for symptom reduction in children with autism spectrum disorder.	[Bieleninik, Lucja; Geretsegger, Monika; Mossler, Karin; Assmus, Jorg; Gold, Christian] Uni Res, GAMUT Grieg Acad Mus Therapy Res Ctr, Uni Res Hlth, POB 7805, N-5020 Bergen, Norway; [Thompson, Grace] Univ Melbourne, Melbourne Conservatorium Mus, Melbourne, Vic, Australia; [Gattino, Gustavo] Aalborg Univ, Dept Commun & Psychol, Aalborg, Denmark; [Gattino, Gustavo] Rio Grande do Sul Fed Univ, Postgrad Program Child & Adolescent Hlth, Fac Med, Porto Alegre, RS, Brazil; [Elefant, Cochavit] Univ Haifa, Sch Creat Arts Therapies, Haifa, Israel; [Gottfried, Tali] David Yelin Coll, Mus Therapy Program, Jerusalem, Israel; [Igliozzi, Roberta; Muratori, Filippo; Suvini, Ferdinando] IRCCS Stella Maris Fdn, Pisa, Italy; [Muratori, Filippo] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Kim, Jinah] Jeonju Univ, Jeonju, South Korea; [Crawford, Mike J.] Imperial Coll London, Ctr Psychiat, London, England; [Odell-Miller, Helen; Oldfield, Amelia; Casey, Orla; Finnemann, Johanna] Anglia Ruskin Univ, Cambridge, England; [Finnemann, Johanna] Univ Cambridge, Dept Psychiat, Cambridge, England; [Carpente, John] Rockville Ctr, Rebecca Ctr Mus Therapy, Molloy Coll, New York, NY USA; [Park, A-La] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, LSE Hlth & Social Care, London, England; [Grossi, Enzo] Villa Santa Maria Inst, Tavernerio, Italy	University of Melbourne; Aalborg University; Universidade Federal do Rio Grande do Sul; University of Haifa; IRCCS Fondazione Stella Maris; University of Pisa; Jeonju University; Imperial College London; Anglia Ruskin University; University of Cambridge; University of London; London School Economics & Political Science	Gold, C (corresponding author), Uni Res, GAMUT Grieg Acad Mus Therapy Res Ctr, Uni Res Hlth, POB 7805, N-5020 Bergen, Norway.	christian.gold@uni.no	Bargagna, Stefania/AAB-7603-2019; Igliozzi, Roberta/AAA-4568-2021; Muratori, Filippo/K-3187-2018; Gold, Christian/K-1774-2015; Bieleninik, Łucja/I-7804-2019; Park, A-La/W-2101-2018; Grossi, Enzo/AAF-7765-2020; Gattino, Gustavo/AAB-3824-2019	Bargagna, Stefania/0000-0001-6430-9494; Igliozzi, Roberta/0000-0002-1245-972X; Muratori, Filippo/0000-0001-9598-0096; Bieleninik, Łucja/0000-0001-9685-2934; Park, A-La/0000-0002-4704-4874; Gattino, Gustavo/0000-0002-3048-6246; Finnemann, Johanna/0000-0002-1049-2155; Kim, Jinah/0000-0002-9528-3773; Crawford, Mike/0000-0003-3137-5772; Thompson, Grace/0000-0002-7501-5325	Research Council of Norway [213844]; POLYFON Knowledge Cluster for Music Therapy, The Grieg Academy Department of Music, University of Bergen; Australia: Melbourne Conservatorium of Music, The University of Melbourne; Austria: Danish Council for Independent Research/Humanities (FKK); Austria: Aalborg University; Austria: Faculty of Psychology, University of Vienna; Brazil: Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Italy: IRCCS Stella Maris Foundation, Pisa; Italy: University of Pisa; Korea: Research Institute of Health and Science, Jeonju University; Norway: Health Authority of Western Norway [911800]; Norway: Bergen municipality (Bergen Culture School); Norway: Fjell municipality (Fjell Culture School); United Kingdom: National Institute for Health Research [12/167/95]; United Kingdom: Cambridge and Peterborough Foundation National Health Service Trust; United Kingdom: Evelyn Trust; United Kingdom: Cambridgeshire Music; United Kingdom: Anglia Ruskin University; United States: Molloy College Faculty research scholarship; United States: Mid-Atlantic Region of the American Music Therapy Association; National Institute for Health Research [12/167/95] Funding Source: researchfish	Research Council of Norway(Research Council of Norway); POLYFON Knowledge Cluster for Music Therapy, The Grieg Academy Department of Music, University of Bergen; Australia: Melbourne Conservatorium of Music, The University of Melbourne; Austria: Danish Council for Independent Research/Humanities (FKK); Austria: Aalborg University; Austria: Faculty of Psychology, University of Vienna; Brazil: Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Italy: IRCCS Stella Maris Foundation, Pisa; Italy: University of Pisa; Korea: Research Institute of Health and Science, Jeonju University; Norway: Health Authority of Western Norway; Norway: Bergen municipality (Bergen Culture School); Norway: Fjell municipality (Fjell Culture School); United Kingdom: National Institute for Health Research(National Institute for Health Research (NIHR)); United Kingdom: Cambridge and Peterborough Foundation National Health Service Trust; United Kingdom: Evelyn Trust; United Kingdom: Cambridgeshire Music; United Kingdom: Anglia Ruskin University; United States: Molloy College Faculty research scholarship; United States: Mid-Atlantic Region of the American Music Therapy Association; National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by the Research Council of Norway (grant 213844, the Clinical Research and Mental Health Programmes). Additional funding was provided by the POLYFON Knowledge Cluster for Music Therapy, The Grieg Academy Department of Music, University of Bergen. Funding for the individual countries came from the following sources: Australia: Melbourne Conservatorium of Music, The University of Melbourne; Austria: Danish Council for Independent Research/Humanities (FKK), Aalborg University, and Faculty of Psychology, University of Vienna; Brazil: Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Italy: IRCCS Stella Maris Foundation, Pisa, and University of Pisa; Korea: Research Institute of Health and Science, Jeonju University; Norway: Health Authority of Western Norway (Helse Vest grant 911800), Bergen municipality (Bergen Culture School), Fjell municipality (Fjell Culture School); United Kingdom: National Institute for Health Research (Health Technology Assessment Programme, National Institute for Health Research grant 12/167/95), Cambridge and Peterborough Foundation National Health Service Trust, The Evelyn Trust, Cambridgeshire Music, Anglia Ruskin University; United States: Molloy College Faculty research scholarship and a collaborative research grant from the Mid-Atlantic Region of the American Music Therapy Association.	Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; Alvin J., 1978, MUSIC THERAPY AUTIST; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X; Blauth LK, 2017, HEALTH PSYCHOL REP, V5, P138, DOI 10.5114/hpr.2017.63558; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Constantino J.N., 2012, SOCIAL RESPONSIVENES; Dawson Geraldine, 2010, Pediatrics, V125, pe17, DOI 10.1542/peds.2009-0958; Geretsegger M, 2016, J MUSIC THER, V53, P93, DOI 10.1093/jmt/thv038; Geretsegger M, 2015, J MUSIC THER, V52, P258, DOI 10.1093/jmt/thv005; Geretsegger M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004381.pub3; Geretsegger M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-2; Gold C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004381.pub2; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Gottfried T, 2016, NORD J MUSIC THER, V25, P89, DOI 10.1080/08098131.2016.1180085; Green J, 2010, LANCET, V375, P2152, DOI 10.1016/S0140-6736(10)60587-9; Howlin P, 2007, J CHILD PSYCHOL PSYC, V48, P473, DOI 10.1111/j.1469-7610.2006.01707.x; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Malloch S., 2008, COMMUNICATIVE MUSICA; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Mossler K, 2016, NORD J MUSIC THER, V25, P51, DOI 10.1080/08098131.2016.1179960; Pickles A, 2016, LANCET, V388, P2501, DOI 10.1016/S0140-6736(16)31229-6; Reichow B, 2012, J AUTISM DEV DISORD, V42, P512, DOI 10.1007/s10803-011-1218-9; Silberman S., 2015, NEUROTRIBES LEGACY A; Solomon R, 2014, J DEV BEHAV PEDIATR, V35, P475, DOI 10.1097/DBP.0000000000000096; Stern D. N, 2010, FORMS VITALITY EXPLO; Weitlauf AS, 2014, THERAPIES CHILDREN W; Wong C, 2015, J AUTISM DEV DISORD, V45, P1951, DOI 10.1007/s10803-014-2351-z; World Health Organization, 2018, INT CLASSIFICATION D	30	66	66	6	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					525	535		10.1001/jama.2017.9478	http://dx.doi.org/10.1001/jama.2017.9478			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	FC9KM	28787504	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000407160100015
J	Chung, HT; Cullen, DA; Higgins, D; Sneed, BT; Holby, EF; More, KL; Zelenay, P				Chung, Hoon T.; Cullen, David A.; Higgins, Drew; Sneed, Brian T.; Holby, Edward F.; More, Karren L.; Zelenay, Piotr			Direct atomic-level insight into the active sites of a high-performance PGM-free ORR catalyst	SCIENCE			English	Article							OXYGEN REDUCTION REACTION; NONPRECIOUS METAL CATALYST; NITROGEN-DOPED GRAPHENE; PEM FUEL-CELL; CATHODE CATALYSTS; CARBON; IRON; ELECTROCATALYSTS; POLYANILINE; ELECTROREDUCTION	Platinum group metal-free (PGM-free) metal-nitrogen-carbon catalysts have emerged as a promising alternative to their costly platinum (Pt)-based counterparts in polymer electrolyte fuel cells (PEFCs) but still face some major challenges, including (i) the identification of the most relevant catalytic site for the oxygen reduction reaction (ORR) and (ii) demonstration of competitive PEFC performance under automotive-application conditions in the hydrogen (H2)-air fuel cell. Herein, we demonstrate H2-air performance gains achieved with an iron-nitrogen-carbon catalyst synthesized with two nitrogen precursors that developed hierarchical porosity. Current densities recorded in the kinetic region of cathode operation, at fuel cell voltages greater than similar to 0.75 V, were the same as those obtained with a Pt cathode at a loading of 0.1 milligram of Pt per centimeter squared. The proposed catalytic active site, carbon-embedded nitrogen-coordinated iron (FeN4), was directly visualized with aberration-corrected scanning transmission electron microscopy, and the contributions of these active sites associated with specific lattice-level carbon structures were explored computationally.	[Chung, Hoon T.; Higgins, Drew; Zelenay, Piotr] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA; [Cullen, David A.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Sneed, Brian T.; More, Karren L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Holby, Edward F.] Los Alamos Natl Lab, Sigma Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Zelenay, P (corresponding author), Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA.	zelenay@lanl.gov	Cullen, David/A-2918-2015; Chung, Hoon T/A-7916-2012	Cullen, David/0000-0002-2593-7866; Chung, Hoon T/0000-0002-5367-9294; Holby, Edward/0000-0001-8419-6298	Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy (DOE) through the Fuel Cell Technologies Office	Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy (DOE) through the Fuel Cell Technologies Office(United States Department of Energy (DOE))	This work was supported by the Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy (DOE) through the Fuel Cell Technologies Office. Microscopy was performed as part of a user project supported by Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. Computational resources were provided by the Institutional Computing program of Los Alamos National Laboratory. We thank A. Dattelbaum and J. Spendelow (Los Alamos National Laboratory), R. Adzic (Brookhaven National Laboratory), G. Wu (University at Buffalo), and P. Atanassov (University of New Mexico) for worthwhile discussions. All results are presented in the main paper and supplementary materials. The binary nitrogen precursors PGM-free catalyst synthesis method has been patented by H.T.C. and P.Z. as U.S. patent number US20160351915 A9, Non-precious metal catalysts.	Babu SK, 2016, ACS APPL MATER INTER, V8, P32764, DOI 10.1021/acsami.6b08844; Chung HT, 2015, CHEM COMMUN, V51, P13546, DOI 10.1039/c5cc04621a; Chung HT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2944; Chung HT, 2010, ELECTROCHEM COMMUN, V12, P1792, DOI 10.1016/j.elecom.2010.10.027; Cullen DA, 2014, J ELECTROCHEM SOC, V161, pF1111, DOI 10.1149/2.1091410jes; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Fei HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9668; Ferrandon M, 2012, J PHYS CHEM C, V116, P16001, DOI 10.1021/jp302396g; Holby EF, 2016, NANO ENERGY, V29, P54, DOI 10.1016/j.nanoen.2016.05.025; Holby EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09286; Holby EF, 2014, J PHYS CHEM C, V118, P14388, DOI 10.1021/jp503266h; James B. D., 2014, US DEP EN 2014 ANN M; Jaouen F, 2009, ACS APPL MATER INTER, V1, P1623, DOI 10.1021/am900219g; Kongkanand A, 2016, ACS CATAL, V6, P1578, DOI 10.1021/acscatal.5b02819; Kramm UI, 2014, J AM CHEM SOC, V136, P978, DOI 10.1021/ja410076f; Li JK, 2016, ENERG ENVIRON SCI, V9, P2418, DOI 10.1039/c6ee01160h; Ma SQ, 2011, CHEM-EUR J, V17, P2063, DOI 10.1002/chem.201003080; Mamtani K, 2015, CATAL LETT, V145, P436, DOI 10.1007/s10562-014-1434-y; Masa J, 2015, ANGEW CHEM INT EDIT, V54, P10102, DOI 10.1002/anie.201500569; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Sahraie NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9618; Serov A, 2016, J POWER SOURCES, V327, P557, DOI 10.1016/j.jpowsour.2016.07.087; Serov A, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301735; Shui JL, 2015, P NATL ACAD SCI USA, V112, P10629, DOI 10.1073/pnas.1507159112; Strickland K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8343; Tian J, 2013, ANGEW CHEM INT EDIT, V52, P6867, DOI 10.1002/anie.201303025; Varela AS, 2015, ANGEW CHEM INT EDIT, V54, P10758, DOI 10.1002/anie.201502099; Wu G, 2013, ACCOUNTS CHEM RES, V46, P1878, DOI 10.1021/ar400011z; Wu G, 2011, J MATER CHEM, V21, P11392, DOI 10.1039/c0jm03613g; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Yoshida T, 2015, ELECTROCHEM SOC INTE, V24, P45, DOI 10.1149/2.F03152IF; Zan R, 2013, ACS NANO, V7, P10167, DOI 10.1021/nn4044035; Zhao D, 2014, ADV MATER, V26, P1093, DOI 10.1002/adma.201304238; Zitolo A, 2015, NAT MATER, V14, P937, DOI [10.1038/NMAT4367, 10.1038/nmat4367]	34	959	964	78	1164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					479	483		10.1126/science.aan2255	http://dx.doi.org/10.1126/science.aan2255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774924	Green Submitted			2022-12-28	WOS:000406840100032
J	Hand, E				Hand, Eric			ASTROPHYSICS Cosmic ray catcher will probe supernovae from new perch	SCIENCE			English	News Item														Seo, Eun-Suk/0000-0001-8682-805X					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					437	438		10.1126/science.357.6350.437	http://dx.doi.org/10.1126/science.357.6350.437			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774907				2022-12-28	WOS:000406840100012
J	van den Bent, MJ; Baumert, B; Erridge, SC; Vogelbaum, MA; Nowak, AK; Sanson, M; Brandes, AA; Clement, PM; Baurain, JF; Mason, WP; Wheeler, H; Chinot, OL; Gill, S; Griffin, M; Brachman, DG; Taal, W; Ruda, R; Weller, M; McBain, C; Reijneveld, J; Enting, RH; Weber, DC; Lesimple, T; Clenton, S; Gijtenbeek, A; Pascoe, S; Herrlinger, U; Hau, P; Dhermain, F; van Heuvel, I; Stupp, R; Aldape, K; Jenkins, RB; Dubbink, HJ; Dinjens, WNM; Wesseling, P; Nuyens, S; Golfinopoulos, V; Gorlia, T; Wick, W; Kros, JM				van den Bent, Martin J.; Baumert, Brigitta; Erridge, Sara C.; Vogelbaum, Michael A.; Nowak, Anna K.; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M.; Baurain, Jean Francais; Mason, Warren P.; Wheeler, Helen; Chinot, Olivier L.; Gill, Sanjeev; Griffin, Matthew; Brachman, David G.; Taal, Walter; Ruda, Roberta; Weller, Michael; McBain, Catherine; Reijneveld, Jaap; Enting, Roelien H.; Weber, Damien C.; Lesimple, Thierry; Clenton, Susan; Gijtenbeek, Anja; Pascoe, Sarah; Herrlinger, Ulrich; Hau, Peter; Dhermain, Frederic; van Heuvel, Irene; Stupp, Roger; Aldape, Ken; Jenkins, Robert B.; Dubbink, Hendrikus Jan; Dinjens, Winand N. M.; Wesseling, Pieter; Nuyens, Sarah; Golfinopoulos, Vassilis; Gorlia, Thierry; Wick, Wolfgang; Kros, Johan M.			Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study	LANCET			English	Article							BRAIN-TUMOR GROUP; LOW-GRADE GLIOMA; EUROPEAN ORGANIZATION; OLIGODENDROGLIAL TUMORS; IDH2 MUTATIONS; III TRIAL; PROCARBAZINE; VINCRISTINE; GLIOBLASTOMA; CHEMOTHERAPY	Background The role of temozolomide chemotherapy in newly diagnosed 1p/19q non-co-deleted anaplastic gliomas, which are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumours, is unclear. We assessed the use of radiotherapy with concurrent and adjuvant temozolomide in adults with non-codeleted anaplastic gliomas. Methods This was a phase 3, randomised, open-label study with a 2 x 2 factorial design. Eligible patients were aged 18 years or older and had newly diagnosed non-co-deleted anaplastic glioma with WHO performance status scores of 0-2. The randomisation schedule was generated with the electronic EORTC web-based ORTA system. Patients were assigned in equal numbers (1:1:1:1), using the minimisation technique, to receive radiotherapy (59.4 Gy in 33 fractions of 1.8 Gy) alone or with adjuvant temozolomide (12 4-week cycles of 150-200 mg/m(2) temozolomide given on days 1-5); or to receive radiotherapy with concurrent temozolomide 75 mg/m(2) per day, with or without adjuvant temozolomide. The primary endpoint was overall survival adjusted for performance status score, age, 1p loss of heterozygosity, presence of oligodendroglial elements, and MGMT promoter methylation status, analysed by intention to treat. We did a planned interim analysis after 219 (41%) deaths had occurred to test the null hypothesis of no efficacy (threshold for rejection p<0.0084). This trial is registered with ClinicalTrials.gov, number NCT00626990. Findings At the time of the interim analysis, 745 (99%) of the planned 748 patients had been enrolled. The hazard ratio for overall survival with use of adjuvant temozolomide was 0.65 (99.145% CI 0.45-0.93). Overall survival at 5 years was 55.9% (95% CI 47.2-63.8) with and 44.1% (36.3-51.6) without adjuvant temozolomide. Grade 3-4 adverse events were seen in 8-12% of 549 patients assigned temozolomide, and were mainly haematological and reversible. Interpretation Adjuvant temozolomide chemotherapy was associated with a significant survival benefit in patients with newly diagnosed non-co-deleted anaplastic glioma. Further analysis of the role of concurrent temozolomide treatment and molecular factors is needed. Funding Schering Plough and MSD.	[van den Bent, Martin J.; Taal, Walter] Erasmus MC Canc Inst, Brain Tumour Ctr, Neurooncol Unit, Rotterdam, Netherlands; [Dubbink, Hendrikus Jan; Dinjens, Winand N. M.; Kros, Johan M.] Erasmus MC Canc Inst, Brain Tumour Ctr, Dept Pathol, Rotterdam, Netherlands; [Baumert, Brigitta] Maastricht Univ Med Ctr MUMC, Dept Radiation Oncol MAASTRO, Maastricht, Netherlands; [Baumert, Brigitta] Maastricht Univ Med Ctr MUMC, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Baumert, Brigitta] Univ Munster, Dept Radiat Oncol, Munster, Germany; [Baumert, Brigitta] Paracelsus Clin, Osnabruck, Germany; [Erridge, Sara C.] Univ Edinburgh, Western Gen Hosp, Edinburgh Ctr Neurooncol, Edinburgh, Midlothian, Scotland; [Vogelbaum, Michael A.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Vogelbaum, Michael A.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA; [Nowak, Anna K.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Nowak, Anna K.] Univ Sydney, Cooperat Grp Neurooncol, Camperdown, NSW, Australia; [Nowak, Anna K.] Sir Charles Gairdner Hosp, Dept Med Oncol, Hosp Ave, Nedlands, WA, Australia; [Sanson, Marc] Univ Paris VI, Sorbonne Univ UPMC, Hop Pitie Salpetriere, APHP,CNRS,INSERM,ICM, F-75013 Paris, France; [Brandes, Alba Ariela] AUSL IRCCS Sci Neurol, Med Oncol Dept, Bologna, Italy; [Clement, Paul M.] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Clement, Paul M.] UZ Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium; [Baurain, Jean Francais] Catholic Univ Louvain, Clin Univ St Luc, King Albert Canc Inst 2, Dept Med Oncol, Brussels, Belgium; [Mason, Warren P.; Aldape, Ken] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Wheeler, Helen] North Shore Hosp, Northern Sydney Canc Ctr, St Leonards, NSW, Australia; [Wheeler, Helen] Univ Sydney, Dept Med, Sydney, NSW, Australia; [Chinot, Olivier L.] Aix Marseille Univ, AP HM, Neurooncol Div, Marseille, France; [Gill, Sanjeev] Alfred Hosp, Dept Med Oncol, Melbourne, Vic, Australia; [Griffin, Matthew] Nottingham Univ Hosp NHS Trust, Dept Clin Oncol, Nottingham, England; [Brachman, David G.] Barrow Neurol Inst, Dept Radiat Oncol, Phoenix, AZ 85013 USA; [Ruda, Roberta] City Hlth & Sci Hosp, Dept Neurooncol, Turin, Italy; [Ruda, Roberta] Univ Turin, Turin, Italy; [Weller, Michael] Univ Hosp, Dept Neurol & Brain Tumour Ctr, Zurich, Switzerland; [Stupp, Roger] Univ Hosp, Dept Med Oncol, Zurich, Switzerland; [Stupp, Roger] Univ Zurich, Zurich, Switzerland; [McBain, Catherine] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England; [Reijneveld, Jaap] Vrije Univ Amsterdam, Med Ctr, VUmc Canc Ctr Amsterdam, Amsterdam, Netherlands; [Reijneveld, Jaap] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Wesseling, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Reijneveld, Jaap] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Reijneveld, Jaap] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Enting, Roelien H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Weber, Damien C.] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland; [Lesimple, Thierry] Comprehens Canc Ctr Eugene Marquis, Dept Clin Oncol, Rennes, France; [Clenton, Susan] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Gijtenbeek, Anja] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands; [Wesseling, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands; [Pascoe, Sarah] Plymouth Hosp NHS Trust, Dept Clin Oncol, Plymouth, Devon, England; [Herrlinger, Ulrich] Univ Bonn, Med Ctr, Dept Neurol, Div Clin Neuro Oncol, Bonn, Germany; [Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander Neurooncol Unit, Regensburg, Germany; [Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Dhermain, Frederic] Gustave Roussy Univ Hosp, Radiotherapy Dept, Villejuif, France; [Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Nuyens, Sarah; Golfinopoulos, Vassilis; Gorlia, Thierry] EORTC, Brussels, Belgium; [Wick, Wolfgang] Tumorerkrankungen Univ Klin, Neurol Klin, Heidelberg, Germany; [Wick, Wolfgang] Tumorerkrankungen Univ Klin, Natl Zentrum, Heidelberg, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Munster; University of Edinburgh; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Western Australia; University of Sydney; University of Western Australia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; KU Leuven; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Royal North Shore Hospital; University of Sydney; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Florey Institute of Neuroscience & Mental Health; Nottingham University Hospital NHS Trust; Barrow Neurological Institute; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Christie NHS Foundation Trust; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Geneva; UNICANCER; Centre Eugene Marquis; Weston Park Hospital; Radboud University Nijmegen; Radboud University Nijmegen; University of Plymouth; University of Bonn; University of Regensburg; University of Regensburg; Mayo Clinic; European Organisation for Research & Treatment of Cancer	van den Bent, MJ (corresponding author), Erasmus MC Canc Inst, Brain Tumour Ctr, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	m.vandenbent@erasmusmc.nl	Clement, Paul/HGC-8376-2022; Stupp, Roger/L-3303-2019; Wick, Wolfgang/AAA-2545-2020; Nowak, Anna K/B-2487-2013; Baumert, Brigitta G./AAM-6549-2020; Wesseling, P./H-8114-2014; CHINOT, Olivier/M-9196-2018	Wick, Wolfgang/0000-0002-6171-634X; Nowak, Anna K/0000-0002-9317-9526; Baumert, Brigitta G./0000-0001-8871-4654; Wesseling, P./0000-0001-5453-5201; CHINOT, Olivier/0000-0001-6317-9691; RUDA', Roberta/0000-0001-9134-1537; Taal, Walter/0000-0002-5530-7259; Gkolfinopoulos, Vasileios/0000-0002-8667-9477; Weller, Michael/0000-0002-1748-174X; van den Bent, Martin/0000-0001-5710-5127; Hau, Peter/0000-0003-3894-5053	Schering Plough; MSD; NATIONAL CANCER INSTITUTE [U10CA180863, U10CA180822, U24CA196067, U10CA180868, U10CA021661] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12023/20, MC_UU_12023/28, MC_UU_12023/10, MC_U122861383] Funding Source: researchfish; MRC [MC_UU_12023/28, MC_U122861383, MC_UU_12023/10] Funding Source: UKRI	Schering Plough(Merck & CompanySchering Plough Corporation); MSD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Schering Plough and MSD.	[Anonymous], 1993, 50 ICRU; Bady P, 2012, ACTA NEUROPATHOL; Bady P, 2016, J MOL DIAGN, V18, P350, DOI 10.1016/j.jmoldx.2015.11.009; Baumert BG, 2016, LANCET ONCOL, V17, P1521, DOI 10.1016/S1470-2045(16)30313-8; Blumenthal DT, 2017, NEURO-ONCOLOGY, V19, P1119, DOI 10.1093/neuonc/nox025; Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Chang S, 2017, NEURO-ONCOLOGY, V19, P252, DOI 10.1093/neuonc/now236; Dubbink HJ, 2016, J MOL DIAGN, V18, P775, DOI 10.1016/j.jmoldx.2016.06.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; ICRU, 1999, 62 ICRU; Jenkins RB, 2001, AM J CLIN ONCOL-CANC, V24, P506; Louis DN, WHO CLASSIFICATION T, V4; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taphoorn MJB, 2007, J CLIN ONCOL, V25, P5723, DOI 10.1200/JCO.2007.12.7514; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; van den Bent MJ, 2013, CLIN CANCER RES, V19, P5513, DOI 10.1158/1078-0432.CCR-13-1157; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Wick W, 2016, NEURO-ONCOLOGY, V18, P1529, DOI 10.1093/neuonc/now133; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Wiestler B, 2014, ACTA NEUROPATHOL; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	32	209	208	0	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1645	1653		10.1016/S0140-6736(17)31442-3	http://dx.doi.org/10.1016/S0140-6736(17)31442-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI9TS	28801186	Green Accepted			2022-12-28	WOS:000412352800024
J	Piwecka, M; Glazar, P; Hernandez-Miranda, LR; Memczak, S; Wolf, SA; Rybak-Wolf, A; Filipchyk, A; Klironomos, F; Jara, CAC; Fenske, P; Trimbuch, T; Zywitza, V; Plass, M; Schreyer, L; Ayoub, S; Kocks, C; Kuhn, R; Rosenmund, C; Birchmeier, C; Rajewsky, N				Piwecka, Monika; Glazar, Petar; Hernandez-Miranda, Luis R.; Memczak, Sebastian; Wolf, Susanne A.; Rybak-Wolf, Agnieszka; Filipchyk, Andrei; Klironomos, Filippos; Jara, Cledi Alicia Cerda; Fenske, Pascal; Trimbuch, Thorsten; Zywitza, Vera; Plass, Mireya; Schreyer, Luisa; Ayoub, Salah; Kocks, Christine; Kuhn, Ralf; Rosenmund, Christian; Birchmeier, Carmen; Rajewsky, Nikolaus			Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function	SCIENCE			English	Article							PREPULSE INHIBITION; EXON CIRCULARIZATION; NEURONAL ENSEMBLES; EXPRESSION; STARTLE; SCHIZOPHRENIA; PLASTICITY; MICRORNA-7; DISCOVERY; EFFICIENT	Hundreds of circular RNAs (circRNAs) are highly abundant in the mammalian brain, often with conserved expression. Here we show that the circRNA Cdr1as is massively bound by the microRNAs (miRNAs) miR-7 and miR-671 in human and mouse brains. When the Cdr1as locus was removed from the mouse genome, knockout animals displayed impaired sensorimotor gating-a deficit in the ability to filter out unnecessary information-which is associated with neuropsychiatric disorders. Electrophysiological recordings revealed dysfunctional synaptic transmission. Expression of miR-7 and miR-671 was specifically and posttranscriptionally misregulated in all brain regions analyzed. Expression of immediate early genes such as Fos, a direct miR-7 target, was enhanced in Cdr1as-deficient brains, providing a possible molecular link to the behavioral phenotype. Our data indicate an in vivo loss-of-function circRNA phenotype and suggest that interactions between Cdr1as and miRNAs are important for normal brain function.	[Piwecka, Monika; Glazar, Petar; Memczak, Sebastian; Rybak-Wolf, Agnieszka; Filipchyk, Andrei; Klironomos, Filippos; Jara, Cledi Alicia Cerda; Zywitza, Vera; Plass, Mireya; Schreyer, Luisa; Ayoub, Salah; Kocks, Christine; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Robert Rossle Str 10, Berlin, Germany; [Hernandez-Miranda, Luis R.; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Lab Dev Biol & Signal Transduct, Robert Rossle Str 10, Berlin, Germany; [Memczak, Sebastian] Charite Med Fac, Expt & Clin Res Ctr, Robert Rossle Str 10, Berlin, Germany; [Memczak, Sebastian] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, Berlin, Germany; [Wolf, Susanne A.] Max Delbruck Ctr Mol Med, Lab Cellular Neurosci, Robert Rossle Str 10, Berlin, Germany; [Fenske, Pascal; Trimbuch, Thorsten] Charite, NeuroCure Cluster Excellence, Dept Neurophysiol, Berlin, Germany; [Kuhn, Ralf] Max Delbruck Ctr Mol Med, Transgen Core Facil, Robert Rossle Str 10, Berlin, Germany; [Kuhn, Ralf] Berlin Inst Hlth, Kapelle Ufer 2, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Berlin Institute of Health	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Robert Rossle Str 10, Berlin, Germany.	rajewsky@mdc-berlin.de	plass, mireya/AAB-7483-2019; Hernandez-Miranda, Luis R./ABE-1283-2021; Wolf, Susanne/AAA-6598-2022; Kühn, Ralf/U-1278-2017; Hernandez-Miranda, Luis Rodrigo/ABE-1269-2021; Plass, Mireya/B-4240-2010; Rosenmund, Christian/AAC-3596-2020	plass, mireya/0000-0002-9891-2723; Kühn, Ralf/0000-0003-1694-9803; Plass, Mireya/0000-0002-9891-2723; Rosenmund, Christian/0000-0002-3905-2444; Piwecka, Monika/0000-0003-4104-6577; Rybak-Wolf, Agnieszka/0000-0002-1192-5290; Wolf, Susanne/0000-0003-0922-8418; Filipchyk, Andrei/0000-0002-2029-8460; Rajewsky, Nikolaus/0000-0002-4785-4332; Zywitza, Vera/0000-0003-3055-8569; Hernandez-Miranda, Luis R./0000-0002-0498-708X; Memczak, Sebastian/0000-0001-9518-7135; Cerda-Jara, Cledi/0000-0003-1783-5533; Trimbuch, Thorsten/0000-0001-7512-8955; Birchmeier, Carmen/0000-0002-2041-8872; Fenske, Pascal/0000-0003-4709-8984	European Commission [302477]; Berlin Institute of Health (BIH) [CRG 2a TP7]; DFG (German Research Foundation) [RA 838/6-1]; DFG Graduate School "Computational Systems Biology" [CSB-GRK 1772]; DZHK (German Centre for Cardiovascular Research); DEEP (Deutsches Epigenom Programm); DFG [WO 1418/3-1, RA 838/5-1, SFB/TRR 186 A 04]; Max Delbruck Center for Molecular Medicine graduate program; BIH [CRG 2b T1]	European Commission(European CommissionEuropean Commission Joint Research Centre); Berlin Institute of Health (BIH); DFG (German Research Foundation)(German Research Foundation (DFG)); DFG Graduate School "Computational Systems Biology"; DZHK (German Centre for Cardiovascular Research); DEEP (Deutsches Epigenom Programm); DFG(German Research Foundation (DFG)); Max Delbruck Center for Molecular Medicine graduate program(Helmholtz Association); BIH	We thank all members of the N. Rajewsky laboratory and the C. Birchmeier laboratory for helpful discussions and support. We thank M. Herzog for organizational help, M. Schilling for computational assistance, T. Muller for technical advice on the primary neuronal cultures and discussions, and G. Matz, A. Boltengagen, P. Stallerow, M. Terne, S. Buchert, R. Kabisch, A. Leschke, D. Schreiber, and R. Dannenberg for their technical assistance. L.R.H.-M. acknowledges the European Commission for funding under the scheme Marie Sklodowska-Curie (fellowship 302477). A.R.W. acknowledges funding by Berlin Institute of Health (BIH) grant CRG 2a TP7. S.M. was funded by DFG (German Research Foundation) grant RA 838/6-1. A.F. thanks the DFG Graduate School "Computational Systems Biology" CSB-GRK 1772 for a fellowship and the DZHK (German Centre for Cardiovascular Research) for funding. F.K. and P.G. acknowledge funding from DEEP (Deutsches Epigenom Programm). S.A.W. is supported by DFG grant WO 1418/3-1. C.A.C.J. is funded by the Max Delbruck Center for Molecular Medicine graduate program. L.S. acknowledges funding by DFG grant RA 838/5-1. P.F. is funded by DFG grant SFB/TRR 186 A 04. C.R. acknowledges funding by BIH grant CRG 2b T1. RNA sequencing data are deposited in the Gene Expression Omnibus with accession number GSE93130.	ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; de Chevigny A, 2012, NAT NEUROSCI, V15, P1120, DOI 10.1038/nn.3142; de la Mata M, 2015, EMBO REP, V16, P500, DOI 10.15252/embr.201540078; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Franken P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-87; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Giles KM, 2013, BIOCHEM BIOPH RES CO, V430, P706, DOI 10.1016/j.bbrc.2012.11.086; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Grottick AJ, 2005, MOL BRAIN RES, V139, P153, DOI 10.1016/j.molbrainres.2005.05.020; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Pollock A, 2014, CELL REP, V7, P1184, DOI 10.1016/j.celrep.2014.04.003; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Stevanato L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt437; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Wolf SA, 2011, BRAIN BEHAV IMMUN, V25, P971, DOI 10.1016/j.bbi.2010.10.014; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhao XD, 2015, J CELL BIOL, V210, P613, DOI 10.1083/jcb.201501073	44	712	745	9	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357							eaam8526	10.1126/science.aam8526	http://dx.doi.org/10.1126/science.aam8526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7BX	28798046				2022-12-28	WOS:000411337700036
J	Jenkins, C				Jenkins, Christine			Eliminating asthma deaths: have we stalled?	LANCET			English	Editorial Material									[Jenkins, Christine] Univ New South Wales, George Inst Global Hlth, Sydney, NSW 2042, Australia	George Institute for Global Health; University of New South Wales Sydney; University of Sydney	Jenkins, C (corresponding author), Univ New South Wales, George Inst Global Hlth, Sydney, NSW 2042, Australia.	christine.jenkins@sydney.edu.au						[Anonymous], 1990, BMJ, V301, P651; Ebmeier SJ, 2017, LANCET; Kolbe J, 2002, THORAX, V57, P317, DOI 10.1136/thorax.57.4.317; PEARCE N, 1995, LANCET, V345, P41, DOI 10.1016/S0140-6736(95)91159-6; Price D, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.9; Royal College of Physicians, 2014, EUR RESPIR J; Sturdy PM, 2002, THORAX, V57, P1034, DOI 10.1136/thorax.57.12.1034; To T, 2016, J ASTHMA, V53, P505, DOI 10.3109/02770903.2015.1064949; Tsai CL, 2012, J ALLERGY CLIN IMMUN, V129, P1252, DOI 10.1016/j.jaci.2012.01.061; van Asperen P, 2015, MED J AUSTRALIA, V202, P125, DOI 10.5694/mja14.01645	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					915	916		10.1016/S0140-6736(17)31587-8	http://dx.doi.org/10.1016/S0140-6736(17)31587-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28797515				2022-12-28	WOS:000408746300004
J	Karath, K				Karath, Kata			CONSERVATION BIOLOGY 'Safe spaces' may save the European mink	SCIENCE			English	News Item																			0	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					636	636		10.1126/science.357.6352.636	http://dx.doi.org/10.1126/science.357.6352.636			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818925				2022-12-28	WOS:000407793600013
J	Brown, S; Pineda, CM; Xin, TC; Boucher, J; Suozzi, KC; Park, S; Matte-Martone, C; Gonzalez, DG; Rytlewski, J; Beronja, S; Greco, V				Brown, Samara; Pineda, Cristiana M.; Xin, Tianchi; Boucher, Jonathan; Suozzi, Kathleen C.; Park, Sangbum; Matte-Martone, Catherine; Gonzalez, David G.; Rytlewski, Julie; Beronja, Slobodan; Greco, Valentina			Correction of aberrant growth preserves tissue homeostasis	NATURE			English	Article							HAIR-FOLLICLE; BETA-CATENIN; STEM-CELL; MUTATIONS; ACTIVATION; MICE; EXPRESSION; NICHE	Cells in healthy tissues acquire mutations with surprising frequency. Many of these mutations are associated with abnormal cellular behaviours such as differentiation defects and hyperproliferation, yet fail to produce macroscopically detectable phenotypes(1-3). It is currently unclear how the tissue remains phenotypically normal, despite the presence of these mutant cells. Here we use intravital imaging to track the fate of mouse skin epithelium burdened with varying numbers of activated Wnt/beta-catenin stem cells. We show that all resulting growths that deform the skin tissue architecture regress, irrespective of their size. Wild-type cells are required for the active elimination of mutant cells from the tissue, while utilizing both endogenous and ectopic cellular behaviours to dismantle the aberrant structures. After regression, the remaining structures are either completely eliminated or converted into functional skin appendages in a niche-dependent manner. Furthermore, tissue aberrancies generated from oncogenic Hras, and even mutationin-dependent deformations to the tissue, can also be corrected, indicating that this tolerance phenomenon reflects a conserved principle in the skin. This study reveals an unanticipated plasticity of the adult skin epithelium when faced with mutational and non-mutational insult, and elucidates the dynamic cellular behaviours used for its return to a homeostatic state.	[Brown, Samara; Pineda, Cristiana M.; Xin, Tianchi; Boucher, Jonathan; Suozzi, Kathleen C.; Park, Sangbum; Matte-Martone, Catherine; Gonzalez, David G.; Greco, Valentina] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Rytlewski, Julie; Beronja, Slobodan] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Greco, Valentina] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Greco, Valentina] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Fred Hutchinson Cancer Center; Yale University; Yale University; Yale University; Yale University	Greco, V (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Beronja, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.; Greco, V (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Greco, V (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.; Greco, V (corresponding author), Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA.; Greco, V (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	beronja@fredhutch.org; Valentina.Greco@yale.edu	Xin, Tianchi/AAU-6803-2020; Rytlewski, Julie/O-6811-2019	Xin, Tianchi/0000-0002-6982-8610; Rytlewski, Julie/0000-0001-5244-6790; Beronja, Slobodan/0000-0002-6769-9261; Boucher, Jonathan/0000-0001-6938-4813	New York Stem Cell Foundation; Edward Mallinckrodt, Jr. Foundation; Howard Hughes Medical Institute Scholar award; National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health (NIH) [5R01AR063663-04, 1R01AR067755-01A1]; NIH Predoctoral Program in Cellular and Molecular Biology [NIH T32GM007223]; Human Genetics Training Grant [NIH T32HD001749]; National Cancer Institute of the NIH [F31CA206419]; James Hudson Brown - Alexander Brown Coxe Postdoctoral Fellowship; CT Stem Cell Grant [14-SCA-YALE-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA206419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, R01AR067755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Edward Mallinckrodt, Jr. Foundation; Howard Hughes Medical Institute Scholar award; National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health (NIH); NIH Predoctoral Program in Cellular and Molecular Biology; Human Genetics Training Grant; National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James Hudson Brown - Alexander Brown Coxe Postdoctoral Fellowship; CT Stem Cell Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Cockburn, K. Mesa, and S. Guo for feedback on the manuscript. We thank G. Panse, P. Myung, and C. Ko for assistance with brightfield images and clinical assessment of haematoxylin and eosin sections. We thank G. Gu for K19cre<SUP>ER</SUP> and M. Taketo for beta-catnflox(Ex3)/+ mice. This work was supported by The New York Stem Cell Foundation and grants to V.G. by the Edward Mallinckrodt, Jr. Foundation, a Howard Hughes Medical Institute Scholar award, and National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health (NIH), grant numbers 5R01AR063663-04 and 1R01AR067755-01A1. The content is the responsibility of the authors and does not necessarily represent the official views of the NIH. S. Br. was supported by the NIH Predoctoral Program in Cellular and Molecular Biology, grant number NIH T32GM007223. C. M. P. was supported by Human Genetics Training Grant NIH T32HD001749 and is currently supported by the National Cancer Institute of the NIH under Award Number F31CA206419. S. P. was supported by a James Hudson Brown - Alexander Brown Coxe Postdoctoral Fellowship and is currently supported by CT Stem Cell Grant 14-SCA-YALE-05. V.G. is a New York Stem Cell Foundation Robertson Investigator. beta-catn<SUP>flow(Ex3)</SUP> mice are available from M. Taketo under a material transfer agreement with Banyu-Merck. We thank the Marine Biological Laboratory, Woods Hole, Massachusetts, for support while writing this manuscript.	Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Beronja Slobodan, 2013, Methods Mol Biol, V961, P351, DOI 10.1007/978-1-62703-227-8_23; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fuchs Y, 2013, SCIENCE, V341, P286, DOI 10.1126/science.1233029; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Fullgrabe A, 2015, STEM CELL REP, V5, P843, DOI 10.1016/j.stemcr.2015.09.013; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kretzschmar K, 2016, CELL REP, V14, P269, DOI 10.1016/j.celrep.2015.12.041; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Ling G, 2001, AM J PATHOL, V159, P1247, DOI 10.1016/S0002-9440(10)62511-4; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pineda CM, 2015, NAT PROTOC, V10, P1116, DOI 10.1038/nprot.2015.070; Pruitt SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3626; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673	35	99	101	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					334	+		10.1038/nature23304	http://dx.doi.org/10.1038/nature23304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28783732	Green Accepted			2022-12-28	WOS:000407748400033
J	Brown, JL				Brown, Jeffrey L.			Trials and Tribulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brown, Jeffrey L.] New York Med Coll, Valhalla, NY 10595 USA; [Brown, Jeffrey L.] Weill Cornell Med Coll, New York, NY USA	New York Medical College; Cornell University	Brown, JL (corresponding author), New York Med Coll, Dept Pediat, 10 Walnut Ct, White Plains, NY 10605 USA.; Brown, JL (corresponding author), Weill Cornell Med Coll, Dept Pediat, 10 Walnut Ct, White Plains, NY 10605 USA.; Brown, JL (corresponding author), Weill Cornell Med Coll, Dept Psychiat, 10 Walnut Ct, White Plains, NY 10605 USA.	jlbrown100@msn.com						Brown JL, 2012, MEDICOLEGAL ISSUES P, P17; Brown JL, 2013, AAP NEWS, V33, P6; Mello MM, 2014, JAMA-J AM MED ASSOC, V312, P2146, DOI 10.1001/jama.2014.10705; Paul SR, 2013, AAP NEWS, V34, P1; Paul SR, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3862	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					612	613		10.1001/jama.2017.7106	http://dx.doi.org/10.1001/jama.2017.7106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810028				2022-12-28	WOS:000407616000013
J	Kaelin, WG				Kaelin, William G., Jr.			Climate Change What Would Lincoln Do?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kaelin, William G., Jr.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA	Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kaelin, WG (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Mayer Bldg,Room 457,450 Brookline Ave, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					611	611		10.1001/jama.2017.6999	http://dx.doi.org/10.1001/jama.2017.6999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810027				2022-12-28	WOS:000407616000012
J	Kansagara, D; Wilt, TJ; Frost, J; Qaseem, A				Kansagara, Devan; Wilt, Timothy J.; Frost, Jennifer; Qaseem, Amir			Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kansagara, Devan] Portland Evidence Based Synth Program, Portland, OR 97239 USA; [Kansagara, Devan] Portland VA Med Ctr, Portland, OR 97239 USA; [Wilt, Timothy J.] Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Frost, Jennifer] Amer Acad Family Phys, Leawood, KS USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of Minnesota System; University of Minnesota Twin Cities; American College of Physicians	Kansagara, D (corresponding author), Portland Evidence Based Synth Program, Portland, OR 97239 USA.; Kansagara, D (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.							Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754	5	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					291	292		10.7326/L17-0286	http://dx.doi.org/10.7326/L17-0286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806807				2022-12-28	WOS:000407797500026
J	Fruman, DA; Chiu, H; Hopkins, BD; Bagrodia, S; Cantley, LC; Abraham, RT				Fruman, David A.; Chiu, Honyin; Hopkins, Benjamin D.; Bagrodia, Shubha; Cantley, Lewis C.; Abraham, Robert T.			The PI3K Pathway in Human Disease	CELL			English	Review							TUBEROUS SCLEROSIS COMPLEX; I DOSE-ESCALATION; PHOSPHOINOSITIDE 3-KINASE P110-DELTA; RECEPTOR TYROSINE KINASES; BREAST-CANCER; PHASE-I; T-CELLS; B-CELL; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN TARGET	Phosphoinositide 3-kinase (PI3K) activity is stimulated by diverse oncogenes and growth factor receptors, and elevated PI3K signaling is considered a hallmark of cancer. Many PI3K pathway-targeted therapies have been tested in oncology trials, resulting in regulatory approval of one isoform-selective inhibitor (idelalisib) for treatment of certain blood cancers and a variety of other agents at different stages of development. In parallel to PI3K research by cancer biologists, investigations in other fields have uncovered exciting and often unpredicted roles for PI3K catalytic and regulatory subunits in normal cell function and in disease. Many of these functions impinge upon oncology by influencing the efficacy and toxicity of PI3K-targeted therapies. Here we provide a perspective on the roles of class I PI3Ks in the regulation of cellular metabolism and in immune system functions, two topics closely intertwined with cancer biology. We also discuss recent progress developing PI3K-targeted therapies for treatment of cancer and other diseases.	[Fruman, David A.; Chiu, Honyin] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Hopkins, Benjamin D.; Cantley, Lewis C.] Weill Cornell Med Coll, Meyer Canc Ctr, 413 E 69th St, New York, NY 10021 USA; [Bagrodia, Shubha; Abraham, Robert T.] Pfizer Worldwide Res & Dev, Oncol R&D Grp, 10646-CB4 Sci Ctr Dr, San Diego, CA 92121 USA	University of California System; University of California Irvine; Cornell University; Pfizer	Fruman, DA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	dfruman@uci.edu			NIH [R01-CA158383, R21-AI124146, GM041890, R35 CA197588]; Revolution Medicines; Petra Pharmaceuticals; NATIONAL CANCER INSTITUTE [U54CA210184, R35CA197588, R01CA158383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Revolution Medicines; Petra Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ji Luo for reading the manuscript and providing helpful comments. PI3K/mTOR-related research in our laboratories was supported by NIH grants R01-CA158383 and R21-AI124146 (to D.A.F.) and GM041890 and R35 CA197588 (to L.C.C.). D.A.F. receives research support from Revolution Medicines. L.C.C. is a founder and member of the Board of Directors of Agios Pharmaceuticals and is a founder and receives research support from Petra Pharmaceuticals. R.T.A. and S.B. are employees and shareholders at Pfizer. These companies are developing novel therapies for cancer.	Adams DM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3257; Ahmad S, 2017, CANCER RES, V77, P1892, DOI 10.1158/0008-5472.CAN-16-1839; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Andre F, 2016, J CLIN ONCOL, V34, P2115, DOI 10.1200/JCO.2015.63.9161; [Anonymous], CANC CELL, V27, P109; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Backer JM, 2016, BIOCHEM J, V473, P2251, DOI 10.1042/BCJ20160170; Backer JM, 2010, CURR TOP MICROBIOL, V346, P87, DOI 10.1007/82_2010_52; Bago R, 2016, EMBO J, V35, P1902, DOI 10.15252/embj.201693929; Barr PM, 2016, BLOOD, V127, P2411, DOI 10.1182/blood-2015-12-683516; Baselga J, 2017, LANCET ONCOL, V18, P904, DOI 10.1016/S1470-2045(17)30376-5; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Basu B, 2015, CLIN CANCER RES, V21, P3412, DOI 10.1158/1078-0432.CCR-14-2422; Bendell JC, 2015, CANCER-AM CANCER SOC, V121, P3481, DOI 10.1002/cncr.29422; Bendell JC, 2015, INVEST NEW DRUG, V33, P187, DOI 10.1007/s10637-014-0177-3; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bentley J, 2003, J BIOL CHEM, V278, P39337, DOI 10.1074/jbc.M305689200; Bihani T, 2015, ONCOTARGET, V6, P2407, DOI 10.18632/oncotarget.2964; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Bohnacker T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14683; Bojarczuk K, 2016, BLOOD, V127, P3192, DOI 10.1182/blood-2015-10-675009; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Brown Kristin K, 2015, F1000Prime Rep, V7, P13, DOI 10.12703/P7-13; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; CANTLEY LC, 1994, J CELL SCI, P121; Cardnell RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152584; Cardnell RJ, 2013, CLIN CANCER RES, V19, P6322, DOI 10.1158/1078-0432.CCR-13-1975; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Castel P, 2016, CANCER CELL, V30, P229, DOI 10.1016/j.ccell.2016.06.004; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cheah CY, 2015, BLOOD, V125, P3357, DOI 10.1182/blood-2015-03-633156; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023; Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Coutre SE, 2015, LEUKEMIA LYMPHOMA, V56, P2779, DOI 10.3109/10428194.2015.1022770; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dickler MN, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.501; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; DORMAN JB, 1995, GENETICS, V141, P1399; Dornan GL, 2017, P NATL ACAD SCI USA, V114, P1982, DOI 10.1073/pnas.1617244114; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Fan QW, 2017, CANCER CELL, V31, P424, DOI 10.1016/j.ccell.2017.01.014; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; Fazio N, 2016, ANTICANCER RES, V36, P713; Feng DD, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0043-z; Foukas LC, 2013, EMBO MOL MED, V5, P563, DOI 10.1002/emmm.201201953; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Franco J, 2014, ONCOTARGET, V5, P6512, DOI 10.18632/oncotarget.2270; Franz DN, 2014, LANCET ONCOL, V15, P1513, DOI 10.1016/S1470-2045(14)70489-9; Friedman LS, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.SABCS16-S6-04; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 2014, NEW ENGL J MED, V370, P1061, DOI 10.1056/NEJMe1400055; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gallagher EJ, 2012, ONCOGENE, V31, P3213, DOI 10.1038/onc.2011.495; Gammon A, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S41947; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Garrett JT, 2013, CANCER RES, V73, P6013, DOI 10.1158/0008-5472.CAN-13-1191; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Ghobrial IM, 2016, AM J HEMATOL, V91, P400, DOI 10.1002/ajh.24300; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Guichard SM, 2015, MOL CANCER THER, V14, P2508, DOI 10.1158/1535-7163.MCT-15-0365; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Gupta A, 2017, MOL CELL, V65, P999, DOI 10.1016/j.molcel.2017.02.019; Harbst K, 2016, CANCER RES, V76, P4765, DOI 10.1158/0008-5472.CAN-15-3476; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hawkins PT, 2016, BIOCHEM SOC T, V44, P307, DOI 10.1042/BST20150248; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Herman SEM, 2014, LEUKEMIA, V28, P2188, DOI 10.1038/leu.2014.122; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Heurtier L, 2017, HAEMATOLOGICA, V102, pE278, DOI 10.3324/haematol.2017.167601; Hopkins BD, 2016, J CLIN ONCOL, V34, P4277, DOI 10.1200/JCO.2016.67.9712; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Houslay DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0453; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hudson K, 2016, MOL CANCER THER, V15, P877, DOI 10.1158/1535-7163.MCT-15-0687; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ilagan E, 2016, TRENDS CANCER, V2, P241, DOI 10.1016/j.trecan.2016.03.008; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Jansen VM, 2017, CANCER RES, V77, P2488, DOI 10.1158/0008-5472.CAN-16-2653; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jellusova J, 2016, CRIT REV BIOCHEM MOL, V51, P359, DOI 10.1080/10409238.2016.1215288; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jozwiak S, 2016, PEDIATR NEUROL, V61, P21, DOI 10.1016/j.pediatrneurol.2016.04.003; Juric D, 2017, CLIN CANC RES; Juric D, 2017, CANCER DISCOV, V7, P704, DOI 10.1158/2159-8290.CD-16-1080; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Krueger DA, 2016, NEUROLOGY, V87, P2408, DOI 10.1212/WNL.0000000000003400; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Kurimchak AM, 2016, CELL REP, V16, P1273, DOI 10.1016/j.celrep.2016.06.091; Lam HC, 2017, J PATHOL, V241, P219, DOI 10.1002/path.4827; Lampson BL, 2016, BLOOD, V128, P195, DOI 10.1182/blood-2016-03-707133; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le XN, 2016, CANCER DISCOV, V6, P1134, DOI 10.1158/2159-8290.CD-16-0305; Lien EC, 2016, RECENT RESULTS CANC, V207, P39, DOI 10.1007/978-3-319-42118-6_3; Lim SM, 2016, ONCOTARGET, V7, P10547, DOI 10.18632/oncotarget.7234; Limon JJ, 2014, P NATL ACAD SCI USA, V111, pE5076, DOI 10.1073/pnas.1407104111; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Linke M, 2017, NAT IMMUNOL, V18, P293, DOI 10.1038/ni.3655; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu NS, 2013, MOL CANCER THER, V12, P2319, DOI 10.1158/1535-7163.MCT-12-0993-T; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Loconte DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123092; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Loron MC, 2015, J CLIN ONCOL, V33, pE45, DOI 10.1200/JCO.2013.49.9277; LoRusso P, 2012, J CLIN ONCOL S, V30; Low PC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4450; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Ma CX, 2016, CLIN CANCER RES, V22, P1583, DOI 10.1158/1078-0432.CCR-15-1745; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Malka-Mahieu H, 2017, CLIN CANCER RES, V23, P21, DOI 10.1158/1078-0432.CCR-14-2362; Mallon R, 2011, CLIN CANCER RES, V17, P3193, DOI 10.1158/1078-0432.CCR-10-1694; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marshall NA, 2012, CANCER RES, V72, P581, DOI 10.1158/0008-5472.CAN-11-0307; Marwick JA, 2010, J ALLERGY CLIN IMMUN, V125, P1146, DOI 10.1016/j.jaci.2010.02.003; Matulonis UA, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw374.47; Mayer IA, 2017, CLIN CANCER RES, V23, P26, DOI 10.1158/1078-0432.CCR-16-0134; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; MICHALAREA V, 2016, CANCER RES S14, V76; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mizrachi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14292; Moniz LS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39985; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Munoz J, 2012, NAT REV CLIN ONCOL, V9, P631, DOI 10.1038/nrclinonc.2012.160; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Nakanishi Y, 2016, CANCER RES, V76, P1193, DOI 10.1158/0008-5472.CAN-15-2201; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Nathan N, 2017, DERMATOL CLIN, V35, P51, DOI 10.1016/j.det.2016.07.001; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2016, CANCER DISCOV, V6, P1090, DOI 10.1158/2159-8290.CD-16-0716; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pan H, 2017, J BIOL CHEM, V292, P6452, DOI 10.1074/jbc.R116.771915; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Ragon BK, 2017, AM J HEMATOL, V92, P7, DOI 10.1002/ajh.24568; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rehman FL, 2012, CANCER DISCOV, V2, P982, DOI 10.1158/2159-8290.CD-12-0433; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki CY, 2016, EUR J IMMUNOL, V46, P212, DOI 10.1002/eji.201445422; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schmit F, 2014, P NATL ACAD SCI USA, V111, P6395, DOI 10.1073/pnas.1323004111; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sherr CJ, 2017, ANNU REV CANC BIOL, V1, P41, DOI 10.1146/annurev-cancerbio-040716-075628; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Shojaee S, 2016, NAT MED, V22, P379, DOI 10.1038/nm.4062; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; So L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8463; Soond DR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00244; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Stamatkin C, 2015, CANCER BIOL THER, V16, P1341, DOI 10.1080/15384047.2015.1070986; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; Sun YL, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0949; Switon K, 2016, IUBMB LIFE, V68, P955, DOI 10.1002/iub.1579; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tamura K, 2016, CANCER CHEMOTH PHARM, V77, P787, DOI 10.1007/s00280-016-2987-9; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Thien A, 2015, DEV CELL, V32, P617, DOI 10.1016/j.devcel.2015.01.026; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Toska E, 2017, SCIENCE, V355, P1324, DOI 10.1126/science.aah6893; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Venkataraman S, 2014, ONCOTARGET, V5, P2355; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wang D, 2016, ONCOTARGET, V7, P13153, DOI 10.18632/oncotarget.7549; Wei W, 2016, CANCER CELL, V29, P563, DOI 10.1016/j.ccell.2016.03.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Weigelt B, 2013, CLIN CANCER RES, V19, P3533, DOI 10.1158/1078-0432.CCR-12-3815; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yates DH, 2016, EXPERT REV RESP MED, V10, P249, DOI 10.1586/17476348.2016.1148603; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Yuasa T, 2009, ENDOCR J, V56, P345, DOI 10.1507/endocrj.K08E-216; Zelenetz AD, 2017, LANCET ONCOL, V18, P297, DOI 10.1016/S1470-2045(16)30671-4; Zhang KJ, 2013, J CLIN IMMUNOL, V33, P673; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	278	1120	1169	27	246	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					605	635		10.1016/j.cell.2017.07.029	http://dx.doi.org/10.1016/j.cell.2017.07.029			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802037	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000407445700005
J	Hamperl, S; Bocek, MJ; Saldivar, JC; Swigut, T; Cimprich, KA				Hamperl, Stephan; Bocek, Michael J.; Saldivar, Joshua C.; Swigut, Tomek; Cimprich, Karlene A.			Transcription-Replication Conflict Orientation Modulates R-Loop Levels and Activates Distinct DNA Damage Responses	CELL			English	Article							FRAGILE SITE INSTABILITY; GENOMIC INSTABILITY; INITIATION; IMPAIRMENT; SENATAXIN; STRESS; ORIP; MAINTENANCE; DEFICIENCY; ORIGINS	Conflicts between transcription and replication are a potent source of DNA damage. Co-transcriptional R-loops could aggravate such conflicts by creating an additional barrier to replication fork progression. Here, we use a defined episomal system to investigate how conflict orientation and R-loop formation influence genome stability in human cells. R-loops, but not normal transcription complexes, induce DNA breaks and orientation-specific DNA damage responses during conflicts with replication forks. Unexpectedly, the replisome acts as an orientation-dependent regulator of R-loop levels, reducing R-loops in the co-directional (CD) orientation but promoting their formation in the head-on (HO) orientation. Replication stress and deregulated origin firing increase the number of HO collisions leading to genome-destabilizing R-loops. Our findings connect DNA replication to R-loop homeostasis and suggest a mechanistic basis for genome instability resulting from deregulated DNA replication, observed in cancer and other disease states.	[Hamperl, Stephan; Bocek, Michael J.; Saldivar, Joshua C.; Swigut, Tomek; Cimprich, Karlene A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Cimprich, KA (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	cimprich@stanford.edu		Swigut, Tomek/0000-0002-7649-6781; Saldivar, Joshua/0000-0001-7821-1615; Hamperl, Stephan/0000-0002-1658-7948	NIH [GM119334]; American Cancer Society [PF-15-165-01-DMC]; Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund [1013979]; German Research Foundation DFG [HA 6996/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund; German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Frederic Chedin for reagents and protocols for in vitro transcription assays, Frederic Chedin and members of the Cimprich laboratory for helpful discussions, and Joanna Wysocka and Dan Jarosz for manuscript feedback. This work was supported by a grant from the NIH (GM119334) to K.A.C., a fellowship from the American Cancer Society (PF-15-165-01-DMC) and a Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund (1013979) to J.C.S. and from the German Research Foundation DFG (HA 6996/1-1) to S.H.	Aguilera A., 2005, BIOINFORMATICS, V24; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Griesenbeck J, 2004, METHOD ENZYMOL, V375, P170; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Kahij M., 2016, EMBO J, V7, P10208; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kunnev D, 2015, GENOME RES, V25, P558, DOI 10.1101/gr.176099.114; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Tallec B, 2014, CELL MOL LIFE SCI, V71, P4489, DOI 10.1007/s00018-014-1720-2; Lee CS, 2014, NAT STRUCT MOL BIOL, V21, P103, DOI 10.1038/nsmb.2737; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Rocha EPC, 2008, CURR OPIN MICROBIOL, V11, P454, DOI 10.1016/j.mib.2008.09.007; Sankar TS, 2016, NATURE, V535, P178, DOI 10.1038/nature18316; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Soni D.V., 2009, NAT COMMUN, V35, P228; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Stork CT, 2016, ELIFE, V5, DOI 10.7554/eLife.17548; Sun QW, 2013, SCIENCE, V340, P619, DOI 10.1126/science.1234848; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Yekezare M, 2013, J CELL SCI, V126, P1297, DOI 10.1242/jcs.096701; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou J, 2009, J VIROL, V83, P2154, DOI 10.1128/JVI.02115-08	69	269	272	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					774	+		10.1016/j.cell.2017.07.043	http://dx.doi.org/10.1016/j.cell.2017.07.043			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802045	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000407445700017
J	Witze, A				Witze, Alexandra			Eclipse promises to reveal mysteries of Sun's corona	NATURE			English	News Item																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					146	147		10.1038/548146a	http://dx.doi.org/10.1038/548146a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796225	Bronze			2022-12-28	WOS:000407284300018
J	Steed, AL; Christophi, GP; Kaiko, GE; Sun, LL; Goodwin, VM; Jain, U; Esaulova, E; Artyomov, MN; Morales, DJ; Holtzman, MJ; Boon, ACM; Lenschow, DJ; Stappenbeck, TS				Steed, Ashley L.; Christophi, George P.; Kaiko, Gerard E.; Sun, Lulu; Goodwin, Victoria M.; Jain, Umang; Esaulova, Ekaterina; Artyomov, Maxim N.; Morales, David J.; Holtzman, Michael J.; Boon, Adrianus C. M.; Lenschow, Deborah J.; Stappenbeck, Thaddeus S.			The microbial metabolite desaminotyrosine protects from influenza through type I interferon	SCIENCE			English	Article							ACUTE LUNG INJURY; A VIRUS; COMMENSAL BACTERIA; ANTIVIRAL IMMUNITY; DIETARY FIBER; H5N1 VIRUSES; INFECTION; CELLS; INDUCTION; DISEASE	The microbiota is known to modulate the host response to influenza infection through as-yet-unclear mechanisms. We hypothesized that components of the microbiota exert effects through type I interferon (IFN), a hypothesis supported by analysis of influenza in a gain-of-function genetic mouse model. Here we show that a microbially associated metabolite, desaminotyrosine (DAT), protects from influenza through augmentation of type I IFN signaling and diminution of lung immunopathology. A specific human-associated gut microbe, Clostridium orbiscindens, produced DAT and rescued antibiotic-treated influenza-infected mice. DAT protected the host by priming the amplification loop of type I IFN signaling. These findings show that specific components of the enteric microbiota have distal effects on responses to lethal infections through modulation of type I IFN.	[Steed, Ashley L.; Goodwin, Victoria M.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Christophi, George P.; Morales, David J.; Holtzman, Michael J.; Boon, Adrianus C. M.; Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Steed, Ashley L.; Christophi, George P.; Kaiko, Gerard E.; Sun, Lulu; Goodwin, Victoria M.; Jain, Umang; Esaulova, Ekaterina; Artyomov, Maxim N.; Morales, David J.; Boon, Adrianus C. M.; Lenschow, Deborah J.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Esaulova, Ekaterina] St Petersburg Natl Res Univ Informat Technol Mech, Comp Technol Dept, St Petersburg 197101, Russia; [Boon, Adrianus C. M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); ITMO University; Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@pathology.wustl.edu	Kaiko, Gerard/ABC-2169-2021	Kaiko, Gerard/0000-0002-3167-3174; Sun, Lulu/0000-0001-7543-1532; Boon, Adrianus/0000-0002-4700-8224; jain, umang/0000-0002-0220-8230	Pediatric Scientist Development Program; National Institute of Child Health and Human Development, NIH [5K12HD000850-30, T32 DK007130-43]; NIAID [U19-AI070412, R01-AI111605]; Crohn's and Colitis Foundation/Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH3HL123429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412, R01AI130591, U19AI070489, R01AI111605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007130, P30DK056341] Funding Source: NIH RePORTER	Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Crohn's and Colitis Foundation/Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Pediatric Scientist Development Program and funded by the National Institute of Child Health and Human Development, NIH 5K12HD000850-30 (A.L.S.), T32 DK007130-43 (G.P.C.), NIAID U19-AI070412 (MJH and TS), R01-AI111605 (MJH) and the Crohn's and Colitis Foundation/Helmsley Charitable Trust. Additionally, we thank D. Kreamalmeyer for expertise in animal care and the Proteomics and Mass Spectrometry Facility at the Danforth Plant Science Center. All data to understand and assess the conclusions of this research are available in the main text and supplementary materials. RNA sequencing data are available via the following repository: ArrayExpress website, accession no. E-MTAB-5337. T.S.S., A.L.S., G.P.C., and G.E.K. are inventors on patent application no. 62413241 submitted by Washington University that covers the use of desaminotyrosine to enhance type I interferon stimulation.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Arimori Y, 2013, ANTIVIR RES, V99, P230, DOI 10.1016/j.antiviral.2013.05.007; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Beilharz MW, 2007, BIOCHEM BIOPH RES CO, V355, P740, DOI 10.1016/j.bbrc.2007.02.019; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fujikura D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055321; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; LAMBERT MA, 1980, J CLIN MICROBIOL, V12, P291, DOI 10.1128/JCM.12.2.291-293.1980; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oldstone MBA, 2013, VIROLOGY, V435, P92, DOI 10.1016/j.virol.2012.09.039; Patel DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036594; Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000; Ryu SH, 2015, IMMUNITY, V43, P216, DOI 10.1016/j.immuni.2015.08.003; Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stevens VW, 2017, JAMA INTERN MED, V177, P546, DOI 10.1001/jamainternmed.2016.9045; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; VANROOIJEN N, 1984, CELL TISSUE RES, V238, P355, DOI 10.1007/BF00217308; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090531	49	263	282	11	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					498	502		10.1126/science.aam5336	http://dx.doi.org/10.1126/science.aam5336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774928	Green Accepted			2022-12-28	WOS:000406840100037
J	Dietz, J; Epstein, L; Abel, SW				Dietz, Jason; Epstein, Laura; Abel, Sidney W.			GM-food regulations: US agencies respond	NATURE			English	Letter									[Dietz, Jason; Epstein, Laura] US FDA, Silver Spring, MD 20993 USA; [Abel, Sidney W.] US Anim & Plant Hlth Inspect Serv, USDA, Riverdale, MD USA	US Food & Drug Administration (FDA); United States Department of Agriculture (USDA)	Dietz, J (corresponding author), US FDA, Silver Spring, MD 20993 USA.	jason.dietz@fda.hhs.gov						Nature Editorial, 2017, NATURE, V546, P327	1	0	0	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					31	31		10.1038/548031c	http://dx.doi.org/10.1038/548031c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770849	Bronze			2022-12-28	WOS:000406831700023
J	Beck, RW; Riddlesworth, TD; Ruedy, K; Ahmann, A; Haller, S; Kruger, D; McGill, JB; Polonsky, W; Price, D; Aronoff, S; Aronson, R; Toschi, E; Kollman, C; Bergenstal, R				Beck, Roy W.; Riddlesworth, Tonya D.; Ruedy, Katrina; Ahmann, Andrew; Haller, Stacie; Kruger, Davida; McGill, Janet B.; Polonsky, William; Price, David; Aronoff, Stephen; Aronson, Ronnie; Toschi, Elena; Kollman, Craig; Bergenstal, Richard		DIAMOND Study Grp	Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEMOGLOBIN A1C; HYPOGLYCEMIA; MELLITUS; SATISFACTION; REDUCTION; FREQUENCY; THERAPY; IMPACT; ADULTS; LIFE	Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective: To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials. gov: NCT02282397) Setting: 25 endocrinology practices in North America. Patients: 158 adults who had had type 2 diabetes for a median of 17 years (interquartile range, 11 to 23 years). Participants were aged 35 to 79 years (mean, 60 years [SD, 10]), were receiving multiple daily injections of insulin, and had hemoglobin A1c (HbA(1c)) levels of 7.5% to 9.9% (mean, 8.5%). Intervention: Random assignment to CGM (n = 79) or usual care (control group, n = 79). Measurements: The primary outcome was HbA1c reduction at 24 weeks. Results: Mean HbA(1c) levels decreased to 7.7% in the CGM group and 8.0% in the control group at 24 weeks (adjusted difference in mean change, -0.3% [ 95% CI, -0.5% to 0.0%]; P = 0.022). The groups did not differ meaningfully in CGMmeasured hypoglycemia or quality-of-life outcomes. The CGM group averaged 6.7 days (SD, 0.9) of CGM use per week. Limitation: 6-month follow-up. Conclusion: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control. Because few insulin-treated patients with type 2 diabetes currently use CGM, these results support an additional management method that may benefit these patients.	[Beck, Roy W.; Riddlesworth, Tonya D.; Ruedy, Katrina; Kollman, Craig] Jaeb Ctr Hlth Res, 15310 Amberly Dr,350, Tampa, FL 33647 USA; [Ahmann, Andrew] Oregon Hlth & Sci Univ, Harold Schnitzer Diabet Hlth Ctr, 3147 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Haller, Stacie] Diabet & Glandular Dis Clin, 5107 Med Dr, San Antonio, TX 78229 USA; [Kruger, Davida] Henry Ford Med Ctr, Div Endocrinol, 3031 West Grand Blvd,Suite 800, Detroit, MI 48202 USA; [McGill, Janet B.] Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA; [Polonsky, William] Behav Diabet Inst, 5405 Oberlin Dr,Suite 100, San Diego, CA 92121 USA; Dexcom, San Diego, CA USA; [Aronoff, Stephen] Res Inst Dallas, 10260 North Cent Expressway,Suite 100N, Dallas, TX 75231 USA; [Aronson, Ronnie] LMC Diabet & Endocrinol, 1929 Bayview Ave 106, Toronto, ON M4G 3E8, Canada; [Toschi, Elena] Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA; Pk Nicollet Int Diabet Ctr, St Louis Pk, MN USA; [Price, David] Dexcom Inc, 6340 Sequence Dr, San Diego, CA 92121 USA; [Bergenstal, Richard] Pk Nicollet Inst, Int Diabet Ctr, 3800 Pk Nicollet Blvd, St Louis Pk, MN 55416 USA	JAEB Center For Health Research; Oregon Health & Science University; Henry Ford Health System; Washington University (WUSTL); Harvard University; Joslin Diabetes Center, Inc.; International Diabetes Center; International Diabetes Center	Beck, RW (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,350, Tampa, FL 33647 USA.	rbeck@jaeb.org			Dexcom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Dexcom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dexcom.	American Diabetes Association, STAT DIAB OV NUMB DI; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], HDB PSYCHOL DIABETES; Bailey TS, 2007, DIABETES TECHNOL THE, V9, P203, DOI 10.1089/dia.2007.0205; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Cariou B, 2015, DIABETES METAB, V41, P116, DOI 10.1016/j.diabet.2014.10.007; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; EuroQol Research Foundation, EQ 5D 5L INSTR; Fonseca VA, 2016, ENDOCR PRACT, V22, P1008, DOI 10.4158/EP161392.CS; Gandhi Gunjan Y, 2011, J Diabetes Sci Technol, V5, P952; Garg S, 2006, DIABETES CARE, V29, P44, DOI 10.2337/diacare.29.01.06.dc05-1686; Garg S, 2006, DIABETES CARE, V29, P2644, DOI 10.2337/dc06-1361; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Haak T, 2017, DIABETES THER, V8, P55, DOI 10.1007/s13300-016-0223-6; Hajos TR, 2017, ANN INTERN MED, V167, P373; Hirsch IB, 2010, DIABETES TECHNOL THE, V12, P679, DOI 10.1089/dia.2010.0015; Hommel E, 2014, ACTA DIABETOL, V51, P845, DOI 10.1007/s00592-014-0598-7; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Little RJA, 1987, STAT ANAL MISSING DA, V164, P260; Nichols GA, 2010, CURR MED RES OPIN, V26, P9, DOI 10.1185/03007990903417679; Pazos-Couselo M, 2015, CAN J DIABETES, V39, P428, DOI 10.1016/j.jcjd.2015.05.007; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Polonsky WH, 2017, DIABETES TECHNOL THE, V19, P131, DOI 10.1089/dia.2016.0366; Reznik Y, 2014, LANCET, V384, P1265, DOI 10.1016/S0140-6736(14)61037-0; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Selvin E, 2016, DIABETES CARE, V39, pE33, DOI 10.2337/dc15-2229; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Vigersky RA, 2012, DIABETES CARE, V35, P32, DOI 10.2337/dc11-1438; Weinzimer S, 2010, DIABETES CARE, V33, P17, DOI 10.2337/dc09-1502; Weiss R, 2015, DIABETES TECHNOL THE, V17, P542, DOI 10.1089/dia.2014.0306; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508	36	217	220	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					365	+		10.7326/M16-2855	http://dx.doi.org/10.7326/M16-2855			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828487				2022-12-28	WOS:000411009900013
J	van Es, N; Le Gal, G; Otten, HM; Robin, P; Piccioli, A; Lecumberri, R; Jara-Palomares, L; Religa, P; Rieu, V; Rondina, M; Beckers, MM; Prandoni, P; Salaun, PY; Di Nisio, M; Bossuyt, PM; Buller, HR; Carrier, M				van Es, Nick; Le Gal, Gregoire; Otten, Hans-Martin; Robin, Philippe; Piccioli, Andrea; Lecumberri, Ramon; Jara-Palomares, Luis; Religa, Piotr; Rieu, Virginie; Rondina, Matthew; Beckers, Marielle M.; Prandoni, Paolo; Salaun, Pierre-Yves; Di Nisio, Marcello; Bossuyt, Patrick M.; Buller, Harry R.; Carrier, Marc			Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis of Individual Patient Data	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CLINICAL-TRIAL; FDG-PET/CT; RISK; MALIGNANCY; THROMBOSIS	Background: Screening for cancer in patients with unprovoked venous thromboembolism (VTE) often is considered, but clinicians need precise data on cancer prevalence, risk factors, and the effect of different types of screening strategies. Purpose: To estimate the prevalence of occult cancer in patients with unprovoked VTE, including in subgroups of different ages or those that have had different types of screening. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials up to 19 January 2016. Study Selection: Prospective studies evaluating cancer screening strategies in adults with unprovoked VTE that began enrolling patients after 1 January 2000 and had at least 12 months of follow-up. Data Extraction: 2 investigators independently reviewed abstracts and full-text articles and independently assessed risk of bias. Data Synthesis: 10 eligible studies were identified. Individual data were obtained for all 2316 patients. Mean age was 60 years; 58% of patients received extensive screening. The 12-month period prevalence of cancer after VTE diagnosis was 5.2% (95% CI, 4.1% to 6.5%). The point prevalence of cancer was higher in patients who had extensive screening than in those who had more limited screening initially (odds ratio [OR], 2.0 [CI, 1.2 to 3.4]) but not at 12 months (OR, 1.4 [CI, 0.89 to 2.1]). Cancer prevalence increased linearly with age and was 7-fold higher in patients aged 50 years or older than in younger patients (OR, 7.1 [CI, 3.1 to 16]). Limitation: Variation in patient characteristics and extensive screening strategies; unavailability of long-term mortality data. Conclusion: Occult cancer is detected in 1 in 20 patients within a year of receiving a diagnosis of unprovoked VTE. Older age is associated with a higher cancer prevalence. Although an extensive screening strategy initially may detect more cancer cases than limited screening, whether this translates into improved patient outcomes remains unclear.	[van Es, Nick; Buller, Harry R.] Acad Med Ctr, Afdeling Vasc Geneeskunde, Room F4-136,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bossuyt, Patrick M.] Acad Med Ctr, Afdeling Klin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; Slotervaartziekenhuis, Amsterdam, Netherlands; Ottawa Hosp Res Inst, Ottawa, ON, Canada; Univ Bretagne Occidentale, Brest, France; Hosp Padua, Padua, Italy; Clin Univ Navarra, Pamplona, Spain; Virgen del Rocio Hosp, Seville, Spain; Karolinska Inst, Stockholm, Sweden; Warsaw Med Univ, Warsaw, Poland; [Rieu, Virginie] Ctr Hosp Univ Estaing, Dept Internal Med, 1 Rue Lucie Aubrac, F-63100 Clermont Ferrand, France; Univ Utah, Salt Lake City, UT USA; Univ Hosp Leuven, Leuven, Belgium; [Di Nisio, Marcello] Univ G DAnnunzio, Dept Med & Ageing Sci, Via Vestini 31, I-66100 Chieti, CH, Italy; [Le Gal, Gregoire; Carrier, Marc] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa Hosp Gen Campus,501 Smyth Rd,Box 201a, Ottawa, ON K1H 8L6, Canada; [Otten, Hans-Martin] MC Slotervaart, Afdeling Interne Geneeskunde, Louwesweg 6, NL-1066 EC Amsterdam, Netherlands; [Robin, Philippe; Salaun, Pierre-Yves] CHU Brest, Dept Med Interne & Pneumol, 2 Ave Foch, F-29609 Brest, France; [Piccioli, Andrea; Prandoni, Paolo] Univ Hosp Padua, Dept Med, Via Giustiniani 2, I-35128 Padua, Italy; [Lecumberri, Ramon] Clin Univ Navarra, Hematol Serv, Ave Pio 12,36, Navarra 31008, Spain; [Jara-Palomares, Luis] Hosp Univ Virgen del Rocio, Med Surg Unit Resp Dis, Ave Manuel Siurot, Seville 41013, Spain; [Religa, Piotr] Karolinska Inst, Dept Med, Solnavagen 1, S-17177 Solna, Sweden; [Rondina, Matthew] Univ Utah Hosp, Div Gen Internal Med, 50 North Med Dr, Salt Lake City, UT 84132 USA; [Beckers, Marielle M.] UZ Leuven, Afdeling Hematol, Herestr 49, B-3000 Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Slotervaart Hospital; University of Ottawa; Ottawa Hospital Research Institute; Universite de Bretagne Occidentale; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Navarra; Virgen del Rocio University Hospital; Karolinska Institutet; Medical University of Warsaw; CHU Clermont Ferrand; Utah System of Higher Education; University of Utah; KU Leuven; University Hospital Leuven; G d'Annunzio University of Chieti-Pescara; University of Ottawa; Ottawa Hospital Research Institute; Slotervaart Hospital; CHU Brest; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Navarra; Virgen del Rocio University Hospital; Karolinska Institutet; Utah System of Higher Education; University of Utah; University of Utah Hospital; KU Leuven; University Hospital Leuven	Carrier, M (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Ottawa Hosp Gen Campus,501 Smyth Rd,Box 201a, Ottawa, ON K1H 8L6, Canada.	mcarrier@toh.ca	SALAUN, Pierre-Yves/X-6701-2019; Lecumberri, Ramón/ABD-5071-2021; Bossuyt, Patrick M./B-4557-2016; Robin, Philippe/X-6290-2019; Bossuyt, Patrick M/AAR-1183-2021; Jara-Palomares, Luis/A-4090-2017	SALAUN, Pierre-Yves/0000-0002-3899-2135; Lecumberri, Ramón/0000-0002-8850-8866; Bossuyt, Patrick M./0000-0003-4427-0128; Robin, Philippe/0000-0001-5521-9454; Bossuyt, Patrick M/0000-0003-4427-0128; Jara-Palomares, Luis/0000-0002-4125-3376; van Es, Nick/0000-0001-5256-6346	PROSPERO [CRD42016033371]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126547] Funding Source: NIH RePORTER	PROSPERO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	None. (PROSPERO: CRD42016033371)	Alfonso A, 2013, INT J CANCER, V133, P2157, DOI 10.1002/ijc.28229; Beckers MMJ, 2008, ANN ONCOL, V19, DOI 10.1093/annonc/mdn156; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Carrier M, 2010, BLOOD COAGUL FIBRIN, V21, P709, DOI 10.1097/MBC.0b013e32833c3714; Ihaddadene R, 2016, BLOOD, V127, P2035, DOI 10.1182/blood-2015-11-682963; Jara-Palomares L, 2010, THROMB RES, V125, P29, DOI 10.1016/j.thromres.2009.04.012; Khorana AA, 2016, J THROMB THROMBOLYS, V41, P81, DOI 10.1007/s11239-015-1313-4; Klein A, 2017, EUR J INTERN MED, V42, P74, DOI 10.1016/j.ejim.2017.05.007; National Institutes of Health; National Cancer Institute, SURV EP END RES PROG; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Prandoni P, 2010, J THROMB HAEMOST, V8, P1126, DOI 10.1111/j.1538-7836.2010.03797.x; Prandoni P, 2016, SEMIN THROMB HEMOST, V42, P884, DOI 10.1055/s-0036-1592335; Rieu V, 2011, INTERN MED J, V41, P769, DOI 10.1111/j.1445-5994.2011.02448.x; Robertson L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010837.pub2; Robin P, 2016, LANCET ONCOL, V17, P193, DOI 10.1016/S1470-2045(15)00480-5; Rondina MT, 2012, THROMB RES, V129, P22, DOI 10.1016/j.thromres.2011.06.025; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x; van Es N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015562; Wells G., NEWCASTLE OTTAWA SCA; Wells PS, 2016, CHEST, V150, P1059, DOI 10.1016/j.chest.2016.05.023; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	25	79	82	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					410	+		10.7326/M17-0868	http://dx.doi.org/10.7326/M17-0868			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828492				2022-12-28	WOS:000411009900017
J	Limaye, AP; Stapleton, RD; Peng, LL; Gunn, SR; Kimball, LE; Hyzy, R; Exline, MC; Files, DC; Morris, PE; Frankel, SK; Mikkelsen, ME; Hite, D; Enfield, KB; Steingrub, J; O'Brien, J; Parsons, PE; Cuschieri, J; Wunderink, RG; Hotchkin, DL; Chen, YQ; Rubenfeld, GD; Boeckh, M				Limaye, Ajit P.; Stapleton, Renee D.; Peng, Lili; Gunn, Scott R.; Kimball, Louise E.; Hyzy, Robert; Exline, Matthew C.; Files, D. Clark; Morris, Peter E.; Frankel, Stephen K.; Mikkelsen, Mark E.; Hite, Duncan; Enfield, Kyle B.; Steingrub, Jay; O'Brien, James; Parsons, Polly E.; Cuschieri, Joseph; Wunderink, Richard G.; Hotchkin, David L.; Chen, Ying Q.; Rubenfeld, Gordon D.; Boeckh, Michael			Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; VENTILATOR-FREE DAYS; ACUTE LUNG INJURY; IMMUNOCOMPETENT MICE; PULMONARY CYTOMEGALOVIRUS; MECHANICAL VENTILATION; TRANSPLANT RECIPIENTS; ILL PATIENTS; REACTIVATION; INFECTION	IMPORTANCE The role of cytomegalovirus (CMV) reactivation in mediating adverse clinical outcomes in nonimmunosuppressed adults with critical illness is unknown. OBJECTIVE To determine whether ganciclovir prophylaxis reduces plasma interleukin 6 (IL-6) levels in CMV-seropositive adults who are critically ill. DESIGN, SETTING, AND PARTICIPANTS Double-blind, placebo-controlled, randomized clinical trial (conducted March 10, 2011-April 29, 2016) with a follow-up of 180 days (November 10, 2016) that included 160 CMV-seropositive adults with either sepsis or trauma and respiratory failure at 14 university intensive care units (ICUs) across the United States. INTERVENTIONS Patients were randomized (1: 1) to receive either intravenous ganciclovir (5 mg/kg twice daily for 5 days), followed by either intravenous ganciclovir or oral valganciclovir once daily until hospital discharge (n = 84) or to receive matching placebo (n = 76). MAIN OUTCOMES AND MEASURES The primary outcome was change in IL-6 level from day 1 to 14. Secondary outcomes were incidence of CMV reactivation in plasma, mechanical ventilation days, incidence of secondary bacteremia or fungemia, ICU length of stay, mortality, and ventilator-free days (VFDs) at 28 days. RESULTS Among 160 randomized patients (mean age, 57 years; women, 43%), 156 received 1 or more dose(s) of treatment, and 132 (85%) completed the study. The mean between-group change in IL-6 level was not significantly different. Among secondary outcomes, CMV reactivation in plasma was significantly lower in the ganciclovir group. The ganciclovir group had more VFDs in both the intention-to-treat population and in the prespecified sepsis subgroup. There were no significant between-group differences in other secondary outcomes. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among CMV-seropositive adults with critical illness due to sepsis or trauma, ganciclovir did not reduce IL-6 levels and the current study does not support routine clinical use of ganciclovir as a prophylactic agent in patients with sepsis. Additional research is necessary to determine the clinical efficacy and safety of CMV suppression in this setting.	[Limaye, Ajit P.; Boeckh, Michael] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Stapleton, Renee D.; Parsons, Polly E.] Univ Vermont, Coll Med, Pulm & Crit Care Div, Burlington, VT 05405 USA; [Peng, Lili; Kimball, Louise E.; Chen, Ying Q.; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Gunn, Scott R.] Univ Pittsburgh, Med Ctr, Crit Care Div, Pittsburgh, PA USA; [Hyzy, Robert] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Exline, Matthew C.; O'Brien, James] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Files, D. Clark; Morris, Peter E.] Wake Forest Sch Med, Dept Pulm & Crit Care Med, Winston Salem, NC USA; [Frankel, Stephen K.] Natl Jewish Sleep Ctr, Div Pulm Crit Care & Sleep Med, Denver, CO USA; [Mikkelsen, Mark E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hite, Duncan] Cleveland Clin, Dept Crit Care Med, Cleveland, OH 44106 USA; [Enfield, Kyle B.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Steingrub, Jay] Baystate Med Ctr, Div Crit Care Pulm Med, Springfield, MA USA; [Cuschieri, Joseph] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Wunderink, Richard G.] Northwestern Feinberg Sch Med, Div Pulm & Crit Care, Chicago, IL USA; [Hotchkin, David L.] Oregon Clin, Div Pulm & Crit Care Med, Portland, OR USA; [Rubenfeld, Gordon D.] Sunnybrook Hlth Sci Ctr, Interdept Div Crit Care Med, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Vermont; Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; Wake Forest University; University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; University of Virginia; Baystate Medical Center; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Limaye, AP (corresponding author), Univ Washington, POB 356174,1959 NE Pacific St, Seattle, WA 98195 USA.	limaye@u.washington.edu	Enfield, Kyle/J-1840-2019; Boeckh, Michael/AAA-1607-2022	Enfield, Kyle/0000-0003-4624-0176; Files, Daniel Clark/0000-0002-1595-4080; Chen, Ying Qing/0000-0002-2726-3391	US National Institutes of Health's National Heart, Lung, and Blood Institute [UO1 HL 102547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL102547] Funding Source: NIH RePORTER	US National Institutes of Health's National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigator-initiated study was supported by grant UO1 HL 102547 from the US National Institutes of Health's National Heart, Lung, and Blood Institute. Genentech supplied the initial batch of study drug (ganciclovir, valganciclovir, and placebo).	Abad CL, 2017, EXPERT REV ANTI-INFE, V15, P93, DOI 10.1080/14787210.2017.1266253; Al-Omari A, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0207-8; BALTHESEN M, 1993, J VIROL, V67, P5360, DOI 10.1128/JVI.67.9.5360-5366.1993; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Botto S, 2011, BLOOD, V117, P352, DOI 10.1182/blood-2010-06-291245; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caldes A, 2009, ANTIMICROB AGENTS CH, V53, P4816, DOI 10.1128/AAC.00085-09; Cook CH, 2006, CRIT CARE MED, V34, P842, DOI 10.1097/01.CCM.0000201876.11059.05; Cook CH, 2002, J INFECT DIS, V185, P1395, DOI 10.1086/340508; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Cowley NJ, 2017, JAMA INTERN MED, V177, P774, DOI 10.1001/jamainternmed.2017.0895; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Geist LJ, 1996, TRANSPLANTATION, V62, P653, DOI 10.1097/00007890-199609150-00020; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Humar A, 1999, J INFECT DIS, V179, P484, DOI 10.1086/314602; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kawazoe Y, 2017, JAMA-J AM MED ASSOC, V317, P1321, DOI 10.1001/jama.2017.2088; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Limaye AP, 2010, REV MED VIROL, V20, P372, DOI 10.1002/rmv.664; Ong DSY, 2016, INTENS CARE MED, V42, P333, DOI 10.1007/s00134-015-4071-z; Papazian L, 2016, INTENS CARE MED, V42, P28, DOI 10.1007/s00134-015-4066-9; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; TOORKEY CB, 1989, J INFECT DIS, V160, P741, DOI 10.1093/infdis/160.5.741; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6; Young P, 2012, CRIT CARE RESUSC, V14, P211	29	69	73	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					731	740		10.1001/jama.2017.10569	http://dx.doi.org/10.1001/jama.2017.10569			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829877	Green Published			2022-12-28	WOS:000408095800024
J	Duggan, CP; Jaksic, T				Duggan, Christopher P.; Jaksic, Tom			Pediatric Intestinal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SHORT-BOWEL SYNDROME; SERIAL TRANSVERSE ENTEROPLASTY; PARENTERAL-NUTRITION; IMPROVED SURVIVAL; LIVER-DISEASE; CHILDREN; OUTCOMES; INFANTS; RISK; ADAPTATION		[Duggan, Christopher P.; Jaksic, Tom] Boston Childrens Hosp, Ctr Adv Intestinal Rehabil, Boston, MA USA; [Duggan, Christopher P.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Jaksic, Tom] Boston Childrens Hosp, Dept Surg, Boston, MA USA; Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Duggan, CP (corresponding author), Boston Childrens Hosp, Ctr Nutr, Div Gastroenterol Hepatol & Nutr, 333 Longwood Ave, Boston, MA 02115 USA.	duggan@childrens.harvard.edu			Shire Pharmaceuticals; MedShape	Shire Pharmaceuticals; MedShape	Dr. Duggan reports receiving grant support from Shire Pharmaceuticals; and Dr. Jaksic, receiving grant support from MedShape and holding a pending patent for "Extraluminal enterogenesis device" (no. 14/881,150). No other potential conflict of interest relevant to this article was reported.	Andorsky DJ, 2001, J PEDIATR-US, V139, P27, DOI 10.1067/mpd.2001.114481; Ardura MI, 2015, JAMA PEDIATR, V169, P324, DOI 10.1001/jamapediatrics.2014.3291; AYNSLEYGREEN A, 1982, ACTA PAEDIATR SCAND, V71, P379, DOI 10.1111/j.1651-2227.1982.tb09438.x; BIANCHI A, 1980, J PEDIATR SURG, V15, P145, DOI 10.1016/S0022-3468(80)80005-4; Bines J, 1998, J PEDIATR GASTR NUTR, V26, P123, DOI 10.1097/00005176-199802000-00001; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Carter BA, 2017, J PEDIATR-US, V181, P102, DOI 10.1016/j.jpeds.2016.10.027; Chang RW, 2006, ANN SURG, V243, P223, DOI 10.1097/01.sla.0000197704.76166.07; Chen GQ, 2013, DIGEST DIS SCI, V58, P2478, DOI 10.1007/s10620-013-2680-3; Cober MP, 2012, J PEDIATR-US, V160, P421, DOI 10.1016/j.jpeds.2011.08.047; Cole CR, 2008, PEDIATRICS, V122, pE573, DOI 10.1542/peds.2007-3449; Collier S, 2012, CLINICAL MANAGEMENT OF INTESTINAL FAILURE, P117; CORTOT A, 1979, NEW ENGL J MED, V300, P79, DOI 10.1056/NEJM197901113000207; D'Antiga L, 1999, J PEDIATR GASTR NUTR, V29, P588, DOI 10.1097/00005176-199911000-00021; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; DeLegge M, 2010, NUTR CLIN PRACT, V25, P76, DOI 10.1177/0884533609354901; Diamond IR, 2016, JPEN J PARENTER ENTE; Duro D, 2008, J PEDIATR GASTR NUTR, V46, P461, DOI 10.1097/MPG.0b013e3181373b91; El Kasmi KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006898; Fisher JG, 2015, J PEDIATR SURG, V50, P938, DOI 10.1016/j.jpedsurg.2015.03.013; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Frongia G, 2013, J PEDIATR SURG, V48, P1794, DOI 10.1016/j.jpedsurg.2013.05.018; Gosselin KB, 2014, J PEDIATR-US, V165, P1085, DOI 10.1016/j.jpeds.2014.08.012; Goulet O, 2004, J PEDIATR GASTR NUTR, V38, P250, DOI 10.1097/00005176-200403000-00006; Grant CN, 2015, AM J PHYSIOL-GASTR L, V308, pG664, DOI 10.1152/ajpgi.00111.2014; Groen H, 2017, AM J CLIN NUTR, V105, P417, DOI 10.3945/ajcn.116.135160; Gutierrez IM, 2012, J PEDIATR SURG, V47, P1150, DOI 10.1016/j.jpedsurg.2012.03.019; Hess RA, 2011, J SURG RES, V170, P27, DOI 10.1016/j.jss.2011.03.037; Hong SN, 2016, STEM CELL TRANSL MED; Jeppesen PB, 2011, GUT, V60, P902, DOI 10.1136/gut.2010.218271; Jeppesen PB, 2005, GUT, V54, P1224, DOI 10.1136/gut.2004.061440; Jeppesen PB, 2003, J NUTR, V133, P3721, DOI 10.1093/jn/133.11.3721; Joly F, 2009, GASTROENTEROLOGY, V136, P824, DOI 10.1053/j.gastro.2008.10.084; Jones AM, 2016, MMWR-MORBID MORTAL W, V65, P23, DOI 10.15585/mmwr.mm6502a2; Jones BA, 2013, J AM COLL SURGEONS, V216, P438, DOI 10.1016/j.jamcollsurg.2012.12.018; Kaufman SS, 2001, PEDIATR TRANSPLANT, V5, P80, DOI 10.1034/j.1399-3046.2001.005002080.x; Kelly DG, 2014, JPEN-PARENTER ENTER, V38, P427, DOI 10.1177/0148607113512678; Khan FA, 2015, J PEDIAT, V167; Kim HB, 2003, J PEDIATR SURG, V38, P425, DOI 10.1053/jpsu.2003.50073; Kulkarni S, 2013, J PEDIATR GASTR NUTR, V57, P383, DOI 10.1097/MPG.0b013e31829b68f3; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Lau ECT, 2016, J PEDIATR SURG, V51, P1914, DOI 10.1016/j.jpedsurg.2016.09.010; Lee WS, 2015, J PEDIATR-US, V167, P519, DOI 10.1016/j.jpeds.2015.05.048; McSweeney Maireade E, 2016, Gastrointest Endosc Clin N Am, V26, P169, DOI 10.1016/j.giec.2015.09.001; Mercer DF, 2014, J PEDIATR-US, V164, P93, DOI 10.1016/j.jpeds.2013.08.039; Miller M, 2013, J PEDIATR SURG, V48, P1099, DOI 10.1016/j.jpedsurg.2013.01.023; Modi BP, 2008, J PEDIATR SURG, V43, P20, DOI 10.1016/j.jpedsurg.2007.09.014; Modi BP, 2012, SURG CLIN N AM, V92, P729, DOI 10.1016/j.suc.2012.03.012; Nandivada P, 2017, JPEN-PARENTER ENTER, V41, P930, DOI 10.1177/0148607116633796; Nandivada P, 2016, AM J CLIN NUTR, V103, p629S, DOI 10.3945/ajcn.114.103986; NEHME AE, 1980, JAMA-J AM MED ASSOC, V243, P1906, DOI 10.1001/jama.243.19.1906; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Huynh N, 2016, J PEDIATR SURG, V51, P1983, DOI 10.1016/j.jpedsurg.2016.09.024; NORDGAARD I, 1994, LANCET, V343, P373, DOI 10.1016/S0140-6736(94)91220-3; O'Keefe SJD, 2013, CLIN GASTROENTEROL H, V11, P815, DOI 10.1016/j.cgh.2012.12.029; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; PARKER P, 1981, J PEDIATR-US, V99, P360, DOI 10.1016/S0022-3476(81)80318-6; Pereira-Fantini PM, 2008, JPEN-PARENTER ENTER, V32, P266, DOI 10.1177/0148607108316197; Puder M, 2009, ANN SURG, V250, P395, DOI 10.1097/SLA.0b013e3181b36657; Rangel SJ, 2012, J PEDIATR SURG, V47, P225, DOI 10.1016/j.jpedsurg.2011.10.007; RICKHAM P P, 1967, Annals of the Royal College of Surgeons of England, V41, P480; Rollins MD, 2013, J PEDIATR SURG, V48, P1348, DOI 10.1016/j.jpedsurg.2013.03.040; ROYALL D, 1992, AM J GASTROENTEROL, V87, P751; Rubin DC, 2016, BEST PRACT RES CL GA, V30, P237, DOI 10.1016/j.bpg.2016.03.007; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sentongo TA, 2008, J PEDIATR GASTR NUTR, V46, P41, DOI 10.1097/01.mpg.0000304452.92175.f5; Shores DR, 2015, J PERINATOL, V35, P941, DOI 10.1038/jp.2015.105; Smith JM, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14127; So S, 2016, EARLY HUM DEV, V101, P11, DOI 10.1016/j.earlhumdev.2016.05.012; Sondheimer JM, 1998, J PEDIATR-US, V132, P80, DOI 10.1016/S0022-3476(98)70489-5; Squires RH, 2014, J PEDIATR GASTR NUTR, V59, P537, DOI 10.1097/MPG.0000000000000456; Squires RH, 2012, J PEDIATR-US, V161, P723, DOI 10.1016/j.jpeds.2012.03.062; Stanger JD, 2013, J PEDIATR SURG, V48, P983, DOI 10.1016/j.jpedsurg.2013.02.070; Sudan D, 2014, AM J TRANSPLANT, V14, P1976, DOI 10.1111/ajt.12812; Sueyoshi R, 2014, TISSUE ENG PT A, V20, P830, DOI 10.1089/ten.TEA.2013.0383; Ubesie AC, 2013, J PEDIATR GASTR NUTR, V57, P372, DOI 10.1097/MPG.0b013e31829c10eb; VANDERHOOF JA, 1984, JPEN-PARENTER ENTER, V8, P685, DOI 10.1177/0148607184008006685; Wales PW, 2014, JPEN-PARENTER ENTER, V38, P538, DOI 10.1177/0148607114527772; Wales PW, 2004, J PEDIATR SURG, V39, P690, DOI 10.1016/j.jpedsurg.2004.01.036; Wester T, 2014, BRIT J SURG, V101, P1329, DOI 10.1002/bjs.9583; WILLIAMSON RCN, 1978, NEW ENGL J MED, V298, P1444, DOI 10.1056/NEJM197806292982604; WILLIAMSON RCN, 1978, NEW ENGL J MED, V298, P1393, DOI 10.1056/NEJM197806222982505; WILMORE DW, 1972, J PEDIATR-US, V80, P88, DOI 10.1016/S0022-3476(72)80459-1; Winkler MF, 2016, JPEN-PARENTER ENTER, V40, P1140, DOI 10.1177/0148607115586575; Yang CF, 2011, J PEDIAT, V159	85	127	130	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					666	675		10.1056/NEJMra1602650	http://dx.doi.org/10.1056/NEJMra1602650			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7FG	28813225				2022-12-28	WOS:000407691400009
J	Hodaei, H; Hassan, AU; Wittek, S; Garcia-Gracia, H; El-Ganainy, R; Christodoulides, DN; Khajavikhan, M				Hodaei, Hossein; Hassan, Absar U.; Wittek, Steffen; Garcia-Gracia, Hipolito; El-Ganainy, Ramy; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh			Enhanced sensitivity at higher-order exceptional points	NATURE			English	Article							PARITY-TIME SYMMETRY; MICRORING LASERS; LABEL-FREE; MICROCAVITIES	Non-Hermitian degeneracies, also known as exceptional points, have recently emerged as a new way to engineer the response of open physical systems, that is, those that interact with the environment. They correspond to points in parameter space at which the eigenvalues of the underlying system and the corresponding eigenvectors simultaneously coalesce(1-3). In optics, the abrupt nature of the phase transitions that are encountered around exceptional points has been shown to lead to many intriguing phenomena, such as loss-induced transparency(4), unidirectional invisibility(5,6), band merging(7,8), topological chirality(9,10) and laser mode selectivity(11,12). Recently, it has been shown that the bifurcation properties of second-order non-Hermitian degeneracies can provide a means of enhancing the sensitivity (frequency shifts) of resonant optical structures to external perturbations(13). Of particular interest is the use of even higher-order exceptional points (greater than second order), which in principle could further amplify the effect of perturbations, leading to even greater sensitivity. Although a growing number of theoretical studies have been devoted to such higher-order degeneracies(14-16), their experimental demonstration in the optical domain has so far remained elusive. Here we report the observation of higher-order exceptional points in a coupled cavity arrangement-specifically, a ternary, parity-time-symmetric photonic laser molecule-with a carefully tailored gain-loss distribution. We study the system in the spectral domain and find that the frequency response associated with this system follows a cube-root dependence on induced perturbations in the refractive index. Our work paves the way for utilizing non-Hermitian degeneracies in fields including photonics, optomechanics(10), microwaves(9) and atomic physics(17,18).	[Hodaei, Hossein; Hassan, Absar U.; Wittek, Steffen; Garcia-Gracia, Hipolito; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh] Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA; [El-Ganainy, Ramy] Michigan Technol Univ, Dept Phys, Houghton, MI 49931 USA; [El-Ganainy, Ramy] Michigan Technol Univ, Henes Ctr Quantum Phenomena, Houghton, MI 49931 USA	State University System of Florida; University of Central Florida; Michigan Technological University; Michigan Technological University	Khajavikhan, M (corresponding author), Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA.	mercedeh@creol.ucf.edu	Wittek, Steffen/T-8248-2019	Khajavikhan, Mercedeh/0000-0002-7091-1470; Hassan, Absar U./0000-0002-8299-5798	Office of Naval Research (ONR) [N00014-16-1-2640]; National Science Foundation (NSF) [ECCS-1454531, DMR-1420620]; Air force Office of Scientific Research (AFOSR) [FA9550-14-1-0037]; Army Research Office (ARO) [W911NF-16-1-0013]; Qatar National Research Fund [NPRP 9-020-1-006]; Henes Center for Quantum Phenomena at Michigan Tech University	Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); Air force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office (ARO); Qatar National Research Fund(Qatar National Research Fund (QNRF)); Henes Center for Quantum Phenomena at Michigan Tech University	We acknowledge financial support from the Office of Naval Research (ONR; N00014-16-1-2640), the National Science Foundation (NSF; ECCS-1454531, DMR-1420620), the Air force Office of Scientific Research (AFOSR; FA9550-14-1-0037) and the Army Research Office (ARO; W911NF-16-1-0013). This work was also partially funded by the Qatar National Research Fund (NPRP 9-020-1-006). R.E.-G. acknowledges support from the Henes Center for Quantum Phenomena at Michigan Tech University. H.H. thanks J. Boroumand from UCF for helping with the SEM images.	Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Arnold S, 2010, OPT EXPRESS, V18, P281, DOI 10.1364/OE.18.000281; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Chong YD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.063902; CHOW WW, 1985, REV MOD PHYS, V57, P61, DOI 10.1103/RevModPhys.57.61; Demange G, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/2/025303; Ding K, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021007; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hassan AU, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063807; Heiss WD, 1999, EUR PHYS J D, V7, P1, DOI 10.1007/s100530050339; Hodaei H, 2015, OPT LETT, V40, P4955, DOI 10.1364/OL.40.004955; Hodaei H., 2016, IEEE J SEL TOP QUANT, V22; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Jing H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03546-7; Kato T, 2013, PERTURBATION THEORY; Lee H, 2012, NAT PHOTONICS, V6, P369, DOI [10.1038/nphoton.2012.109, 10.1038/NPHOTON.2012.109]; Lin Z, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.107402; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Peng P, 2016, NAT PHYS, V12, P1139, DOI [10.1038/NPHYS3842, 10.1038/nphys3842]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ren J, 2017, OPT LETT, V42, P1556, DOI 10.1364/OL.42.001556; Santis CT, 2014, P NATL ACAD SCI USA, V111, P2879, DOI 10.1073/pnas.1400184111; Schomerus H, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061801; Teimourpour MH, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.053817; Weimann S, 2017, NAT MATER, V16, P433, DOI [10.1038/NMAT4811, 10.1038/nmat4811]; Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901; Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604; Yoo G, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063833; Zhang ZY, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.123601; Zhen B, 2015, NATURE, V525, P354, DOI 10.1038/nature14889; Zhu JG, 2010, NAT PHOTONICS, V4, P46, DOI 10.1038/NPHOTON.2009.237	37	760	766	24	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					187	+		10.1038/nature23280	http://dx.doi.org/10.1038/nature23280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796201				2022-12-28	WOS:000407284300038
J	Yan, H; Opachaloemphan, C; Mancini, G; Yang, H; Gallitto, M; Mlejnek, J; Leibholz, A; Haight, K; Ghaninia, M; Huo, L; Perry, M; Slone, J; Zhou, XF; Traficante, M; Penick, CA; Dolezal, K; Gokhale, K; Stevens, K; Fetter-Pruneda, I; Bonasio, R; Zwiebel, LJ; Berger, SL; Liebig, J; Reinberg, D; Desplan, C				Yan, Hua; Opachaloemphan, Comzit; Mancini, Giacomo; Yang, Huan; Gallitto, Matthew; Mlejnek, Jakub; Leibholz, Alexandra; Haight, Kevin; Ghaninia, Majid; Huo, Lucy; Perry, Michael; Slone, Jesse; Zhou, Xiaofan; Traficante, Maria; Penick, Clint A.; Dolezal, Kelly; Gokhale, Kaustubh; Stevens, Kelsey; Fetter-Pruneda, Ingrid; Bonasio, Roberto; Zwiebel, Laurence J.; Berger, Shelley L.; Liebig, Jurgen; Reinberg, Danny; Desplan, Claude			An Engineered orco Mutation Produces Aberrant Social Behavior and Defective Neural Development in Ants	CELL			English	Article							CUTICULAR HYDROCARBONS; CHEMOSENSORY RECEPTORS; TARGETED MUTAGENESIS; ODORANT RECEPTORS; INSECT; WORKERS; MAP; EVOLUTION; PATTERNS; COMMUNICATION	Ants exhibit cooperative behaviors and advanced forms of sociality that depend on pheromone-mediated communication. Odorant receptor neurons (ORNs) express specific odorant receptors (ORs) encoded by a dramatically expanded gene family in ants. In most eusocial insects, only the queen can transmit genetic information, restricting genetic studies. In contrast, workers in Harpegnathos saltator ants can be converted into gamergates (pseudoqueens) that can found entire colonies. This feature facilitated CRISPR-Cas9 generation of germline mutations in orco, the gene that encodes the obligate co-receptor of all ORs. orco mutations should significantly impact olfaction. We demonstrate striking functions of Orco in odorant perception, reproductive physiology, and social behavior plasticity. Surprisingly, unlike in other insects, loss of OR functionality also dramatically impairs development of the antennal lobe to which ORNs project. Therefore, the development of genetics in Harpegnathos establishes this ant species as a model organism to study the complexity of eusociality.	[Yan, Hua; Opachaloemphan, Comzit; Yang, Huan; Gallitto, Matthew; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Mancini, Giacomo; Mlejnek, Jakub; Leibholz, Alexandra; Huo, Lucy; Perry, Michael; Traficante, Maria; Stevens, Kelsey; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Haight, Kevin; Ghaninia, Majid; Penick, Clint A.; Dolezal, Kelly; Gokhale, Kaustubh; Liebig, Jurgen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Slone, Jesse; Zhou, Xiaofan; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Fetter-Pruneda, Ingrid] Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA; [Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Biol, Philadelphia, PA 19104 USA; [Yan, Hua; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; Arizona State University; Arizona State University-Tempe; Vanderbilt University; Rockefeller University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; New York University	Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Desplan, C (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.; Liebig, J (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Berger, SL (corresponding author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Dept Biol, Philadelphia, PA 19104 USA.; Reinberg, D (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	bergers@mail.med.upenn.edu; juergen.liebig@asu.edu; danny.reinberg@nyumc.org; cd38@nyu.edu	Zhou, Xiaofan/H-2958-2019	Zhou, Xiaofan/0000-0002-2879-6317; Mlejnek, Jakub/0000-0003-4997-2735; Berger, Shelley/0000-0001-5398-4400; Traficante, Maria/0000-0003-3403-0489; Desplan, Claude/0000-0002-6914-1413; Penick, Clint/0000-0002-5368-507X; Slone, Jesse/0000-0002-2478-3295; Fetter-Pruneda, Ingrid/0000-0002-9122-3159; Zwiebel, Laurence/0000-0001-6686-7289; Perry, Michael/0000-0002-5977-8031; Reinberg, Danny/0000-0003-4288-2016	Howard Hughes Medical Institute [2009005]; HCIA [2009005]; NIH [R21GM114457, EY13010, K99 EY027016, DP2MH107055]; Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE [K99EY027016, R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH107055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055570, F32AG044971] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HCIA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We appreciate the advice and assistance from Gregory Pask, Daniel Simola, and Takahiro Ohde in designing orco sgRNAs and improving reproduction of individually isolated ants; from Brittany Enzmann for embryo injections; from Christopher Albin-Brooks for behavioral responses to odorants; from Waring (Buck) Trible (Daniel Kronauer's lab) for deep sequencing to test somatic mutation efficiency; from Haiyan Zheng and Shengjiang Tu for mass spectrometry; and from Lynne Vales for helping in manuscript preparation. We also appreciate the assistance from Heike Pelka, Anika Paradkar, Nicholas Rogers, and Chen Dong in managing the ant room, maintaining ant colonies, or analyzing behavioral videos. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Award (CIA; #2009005) (to D.R., S.L.B., and J.L.), HCIA #2009005 (to D.R., S.L.B., J.L., C.D., and L.J.Z.), NIH grants (R21GM114457 to D.R.; EY13010 to C.D.). H. Yan was an NIH Ruth L. Kirschstein NRSA Postdoctoral Fellow (F32AG044971). M.P. was supported by NIH grant K99 EY027016. R.B. was supported by the Helen Hay Whitney Foundation and by an NIH New Innovator Award (DP2MH107055).	ALI MF, 1990, BIOL REV, V65, P227, DOI 10.1111/j.1469-185X.1990.tb01425.x; [Anonymous], TITLE ERROR; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonasio R, 2012, ANN NY ACAD SCI, V1260, P14, DOI 10.1111/j.1749-6632.2011.06363.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Capinera JL, 2004, ENCY ENTOMOLOGY; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Ghaninia M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03964-7; Haight KL, 2012, J INSECT PHYSIOL, V58, P1568, DOI 10.1016/j.jinsphys.2012.09.011; Hassan BA, 2015, CELL, V163, P285, DOI 10.1016/j.cell.2015.09.031; Henderson D. S., 2004, DROSOPHILA CYTOGENET; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Hoyer SC, 2005, ARTHROPOD STRUCT DEV, V34, P429, DOI 10.1016/j.asd.2005.03.003; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Khila A., 2009, COLD SPRING HARB PRO, V7; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Laissue PP, 2008, ADV EXP MED BIOL, V628, P102, DOI 10.1007/978-0-387-78261-4_7; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Liebig J, 1998, NATURWISSENSCHAFTEN, V85, P133, DOI 10.1007/s001140050470; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McKenzie SK, 2016, P NATL ACAD SCI USA, V113, P14091, DOI 10.1073/pnas.1610800113; McKenzie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-718; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nakanishi A, 2009, CELL TISSUE RES, V338, P79, DOI 10.1007/s00441-009-0863-1; Oland LA, 1996, J NEUROBIOL, V30, P92; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Penick CA, 2012, J INSECT PHYSIOL, V58, P1643, DOI 10.1016/j.jinsphys.2012.10.004; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Petsakou A, 2015, CELL, V162, P823, DOI 10.1016/j.cell.2015.07.010; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Sasaki T, 2016, AM NAT, V187, P765, DOI 10.1086/686259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Watanabe T, 2014, METHODS, V69, P17, DOI 10.1016/j.ymeth.2014.05.006; Wicher D, 2015, PROG MOL BIOL TRANSL, V130, P37, DOI 10.1016/bs.pmbts.2014.11.002; WILT FH, 1967, METHODS DEV BIOL; Yan H, 2014, NAT REV GENET, V15, P677, DOI 10.1038/nrg3787; Yang B, 2016, INSECT BIOCHEM MOLEC, V70, P53, DOI 10.1016/j.ibmb.2015.12.003; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao N, 2010, PLANT PHYSIOL BIOCH, V48, P279, DOI 10.1016/j.plaphy.2010.01.023; Zhou XF, 2015, GENOME BIOL EVOL, V7, P2407, DOI 10.1093/gbe/evv149; Zube C, 2008, ARTHROPOD STRUCT DEV, V37, P469, DOI 10.1016/j.asd.2008.05.004	74	120	125	3	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					736	+		10.1016/j.cell.2017.06.051	http://dx.doi.org/10.1016/j.cell.2017.06.051			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802043	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000407445700014
J	[Anonymous]				[Anonymous]			A GUIDE TO THE NATURE INDEX	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S32	S32						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792920	Bronze			2022-12-28	WOS:000407284300011
J	[Anonymous]				[Anonymous]			CHARTING INFLUENCE	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S6	S6						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792922				2022-12-28	WOS:000407284300002
J	Adamczyk, L; Adkins, JK; Agakishiev, G; Aggarwal, MM; Ahammed, Z; Ajitanand, NN; Alekseev, I; Anderson, DM; Aoyama, R; Aparin, A; Arkhipkin, D; Aschenauer, EC; Ashraf, MU; Attri, A; Averichev, GS; Bai, X; Bairathi, V; Behera, A; Bellwied, R; Bhasin, A; Bhati, AK; Bhattarai, P; Bielcik, J; Bielcikova, J; Bland, LC; Bordyuzhin, IG; Bouchet, J; Brandenburg, JD; Brandin, AV; Brown, D; Bunzarov, I; Butterworth, J; Caines, H; Sanchez, MCDLB; Campbell, JM; Cebra, D; Chakaberia, I; Chaloupka, P; Chang, Z; Chankova-Bunzarova, N; Chatterjee, A; Chattopadhyay, S; Chen, X; Chen, JH; Chen, X; Cheng, J; Cherney, M; Christie, W; Contin, G; Crawford, HJ; Das, S; De Silva, LC; Debbe, RR; Dedovich, TG; Deng, J; Derevschikov, AA; Didenko, L; Dilks, C; Dong, X; Drachenberg, JL; Draper, JE; Dunkelberger, LE; Dunlop, JC; Efimov, LG; Elsey, N; Engelage, J; Eppley, G; Esha, R; Esumi, S; Evdokimov, O; Ewigleben, J; Eyser, O; Fatemi, R; Fazio, S; Federic, P; Federicova, P; Fedorisin, J; Feng, Z; Filip, P; Finch, E; Fisyak, Y; Flores, CE; Fulek, L; Gagliardi, CA; Garand, D; Geurts, F; Gibson, A; Girard, M; Grosnick, D; Gunarathne, DS; Guo, Y; Gupta, A; Gupta, S; Guryn, W; Hamad, AI; Hamed, A; Harlenderova, A; Harris, JW; He, L; Heppelmann, S; Heppelmann, S; Hirsch, A; Hoffmann, GW; Horvat, S; Huang, T; Huang, B; Huang, X; Huang, HZ; Humanic, TJ; Huo, P; Igo, G; Jacobs, WW; Jentsch, A; Jia, J; Jiang, K; Jowzaee, S; Judd, EG; Kabana, S; Kalinkin, D; Kang, K; Kauder, K; Ke, HW; Keane, D; Kechechyan, A; Khan, Z; Kikola, DP; Kisel, I; Kisiel, A; Kochenda, L; Kocmanek, M; Kollegger, T; Kosarzewski, LK; Kraishan, AF; Kravtsov, P; Krueger, K; Kulathunga, N; Kumar, L; Kvapil, J; Kwasizur, JH; Lacey, R; Landgraf, JM; Landry, KD; Lauret, J; Lebedev, A; Lednicky, R; Lee, JH; Li, X; Li, C; Li, W; Li, Y; Lidrych, J; Lin, T; Lisa, MA; Liu, H; Liu, P; Liu, Y; Liu, F; Ljubicic, T; Llope, WJ; Lomnitz, M; Longacre, RS; Luo, S; Luo, X; Ma, GL; Ma, L; Ma, YG; Ma, R; Magdy, N; Majka, R; Mallick, D; Margetis, S; Markert, C; Matis, HS; Meehan, K; Mei, JC; Miller, ZW; Minaev, NG; Mioduszewski, S; Mishra, D; Mizuno, S; Mohanty, B; Mondal, MM; Morozov, DA; Mustafa, MK; Nasim, M; Nayak, TK; Nelson, JM; Nie, M; Nigmatkulov, G; Niida, T; Nogach, LV; Nonaka, T; Nurushev, SB; Odyniec, G; Ogawa, A; Oh, K; Okorokov, VA; Jr, DO; Page, BS; Pak, R; Pandit, Y; Panebratsev, Y; Pawlik, B; Pei, H; Perkins, C; Pile, P; Pluta, J; Poniatowska, K; Porter, J; Posik, M; Poskanzer, AM; Pruthi, NK; Przybycien, M; Putschke, J; Qiu, H; Quintero, A; Ramachandran, S; Ray, RL; Reed, R; Rehbein, MJ; Ritter, HG; Roberts, JB; Rogachevskiy, OV; Romero, JL; Roth, JD; Ruan, L; Rusnak, J; Rusnakova, O; Sahoo, NR; Sahu, PK; Salur, S; Sandweiss, J; Saur, M; Schambach, J; Schmah, AM; Schmidke, WB; Schmitz, N; Schweid, BR; Seger, J; Sergeeva, M; Seyboth, P; Shah, N; Shahaliev, E; Shanmuganathan, PV; Shao, M; Sharma, A; Sharma, MK; Shen, WQ; Shi, Z; Shi, SS; Shou, QY; Sichtermann, EP; Sikora, R; Simko, M; Singha, S; Skoby, MJ; Smirnov, N; Smirnov, D; Solyst, W; Song, L; Sorensen, P; Spinka, HM; Srivastava, B; Stanislaus, TDS; Strikhanov, M; Stringfellow, B; Sugiura, T; Sumbera, M; Summa, B; Sun, Y; Sun, XM; Sun, X; Surrow, B; Svirida, DN; Tang, AH; Tang, Z; Taranenko, A; Tarnowsky, T; Tawfik, A; Thader, J; Thomas, JH; Timmins, AR; Tlusty, D; Todoroki, T; Tokarev, M; Trentalange, S; Tribble, RE; Tribedy, P; Tripathy, SK; Trzeciak, BA; Tsai, OD; Ullrich, T; Underwood, DG; Upsal, I; Van Buren, G; Van Nieuwenhuizen, G; Vasiliev, AN; Videbaek, F; Vokal, S; Voloshin, SA; Vossen, A; Wang, G; Wang, Y; Wang, F; Wang, Y; Webb, JC; Webb, G; Wen, L; Westfall, GD; Wieman, H; Wissink, SW; Witt, R; Wu, Y; Xiao, ZG; Xie, W; Xie, G; Xu, J; Xu, N; Xu, QH; Xu, YF; Xu, Z; Yang, Y; Yang, Q; Yang, C; Yang, S; Ye, Z; Ye, Z; Yi, L; Yip, K; Yoo, IK; Yu, N; Zbroszczyk, H; Zha, W; Zhang, Z; Zhang, XP; Zhang, JB; Zhang, S; Zhang, J; Zhang, Y; Zhang, J; Zhang, S; Zhao, J; Zhong, C; Zhou, L; Zhou, C; Zhu, X; Zhu, Z; Zyzak, M				Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Ajitanand, N. N.; Alekseev, I.; Anderson, D. M.; Aoyama, R.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Ashraf, M. U.; Attri, A.; Averichev, G. S.; Bai, X.; Bairathi, V.; Behera, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandenburg, J. D.; Brandin, A. V.; Brown, D.; Bunzarov, I.; Butterworth, J.; Caines, H.; Sanchez, M. Calderon De la Barca; Campbell, J. M.; Cebra, D.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chankova-Bunzarova, N.; Chatterjee, A.; Chattopadhyay, S.; Chen, X.; Chen, J. H.; Chen, X.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Elsey, N.; Engelage, J.; Eppley, G.; Esha, R.; Esumi, S.; Evdokimov, O.; Ewigleben, J.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Federicova, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Finch, E.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, A.; Gupta, S.; Guryn, W.; Hamad, A. I.; Hamed, A.; Harlenderova, A.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Horvat, S.; Huang, T.; Huang, B.; Huang, X.; Huang, H. Z.; Humanic, T. J.; Huo, P.; Igo, G.; Jacobs, W. W.; Jentsch, A.; Jia, J.; Jiang, K.; Jowzaee, S.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z.; Kikola, D. P.; Kisel, I.; Kisiel, A.; Kochenda, L.; Kocmanek, M.; Kollegger, T.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kulathunga, N.; Kumar, L.; Kvapil, J.; Kwasizur, J. H.; Lacey, R.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, X.; Li, C.; Li, W.; Li, Y.; Lidrych, J.; Lin, T.; Lisa, M. A.; Liu, H.; Liu, P.; Liu, Y.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, S.; Luo, X.; Ma, G. L.; Ma, L.; Ma, Y. G.; Ma, R.; Magdy, N.; Majka, R.; Mallick, D.; Margetis, S.; Markert, C.; Matis, H. S.; Meehan, K.; Mei, J. C.; Miller, Z. W.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mizuno, S.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nasim, Md.; Nayak, T. K.; Nelson, J. M.; Nie, M.; Nigmatkulov, G.; Niida, T.; Nogach, L. V.; Nonaka, T.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V. A.; Jr, D. Olvitt; Page, B. S.; Pak, R.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Pile, P.; Pluta, J.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Pruthi, N. K.; Przybycien, M.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Ray, R. L.; Reed, R.; Rehbein, M. J.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roth, J. D.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Salur, S.; Sandweiss, J.; Saur, M.; Schambach, J.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Schweid, B. R.; Seger, J.; Sergeeva, M.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, A.; Sharma, M. K.; Shen, W. Q.; Shi, Z.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Singha, S.; Skoby, M. J.; Smirnov, N.; Smirnov, D.; Solyst, W.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Strikhanov, M.; Stringfellow, B.; Sugiura, T.; Sumbera, M.; Summa, B.; Sun, Y.; Sun, X. M.; Sun, X.; Surrow, B.; Svirida, D. N.; Tang, A. H.; Tang, Z.; Taranenko, A.; Tarnowsky, T.; Tawfik, A.; Thader, J.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Todoroki, T.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Trzeciak, B. A.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; Van Buren, G.; Van Nieuwenhuizen, G.; Vasiliev, A. N.; Videbaek, F.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, G.; Wang, Y.; Wang, F.; Wang, Y.; Webb, J. C.; Webb, G.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y.; Xiao, Z. G.; Xie, W.; Xie, G.; Xu, J.; Xu, N.; Xu, Q. H.; Xu, Y. F.; Xu, Z.; Yang, Y.; Yang, Q.; Yang, C.; Yang, S.; Ye, Z.; Ye, Z.; Yi, L.; Yip, K.; Yoo, I-K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, Z.; Zhang, X. P.; Zhang, J. B.; Zhang, S.; Zhang, J.; Zhang, Y.; Zhang, J.; Zhang, S.; Zhao, J.; Zhong, C.; Zhou, L.; Zhou, C.; Zhu, X.; Zhu, Z.; Zyzak, M.		STAR Collaboration	Global Lambda hyperon polarization in nuclear collisions	NATURE			English	Article							VORTICITY	The extreme energy densities generated by ultra-relativistic collisions between heavy atomic nuclei produce a state of matter that behaves surprisingly like a fluid, with exceptionally high temperature and low viscosity(1). Non-central collisions have angular momenta of the order of 1,000., and the resulting fluid may have a strong vortical structure(2-4) that must be understood to describe the fluid properly. The vortical structure is also of particular interest because the restoration of fundamental symmetries of quantum chromodynamics is expected to produce novel physical effects in the presence of strong vorticity(5). However, no experimental indications of fluid vorticity in heavy ion collisions have yet been found. Since vorticity represents a local rotational structure of the fluid, spin-orbit coupling can lead to preferential orientation of particle spins along the direction of rotation. Here we present measurements of an alignment between the global angular momentum of a non-central collision and the spin of emitted particles (in this case the collision occurs between gold nuclei and produces Lambda baryons), revealing that the fluid produced in heavy ion collisions is the most vortical system so far observed. (At high energies, this fluid is a quark-gluon plasma.) We find that Lambda and (Lambda) over bar hyperons show a positive polarization of the order of a few per cent, consistent with some hydrodynamic predictions(6). (A hyperon is a particle composed of three quarks, at least one of which is a strange quark; the remainder are up and down quarks, found in protons and neutrons.) A previous measurement(7) that reported a null result, that is, zero polarization, at higher collision energies is seen to be consistent with the trend of our observations, though with larger statistical uncertainties. These data provide experimental access to the vortical structure of the nearly ideal liquid(8) created in a heavy ion collision and should prove valuable in the development of hydrodynamic models that quantitatively connect observations to the theory of the strong force.	[Adamczyk, L.; Fulek, L.; Przybycien, M.; Sikora, R.] AGH Univ Sci & Technol, FPACS, PL-30059 Krakow, Poland; [Adkins, J. K.; Fatemi, R.; Ramachandran, S.] Univ Kentucky, Lexington, KY 40506 USA; [Agakishiev, G.; Aparin, A.; Averichev, G. S.; Bunzarov, I.; Chankova-Bunzarova, N.; Dedovich, T. G.; Efimov, L. G.; Fedorisin, J.; Filip, P.; Lednicky, R.; Panebratsev, Y.; Rogachevskiy, O. V.; Shahaliev, E.; Tokarev, M.; Vokal, S.] Joint Inst Nucl Res, Dubna 141980, Russia; [Aggarwal, M. M.; Attri, A.; Bhati, A. K.; Kumar, L.; Pruthi, N. K.] Panjab Univ, Chandigarh 160014, India; [Ahammed, Z.; Chatterjee, A.; Chattopadhyay, S.; Nayak, T. K.] Variable Energy Cyclotron Ctr, Kolkata 700064, India; [Ajitanand, N. N.; Behera, A.; Huo, P.; Jia, J.; Lacey, R.; Liu, P.; Magdy, N.; Schweid, B. R.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Alekseev, I.; Bordyuzhin, I. G.; Svirida, D. N.] Alikhanov Inst Theoret & Expt Phys, Moscow 117218, Russia; [Alekseev, I.; Brandin, A. V.; Kochenda, L.; Kravtsov, P.; Nigmatkulov, G.; Okorokov, V. A.; Strikhanov, M.; Taranenko, A.] Natl Res Nucl Univ, MEPhI, Moscow 115409, Russia; [Anderson, D. M.; Chang, Z.; Gagliardi, C. A.; Hamed, A.; Liu, Y.; Mioduszewski, S.; Sahoo, N. R.; Tribble, R. E.] Texas A&M Univ, College Stn, TX 77843 USA; [Aoyama, R.; Esumi, S.; Nonaka, T.; Sugiura, T.] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Arkhipkin, D.; Aschenauer, E. C.; Bland, L. C.; Chakaberia, I.; Christie, W.; Debbe, R. R.; Didenko, L.; Dunlop, J. C.; Eyser, O.; Fazio, S.; Fisyak, Y.; Guryn, W.; Jia, J.; Ke, H. W.; Landgraf, J. M.; Lauret, J.; Lebedev, A.; Lee, J. H.; Ljubicic, T.; Longacre, R. S.; Ma, R.; Ogawa, A.; Page, B. S.; Pak, R.; Pile, P.; Ruan, L.; Schmidke, W. B.; Smirnov, D.; Sorensen, P.; Tang, A. H.; Todoroki, T.; Tribedy, P.; Ullrich, T.; Van Buren, G.; Van Nieuwenhuizen, G.; Videbaek, F.; Webb, J. C.; Webb, G.; Xu, Z.; Yang, S.; Yip, K.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Cheng, J.; Kang, K.] Tsinghua Univ, Beijing 100084, Peoples R China; [Bai, X.; Das, S.; Feng, Z.; Liu, F.; Luo, X.; Pei, H.; Shi, S. S.; Sun, X. M.; Sun, X.; Wang, Y.; Xu, J.; Yu, N.; Zhang, J. B.] Cent China Normal Univ, Wuhan 430079, Hubei, Peoples R China; [Bairathi, V.; Mallick, D.; Mishra, D.; Mohanty, B.] Natl Inst Sci Educ & Res, Bhubaneswar 751005, Orissa, India; [Bellwied, R.; Kulathunga, N.; Song, L.; Timmins, A. R.] Univ Houston, Houston, TX 77204 USA; [Bhasin, A.; Gupta, A.; Gupta, S.; Sharma, A.; Sharma, M. K.] Univ Jammu, Jammu 180001, India; [Bhattarai, P.; Hoffmann, G. W.; Jentsch, A.; Markert, C.; Ray, R. L.; Schambach, J.] Univ Texas Austin, Austin, TX 78712 USA; [Bielcik, J.; Chaloupka, P.; Federicova, P.; Harlenderova, A.; Kvapil, J.; Lidrych, J.; Rusnakova, O.; Trzeciak, B. A.] Czech Tech Univ, FNSPE, Prague 11519, Czech Republic; [Bielcikova, J.; Federic, P.; Kocmanek, M.; Rusnak, J.; Saur, M.; Simko, M.; Sumbera, M.] Nucl Phys Inst AS CR, Prague 25068, Czech Republic; [Bouchet, J.; Guo, Y.; Hamad, A. I.; Kabana, S.; Keane, D.; Margetis, S.; Singha, S.; Wu, Y.] Kent State Univ, Kent, OH 44242 USA; [Brandenburg, J. D.; Butterworth, J.; Eppley, G.; Geurts, F.; Roberts, J. B.; Tlusty, D.] Rice Univ, Houston, TX 77251 USA; [Brown, D.; Ewigleben, J.; Reed, R.; Shanmuganathan, P. V.] Lehigh Univ, Bethlehem, PA 18015 USA; [Caines, H.; Harris, J. W.; Horvat, S.; Majka, R.; Sandweiss, J.; Smirnov, N.; Yi, L.] Yale Univ, New Haven, CT 06520 USA; [Sanchez, M. Calderon De la Barca; Cebra, D.; Draper, J. E.; Flores, C. E.; Heppelmann, S.; Meehan, K.; Romero, J. L.] Univ Calif Davis, Davis, CA 95616 USA; [Campbell, J. M.; Humanic, T. J.; Lisa, M. A.; Upsal, I.] Ohio State Univ, Columbus, OH 43210 USA; [Chen, X.; Jiang, K.; Li, X.; Li, C.; Shao, M.; Sun, Y.; Tang, Z.; Xie, G.; Yang, Q.; Zha, W.; Zhang, S.; Zhang, Y.; Zhou, L.] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Chen, J. H.; Li, W.; Ma, G. L.; Ma, L.; Ma, Y. G.; Nie, M.; Shah, N.; Shen, W. Q.; Shou, Q. Y.; Xu, Y. F.; Zhang, Z.; Zhang, S.; Zhong, C.; Zhou, C.] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Chen, X.; Zhang, J.] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Gansu, Peoples R China; [Cherney, M.; De Silva, L. C.; Rehbein, M. J.; Roth, J. D.; Seger, J.] Creighton Univ, Omaha, NE 68178 USA; [Contin, G.; Dong, X.; Lomnitz, M.; Matis, H. S.; Mizuno, S.; Mustafa, M. K.; Odyniec, G.; Porter, J.; Poskanzer, A. M.; Ritter, H. G.; Salur, S.; Schmah, A. M.; Shi, Z.; Sichtermann, E. P.; Thader, J.; Thomas, J. H.; Wieman, H.; Xu, N.; Zhang, J.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Crawford, H. J.; Engelage, J.; Judd, E. G.; Nelson, J. M.; Perkins, C.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Deng, J.; Mei, J. C.; Xu, Q. H.; Yang, C.; Zhu, Z.] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Derevschikov, A. A.; Minaev, N. G.; Morozov, D. A.; Nogach, L. V.; Nurushev, S. B.; Vasiliev, A. N.] Inst High Energy Phys, Protvino 142281, Russia; [Dilks, C.; Heppelmann, S.; Summa, B.] Penn State Univ, University Pk, PA 16802 USA; [Drachenberg, J. L.] Lamar Univ, Dept Phys, Beaumont, TX 77710 USA; [Dunkelberger, L. E.; Esha, R.; Huang, H. Z.; Igo, G.; Landry, K. D.; Nasim, Md.; Sergeeva, M.; Trentalange, S.; Tsai, O. D.; Wang, G.; Wen, L.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Elsey, N.; Jowzaee, S.; Kauder, K.; Llope, W. J.; Niida, T.; Putschke, J.; Voloshin, S. A.] Wayne State Univ, Detroit, MI 48201 USA; [Evdokimov, O.; Huang, B.; Khan, Z.; Luo, S.; Miller, Z. W.; Pandit, Y.] Univ Illinois, Chicago, IL 60607 USA; [Finch, E.] Southern Connecticut State Univ, New Haven, CT 06515 USA; [Garand, D.; He, L.; Hirsch, A.; Qiu, H.; Srivastava, B.; Stringfellow, B.; Wang, F.; Xie, W.; Zhao, J.] Purdue Univ, W Lafayette, IN 47907 USA; [Gibson, A.; Grosnick, D.; Stanislaus, T. D. S.] Valparaiso Univ, Valparaiso, IN 46383 USA; [Girard, M.; Kikola, D. P.; Kisiel, A.; Kosarzewski, L. K.; Pluta, J.; Poniatowska, K.; Zbroszczyk, H.] Warsaw Univ Technol, PL-00661 Warsaw, Poland; [Gunarathne, D. S.; Kraishan, A. F.; Jr, D. Olvitt; Posik, M.; Quintero, A.; Surrow, B.] Temple Univ, Philadelphia, PA 19122 USA; [Huang, T.; Yang, Y.] Natl Cheng Kung Univ, Tainan 70101, Taiwan; [Jacobs, W. W.; Kalinkin, D.; Kwasizur, J. H.; Lin, T.; Liu, H.; Skoby, M. J.; Solyst, W.; Vossen, A.; Wissink, S. W.] Indiana Univ, Bloomington, IN 47408 USA; [Kisel, I.; Kollegger, T.; Zyzak, M.] FIAS, D-60438 Frankfurt, Germany; [Krueger, K.; Spinka, H. M.; Underwood, D. G.] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA; [Mondal, M. M.] Inst Phys, Bhubaneswar 751005, Orissa, India; [Oh, K.; Yoo, I-K.] Pusan Natl Univ, Pusan 46241, South Korea; [Pawlik, B.] PAN, Inst Nucl Phys, PL-31342 Krakow, Poland; [Schmitz, N.; Seyboth, P.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Tarnowsky, T.; Westfall, G. D.] Michigan State Univ, E Lansing, MI 48824 USA; [Tawfik, A.] World Lab Cosmol & Particle Phys WLCAPP, Cairo 11571, Egypt; [Witt, R.] US Naval Acad, Annapolis, MD 21402 USA	AGH University of Science & Technology; University of Kentucky; Joint Institute for Nuclear Research - Russia; Panjab University; Variable Energy Cyclotron Centre; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Texas A&M University System; Texas A&M University College Station; University of Tsukuba; United States Department of Energy (DOE); Brookhaven National Laboratory; Tsinghua University; Central China Normal University; National Institute of Science Education & Research (NISER); University of Houston System; University of Houston; University of Jammu; University of Texas System; University of Texas Austin; Czech Technical University Prague; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Rice University; Lehigh University; Yale University; University of California System; University of California Davis; University System of Ohio; Ohio State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Creighton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Shandong University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas State University System; Lamar University; University of California System; University of California Los Angeles; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Connecticut State University System; Southern Connecticut State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Valparaiso University; Warsaw University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Cheng Kung University; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Argonne National Laboratory; Institute of Physics Bhubaneswar (IOPB); Pusan National University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Max Planck Society; Michigan State University; United States Department of Defense; United States Navy; United States Naval Academy	Adamczyk, L (corresponding author), AGH Univ Sci & Technol, FPACS, PL-30059 Krakow, Poland.		Rusnak, Jan/G-8462-2014; Aparin, Alexey/AAE-1455-2022; Tokarev, Mikhail/GRE-9737-2022; Tawfik, Abdel Nasser/M-6220-2013; Svirida, Dmitry N/R-4909-2016; Fazio, Salvatore/G-5156-2010; Bhasin, Anju/AAS-4745-2021; Strikhanov, Mikhail N/P-7393-2014; Hamed, Ahmed Abdeen/AAF-4658-2020; Kisiel, Adam/O-8754-2015; Chatterjee, Arghya/AAR-9237-2020; Sahoo, Nihar Ranjan/ABF-3516-2021; Taranenko, Arkadiy/AAH-9189-2019; Matis, Howard/AAO-2082-2021; Kisel, Ivan/H-7077-2017; Ashraf, Muhammad Usman/GNM-5453-2022; Vasiliev, Alexander N/N-4742-2017; Alekseev, Igor G/J-8070-2014; Sumbera, Michal/O-7497-2014; Chaloupka, Petr/E-5965-2012; Pawlik, Bogdan/W-2346-2018; Bielcikova, Jana/AAB-4862-2020; Fulek, Lukasz/AAA-5721-2021; Sikora, Rafał/AAM-4274-2021; singha, subhash/N-2683-2018; Okorokov, Vitaly/C-4800-2017; Zhao, Jie/AAD-3191-2022; Bordyuzhin, Igor/AGX-2537-2022; Zyzak, Maksym/J-4692-2017; Nigmatkulov, Grigory/AAH-9428-2019; Lednicky, Richard/K-4164-2013; Kumar, Lokesh/A-6154-2010; Kabana, Sonia/ABF-5974-2020; Bairathi, Vipul/AAR-3812-2021; Ashraf, Muhammad Usman/GNM-5760-2022; Bielcikova, Jana/G-9342-2014; YANG, CHI/AAF-6393-2021; Yi, Li/GOV-3489-2022; Ma, Yu-Gang/M-8122-2013; Yip, Kin/D-6860-2013; Fisyak, Yuri/K-2142-2017	Rusnak, Jan/0000-0002-4738-7869; Tawfik, Abdel Nasser/0000-0002-1679-0225; Svirida, Dmitry N/0000-0002-0334-7304; Fazio, Salvatore/0000-0002-4321-1946; Strikhanov, Mikhail N/0000-0003-2586-0405; Kisiel, Adam/0000-0001-8322-9510; Chatterjee, Arghya/0000-0002-2895-6085; Sahoo, Nihar Ranjan/0000-0003-4518-6630; Kisel, Ivan/0000-0002-4808-419X; Alekseev, Igor G/0000-0003-3358-9635; Sumbera, Michal/0000-0002-0639-7323; Pawlik, Bogdan/0000-0003-1197-5180; Fulek, Lukasz/0000-0002-9606-5954; Sikora, Rafał/0000-0001-5185-2367; singha, subhash/0000-0002-3952-3648; Okorokov, Vitaly/0000-0002-7162-5345; Zhao, Jie/0000-0001-6408-2314; Nigmatkulov, Grigory/0000-0003-2232-5124; Lednicky, Richard/0000-0001-6887-1804; Kumar, Lokesh/0000-0002-2746-9840; Kabana, Sonia/0000-0003-0568-5750; Ashraf, Muhammad Usman/0000-0001-8855-8348; YANG, CHI/0000-0001-9976-8631; Yi, Li/0000-0002-7512-2657; Chattopadhyay, Subhasis/0000-0003-1097-8806; Chang, Zilong/0000-0003-4729-8708; Thomas, James/0000-0002-6256-4536; Ma, Yu-Gang/0000-0002-0233-9900; Abdelrahman, Niseem/0000-0002-6458-6552; Finch, Evan/0000-0002-6150-8612; Rogachevsky, Oleg/0000-0002-1539-8096; Federic, Pavol/0000-0001-5137-473X; Tripathy, Srikanta Kumar/0000-0002-9367-0884; Sorensen, Paul/0000-0001-5056-9391; Todoroki, Takahito/0000-0001-6475-7174; Chakaberia, Irakli/0000-0002-9614-4046; Evdokimov, Olga/0000-0002-1250-8931; Aparin, Alexey/0000-0002-2421-7517; Trzeciak, Barbara/0000-0002-8672-2295; Kikola, Daniel/0000-0001-6896-6475; Adamczyk, Leszek/0000-0002-5859-2075; Luo, Xiaofeng/0000-0002-4919-303X; Vossen, Anselm/0000-0003-0983-4936; M. Hamed, Ahmed/0000-0003-1732-8443; Yip, Kin/0000-0002-8576-4311; Fisyak, Yuri/0000-0002-3151-8377; Geurts, Frank/0000-0003-2856-9090; Bairathi, Vipul/0000-0003-3415-6911	RHIC Operations Group; RCF at Brookhaven National Laboratory; NERSC Center at Lawrence Berkeley National Laboratory; Open Science Grid consortium; Office of Nuclear Physics within the US Department of Energy Office of Science; US National Science Foundation; Ministry of Education and Science of the Russian Federation; National Natural Science Foundation of China; Chinese Academy of Science; Ministry of Science and Technology of China; Chinese Ministry of Education; National Research Foundation of Korea; GA of the Czech Republic; MSMT of the Czech Republic; Department of Atomic Energy; Department of Science and Technology of the Government of India; National Science Centre of Poland; National Research Foundation; Ministry of Science, Education and Sports of Croatia; RosAtom of Russia; Direct For Mathematical & Physical Scien [1613939] Funding Source: National Science Foundation	RHIC Operations Group; RCF at Brookhaven National Laboratory; NERSC Center at Lawrence Berkeley National Laboratory; Open Science Grid consortium; Office of Nuclear Physics within the US Department of Energy Office of Science(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); National Research Foundation of Korea(National Research Foundation of Korea); GA of the Czech Republic; MSMT of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Department of Atomic Energy(Department of Atomic Energy (DAE)); Department of Science and Technology of the Government of India(Department of Science & Technology (India)); National Science Centre of Poland(National Science Centre, Poland); National Research Foundation; Ministry of Science, Education and Sports of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); RosAtom of Russia; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the RHIC Operations Group and RCF at Brookhaven National Laboratory, the NERSC Center at Lawrence Berkeley National Laboratory, and the Open Science Grid consortium for providing resources and support. This work was supported in part by the Office of Nuclear Physics within the US Department of Energy Office of Science, the US National Science Foundation, the Ministry of Education and Science of the Russian Federation, the National Natural Science Foundation of China, the Chinese Academy of Science, the Ministry of Science and Technology of China and the Chinese Ministry of Education, the National Research Foundation of Korea, the GA and MSMT of the Czech Republic, Department of Atomic Energy and Department of Science and Technology of the Government of India, the National Science Centre of Poland, the National Research Foundation, the Ministry of Science, Education and Sports of Croatia, and RosAtom of Russia.	Abelev BI, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.024915; Ackermann KH, 2003, NUCL INSTRUM METH A, V499, P624, DOI 10.1016/S0168-9002(02)01960-5; Adamczyk L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.162301; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; Becattini F, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3624-1; Becattini F, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.034905; Becattini F, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.024906; Becattini F, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.054902; Betz B, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.044901; BUNCE G, 1976, PHYS REV LETT, V36, P1113, DOI 10.1103/PhysRevLett.36.1113; Choi DS, 2007, ICARUS, V188, P35, DOI 10.1016/j.icarus.2006.10.037; Csernai LP, 2014, J PHYS G NUCL PARTIC, V41, DOI 10.1088/0954-3899/41/12/124001; DONNELLY RJ, 1993, ANNU REV FLUID MECH, V25, P325; Gomez LF, 2014, SCIENCE, V345, P906, DOI 10.1126/science.1252395; Heinz U, 2013, ANNU REV NUCL PART S, V63, P123, DOI 10.1146/annurev-nucl-102212-170540; Jiang Y, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.044910; Kharzeev DE, 2016, PROG PART NUCL PHYS, V88, P1, DOI 10.1016/j.ppnp.2016.01.001; Kolb EW., 1990, EARLY UNIVERSE FRONT, V69, P1, DOI [10.1201/9780429492860, DOI 10.1201/9780429492860]; Komm R, 2007, ASTROPHYS J, V667, P571, DOI 10.1086/520765; Liang ZT, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.102301; Meuel T., 2013, SCI REP-UK, V3, P1; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Pang LG, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.192301; Perry CA, 2006, INT J CLIMATOL, V26, P207, DOI 10.1002/joc.1248; PONDROM LG, 1985, PHYS REP, V122, P57, DOI 10.1016/0370-1573(85)90049-3; SHURYAK EV, 1980, PHYS REP, V61, P71, DOI 10.1016/0370-1573(80)90105-2; Skokov VV, 2009, INT J MOD PHYS A, V24, P5925, DOI 10.1142/S0217751X09047570; Takahashi R, 2016, NAT PHYS, V12, P52, DOI [10.1038/nphys3526, 10.1038/NPHYS3526]; Voloshin SA, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.021901; Wurman J, 2007, MON WEATHER REV, V135, P2392, DOI 10.1175/MWR3404.1	30	361	364	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					62	+		10.1038/nature23004	http://dx.doi.org/10.1038/nature23004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770839	Green Submitted			2022-12-28	WOS:000406831700036
J	Hoffmann, C; Zimmermann, F; Biek, R; Kuehl, H; Nowak, K; Mundry, R; Agbor, A; Angedakin, S; Arandjelovic, M; Blankenburg, A; Brazolla, G; Corogenes, K; Couacy-Hymann, E; Deschner, T; Dieguez, P; Dierks, K; Dux, A; Dupke, S; Eshuis, H; Formenty, P; Yuh, YGI; Oedmakers, AG; Ogarten, JFG; Ranjon, ACG; McGraw, S; Runow, RG; Hart, J; Jones, S; Junker, J; Kiang, J; Langergraber, K; Lapuente, J; Lee, K; Leendertz, SA; Leguillon, F; Leinert, V; Lohrich, T; Marrocoli, S; Matz-Rensing, K; Meier, A; Merkel, K; Metzger, S; Murai, M; Niedorf, S; De Nys, H; Achse, AS; van Schijndel, J; Thiesen, U; Ton, E; Wu, D; Wieler, LH; Boesch, C; Klee, SR; Wittig, RM; Calvignac-Spencer, S; Leendertz, FH				Hoffmann, Constanze; Zimmermann, Fee; Biek, Roman; Kuehl, Hjalmar; Nowak, Kathrin; Mundry, Roger; Agbor, Anthony; Angedakin, Samuel; Arandjelovic, Mimi; Blankenburg, Anja; Brazolla, Gregory; Corogenes, Katherine; Couacy-Hymann, Emmanuel; Deschner, Tobias; Dieguez, Paula; Dierks, Karsten; Duex, Ariane; Dupke, Susann; Eshuis, Henk; Formenty, Pierre; Yuh, Yisa G. Inath; Oedmakers, Annemarie G.; Ogarten, Jan F. G.; Ranjon, Anne-Celine G.; McGraw, Scott; Runow, Roland G.; Hart, John; Jones, Sorrel; Junker, Jessica; Kiang, John; Langergraber, Kevin; Lapuente, Juan; Lee, Kevin; Leendertz, Siv Aina; Leguillon, Floraine; Leinert, Vera; Loehrich, Therese; Marrocoli, Sergio; Maetz-Rensing, Kerstin; Meier, Amelia; Merkel, Kevin; Metzger, Sonja; Murai, Mizuki; Niedorf, Svenja; De Nys, Helene; Achse, Andreas S.; van Schijndel, Joost; Thiesen, Ulla; Ton, Els; Wu, Doris; Wieler, Lothar H.; Boesch, Christophe; Klee, Silke R.; Wittig, Roman M.; Calvignac-Spencer, Sebastien; Leendertz, Fabian H.			Persistent anthrax as a major driver of wildlife mortality in a tropical rainforest	NATURE			English	Article							ANCIENT DNA EXTRACTION; BACILLUS-ANTHRACIS; OUTBREAK; PHYLOGENETICS; PERFORMANCE; EVOLUTION; FRAMEWORK	Anthrax is a globally important animal disease and zoonosis. Despite this, our current knowledge of anthrax ecology is largely limited to arid ecosystems, where outbreaks are most commonly reported(1-3). Here we show that the dynamics of an anthrax-causing agent, Bacillus cereus biovar anthracis, in a tropical rainforest have severe consequences for local wildlife communities. Using data and samples collected over three decades, we show that rainforest anthrax is a persistent and widespread cause of death for a broad range of mammalian hosts. We predict that this pathogen will accelerate the decline and possibly result in the extirpation of local chimpanzee (Pan troglodytes verus) populations. We present the epidemiology of a cryptic pathogen and show that its presence has important implications for conservation.	[Hoffmann, Constanze; Zimmermann, Fee; Nowak, Kathrin; Blankenburg, Anja; Duex, Ariane; Ogarten, Jan F. G.; Leendertz, Siv Aina; Leguillon, Floraine; Loehrich, Therese; Merkel, Kevin; Metzger, Sonja; Niedorf, Svenja; De Nys, Helene; Achse, Andreas S.; Thiesen, Ulla; Wu, Doris; Calvignac-Spencer, Sebastien; Leendertz, Fabian H.] Robert Koch Inst, Epidemiol Highly Pathogen Microorganisms P3, Seestr 10-11, D-13353 Berlin, Germany; [Zimmermann, Fee; Dupke, Susann; Runow, Roland G.; Klee, Silke R.] Robert Koch Inst, ZBS Ctr Biol Threats & Special Pathogens, Highly Pathogen Microorganisms, Seestr 10-11, D-13353 Berlin, Germany; [Biek, Roman] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Kuehl, Hjalmar; Mundry, Roger; Agbor, Anthony; Angedakin, Samuel; Arandjelovic, Mimi; Brazolla, Gregory; Corogenes, Katherine; Deschner, Tobias; Dieguez, Paula; Dierks, Karsten; Eshuis, Henk; Yuh, Yisa G. Inath; Ogarten, Jan F. G.; Ranjon, Anne-Celine G.; Jones, Sorrel; Junker, Jessica; Lapuente, Juan; Lee, Kevin; Loehrich, Therese; Marrocoli, Sergio; Meier, Amelia; Murai, Mizuki; De Nys, Helene; van Schijndel, Joost; Wu, Doris; Boesch, Christophe; Wittig, Roman M.] Max Planck Inst Evolutionary Anthropol MPI EVAN, Deutsch Pl 6, D-04103 Leipzig, Germany; [Couacy-Hymann, Emmanuel] LANADA LCVB, Bingerville 206, Cote Ivoire; [Formenty, Pierre] WHO, CH-1211 Geneva 27, Switzerland; [Oedmakers, Annemarie G.; Ton, Els] Chimbo Fdn, Amstel 49, NL-1011 PW Amsterdam, Netherlands; [Ogarten, Jan F. G.] McGill Univ, Dept Biol, 855 Sherbrooke St, West Montreal, PQ H3A 2T7, Canada; [McGraw, Scott] Ohio State Univ, Dept Anthropol, 4034 Smith Lab,174 West 18th Ave, Columbus, OH 43210 USA; [Hart, John] Lukuru Fdn, 1235 Ave Poids Lourds Quartier Kingabois, Kinshasa, DEM REP CONGO; [Kiang, John] Limbe Wildlife Ctr, Limbe, Cameroon; [Langergraber, Kevin] Arizona State Univ, POB 872402, Tempe, AZ 85287 USA; [Leinert, Vera] Wild Chimpanzee Fdn WCF, Deutsch Pl 6, D-04103 Leipzig, Germany; [Maetz-Rensing, Kerstin] German Primate Ctr, Kellnerweg 4, D-37077 Gottingen, Germany; [Wieler, Lothar H.] Robert Koch Inst, Seestr 10-11, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; University of Glasgow; World Health Organization; McGill University; University System of Ohio; Ohio State University; Arizona State University; Arizona State University-Tempe; Deutsches Primatenzentrum (DPZ); Robert Koch Institute	Leendertz, FH (corresponding author), Robert Koch Inst, Epidemiol Highly Pathogen Microorganisms P3, Seestr 10-11, D-13353 Berlin, Germany.	leendertzf@rki.de	Lapuente, Juan/ABG-3912-2021; Calvignac-Spencer, Sebastien/D-2313-2010; Leendertz, Fabian Hubertus/H-8902-2019; Düx, Ariane/HIK-1574-2022; Biek, Roman/AAT-8109-2020	Lapuente, Juan/0000-0002-6783-5585; Calvignac-Spencer, Sebastien/0000-0003-4834-0509; Düx, Ariane/0000-0003-1819-8556; Biek, Roman/0000-0003-3471-5357; Nowak, Kathrin/0000-0001-7537-5200; Zimmermann, Fee/0000-0003-0616-9758; Wieler, Lothar H./0000-0003-4365-3717; Arandjelovic, Mimi/0000-0001-8920-9684; De Nys, Helene Marie/0000-0002-2942-4531	German Research Council DFG [KL 2521/1-1]; Sonnenfeld-Stiftung; Max-Planck-Society; Krekeler Foundation	German Research Council DFG(German Research Foundation (DFG)); Sonnenfeld-Stiftung; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Krekeler Foundation	We thank the authorities in Cote d'Ivoire for long-term support, especially the Ministry of the Environment and Forests, the Ministry of Research, the directorship of the TNP and the CSRS in Abidjan; and national authorities from all other countries for providing permissions for our research (MINFoF, MINRESI, the Service de la Conservation de la Reserve du Dja, Cameroon, in Central African Republic; the Ministere des Eaux et Forets, Chasse et Peche and the Ministere de l'Education Nationale, de l'Alphabetisation, de l'Enseignement Superieur, et de la Recherche, the Agence Nationale des Parcs Nationaux, Gabon; Centre National de la Recherche Scientifique et Technologique, Gabon; Direction des Eaux, Forets et Chasses, Senegal; Forestry Development Authority, Liberia; Institut Congolais pour la Conservation de la Nature, Democratic Republic of the Congo; Ministere de l'Agriculture de l'Elevage et des Eaux et Forets, Guinea; Instituto da Biodiversidade e das Areas Protegidas (IBAP), Guinea-Bissau; Ministere de la Recherche Scientifique, Democratic Republic of the Congo; Ministere de le Recherche Scientifique et Technologique, Democratic Republic of the Congo; Nigeria National Park Service, Nigeria, Uganda National Council for Science and Technology, Ugandan Wildlife Authority, Uganda). We thank the WWF Central African Republic, T. Bording, T. Hicks, Y. Moebius, V. Sommer, K. Zuberbuhler and M. Peeters for their logistical support; the field assistants A. Henlin, K. Albrechtova and A. Lang for the collection of samples in TNP; and the field assistants from all other sites for their support; S. Becker, T. Franz, S. Howaldt, A. Lander, P. Lochau, H. Nattermann and A. Schneider for the laboratory work; J. Hinzmann, A. Nitsche and J. Tesch for sequencing; P. Wojciech Dabrowski and T. Semmler from RKI, as well as G. Hamilton at Glasgow Polyomics, for bioinformatic support; and M. Kovacev-Wegener for administrative support. We thank the German Research Council DFG KL 2521/1-1 and the Sonnenfeld-Stiftung for funding; and the Max-Planck-Society and Krekeler Foundation for funding of the Pan African Programme.	Antonation KS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004923; Baayen H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berry H.H., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P137; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Blackburn JK, 2014, VECTOR-BORNE ZOONOT, V14, P576, DOI 10.1089/vbz.2013.1538; Boesch C, 2000, CHIMPANZEES TAI FORE; Brezillon C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003455; Buffalo V., 2014, SCYTHE 3 END ADAPTER; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Clegg SB, 2007, VET REC, V160, P113, DOI 10.1136/vr.160.4.113; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Vos V., 1990, SALISBURY MED B S, V678, P19; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; Ersts P, 2011, GEOGRAPHIC DISTANCE; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gamba C, 2016, MOL ECOL RESOUR, V16, P459, DOI 10.1111/1755-0998.12470; Good KM, 2008, J WILDLIFE DIS, V44, P721, DOI 10.7589/0090-3558-44.3.721; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hampson K, 2011, J APPL ECOL, V48, P1333, DOI 10.1111/j.1365-2664.2011.02030.x; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Joshi N.A., 2011, SICKLE SLIDING WINDO; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kuehl HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002440; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Lembo T, 2011, EMERG INFECT DIS, V17, P387, DOI 10.3201/eid1703.101290; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muoria PK, 2007, AFR J ECOL, V45, P483, DOI 10.1111/j.1365-2028.2007.00758.x; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00; R Development Core Team, 2009, R LANG ENV STAT COMP; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Turnbull P. C. B., 1998, GUIDELINES SURVEILLA; Turnbull P. C. B., 2008, WHO GUIDELINES APPRO; TURNBULL PCB, 1991, VET REC, V128, P399, DOI 10.1136/vr.128.17.399; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vergnaud G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146216; Wafula MM, 2008, AFR J ECOL, V46, P24, DOI 10.1111/j.1365-2028.2007.00796.x	60	63	65	3	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					82	+		10.1038/nature23309	http://dx.doi.org/10.1038/nature23309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770842	Green Accepted			2022-12-28	WOS:000406831700041
J	Ledford, H				Ledford, Heidi			BIOTECHNOLOGY CRISPR fixes embryo error	NATURE			English	News Item							CAS9											Ma H., 2017, NATURE, V72, P1117; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Winblad N., 2017, NATURE	4	14	16	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					13	14		10.1038/nature.2017.22382	http://dx.doi.org/10.1038/nature.2017.22382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770860	Bronze			2022-12-28	WOS:000406831700006
J	Berry, MR; Mathews, RJ; Ferdinand, JR; Jing, CZ; Loudon, KW; Wlodek, E; Dennison, TW; Kuper, C; Neuhofer, W; Clatworthy, MR				Berry, Miriam R.; Mathews, Rebeccah J.; Ferdinand, John R.; Jing, Chenzhi; Loudon, Kevin W.; Wlodek, Elizabeth; Dennison, Thomas W.; Kuper, Christoph; Neuhofer, Wolfgang; Clatworthy, Menna R.			Renal Sodium Gradient Orchestrates a Dynamic Antibacterial Defense Zone	CELL			English	Article							DENDRITIC CELLS; ESCHERICHIA-COLI; MACROPHAGES; EXPRESSION; INDUCTION; MIGRATION; IMMUNITY; SKIN; RESISTANCE; MONOCYTES	Lower urinary tract infections are among the most common human bacterial infections, but extension to the kidneys is rare. This has been attributed to mechanical forces, such as urine flow, that prevent the ascent of bladder microbes. Here, we show that the regional hypersalinity, required for the kidney's urine-concentrating function, instructs epithelial cells to produce chemokines that localize monocyte-derived mononuclear phagocytes (MNPs) to the medulla. This hypersaline environment also increases the intrinsic bactericidal and neutrophil chemotactic activities of MNPs to generate a zone of defense. Because MNP positioning and function are dynamically regulated by the renal salt gradient, we find that patients with urinary concentrating defects are susceptible to kidney infection. Our work reveals a critical accessory role for the homeostatic function of a vital organ in optimizing tissue defense.	[Berry, Miriam R.; Mathews, Rebeccah J.; Ferdinand, John R.; Jing, Chenzhi; Loudon, Kevin W.; Wlodek, Elizabeth; Dennison, Thomas W.; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge CB2 0QQ, England; [Kuper, Christoph; Neuhofer, Wolfgang] Univ Munich, Dept Physiol, D-80336 Munich, Germany	University of Cambridge; University of Munich	Clatworthy, MR (corresponding author), Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge CB2 0QQ, England.	mrc38@cam.ac.uk	Jing, Chenzhi/AAY-9690-2020	Mathews, Rebeccah/0000-0002-3834-4744; Ferdinand, John Robert/0000-0003-0936-0128; Clatworthy, Menna/0000-0002-3340-9828	Medical Research Council/Kidney Research UK Research Training Fellowship [MR/K023934/1]; Evelyn Trust Clinical Research Fellowship; China Scholarship Council [201408060241]; National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre; NIHR Blood and Transplant Research Unit [NIHR BTRU-2014-10027]; Medical Research Council New Investigator Research Grant [MR/N024907/1]; MRC [MR/K023934/1, MR/N024907/1] Funding Source: UKRI; Kidney Research UK [JF1/2013] Funding Source: researchfish; Medical Research Council [MR/K023934/1, MR/N024907/1] Funding Source: researchfish	Medical Research Council/Kidney Research UK Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evelyn Trust Clinical Research Fellowship; China Scholarship Council(China Scholarship Council); National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Blood and Transplant Research Unit; Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Professor Lalita Ramakrishnan, Dr. Ronald Germain, Professor Kenneth Smith, Professor Paul Edelstein, and Mr. Steven Levitte for helpful discussions; Dr. Edward Banham-Hall, Mr. Keith Burling, Professor Donald Fraser, Mr. Michael Hope, Dr. Robert Jenkins, Dr. Darren Roberts, Dr. David Thomas, and Dr. Patrick Trotter for technical advice and assistance; Dr. Antonio Bravo-Blas and Dr. Elizabeth Mann for sharing murine tissue; Dr. Callum Bain and Professor Simon Jenkins for the kind gift of the CCR2<SUP>-/-</SUP> mice; the NIHR Cambridge BRC Cell Phenotyping Hub; The Evelyn Trust; Mr. Marcus Gregson; NHS Blood and Transplant; and all transplant coordinators, organ donors, and their families. M.R.B. is supported by a Medical Research Council/Kidney Research UK Research Training Fellowship (MR/K023934/1) and previously The Evelyn Trust Clinical Research Fellowship. C.J. is funded by the China Scholarship Council (201408060241). R.J.M. and M.R.C. are supported by the National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre; M.R.C. and J.R.F. are supported by the NIHR Blood and Transplant Research Unit (NIHR BTRU-2014-10027); and MRC is supported by a Medical Research Council New Investigator Research Grant (MR/N024907/1). The Molecular Immunity Unit is within the MRC Laboratory of Molecular Biology, and the authors are grateful for the use of the core facilities.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Berl T, 2015, NEW ENGL J MED, V373, P981, DOI 10.1056/NEJMc1508385; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Carey AJ, 2016, J INFECT DIS, V213, P659, DOI 10.1093/infdis/jiv424; Edwards B. R., 1981, KIDNEY DEV, P233; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godaly G, 2001, J LEUKOCYTE BIOL, V69, P899; GOTTSCHALK CW, 1959, AM J PHYSIOL, V196, P927, DOI 10.1152/ajplegacy.1959.196.4.927; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; HATCH FE, 1967, J CLIN INVEST, V46, P336, DOI 10.1172/JCI105535; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Ho SN, 2006, J CELL PHYSIOL, V206, P9, DOI 10.1002/jcp.20445; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klaus F, 2008, J PHYSIOL-LONDON, V586, P1539, DOI 10.1113/jphysiol.2007.146191; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Knepper MA, 2015, NEW ENGL J MED, V373, P196, DOI 10.1056/NEJMc1505505; KOEPSELL H, 1974, PFLUG ARCH EUR J PHY, V350, P167, DOI 10.1007/BF00586235; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kondo Yoshiaki, 2006, Clin Exp Nephrol, V10, P165, DOI 10.1007/s10157-006-0429-4; Kortenoeven MLA, 2013, AM J PHYSIOL-RENAL, V305, pF1705, DOI 10.1152/ajprenal.00723.2012; Kuper C, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00264; Kuper C, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00507; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; LEVITIN H, 1962, J CLIN INVEST, V41, P1145, DOI 10.1172/JCI104567; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Statius van Eps LW, 1970, LANCET, V1, P450; STEADMAN R, 1991, J INFECT DIS, V163, P1033, DOI 10.1093/infdis/163.5.1033; Svensson M, 2008, KIDNEY INT, V74, P81, DOI 10.1038/ki.2008.105; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Zhang WC, 2015, CELL RES, V25, P893, DOI 10.1038/cr.2015.87	57	85	85	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					860	+	874.e19	10.1016/j.cell.2017.07.022	http://dx.doi.org/10.1016/j.cell.2017.07.022			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28803730	Bronze, Green Submitted			2022-12-28	WOS:000408372400007
J	Frazier, W; Cochran, G; Lo-Ciganic, WH; Gellad, WF; Gordon, AJ; Chang, CCH; Donohue, JM				Frazier, Winfred; Cochran, Gerald; Lo-Ciganic, Wei-Hsuan; Gellad, Walid F.; Gordon, Adam J.; Chang, Chung-Chou H.; Donohue, Julie M.			Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Frazier, Winfred; Donohue, Julie M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, 130 DeSoto St,Crabtree Hall,A635, Pittsburgh, PA 15261 USA; [Cochran, Gerald] Univ Pittsburgh, Sch Social Work, Pittsburgh, PA 15260 USA; [Lo-Ciganic, Wei-Hsuan] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Gordon, Adam J.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Donohue, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, 130 DeSoto St,Crabtree Hall,A635, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu	Gordon, Adam Joseph/AAX-9001-2020	Gordon, Adam Joseph/0000-0002-2453-8871	Centers for Disease Control and Prevention (CDC) [U01CE002496]; Pennsylvania Department of Human Services (PADHS); University of Pittsburgh; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [U01CE002496] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pennsylvania Department of Human Services (PADHS); University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by grant U01CE002496 from the Centers for Disease Control and Prevention (CDC) and an intergovernmental agreement between the Pennsylvania Department of Human Services (PADHS) and the University of Pittsburgh.	D'Onofrio G, 2017, J GEN INTERN MED, V32, P660, DOI 10.1007/s11606-017-3993-2; Kampman K, 2015, J ADDICT MED, V9, P358, DOI 10.1097/ADM.0000000000000166; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; Naeger S, 2016, J SUBST ABUSE TREAT, V69, P64, DOI 10.1016/j.jsat.2016.07.004; Seymour RB, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0352-x; Sharp MJ, 2015, MMWR-MORBID MORTAL W, V64, P377	6	40	40	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					750	752		10.1001/jama.2017.7818	http://dx.doi.org/10.1001/jama.2017.7818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829862	Green Published			2022-12-28	WOS:000408095800029
J	Voelker, R				Voelker, Rebecca			Professional Jobs Linked With ALS and Parkinson Disease Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					691	691		10.1001/jama.2017.10459	http://dx.doi.org/10.1001/jama.2017.10459			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829883				2022-12-28	WOS:000408095800011
J	Vennes, S; Nemeth, P; Kawka, A; Thorstensen, JR; Khalack, V; Ferrario, L; Alper, EH				Vennes, S.; Nemeth, P.; Kawka, A.; Thorstensen, J. R.; Khalack, V.; Ferrario, L.; Alper, E. H.			An unusual white dwarf star may be a surviving remnant of a subluminous Type Ia supernova	SCIENCE			English	Article							EVOLUTION; MODEL; HYPERVELOCITY; BINARIES; LAMBDA	Subluminous Type Ia supernovae, such as the Type Iax-class prototype SN 2002cx, are described by a variety of models such as the failed detonation and partial deflagration of an accreting carbon-oxygen white dwarf star or the explosion of an accreting, hybrid carbon-oxygen-neon core. These models predict that bound remnants survive such events with, according to some simulations, a high kick velocity. We report the discovery of a high proper motion, low-mass white dwarf (LP 40-365) that travels at a velocity greater than the Galactic escape velocity and whose peculiar atmosphere is dominated by intermediate-mass elements. Strong evidence indicates that this partially burnt remnant was ejected following a subluminous Type Ia supernova event. This supports the viability of single-degenerate supernova progenitors.	[Vennes, S.; Kawka, A.] Akad Ceske Republ, Astron Ustav, Fricova 298, CZ-25165 Ondrejov, Czech Republic; [Nemeth, P.] Univ Erlangen Nurnberg, Dr Karl Remeis Sternwarte Astron Inst, Sternwartstr 7, D-96049 Bamberg, Germany; [Nemeth, P.] Astroserver Org, H-8533 Malomsok, Hungary; [Thorstensen, J. R.; Alper, E. H.] Dartmouth Coll, Dept Phys & Astron, 6127 Wilder Lab, Hanover, NH 03755 USA; [Khalack, V.] Univ Moncton, Dept Phys & Astron, Moncton, NB E1A 3E9, Canada; [Ferrario, L.] Australian Natl Univ, Math Sci Inst, Canberra, ACT 0200, Australia	Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; University of Erlangen Nuremberg; Dartmouth College; University of Moncton; Australian National University	Vennes, S (corresponding author), Akad Ceske Republ, Astron Ustav, Fricova 298, CZ-25165 Ondrejov, Czech Republic.	vennes@asu.cas.cz	Vennes, Stephane/G-9903-2014; Nemeth, Peter/E-4515-2016; Ferrario, Lilia/K-4029-2016; Kawka, Adela/G-9899-2014	Nemeth, Peter/0000-0003-0963-0239; Ferrario, Lilia/0000-0002-0485-0518; Kawka, Adela/0000-0002-4485-6471; Vennes, Stephane/0000-0001-6860-0158; Thorstensen, John/0000-0002-4964-4144; Alper, Erek/0000-0002-2923-7840	Grant Agency of the Czech Republic [15-15943S]; European Community [312430]; NSF [AST-1008217];  [RVO: 67985815];  [GN-2016A-FT-24]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Community(European Commission); NSF(National Science Foundation (NSF)); ; 	A.K. and S.V. acknowledge support from the Grant Agency of the Czech Republic (15-15943S). A.K. was a visiting astronomer at KPNO, National Optical Astronomy Observatory. This work was also supported by the project RVO: 67985815 in the Czech Republic. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2013-2016) under grant agreement number 312430 [Optical Infrared Coordination Network for Astronomy (OPTICON)]. J.R.T. acknowledges support from NSF grant AST-1008217. This research made use of services at Astroserver.org under the reference number NWKZKA and is based on observations obtained at KPNO, National Optical Astronomy Observatory, and at the Gemini Observatory, program GN-2016A-FT-24, using ESPaDOnS, located at the CFHT. This publication makes use of data products from the Wide-field Infrared Survey Explorer, the Two Micron All-Sky Survey, and the American Association of Variable Sky Observers (AAVSO) Photometric All-Sky Survey (APASS). Complete acknowledgments are included in the supplementary material. Observational data are available in publicly available archives, as are our calculated model atmospheres. Full details and URLs are given in the supplementary material.	ALLEN C, 1991, REV MEX ASTRON ASTR, V22, P255; Althaus LG, 1997, ASTROPHYS J, V477, P313, DOI 10.1086/303686; Benvenuto OG, 1999, MON NOT R ASTRON SOC, V303, P30, DOI 10.1046/j.1365-8711.1999.02215.x; Branch D, 2004, PUBL ASTRON SOC PAC, V116, P903, DOI 10.1086/425081; Bravo E, 2016, ASTRON ASTROPHYS, V589, DOI 10.1051/0004-6361/201527861; Brown WR, 2015, ANNU REV ASTRON ASTR, V53, P15, DOI 10.1146/annurev-astro-082214-122230; Doherty CL, 2015, MON NOT R ASTRON SOC, V446, P2599, DOI 10.1093/mnras/stu2180; Fink M, 2014, MON NOT R ASTRON SOC, V438, P1762, DOI 10.1093/mnras/stt2315; Foley RJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/29; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Freire PCC, 2011, MON NOT R ASTRON SOC, V412, P2763, DOI 10.1111/j.1365-2966.2010.18109.x; Geier S, 2015, SCIENCE, V347, P1126, DOI 10.1126/science.1259063; Gianninas A, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/35; HILLS JG, 1988, NATURE, V331, P687, DOI 10.1038/331687a0; HUBENY I, 1995, ASTROPHYS J, V439, P875, DOI 10.1086/175226; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; JOHNSON DRH, 1987, ASTRON J, V93, P864, DOI 10.1086/114370; Jordan GC, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/2/L23; Justham S, 2009, ASTRON ASTROPHYS, V493, P1081, DOI 10.1051/0004-6361:200810106; Kepler SO, 2016, SCIENCE, V352, P67, DOI 10.1126/science.aad6705; Kromer M, 2015, MON NOT R ASTRON SOC, V450, P3045, DOI 10.1093/mnras/stv886; Kromer M, 2013, MON NOT R ASTRON SOC, V429, P2287, DOI 10.1093/mnras/sts498; Lepine S, 2005, ASTRON J, V129, P1483, DOI 10.1086/427854; Luyten W J, 1970, PROPER MOTION SURVEY; Maoz D, 2014, ANNU REV ASTRON ASTR, V52, P107, DOI 10.1146/annurev-astro-082812-141031; McCully C, 2014, NATURE, V512, P54, DOI 10.1038/nature13615; Nomoto K, 1997, SCIENCE, V276, P1378, DOI 10.1126/science.276.5317.1378; Panei JA, 2000, ASTRON ASTROPHYS, V353, P970; PAQUETTE C, 1986, ASTROPHYS J SUPPL S, V61, P197, DOI 10.1086/191112; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Perryman MAC, 2001, ASTRON ASTROPHYS, V369, P339, DOI 10.1051/0004-6361:20010085; Portegies Zwart S, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/55; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Wang B, 2012, NEW ASTRON REV, V56, P122, DOI 10.1016/j.newar.2012.04.001; Watson C. L, 2016, VIZIER ONLINE DATA C	35	50	50	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					680	+		10.1126/science.aam8378	http://dx.doi.org/10.1126/science.aam8378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818942	Green Submitted			2022-12-28	WOS:000407793600033
J	LaCasce, AS; Flores, EJ; Goldstein, RH; Sohani, AR				LaCasce, Ann S.; Flores, Efren J.; Goldstein, Robert H.; Sohani, Aliyah R.			Case 25-2017: A 45-Year-Old Man with Headache, Fever, and Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LYMPHOMA; INFECTIOUS-MONONUCLEOSIS; CASTLEMAN DISEASE		[LaCasce, Ann S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Flores, Efren J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Goldstein, Robert H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [LaCasce, Ann S.; Goldstein, Robert H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Flores, Efren J.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Sohani, Aliyah R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LaCasce, AS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; LaCasce, AS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.			Flores, Efren/0000-0003-1398-0426	Forty-Seven; Seattle Genetics; Bristol-Myers Squibb	Forty-Seven; Seattle Genetics; Bristol-Myers Squibb(Bristol-Myers Squibb)	Dr. LaCasce reports receiving fees for serving on an advisory board from Forty-Seven and Seattle Genetics and fees for serving on a data and safety monitoring board from Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Auwaerter PG, 1999, JAMA-J AM MED ASSOC, V281, P454, DOI 10.1001/jama.281.5.454; Fajgenbaum DC, 2017, BLOOD, V129, P1646, DOI 10.1182/blood-2016-10-746933; Federico M, 2013, J CLIN ONCOL, V31, P240, DOI 10.1200/JCO.2011.37.3647; Louissaint A, 2012, MODERN PATHOL, V25, P1149, DOI 10.1038/modpathol.2012.70; Lunning MA, 2017, BLOOD, V129, P1095, DOI 10.1182/blood-2016-09-692541; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Quintanilla-Martinez L., 2017, HEMATOPATHOLOGY, P153; Rosenthal NS, 2017, HEMATOPATHOLOGY, P235; Weisberger J, 2003, AM J CLIN PATHOL, V120, P49, DOI 10.1309/VC7M24UC5VG7EUEC; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x; Yu L, 2017, BLOOD, V129, P1658, DOI 10.1182/blood-2016-11-748855	11	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					677	688		10.1056/NEJMcpc1706099	http://dx.doi.org/10.1056/NEJMcpc1706099			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7FG	28813220				2022-12-28	WOS:000407691400012
J	Ohnaka, K; Weigelt, G; Hofmann, KH				Ohnaka, K.; Weigelt, G.; Hofmann, K. -H.			Vigorous atmospheric motion in the red supergiant star Antares	NATURE			English	Article							1ST OVERTONE LINES; ALPHA-ORIONIS; DYNAMICAL ATMOSPHERE; EXTENDED ATMOSPHERE; INTERFEROMETRIC OBSERVATIONS; DATA REDUCTION; MU CEPHEI; BETELGEUSE; VLTI/AMBER; SURFACE	Red supergiant stars represent a late stage of the evolution of stars more massive than about nine solar masses, in which they develop complex, multi-component atmospheres. Bright spots have been detected in the atmosphere of red supergiants using interferometric imaging(1-5). Above the photosphere of a red supergiant, the molecular outer atmosphere extends up to about two stellar radii(6-14). Furthermore, the hot chromosphere (5,000 to 8,000 kelvin) and cool gas (less than 3,500 kelvin) of a red supergiant coexist at about three stellar radii(15-18). The dynamics of such complex atmospheres has been probed by ultraviolet and optical spectroscopy(19-22). The most direct approach, however, is to measure the velocity of gas at each position over the image of stars as in observations of the Sun. Here we report the mapping of the velocity field over the surface and atmosphere of the nearby red supergiant Antares. The two-dimensional velocity field map obtained from our near-infrared spectro-interferometric imaging reveals vigorous upwelling and downdrafting motions of several huge gas clumps at velocities ranging from about -20 to +20 kilometres per second in the atmosphere, which extends out to about 1.7 stellar radii. Convection alone cannot explain the observed turbulent motions and atmospheric extension, suggesting that an unidentified process is operating in the extended atmosphere.	[Ohnaka, K.] Univ Catolica Norte, Inst Astron, Ave Angamos 0610, Antofagasta, Chile; [Weigelt, G.; Hofmann, K. -H.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany	Universidad Catolica del Norte; Max Planck Society	Ohnaka, K (corresponding author), Univ Catolica Norte, Inst Astron, Ave Angamos 0610, Antofagasta, Chile.	k1.ohnaka@gmail.com			Universidad Catolica del Norte; VLTI of the ESO [093.D-0468A/B]	Universidad Catolica del Norte; VLTI of the ESO	We thank the ESO VLTI team for supporting our VLTI/AMBER observations. This work is based on AMBER observations made with the VLTI of the ESO (program ID: 093.D-0468A/B). K.O. acknowledges the grant from the Universidad Catolica del Norte.	Arroyo-Torres B, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425212; Baron F, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/46; Burns D, 1997, MON NOT R ASTRON SOC, V290, pL11, DOI 10.1093/mnras/290.1.L11; BUSCHER DF, 1990, MON NOT R ASTRON SOC, V245, pP7; Chelli A, 2009, ASTRON ASTROPHYS, V502, P705, DOI 10.1051/0004-6361/200811039; Chiavassa A, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117463; Efron B., 1994, MONOGRAPHS STAT APPL; Gilliland RL, 1996, ASTROPHYS J, V463, pL29, DOI 10.1086/310043; Gray DF, 2008, ASTRON J, V135, P1450, DOI 10.1088/0004-6256/135/4/1450; Gray DF, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/4/92; Harper GM, 2001, ASTROPHYS J, V551, P1073, DOI 10.1086/320215; Harper GM, 2006, ASTROPHYS J, V646, P1179, DOI 10.1086/505073; Harper GM, 2009, ASTROPHYS J, V701, P1464, DOI 10.1088/0004-637X/701/2/1464; Haubois X, 2009, ASTRON ASTROPHYS, V508, P923, DOI 10.1051/0004-6361/200912927; Hestroffer D, 1997, ASTRON ASTROPHYS, V327, P199; Josselin E, 2007, ASTRON ASTROPHYS, V469, P671, DOI 10.1051/0004-6361:20066353; Kervella P, 2003, ASTRON ASTROPHYS, V404, P1087, DOI 10.1051/0004-6361:20030570; Lim J, 1998, NATURE, V392, P575, DOI 10.1038/33352; Lobel A, 2001, ASTROPHYS J, V558, P815, DOI 10.1086/322284; Lobel A, 2000, ASTROPHYS J, V545, P454, DOI 10.1086/317784; Millour F, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201016193; Montarges M, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527028; Montarges M, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423538; Ohnaka K, 2004, ASTRON ASTROPHYS, V421, P1149, DOI 10.1051/0004-6361.20035668; Ohnaka K, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321063; Ohnaka K, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016279; Ohnaka K, 2009, ASTRON ASTROPHYS, V503, P183, DOI 10.1051/0004-6361/200912247; Perrin G, 2004, ASTRON ASTROPHYS, V418, P675, DOI 10.1051/0004-6361:20040052; Petrov RG, 2007, ASTRON ASTROPHYS, V464, P1, DOI 10.1051/0004-6361:20066496; Tatulli E, 2007, ASTRON ASTROPHYS, V464, P29, DOI 10.1051/0004-6361:20064799; Thiebaut E, 2008, PROC SPIE, V7013, DOI 10.1117/12.788822; Tsuji T, 2000, ASTROPHYS J, V538, P801, DOI 10.1086/309185; Tsuji T, 2000, ASTROPHYS J, V540, pL99, DOI 10.1086/312879; Tuthill PG, 1997, MON NOT R ASTRON SOC, V285, P529, DOI 10.1093/mnras/285.3.529; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Young JS, 2000, MON NOT R ASTRON SOC, V315, P635, DOI 10.1046/j.1365-8711.2000.03438.x	36	32	32	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					310	+		10.1038/nature23445	http://dx.doi.org/10.1038/nature23445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816248	Green Submitted			2022-12-28	WOS:000407748400027
J	Cushman, WC; Johnson, KC; Applegate, WB; Cutler, JA				Cushman, William C.; Johnson, Karen C.; Applegate, William B.; Cutler, Jeffrey A.			Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cushman, William C.] Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Applegate, William B.] Wake Forest Univ, Winston Salem, NC 27109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University	Cushman, WC (corresponding author), Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA.				Eli Lilly	Eli Lilly(Eli Lilly)	All authors are investigators in SPRINT. Dr. Cushman is an uncompensated consultant for Takeda and Novartis and has an institutional grant with Eli Lilly. The content is solely the responsibility of the authors and does not necessarily represent the official views of the SPRINT Research Group, National Institutes of Health, U.S. Department of Veterans Affairs, or U.S. government.	[Anonymous], 1991, JAMA-J AM MED ASSOC, V265, P3255, DOI [DOI 10.1001/JAMA.1991.03460240051027, 10.1001/jama.1991.03460240051027]; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					290	291		10.7326/L17-0284	http://dx.doi.org/10.7326/L17-0284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806805				2022-12-28	WOS:000407797500025
J	Fekete, T				Fekete, Thomas			Dexamethasone did not increase resolution of acute sore throat symptoms at 24 hours	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fekete, Thomas] Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022						0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC16	JC16		10.7326/ACPJC-2017-167-4-016	http://dx.doi.org/10.7326/ACPJC-2017-167-4-016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806797				2022-12-28	WOS:000407797500004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The cult of CPR	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Sokol DK, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i26	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2017	358								j3831	10.1136/bmj.j3831	http://dx.doi.org/10.1136/bmj.j3831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BX	28811291	Green Published, Bronze			2022-12-28	WOS:000408228100002
J	Slavitt, A; Wilensky, G				Slavitt, Andy; Wilensky, Gail			Reforming Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Slavitt, Andy; Wilensky, Gail] Bipartisan Policy Ctr, Initiat Future Hlth care, Washington, DC 20005 USA; [Slavitt, Andy] Ctr Medicare & Medicaid Serv President Obama Slav, Baltimore, MD USA; [Wilensky, Gail] Project HOPE, Bethesda, MD 20814 USA		Slavitt, A (corresponding author), Bipartisan Policy Ctr, Initiat Future Hlth care, Washington, DC 20005 USA.; Slavitt, A (corresponding author), Ctr Medicare & Medicaid Serv President Obama Slav, Baltimore, MD USA.	andy.slavitt@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					601	602		10.1001/jama.2017.10341	http://dx.doi.org/10.1001/jama.2017.10341			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810011				2022-12-28	WOS:000407616000002
J	Cohen, SP; Hooten, WM				Cohen, Steven P.; Hooten, W. Michael			Advances in the diagnosis and management of neck pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOW-BACK-PAIN; SPONDYLOTIC CERVICAL MYELOPATHY; 2000-2010 TASK-FORCE; WHIPLASH-ASSOCIATED DISORDERS; MYOFASCIAL TRIGGER POINTS; INTERLAMINAR EPIDURAL INJECTIONS; RANDOMIZED CONTROLLED-TRIALS; BOTULINUM TOXIN INJECTION; DISC ARTHROPLASTY CDA; TERM-FOLLOW-UP	Neck pain imposes a considerable personal and socioeconomic burden-it is one of the top five chronic pain conditions in terms of prevalence and years lost to disability-yet it receives a fraction of the research funding given to low back pain. Although most acute episodes resolve spontaneously, more than a third of affected people still have low grade symptoms or recurrences more than one year later, with genetics and psychosocial factors being risk factors for persistence. Nearly half of people with chronic neck pain have mixed neuropathic-nociceptive symptoms or predominantly neuropathic symptoms. Few clinical trials are dedicated solely to neck pain. Muscle relaxants and non-steroidal anti-inflammatory drugs are effective for acute neck pain, and clinical practice is mostly guided by the results of studies performed for other chronic pain conditions. Among complementary and alternative treatments, the strongest evidence is for exercise, with weaker evidence supporting massage, acupuncture, yoga, and spinal manipulation in different contexts. For cervical radiculopathy and facet arthropathy, weak evidence supports epidural steroid injections and radiofrequency denervation, respectively. Surgery is more effective than conservative treatment in the short term but not in the long term for most of these patients, and clinical observation is a reasonable strategy before surgery.	[Cohen, Steven P.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21029 USA; [Cohen, Steven P.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21029 USA; [Cohen, Steven P.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21029 USA; [Cohen, Steven P.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20889 USA; [Hooten, W. Michael] Mayo Clin, Sch Med, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; Mayo Clinic	Cohen, SP (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21029 USA.; Cohen, SP (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21029 USA.; Cohen, SP (corresponding author), Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21029 USA.; Cohen, SP (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20889 USA.	scohen40@jhmi.edu			Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences	Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences	Funded in part by the Centers for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences.	Adams MA, 2015, CLIN ANAT, V28, P195, DOI 10.1002/ca.22404; Ainpradub K, 2016, MANUAL THER, V22, P31, DOI 10.1016/j.math.2015.10.012; Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; American Association of Electrodiagnostic Medicine, 1999, Muscle Nerve Suppl, V8, pS209; Anderberg L, 2007, EUR SPINE J, V16, P321, DOI 10.1007/s00586-006-0142-8; Ashkan K, 2002, BRIT J NEUROSURG, V16, P146, DOI 10.1080/02688690220131741; Audette JF, 2004, AM J PHYS MED REHAB, V83, P368, DOI 10.1097/01.PHM.0000118037.61143.7C; BARNSLEY L, 1994, NEW ENGL J MED, V330, P1047, DOI 10.1056/NEJM199404143301504; BARNSLEY L, 1993, CLIN J PAIN, V9, P124, DOI 10.1097/00002508-199306000-00007; BARNSLEY L, 1995, SPINE, V20, P20, DOI 10.1097/00007632-199501000-00004; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Bednarik J, 2008, EUR SPINE J, V17, P421, DOI 10.1007/s00586-008-0585-1; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; BERRY H, 1981, RHEUMATOL REHABIL, V20, P46, DOI 10.1093/rheumatology/20.1.46; Bertozzi L, 2013, PHYS THER, V93, P1026, DOI 10.2522/ptj.20120412; Bicket MC, 2013, ANESTHESIOLOGY, V119, P907, DOI 10.1097/ALN.0b013e31829c2ddd; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; BOGDUK N, 1993, PAIN, V54, P213, DOI 10.1016/0304-3959(93)90211-7; Bogduk N, 2001, CLIN BIOMECH, V16, P267, DOI 10.1016/S0268-0033(01)00003-1; Bogduk N, 2000, PAIN MED, V1, P24, DOI 10.1046/j.1526-4637.2000.99104.x; Bogduk N, 1997, CLIN J PAIN, V13, P285, DOI 10.1097/00002508-199712000-00003; Bogduk N, 2013, PRACTICE GUIDELINES, P65; Bono CM, 2011, SPINE J, V11, P64, DOI 10.1016/j.spinee.2010.10.023; Borenstein DG, 2003, CLIN THER, V25, P1056, DOI 10.1016/S0149-2918(03)80067-X; Boswell MV, 2015, PAIN PHYSICIAN, V18, pE497; Brison RJ, 2005, SPINE, V30, P1799, DOI 10.1097/01.brs.0000174115.58954.17; Bronfort G, 2012, ANN INTERN MED, V156, P1, DOI 10.7326/0003-4819-156-1-201201030-00002; BYRN C, 1993, LANCET, V341, P449, DOI 10.1016/0140-6736(93)90204-T; Cannon DE, 2007, ARCH PHYS MED REHAB, V88, P1256, DOI 10.1016/j.apmr.2007.07.010; Carragee EJ, 2008, SPINE, V33, pS153, DOI 10.1097/BRS.0b013e31816445ea; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Chiarotto A, 2016, ARCH PHYS MED REHAB, V97, P316, DOI 10.1016/j.apmr.2015.09.021; Christensen JO, 2014, PAIN, V155, P1262, DOI 10.1016/j.pain.2014.03.021; Cohen SP, 2015, MAYO CLIN PROC, V90, P284, DOI 10.1016/j.mayocp.2014.09.008; Cohen SP, 2014, ANESTHESIOLOGY, V121, P1045, DOI 10.1097/ALN.0000000000000409; Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Cohen SP, 2013, NAT REV RHEUMATOL, V9, P101, DOI 10.1038/nrrheum.2012.198; Cohen SP, 2010, ANESTHESIOLOGY, V113, P395, DOI 10.1097/ALN.0b013e3181e33ae5; CONNOR PM, 1993, SPINE, V18, P2035, DOI 10.1097/00007632-199310001-00018; Cook CE, 2007, PHYS THER, V87, P1233, DOI 10.2522/ptj.20060150; Cooper KL, 2013, COMPLEMENT THER CLIN, V19, P214, DOI 10.1016/j.ctcp.2013.06.006; Cote P, 2009, J MANIP PHYSIOL THER, V32, pS70, DOI 10.1016/j.jmpt.2008.11.012; Cramer H, 2017, CLIN REHABI IN PRESS; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; Cronin DS, 2014, J MECH BEHAV BIOMED, V33, P55, DOI 10.1016/j.jmbbm.2013.01.006; Cunningham MRA, 2010, SPINE, V35, P537, DOI 10.1097/BRS.0b013e3181b204cc; De Gregori M, 2016, J PAIN RES, V9, P1179, DOI 10.2147/JPR.S115068; DePalma MJ, 2016, BRADDOMS PHYS MED RE, P687; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Dressler Dirk, 2004, Suppl Clin Neurophysiol, V57, P159; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; El Sissi W, 2010, J INT MED RES, V38, P2135, DOI 10.1177/147323001003800629; Engquist M, 2017, J NEUROSURG-SPINE, V26, P19, DOI 10.3171/2016.6.SPINE151427; Falco FJE, 2012, PAIN PHYSICIAN, V15, pE807; Fehlings MG, 2013, SPINE, V38, pS19, DOI 10.1097/BRS.0b013e3182a7f4de; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fernandez-Carnero J, 2017, AM J PHYS MED REHAB, V96, P733, DOI 10.1097/PHM.0000000000000733; Ferrante FM, 2005, ANESTHESIOLOGY, V103, P377, DOI 10.1097/00000542-200508000-00021; Fice JB, 2012, J BIOMECH, V45, P1098, DOI 10.1016/j.jbiomech.2012.01.016; Fishbain DA, 2014, PAIN MED, V15, P4, DOI 10.1111/pme.12229; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Fukui S, 1996, PAIN, V68, P79, DOI 10.1016/S0304-3959(96)03173-9; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub2; Ghasemi M, 2013, J RES MED SCI, V18, pS35; Gobel H, 2006, PAIN, V125, P82, DOI 10.1016/j.pain.2006.05.001; GORE DR, 1987, SPINE, V12, P1, DOI 10.1097/00007632-198701000-00001; Graham N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006408.pub2; Gross AR, 2016, MANUAL THER, V24, P25, DOI 10.1016/j.math.2016.04.005; Gross A, 2010, MANUAL THER, V15, P315, DOI 10.1016/j.math.2010.04.002; Grubb SA, 2000, SPINE, V25, P1382, DOI 10.1097/00007632-200006010-00010; Haroutiunian S, 2010, PAIN MED, V11, P535, DOI 10.1111/j.1526-4637.2010.00809.x; Harris PE, 2012, INT J CLIN PRACT, V66, P924, DOI 10.1111/j.1742-1241.2012.02945.x; Hedlund R, 2016, SPINE J, V16, P579, DOI 10.1016/j.spinee.2015.08.065; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; HOLT EP, 1964, JAMA-J AM MED ASSOC, V188, P799; Hong S, 2016, J PHYS THER SCI, V28, P218, DOI [10.1589/jpts.28.218, 10.1589/jpts.28.2171]; Hsieh LF, 2010, J PAIN SYMPTOM MANAG, V39, P116, DOI 10.1016/j.jpainsymman.2009.05.016; Hu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149312; Hubach P C, 1994, Eur Spine J, V3, P209, DOI 10.1007/BF02221594; Iencean SM, 2000, ACTA NEUROCHIR, V142, P669, DOI 10.1007/s007010070111; Jacobs W, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008326.pub2; Jaeger Bernadette, 2013, Alpha Omegan, V106, P14; Jamison DE, 2016, PAIN 2016 REFRESHER, P151; Joaquim AF, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.10.FOCUS16354; Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030; Kaaria S, 2012, EUR J PAIN, V16, P911, DOI 10.1002/j.1532-2149.2011.00065.x; Kadanka Z, 2005, EUR J NEUROL, V12, P55, DOI 10.1111/j.1468-1331.2004.00896.x; Kadanka Z, 2002, SPINE, V27, P2205, DOI 10.1097/00007632-200210150-00003; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Kadanka Z, 2011, EUR SPINE J, V20, P1533, DOI 10.1007/s00586-011-1811-9; Kamanli A, 2005, RHEUMATOL INT, V25, P604, DOI 10.1007/s00296-004-0485-6; KAMWENDO K, 1991, SCAND J REHABIL MED, V23, P143; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Karlsson A, 2016, J ORTHOP SPORT PHYS, V46, P886, DOI 10.2519/jospt.2016.6553; Kelly JC, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/393642; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Khot A, 2004, SPINE, V29, P833, DOI 10.1097/00007632-200404150-00002; KIKUCHI S, 1981, J BONE JOINT SURG BR, V63, P272, DOI 10.1302/0301-620X.63B2.7217155; Kim HJ, 2016, ASIAN SPINE J, V10, P231, DOI 10.4184/asj.2016.10.2.231; King W, 2007, SPINE J, V7, P22, DOI 10.1016/j.spinee.2006.07.009; Kiralp M. Zeki, 2006, Pain Clinic, V18, P63, DOI 10.1163/156856906775249794; KONDO K, 1981, MINN MED, V64, P751; Kong LJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/613279; Kongsted A, 2008, EUR SPINE J, V17, P996, DOI 10.1007/s00586-008-0687-9; Kotsenas AL, 2012, RADIOL CLIN N AM, V50, P705, DOI 10.1016/j.rcl.2012.04.008; Kroeling P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004251.pub5; Kuan TS, 2009, CURR PAIN HEADACHE R, V13, P365, DOI 10.1007/s11916-009-0059-0; Kuijper B, 2011, J NEUROL NEUROSUR PS, V82, P561, DOI 10.1136/jnnp.2010.217182; Kwanchuay Photsawee, 2015, Journal of the Medical Association of Thailand, V98, P1231; Lebl DR, 2015, J AM ACAD ORTHOP SUR, V23, P648, DOI 10.5435/JAAOS-D-14-00250; Lee MJ, 2009, SPINE J, V9, P711, DOI 10.1016/j.spinee.2009.04.016; Lee TH, 2013, J KOREAN NEUROSURG S, V53, P89, DOI 10.3340/jkns.2013.53.2.89; LEHTO IJ, 1994, NEURORADIOLOGY, V36, P49, DOI 10.1007/BF00599196; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Liu R, 2017, REGION ANESTH PAIN M, V42, P52, DOI 10.1097/AAP.0000000000000505; Lluch E, 2015, J MANIP PHYSIOL THER, V38, P587, DOI 10.1016/j.jmpt.2015.08.004; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; LORD SM, 1995, CLIN J PAIN, V11, P208, DOI 10.1097/00002508-199509000-00008; Lu Y, 2014, SPINE, V39, P1314, DOI 10.1097/BRS.0000000000000401; MacVicar J, 2012, PAIN MED, V13, P647, DOI 10.1111/j.1526-4637.2012.01351.x; Maher DP, 2017, ANESTH ANALG, V124, P661, DOI 10.1213/ANE.0000000000001787; MAIGNE JY, 1994, SPINE, V19, P189, DOI 10.1097/00007632-199401001-00013; Malanga Gerard A, 2003, Pain Physician, V6, P199; Malik Khalid M, 2015, Anesth Pain Med, V5, pe28110, DOI 10.5812/aapm.28110; Manchikanti L, 2014, INT J MED SCI, V11, P309, DOI 10.7150/ijms.8069; Manchikanti L, 2013, PAIN PHYSICIAN, V16, P465; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pS49; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pE59; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P13; Maroufi N, 2011, J MAZANDARAN U MED S, V21, P38; Mathieson S, 2017, NEW ENGL J MED, V376, P1111, DOI 10.1056/NEJMoa1614292; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Matsumoto M, 2001, SPINE, V26, P1592, DOI 10.1097/00007632-200107150-00021; McCleane GJ, 2001, PAIN CLINIC, V13, P103, DOI 10.1163/156856901753420945; Melancia Joao Levy, 2014, Handb Clin Neurol, V119, P541, DOI 10.1016/B978-0-7020-4086-3.00035-7; Michaleff ZA, 2014, LANCET, V384, P133, DOI 10.1016/S0140-6736(14)60457-8; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Narayanaswami P, 2016, NEUROLOGY, V86, P218, DOI 10.1212/WNL.0000000000002292; Narouze SN, 2007, PAIN MED, V8, P184, DOI 10.1111/j.1526-4637.2006.00247.x; Nevalainen MT, 2016, CLIN RADIOL, V71, P570, DOI 10.1016/j.crad.2016.02.026; Nguyen C, 2017, ANN INTERN MED; Nicol AL, 2014, ANESTH ANALG, V118, P1326, DOI 10.1213/ANE.0000000000000192; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Ojala T, 2006, CLIN J PAIN, V22, P90, DOI 10.1097/01.ajp.0000151871.51406.c3; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Onyewu O, 2012, PAIN PHYSICIAN, V15, pE777; Pandya S K, 1972, Neurol India, V20, P13; Pecos-Martin D, 2015, ARCH PHYS MED REHAB, V96, P775, DOI 10.1016/j.apmr.2014.12.016; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; Predel HG, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-250; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao Raj, 2003, Instr Course Lect, V52, P479; Rathmell JP, 2015, ANESTHESIOLOGY, V122, P974, DOI 10.1097/ALN.0000000000000614; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Rothman SM, 2010, ANN BIOMED ENG, V38, P2563, DOI 10.1007/s10439-010-0012-8; Rubinstein SM, 2007, EUR SPINE J, V16, P307, DOI 10.1007/s00586-006-0225-6; SADASIVAN KK, 1993, YALE J BIOL MED, V66, P235; Salemi G, 1996, ACTA NEUROL SCAND, V93, P184; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Sari H, 2012, EUR J PHYS REHAB MED, V48, P237; Sasso WR, 2017, SPINE, V42, P209, DOI 10.1097/BRS.0000000000001746; Schoenfeld AJ, 2012, J SPINAL DISORD TECH, V25, P17, DOI 10.1097/BSD.0b013e31820d77ea; Schofferman J, 2007, J AM ACAD ORTHOP SUR, V15, P596, DOI 10.5435/00124635-200710000-00004; Schutz U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027991; Schukro RP, 2016, ANESTHESIOLOGY, V124, P150, DOI 10.1097/ALN.0000000000000902; Scott NA, 2009, PAIN MED, V10, P54, DOI 10.1111/j.1526-4637.2008.00526.x; Shimomura T, 2007, SPINE, V32, P2474, DOI 10.1097/BRS.0b013e3181573aee; Sierink JC, 2013, EUR J RADIOL, V82, P974, DOI 10.1016/j.ejrad.2013.02.009; Southerst D, 2016, SPINE J, V16, P1503, DOI 10.1016/j.spinee.2014.02.014; STAV A, 1993, ACTA ANAESTH SCAND, V37, P562, DOI 10.1111/j.1399-6576.1993.tb03765.x; Sterling M, 2015, PAIN, V156, P635, DOI 10.1097/01.j.pain.0000460359.40116.c1; Stewart MJ, 2007, PAIN, V128, P59, DOI 10.1016/j.pain.2006.08.030; Stoker GE, 2013, J SPINAL DISORD TECH, V26, P444, DOI 10.1097/BSD.0b013e31825c36c0; Stovner LJ, 2004, CEPHALALGIA, V24, P821, DOI 10.1111/j.1468-2982.2004.00773.x; Taheri Navid, 2016, Ortop Traumatol Rehabil, V18, P149, DOI 10.5604/15093492.1205022; TAKALA EP, 1994, SCAND J REHABIL MED, V26, P17; Tetreault L, 2016, J NEUROSURG-SPINE, V24, P77, DOI 10.3171/2015.3.SPINE14971; TRACsa: Trauma and Injury Recovery South Australia, 2008, CLIN GUID BEST PRACT; Uriell ML, 2017, INJURY, V48, P133, DOI 10.1016/j.injury.2016.10.031; van Eerd M, 2014, PAIN PRACT, V14, P8, DOI 10.1111/papr.12043; Van Zundert J, 2007, PAIN, V127, P173, DOI 10.1016/j.pain.2006.09.002; Vasseljen O, 2013, PAIN, V154, P1237, DOI 10.1016/j.pain.2013.03.032; Vos CJ, 2008, PAIN MED, V9, P572, DOI 10.1111/j.1526-4637.2008.00456.x; Wei G, 2016, INT ORTHOP, V40, P2533, DOI 10.1007/s00264-016-3220-5; Wei X, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9519285; Wheeler AH, 1998, SPINE, V23, P1662, DOI 10.1097/00007632-199808010-00009; Wong JJ, 2014, SPINE J, V14, P1781, DOI 10.1016/j.spinee.2014.02.032; Woodhouse A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1326-5; Wytrazek M, 2011, FUNCT NEUROL, V26, P141; Xie L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2851-8; Yap EC, 2007, ANN ACAD MED SINGAP, V36, P43; Yin W, 2008, PAIN MED, V9, P196, DOI 10.1111/j.1526-4637.2007.00369.x; Yuan Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130209; Zhu LG, 2016, CLIN REHABIL, V30, P145, DOI 10.1177/0269215515570382; Zou SH, 2017, EUR SPINE J, V26, P985, DOI 10.1007/s00586-016-4655-5	200	104	110	2	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2017	358								j3221	10.1136/bmj.j3221	http://dx.doi.org/10.1136/bmj.j3221			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BV	28807894				2022-12-28	WOS:000408227900001
J	Bloschl, G; Hall, J; Parajka, J; Perdigao, RAP; Merz, B; Arheimer, B; Aronica, GT; Bilibashi, A; Bonacci, O; Borga, M; Canjevac, I; Castellarin, A; Chirico, GB; Claps, P; Fiala, K; Frolova, N; Gorbachova, L; Gul, A; Hannaford, J; Harrigan, S; Kireeva, M; Kiss, A; Kjeldsen, TR; Kohnova, S; Koskela, JJ; Ledvinka, O; Macdonald, N; Mavrova-Guirguinova, M; Mediero, L; Merz, R; Molnar, P; Montanari, A; Murphy, C; Osuch, M; Ovcharuk, V; Radevski, I; Rogger, M; Salinas, JL; Sauquet, E; Sraj, M; Szolgay, J; Viglione, A; Volpi, E; Wilson, D; Zaimi, K; Zivkovic, N				Bloeschl, Guenter; Hall, Julia; Parajka, Juraj; Perdigao, Rui A. P.; Merz, Bruno; Arheimer, Berit; Aronica, Giuseppe T.; Bilibashi, Ardian; Bonacci, Ognjen; Borga, Marco; Canjevac, Ivan; Castellarin, Attilio; Chirico, Giovanni B.; Claps, Pierluigi; Fiala, Kayroly; Frolova, Natalia; Gorbachova, Liudmyla; Gul, Ali; Hannaford, Jamie; Harrigan, Shaun; Kireeva, Maria; Kiss, Andrea; Kjeldsen, Thomas R.; Kohnova, Silvia; Koskela, Jarkko J.; Ledvinka, Ondrej; Macdonald, Neil; Mavrova-Guirguinova, Maria; Mediero, Luis; Merz, Ralf; Molnar, Peter; Montanari, Alberto; Murphy, Conor; Osuch, Marzena; Ovcharuk, Valeryia; Radevski, Ivan; Rogger, Magdalena; Salinas, Jose L.; Sauquet, Eric; Sraj, Mojca; Szolgay, Jan; Viglione, Alberto; Volpi, Elena; Wilson, Donna; Zaimi, Klodian; Zivkovic, Nenad			Changing climate shifts timing of European floods	SCIENCE			English	Article							LARGE-SCALE; TRENDS	A warming climate is expected to have an impact on the magnitude and timing of river floods; however, no consistent large-scale climate change signal in observed flood magnitudes has been identified so far. We analyzed the timing of river floods in Europe over the past five decades, using a pan-European database from 4262 observational hydrometric stations, and found clear patterns of change in flood timing. Warmer temperatures have led to earlier spring snowmelt floods throughout northeastern Europe; delayed winter storms associated with polar warming have led to later winter floods around the North Sea and some sectors of the Mediterranean coast; and earlier soil moisture maxima have led to earlier winter floods in western Europe. Our results highlight the existence of a clear climate signal in flood observations at the continental scale.	[Bloeschl, Guenter; Hall, Julia; Parajka, Juraj; Perdigao, Rui A. P.; Kiss, Andrea; Rogger, Magdalena; Salinas, Jose L.; Viglione, Alberto] Vienna Univ Technol, Inst Hydraul Engn & Water Resources Managem, Vienna, Austria; [Merz, Bruno] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Potsdam, Germany; [Arheimer, Berit] Swedish Meteorol & Hydrol Inst, Norrkoping, Sweden; [Aronica, Giuseppe T.] Univ Messina, Dept Engn, Messina, Italy; [Bilibashi, Ardian] Renewable Energy Syst Technol, Control Syst Engn, Tirana, Albania; [Bonacci, Ognjen] Split Univ, Fac Civil Engn Architecture & Geodesy, Split, Croatia; [Borga, Marco] Univ Padua, Dept Land Environm Agr & Forestry, Padua, Italy; [Canjevac, Ivan] Univ Zagreb, Fac Sci, Dept Geog, Zagreb, Croatia; [Castellarin, Attilio; Montanari, Alberto] Univ Bologna, Dept Civil Chem Environm & Mat Engn DICAM, Bologna, Italy; [Chirico, Giovanni B.] Univ Naples Federico II, Dept Agr Sci, Naples, Italy; [Claps, Pierluigi] Politecn Torino, Dept Environm Land & Infrastruct Engn DIATI, Turin, Italy; [Fiala, Kayroly] Lower Tisza Dist Water Directorate, Szeged, Hungary; [Frolova, Natalia; Kireeva, Maria] Lomonosov Moscow State Univ, Dept Land Hydrol, Moscow, Russia; [Gorbachova, Liudmyla] Ukrainian Hydrometeorol Inst, Dept Hydrol Res, Kiev, Ukraine; [Gul, Ali] Dokuz Eylul Univ, Dept Civil Engn, Izmir, Turkey; [Hannaford, Jamie; Harrigan, Shaun] Ctr Ecol Hydrol, Wallingford, Oxon, England; [Kjeldsen, Thomas R.] Univ Bath, Dept Architecture & Civil Engn, Bath, Avon, England; [Kohnova, Silvia; Szolgay, Jan] Slovak Univ Technol Bratislava, Fac Civil Engn, Dept Land & Water Resources Management, Bratislava 81005, Slovakia; [Koskela, Jarkko J.] Finnish Environm Inst, Helsinki, Finland; [Ledvinka, Ondrej] Czech Hydrometeorol Inst, Prague, Czech Republic; [Macdonald, Neil] Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England; [Macdonald, Neil] Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England; [Mavrova-Guirguinova, Maria] Univ Architecture, Civil Engn & Geodesy Sofia, Sofia, Bulgaria; [Mediero, Luis] Tech Univ Madrid, Dept Civil Engn Hydraul Energy & Environm, Madrid, Spain; [Merz, Ralf] UFZ Helmholtz Ctr Environm Res, Dept Catchment Hydrol, Halle, Germany; [Molnar, Peter] ETH, Inst Environm Engn, Zurich, Switzerland; [Murphy, Conor] Maynooth Univ, Irish Climate Anal & Res Units, Dept Geog, Maynooth, Kildare, Ireland; [Osuch, Marzena] Polish Acad Sci, Inst Geophys, Dept Hydrol & Hydrodynam, Warsaw, Poland; [Ovcharuk, Valeryia] Odessa State Environm Univ, Hydrometeorol Inst, Odessa, Ukraine; [Radevski, Ivan] Ss Cyril & Methodius Univ, Fac Nat Sci & Math, Inst Geog, Skopje, Macedonia; [Sauquet, Eric] UR HHLY, Irstea, Hydrology Hydraul Res Unit, Lyon, France; [Sraj, Mojca] Univ Ljubljana, Fac Civil & Geodet Engn, Ljubljana, Slovenia; [Volpi, Elena] Univ Rome Tre, Dept Engn, Rome, Italy; [Wilson, Donna] Norwegian Water Resources & Energy Directorate, Oslo, Norway; [Zaimi, Klodian] Polytechn Univ Tirana, Inst Geo Sci Energy Water & Environm, Tirana, Albania; [Zivkovic, Nenad] Univ Belgrade, Fac Geog, Belgrade, Serbia	Technische Universitat Wien; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Swedish Meteorological & Hydrological Institute; University of Messina; University of Split; University of Padua; University of Zagreb; University of Bologna; University of Naples Federico II; Polytechnic University of Turin; Lomonosov Moscow State University; National Academy of Sciences Ukraine; Ukrainian Hydrometeorological Institute of the State Emergency Service of Ukraine & National Academy of Sciences of Ukraine; Dokuz Eylul University; UK Centre for Ecology & Hydrology (UKCEH); University of Bath; Slovak University of Technology Bratislava; Finnish Environment Institute; Czech Hydrometeorological Institute; University of Liverpool; University of Liverpool; University of Architecture & Civil Engineering - Bulgaria; Universidad Politecnica de Madrid; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Maynooth University; Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences; Ministry of Education & Science of Ukraine; Odessa State Environmental University; Saints Cyril & Methodius University of Skopje; INRAE; University of Ljubljana; Roma Tre University; Norwegian Water Resources & Energy Directorate; University of Tirana (UT); University of Belgrade	Bloschl, G (corresponding author), Vienna Univ Technol, Inst Hydraul Engn & Water Resources Managem, Vienna, Austria.	bloeschl@hydro.tuwien.ac.at	Hall, Julia/F-2651-2015; Frolova, Natalia/AAT-2671-2020; Castellarin, Attilio/B-2508-2009; Radevski, Ivan/C-9154-2014; Viglione, Alberto/M-4860-2017; Parajka, Juraj/AAI-6778-2020; Claps, Pierluigi/F-5081-2012; Kohnova, Silvia/AAC-4930-2019; Harrigan, Shaun/X-5048-2019; Bonacci, Ognjen/D-5814-2017; Radevski, Ivan/N-3004-2019; Ledvinka, Ondrej/M-4579-2016; Kohnova, Silvia/GLT-0065-2022; Radevski, Ivan/HGE-4913-2022; Sraj, Mojca/I-3502-2019; Montanari, Alberto/B-5427-2009; Perdigão, Rui A. P./K-9896-2015; Molnar, Peter/F-3066-2013; Szolgay, Jan/AAC-5336-2019; Gorbachova, Liudmyla/AAB-9162-2020; Ovcharuk, Valeriya A/H-3953-2018; Merz, Ralf/N-7614-2014; Macdonald, Neil/ABD-6120-2021; Gül, Ali/Q-1054-2019; Ovcharuk, Valeriya A/B-6240-2016; Čanjevac, Ivan/AAA-6432-2022; Mediero, Luis/K-6430-2014; Borga, Marco/C-6697-2014; Ovcharuk, Valeriya/Q-8215-2019; Zaimi, Klodian/GVS-3765-2022; Hannaford, Jamie/I-6095-2012; Frolova, Natalia L./E-2775-2012; Kireeva, Maria/B-2482-2014; Zaimi, Klodian/GWU-9487-2022	Hall, Julia/0000-0002-4242-2020; Frolova, Natalia/0000-0003-3576-285X; Castellarin, Attilio/0000-0002-6111-0612; Radevski, Ivan/0000-0003-4408-4691; Viglione, Alberto/0000-0002-7587-4832; Parajka, Juraj/0000-0002-1177-5181; Claps, Pierluigi/0000-0002-9624-7408; Harrigan, Shaun/0000-0002-0992-3667; Bonacci, Ognjen/0000-0002-7123-3421; Ledvinka, Ondrej/0000-0002-0203-7064; Sraj, Mojca/0000-0001-7796-5618; Montanari, Alberto/0000-0001-7428-0410; Perdigão, Rui A. P./0000-0001-5543-1754; Molnar, Peter/0000-0001-6437-4931; Szolgay, Jan/0000-0003-4348-3332; Gorbachova, Liudmyla/0000-0003-1033-9385; Ovcharuk, Valeriya A/0000-0003-1638-841X; Merz, Ralf/0000-0002-3698-2339; Macdonald, Neil/0000-0003-0350-7096; Gül, Ali/0000-0001-8137-8950; Ovcharuk, Valeriya A/0000-0001-5654-3731; Mediero, Luis/0000-0002-9346-6592; Borga, Marco/0000-0003-3435-2779; Ovcharuk, Valeriya/0000-0001-5654-3731; Hannaford, Jamie/0000-0002-5256-3310; Kireeva, Maria/0000-0002-8285-9761; Sauquet, Eric/0000-0001-9539-7730; Zaimi, Klodian/0000-0003-0495-586X; Kiss, Andrea/0000-0003-4254-2759; Volpi, Elena/0000-0002-9511-1496; Zivkovic, Nenad/0000-0002-2731-2835; Kjeldsen, Thomas Rodding/0000-0001-9423-5203; Murphy, Conor/0000-0003-4891-2650; Merz, Bruno/0000-0002-5992-1440; Arheimer, Berit/0000-0001-8314-0735; Aronica, Giuseppe Tito/0000-0003-0485-6466; Chirico, Giovanni Battista/0000-0002-9536-4741	ERC [291152]; Austrian Science Funds (FWF) as part of the Doctoral Programme on Water Resource Systems [W1219-N22]; EU [603587]; Russian Science Foundation [14-17-00155]; Russian Science Foundation [17-17-00013] Funding Source: Russian Science Foundation	ERC(European Research Council (ERC)European Commission); Austrian Science Funds (FWF) as part of the Doctoral Programme on Water Resource Systems(Austrian Science Fund (FWF)); EU(European Commission); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Supported by ERC Advanced Grant "FloodChange," project no. 291152; the Austrian Science Funds (FWF) as part of the Doctoral Programme on Water Resource Systems (W1219-N22); the EU FP7 project SWITCH-ON (grant 603587); and Russian Science Foundation project no. 14-17-00155. We acknowledge the involvement in the data screening process of C. Alvaro Diaz, I. Borzi, E. Diamantini, K. Jeneiova, M. Kupfersberger, and S. Mallucci during their stays at the Vienna University of Technology. We thank L. Gaal and D. Rosbjerg for contacting Finish and Danish data holders, respectively; A. Christofides for pointing us to the Greek data source; B. Renard (France), T. Kiss (Hungary), W. Rigott (South Tyrol, Italy), G. Lindstrom (Sweden), and P. Burlando (Switzerland) for assistance in preparing and/or providing data or metadata from their respective regions; and B. Luthi and Y. Hundecha for preparing supporting data that are not part of the paper, to cross-check the results. The flood date data used in this paper can be downloaded from www.hydro.tuwien.ac.at/fileadmin/mediapool-hydro/Downloads/Data.zip. The precipitation and temperature data can be downloaded from www.ecad.eu/download/ensembles/ensembles.php. The soil moisture data can be downloaded from www.esrl.noaa.gov/psd.	[Anonymous], 2015, MAK DEV SUST FUT DIS; Arheimer B, 2015, HYDROL EARTH SYST SC, V19, P771, DOI 10.5194/hess-19-771-2015; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bayliss A.C., 1993, PEAKS OVER THRESHOLD; Draveniece A, 2009, BOREAL ENVIRON RES, V14, P89; Gillett NP, 2008, NAT GEOSCI, V1, P750, DOI 10.1038/ngeo338; Hall J, 2014, HYDROL EARTH SYST SC, V18, P2735, DOI 10.5194/hess-18-2735-2014; Hanna E, 2015, INT J CLIMATOL, V35, P2540, DOI 10.1002/joc.4157; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; IPCC, 2012, MAN RISKS EXTR EV DI; Ivancan-Picek B, 2014, NAT HAZARDS, V72, P1231, DOI 10.1007/s11069-014-1066-y; Klaus S, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-6096-1; Kundzewicz Z.W, 2012, CHANGES FLOOD RISK E; Merz R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001952; Mudelsee M, 2003, NATURE, V425, P166, DOI 10.1038/nature01928; Parajka J, 2010, J HYDROL, V394, P78, DOI 10.1016/j.jhydrol.2010.05.015; Sarauskiene D, 2015, J ENVIRON ENG LANDSC, V23, P28, DOI 10.3846/16486897.2014.937438; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sivapalan M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003439; Wilson D, 2010, J HYDROL, V394, P334, DOI 10.1016/j.jhydrol.2010.09.010; Winsemius HC, 2016, NAT CLIM CHANGE, V6, P381, DOI [10.1038/nclimate2893, 10.1038/NCLIMATE2893]; Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0	22	405	413	27	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					588	590		10.1126/science.aan2506	http://dx.doi.org/10.1126/science.aan2506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798129	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000407324800040
J	Schmidt, C				Schmidt, Charles			DRUG DEVELOPMENT Children with cancer get more access to experimental drugs	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					540	540		10.1126/science.357.6351.540	http://dx.doi.org/10.1126/science.357.6351.540			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798112				2022-12-28	WOS:000407324800019
J	Spang, A; Caceres, EF; Ettema, TJG				Spang, Anja; Caceres, Eva F.; Ettema, Thijs J. G.			MICROBIAL GENOMICS Genomic exploration of the diversity, ecology, and evolution of the archaeal domain of life	SCIENCE			English	Review							MARINE SUBSURFACE SEDIMENTS; YELLOWSTONE-NATIONAL-PARK; WOOD-LJUNGDAHL PATHWAY; DEEP-SEA ARCHAEA; METHANE OXIDATION; METHANOTROPHIC ARCHAEA; ANAEROBIC OXIDATION; EXPRESSION ANALYSES; PHYLOGENETIC TREES; ORTHOLOGOUS GENES	About 40 years ago, Archaea were recognized as a major prokaryotic domain of life besides Bacteria. Recently, cultivation-independent sequencing methods have produced a wealth of genomic data for previously unidentified archaeal lineages, several of which appear to represent newly revealed branches in the tree of life. Analyses of some recently obtained genomes have uncovered previously unknown metabolic traits and provided insights into the evolution of archaea and their relationship to eukaryotes. On the basis of our current understanding, much archaeal diversity still defies genomic exploration. Efforts to obtain and study genomes and enrichment cultures of uncultivated microbial lineages will likely further expand our knowledge about archaeal phylogenetic and metabolic diversity and their cell biology and ecological function.	[Spang, Anja; Caceres, Eva F.; Ettema, Thijs J. G.] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden	Uppsala University	Ettema, TJG (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden.	thijs.ettema@icm.uu.se		Ettema, Thijs/0000-0002-6898-6377; Spang, Anja/0000-0002-6518-8556	European Research Council (ERC) [310039-PUZZLE_CELL]; Swedish Foundation for Strategic Research [SSF-FFL5]; Swedish Research Council (VR) [2015-04959]	European Research Council (ERC)(European Research Council (ERC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council)	We thank the anonymous reviewers for providing constructive comments that helped improve the clarity of this manuscript. We also acknowledge all those researchers that have contributed to this field and whose literature could not be cited because of space restrictions. The work in the T.J.G.E. laboratory is supported by grants from the European Research Council (ERC Starting Grant 310039-PUZZLE_CELL), the Swedish Foundation for Strategic Research (SSF-FFL5), and the Swedish Research Council (VR grant 2015-04959).	Baker BJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.2, 10.1038/nmicrobiol.2016.2]; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Becker EA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004784; Bird JT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01221; Blank CE, 2009, ASTROBIOLOGY, V9, P193, DOI 10.1089/ast.2008.0248; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Borrel G, 2016, GENOME BIOL EVOL, V8, P1706, DOI 10.1093/gbe/evw114; Borrel G, 2013, GENOME BIOL EVOL, V5, P1769, DOI 10.1093/gbe/evt128; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; Deschamps P, 2014, GENOME BIOL EVOL, V6, P1549, DOI 10.1093/gbe/evu127; Durbin AM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00168; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Eloe-Fadrosh EA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.32, 10.1038/nmicrobiol.2015.32]; Evans PN, 2015, SCIENCE, V350, P434, DOI 10.1126/science.aac7745; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Gribaldo S, 2012, TRENDS MICROBIOL, V20, P209, DOI 10.1016/j.tim.2012.02.006; Groussin M, 2016, MOL BIOL EVOL, V33, P305, DOI 10.1093/molbev/msv249; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Guy L, 2014, ISME J, V8, P1353, DOI 10.1038/ismej.2014.6; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; He Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.35, 10.1038/NMICROBIOL.2016.35]; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; KANDLER O, 1977, ARCH MICROBIOL, V113, P57, DOI 10.1007/BF00428580; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klinger CM, 2016, MOL BIOL EVOL, V33, P1528, DOI 10.1093/molbev/msw034; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Koonin Eugene V, 2016, F1000Res, V5, DOI 10.12688/f1000research.8737.1; Kozubal MA, 2013, ISME J, V7, P622, DOI 10.1038/ismej.2012.132; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LANGWORTHY TA, 1972, J BACTERIOL, V112, P1193, DOI 10.1128/JB.112.3.1193-1200.1972; Laso-Perez R, 2016, NATURE, V539, P396, DOI 10.1038/nature20152; Lazar CS, 2017, ISME J, V11, P1118, DOI 10.1038/ismej.2016.189; Lazar CS, 2016, ENVIRON MICROBIOL, V18, P1200, DOI 10.1111/1462-2920.13142; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9933; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lopez-Garcia P, 2015, TRENDS ECOL EVOL, V30, P697, DOI 10.1016/j.tree.2015.09.005; Lopez-Garcia P, 2015, NAT REV MICROBIOL, V13, P447, DOI 10.1038/nrmicro3485; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Mwirichia R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19181; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Nobu MK, 2016, ISME J, V10, P2478, DOI 10.1038/ismej.2016.33; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Oren A, 2014, EXTREMOPHILES, V18, P825, DOI 10.1007/s00792-014-0654-9; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Petitjean C, 2015, GENOME BIOL EVOL, V7, P191, DOI 10.1093/gbe/evu274; Podar M, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-9; Probst AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6497; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Raymann K, 2015, P NATL ACAD SCI USA, V112, P6670, DOI 10.1073/pnas.1420858112; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rout MP, 2017, ANNU REV BIOCHEM, V86, P637, DOI 10.1146/annurev-biochem-061516-044643; Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Seitz KW, 2016, ISME J, V10, P1696, DOI 10.1038/ismej.2015.233; Sorokin DY, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.81; Sorokin DY, 2016, ISME J, V10, P240, DOI 10.1038/ismej.2015.79; Sousa FL, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.34, 10.1038/nmicrobiol.2016.34]; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; STANIER RY, 1962, ARCH MIKROBIOL, V42, P17, DOI 10.1007/BF00425185; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Surkont J, 2016, MOL BIOL EVOL, V33, P1833, DOI 10.1093/molbev/msw061; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Vanwonterghem I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.170, 10.1038/nmicrobiol.2016.170]; Vavourakis CD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00211; Wegener G, 2015, NATURE, V526, P587, DOI 10.1038/nature15733; Williams TA, 2017, P NATL ACAD SCI USA, V114, pE4602, DOI 10.1073/pnas.1618463114; Williams TA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0336; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Youssef NH, 2015, ISME J, V9, P447, DOI 10.1038/ismej.2014.141; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031; ZILLIG W, 1979, EUR J BIOCHEM, V96, P597, DOI 10.1111/j.1432-1033.1979.tb13074.x	103	159	166	13	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351							eaaf3883	10.1126/science.aaf3883	http://dx.doi.org/10.1126/science.aaf3883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798101				2022-12-28	WOS:000407324800034
J	Chan, KCA; Woo, JKS; King, A; Zee, BCY; Lam, WKJ; Chan, SL; Chu, SWI; Mak, C; Tse, IOL; Leung, SYM; Chan, G; Hui, EP; Ma, BBY; Chiu, RWK; Leung, SF; van Hasselt, AC; Chan, ATC; Lo, YMD				Chan, K. C. Allen; Woo, John K. S.; King, Ann; Zee, Benny C. Y.; Lam, W. K. Jacky; Chan, Stephen L.; Chu, Sam W. I.; Mak, Constance; Tse, Irene O. L.; Leung, Samantha Y. M.; Chan, Gloria; Hui, Edwin P.; Ma, Brigette B. Y.; Chiu, Rossa W. K.; Leung, Sing-Fai; van Hasselt, Andrew C.; Chan, Anthony T. C.; Lo, Y. M. Dennis			Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY NUMBER ABERRATIONS; EBV DNA; CARCINOMA; LYMPHOMA; MARKER; TRENDS; SERUM; RISK	BACKGROUND Circulating cell-free Epstein-Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to screen for early nasopharyngeal carcinoma in asymptomatic persons. METHODS We analyzed EBV DNA in plasma specimens to screen participants who did not have symptoms of nasopharyngeal carcinoma. Participants with initially positive results were retested approximately 4 weeks later, and those with persistently positive EBV DNA in plasma underwent nasal endoscopic examination and magnetic resonance imaging (MRI). RESULTS A total of 20,174 participants underwent screening. EBV DNA was detectable in plasma samples obtained from 1112 participants (5.5%), and 309 (1.5% of all patients and 27.8% of those who initially tested positive) had persistently positive results on the repeated sample. Among these 309 participants, 300 underwent endoscopic examination, and 275 underwent both endoscopic examination and MRI; of these participants, 34 had nasopharyngeal carcinoma. A significantly higher proportion of participants with nasopharyngeal carcinoma that was identified by screening had stage I or II disease than in a historical cohort (71% vs. 20%, P<0.001 by the chi-square test) and had superior 3-year progression-free survival (97% vs. 70%; hazard ratio, 0.10; 95% confidence interval, 0.05 to 0.18). Nine participants declined to undergo further testing, and 1 of them presented with advanced nasopharyngeal carcinoma 32 months after enrollment. Nasopharyngeal carcinoma developed in only 1 participant with negative EBV DNA in plasma samples within 1 year after testing. The sensitivity and specificity of EBV DNA in plasma samples in screening for nasopharyngeal carcinoma were 97.1% and 98.6%, respectively. CONCLUSIONS Analysis of EBV DNA in plasma samples was useful in screening for early asymptomatic nasopharyngeal carcinoma. Nasopharyngeal carcinoma was detected significantly earlier and outcomes were better in participants who were identified by screening than in those in a historical cohort. (Funded by the Kadoorie Charitable Foundation and the Research Grants Council of the Hong Kong government; ClinicalTrials.gov number, NCT02063399.)	[Chan, K. C. Allen; Lam, W. K. Jacky; Chu, Sam W. I.; Mak, Constance; Tse, Irene O. L.; Leung, Samantha Y. M.; Chan, Gloria; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, K. C. Allen; Lam, W. K. Jacky; Chu, Sam W. I.; Mak, Constance; Tse, Irene O. L.; Leung, Samantha Y. M.; Chan, Gloria; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China; [Chan, K. C. Allen; Lam, W. K. Jacky; Chan, Stephen L.; Chu, Sam W. I.; Mak, Constance; Tse, Irene O. L.; Leung, Samantha Y. M.; Chan, Gloria; Hui, Edwin P.; Ma, Brigette B. Y.; Chiu, Rossa W. K.; Leung, Sing-Fai; van Hasselt, Andrew C.; Chan, Anthony T. C.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Oncol South China, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Woo, John K. S.; Lam, W. K. Jacky; van Hasselt, Andrew C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Hong Kong, Peoples R China; [King, Ann] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Zee, Benny C. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Jockey Club Sch Publ Hlth & Primary, Hong Kong, Hong Kong, Peoples R China; [Chan, Stephen L.; Hui, Edwin P.; Ma, Brigette B. Y.; Leung, Sing-Fai; Chan, Anthony T. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; State Key Lab Oncology South China; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	allen@cuhk.edu.hk; loym@cuhk.edu.hk	King, Ann D/C-9845-2011; Chan, Anthony Tak Cheung/R-3940-2018; Hui, Edwin/ABC-1818-2021; B.Y., Brigette/H-4681-2017; Zee, Benny Chung Ying/G-5606-2017; Lo, Yuk Ming Dennis/D-4468-2011; Chan, Stephen Lam/F-9149-2011; Lam, Jacky/AAD-6935-2020; Leung, Suet Yi/T-9620-2019	King, Ann D/0000-0002-5280-8349; Chan, Anthony Tak Cheung/0000-0002-6912-8091; B.Y., Brigette/0000-0003-4802-1102; Zee, Benny Chung Ying/0000-0002-7238-845X; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, Stephen Lam/0000-0001-8998-5480; Lam, Jacky/0000-0001-8922-5609; Leung, Suet Yi/0000-0001-8614-4619	Kadoorie Charitable Foundation; Research Grants Council of the Hong Kong government	Kadoorie Charitable Foundation; Research Grants Council of the Hong Kong government(Hong Kong Research Grants Council)	Funded by the Kadoorie Charitable Foundation and the Research Grants Council of the Hong Kong government; ClinicalTrials.gov number, NCT02063399.	ANDERSSONANVRET M, 1977, INT J CANCER, V20, P486, DOI 10.1002/ijc.2910200403; [Anonymous], 2010, AJCC CANC STAGING MA; Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Cai X, 2015, TRENDS GENET, V31, P564, DOI 10.1016/j.tig.2015.06.001; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2013, P NATL ACAD SCI USA, V110, P18761, DOI 10.1073/pnas.1313995110; Chan KCA, 2013, CANCER-AM CANCER SOC, V119, P1838, DOI 10.1002/cncr.28001; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chan KCA, 2003, CANCER RES, V63, P2028; Chun S, 2015, ANN HEPATOL, V14, P881, DOI 10.5604/16652681.1171776; Coghill AE, 2014, CANCER EPIDEM BIOMAR, V23, P1213, DOI 10.1158/1055-9965.EPI-13-1262; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; Kurtz DM, 2015, BLOOD, V125, P3679, DOI 10.1182/blood-2015-03-635169; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Li K, 2014, ASIAN PAC J CANCER P, V15, P9899, DOI 10.7314/APJCP.2014.15.22.9899; Lo S.S., 2010, NASOPHARYNGEAL CANC, P41; Lo YMD, 1999, CANCER RES, V59, P1188; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Ng WT, 2005, INT J CANCER, V113, P998, DOI 10.1002/ijc.20672; Pak MW, 2002, HEAD NECK-J SCI SPEC, V24, P989, DOI 10.1002/hed.10161; Le QT, 2013, CLIN CANCER RES, V19, P2208, DOI 10.1158/1078-0432.CCR-12-3702; Tan DSW, 2016, J THORAC ONCOL, V11, P946, DOI 10.1016/j.jtho.2016.05.008; Tang LL, 2016, CANCER LETT, V374, P22, DOI 10.1016/j.canlet.2016.01.040; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; To EWH, 2003, CLIN CANCER RES, V9, P3254; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158285; Wong IHN, 1999, CANCER RES, V59, P71; Wong LP, 2005, INT J CANCER, V117, P515, DOI 10.1002/ijc.21194; Xie SH, 2015, CANCER CAUSE CONTROL, V26, P913, DOI 10.1007/s10552-015-0572-x; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006	35	356	376	15	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					513	522		10.1056/NEJMoa1701717	http://dx.doi.org/10.1056/NEJMoa1701717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28792880	Bronze			2022-12-28	WOS:000407212600004
J	Gospocic, J; Shields, EJ; Glastad, KM; Lin, YP; Penick, CA; Yan, H; Mikheyev, AS; Linksvayer, TA; Garcia, BA; Berger, SL; Liebig, J; Reinberg, D; Bonasio, R				Gospocic, Janko; Shields, Emily J.; Glastad, Karl M.; Lin, Yanping; Penick, Clint A.; Yan, Hua; Mikheyev, Alexander S.; Linksvayer, Timothy A.; Garcia, Benjamin A.; Berger, Shelley L.; Liebig, Jurgen; Reinberg, Danny; Bonasio, Roberto			The Neuropeptide Corazonin Controls Social Behavior and Caste Identity in Ants	CELL			English	Article							GENE-EXPRESSION; DROSOPHILA; WORKERS; BRAIN; QUEENS; VITELLOGENIN; EPIGENETICS; METABOLISM; SIGNATURES; EVOLUTION	Social insects are emerging models to study how gene regulation affects behavior because their colonies comprise individuals with the same genomes but greatly different behavioral repertoires. To investigate the molecular mechanisms that activate distinct behaviors in different castes, we exploit a natural behavioral plasticity in Harpegnathos saltator, where adult workers can transition to a reproductive, queen-like state called gamergate. Analysis of brain transcriptomes during the transition reveals that corazonin, a neuropeptide homologous to the vertebrate gonadotropin-releasing hormone, is downregulated as workers become gamergates. Corazonin is also preferentially expressed in workers and/or foragers from other social insect species. Injection of corazonin in transitioning Harpegnathos individuals suppresses expression of vitellogenin in the brain and stimulates worker-like hunting behaviors, while inhibiting gamergate behaviors, such as dueling and egg deposition. We propose that corazonin is a central regulator of caste identity and behavior in social insects.	[Gospocic, Janko; Shields, Emily J.; Glastad, Karl M.; Lin, Yanping; Garcia, Benjamin A.; Berger, Shelley L.; Bonasio, Roberto] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Gospocic, Janko; Shields, Emily J.; Glastad, Karl M.; Berger, Shelley L.; Bonasio, Roberto] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Shields, Emily J.] Univ Penn, Perelman Sch Med, Grad Grp Genom & Computat Biol, Philadelphia, PA 19104 USA; [Lin, Yanping; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Linksvayer, Timothy A.] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Penick, Clint A.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Penick, Clint A.] North Carolina State Univ, Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Yan, Hua; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Yan, Hua; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Mikheyev, Alexander S.] Okinawa Inst Sci & Technol, Ecol & Evolut Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan; [Mikheyev, Alexander S.] Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia; [Liebig, Jurgen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Howard Hughes Medical Institute; New York University; New York University; Okinawa Institute of Science & Technology Graduate University; Australian National University; Arizona State University; Arizona State University-Tempe	Bonasio, R (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.; Bonasio, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	rbon@mail.med.upenn.edu	Mikheyev, Alexander/E-7999-2013	Mikheyev, Alexander/0000-0003-4369-1019; Penick, Clint/0000-0002-5368-507X; Berger, Shelley/0000-0001-5398-4400; Glastad, Karl/0000-0002-8142-1821; Linksvayer, Timothy/0000-0001-7034-1546; Reinberg, Danny/0000-0003-4288-2016; Gospocic, Janko/0000-0002-6716-8524	NIH [DP2MH107055, T32HG000046, F32AG044971]; Searle Scholars Program [15-SSP-102]; March of Dimes Foundation [1-FY-15-344]; Linda Pechenik Montague Investigator Award; Charles E. Kaufman Foundation [KA2016-85223]; Howard Hughes Medical Institute [2009005]; NSF [IOS-1452520]; NATIONAL CANCER INSTITUTE [P01CA196539] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH107055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG044971, R01AG055570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; March of Dimes Foundation(March of Dimes); Linda Pechenik Montague Investigator Award; Charles E. Kaufman Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Cristina Brady, Timothy Christopher, Capucine Le Meur, Maria-Isabel Navarro Sanchez, Julian Roessler, Jordan Bednarzi, and Emma Vales for their technical support; Michael Warner for Mononomorium RNA-seq; and Claude Desplan, Cornelius Gross, Anandasankar Ray, and Larry Zwiebel for comments on the manuscript. R.B. acknowledges support from the NIH (DP2MH107055), the Searle Scholars Program (15-SSP-102), the March of Dimes Foundation (1-FY-15-344), a Linda Pechenik Montague Investigator Award, and the Charles E. Kaufman Foundation (KA2016-85223). E.J.S. acknowledges financial support from the NIH (T32HG000046). The ant projects in the laboratories of S.L.B., D.R., and J.L. were funded by a Howard Hughes Medical Institute Collaborative Innovation Award (#2009005). T.A.L. was supported by an NSF award (IOS-1452520). H.Y. was supported by the NIH F32 postdoctoral fellowship (F32AG044971).	Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; [Anonymous], ANIM BEHAV, V79, P1001; [Anonymous], CURR BIOL, V22, P1831; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bendesky A, 2017, NATURE, V544, P434, DOI 10.1038/nature22074; Bonasio R, 2012, ANN NY ACAD SCI, V1260, P14, DOI 10.1111/j.1749-6632.2011.06363.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Corona M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003730; Dani N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003031; Daugherty THF, 2011, MOL ECOL, V20, P5337, DOI 10.1111/j.1365-294X.2011.05344.x; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Ernst UR, 2015, J EXP BIOL, V218, P88, DOI 10.1242/jeb.107078; Gronenberg W, 1999, NATURWISSENSCHAFTEN, V86, P343, DOI 10.1007/s001140050631; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Holldobler B., 1990, pi; Jerdon TC, 1851, MADRAS J LIT SCI, V17, P103, DOI DOI 10.1080/03745485709496303; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Khamis AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11136; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kubrak OI, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160152; Libbrecht R, 2013, P NATL ACAD SCI USA, V110, P11050, DOI 10.1073/pnas.1221781110; Lockett GA, 2016, EXP GERONTOL, V77, P52, DOI 10.1016/j.exger.2016.02.007; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; McClure KD, 2013, J NEUROSCI, V33, P4044, DOI 10.1523/JNEUROSCI.3413-12.2013; Mishra D, 2013, CURR BIOL, V23, P1466, DOI 10.1016/j.cub.2013.06.028; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Munch D, 2015, EXP GERONTOL, V71, P103, DOI 10.1016/j.exger.2015.08.001; Oxley PR, 2014, CURR BIOL, V24, P451, DOI 10.1016/j.cub.2014.01.018; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Patalano S, 2015, P NATL ACAD SCI USA, V112, P13970, DOI 10.1073/pnas.1515937112; PEETERS C, 1984, NATURWISSENSCHAFTEN, V71, P50, DOI 10.1007/BF00365989; PEETERS C, 1995, P NATL ACAD SCI USA, V92, P10977, DOI 10.1073/pnas.92.24.10977; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Penick CA, 2014, J EXP BIOL, V217, P1496, DOI 10.1242/jeb.098301; Predel R, 2007, PEPTIDES, V28, P3, DOI 10.1016/j.peptides.2006.10.011; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Sasaki T, 2016, AM NAT, V187, P765, DOI 10.1086/686259; Schmitt F, 2015, J PROTEOME RES, V14, P1504, DOI 10.1021/pr5011636; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Simola DF, 2016, SCIENCE, V351, DOI 10.1126/science.aac6633; Sugahara R, 2015, J INSECT PHYSIOL, V79, P80, DOI 10.1016/j.jinsphys.2015.06.009; Tanaka Y, 2002, J INSECT PHYSIOL, V48, P707, DOI 10.1016/S0022-1910(02)00094-X; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; TIAN S, 2016, SCI REP UK, V6; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Varga K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34641; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; von Wyschetzki K, 2015, MOL BIOL EVOL, V32, P3173, DOI 10.1093/molbev/msv186; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042102; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2013, J EXP BIOL, V216, P4347, DOI 10.1242/jeb.085779; Warner MR, 2017, MOL BIOL EVOL, V34, P1780, DOI 10.1093/molbev/msx123; West-Eberhard M.J., 1987, P35; White SA, 2002, J EXP BIOL, V205, P2567; Yan H, 2014, NAT REV GENET, V15, P677, DOI 10.1038/nrg3787; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	70	95	96	6	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					748	+		10.1016/j.cell.2017.07.014	http://dx.doi.org/10.1016/j.cell.2017.07.014			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802044	Green Accepted, Bronze			2022-12-28	WOS:000407445700015
J	Kallioinen, M; Eadon, H; Murphy, MS; Baird, G				Kallioinen, Maija; Eadon, Hilary; Murphy, M. Stephen; Baird, Gillian		Guideline Comm	GUIDELINES Developmental follow-up of children and young people born preterm: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kallioinen, Maija; Eadon, Hilary; Murphy, M. Stephen] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England; [Baird, Gillian] Guys & St Thomas NHS Trust, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Baird, G (corresponding author), Guys & St Thomas NHS Trust, London SE1 9RT, England.	Baird@gstt.nhs.uk							0	8	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2017	358								j3514	10.1136/bmj.j3514	http://dx.doi.org/10.1136/bmj.j3514			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7YD	28798150				2022-12-28	WOS:000407741100001
J	Vander Heiden, MG				Vander Heiden, Matthew G.			Metabolism and Congenital Malformations - NAD's Effects on Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vander Heiden, Matthew G.] MIT, Koch Inst Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Vander Heiden, MG (corresponding author), MIT, Koch Inst Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Kraus WL, 2015, MOL CELL, V58, P902, DOI 10.1016/j.molcel.2015.06.006; Naganathan SR, 2017, DEV CELL, V40, P323, DOI 10.1016/j.devcel.2017.02.012; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027	4	3	3	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					509	511		10.1056/NEJMp1707487	http://dx.doi.org/10.1056/NEJMp1707487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28792881	Green Published			2022-12-28	WOS:000407212600003
J	Wu, S; Zhu, W; Hannun, YA				Wu, Song; Zhu, Wei; Hannun, Yusuf A.			Role of stem-cell divisions in cancer risk Reply	NATURE			English	Letter									[Wu, Song; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Wu, Song; Zhu, Wei; Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Dept Pathol, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Dept Med, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Dept Biochem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Pathol, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Biochem, Stony Brook, NY 11794 USA.	Yusuf.Hannun@stonybrookmedicine.edu						Tomasetti C, 2017, NATURE, V548, pE13, DOI 10.1038/nature23302; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	3	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					E15	E15		10.1038/nature23303	http://dx.doi.org/10.1038/nature23303			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796207	Bronze			2022-12-28	WOS:000407284300006
J	Goel, S; DeCristo, MJ; Watt, AC; BrinJones, H; Sceneay, J; Li, BB; Khan, N; Ubellacker, JM; Xie, SZ; Metzger-Filho, O; Hoog, J; Ellis, MJ; Ma, CX; Ramm, S; Krop, IE; Winer, EP; Roberts, TM; Kim, HJ; McAllister, SS; Zhao, JJ				Goel, Shom; DeCristo, Molly J.; Watt, April C.; BrinJones, Haley; Sceneay, Jaclyn; Li, Ben B.; Khan, Naveed; Ubellacker, Jessalyn M.; Xie, Shaozhen; Metzger-Filho, Otto; Hoog, Jeremy; Ellis, Matthew J.; Ma, Cynthia X.; Ramm, Susanne; Krop, Ian E.; Winer, Eric P.; Roberts, Thomas M.; Kim, Hye-Jung; McAllister, Sandra S.; Zhao, Jean J.			CDK4/6 inhibition triggers anti-tumour immunity	NATURE			English	Article							BREAST-CANCER; REQUIREMENT; METHYLATION; SENESCENCE; EXPRESSION; CELLS	Cyclin-dependent kinases 4 and 6 (CDK4/6) are fundamental drivers of the cell cycle and are required for the initiation and progression of various malignancies(1,2). Pharmacological inhibitors of CDK4/6 have shown significant activity against several solid tumours(3,4). Their primary mechanism of action is thought to be the inhibition of phosphorylation of the retinoblastoma tumour suppressor, inducing G1 cell cycle arrest in tumour cells(5). Here we use mouse models of breast carcinoma and other solid tumours to show that selective CDK4/6 inhibitors not only induce tumour cell cycle arrest, but also promote anti-tumour immunity. We confirm this phenomenon through transcriptomic analysis of serial biopsies from a clinical trial of CDK4/6 inhibitor treatment for breast cancer. The enhanced antitumour immune response has two underpinnings. First, CDK4/6 inhibitors activate tumour cell expression of endogenous retroviral elements, thus increasing intracellular levels of double-stranded RNA. This in turn stimulates production of type III interferons and hence enhances tumour antigen presentation. Second, CDK4/6 inhibitors markedly suppress the proliferation of regulatory T cells. Mechanistically, the effects of CDK4/6 inhibitors both on tumour cells and on regulatory T cells are associated with reduced activity of the E2F target, DNA methyltransferase 1. Ultimately, these events promote cytotoxic T-cell-mediated clearance of tumour cells, which is further enhanced by the addition of immune checkpoint blockade. Our findings indicate that CDK4/6 inhibitors increase tumour immunogenicity and provide a rationale for new combination regimens comprising CDK4/6 inhibitors and immunotherapies as anti-cancer treatment.	[Goel, Shom; Watt, April C.; BrinJones, Haley; Li, Ben B.; Khan, Naveed; Xie, Shaozhen; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Goel, Shom; Metzger-Filho, Otto; Krop, Ian E.; Winer, Eric P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [DeCristo, Molly J.; Sceneay, Jaclyn; Ubellacker, Jessalyn M.; McAllister, Sandra S.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [DeCristo, Molly J.; Sceneay, Jaclyn; Ubellacker, Jessalyn M.; McAllister, Sandra S.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Hoog, Jeremy; Ma, Cynthia X.] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, Matthew J.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Ramm, Susanne] Harvard Med Sch, Harvard Program Therapeut Sci, Lab Syst Pharmacol, Boston, MA 02115 USA; [Ramm, Susanne] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Kim, Hye-Jung] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Kim, Hye-Jung] Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [McAllister, Sandra S.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [McAllister, Sandra S.; Zhao, Jean J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Zhao, Jean J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Washington University (WUSTL); Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Goel, S; Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Goel, S (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; McAllister, SS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; McAllister, SS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.; McAllister, SS (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA.; McAllister, SS; Zhao, JJ (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Zhao, JJ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	shom_goel@dfci.harvard.edu; smcallister1@bwh.harvard.edu; jean_zhao@dfci.harvard.edu	Goel, Shom/E-2399-2011	Goel, Shom/0000-0001-8329-9084; Ramm, Susanne/0000-0003-1108-5620; Watt, April/0000-0002-5145-5334	DF/HCC SPORE in Breast Cancer (National Institutes of Health (NIH) [2015 P50 CA]; Landry Cancer Biology Research Fellowship; DOD Era of Hope award [W81XWH-14-1-0191]; NIH (NCI) [RO1 CA166284]; Presidential Early Career Award for Scientists and Engineers; Breast Cancer Research Foundation; DF/HCC SPORE in Breast Cancer [P50 CA168504]; NIH [CA187918-02, CA210057-01, CA172461-04]; NATIONAL CANCER INSTITUTE [P50CA168504, R01CA187918, R01CA172461, R35CA210057, R01CA166284] Funding Source: NIH RePORTER	DF/HCC SPORE in Breast Cancer (National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Landry Cancer Biology Research Fellowship; DOD Era of Hope award; NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; DF/HCC SPORE in Breast Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award from the DF/HCC SPORE in Breast Cancer (National Institutes of Health (NIH) 2015 P50 CA, to S.G.), a Landry Cancer Biology Research Fellowship (to M.J.D.), a DOD Era of Hope award (W81XWH-14-1-0191 to S.S.M.), NIH (NCI) RO1 CA166284 (to S.S.M.), a Presidential Early Career Award for Scientists and Engineers (to S.S.M.), the Breast Cancer Research Foundation (to J.J.Z.), the DF/HCC SPORE in Breast Cancer (P50 CA168504, to I.E.K., E.P.W., T.M.R. and J.J.Z.), and NIH awards CA187918-02 (to T.M.R. and J.J.Z.), CA210057-01 (to J.J.Z.), and CA172461-04 (to J.J.Z.). We thank T. Laszewski, A. Molineaux, J. Almeida, the Nikon Imaging Center at Harvard Medical School, and Boston Children's Hospital Heme/Onc-HSCI Flow Cytometry facility for experimental assistance. We thank providers of reagents: pHAGE-deltaOVA-zsGreen plasmid (R. E. Tay, K. Wucherpfennig), LCMV-P14 transgenic mice (A. Cartwright, K. Wucherpfennig), CT-26 cell line (S. Elledge), and MMTV-PyMT-S2WTP3 cell line (A. Moller). We thank S. Stewart for advice.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CX, 2017, CLIN CANC RES; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ni J, 2016, NAT MED, V22, P723, DOI 10.1038/nm.4120; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012	30	688	712	14	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					471	+		10.1038/nature23465	http://dx.doi.org/10.1038/nature23465			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813415	Green Accepted, Green Submitted			2022-12-28	WOS:000408279000042
J	Chatterjee, S; Giri, J				Chatterjee, Saurav; Giri, Jay			Intravenous fibrinolytics in STEMI: a 25-year perspective	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION		[Chatterjee, Saurav] Univ Connecticut, Sch Med, St Francis Hosp, Div Cardiol,Teaching Affiliate, Hartford, CT 06112 USA; [Giri, Jay] Univ Penn, Perelman Sch Med, Cardiovasc Med Div, Penn Cardiovasc Outcomes Qual & Evaluat Res Ctr, 423 Guardian Dr, Philadelphia, PA 19104 USA	Saint Francis Hospital & Medical Center; University of Connecticut; University of Pennsylvania	Giri, J (corresponding author), Univ Penn, Perelman Sch Med, Cardiovasc Med Div, Penn Cardiovasc Outcomes Qual & Evaluat Res Ctr, 423 Guardian Dr, Philadelphia, PA 19104 USA.	jay.giri@uphs.upenn.edu						Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Jinatongthai P, 2017, LANCET, V390, P747, DOI 10.1016/S0140-6736(17)31441-1; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; RIVAS F, 1976, CIRC RES, V38, P439, DOI 10.1161/01.RES.38.5.439	8	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					718	720		10.1016/S0140-6736(17)32214-6	http://dx.doi.org/10.1016/S0140-6736(17)32214-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28831981				2022-12-28	WOS:000407858900005
J	Huang, DL; Bax, NA; Buckley, CD; Weis, WI; Dunn, AR				Huang, Derek L.; Bax, Nicolas A.; Buckley, Craig D.; Weis, William I.; Dunn, Alexander R.			Vinculin forms a directionally asymmetric catch bond with F-actin	SCIENCE			English	Article							DEPENDENT MANNER; CELL-ADHESION; FORCE; MIGRATION; FILAMENTS; POLARITY; BINDING; LAMELLIPODIA; ORGANIZATION; MECHANISMS	Vinculin is an actin-binding protein thought to reinforce cell-cell and cell-matrix adhesions. However, how mechanical load affects the vinculin-F-actin bond is unclear. Using a single-molecule optical trap assay, we found that vinculin forms a force-dependent catch bond with F-actin through its tail domain, but with lifetimes that depend strongly on the direction of the applied force. Force toward the pointed (-) end of the actin filament resulted in a bond that was maximally stable at 8 piconewtons, with a mean lifetime (12 seconds) 10 times as long as the mean lifetime when force was applied toward the barbed (+) end. A computational model of lamellipodial actin dynamics suggests that the directionality of the vinculin-F-actin bond could establish long-range order in the actin cytoskeleton. The directional and force-stabilized binding of vinculin to F-actin may be a mechanism by which adhesion complexes maintain front-rear asymmetry in migrating cells.	[Huang, Derek L.; Weis, William I.; Dunn, Alexander R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Bax, Nicolas A.; Weis, William I.] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Buckley, Craig D.; Dunn, Alexander R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Dunn, Alexander R.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Weis, WI; Dunn, AR (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA.; Dunn, AR (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Dunn, AR (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	bill.weis@stanford.edu; alex.dunn@stanford.edu	Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150	National Institutes of Health (NIH) [R01GM11462]; Howard Hughes Medical Institute; NIH [T32 GM007276]; Graduate Research Fellowship from National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, T32GM007276, R01GM114462, R01GM117457, R01GM114621] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Research Fellowship from National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank T. Omabegho and P.V. Ruijgrok of the Bryant Lab (Stanford University) for providing the myosin VI protein construct and W. J. Nelson for advice and discussion. The data reported in this paper are further detailed in the supplementary materials. Research reported in this publication was supported by grant R01GM11462 from the National Institutes of Health (NIH). The research of A.R.D. was supported in part by a Faculty Scholar grant from the Howard Hughes Medical Institute. D.L.H. and N.A.B. were supported by training grant T32 GM007276 from the NIH. D.L.H. was supported by a Graduate Research Fellowship from the National Science Foundation. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Cleary FB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5587; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Pruitt BL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001996; Rahman A, 2016, MOL BIOL CELL, V27, P1431, DOI 10.1091/mbc.E15-06-0432; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Swailes NT, 2004, J ANAT, V205, P381, DOI 10.1111/j.0021-8782.2004.00341.x; Thievessen I, 2015, FASEB J, V29, P4555, DOI 10.1096/fj.14-268235; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; VARNUMFINNEY B, 1994, J CELL BIOL, V127, P1071, DOI 10.1083/jcb.127.4.1071; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Xu WM, 1998, DEVELOPMENT, V125, P327; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	36	130	132	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					703	706		10.1126/science.aan2556	http://dx.doi.org/10.1126/science.aan2556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818948	Green Accepted			2022-12-28	WOS:000407793600039
J	Braun, R; Holler, E				Braun, Regine; Holler, Ernst			Acute Ocular Graft-versus-Host Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Braun, Regine; Holler, Ernst] Univ Klinikum Regensburg, Regensburg, Germany	University of Regensburg	Braun, R (corresponding author), Univ Klinikum Regensburg, Regensburg, Germany.	regine.braun@ukr.de							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					676	676		10.1056/NEJMicm1701185	http://dx.doi.org/10.1056/NEJMicm1701185			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813228				2022-12-28	WOS:000407691400010
J	Tollefson, J				Tollefson, Jeff			CLIMATE SCIENCE California mulls major climate-research effort	NATURE			English	News Item																			0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					267	268		10.1038/548267a	http://dx.doi.org/10.1038/548267a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816260	Bronze			2022-12-28	WOS:000407748400004
J	[Anonymous]				[Anonymous]			Sickle Cell Therapy Drought Ends	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					604	604		10.1001/jama.2017.10152	http://dx.doi.org/10.1001/jama.2017.10152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810008				2022-12-28	WOS:000407616000007
J	Zhang, DJ; Zhang, NM; Wang, J; Ha, BB; Dong, GH; Chen, FH				Zhang, Dongju; Zhang, Naimeng; Wang, Jian; Ha, Bibu; Dong, Guanghui; Chen, Fahu			Comment on "Permanent human occupation of the central Tibetan Plateau in the early Holocene"	SCIENCE			English	Editorial Material							CHINA	Meyer et al. (Reports, 6 January 2017, p. 64) claim that permanent human occupation of the central Tibetan Plateau started in the early Holocene without the support of an agropastoral economy. By careful examination, we find that neither the archaeological evidence nor the travel cost modeling provided by Meyer et al. could support the permanent human occupation assertion.	[Zhang, Dongju; Zhang, Naimeng; Wang, Jian; Dong, Guanghui; Chen, Fahu] Lanzhou Univ, Coll Earth Environm Sci, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Gansu, Peoples R China; [Ha, Bibu] Tibetan Cultural Rel Conservat Inst, Lhasa 850000, Peoples R China	Lanzhou University	Zhang, DJ; Chen, FH (corresponding author), Lanzhou Univ, Coll Earth Environm Sci, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Gansu, Peoples R China.	djzhang@lzu.edu.cn; fhchen@lzu.edu.cn	Zhang, Dongju/ABH-9307-2022; Fahu, Chen/B-2788-2011; Dong, Guanghui/C-5985-2013	Dong, Guanghui/0000-0001-8005-759X; Chen, Fahu/0000-0002-8874-1035	National Natural Science Foundation of China [41620104007]; International Partnership Program of the Chinese Academy of Sciences [131C11KYSB20160061]; Fundamental Research Funds for the Central Universities [lzujbky-2016-159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Partnership Program of the Chinese Academy of Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Natural Science Foundation of China (grant 41620104007), the International Partnership Program of the Chinese Academy of Sciences (grant 131C11KYSB20160061), and the Fundamental Research Funds for the Central Universities (grant lzujbky-2016-159).	Aldenderfer M, 2004, J WORLD PREHIST, V18, P1, DOI 10.1023/B:JOWO.0000038657.79035.9e; Barton L, 2016, ARCHAEOL RES ASIA, V5, P4, DOI 10.1016/j.ara.2016.01.001; Boulanger MT., 2010, LOUISIANA ARCHAEOL, V37, P81; Brantingham PJ, 2007, DEV QUATER SCI, V9, P129, DOI 10.1016/S1571-0866(07)09010-0; Brantingham PJ, 2013, GEOARCHAEOLOGY, V28, P413, DOI 10.1002/gea.21448; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Hudson AM, 2014, GEOARCHAEOLOGY, V29, P33, DOI 10.1002/gea.21459; Kelly RL, 2007, FORAGING SPECTRUM; Madsen DB, 2006, J ARCHAEOL SCI, V33, P1433, DOI 10.1016/j.jas.2006.01.017; Meyer MC, 2017, SCIENCE, V355, P64, DOI 10.1126/science.aag0357; Perreault C, 2016, J ARCHAEOL SCI-REP, V5, P392, DOI 10.1016/j.jasrep.2015.12.009; Rhode D, 2007, J ARCHAEOL SCI, V34, P600, DOI 10.1016/j.jas.2006.06.016; Sun YJ, 2010, QUAT GEOCHRONOL, V5, P360, DOI 10.1016/j.quageo.2009.02.013; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749; Zhang DJ, 2016, SCI CHINA EARTH SCI, V59, P1765, DOI 10.1007/s11430-015-5482-x	15	14	16	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351							eaam8273	10.1126/science.aam8273	http://dx.doi.org/10.1126/science.aam8273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FD1VM	28798102				2022-12-28	WOS:000407324800001
J	Servick, K				Servick, Kelly			HUMAN REPRODUCTION Embryo editing takes another step to clinic	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					436	437		10.1126/science.357.6350.436	http://dx.doi.org/10.1126/science.357.6350.436			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774906				2022-12-28	WOS:000406840100011
J	Servick, K				Servick, Kelly			THE STEM CELL SKEPTIC	SCIENCE			English	Editorial Material								Through 7 years and 2000 blog posts, Paul Knoepfler has insisted that stem cells are being oversold											0	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					441	443		10.1126/science.357.6350.441	http://dx.doi.org/10.1126/science.357.6350.441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774910				2022-12-28	WOS:000406840100015
J	Kornfeld, DS; Titus, SL				Kornfeld, Donald S.; Titus, Sandra L.			More research won't crack misconduct	NATURE			English	Letter									[Kornfeld, Donald S.] Columbia Univ, New York, NY 10027 USA	Columbia University	Kornfeld, DS (corresponding author), Columbia Univ, New York, NY 10027 USA.	dsk3@cumc.columbia.edu							0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					31	31		10.1038/548031a	http://dx.doi.org/10.1038/548031a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770833	Bronze			2022-12-28	WOS:000406831700021
J	Rook, G; Bakhed, F; Levin, BR; McFall-Ngai, MJ; McLean, AR				Rook, Graham; Backhed, Fredrik; Levin, Bruce R.; McFall-Ngai, Margaret J.; McLean, Angela R.			Evolution, human-microbe interactions, and life history plasticity	LANCET			English	Article							CRITICAL COMMUNITY SIZE; C-REACTIVE PROTEIN; GUT MICROBIOTA; INTESTINAL MICROBIOTA; NATURAL-ENVIRONMENT; ATOPIC-DERMATITIS; OLD FRIENDS; T-CELLS; HEALTH; DIET	A bacterium was once a component of the ancestor of all eukaryotic cells, and much of the human genome originated in microorganisms. Today, all vertebrates harbour large communities of microorganisms (microbiota), particularly in the gut, and at least 20% of the small molecules in human blood are products of the microbiota. Changing human lifestyles and medical practices are disturbing the content and diversity of the microbiota, while simultaneously reducing our exposures to the so-called old infections and to organisms from the natural environment with which human beings co-evolved. Meanwhile, population growth is increasing the exposure of human beings to novel pathogens, particularly the crowd infections that were not part of our evolutionary history. Thus some microbes have co-evolved with human beings and play crucial roles in our physiology and metabolism, whereas others are entirely intrusive. Human metabolism is therefore a tug-of-war between managing beneficial microbes, excluding detrimental ones, and channelling as much energy as is available into other essential functions (eg, growth, maintenance, reproduction). This tug-of-war shapes the passage of each individual through life history decision nodes (eg, how fast to grow, when to mature, and how long to live).	[Rook, Graham] UCL, Ctr Clin Microbiol, Dept Infect, London WC1E 6BT, England; [Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [McFall-Ngai, Margaret J.] Univ Hawaii Manoa, Pacif Biosci Res Ctr, Hawaii, HI USA; [McLean, Angela R.] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England	University of London; University College London; University of Gothenburg; Emory University; University of Hawaii System; University of Hawaii Manoa; University of Oxford	Rook, G (corresponding author), UCL, Ctr Clin Microbiol, Dept Infect, London WC1E 6BT, England.	g.rook@ucl.ac.uk	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818	NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016798, NNF13OC0008163] Funding Source: researchfish	NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)		Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; BLACK FL, 1966, J THEOR BIOL, V11, P207, DOI 10.1016/0022-5193(66)90161-5; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Bremner SA, 2008, ALLERGY, V63, P274, DOI 10.1111/j.1398-9995.2007.01599.x; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141; Correale J, 2013, J IMMUNOL, V191, P3827, DOI 10.4049/jimmunol.1301110; Correale J, 2011, J NEUROIMMUNOL, V233, P6, DOI 10.1016/j.jneuroim.2011.01.002; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; Hong HA, 2009, RES MICROBIOL, V160, P375, DOI 10.1016/j.resmic.2009.06.006; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jasienska G, 2017, LANCET, V390, P510, DOI [10.1016/S0140-6736(17)30573-1, 10.1016/s0140-6736(17)30573-1]; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Knoll AH, 2004, LIFE YOUNG PLANET 1; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kubiak RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000947; Lane N, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015982; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Martinez-Gonzalez MA, 2015, PROG CARDIOVASC DIS, V58, P50, DOI 10.1016/j.pcad.2015.04.003; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Mohammadi-Bardbori A, 2012, CHEM RES TOXICOL, V25, P1878, DOI 10.1021/tx300169e; Moore MN, 2015, ENVIRON RES, V140, P65, DOI 10.1016/j.envres.2015.03.015; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Pace NR, 2012, P NATL ACAD SCI USA, V109, P1011, DOI 10.1073/pnas.1109716109; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; Prevention and control of intestinal parasitic infections, 1987, WHO TECH REP SER, V749, P1; Price KC, 1999, OBSTET GYNECOL, V94, P128, DOI 10.1016/S0029-7844(99)00269-0; Reynolds LA, 2015, J IMMUNOL, V195, P4059, DOI 10.4049/jimmunol.1501432; Rook GAW, 2014, CLIN EXP IMMUNOL, V177, P1, DOI 10.1111/cei.12269; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Rook GAW, 2014, ADV EXP MED BIOL, V817, P319, DOI 10.1007/978-1-4939-0897-4_15; Rook GAW, 2011, IMMUNOL REV, V240, P141, DOI 10.1111/j.1600-065X.2010.00987.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sharland M., 2016, MANUAL CHILDHOOD INF, V4th; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Timm S, 2014, EUR J EPIDEMIOL, V29, P429, DOI 10.1007/s10654-014-9922-3; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vanamala JKP, 2015, CELL METAB, V22, P960, DOI 10.1016/j.cmet.2015.11.009; von Hertzen LC, 2011, CANCER METAST REV, V30, P211, DOI 10.1007/s10555-011-9284-1; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wells JCK, 2016, METABOLIC GHETTO: AN EVOLUTIONARY PERSPECTIVE ON NUTRITION, POWER RELATIONS AND CHRONIC DISEASE; Wells JCK, 2017, LANCET, V390, P500, DOI 10.1016/S0140-6736(17)30572-X; Wells JCK, 2011, TRENDS ENDOCRIN MET, V22, P421, DOI 10.1016/j.tem.2011.05.006; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170; Winglee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097048; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	101	122	123	6	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					521	530		10.1016/S0140-6736(17)30566-4	http://dx.doi.org/10.1016/S0140-6736(17)30566-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792414	Green Submitted			2022-12-28	WOS:000406463400033
J	Yang, HC; Berry, S; Olsson, TSG; Hartley, M; Howard, M; Dean, C				Yang, Hongchun; Berry, Scott; Olsson, Tjelvar S. G.; Hartley, Matthew; Howard, Martin; Dean, Caroline			Distinct phases of Polycomb silencing to hold epigenetic memory of cold in Arabidopsis	SCIENCE			English	Article							HISTONE H3; PROTEIN; LHP1; VERNALIZATION; THALIANA; H3K27ME3; SWITCH	Gene silencing by Polycomb complexes is central to eukaryotic development. Cold-induced epigenetic repression of FLOWERING LOCUS C (FLC) in the plant Arabidopsis provides an opportunity to study initiation and maintenance of Polycomb silencing. Here, we show that a subset of Polycomb repressive complex 2 factors nucleate silencing in a small region within FLC, locally increasing H3K27me3 levels. This nucleation confers a silenced state that is metastably inherited, with memory held in the local chromatin. Metastable memory is then converted to stable epigenetic silencing through separate Polycomb factors, which spread across the locus after cold to enlarge the domain that contains H3K27me3. Polycomb silencing at FLC thus has mechanistically distinct phases, which involve specialization of distinct Polycomb components to deliver first metastable then long-term epigenetic silencing.	[Yang, Hongchun; Berry, Scott; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Berry, Scott; Olsson, Tjelvar S. G.; Hartley, Matthew; Howard, Martin] John Innes Ctr, Dept Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.; Howard, M (corresponding author), John Innes Ctr, Dept Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	martin.howard@jic.ac.uk; caroline.dean@jic.ac.uk	Berry, Scott/O-5498-2014; Howard, Martin/C-3629-2016	Berry, Scott/0000-0002-1838-4976; Yang, Hongchun/0000-0002-8265-3958; Olsson, Tjelvar/0000-0001-8791-4531; Hartley, Matthew/0000-0001-6178-2884; Howard, Martin/0000-0001-7670-0781; Dean, Caroline/0000-0002-6555-3525	European Research Council [233039, 339462]; UK Biotechnology and Biological Sciences Research Council Institute Strategic Programme [BB/J004588/1]; John Innes Foundation studentship; BBSRC [BB/P006590/1, BBS/E/J/000PR9773, BB/K00008X/1, BBS/E/J/000CA537, BBS/E/J/000PR9789] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9789, BB/P006590/1, BBS/E/J/000PR9773, BBS/E/J/000CA537, BB/K00008X/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Biotechnology and Biological Sciences Research Council Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Wang for technical help, S. Chen for plant handling, J. Goodrich for 35S::GFP-CLF/clf-28 seeds, G. Calder for microscopy support, and members of the C.D. and M. Howard research groups for discussions. The project was supported by European Research Council grants 233039 and 339462 and by the UK Biotechnology and Biological Sciences Research Council Institute Strategic Programme grant BB/J004588/1. S.B. was supported by a John Innes Foundation studentship. Additional data are provided in the supplementary materials.	Angel A, 2015, P NATL ACAD SCI USA, V112, P4146, DOI 10.1073/pnas.1503100112; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; [Anonymous], 2016, NAT GENET; [Anonymous], 2005, PLANT J; [Anonymous], 2016, DEAN SCI; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Obersriebnig MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11518; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Veluchamy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158936; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005771; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yang HC, 2014, CURR BIOL, V24, P1793, DOI 10.1016/j.cub.2014.06.047; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	26	89	92	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2017	357	6356					1142	1145		10.1126/science.aan1121	http://dx.doi.org/10.1126/science.aan1121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7XX	28818969				2022-12-28	WOS:000410639800042
J	Chen, SS; Zhao, Y; Wang, YH; Shekhar, M; Tajkhorshid, E; Gouaux, E				Chen, Shanshuang; Zhao, Yan; Wang, Yuhang; Shekhar, Mrinal; Tajkhorshid, Emad; Gouaux, Eric			Activation and Desensitization Mechanism of AMPA Receptor-TARP Complex by Cryo-EM	CELL			English	Article							MOLECULAR-DYNAMICS SIMULATION; CALCIUM-PERMEABLE AMPA; GLUTAMATE-RECEPTOR; ION-CHANNEL; INWARD RECTIFICATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; STARGAZIN; GLUR2; PORE	AMPA receptors mediate fast excitatory neurotransmission in the mammalian brain and transduce the binding of presynaptically released glutamate to the opening of a transmembrane cation channel. Within the postsynaptic density, however, AMPA receptors coassemble with transmembrane AMPA receptor regulatory proteins (TARPs), yielding a receptor complex with altered gating kinetics, pharmacology, and pore properties. Here, we elucidate structures of the GluA2-TARP gamma 2 complex in the presence of the partial agonist kainate or the full agonist quisqualate together with a positive allosteric modulator or with quisqualate alone. We show how TARPs sculpt the ligand-binding domain gating ring, enhancing kainate potency and diminishing the ensemble of desensitized states. TARPs encircle the receptor ion channel, stabilizing M2 helices and pore loops, illustrating how TARPs alter receptor pore properties. Structural and computational analysis suggests the full agonist and modulator complex harbors an ion-permeable channel gate, providing the first view of an activated AMPA receptor.	[Chen, Shanshuang; Zhao, Yan; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wang, Yuhang; Shekhar, Mrinal; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Dept Biochem, NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA; [Wang, Yuhang; Shekhar, Mrinal; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Chen, Shanshuang/N-6665-2019; Shekhar, Mrinal/J-8724-2019; Wang, Yuhang/AAH-4816-2019; Gouaux, Eric/Y-4370-2019; Tajkhorshid, Emad/AAN-8323-2021	Chen, Shanshuang/0000-0003-2317-6589; Wang, Yuhang/0000-0003-3715-8349; Gouaux, Eric/0000-0002-8549-2360; 	American Heart Association [16POST27790099]; NIH [NS-038631, P41-GM104601, U54-GM087519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, P41GM104601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631, P30NS061800, R01NS038631] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Nakagawa for providing the clone #10 cell line, the Multiscale Microscopy Core (OHSU) for support with microscopy, and the Advanced Computing Center (OHSU) for computational support. We are grateful to L. Vaskalis for assistance with figures, H. Owen for help with proofreading, and other Gouaux laboratory members for helpful discussions. S.C. is supported by an American Heart Association postdoctoral fellowship (16POST27790099). This work was supported by the NIH (NS-038631 to E.G., and P41-GM104601 and U54-GM087519 to E.T.). Computational resources were provided by XSEDE (MCA06N060 to E.T.) and Blue Waters (ACI-1440026 to E.T.). E.G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulsen MH, 2014, MOL PHARMACOL, V85, P261, DOI 10.1124/mol.113.089961; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Singharoy A, 2016, ELIFE, V5, DOI 10.7554/eLife.16105; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wells DB, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770738; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	67	77	79	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1234	1246		10.1016/j.cell.2017.07.045	http://dx.doi.org/10.1016/j.cell.2017.07.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28823560	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000409536000019
J	Wilkinson, ST; Sanacora, G				Wilkinson, Samuel T.; Sanacora, Gerard			Considerations on the Off-label Use of Ketamine as a Treatment forMood Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilkinson, Samuel T.; Sanacora, Gerard] Yale Sch Med, Dept Psychiat, 100 York St,Ste 2J, New Haven, CT 06511 USA; [Wilkinson, Samuel T.; Sanacora, Gerard] Yale New Haven Hlth, Yale Psychiat Hosp, New Haven, CT USA	Yale University; Yale University	Sanacora, G (corresponding author), Yale Sch Med, Dept Psychiat, 100 York St,Ste 2J, New Haven, CT 06511 USA.	gerard.sanacora@yale.edu	Sanacora, Gerard/AAF-1135-2019; Wilkinson, Samuel/GQP-1952-2022		National Institute of Mental Health [T32MH062994-15]; Brain and Behavior Research Foundation; Robert F. Leet and Clara Guthrie Patterson Trust; State of Connecticut Department of Mental Health and Additive Services; Pfeiffer Research Foundation; Yale New Haven Hospital; National Center for Posttraumatic Stress Disorder; Allergan; Alkermes; AstraZeneca; Avanier Pharmaceuticals; BioHaven Pharmaceuticals; Hoffmann-La Roche; Janssen; Merck; Naurex; Novartis; Noven Pharmaceuticals; Sage Pharmaceuticals; Servier Pharmaceuticals; Taisho Pharmaceuticals; Teva; Valeant; Vistagen Therapeutics; Bristol-Myers Squibb; Eli Lilly; Johnson Johnson; Servier; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH062994] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Robert F. Leet and Clara Guthrie Patterson Trust; State of Connecticut Department of Mental Health and Additive Services; Pfeiffer Research Foundation; Yale New Haven Hospital; National Center for Posttraumatic Stress Disorder; Allergan(AbbVieAllergan); Alkermes; AstraZeneca(AstraZeneca); Avanier Pharmaceuticals; BioHaven Pharmaceuticals; Hoffmann-La Roche(Hoffmann-La Roche); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Naurex; Novartis(Novartis); Noven Pharmaceuticals; Sage Pharmaceuticals; Servier Pharmaceuticals(Servier); Taisho Pharmaceuticals; Teva(Teva Pharmaceutical Industries); Valeant; Vistagen Therapeutics; Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Servier(Servier); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Both authors have completed and submitted the ICMJE Formfor Disclosure of Potential Conflicts of Interest. Dr Wilkinson receives research and salary support fromthe National Institute of Mental Health (T32MH062994-15), the Brain and Behavior Research Foundation, and the Robert F. Leet and Clara Guthrie Patterson Trust. Dr Sanacora acknowledges the support of the State of Connecticut Department of Mental Health and Additive Services, the Brain and Behavior Research Foundation, the Pfeiffer Research Foundation, Yale New Haven Hospital, and the National Center for Posttraumatic Stress Disorder. Over the last 36 months, Dr Sanacora has received consulting fees from Allergan, Alkermes, AstraZeneca, Avanier Pharmaceuticals, BioHaven Pharmaceuticals, Hoffmann-La Roche, Janssen, Merck, Naurex, Novartis, Noven Pharmaceuticals, Sage Pharmaceuticals, Servier Pharmaceuticals, Taisho Pharmaceuticals, Teva, Valeant, and Vistagen Therapeutics. He has also received additional research contracts from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Hoffmann-La Roche, Merck, Naurex, and Servier over the last 36 months. Contracts with Johnson & Johnson are related to the development of esketamine, a proprietary compound that is an enantiomer of racemic ketamine, as an antidepressant. No-cost medication was provided to Dr Sanacora for a National Institutes of Health-sponsored study by Sanofi-Aventis. In addition, he holds shares in BioHaven Pharmaceuticals Holding Company and is a coinventor on a patent (Glutamate agents in the treatment of mental disorders, No. 8778979).	Fava M, 2017, ANN M AM SOC CLIN PH; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Sanacora G, 2017, JAMA PSYCHIAT, V74, P399, DOI 10.1001/jamapsychiatry.2017.0080; Singh JB, 2016, AM J PSYCHIAT, V173, P816, DOI 10.1176/appi.ajp.2016.16010037; Su TP, 2017, NEUROPSYCHOPHARMACOL, V42, P2482, DOI 10.1038/npp.2017.94; Vuyk J, 2015, MILLERS ANESTHESIA, V8th, P854; Wilkinson ST, 2017, AM J PSYCHIAT, V174, P695, DOI 10.1176/appi.ajp.2017.17020239	7	21	22	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					793	794		10.1001/jama.2017.10697	http://dx.doi.org/10.1001/jama.2017.10697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28806440	Green Accepted			2022-12-28	WOS:000409183700006
J	Giugliano, RP; Mach, F; Zavitz, K; Kurtz, C; Im, K; Kanevsky, E; Schneider, J; Wang, HE; Keech, A; Pedersen, TR; Sabatine, MS; Sever, PS; Robinson, JG; Honarpour, N; Wasserman, SM; Ott, BR				Giugliano, Robert P.; Mach, Francois; Zavitz, Kenton; Kurtz, Christopher; Im, Kyungah; Kanevsky, Estella; Schneider, Jingjing; Wang, Huei; Keech, Anthony; Pedersen, Terje R.; Sabatine, Marc S.; Sever, Peter S.; Robinson, Jennifer G.; Honarpour, Narimon; Wasserman, Scott M.; Ott, Brian R.		EBBINGHAUS Investigators	Cognitive Function in a Randomized Trial of Evolocumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPATIAL WORKING-MEMORY; CARDIOVASCULAR EVENTS; REDUCING LIPIDS; SAFETY; DISEASE; RATIONALE; EFFICACY; DESIGN; RISK; METAANALYSIS	BACKGROUND Findings from clinical trials of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors have led to concern that these drugs or the low levels of low-density lipoprotein (LDL) cholesterol that result from their use are associated with cognitive deficits. METHODS In a subgroup of patients from a randomized, placebo-controlled trial of evolocumab added to statin therapy, we prospectively assessed cognitive function using the Cambridge Neuropsychological Test Automated Battery. The primary end point was the score on the spatial working memory strategy index of executive function (scores range from 4 to 28, with lower scores indicating a more efficient use of strategy and planning). Secondary end points were the scores for working memory (scores range from 0 to 279, with lower scores indicating fewer errors), episodic memory (scores range from 0 to 70, with lower scores indicating fewer errors), and psychomotor speed (scores range from 100 to 5100 msec, with faster times representing better performance). Assessments of cognitive function were performed at baseline, week 24, yearly, and at the end of the trial. The primary analysis was a noninferiority comparison of the mean change from baseline in the score on the spatial working memory strategy index of executive function between the patients who received evolocumab and those who received placebo; the noninferiority margin was set at 20% of the standard deviation of the score in the placebo group. RESULTS A total of 1204 patients were followed for a median of 19 months; the mean (+/- SD) change from baseline over time in the raw score for the spatial working memory strategy index of executive function (primary end point) was -0.21 +/- 2.62 in the evolocumab group and -0.29 +/- 2.81 in the placebo group (P< 0.001 for noninferiority; P = 0.85 for superiority). There were no significant between-group differences in the secondary end points of scores for working memory (change in raw score, -0.52 in the evolocumab group and -0.93 in the placebo group), episodic memory (change in raw score, -1.53 and -1.53, respectively), or psychomotor speed (change in raw score, 5.2 msec and 0.9 msec, respectively). In an exploratory analysis, there were no associations between LDL cholesterol levels and cognitive changes. CONCLUSIONS In a randomized trial involving patients who received either evolocumab or placebo in addition to statin therapy, no significant between-group difference in cognitive function was observed over a median of 19 months.	[Giugliano, Robert P.; Im, Kyungah; Kanevsky, Estella; Sabatine, Marc S.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA; [Mach, Francois] Hop Univ Geneva, Hop Cantonal, Geneva, Switzerland; [Zavitz, Kenton] Cambridge Cognit, Cambridge, England; [Sever, Peter S.] Imperial Coll London, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England; [Kurtz, Christopher; Schneider, Jingjing; Wang, Huei; Honarpour, Narimon; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Keech, Anthony] Univ Sydney, Sydney Med Sch, NHMRC, Clin Trials Ctr, Sydney, NSW, Australia; [Pedersen, Terje R.] Oslo Univ Hosp, Ulleval, Norway; [Pedersen, Terje R.] Univ Oslo, Med Fac, Oslo, Norway; [Robinson, Jennifer G.] Univ Iowa, Iowa City, IA USA; [Ott, Brian R.] Brown Univ, Rhode Isl Hosp, Dept Neurol, Alpert Med Sch, Providence, RI 02903 USA	Harvard University; Brigham & Women's Hospital; University of Geneva; Imperial College London; Amgen; University of Sydney; University of Oslo; University of Oslo; University of Iowa; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Giugliano, RP (corresponding author), TIMI Study Off, 60 Fenwood Rd,Ste 7022, Boston, MA 02115 USA.	rgiugliano@bwh.harvard.edu	Sabatine, Marc/AAJ-6751-2020; , Jennifer/AAD-8336-2019; Saravanan, Ponnusamy/M-6142-2016; Giugliano, Robert/N-7233-2017	Sabatine, Marc/0000-0002-0691-3359; Hove, Jens/0000-0002-5600-5623; Pijanowski, Zbigniew/0000-0002-6624-7642; Ballantyne, Christie/0000-0002-6432-1730; Cariou, Bertrand/0000-0002-1580-8040; Saravanan, Ponnusamy/0000-0002-9566-2626; Blicharski, Tomasz/0000-0001-9747-8817; Giugliano, Robert/0000-0003-4110-7675	Amgen	Amgen(Amgen)	Funded by Amgen; EBBINGHAUS ClinicalTrials.gov number, NCT02207634.	Abbott RA, 2015, ALZHEIMERS DEMENT, V11, P564; [Anonymous], 2012, FDA DRUG SAF COMM IM; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barnett JH, 2016, CURR TOP BEHAV NEURO, V28, P449, DOI 10.1007/7854_2015_5001; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cohen J., 1988, STAT POWER ANAL SOCI, V2; Farias ST, 2008, NEUROPSYCHOLOGY, V22, P531, DOI 10.1037/0894-4105.22.4.531; Giugliano RP, 2017, CLIN CARDIOL, V40, P59, DOI 10.1002/clc.22678; Greer T., 2013, OPEN J DEPRESSION, V02, P45, DOI [10.4236/ojd.2013.24010, DOI 10.4236/OJD.2013.24010]; Jessup C., 2017, FDA NEWS        0126; Kollins SH, 2011, J CHILD ADOL PSYCHOP, V21, P111, DOI 10.1089/cap.2010.0064; Koren MJ, 2017, JAMA CARDIOL, V2, P598, DOI 10.1001/jamacardio.2017.0747; Kuzmickiene J, 2015, MED SCI MONITOR, V21, P2572, DOI 10.12659/MSM.895381; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Muller U, 2013, NEUROPHARMACOLOGY, V64, P490, DOI 10.1016/j.neuropharm.2012.07.009; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Roiser JP, 2016, DRUG DISCOV TODAY, V21, P445, DOI 10.1016/j.drudis.2015.11.003; Rojas-Fernandez CH, 2014, J CLIN LIPIDOL, V8, pS5, DOI 10.1016/j.jacl.2014.02.013; Rovio SP, 2016, NEUROPSYCHOLOGY, V30, P532, DOI 10.1037/neu0000239; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sabatine MS, 2016, AM HEART J, V173, P94, DOI 10.1016/j.ahj.2015.11.015; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Saunders NLJ, 2011, NEUROPSYCHOLOGY, V25, P237, DOI 10.1037/a0021134; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Taylor BA, 2017, AM COLL CARD 66 ANN	32	275	286	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					633	643		10.1056/NEJMoa1701131	http://dx.doi.org/10.1056/NEJMoa1701131			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813214	Green Published, Bronze			2022-12-28	WOS:000407691400006
J	Joung, J; Engreitz, JM; Konermann, S; Abudayyeh, OO; Verdine, VK; Aguet, F; Gootenberg, JS; Sanjana, NE; Wright, JB; Fulco, CP; Tseng, YY; Yoon, CH; Boehm, JS; Lander, ES; Zhang, F				Joung, Julia; Engreitz, Jesse M.; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Aguet, Francois; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Fulco, Charles P.; Tseng, Yuen-Yi; Yoon, Charles H.; Boehm, Jesse S.; Lander, Eric S.; Zhang, Feng			Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood	NATURE			English	Article							NONCODING RNAS; TRANSCRIPTIONAL ACTIVATION; CHROMATIN; REVEALS; EXPRESSION; INTERFERENCE; SENSITIVITY; SEQ; MAP	Mammalian genomes contain thousands of loci that transcribe long noncoding RNAs (lncRNAs)(1,2), some of which are known to carry out critical roles in diverse cellular processes through a variety of mechanisms(3-8). Although some lncRNA loci encode RNAs that act non-locally (in trans)(5), there is emerging evidence that many lncRNA loci act locally (in cis) to regulate the expression of nearby genes-for example, through functions of the lncRNA promoter, transcription, or transcript itself(3,6-8). Despite their potentially important roles, it remains challenging to identify functional lncRNA loci and distinguish among these and other mechanisms. Here, to address these challenges, we developed a genome-scale CRISPR-Cas9 activation screen that targets more than 10,000 lncRNA transcriptional start sites to identify noncoding loci that influence a phenotype of interest. We found 11 lncRNA loci that, upon recruitment of an activator, mediate resistance to BRAF inhibitors in human melanoma cells. Most candidate loci appear to regulate nearby genes. Detailed analysis of one candidate, termed EMICERI, revealed that its transcriptional activation resulted in dosage-dependent activation of four neighbouring protein-coding genes, one of which confers the resistance phenotype. Our screening and characterization approach provides a CRISPR toolkit with which to systematically discover the functions of noncoding loci and elucidate their diverse roles in gene regulation and cellular function.	[Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Engreitz, Jesse M.; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Aguet, Francois; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Fulco, Charles P.; Tseng, Yuen-Yi; Boehm, Jesse S.; Lander, Eric S.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Joung, Julia; Konermann, Silvana; Abudayyeh, Omar O.; Verdine, Vanessa K.; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Konermann, Silvana; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Sanjana, Neville E.; Wright, Jason B.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Fulco, Charles P.; Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Yoon, Charles H.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Konermann, Silvana] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Salk Institute; New York University	Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lander, ES; Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Lander, ES (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Lander, ES (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@broadinstitute.org; zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Joung, Julia/HCH-8944-2022; Gootenberg, Jonathan/AAY-8174-2021; Abudayyeh, Omar/ABF-1746-2020	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220	Fannie and John Hertz Foundation; Paul and Daisy Soros Fellowship; National Defense Science and Engineering Fellowship; DOE Computational Science Graduate Fellowship; NIH through NHGRI [R00-HG008171]; NIH through NIDDK [F32-DK096822]; National Defense Science and Engineering Graduate Fellowship; Broad Institute; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; Howard Hughes Medical Institute; New York Stem Cell; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation;  [UM1HG008895]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG008171, RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK096822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; Paul and Daisy Soros Fellowship; National Defense Science and Engineering Fellowship(United States Department of Defense); DOE Computational Science Graduate Fellowship(United States Department of Energy (DOE)); NIH through NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH through NIDDK; National Defense Science and Engineering Graduate Fellowship; Broad Institute; NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York Stem Cell; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Guttman, C. M. Johannessen and M. Ghandi for helpful discussions and insights; A. Sayeed, R. Deasy, A. Rotem and B. Izar for generating the primary patient melanoma cell lines; and R. Belliveau, R. Macrae and the Zhang laboratory for support and advice. J.M.E. is supported by the Fannie and John Hertz Foundation. O.A.A. is supported by a Paul and Daisy Soros Fellowship and National Defense Science and Engineering Fellowship. J.S.G. is supported by a DOE Computational Science Graduate Fellowship. N.E.S. is supported by the NIH through NHGRI (R00-HG008171). J.B.W. is supported by the NIH through NIDDK (F32-DK096822). C.P.F. is supported by the National Defense Science and Engineering Graduate Fellowship. E.S.L. is supported by UM1HG008895 and funds from the Broad Institute. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049), NSF, Howard Hughes Medical Institute, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng.	Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	28	243	257	7	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					343	+		10.1038/nature23451	http://dx.doi.org/10.1038/nature23451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792927	Green Accepted, Green Submitted			2022-12-28	WOS:000407748400035
J	Li, JF; Luo, LQ				Li, Jiefu; Luo, Liqun			NEUROBIOLOGY A bitter-sweet symphony	NATURE			English	Editorial Material									[Li, Jiefu; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Li, Jiefu; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	; /M-8065-2017	Luo, Liqun/0000-0001-5467-9264; /0000-0002-0062-4652	NIDCD NIH HHS [R01 DC005982] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Hong WZ, 2014, GENETICS, V196, P17, DOI 10.1534/genetics.113.154336; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lee H, 2017, NATURE, V548, P330, DOI 10.1038/nature23299; Li H, 2017, PREPRINT; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang KX, 2016, CELL REP, V14, P1258, DOI 10.1016/j.celrep.2015.12.102; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	9	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					285	287		10.1038/nature23537	http://dx.doi.org/10.1038/nature23537			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792928				2022-12-28	WOS:000407748400020
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: In support of acute internal medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						Jones M., 2016, HOSP J, V358, P45; Kar P., 2017, FULL CIRCLE; NHS Improvement, 2017, GOOD PRACT GUID FOC; Oliver David, 2016, Future Hosp J, V3, P49, DOI 10.7861/futurehosp.3-1-49; Oliver D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1684; Ross Calum N, 2017, Future Healthc J, V4, P151, DOI 10.7861/futurehosp.4-2-151a; Royal College of Physicians, 2016, 2015 16 CENS UK CONS; Royal College of Physicians, 2014, SPEC SPOTTL AC INT M; Royal College of Physicians, 2017, MED CARE	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2017	358								j3832	10.1136/bmj.j3832	http://dx.doi.org/10.1136/bmj.j3832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BX	28811277	Green Published, Bronze			2022-12-28	WOS:000408228100003
J	Luo, CY; Keown, CL; Kurihara, L; Zhou, JT; He, YP; Li, JH; Castanon, R; Lucero, J; Nery, JR; Sandoval, JP; Bui, B; Sejnowski, TJ; Harkins, TT; Mukamel, EA; Behrens, MM; Ecker, JR				Luo, Chongyuan; Keown, Christopher L.; Kurihara, Laurie; Zhou, Jingtian; He, Yupeng; Li, Junhao; Castanon, Rosa; Lucero, Jacinta; Nery, Joseph R.; Sandoval, Justin P.; Bui, Brian; Sejnowski, Terrence J.; Harkins, Timothy T.; Mukamel, Eran A.; Behrens, M. Margarita; Ecker, Joseph R.			Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex	SCIENCE			English	Article							EPIGENETIC HETEROGENEITY; EPIGENOMIC SIGNATURES; RADIAL GLIA; HUMAN BRAIN; SPECIFICATION; DIVERSITY; GENOME	The mammalian brain contains diverse neuronal types, yet we lack single-cell epigenomic assays that are able to identify and characterize them. DNA methylation is a stable epigenetic mark that distinguishes cell types and marks regulatory elements. We generated >6000 methylomes from single neuronal nuclei and used them to identify 16 mouse and 21 human neuronal subpopulations in the frontal cortex. CG and non-CG methylation exhibited cell type-specific distributions, and we identified regulatory elements with differential methylation across neuron types. Methylation signatures identified a layer 6 excitatory neuron subtype and a unique human parvalbumin-expressing inhibitory neuron subtype. We observed stronger cross-species conservation of regulatory elements in inhibitory neurons than in excitatory neurons. Single-nucleus methylomes expand the atlas of brain cell types and identify regulatory elements that drive conserved brain cell diversity.	[Luo, Chongyuan; Zhou, Jingtian; He, Yupeng; Castanon, Rosa; Nery, Joseph R.; Sandoval, Justin P.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Luo, Chongyuan; Sejnowski, Terrence J.; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Keown, Christopher L.; Li, Junhao; Mukamel, Eran A.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92037 USA; [Kurihara, Laurie; Harkins, Timothy T.] Swift Biosci Inc, 58 Parkland Plaza,Suite 100, Ann Arbor, MI 48103 USA; [Zhou, Jingtian; He, Yupeng] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Lucero, Jacinta; Bui, Brian; Sejnowski, Terrence J.; Behrens, M. Margarita] Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.; Mukamel, EA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92037 USA.; Behrens, MM (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	emukamel@ucsd.edu; mbehrens@salk.edu; ecker@salk.edu	Li, Junhao/AAI-2570-2019; Ecker, Joseph R/B-9144-2008; Sejnowski, Terrence/AAV-5558-2021; Nery, Joseph/AAE-8422-2019	Li, Junhao/0000-0001-6784-3780; Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Keown, Christopher/0000-0002-0800-372X	NIH BRAIN initiative grants [5U01MH105985, 1R21MH112161, 1R21HG009274]; NIH [2T32MH020002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG009274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH112161, T32MH020002, U01MH105985] Funding Source: NIH RePORTER	NIH BRAIN initiative grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. O'Connor and C. Fitzpatrick at Salk Institute Flow Cytometry Core for sorting of nuclei; U. Manor and T. Zhang at Salk Institute Waitt Advanced Biophotonics Core for assisting with imaging; R. Loughnan for assistance of data analysis; and J. Simon for assisting with illustration. Supported by NIH BRAIN initiative grants 5U01MH105985 and 1R21MH112161 (J.R.E. and M.M.B.) and 1R21HG009274 (J.R.E.) and by NIH grant 2T32MH020002 (C.L.K.). T.J.S. and J.R.E. are investigators of the Howard Hughes Medical Institute. Data can be downloaded from NCBI GEO (GSE97179) and http://brainome.org. L.K. is an inventor on a patent application (US 14/384,113) submitted by Swift Biosciences Inc. that covers Adaptase. The source code for bioinformatic analyses is available at https://github.com/mukamel-lab/snmcseq and https://github.com/yupenghe/methylpy.	Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Kozlenkov A, 2016, NUCLEIC ACIDS RES, V44, P2593, DOI 10.1093/nar/gkv1304; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Mo A, 2016, ELIFE, V5, DOI 10.7554/eLife.11613; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	24	232	235	10	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					600	604		10.1126/science.aan3351	http://dx.doi.org/10.1126/science.aan3351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798132	Green Accepted			2022-12-28	WOS:000407324800043
J	Hatanaka, F; Ocampo, A; Belmonte, JCI				Hatanaka, Fumiyuki; Ocampo, Alejandro; Belmonte, Juan Carlos Izpisua			Keeping the Rhythm while Changing the Lyrics: Circadian Biology in Aging	CELL			English	Editorial Material							CLOCK; METABOLISM; SIRTUINS; BRAIN		[Hatanaka, Fumiyuki; Ocampo, Alejandro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu		Ocampo, Alejandro/0000-0002-3731-3647				[Anonymous], TITLE ERROR; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Brunet A, 2017, CURR OPIN CELL BIOL, V45, P1, DOI 10.1016/j.ceb.2016.12.009; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Masri S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005685	9	8	8	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					599	600		10.1016/j.cell.2017.07.039	http://dx.doi.org/10.1016/j.cell.2017.07.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802034	Bronze			2022-12-28	WOS:000407445700002
J	Kong, LY; Longtin, Y				Kong, Ling Yuan; Longtin, Yves			Left-Middle-Lobe Pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kong, Ling Yuan] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Longtin, Yves] Jewish Gen Hosp, Montreal, PQ, Canada	McGill University; McGill University	Kong, LY (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ, Canada.	ling.kong@mail.mcgill.ca		Longtin, Yves/0000-0002-4532-379X					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					E8	E8		10.1056/NEJMicm1700661	http://dx.doi.org/10.1056/NEJMicm1700661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28792883				2022-12-28	WOS:000407212600011
J	Parry, V				Parry, Vivienne			Commit to talks on patient data and public health	NATURE			English	Editorial Material									[Parry, Vivienne] Genom England, Engagement, London, England		Parry, V (corresponding author), Genom England, Engagement, London, England.	v@vparry.co.uk							0	3	5	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					137	137		10.1038/548137a	http://dx.doi.org/10.1038/548137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28796226	Bronze			2022-12-28	WOS:000407284300014
J	Daniel, GW; Schneider, M; McClellan, MB				Daniel, Gregory W.; Schneider, Monika; McClellan, Mark B.			Addressing Antimicrobial Resistance and Stewardship The Priority Antimicrobial Value and Entry (PAVE) Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Daniel, Gregory W.; Schneider, Monika; McClellan, Mark B.] Duke Univ, Ctr Hlth Policy, Washington, DC 20004 USA	Duke University	McClellan, MB (corresponding author), Duke Univ, 1201 Penn Ave NW,Ste 500, Washington, DC 20004 USA.	mark.mcclellan@duke.edu			US Food and Drug Administration; Merck Co.	US Food and Drug Administration; Merck Co.(Merck & Company)	This work was supported by funds from the US Food and Drug Administration and from Merck & Co.	Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P806, DOI 10.1001/jama.2016.9690; Baggs J, 2016, JAMA INTERN MED, V176, P1639, DOI 10.1001/jamainternmed.2016.5651; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Daniel GW, VALUE BASED STRATEGI; Friedrich MJ, 2016, JAMA-J AM MED ASSOC, V316, P1956, DOI 10.1001/jama.2016.16531; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Review on Antimicrobial Resistance, 2014, ANTIMICROBIAL RESIST; Rex JH, 2016, LANCET INFECT DIS, V16, P500, DOI 10.1016/S1473-3099(15)00500-9	8	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2017	318	12					1103	1104		10.1001/jama.2017.10164	http://dx.doi.org/10.1001/jama.2017.10164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI2LE	28772301				2022-12-28	WOS:000411769300012
J	Jagsi, R				Jagsi, Reshma			Early-stage breast cancer: falling risks and emerging options	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; IRRADIATION; RADIOTHERAPY; WOMEN; HEART; OLDER		[Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu			National Institutes of Health [R01, P01]; Doris Duke Foundation; Greenwall Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Greenwall Foundation	I have received grants from the National Institutes of Health (R01 and P01), the Doris Duke Foundation, and the Greenwall Foundation.	[Anonymous], 2006, Clin Adv Hematol Oncol, V4, P719; Coles CE, 2017, LANCET; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Gradishar WJ, 2017, J NATL COMPR CANC NE, V15, P433, DOI 10.6004/jnccn.2017.0044; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Kunkler IH, 2015, LANCET ONCOL, V16, P266, DOI 10.1016/S1470-2045(14)71221-5; Livi L, 2015, EUR J CANCER, V51, P451, DOI 10.1016/j.ejca.2014.12.013; Olivotto IA, 2013, J CLIN ONCOL, V31, P4038, DOI 10.1200/JCO.2013.50.5511; Taylor C, 2017, J CLIN ONCOL, V35, P1641, DOI 10.1200/JCO.2016.72.0722	9	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1010	1012		10.1016/S0140-6736(17)31599-4	http://dx.doi.org/10.1016/S0140-6736(17)31599-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28779962	hybrid			2022-12-28	WOS:000409528600007
J	van der Merwe, A; Graewe, F; Zuhlke, A; Barsdorf, NW; Zarrabi, AD; Viljoen, JT; Ackermann, H; Spies, PV; Opondo, D; Al-Qaoud, T; Bezuidenhout, K; Nel, JD; Bailey, B; Moosa, MR				van der Merwe, Andre; Graewe, Frank; Zuhlke, Alexander; Barsdorf, Nicola W.; Zarrabi, Amir D.; Viljoen, Jeremy T.; Ackermann, Hilgard; Spies, Pieter V.; Opondo, Dedan; Al-Qaoud, Talal; Bezuidenhout, Karla; Nel, Johan D.; Bailey, Bertha; Moosa, M. Rafique			Penile allotransplantation for penis amputation following ritual circumcision: a case report with 24 months of follow-up	LANCET			English	Article							TRADITIONAL MALE CIRCUMCISION; FACE TRANSPLANTATION; DRUG-INTERACTION; MANAGEMENT; EASTERN; ORGAN; ALLOGRAFTS; ETHICS; XHOSA	Introduction Ritual circumcision complicated by gangrene is a leading cause of penile loss in young men in South Africa. This deeply rooted cultural tradition is unlikely to be abolished. Conventional reconstructive techniques using free vascularised tissue flaps with penile implants are undesirable in this often socioeconomically challenged group because donor site morbidity can hinder manual labour and vigorous sexual activity might lead to penile implant extrusion. The psychosociological effects of penile loss in a young man are devastating and replacing it with the same organ is likely to produce the maximum benefit. Methods We first performed a cadaver-to-cadaver penile transplantation as preparation. After approval from the Human Research Ethics Committee was obtained, we recruited potential recipients. We screened the potential participants for both physical and psychological characteristics, including penile stump length, and emotional suitability for the procedure. A suitable donor became available and the penis was harvested. We surgically prepared the penile stump of the recipient and attached the penile graft. Immunosuppression treatment with antithymyocyte globulin, methylprednisolone, tacrolimus, mycophenolate mofetil, and prednisone were commenced. Tadalafil at 5 mg once per day was commenced after 1 week as penile rehabilitation and was continued for 3 months. We collected on qualityof- life scores (Short Form 36 version 2 [SF-36v2] questionnaires) before surgery and during follow-up and measured erectile function (International Index for Erectile Function [IIEF] score) and urine flow rates at 24 months post transplant. Findings The warm ischaemia time for the graft after removal was 4 min and the cold ischaemia time was 16 h. The surgery lasted 9 h. An arterial thrombus required urgent revision 8 h after the operation. On post operative day 6, an infected haematoma and an area of proximal skin necrosis were surgically treated. The recipient was discharged after 1 month and first reported satisfactory sexual intercourse 1 week later (despite advice to the contrary). The recipient reported regular sexual intercourse from 3 months after the operation. An episode of acute kidney injury at 7 months was reversed by reducing the tacrolimus dose to 14 mg twice per day. At 8 months after surgery, the patient had a skin infection with phaeohyphomycosis due to Alternaria alternata, which we treated with topical antifungal medication. Quality-of-life scores improved substantially after the operation (SF-36v2 mental health scores improved from 25 preoperatively, to 57 at 6 months and 46 at 24 months post transplant; physical health scores improved from 37 at baseline to 60 at 6 months and 59 at 24 months post-transplant). At 24 months, measured maximum urine flow rate (16.3 mL/s from a volume voided of 109 mL) and IIEF score (overall satisfaction score of 8 from a maximum of 10) were normal, showing normal voiding and erectile function, respectively. Interpretation Penile transplantation restored normal physiological functions in this transplant recipient without major complications in the first 24 months.	[van der Merwe, Andre; Zarrabi, Amir D.; Viljoen, Jeremy T.; Ackermann, Hilgard; Spies, Pieter V.; Opondo, Dedan] Stellenbosch Univ, Fac Med & Hlth Sci, Div Urol, ZA-8000 Cape Town, South Africa; [Graewe, Frank; Zuhlke, Alexander] Stellenbosch Univ, Fac Med & Hlth Sci, Div Plast & Reconstruct Surg, Cape Town, South Africa; [Barsdorf, Nicola W.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Res Dev & Support, Hlth Res Eth, Cape Town, South Africa; [Bezuidenhout, Karla; Nel, Johan D.; Moosa, M. Rafique] Stellenbosch Univ, Fac Med & Hlth Sci, Div Nephrol, Dept Med, Cape Town, South Africa; [van der Merwe, Andre] Tygerberg Acad Hosp, ZA-8000 Cape Town, South Africa; [Bailey, Bertha] Tygerberg Acad Hosp, Renal Unit, Cape Town, South Africa; [Al-Qaoud, Talal] Univ Wisconsin, Dept Surg, Div Transplant Surg, Milwaukee, WI 53201 USA	Stellenbosch University; Stellenbosch University; Stellenbosch University; Stellenbosch University; University of Wisconsin System; University of Wisconsin Milwaukee	van der Merwe, A (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Urol, ZA-8000 Cape Town, South Africa.; van der Merwe, A (corresponding author), Tygerberg Acad Hosp, ZA-8000 Cape Town, South Africa.	arvdm@sun.ac.za	Al-Qaoud, Talal/AAV-9349-2021	Barsdorf, Nicola/0000-0001-6406-8352	Department of Health, Western Cape Government	Department of Health, Western Cape Government	Department of Health, Western Cape Government.	BASCH SH, 1973, PSYCHOANAL QUART, V42, P364, DOI 10.1080/21674086.1973.11926639; BASCH SH, 1973, TRANSPLANT P, V5, P1125; BLACHER RS, 1970, ARCH GEN PSYCHIAT, V22, P319; Caplan AL, 2017, TRANSPLANTATION, V101, P1200, DOI 10.1097/TP.0000000000001352; CASTELNU.P, 1973, PSYCHOANAL QUART, V42, P349, DOI 10.1080/21674086.1973.11926638; CASTELNUOVOTEDESCO P, 1978, PSYCHOANAL QUART, V47, P381, DOI 10.1080/21674086.1978.11926849; Ciftci H, 2012, J PAK MED ASSOC, V62, P280; Clark PA, 2005, MED SCI MONITOR, V11, pRA41; Coffman KL, 2010, CURR OPIN ORGAN TRAN, V15, P236, DOI 10.1097/MOT.0b013e328337267d; CROWLEY IP, 1990, BRIT J UROL, V66, P318, DOI 10.1111/j.1464-410X.1990.tb14936.x; Darewicz Barbara, 2001, International Urology and Nephrology, V33, P385, DOI 10.1023/A:1015226115774; Dubernard JM, 2006, EUR UROL, V50, P664, DOI 10.1016/j.eururo.2006.07.055; Dubernard JM, 2011, P AM PHILOS SOC, V155, P13; Dubernard JM, 2005, AM J TRANSPLANT, V5, P1580, DOI 10.1111/j.1600-6143.2005.00888.x; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Fischer S, 2014, CURR OPIN ORGAN TRAN, V19, P531, DOI 10.1097/MOT.0000000000000140; Foster BJ, 2015, PEDIATR NEPHROL, V30, P567, DOI 10.1007/s00467-014-2859-7; Foster BJ, 2011, TRANSPLANTATION, V92, P1237, DOI 10.1097/TP.0b013e31823411d7; Fuoco M, 2015, CAN UROL ASS J; GEARHART JP, 1989, J UROLOGY, V142, P799, DOI 10.1016/S0022-5347(17)38893-6; HABERAL M, 1991, RENAL FAILURE, V13, P103, DOI 10.3109/08860229109022154; Hu WL, 2006, EUR UROL, V50, P851, DOI 10.1016/j.eururo.2006.07.026; Jezior JR, 2001, WORLD J SURG, V25, P1602, DOI 10.1007/s00268-001-0157-6; Kadioglu A, 2015, THER ADV UROL, V7, P146, DOI [10.1177/, 10.1177/1756287215576626]; Kepe T, 2010, SOC SCI MED, V70, P729, DOI 10.1016/j.socscimed.2009.11.016; Kuypers DR, 2006, TRANSPLANTATION, V81, P1750, DOI 10.1097/01.tp.0000226080.71764.8c; Kuypers DR, 2005, TRANSPLANTATION, V79, P737, DOI 10.1097/01.TP.0000147462.86886.F3; Lavergne RA, 2012, TRANSPL INFECT DIS, V14, pE156, DOI 10.1111/tid.12020; Leyngold MM, 2014, J RECONSTR MICROSURG, V30, P581, DOI 10.1055/s-0034-1383427; Malan M., 2013, MAIL GUARDIAN; Malan M, 2014, MAIL GUARDIAN; Masala D, 2012, TRANSPL P, V44, P1346, DOI 10.1016/j.transproceed.2012.01.123; Mavundla TR, 2010, QUAL HEALTH RES, V20, P931, DOI 10.1177/1049732310363804; Mavundla TR, 2009, J TRANSCULT NURS, V20, P395, DOI 10.1177/1043659609340801; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Meissner O, 2007, SAMJ S AFR MED J, V97, P371; Ornellas AA, 2008, J SURG ONCOL, V97, P199, DOI 10.1002/jso.20893; Rashid Mamoon, 2013, Indian J Plast Surg, V46, P283, DOI 10.4103/0970-0358.118606; Siemionow M, 2010, AM J TRANSPLANT, V10, P1290, DOI 10.1111/j.1600-6143.2010.03096.x; Siemionow M, 2011, ARCH IMMUNOL THER EX, V59, P157, DOI 10.1007/s00005-011-0121-6; SONG RY, 1982, CLIN PLAST SURG, V9, P21; Tobin GR, 2005, TRANSPLANT P, V37, P1392, DOI 10.1016/j.transproceed.2004.12.179; Trachtman H, 2004, AM J BIOETHICS, V4, pW33, DOI 10.1080/15265160490508963; Tuffaha SH, 2014, PLAST RECONSTR SURG, V134, p1000E, DOI 10.1097/PRS.0000000000000901; Vermeire SE, 2010, DIAGN MICROBIOL INFE; Vieira M. Raquel, 1998, Revista Iberoamericana de Micologia, V15, P97; Wiggins OP, 2004, AM J BIOETHICS, V4, P1, DOI 10.1080/15265160490496507; Wilcken A, 2010, B WORLD HEALTH ORGAN, V88, P907, DOI 10.2471/BLT.09.072975; Williams M, 2013, NAT REV UROL, V10, P504, DOI 10.1038/nrurol.2013.148; Zhang LC, 2010, ASIAN J ANDROL, V12, P795, DOI 10.1038/aja.2010.88	50	46	46	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1038	1047		10.1016/S0140-6736(17)31807-X	http://dx.doi.org/10.1016/S0140-6736(17)31807-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28823494				2022-12-28	WOS:000409528600022
J	Liao, SK; Cai, WQ; Liu, WY; Zhang, L; Li, Y; Ren, JG; Yin, J; Shen, Q; Cao, Y; Li, ZP; Li, FZ; Chen, XW; Sun, LH; Jia, JJ; Wu, JC; Jiang, XJ; Wang, JF; Huang, YM; Wang, Q; Zhou, YL; Deng, L; Xi, T; Ma, L; Hu, T; Zhang, Q; Chen, YA; Liu, NL; Wang, XB; Zhu, ZC; Lu, CY; Shu, R; Peng, CZ; Wang, JY; Pan, JW				Liao, Sheng-Kai; Cai, Wen-Qi; Liu, Wei-Yue; Zhang, Liang; Li, Yang; Ren, Ji-Gang; Yin, Juan; Shen, Qi; Cao, Yuan; Li, Zheng-Ping; Li, Feng-Zhi; Chen, Xia-Wei; Sun, Li-Hua; Jia, Jian-Jun; Wu, Jin-Cai; Jiang, Xiao-Jun; Wang, Jian-Feng; Huang, Yong-Mei; Wang, Qiang; Zhou, Yi-Lin; Deng, Lei; Xi, Tao; Ma, Lu; Hu, Tai; Zhang, Qiang; Chen, Yu-Ao; Liu, Nai-Le; Wang, Xiang-Bin; Zhu, Zhen-Cai; Lu, Chao-Yang; Shu, Rong; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei			Satellite-to-ground quantum key distribution	NATURE			English	Article							ENTANGLEMENT DISTRIBUTION; ATOMIC ENSEMBLES; COMMUNICATION; TELEPORTATION; PURIFICATION; REPEATERS	Quantum key distribution (QKD) uses individual light quanta in quantum superposition states to guarantee unconditional communication security between distant parties. However, the distance over which QKD is achievable has been limited to a few hundred kilometres, owing to the channel loss that occurs when using optical fibres or terrestrial free space that exponentially reduces the photon transmission rate. Satellite-based QKD has the potential to help to establish a global-scale quantum network, owing to the negligible photon loss and decoherence experienced in empty space. Here we report the development and launch of a low-Earth-orbit satellite for implementing decoy-state QKD-a form of QKD that uses weak coherent pulses at high channel loss and is secure because photon-number-splitting eavesdropping can be detected. We achieve a kilohertz key rate from the satellite to the ground over a distance of up to 1,200 kilometres. This key rate is around 20 orders of magnitudes greater than that expected using an optical fibre of the same length. The establishment of a reliable and efficient space-to-ground link for quantum-state transmission paves the way to global-scale quantum networks.	[Liao, Sheng-Kai; Cai, Wen-Qi; Liu, Wei-Yue; Li, Yang; Ren, Ji-Gang; Yin, Juan; Shen, Qi; Cao, Yuan; Li, Zheng-Ping; Li, Feng-Zhi; Chen, Xia-Wei; Sun, Li-Hua; Zhang, Qiang; Chen, Yu-Ao; Liu, Nai-Le; Lu, Chao-Yang; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Liao, Sheng-Kai; Cai, Wen-Qi; Liu, Wei-Yue; Li, Yang; Ren, Ji-Gang; Yin, Juan; Shen, Qi; Cao, Yuan; Li, Zheng-Ping; Li, Feng-Zhi; Chen, Xia-Wei; Sun, Li-Hua; Zhang, Qiang; Chen, Yu-Ao; Liu, Nai-Le; Lu, Chao-Yang; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Liao, Sheng-Kai; Cai, Wen-Qi; Liu, Wei-Yue; Zhang, Liang; Li, Yang; Ren, Ji-Gang; Yin, Juan; Shen, Qi; Cao, Yuan; Li, Zheng-Ping; Li, Feng-Zhi; Chen, Xia-Wei; Sun, Li-Hua; Zhang, Qiang; Chen, Yu-Ao; Liu, Nai-Le; Wang, Xiang-Bin; Lu, Chao-Yang; Shu, Rong; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei] Univ Sci & Technol China, CAS, Ctr Excellence & Synerget Innovat, Ctr Quantum Informat & Quantum Phys, Shanghai 201315, Peoples R China; [Zhang, Liang; Jia, Jian-Jun; Wu, Jin-Cai; Shu, Rong; Wang, Jian-Yu] Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China; [Jiang, Xiao-Jun; Wang, Jian-Feng] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Huang, Yong-Mei; Wang, Qiang; Zhu, Zhen-Cai] Chinese Acad Sci, Inst Opt & Elect, Key Lab Opt Engn, Chengdu 610209, Sichuan, Peoples R China; [Zhou, Yi-Lin; Deng, Lei; Zhu, Zhen-Cai] Shanghai Engn Ctr Microsatellites, Shanghai 201203, Peoples R China; [Xi, Tao] Xian Satellite Control Ctr, State Key Lab Astronaut Dynam, Xian 710061, Shaanxi, Peoples R China; [Ma, Lu] Chinese Acad Sci, Xinjiang Astron Observ, Urumqi 830011, Peoples R China; [Hu, Tai] Chinese Acad Sci, Natl Space Sci Ctr, Beijing 100190, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; Institute of Optics & Electronics, CAS; Chinese Academy of Sciences; Xinjiang Astronomy Observatory, NACO, CAS; Chinese Academy of Sciences; National Space Science Center, CAS	Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.; Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.; Peng, CZ; Wang, JY; Pan, JW (corresponding author), Univ Sci & Technol China, CAS, Ctr Excellence & Synerget Innovat, Ctr Quantum Informat & Quantum Phys, Shanghai 201315, Peoples R China.; Wang, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China.	pcz@ustc.edu.cn; jywang@mail.sitp.ac.cn; pan@ustc.edu.cn	Li, Fengzhi/GXF-0115-2022; Lu, Chao-Yang/D-8481-2011; Pan, Jian-Wei/A-2332-2010; liao, shengkai/L-7149-2019; yin, juan/AAG-3315-2021; wang, xiang-bin/M-8900-2019; Chen, Yu-Ao/B-2057-2013; cao, yuan/GRR-9461-2022	Lu, Chao-Yang/0000-0002-8227-9177; Pan, Jian-Wei/0000-0002-6100-5142; wang, xiang-bin/0000-0002-3026-9364; Chen, Yu-Ao/0000-0002-2309-2281; Li, Yang/0000-0001-5989-4326; Shen, Qi/0000-0001-9494-6005	Strategic Priority Research Program on Space Science, Chinese Academy of Sciences; National Natural Science Foundation of China	Strategic Priority Research Program on Space Science, Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank many colleagues at the National Space Science Center, especially B.-M. Xu, J. Li, J.-C. Gong, B. Chen and J. Liu for their management and coordination. We thank X.-F. Ma, C. Jiang, L. Li, X.-M. Zhang and Y.-W. Chen for discussions. This work was supported by the Strategic Priority Research Program on Space Science, Chinese Academy of Sciences, and the National Natural Science Foundation of China.	Bennett C. H., 1989, SIGACT News, V20, P78, DOI 10.1145/74074.74087; Bennett C.H., 1984, P IEEE INT C COMP SY, P175, DOI DOI 10.1016/J.TCS.2014.05.025; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Brassard G, 2000, PHYS REV LETT, V85, P1330, DOI 10.1103/PhysRevLett.85.1330; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chen TY, 2010, OPT EXPRESS, V18, P27217, DOI 10.1364/OE.18.027217; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Liao SK, 2017, NAT PHOTONICS, V11, P509, DOI [10.1038/nphoton.2017.116, 10.1038/NPHOTON.2017.116]; Lo HK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230504; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Nauerth S, 2013, NAT PHOTONICS, V7, P382, DOI [10.1038/nphoton.2013.46, 10.1038/NPHOTON.2013.46]; Pan JW, 2003, NATURE, V423, P417, DOI 10.1038/nature01623; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Peng CZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150501; Rarity JG, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/382; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; SHANNON CE, 1949, BELL SYST TECH J, V28, P656, DOI 10.1002/j.1538-7305.1949.tb00928.x; Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Vallone G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.040502; Wang JY, 2013, NAT PHOTONICS, V7, P387, DOI [10.1038/nphoton.2013.89, 10.1038/NPHOTON.2013.89]; Wang XB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230503; Wang XB, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075006; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Yang SJ, 2016, NAT PHOTONICS, V10, P381, DOI [10.1038/nphoton.2016.51, 10.1038/NPHOTON.2016.51]; Yin HL, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.190501; Yin J, 2013, OPT EXPRESS, V21, P20032, DOI 10.1364/OE.21.020032; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	32	708	738	47	495	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					43	+		10.1038/nature23655	http://dx.doi.org/10.1038/nature23655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28825707	Green Submitted			2022-12-28	WOS:000409388700029
J	Burgos-Barragan, G; Wit, N; Meiser, J; Dingler, FA; Pietzke, M; Mulderrig, L; Pontel, LB; Rosado, IV; Brewer, TF; Cordell, RL; Monks, PS; Chang, CJ; Vazquez, A; Patel, KJ				Burgos-Barragan, Guillermo; Wit, Niek; Meiser, Johannes; Dingler, Felix A.; Pietzke, Matthias; Mulderrig, Lee; Pontel, Lucas B.; Rosado, Ivan V.; Brewer, Thomas F.; Cordell, Rebecca L.; Monks, Paul S.; Chang, Christopher J.; Vazquez, Alexei; Patel, Ketan J.			Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism	NATURE			English	Article							FOLIC-ACID; LIVING CELLS; HUMAN LIVER; DNA-DAMAGE; FOLATE; MITOCHONDRIAL; DEHYDROGENASE; COMPARTMENTALIZATION; PURIFICATION; CATABOLISM	The folate-driven one-carbon (1C) cycle is a fundamental metabolic hub in cells that enables the synthesis of nucleotides and amino acids and epigenetic modifications. This cycle might also release formaldehyde, a potent protein and DNA crosslinking agent that organisms produce in substantial quantities. Here we show that supplementation with tetrahydrofolate, the essential cofactor of this cycle, and other oxidation-prone folate derivatives kills human, mouse and chicken cells that cannot detoxify formaldehyde or that lack DNA crosslink repair. Notably, formaldehyde is generated from oxidative decomposition of the folate backbone. Furthermore, we find that formaldehyde detoxification in human cells generates formate, and thereby promotes nucleotide synthesis. This supply of 1C units is sufficient to sustain the growth of cells that are unable to use serine, which is the predominant source of 1C units. These findings identify an unexpected source of formaldehyde and, more generally, indicate that the detoxification of this ubiquitous endogenous genotoxin creates a benign 1C unit that can sustain essential metabolism.	[Burgos-Barragan, Guillermo; Wit, Niek; Dingler, Felix A.; Mulderrig, Lee; Pontel, Lucas B.; Patel, Ketan J.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Meiser, Johannes; Pietzke, Matthias; Vazquez, Alexei] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rosado, Ivan V.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville 41013, Spain; [Brewer, Thomas F.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Brewer, Thomas F.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Cordell, Rebecca L.; Monks, Paul S.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	MRC Laboratory Molecular Biology; Beatson Institute; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Leicester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Patel, KJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	kjp@mrc-lmb.cam.ac.uk	Pontel, Lucas/ABI-7791-2020; Monks, Paul/H-6468-2016; Rosado, Ivan/AAZ-9068-2020; meiser, johannes/S-7571-2018	Pontel, Lucas/0000-0001-8384-3422; Monks, Paul/0000-0001-9984-4390; Rosado, Ivan/0000-0001-7409-7341; meiser, johannes/0000-0002-9093-6210; Pietzke, Matthias/0000-0002-6901-8511; Cordell, Rebecca Lynne/0000-0002-3775-0193; Brewer, Thomas/0000-0003-2978-0250	CRUK Cambridge Cancer Centre studentship; Wellcome Trust; Children With Cancer; CRUK; European Union (FEDER) [BFU2013-42918-P, AES15/01409 (CP12/03273)]; NIH [GM 79465, ES004705]; Chemical Biology Training Grant from the NIH [T32 GM066698]; MRC; EPSRC; CRUK [C596/A21140, C596/A18076]; DFG Fellowship [ME 4636/2-1]; Medical Research Council;  [RYC-2015-18670]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, R01ES028096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM079465] Funding Source: NIH RePORTER; Cancer Research UK [23273] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish; Versus Arthritis [21140] Funding Source: researchfish; Wellcome Trust [106202/Z/14/Z] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	CRUK Cambridge Cancer Centre studentship; Wellcome Trust(Wellcome Trust); Children With Cancer; CRUK(Cancer Research UK); European Union (FEDER)(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemical Biology Training Grant from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CRUK(Cancer Research UK); DFG Fellowship(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Knox and the LMB mouse facility, the LMB FACS facility and G. MacKay and D. Sumpton from the Beatson Metabolomics Unit. We thank H. Koyama for providing us with the FANCB-deficient NALM-6 strain. We are grateful to T. Elliott and A. Liang for assistance with the LMB LC-MS analyses. G.B.B. was funded by the CRUK Cambridge Cancer Centre studentship and the Wellcome Trust. N.W. was funded by Children With Cancer and the Wellcome Trust. L.B.P. was funded by the Wellcome Trust. F.A.D. and L.M. were funded by CRUK. I.V.R. was funded by BFU2013-42918-P, AES15/01409 (CP12/03273), European Union (FEDER) and RYC-2015-18670. We thank the NIH (GM 79465 and ES004705 to C.J.C.) for support of this work. C.J.C. is an Investigator of the Howard Hughes Medical Institute. T.F.B. was partially supported by a Chemical Biology Training Grant from the NIH (T32 GM066698). R.L.C. and P.S.M. are supported by the MRC. R.L.C. is also supported by the EPSRC. J.M., M.P. and A.V. were funded by CRUK (C596/A21140 and C596/A18076). J.M. was also funded by a DFG Fellowship (ME 4636/2-1). K.J.P. is supported by the Medical Research Council, CRUK and the Wellcome Trust.	Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Bae S, 2017, J NUTR, V147, P499, DOI 10.3945/jn.116.244467; Brewer TF, 2015, J AM CHEM SOC, V137, P10886, DOI 10.1021/jacs.5b05340; Bruemmer KJ, 2017, J AM CHEM SOC, V139, P5338, DOI 10.1021/jacs.6b12460; CHIPPEL D, 1970, CAN J BIOCHEM CELL B, V48, P999, DOI 10.1139/o70-156; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; HECK HD, 1985, AM IND HYG ASSOC J, V46, P1, DOI 10.1080/15298668591394275; Horne DW, 2003, J NUTR, V133, P476, DOI 10.1093/jn/133.2.476; KOWNACKIBROWN PA, 1993, J NUTR, V123, P1101; Lawrence SA, 2014, J BIOL CHEM, V289, P29386, DOI 10.1074/jbc.M114.593244; Luo WH, 2001, J CHROMATOGR B, V753, P253, DOI 10.1016/S0378-4347(00)00552-1; Marean A, 2011, HUM MOL GENET, V20, P3678, DOI 10.1093/hmg/ddr289; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; Meiser J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601273; MURPHY M, 1979, BIOCHIM BIOPHYS ACTA, V583, P535, DOI 10.1016/0304-4165(79)90071-0; Nagy K, 2004, RAPID COMMUN MASS SP, V18, P2473, DOI 10.1002/rcm.1648; Nomura Y, 2007, GENES CELLS, V12, P1111, DOI 10.1111/j.1365-2443.2007.01124.x; OSBORN MJ, 1960, J AM CHEM SOC, V82, P4921, DOI 10.1021/ja01503a043; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; Pickell L, 2011, BIRTH DEFECTS RES A, V91, P8, DOI 10.1002/bdra.20754; Pontel LB, 2015, MOL CELL, V60, P177, DOI 10.1016/j.molcel.2015.08.020; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; SCHMITZ JC, 1994, BIOCHEM PHARMACOL, V48, P319, DOI 10.1016/0006-2952(94)90103-1; Scott KC, 1996, J NUTR BIOCHEM, V7, P261, DOI 10.1016/0955-2863(96)00026-5; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; UOTILA L, 1974, J BIOL CHEM, V249, P7653; UOTILA L, 1974, J BIOL CHEM, V249, P7664; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Wit N, 2015, NUCLEIC ACIDS RES, V43, P282, DOI 10.1093/nar/gku1301; Witham KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077923	36	167	169	9	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					549	+		10.1038/nature23481	http://dx.doi.org/10.1038/nature23481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28813411	Green Accepted, Green Published			2022-12-28	WOS:000408703100030
J	Liu, XJ; Locasale, JW				Liu, Xiaojing; Locasale, Jason W.			BIOCHEMISTRY A toxin that fuels metabolism	NATURE			English	Editorial Material							ONE-CARBON METABOLISM; SERINE; CANCER; GLYCINE; PATHWAY; TUMORS		[Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Locasale, JW (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	jason.locasale@duke.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502; Liu, Xiaojing/0000-0002-4231-6017	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER; NIH HHS [S10 OD018164] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Burgos-Barragan G, 2017, NATURE, V548, P549, DOI 10.1038/nature23481; Chandel NS., 2015, NAVIGATING METABOLIS; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Meiser J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601273; Pan M, 2016, NAT CELL BIOL, V18, P1090, DOI 10.1038/ncb3410; Ser Z, 2016, CELL REP, V15, P2367, DOI 10.1016/j.celrep.2016.05.035; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81	13	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					533	534		10.1038/nature23541	http://dx.doi.org/10.1038/nature23541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2BO	28813408				2022-12-28	WOS:000408703100026
J	Lee, ACC; Kozuki, N; Cousens, S; Stevens, GA; Blencowe, H; Silveira, MF; Sania, A; Rosen, HE; Schmiegelow, C; Adair, LS; Baqui, AH; Barros, FC; Bhutta, ZA; Caulfield, LE; Christian, P; Clarke, SE; Fawzi, W; Gonzalez, R; Humphrey, J; Huybregts, L; Kariuki, S; Kolsteren, P; Lusingu, J; Manandhar, D; Mongkolchati, A; Mullany, LC; Ndyomugyenyi, R; Nien, JK; Roberfroid, D; Saville, N; Terlouw, DJ; Tielsch, JM; Victora, CG; Velaphi, SC; Watson-Jones, D; Willey, BA; Ezzati, M; Lawn, JE; Black, RE; Katz, J				Lee, Anne C. C.; Kozuki, Naoko; Cousens, Simon; Stevens, Gretchen A.; Blencowe, Hannah; Silveira, Mariangela F.; Sania, Ayesha; Rosen, Heather E.; Schmiegelow, Christentze; Adair, Linda S.; Baqui, Abdullah H.; Barros, Fernando C.; Bhutta, Zulfiqar A.; Caulfield, Laura E.; Christian, Parul; Clarke, Sian E.; Fawzi, Wafaie; Gonzalez, Rogelio; Humphrey, Jean; Huybregts, Lieven; Kariuki, Simon; Kolsteren, Patrick; Lusingu, John; Manandhar, Dharma; Mongkolchati, Aroonsri; Mullany, Luke C.; Ndyomugyenyi, Richard; Jyh Kae Nien; Roberfroid, Dominique; Saville, Naomi; Terlouw, Dianne J.; Tielsch, James M.; Victora, Cesar G.; Velaphi, Sithembiso C.; Watson-Jones, Deborah; Willey, Barbara A.; Ezzati, Majid; Lawn, Joy E.; Black, Robert E.; Katz, Joanne		Cherg Small Gestational	Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; SYSTEMATIC ANALYSIS; RANDOMIZED-TRIAL; COHORT PROFILE; PRETERM BIRTH; FETAL-GROWTH; RISK-FACTORS; DOUBLE-BLIND; TIME TRENDS; VITAMIN-A	OBJECTIVES To estimate small for gestational age birth prevalence and attributable neonatal mortality in low and middle income countries with the INTERGROWTH-21st birth weight standard. DESIGN Secondary analysis of data from the Child Health Epidemiology Reference Group (CHERG), including 14 birth cohorts with gestational age, birth weight, and neonatal follow-up. Small for gestational age was defined as infants weighing less than the 10th centile birth weight for gestational age and sex with the multiethnic, INTERGROWTH-21st birth weight standard. Prevalence of small for gestational age and neonatal mortality risk ratios were calculated and pooled among these datasets at the regional level. With available national level data, prevalence of small for gestational age and population attributable fractions of neonatal mortality attributable to small for gestational age were estimated. SETTING CHERG birth cohorts from 14 population based sites in low and middle income countries. MAIN OUTCOME MEASURES In low and middle income countries in the year 2012, the number and proportion of infants born small for gestational age; number and proportion of neonatal deaths attributable to small for gestational age; the number and proportion of neonatal deaths that could be prevented by reducing the prevalence of small for gestational age to 10%. RESULTS In 2012, an estimated 23.3 million infants (uncertainty range 17.6 to 31.9; 19.3% of live births) were born small for gestational age in low and middle income countries. Among these, 11.2 million (0.8 to 15.8) were term and not low birth weight (>= 2500 g), 10.7 million (7.6 to 15.0) were term and low birth weight (<2500 g) and 1.5 million (0.9 to 2.6) were preterm. In low and middle income countries, an estimated 606 500 (495 000 to 773 000) neonatal deaths were attributable to infants born small for gestational age, 21.9% of all neonatal deaths. The largest burden was in South Asia, where the prevalence was the highest (34%); about 26% of neonatal deaths were attributable to infants born small for gestational age. Reduction of the prevalence of small for gestational age from 19.3% to 10.0% in these countries could reduce neonatal deaths by 9.2% (254 600 neonatal deaths; 164 800 to 449 700). CONCLUSIONS In low and middle income countries, about one in five infants are born small for gestational age, and one in four neonatal deaths are among such infants. Increased efforts are required to improve the quality of care for and survival of these high risk infants in low and middle income countries	[Lee, Anne C. C.] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Lee, Anne C. C.] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Kozuki, Naoko] Int Rescue Comm, 1730 M St NW,Suite 505, Washington, DC 20036 USA; [Kozuki, Naoko; Rosen, Heather E.; Baqui, Abdullah H.; Humphrey, Jean; Mullany, Luke C.; Black, Robert E.; Katz, Joanne] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA; [Cousens, Simon; Blencowe, Hannah; Willey, Barbara A.; Lawn, Joy E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Cousens, Simon; Blencowe, Hannah; Willey, Barbara A.; Lawn, Joy E.] London Sch Hyg & Trop Med, MARCH Ctr, London WC1E 7HT, England; [Stevens, Gretchen A.] WHO, Dept Informat Evidence & Res, CH-1211 Geneva, Switzerland; [Silveira, Mariangela F.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Rua Marechal Deodoro 1160,30 Piso,Centro, BR-96020220 Pelotas, RS, Brazil; [Sania, Ayesha] Columbia Univ, Mailman Sch Publ Hlth, 722 W 68th St, New York, NY 10032 USA; [Schmiegelow, Christentze] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Oester Farimagsgade 5, DK-1014 Copenhagen K, Denmark; [Adair, Linda S.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, 135 Dauer Dr, Chapel Hill, NC 27599 USA; [Adair, Linda S.] Univ North Carolina Chapel Hill, Carolina Populat Ctr, 137 E Franklin, Chapel Hill, NC 27516 USA; [Barros, Fernando C.] Univ Catolica Pelotas, Programa Posgrad Saude & Comportamento, Felix Cunha 412, BR-96010000 Pelotas, RS, Brazil; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, 686 Bay St, Toronto M5G A04, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Stadium Rd POB 3500, Karachi 74800, Pakistan; [Caulfield, Laura E.; Humphrey, Jean] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, 615 N Wolfe St,W2041, Baltimore, MD 21205 USA; [Christian, Parul] Bill & Melinda Gates Fdn, Womens Nutr, Seattle, WA 98102 USA; [Clarke, Sian E.] London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, London WC1E 7HT, England; [Clarke, Sian E.] London Sch Hyg & Trop Med, Malaria Ctr, London WC1E 7HT, England; [Fawzi, Wafaie] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, 677 Huntington Ave, Boston, MA 02115 USA; [Fawzi, Wafaie] Harvard Sch Publ Hlth, Dept Nutr, 677 Huntington Ave, Boston, MA 02115 USA; [Fawzi, Wafaie] Harvard Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Gonzalez, Rogelio] Pontificia Univ Catolica Chile, Sch Med, Ave Libertador Gen Bernardo OHiggins 340, Santiago, Chile; [Gonzalez, Rogelio] Clin Santa Maria, Ave Santa Maria 0410 Providencia, Santiago, Chile; [Humphrey, Jean] Zvitambo Inst Maternal & Child Hlth Res, 06 Lauchlan Rd,Meyrick Pk, Harare, Zimbabwe; [Huybregts, Lieven; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Coupure Links 653, B-9000 Ghent, Belgium; [Huybregts, Lieven] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, 2033 K St NW, Washington, DC 20006 USA; [Kariuki, Simon] Ctr Global Hlth Res, Kenya Med Res Inst, POB 1578-40100, Kisumu, Kenya; [Kariuki, Simon] Ctr Dis Control & Prevent Kenya, Kisumu Busia Highway,POB 1578-40100, Kisumu, Kenya; [Lusingu, John] Natl Inst Med Res, POB 5004, Tanga, Tanzania; [Lusingu, John] Univ Copenhagen, Copenhagen, Denmark; [Manandhar, Dharma; Saville, Naomi] YB Bhawan, MIRA, Kathmandu 921, Nepal; [Mongkolchati, Aroonsri] Mahidol Univ, ASEAN Inst Hlth Dev, 999 Phuttamonthon 4 Rd, Salaya 73170, Nakhon Pathom, Thailand; [Ndyomugyenyi, Richard] Minist Hlth, Vector Control Div, Plot 6 Lourdel Rd, Kampala, Uganda; [Jyh Kae Nien] Clin Davila, Fetal Maternal Med Unit, Ave Recoleta, Santiago 464, Chile; [Jyh Kae Nien] Univ Los Andes, Fac Med, Avda San Carlos Apoquindo, Santiago 2200, Chile; [Roberfroid, Dominique] Belgian Hlth Care Knowledge Ctr, Blvd Jardin Botan 55, Brussels, Belgium; [Saville, Naomi] London Inst Child Hlth, Univ Coll, Inst Global Hlth, London WC1N 1EH, England; [Terlouw, Dianne J.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Terlouw, Dianne J.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, POB 30096, Blantyre 3, Malawi; [Tielsch, James M.] George Washington Univ, Milken Inst School Publ Hlth, Dept Global Hlth, 950 Nov Hampshire Ave,NW,Suite 400, Washington, DC 20052 USA; [Velaphi, Sithembiso C.] Univ Witwatersrand, Fac Hlth Sci, Chris Hani Baragwaireth Hosp, Dept Paediat, Johannesburg, South Africa; [Watson-Jones, Deborah] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Watson-Jones, Deborah] Natl Inst Med Res, Mwariza Intervent Trial Unit, Mwanza, Tanzania; [Ezzati, Majid] Imperial Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Black, Robert E.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Universidade Federal de Pelotas; Columbia University; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universidade Catolica de Pelotas; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Pontificia Universidad Catolica de Chile; Ghent University; CGIAR; International Food Policy Research Institute (IFPRI); Kenya Medical Research Institute; University of Copenhagen; Mahidol University; Clinica Davila; Universidad de los Andes - Chile; University of London; University College London; Liverpool School of Tropical Medicine; University of Malawi; George Washington University; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, ACC (corresponding author), Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA.; Lee, ACC (corresponding author), Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA.	alee6@bwh.harvard.edu	Lusingu, John P. A./GSJ-3228-2022; Nien, Jyh Kae/AAT-2826-2020; Kariuki, Simon/AFT-6596-2022; Clarke, Sian/AAF-5805-2019; Victora, Cesar Gomes/Y-2455-2019; Lawn, Joy/ABE-6382-2020; Huybregts, Lieven/B-9578-2009; Saville, Naomi/J-7244-2015	Victora, Cesar Gomes/0000-0002-2465-2180; Lawn, Joy/0000-0002-4573-1443; Terlouw, Anja/0000-0001-5327-8995; Lusingu, John P. A./0000-0002-9407-0602; Rosen, Heather/0000-0002-5581-6213; shmiegelow, christentze/0000-0002-9360-9741; Huybregts, Lieven/0000-0002-3068-2853; Nien, Jyh Kae/0000-0002-2572-9653; Barros, Fernando/0000-0001-5973-1746; Saville, Naomi/0000-0002-1735-3684; Sania, Ayesha/0000-0002-6445-9481; Katz, Joanne/0000-0002-5997-7823; Blencowe, Hannah/0000-0003-1556-3159	Bill and Melinda Gates Foundation [810.2054]; US Agency for International Development (USAID); Saving, Newborn Lives program by Save the Children (US); Bill and Melinda Gates Foundation (BMGF); India Center for Human Nutrition (JHSPH); Office of Health and Nutrition (USAID); War task Force Sight and ins Nepal; USAID; UNICEF Country Office (Kathmandu, Nepal); BMGF, Nepal; Wellcome Trust; Nepal; National Institutes of Health (NIH); BMGF; Proctor and Gamble; UNICEF; UN System Standing Committee on Nutrition; NiH, Nestle's Coordinating Center for Nutritional Research; Wyeth International; Fold Foundation; US National Academy of Science; WHO; Carolina Population Center USAID; Thailand Research Fund; Health System Research Office; Ministry of Public Health, Thailand; Nutrition Third World, Belgian Ministry of Development; Huffish University Council; Nutrition Third World, Belgian Ministry of Development, Nutriset; Kenya USAID; Royal Netherlands Embassy; Netherlands Foundation For the Advancement of Tropical Research; South Africa; Wellcome trust; South Africa; USAID, National Vaccine Program Office; CDC's Antimicrobial Resistance Woking Group, BMG; Wellcome Trust; Tanzania; National Institute or Child Health and Human Development; European Union; Gates Malaria Partnership (BMGF); Canadian International Development Agency; Center for Canada; UK Overseas Development:Administration; UN Development Fund for Women; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, K23HD091390] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Saving, Newborn Lives program by Save the Children (US); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); India Center for Human Nutrition (JHSPH); Office of Health and Nutrition (USAID); War task Force Sight and ins Nepal; USAID(United States Agency for International Development (USAID)); UNICEF Country Office (Kathmandu, Nepal); BMGF, Nepal; Wellcome Trust; Nepal(Wellcome Trust); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMGF; Proctor and Gamble(Procter & Gamble); UNICEF; UN System Standing Committee on Nutrition; NiH, Nestle's Coordinating Center for Nutritional Research(Nestle SA); Wyeth International(Wyeth); Fold Foundation; US National Academy of Science; WHO(World Health Organization); Carolina Population Center USAID(United States Agency for International Development (USAID)); Thailand Research Fund(Thailand Research Fund (TRF)); Health System Research Office; Ministry of Public Health, Thailand; Nutrition Third World, Belgian Ministry of Development; Huffish University Council; Nutrition Third World, Belgian Ministry of Development, Nutriset; Kenya USAID; Royal Netherlands Embassy; Netherlands Foundation For the Advancement of Tropical Research; South Africa; Wellcome trust; South Africa; USAID, National Vaccine Program Office; CDC's Antimicrobial Resistance Woking Group, BMG; Wellcome Trust; Tanzania; National Institute or Child Health and Human Development; European Union(European Commission); Gates Malaria Partnership (BMGF); Canadian International Development Agency; Center for Canada; UK Overseas Development:Administration; UN Development Fund for Women; Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Bill and Melinda Gates Foundation (810.2054) by a grant to the US Fund for UNICEF to support the activities of the Child Health Epidemiology Reference Group. The funding source was not involved in the design, conduct, analysis, interpretation, and writing up of the study nor the decision to submit it tar publication. The authors were independent from the study sponsors. The funding sources of the individual studies are as follows: Bangladesh (2005) US Agency for International Development (USAID), Saving, Newborn Lives program by Save the Children (US), Bill and Melinda Gates Foundation (BMGF); India (2000) Center for Human Nutrition (JHSPH), Office of Health and Nutrition (USAID), War task Force Sight and ins Nepal. (1999) USAID, UNICEF Country Office (Kathmandu, Nepal), BMGF, Nepal (2003) Wellcome Trust; Nepal. (2004) National Institutes of Health (NIH), BMGF, USAID, Proctor and Gamble; Pakistan (2003)-UNICEF, UN System Standing Committee on Nutrition; Philippines (1983) NiH, Nestle's Coordinating Center for Nutritional Research, Wyeth International, Fold Foundation, US National Academy of Science, WHO, Carolina Population Center USAID; Thailand (2001) Thailand Research Fund, Health System Research Office, Ministry of Public Health, Thailand; Burkina Faso (2004) Nutrition Third World, Belgian Ministry of Development; Burkina Faso (2006) Huffish University Council, Nutrition Third World, Belgian Ministry of Development, Nutriset; Kenya (1995) USAID, Royal Netherlands Embassy, Netherlands Foundation For the Advancement of Tropical Research; South Africa (2001) Wellcome trust; South Africa (2004) USAID, National Vaccine Program Office and CDC's Antimicrobial Resistance Woking Group, BMG; Tanzania (1998)-Wellcome Trust; Tanzania (2001) National Institute or Child Health and Human Development; Tanzania (2008) European Union Framework 7; Uganda (2005)-Gates Malaria Partnership (BMGF); Zimbabwe (1997) Canadian International Development Agency, USAID, BMGF, Rockefeller Foundation, BASF; Brazil (1952) International Development Research Center for Canada, WHO, UK Overseas Development:Administration; Brazil (1993) UN Development Fund for Women; Brazil (2004) Wellcome Trust.; (bile (2000)-----not applicable; Peru (1995) Office or Health and Nutrition (USAiD).	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165; Anderson NH, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.931; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; BHATIA B D, 1981, Indian Pediatrics, V18, P647; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Buck Louis Germaine M, 2015, Am J Obstet Gynecol, V213, DOI 10.1016/j.ajog.2015.08.032; Cheng YKY, 2016, BJOG-INT J OBSTET GY, V123, P48, DOI 10.1111/1471-0528.14008; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Gernand AD, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0072-y; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; Isaranurug Sirikul, 2007, Journal of the Medical Association of Thailand, V90, P2559; Katz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092074; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; Kozuki N, 2015, JAMA PEDS, V169; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S3; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Metrics: Population Attributable Fraction (PAF), 2017, METR POP ATTR FRACT; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Ndyomugyenyi R, 2011, T ROY SOC TROP MED H, V105, P607, DOI 10.1016/j.trstmh.2011.07.012; Organization World Health, 2013, INT CLASS DIS ICD; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Robinson JS, 2000, EUR J OBSTET GYN R B, V92, P13, DOI 10.1016/S0301-2115(00)00421-8; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Santos IS, 2011, INT J EPIDEMIOL, V40, P1461, DOI 10.1093/ije/dyq130; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; The Partnership for Maternal N and Child Health, EV NEWB ACT PLAN END; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; UNICEF, 2016, UND WOMB CAN LEAD DI; Unicef/ UN Populations Division, STAT WORLDS CHILDR; United Nations Economic and Social Council, 2015, MILL DEV GOALS POST; Vander Hoorn S, 2004, COMP QUANTIFICATION, P2129; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Warshaw J., 2006, OSKIS PEDIAT, V3782, P70014; World Health Organization, HLTH STAT INF SYST M; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Zapata-Diomedi B, 2018, BRIT J SPORT MED, V52, P212, DOI 10.1136/bjsports-2015-095531	58	168	179	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2017	358								j3677	10.1136/bmj.j3677	http://dx.doi.org/10.1136/bmj.j3677			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5CB	28819030	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000408228500003
J	Poggianti, BM; Jaffe, YL; Moretti, A; Ullieuszik, MG; Radovich, M; Tonnesen, S; Fritz, J; Bettoni, D; Vulcani, B; Fasano, G; Bellhouse, C; Hau, G; Omizzolo, A				Poggianti, Bianca M.; Jaffe, Yara L.; Moretti, Alessia; Ullieuszik, Marco G.; Radovich, Mario; Tonnesen, Stephanie; Fritz, Jacopo; Bettoni, Daniela; Vulcani, Benedetta; Fasano, Giovanni; Bellhouse, Callum; Hau, George; Omizzolo, Alessandro			Ram-pressure feeding of supermassive black holes	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; VORONOI TESSELLATIONS; PHYSICAL-PROPERTIES; INFRARED GALAXIES; STRIPPING EVENTS; STAR-FORMATION; HOST GALAXIES; LOW-REDSHIFT; MUSE SNEAKS; CLUSTERS	When a supermassive black hole at the centre of a galaxy accretes matter, it gives rise to a highly energetic phenomenon: an active galactic nucleus(1,2). Numerous physical processes have been proposed to account for the funnelling of gas towards the galactic centre to feed the black hole. There are also several physical processes that can remove gas from a galaxy(3), one of which is ram-pressure stripping by the hot gas that fills the space between galaxies in galaxy clusters(4). Here we report that six out of a sample of seven 'jellyfish' galaxies-galaxies with long 'tentacles' of material that extend for dozens of kiloparsecs beyond the galactic disks(5,6)-host an active nucleus, and two of them also have galactic-scale ionization cones. The high incidence of nuclear activity among heavily stripped jellyfish galaxies may be due to ram pressure causing gas to flow towards the centre and triggering the activity, or to an enhancement of the stripping caused by energy injection from the active nucleus, or both. Our analysis of the galactic position and velocity relative to the cluster strongly supports the first hypothesis, and puts forward ram pressure as another possible mechanism for feeding the central supermassive black hole with gas.	[Poggianti, Bianca M.; Moretti, Alessia; Ullieuszik, Marco G.; Radovich, Mario; Bettoni, Daniela; Vulcani, Benedetta; Fasano, Giovanni] INAF Astron Observ Padova, Vicolo Osservatorio 5, I-35122 Padua, Italy; [Jaffe, Yara L.; Bellhouse, Callum; Hau, George] European Southern Observ, Alonso de Cordova 3107,Casilla 19001, Santiago, Chile; [Tonnesen, Stephanie] Carnegie Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA; [Fritz, Jacopo] UNAM, Inst Radioastron & Astrofis, Campus Morelia,AP 3-72, Morelia 58089, Michoacan, Mexico; [Vulcani, Benedetta] Univ Melbourne, Sch Phys, Swanston St & Tin Alley, Parkville, Vic 3010, Australia; [Bellhouse, Callum] Univ Birmingham, Sch Phys & Astron, Birmingham, W Midlands, England; [Omizzolo, Alessandro] Vatican Observ, Vatican City, Vatican	Istituto Nazionale Astrofisica (INAF); University of Padua; European Southern Observatory; Carnegie Institution for Science; Universidad Nacional Autonoma de Mexico; University of Melbourne; University of Birmingham; Vatican Observatory	Poggianti, BM (corresponding author), INAF Astron Observ Padova, Vicolo Osservatorio 5, I-35122 Padua, Italy.	bianca.poggianti@oapd.inaf.it	Fritz, Jacopo/HIK-2511-2022; Moretti, Alessia/N-3896-2019; Jaffé, Yara L/O-2752-2019; Vulcani, Benedetta/ABB-4847-2020	Moretti, Alessia/0000-0002-1688-482X; Jaffé, Yara L/0000-0003-2150-1130; Vulcani, Benedetta/0000-0003-0980-1499; Tonnesen, Stephanie/0000-0002-8710-9206; Radovich, Mario/0000-0002-3585-866X; Gullieuszik, Marco/0000-0002-7296-9780; Bettoni, Daniela/0000-0002-4158-6496; Hau, George/0000-0002-5390-4957; Omizzolo, Alessandro/0000-0002-0838-6580; Bellhouse, Callum/0000-0002-6179-8007	European Organisation for Astronomical Research in the Southern Hemisphere under ESO programme [196.B-0578]; PRIN-INAF; Australian Research Council Discovery Early Career Researcher Award [PD0028506]; Alvin E. Nashman Fellowship in Theoretical Astrophysics; Marie Curie Actions of the European Commission (FP7-COFUND)	European Organisation for Astronomical Research in the Southern Hemisphere under ESO programme; PRIN-INAF(Istituto Nazionale Astrofisica (INAF)Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); Alvin E. Nashman Fellowship in Theoretical Astrophysics; Marie Curie Actions of the European Commission (FP7-COFUND)	This work is based on observations collected at the European Organisation for Astronomical Research in the Southern Hemisphere under ESO programme 196.B-0578. We thank M. Fossati and D. Wilman for developing and making available KUBEVIZ. We acknowledge financial support from PRIN-INAF 2014. B.V. acknowledges support from an Australian Research Council Discovery Early Career Researcher Award (PD0028506). S.T. was supported by an Alvin E. Nashman Fellowship in Theoretical Astrophysics. This work was co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND).	Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Bacon R, 2010, PROC SPIE, V7735, DOI 10.1117/12.856027; Bekki K, 2003, ASTROPHYS J, V596, pL13, DOI 10.1086/379054; Belfiore F, 2016, MON NOT R ASTRON SOC, V461, P3111, DOI 10.1093/mnras/stw1234; Bellhouse C, 2017, ASTROPHYS J, V844, DOI 10.3847/1538-4357/aa7875; Boselli A, 2006, PUBL ASTRON SOC PAC, V118, P517, DOI 10.1086/500691; Boselli A, 2016, ASTRON ASTROPHYS, V587, DOI 10.1051/0004-6361/201527795; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Cava A, 2009, ASTRON ASTROPHYS, V495, P707, DOI 10.1051/0004-6361:200810997; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Diehl S, 2006, MON NOT R ASTRON SOC, V368, P497, DOI 10.1111/j.1365-2966.2006.10125.x; Ebeling H, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/2/L40; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; Fossati M, 2016, MON NOT R ASTRON SOC, V455, P2028, DOI 10.1093/mnras/stv2400; Fritz J., 2017, PREPRINT; Fumagalli M, 2014, MON NOT R ASTRON SOC, V445, P4335, DOI 10.1093/mnras/stu2092; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Gullieuszik M., ASTROPHYS J IN PRESS; Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; Hopkins PF, 2009, ASTROPHYS J, V694, P599, DOI 10.1088/0004-637X/694/1/599; Jaffe YL, 2015, MON NOT R ASTRON SOC, V448, P1715, DOI 10.1093/mnras/stv100; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Kewley LJ, 2001, ASTROPHYS J SUPPL S, V132, P37, DOI 10.1086/318944; Krawczynski H, 2013, FRONT PHYS-BEIJING, V8, P609, DOI 10.1007/s11467-013-0310-3; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Marziani P, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201628941; Moore B, 1996, NATURE, V379, P613, DOI 10.1038/379613a0; Moretti A, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201630030; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Owers MS, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L23; Poggianti BM, 2016, ASTRON J, V151, DOI 10.3847/0004-6256/151/3/78; Poggianti BM, 2017, ASTROPHYS J, V844, DOI 10.3847/1538-4357/aa78ed; Ramos-Martinez M., 2016, IAU S, V319, P143; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Sarzi M, 2010, MON NOT R ASTRON SOC, V402, P2187, DOI 10.1111/j.1365-2966.2009.16039.x; Schulz S, 2001, MON NOT R ASTRON SOC, V328, P185, DOI 10.1046/j.1365-8711.2001.04847.x; Sharp RG, 2010, ASTROPHYS J, V711, P818, DOI 10.1088/0004-637X/711/2/818; Singh R, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322062; Tonnesen S, 2012, MON NOT R ASTRON SOC, V422, P1609, DOI 10.1111/j.1365-2966.2012.20737.x; Tonnesen S, 2009, ASTROPHYS J, V694, P789, DOI 10.1088/0004-637X/694/2/789; Vazdekis A, 2010, MON NOT R ASTRON SOC, V404, P1639, DOI 10.1111/j.1365-2966.2010.16407.x; Wang S, 2016, ASTROPHYS J SUPPL S, V224, DOI 10.3847/0067-0049/224/2/40; Yan RB, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/61	50	78	78	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					304	+		10.1038/nature23462	http://dx.doi.org/10.1038/nature23462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816245	Green Submitted			2022-12-28	WOS:000407748400026
J	Lipscombe, LL				Lipscombe, Lorraine L.			In type 1 diabetes, education with either insulin pumps or daily injections did not differ for HbA(1c) at 2 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lipscombe, Lorraine L.] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Steineck I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3234; Yeh Hsin-Chieh, 2012, Ann Intern Med, V157, P336	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC15	JC15		10.7326/ACPJC-2017-167-4-015	http://dx.doi.org/10.7326/ACPJC-2017-167-4-015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806796				2022-12-28	WOS:000407797500003
J	Rymer, JA; Granger, CB				Rymer, Jennifer A.; Granger, Christopher B.			Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE CORONARY SYNDROME; SYMPTOMS; OUTCOMES		[Rymer, Jennifer A.; Granger, Christopher B.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Rymer, JA (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.			Rymer, Jennifer/0000-0001-9841-2393				Biener M, 2015, CLIN CHEM, V61, P744, DOI 10.1373/clinchem.2014.235317; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					JC23	JC23		10.7326/ACPJC-2017-167-4-023	http://dx.doi.org/10.7326/ACPJC-2017-167-4-023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806804				2022-12-28	WOS:000407797500009
J	Voelker, R				Voelker, Rebecca			New Leukemia, Lymphoma Diagnostic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					604	604		10.1001/jama.2017.10283	http://dx.doi.org/10.1001/jama.2017.10283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810009				2022-12-28	WOS:000407616000008
J	Byndloss, MX; Olsan, EE; Rivera-Chavez, F; Tiffany, CR; Cevallos, SA; Lokken, KL; Torres, TP; Byndloss, AJ; Faber, F; Gao, YD; Litvak, Y; Lopez, CA; Xu, GG; Napoli, E; Giulivi, C; Tsolis, RM; Revzin, A; Lebrilla, CB; Baumler, AJ				Byndloss, Mariana X.; Olsan, Erin E.; Rivera-Chavez, Fabian; Tiffany, Connor R.; Cevallos, Stephanie A.; Lokken, Kristen L.; Torres, Teresa P.; Byndloss, Austin J.; Faber, Franziska; Gao, Yandong; Litvak, Yael; Lopez, Christopher A.; Xu, Gege; Napoli, Eleonora; Giulivi, Cecilia; Tsolis, Renee M.; Revzin, Alexander; Lebrilla, Carlito B.; Baumler, Andreas J.			Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion	SCIENCE			English	Article							CHAIN FATTY-ACIDS; REGULATORY T-CELLS; DENDRITIC CELLS; RECEPTOR-GAMMA; GUT MICROBIOTA; METABOLITE BUTYRATE; BARRIER FUNCTION; DIFFERENTIATION; INDUCTION; HYPOXIA	Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-gamma). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-gamma signaling. Microbiota-induced PPAR-gamma signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward beta-oxidation. Therefore, microbiota-activated PPAR-gamma signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.	[Byndloss, Mariana X.; Olsan, Erin E.; Rivera-Chavez, Fabian; Tiffany, Connor R.; Cevallos, Stephanie A.; Lokken, Kristen L.; Torres, Teresa P.; Byndloss, Austin J.; Faber, Franziska; Litvak, Yael; Lopez, Christopher A.; Tsolis, Renee M.; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA; [Gao, Yandong; Revzin, Alexander] Univ Calif Davis, Coll Engn, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA; [Xu, Gege; Lebrilla, Carlito B.] Univ Calif Davis, Coll Letters & Sci, Dept Chem, One Shields Ave, Davis, CA 95616 USA; [Napoli, Eleonora; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Byndloss, Mariana X/D-9890-2014; Rivera-Chávez, Fabian/ABD-5616-2021; Napoli, Eleonora/AAQ-6079-2021; Xu, Gege/AAC-5097-2019; Litvak, Yael/AAK-9203-2021; Baumler, Andreas J/H-2301-2011; Faber, Franziska/B-5601-2017; Lebrilla, Carlito Bangeles/ABE-6369-2020; Byndloss, Mariana Xavier/ABD-5506-2021; Giulivi, Cecilia/AAV-6774-2021; Giulivi, Cecilia/ABB-7809-2020	Byndloss, Mariana X/0000-0002-2122-4156; Napoli, Eleonora/0000-0001-8808-4242; Xu, Gege/0000-0002-0792-2636; Litvak, Yael/0000-0002-0183-2816; Baumler, Andreas J/0000-0001-9152-7809; Faber, Franziska/0000-0002-8700-6522; Byndloss, Mariana Xavier/0000-0002-2122-4156; Giulivi, Cecilia/0000-0003-1033-7435; Tsolis, Renee/0000-0001-9131-6657; Gao, Yandong/0000-0002-4761-6035; Torres, Teresa/0000-0003-2316-4705	Public Health Service grants [AI060555, TR001861, AI112241, DK087307, AI109799, AI112258, AI112949, AI096528, AI112445, AI114922]; American Heart Association [15PRE21420011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001861, UL1TR001860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096528, R01AI109799, R21AI114922, R01AI112445, F31AI112241, T32AI060555, R21AI112258, R01AI112949, R56AI112949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765, R25GM086262] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Host-Microbe Systems Biology Core (HMSB Core) at the University of California at Davis School of Medicine for expert technical assistance with microbiota sequence analysis. The data reported in the manuscript are tabulated in the main paper and the supplementary materials. M.X.B. and A.J.Ba. filed invention report number 0577501-16-0038 at iEdison.gov for a treatment to prevent postantibiotic expansion of Enterobacteriaceae. This work was supported by Public Health Service grants AI060555 (S.A.C.), TR001861 (E.E.O.), AI112241 (C.A.L.), DK087307 (C.G.), AI109799 (R.M.T.), AI112258 (R.M.T.), AI112949 (A.J.Ba. and R.M.T.), AI096528 (A.J.Ba.), AI112445 (A.J.Ba.), AI112949 (A.J.Ba.), and AI114922 (A.J.Ba.). K.L.L. was supported by an American Heart Association Predoctoral Fellowship (15PRE21420011).	Alex S, 2013, MOL CELL BIOL, V33, P1303, DOI 10.1128/MCB.00858-12; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Lefebvre AM, 1999, J ENDOCRINOL, V162, P331, DOI 10.1677/joe.0.1620331; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Millard AL, 2002, CLIN EXP IMMUNOL, V130, P245; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Terada N, 2007, HISTOCHEM CELL BIOL, V128, P253, DOI 10.1007/s00418-007-0324-4; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wang B, 2008, CELL IMMUNOL, V253, P54, DOI 10.1016/j.cellimm.2008.04.016; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009	25	492	511	13	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					570	+		10.1126/science.aam9949	http://dx.doi.org/10.1126/science.aam9949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798125	Green Accepted			2022-12-28	WOS:000407324800036
J	Powers, AR; Mathys, C; Corlett, PR				Powers, A. R.; Mathys, C.; Corlett, P. R.			Pavlovian conditioning-induced hallucinations result from overweighting of perceptual priors	SCIENCE			English	Article							SCHIZOPHRENIA; PSYCHOSIS; UNCERTAINTY; PREDICTION; CONTINUUM; CORTEX	Some people hear voices that others do not, but only some of those people seek treatment. Using a Pavlovian learning task, we induced conditioned hallucinations in four groups of people who differed orthogonally in their voice-hearing and treatment-seeking statuses. People who hear voices were significantly more susceptible to the effect. Using functional neuroimaging and computational modeling of perception, we identified processes that differentiated voice-hearers from non-voice-hearers and treatment-seekers from non-treatment-seekers and characterized a brain circuit that mediated the conditioned hallucinations. These data demonstrate the profound and sometimes pathological impact of top-down cognitive processes on perception and may represent an objective means to discern people with a need for treatment from those without.	[Powers, A. R.; Corlett, P. R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Mathys, C.] Int Sch Adv Studies SISSA, Trieste, Italy; [Mathys, C.] Max Planck Univ Coll London UCL, Ctr Computat Psychiat & Ageing Res, London, England; [Mathys, C.] Univ Zurich, TNU, Inst Biomed Engn, Zurich, Switzerland; [Mathys, C.] Swiss Fed Inst Technol, Zurich, Switzerland	Yale University; International School for Advanced Studies (SISSA); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Corlett, PR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	philip.corlett@yale.edu	Mathys, Christoph/D-5661-2014; Powers, Albert/AAX-6241-2021	Mathys, Christoph/0000-0003-4079-5453; Corlett, Philip/0000-0002-5368-1992	Connecticut Mental Health Center (CMHC); Connecticut State Department of Mental Health and Addiction Services (DMHAS); International Mental Health Research Organization/Janssen Rising Star Translational Research Award; National Institute of Mental Health (NIMH) [5R01MH067073-09]; Clinical and Translational Science Award grant from the National Center for Research Resources (NCRR) [UL1 TR000142]; National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH); NIH roadmap for Medical Research; Clinical Neurosciences Division of the U.S. Department of Veterans Affairs; National Center for Post-Traumatic Stress Disorders; VA Connecticut Healthcare System (VACHS), West Haven, CT, USA; Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry grant [5R25MH071584-07]; Clinical Neuroscience Research Training in Psychiatry grant from NIMH [5T32MH19961-14]; VA Schizophrenia Research Special Fellowship from VACHS, West Haven, CT, USA; Yale Detre Fellowship for Translational Neuroscience; Brain and Behavior Research Foundation in the form of a National Alliance for Research on Schizophrenia and Depression Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH071584, T32MH019961, R01MH067073] Funding Source: NIH RePORTER	Connecticut Mental Health Center (CMHC); Connecticut State Department of Mental Health and Addiction Services (DMHAS); International Mental Health Research Organization/Janssen Rising Star Translational Research Award; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Clinical and Translational Science Award grant from the National Center for Research Resources (NCRR); National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Neurosciences Division of the U.S. Department of Veterans Affairs; National Center for Post-Traumatic Stress Disorders; VA Connecticut Healthcare System (VACHS), West Haven, CT, USA; Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry grant; Clinical Neuroscience Research Training in Psychiatry grant from NIMH; VA Schizophrenia Research Special Fellowship from VACHS, West Haven, CT, USA; Yale Detre Fellowship for Translational Neuroscience; Brain and Behavior Research Foundation in the form of a National Alliance for Research on Schizophrenia and Depression Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors dedicate this work to the memory and legacy of Ralph E. Hoffman, M.D. Additional thanks go to M. Kelley, A. Bianchi, S. Bhatt, and E. Feeney for technical assistance as well as A. Nidiffer, L. Marks, S. Woods, and J. Krystal for their advice. This work was supported by the Connecticut Mental Health Center (CMHC) and Connecticut State Department of Mental Health and Addiction Services (DMHAS). P.R.C. was funded by an International Mental Health Research Organization/Janssen Rising Star Translational Research Award; National Institute of Mental Health (NIMH) grant 5R01MH067073-09; Clinical and Translational Science Award grant UL1 TR000142 from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH); NIH roadmap for Medical Research; the Clinical Neurosciences Division of the U.S. Department of Veterans Affairs; and the National Center for Post-Traumatic Stress Disorders, VA Connecticut Healthcare System (VACHS), West Haven, CT, USA. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of NIH or the CMHC/DMHAS. A.R.P. was supported by the Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry grant (5R25MH071584-07) as well as the Clinical Neuroscience Research Training in Psychiatry grant (5T32MH19961-14) from NIMH and a VA Schizophrenia Research Special Fellowship from VACHS, West Haven, CT, USA. Additional support was provided by the Yale Detre Fellowship for Translational Neuroscience as well as the Brain and Behavior Research Foundation in the form of a National Alliance for Research on Schizophrenia and Depression Young Investigator Award for A.R.P. The authors declare no conflicts of interest. Model code and data are stored at ModelDB (http://modeldb.yale.edu/229278). Imaging data are stored at NeuroVault (http://neurovault.org/collections/OCFEJCQE/).	Adams Rick A, 2013, Front Psychiatry, V4, P47, DOI 10.3389/fpsyt.2013.00047; BAYES T, 1958, BIOMETRIKA, V45, P296; BENTALL RP, 1985, BRIT J CLIN PSYCHOL, V24, P159, DOI 10.1111/j.2044-8260.1985.tb01331.x; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; Ellson DG, 1941, J EXP PSYCHOL, V28, P1, DOI 10.1037/h0054167; Friston KJ, 2005, BEHAV BRAIN SCI, V28, P764, DOI 10.1017/S0140525X05290131; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Helmholz H. v., 1909, TREATISE PHYSL OPTIC; Horga G, 2014, J NEUROSCI, V34, P8072, DOI 10.1523/JNEUROSCI.0200-14.2014; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; Laurienti PJ, 2003, HUM BRAIN MAPP, V19, P213, DOI 10.1002/hbm.10112; Mathys C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00039; Parker KL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00163; Pearson J, 2016, ELIFE, V5, DOI 10.7554/eLife.17072; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Powers AR, 2017, SCHIZOPHRENIA BULL, V43, P84, DOI 10.1093/schbul/sbw133; Powers AR, 2012, J NEUROSCI, V32, P6263, DOI 10.1523/JNEUROSCI.6138-11.2012; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schiffer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036445; Schmack K, 2017, HUM BRAIN MAPP, V38, P1767, DOI 10.1002/hbm.23480; Shergill SS, 2014, JAMA PSYCHIAT, V71, P28, DOI 10.1001/jamapsychiatry.2013.2974; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Teufel C, 2015, P NATL ACAD SCI USA, V112, P13401, DOI 10.1073/pnas.1503916112; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; WARBURTON DM, 1985, NEUROPSYCHOBIOLOGY, V14, P198, DOI 10.1159/000118227; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Zmigrod L, 2016, NEUROSCI BIOBEHAV R, V69, P113, DOI 10.1016/j.neubiorev.2016.05.037	28	317	321	8	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					596	+		10.1126/science.aan3458	http://dx.doi.org/10.1126/science.aan3458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798131	Green Accepted			2022-12-28	WOS:000407324800042
J	Matacic, C				Matacic, Catherine			ECONOMICS Stealing industrial secrets pays off-at first	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					434	435		10.1126/science.357.6350.434	http://dx.doi.org/10.1126/science.357.6350.434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774904				2022-12-28	WOS:000406840100009
J	Nicholl, D				Nicholl, David			Why I've changed my views on assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicholl, David] City Hosp, Birmingham, W Midlands, England	University of Birmingham	Nicholl, D (corresponding author), City Hosp, Birmingham, W Midlands, England.	david.nicholl@nhs.net							0	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2017	358								j3566	10.1136/bmj.j3566	http://dx.doi.org/10.1136/bmj.j3566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CI	28775164				2022-12-28	WOS:000407207000004
J	Erickson, RP; Fiorenza, MT				Erickson, Robert P.; Fiorenza, Maria Teresa			A hopeful therapy for Niemann-Pick C diseases	LANCET			English	Editorial Material							STORAGE DISORDER; MOUSE; CYCLODEXTRINS; CHOLESTEROL		[Erickson, Robert P.] Univ Arizona, Dept Pediat, Sch Med, Tucson, AZ 85724 USA; [Fiorenza, Maria Teresa] Sapienza Univ, Dept Psychol, Div Neurosci, Rome, Italy; [Fiorenza, Maria Teresa] IRCCS Fdn Santa Lucia, Rome, Italy	University of Arizona; Sapienza University Rome; IRCCS Santa Lucia	Erickson, RP (corresponding author), Univ Arizona, Dept Pediat, Sch Med, Tucson, AZ 85724 USA.	erickson@peds.arizona.edu	Fiorenza, Maria Teresa/AAC-2181-2019	Fiorenza, Maria Teresa/0000-0002-5079-4019				ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Christian AE, 1997, J LIPID RES, V38, P2264; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Muralidhar A, 2011, MOL GENET METAB, V103, P142, DOI 10.1016/j.ymgme.2011.03.001; Nusca S, 2014, NEUROBIOL DIS, V70, P117, DOI 10.1016/j.nbd.2014.06.012; Ory D. S., 2017, LANCET; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; PITHA J, 1994, J PHARM SCI, V83, P833, DOI 10.1002/jps.2600830615; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Tsekhmistrenko T A, 1999, Neurosci Behav Physiol, V29, P405, DOI 10.1007/BF02461076; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239	12	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1720	1721		10.1016/S0140-6736(17)31631-8	http://dx.doi.org/10.1016/S0140-6736(17)31631-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ6GB	28803711				2022-12-28	WOS:000412853100008
J	Batra, R; Nelles, DA; Pirie, E; Blue, SM; Marina, RJ; Wang, H; Chaim, IA; Thomas, JD; Zhang, N; Nguyen, V; Aigner, S; Markmiller, S; Xia, GB; Corbett, KD; Swanson, MS; Yeo, GW				Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Thomas, James D.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Xia, Guangbin; Corbett, Kevin D.; Swanson, Maurice S.; Yeo, Gene W.			Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9	CELL			English	Article							MYOTONIC-DYSTROPHY; ALTERNATIVE POLYADENYLATION; HEXANUCLEOTIDE REPEAT; CRYSTAL-STRUCTURE; C9ORF72; REGION; THERAPY; DISEASE; CELLS; ALS	Microsatellite repeat expansions in DNA produce pathogenic RNA species that cause dominantly inherited diseases such as myotonic dystrophy type 1 and 2 (DM1/2), Huntington's disease, and C9orf72-linked amyotrophic lateral sclerosis (C9-ALS). Means to target these repetitive RNAs are required for diagnostic and therapeutic purposes. Here, we describe the development of a programmable CRISPR system capable of specifically visualizing and eliminating these toxic RNAs. We observe specific targeting and efficient elimination of micro-satellite repeat expansion RNAs both when exogenously expressed and in patient cells. Importantly, RNA-targeting Cas9 (RCas9) reverses hallmark features of disease including elimination of RNA foci among all conditions studied (DM1, DM2, C9-ALS, polyglutamine diseases), reduction of polyglutamine protein products, relocalization of repeat-bound proteins to resemble healthy controls, and efficient reversal of DM1-associated splicing abnormalities in patient myotubes. Finally, we report a truncated RCas9 system compatible with adeno-associated viral packaging. This effort highlights the potential of RCas9 for human therapeutics.	[Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Corbett, Kevin D.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Batra, Ranjan; Nelles, David A.; Pirie, Elaine; Blue, Steven M.; Marina, Ryan J.; Wang, Harrison; Chaim, Isaac A.; Zhang, Nigel; Nguyen, Vu; Aigner, Stefan; Markmiller, Sebastian; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Thomas, James D.] Univ Florida, Ctr NeuroGenet, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Xia, Guangbin] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Corbett, Kevin D.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA USA; [Yeo, Gene W.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore; [Batra, Ranjan; Nelles, David A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol, Singapore, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Agency for Science Technology & Research (A*STAR); National University of Singapore	Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), ASTAR, Mol Engn Lab, Singapore, Singapore.	geneyeo@ucsd.edu	Aigner, Stefan/D-1272-2017; Aigner, Stefan/AAC-2466-2019; Yeo, Gene/AAE-7676-2019	Aigner, Stefan/0000-0002-9511-3328; Yeo, Gene/0000-0002-0799-6037; Zhang, Nigel/0000-0001-5873-2755; Wang, Harrison/0000-0002-5311-1375; /0000-0003-1787-046X; Thomas, James/0000-0002-8893-6350; Marina, Ryan/0000-0003-2427-7912; Swanson, Maurice/0000-0001-6245-5367; Corbett, Kevin/0000-0001-5854-2388; Blue, Steven/0000-0003-0279-6690	NIH [HG004659, NS075449]; start-up grant from the Stem Cell Program at UCSD; National Institute for General Medical Sciences [T32 GM008666]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524, T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449, R01NS103172] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); start-up grant from the Stem Cell Program at UCSD; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge members of the Yeo lab, particularly Kris Brannan and Frederick Tan for critical comments. We thank Dr. Thomas A. Cooper of Baylor College of Medicine for the gift of the tetracycline-inducible expression system for (CTG)<SUP>960</SUP> and Dr. Laura Ranum of the University of Florida for the gifts of the CCTG-300, GGGGCC-120, and CAG-80 vectors. Salary support for G.W.Y. was partially supported by grants from the NIH (HG004659 and NS075449). This work was funded by a start-up grant from the Stem Cell Program at UCSD (G.W.Y). Ranjan Batra is an MDF Postdoctoral Fellow. R.J.M. is supported in part by an institutional award to the UCSD Genetics Training Program from the National Institute for General Medical Sciences, T32 GM008666. D.A.N. and G.W.Y. are co-founders of Locana, Inc. G.W.Y. and M.S.S. are members of its scientific advisory board.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Batra R, 2015, RNA BIOL, V12, P597, DOI 10.1080/15476286.2015.1040974; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cooper-Knock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127376; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gao YZ, 2016, MOL THER, V24, P1378, DOI 10.1038/mt.2016.97; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Goodwin M, 2014, ADV EXP MED BIOL, V825, P353, DOI 10.1007/978-1-4939-1221-6_10; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Poulos M. G., 2011, COLD SPRING HARB PER, V3; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takeshita D, 2007, PROTEINS, V68, P980, DOI 10.1002/prot.21351; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Xia GB, 2013, CELL REPROGRAM, V15, P166, DOI 10.1089/cell.2012.0086; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang WJ, 2014, MOL THER, V22, P312, DOI 10.1038/mt.2013.251; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	56	160	165	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					899	+	912.e10	10.1016/j.cell.2017.07.010	http://dx.doi.org/10.1016/j.cell.2017.07.010			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28803727	Green Accepted, Bronze			2022-12-28	WOS:000408372400010
J	Johnson, DH				Johnson, David H.			Maintenance of Certification and Texas SB 1148 A Threat to Professional Self-regulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GOVERNANCE; PHYSICIAN; MEDICINE; BOARD		[Johnson, David H.] Univ Texas Southwestern Sch Med, Dept Internal Med, 5323 Harry Hines Blvd,Room G5-210A, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Johnson, DH (corresponding author), Univ Texas Southwestern Sch Med, Dept Internal Med, 5323 Harry Hines Blvd,Room G5-210A, Dallas, TX 75390 USA.	david.johnson@utsouthwestern.edu	Johnson, David/AHI-8369-2022					Berkowitz LR, 2015, JAMA SURG, V150, P699, DOI 10.1001/jamasurg.2015.0888; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Cohen JJ, 2015, JAMA-J AM MED ASSOC, V313, P1839, DOI 10.1001/jama.2015.3736; Cruess SR, 2005, VIRTUAL MENTOR, V7; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Lee TH, 2014, JAMA-J AM MED ASSOC, V312, P2340, DOI 10.1001/jama.2014.13566; RELMAN AS, 1979, NEW ENGL J MED, V301, P778, DOI 10.1056/NEJM197910043011408; Teirstein PS, 2015, JAMA-J AM MED ASSOC, V313, P1809, DOI 10.1001/jama.2015.3576	8	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					697	698		10.1001/jama.2017.10127	http://dx.doi.org/10.1001/jama.2017.10127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28783821				2022-12-28	WOS:000408095800014
J	Voelker, R				Voelker, Rebecca			Racial Disparities Remain in Breastfeeding Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					691	691		10.1001/jama.2017.10454	http://dx.doi.org/10.1001/jama.2017.10454			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829882				2022-12-28	WOS:000408095800012
J	Boehnke, KF				Boehnke, Kevin F.			When personal becomes professional	SCIENCE			English	Editorial Material									[Boehnke, Kevin F.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, KF (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Boehnke, Kevin/AAM-9429-2020	Boehnke, Kevin/0000-0003-3696-3979					0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					726	726		10.1126/science.357.6352.726	http://dx.doi.org/10.1126/science.357.6352.726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818951				2022-12-28	WOS:000407793600043
J	Wagner, T; Koch, J; Ermler, U; Shima, S				Wagner, Tristan; Koch, Juergen; Ermler, Ulrich; Shima, Seigo			Methanogenic heterodisulfide reductase (HdrABC-MvhAGD) uses two noncubane [4Fe-4S] clusters for reduction	SCIENCE			English	Article							METHANOBACTERIUM-THERMOAUTOTROPHICUM; ELECTRON BIFURCATION; OXIDOREDUCTASE; CONTAINS; INSIGHTS; ARCHAEA; FERREDOXIN; MECHANISM; PATHWAY; COMPLEX	In methanogenic archaea, the carbon dioxide (CO2) fixation and methane-forming steps are linked through the heterodisulfide reductase (HdrABC)-[NiFe]-hydrogenase (MvhAGD) complex that uses flavin-based electron bifurcation to reduce ferredoxin and the heterodisulfide of coenzymes M and B. Here, we present the structure of the native heterododecameric HdrABC-MvhAGD complex at 2.15-angstrom resolution. HdrB contains two noncubane [4Fe-4S] clusters composed of fused [3Fe-4S]-[2Fe-2S] units sharing 1 iron (Fe) and 1 sulfur (S), which were coordinated at the CCG motifs. Soaking experiments showed that the heterodisulfide is clamped between the two noncubane [4Fe-4S] clusters and homolytically cleaved, forming coenzyme M and B bound to each iron. Coenzymes are consecutively released upon one-by-one electron transfer. The HdrABC-MvhAGD atomic model serves as a structural template for numerous HdrABC homologs involved in diverse microbial metabolic pathways.	[Wagner, Tristan; Koch, Juergen; Shima, Seigo] Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany; [Ermler, Ulrich] Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany	Max Planck Society; Max Planck Society	Shima, S (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de		Wagner, Tristan/0000-0002-3382-8969	Max Planck Society; Deutsche Forschungsgemeinschaft [SH 87/1-1]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank R. Thauer for his discussions and helpful suggestions. This work was supported by grants from the Max Planck Society (to R. Thauer, S.S., and U.E.) and Deutsche Forschungsgemeinschaft (SH 87/1-1, to S.S.). We are also grateful to H. Michel for continuous support and the staff of the Swiss Light Source, Villigen, for help in data collection. We thank the staff from the Proxima I beamline at the SOLEIL synchrotron, especially P. Legrand, to help us to phase the HdrABC-MvhAGD of M. wolfeii. Structure factors and models of HdrABC-MvhAGD from M. thermolithotrophicus have been deposited in the Protein Data Bank under accession numbers 5ODC (cocrystallized with FAD), 5ODI (with FAD and HS-CoM), 5ODQ (with FAD and bromoethanesulfonate), 5ODR (with FAD and incubation for 2 min with CoM-S-S-CoB before freezing), and 5ODH (with FAD and 3.5-min incubation with CoM-S-S-CoB).	Bennati M, 2004, J AM CHEM SOC, V126, P8378, DOI 10.1021/ja0498179; Boughanemi S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw156; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Grein F, 2013, BBA-BIOENERGETICS, V1827, P145, DOI 10.1016/j.bbabio.2012.09.001; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Hamann N, 2009, J BIOL INORG CHEM, V14, P457, DOI 10.1007/s00775-008-0462-8; HEDDERICH R, 1990, EUR J BIOCHEM, V193, P255, DOI 10.1111/j.1432-1033.1990.tb19331.x; Hedderich R, 2005, BIOL CHEM, V386, P961, DOI 10.1515/BC.2005.112; HEDDERICH R, 1994, EUR J BIOCHEM, V225, P253, DOI 10.1111/j.1432-1033.1994.00253.x; Hernandez HH, 2008, BIOCHEMISTRY-US, V47, P9728, DOI 10.1021/bi8006753; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Madadi-Kahkesh S, 2001, EUR J BIOCHEM, V268, P2566, DOI 10.1046/j.1432-1327.2001.02141.x; Mander GJ, 2004, EUR J BIOCHEM, V271, P1106, DOI 10.1111/j.1432-1033.2004.04013.x; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Mock J, 2014, J BACTERIOL, V196, P3303, DOI 10.1128/JB.01839-14; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Ramos AR, 2015, ENVIRON MICROBIOL, V17, P2288, DOI 10.1111/1462-2920.12689; SETZKE E, 1994, EUR J BIOCHEM, V220, P139, DOI 10.1111/j.1432-1033.1994.tb18608.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vitt S, 2014, J MOL BIOL, V426, P2813, DOI 10.1016/j.jmb.2014.05.024; Wagner T, 2016, SCIENCE, V354, P114, DOI 10.1126/science.aaf9284; Watanabe T, 2014, SYST APPL MICROBIOL, V37, P387, DOI 10.1016/j.syapm.2014.05.010; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Yan Z, 2017, MBIO, V8, DOI 10.1128/mBio.02285-16	31	100	103	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					699	702		10.1126/science.aan0425	http://dx.doi.org/10.1126/science.aan0425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818947				2022-12-28	WOS:000407793600038
J	Schwartzstein, RM; Roberts, DH				Schwartzstein, Richard M.; Roberts, David H.			Saying Goodbye to Lectures in Medical School - Paradigm Shift or Passing Fad?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartzstein, Richard M.; Roberts, David H.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Schwartzstein, RM (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.		Schwartzstein, Richard/AGO-8549-2022; Schwartzstein, Richard/L-4420-2019					Brown PC., 2014, J EDUC RES; de Jong T, 2010, INSTR SCI, V38, P105, DOI 10.1007/s11251-009-9110-0; Krupat E, 2016, ACAD MED, V91, P723, DOI 10.1097/ACM.0000000000001004; Roberts DH, 2012, MED TEACH, V34, P274, DOI 10.3109/0142159X.2011.613498; Straumsheim C, 2016, BECOME DOCTOR LECT R	5	75	78	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					605	607		10.1056/NEJMp1706474	http://dx.doi.org/10.1056/NEJMp1706474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813217				2022-12-28	WOS:000407691400001
J	Pathirana, T; Clark, J; Moynihan, R				Pathirana, Thanya; Clark, Justin; Moynihan, Ray			TOO MUCH MEDICINE Mapping the drivers of overdiagnosis to potential solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERTREATMENT; CANCER		[Pathirana, Thanya; Clark, Justin; Moynihan, Ray] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld, Australia.	rmoyniha@bond.edu.au	Pathirana, Thanya/R-6254-2019; Clark, Justin M/P-8173-2018; Moynihan, Ray/ABC-3010-2020; Clark, Justin/AAL-8513-2021	Pathirana, Thanya/0000-0003-2386-2183; Clark, Justin/0000-0003-0133-1613				Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bhatt JR, 2016, EXPERT OPIN PHARMACO, V17, P1, DOI 10.1517/14656566.2016.1115481; Boddington J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1724; Brelin P., 2016, POSITION PAPER; Brindle LA, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12699; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Carpenter CR, 2015, ACAD EMERG MED, V22, P1484, DOI 10.1111/acem.12820; Deval JC, 2015, RADIOLOGIA-MADRID, V57, P188, DOI 10.1016/j.rx.2014.06.007; Chiolero A, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14060; Colla CH, 2016, MED CARE RES REV, DOI [10.1177/1077558716656970, DOI 10.1177/1077558716656970.PMID:27402662]; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Coon ER, 2014, PEDIATRICS, V134, P1013, DOI 10.1542/peds.2014-1778; Doust J, 2017, JAMA INTERN MED, V177, P1020, DOI 10.1001/jamainternmed.2017.1302; Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Hanslik T, 2016, REV MED INTERNE, V37, P201, DOI 10.1016/j.revmed.2015.10.009; Heath I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6123; Heath I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6361; Hensher M, 2017, SOC SCI MED, V176, P77, DOI 10.1016/j.socscimed.2017.01.020; Hicks LK, 2015, J ONCOL PRACT, V11, P168, DOI 10.1200/JOP.2015.004283; Hodgson H, 2015, CLIN MED, V15, P315, DOI 10.7861/clinmedicine.15-4-315; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; Hoffman JR, 2012, ARCH INTERN MED, V172, P1123, DOI 10.1001/archinternmed.2012.3319; Hofmann B, 2016, MED HEALTH CARE PHIL, V19, P253, DOI 10.1007/s11019-016-9693-6; Hofmann B, 2014, EUR J EPIDEMIOL, V29, P599, DOI 10.1007/s10654-014-9920-5; Hofmann BM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h705; Jansen J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2893; KAMEROW D, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F5071; Malhotra A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2308; McCaffery KJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i348; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Morgan DJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4534; Mortani Barbosa Eduardo J Jr, 2016, Acad Radiol, V23, P113, DOI 10.1016/j.acra.2015.09.006; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; MOYNIHAN R, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F7141; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; National Institute for Health and Care Excellence (NICE), BEH CHANG GEN APPR P; Nicholson BD, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12692; Parker LM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1603-4; Parmar MS, 2016, SOUTH MED J, V109, P272, DOI 10.14423/SMJ.0000000000000409; Quebec Medical Association, 2014, OV FIND ACT PLAN; Saini V, 2017, LANCET, V390, P178, DOI 10.1016/S0140-6736(16)30947-3; Samadian S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4790; Schwitzer G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1262; Treadwell J, 2016, BRIT J GEN PRACT, V66, P116, DOI 10.3399/bjgp16X683881; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Van den Bruel A, 2015, FAM PRACT, V32, P127, DOI 10.1093/fampra/cmv008; Welch H, 2011, OVERDIAGNOSED MAKING	51	87	88	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2017	358								j3879	10.1136/bmj.j3879	http://dx.doi.org/10.1136/bmj.j3879			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5BZ	28814436	Green Published			2022-12-28	WOS:000408228300011
J	Sleight, P; Sleight, V; Dawson, A; Januszewski, N				Sleight, P.; Sleight, V.; Dawson, A.; Januszewski, N.			Peter Joseph Wilkinson Monks OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MONKS PJW, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2017	358								j3857	10.1136/bmj.j3857	http://dx.doi.org/10.1136/bmj.j3857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7YF	28801305				2022-12-28	WOS:000407741300003
J	Chen, ZX; Mercer, JAM; Zhu, XL; Romaniuk, JAH; Pfattner, R; Cegelski, L; Martinez, TJ; Burns, NZ; Xia, Y				Chen, Zhixing; Mercer, Jaron A. M.; Zhu, Xiaolei; Romaniuk, Joseph A. H.; Pfattner, Raphael; Cegelski, Lynette; Martinez, Todd J.; Burns, Noah Z.; Xia, Yan			Mechanochemical unzipping of insulating polyladderene to semiconducting polyacetylene	SCIENCE			English	Article							OPENING METATHESIS POLYMERIZATION; MECHANICAL FORCE; MECHANOPHORES; COPOLYMERS; ISOMERIZATION; ACTIVATION; PATHWAYS; POLYMERS; BONDS	Biological systems sense and respond to mechanical stimuli in a complex manner. In an effort to develop synthetic materials that transduce mechanical force into multifold changes in their intrinsic properties, we report on a mechanochemically responsive nonconjugated polymer that converts to a conjugated polymer via an extensive rearrangement of the macromolecular structure in response to force. Our design is based on the facile mechanochemical unzipping of polyladderene, a polymer inspired by a lipid natural product structure and prepared via direct metathesis polymerization. The resultant polyacetylene block copolymers exhibit long conjugation length and uniform trans-configuration and self-assemble into semiconducting nanowires. Calculations support a tandem unzipping mechanism of the ladderene units.	[Chen, Zhixing; Mercer, Jaron A. M.; Zhu, Xiaolei; Romaniuk, Joseph A. H.; Cegelski, Lynette; Martinez, Todd J.; Burns, Noah Z.; Xia, Yan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhu, Xiaolei; Martinez, Todd J.] Stanford Univ, PULSE Inst, Stanford, CA 94305 USA; [Pfattner, Raphael] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Martinez, Todd J.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Martinez, TJ; Burns, NZ; Xia, Y (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Martinez, TJ (corresponding author), Stanford Univ, PULSE Inst, Stanford, CA 94305 USA.	toddmtz@stanford.edu; nburns@stanford.edu; yanx@stanford.edu	Pfattner, Raphael/E-9209-2011; Burns, Noah/AFA-8975-2022; Martinez, Todd/HDN-6985-2022; Martinez, Todd J/F-4306-2010	Pfattner, Raphael/0000-0002-7232-1845; Burns, Noah/0000-0003-1064-4507; Martinez, Todd J/0000-0002-4798-8947; Zhu, Xiaolei/0000-0002-7825-4815; Xia, Yan/0000-0002-5298-748X; Chen, Zhixing/0000-0001-5962-7359; Mercer, Jaron/0000-0001-7078-614X	U.S. Army Research Office [W911NF-15-1-0525]; Stanford University; National Science Foundation; Marie Curie Cofund, Beatriu de Pinos fellowship [AGAUR 2014 BP-A 00094]; Office of Naval Research [N00014-12-1-0828]; Global Climate and Energy Project; National Science Foundation [ACI-1429830]; National Science Foundation CAREER [1453247]; Direct For Computer & Info Scie & Enginr [1429830] Funding Source: National Science Foundation	U.S. Army Research Office; Stanford University(Stanford University); National Science Foundation(National Science Foundation (NSF)); Marie Curie Cofund, Beatriu de Pinos fellowship; Office of Naval Research(Office of Naval Research); Global Climate and Energy Project; National Science Foundation(National Science Foundation (NSF)); National Science Foundation CAREER(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the U.S. Army Research Office under grant number W911NF-15-1-0525 and Stanford University. J.A.M.M. thanks the National Science Foundation for a graduate fellowship. R.P. acknowledges support from Marie Curie Cofund, Beatriu de Pinos fellowship (AGAUR 2014 BP-A 00094). T.J.M. acknowledges support from Office of Naval Research grant N00014-12-1-0828 and the Global Climate and Energy Project. This work used the XStream computational resource supported by the National Science Foundation Major Research Instrumentation program (ACI-1429830). L.C. acknowledges support from the National Science Foundation CAREER Award 1453247. We thank J. I. Brauman for helpful discussion, Z. Bao for conductivity measurement, A. F. Marshall at Stanford Nano Shared Facilities for helping with TEM imaging, and Materia Inc. for a gift of Grubbs catalyst. All data are available in the supplementary materials. The authors declare no competing financial interest.	BAKER GL, 1984, MACROMOLECULES, V17, P2619, DOI 10.1021/ma00142a028; Bohner MU, 2013, J CHEM THEORY COMPUT, V9, P3498, DOI 10.1021/ct400323z; BRAUMAN JI, 1971, TETRAHEDRON, V27, P1275, DOI 10.1016/S0040-4020(01)90876-2; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chen YL, 2012, NAT CHEM, V4, P559, DOI [10.1038/nchem.1358, 10.1038/NCHEM.1358]; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Diesendruck CE, 2014, NAT CHEM, V6, P624, DOI [10.1038/nchem.1938, 10.1038/NCHEM.1938]; Diesendruck CE, 2012, J AM CHEM SOC, V134, P12446, DOI 10.1021/ja305645x; Ducrot E, 2014, SCIENCE, V344, P186, DOI 10.1126/science.1248494; GIBSON HW, 1986, J AM CHEM SOC, V108, P6843, DOI 10.1021/ja00282a001; GORMAN CB, 1993, J AM CHEM SOC, V115, P1397, DOI 10.1021/ja00057a024; Grubbs R. H., 2015, HDB METATHESIS, V3; HARADA I, 1978, CHEM LETT, P1411, DOI 10.1246/cl.1978.1411; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; Kean ZS, 2013, J AM CHEM SOC, V135, P13598, DOI 10.1021/ja4075997; Kean ZS, 2012, J AM CHEM SOC, V134, P12939, DOI 10.1021/ja3063666; Kryger MJ, 2011, J AM CHEM SOC, V133, P18992, DOI 10.1021/ja2086728; Kryger MJ, 2010, J AM CHEM SOC, V132, P4558, DOI 10.1021/ja1008932; Larsen MB, 2013, J AM CHEM SOC, V135, P8189, DOI 10.1021/ja403757p; Lenhardt JM, 2010, SCIENCE, V329, P1057, DOI 10.1126/science.1193412; Li J, 2015, ACCOUNTS CHEM RES, V48, P2181, DOI 10.1021/acs.accounts.5b00184; Liu W, 2010, J AM CHEM SOC, V132, P12847, DOI 10.1021/ja105548x; Mercer JAM, 2016, J AM CHEM SOC, V138, P15845, DOI 10.1021/jacs.6b10706; Nguyen T. Q., 1992, MACROMOLECULES SYNTH, P73; Ong MT, 2009, J AM CHEM SOC, V131, P6377, DOI 10.1021/ja8095834; Piermattei A, 2009, NAT CHEM, V1, P133, DOI [10.1038/NCHEM.167, 10.1038/nchem.167]; Ramirez ALB, 2013, NAT CHEM, V5, P757, DOI [10.1038/NCHEM.1720, 10.1038/nchem.1720]; RUDOLF K, 1987, J ORG CHEM, V52, P3708, DOI 10.1021/jo00392a047; Scherman OA, 2003, J AM CHEM SOC, V125, P8515, DOI 10.1021/ja0301166; SCHUGERL FB, 1981, J CHEM PHYS, V74, P953, DOI 10.1063/1.441151; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Skotheim T.A., 2006, CONJUG POLYM, DOI [10.1201/9781420043594, DOI 10.1201/9781420043594]; Yang QZ, 2009, NAT NANOTECHNOL, V4, P302, DOI [10.1038/NNANO.2009.55, 10.1038/nnano.2009.55]; Yoon KY, 2012, J AM CHEM SOC, V134, P14291, DOI 10.1021/ja305150c	36	173	174	22	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					475	478		10.1126/science.aan2797	http://dx.doi.org/10.1126/science.aan2797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774923				2022-12-28	WOS:000406840100031
J	Normile, D				Normile, Dennis			SCIENTIFIC MISCONDUCT China cracks down on fraud	SCIENCE			English	News Item																			0	6	6	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					435	435		10.1126/science.357.6350.435	http://dx.doi.org/10.1126/science.357.6350.435			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774905				2022-12-28	WOS:000406840100010
J	Maddocks, ODK; Athineos, D; Cheung, EC; Lee, P; Zhang, T; van den Broek, NJF; Mackay, GM; Labuschagne, CF; Gay, D; Kruiswijk, F; Blagih, J; Vincent, DF; Campbell, KJ; Ceteci, F; Sansom, OJ; Blyth, K; Vousden, KH				Maddocks, Oliver D. K.; Athineos, Dimitris; Cheung, Eric C.; Lee, Pearl; Zhang, Tong; van den Broek, Niels J. F.; Mackay, Gillian M.; Labuschagne, Christiaan F.; Gay, David; Kruiswijk, Flore; Blagih, Julianna; Vincent, David F.; Campbell, Kirsteen J.; Ceteci, Fatih; Sansom, Owen J.; Blyth, Karen; Vousden, Karen H.			Modulating the therapeutic response of tumours to dietary serine and glycine starvation (vol 544, pg 372, 2017)	NATURE			English	Correction														Labuschagne, Christiaan/0000-0001-9474-5174; Sansom, Owen J./0000-0001-9540-3010; Blyth, Karen/0000-0002-9304-439X				Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056	1	3	3	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665								10.1038/nature23471	http://dx.doi.org/10.1038/nature23471			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770843	Bronze			2022-12-28	WOS:000406831700050
J	Green, A				Green, Andrew			The omitted epidemic-hepatitis E in the Lake Chad region	LANCET			English	Editorial Material																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					443	444		10.1016/S0140-6736(17)31992-X	http://dx.doi.org/10.1016/S0140-6736(17)31992-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792401				2022-12-28	WOS:000406463400012
J	Korb, E; Herre, M; Zucker-Scharff, I; Gresack, J; Allis, CD; Darnell, RB				Korb, Erica; Herre, Margaret; Zucker-Scharff, Ilana; Gresack, Jodi; Allis, C. David; Darnell, Robert B.			Excess Translation of Epigenetic Regulators Contributes to Fragile X Syndrome and Is Alleviated by Brd4 Inhibition	CELL			English	Article							MENTAL-RETARDATION PROTEIN; MOUSE MODEL; TRANSCRIPTION; MICE; BEHAVIORS; CHROMATIN; AUTISM; FMRP; SYSTEM; CANCER	Fragile X syndrome (FXS) is a leading genetic cause of intellectual disability and autism. FXS results from the loss of function of fragile X mental retardation protein (FMRP), which represses translation of target transcripts. Most of the well-characterized target transcripts of FMRP are synaptic proteins, yet targeting these proteins has not provided effective treatments. We examined a group of FMRP targets that encode transcriptional regulators, particularly chromatin-associated proteins. Loss of FMRP in mice results in widespread changes in chromatin regulation and aberrant gene expression. To determine if targeting epigenetic factors could reverse phenotypes associated with the disorder, we focused on Brd4, a BET protein and chromatin reader targeted by FMRP. Inhibition of Brd4 function alleviated many of the phenotypes associated with FXS. We conclude that loss of FMRP results in significant epigenetic misregulation and that targeting transcription via epigenetic regulators like Brd4 may provide new treatments for FXS.	[Korb, Erica; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Herre, Margaret; Zucker-Scharff, Ilana; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10065 USA; [Herre, Margaret; Zucker-Scharff, Ilana; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Gresack, Jodi] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.; Darnell, RB (corresponding author), Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10065 USA.; Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	alliscd@rockefeller.edu; darnelr@rockefeller.edu	; Darnell, Robert/B-9022-2008	Korb, Erica/0000-0002-7064-8123; Darnell, Robert/0000-0002-5134-8088	Rockefeller University; Robertson Foundation; NIH [F32MH103921, K99 1K99MH111836, R01 NS34389, NS081706, R35NS097404]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH111836, F32MH103921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097404, R01NS034389, R01NS081706] Funding Source: NIH RePORTER	Rockefeller University; Robertson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Mellen, L. Shen, E. Loh, and J. Gerace for suggestions and expertise, N. Heintz for bacTRAP mice, J.C. Darnell for guidance, A. Soshnev for cover illustration and graphical abstract design, and Allis and Darnell lab members for feedback. Support was provided by the Rockefeller University, the Robertson Foundation, the NIH (F32MH103921, K99 1K99MH111836, R01 NS34389, NS081706, and R35NS097404), and a Simons Foundation Research Award. R.B.D. is an Investigator of the Howard Hughes Medical Institute.	Alpatov R, 2014, CELL, V157, P869, DOI 10.1016/j.cell.2014.03.040; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bagley JA, 2014, GENE DEV, V28, P1940, DOI 10.1101/gad.239962.114; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bolden JE, 2014, CELL REP, V8, P1919, DOI 10.1016/j.celrep.2014.08.025; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Gantois I., 2001, Current Molecular Medicine (Hilversum), V1, P447, DOI 10.2174/1566524013363492; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lian HW, 2017, HAEMATOLOGICA, V102, pE17, DOI 10.3324/haematol.2016.154013; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Love M.I., 2014, GENOME BIOL, V15; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Sullivan JM, 2015, J EXP MED, V212, P1771, DOI 10.1084/jem.20151271; Thomas AM, 2011, BEHAV BRAIN RES, V223, P310, DOI 10.1016/j.bbr.2011.04.049; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	70	71	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1209	1223		10.1016/j.cell.2017.07.033	http://dx.doi.org/10.1016/j.cell.2017.07.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28823556	Green Accepted, Bronze			2022-12-28	WOS:000409536000017
J	Falgarone, E; Zwaan, MA; Odard, BG; Bergin, E; Ivison, RJ; Andreani, PM; Bournaud, F; Bussmann, RS; Elbaz, D; Omont, A; Oteo, I; Walter, F				Falgarone, E.; Zwaan, M. A.; Odard, B. G.; Bergin, E.; Ivison, R. J.; Andreani, P. M.; Bournaud, F.; Bussmann, R. S.; Elbaz, D.; Omont, A.; Oteo, I.; Walter, F.			Large turbulent reservoirs of cold molecular gas around high-redshift starburst galaxies	NATURE			English	Article							INTERSTELLAR-MEDIUM; SUBMILLIMETER GALAXIES; STAR-FORMATION; OUTFLOWS; SPECTRA; MODELS; BRIGHT; SHOCKS	Starburst galaxies at the peak of cosmic star formation(1) are among the most extreme star-forming engines in the Universe, producing stars over about 100 million years (ref. 2). The star-formation rates of these galaxies, which exceed 100 solar masses per year, require large reservoirs of cold molecular gas(3) to be delivered to their cores, despite strong feedback from stars or active galactic nuclei(4,5). Consequently, starburst galaxies are ideal for studying the interplay between this feedback and the growth of a galaxy(6). The methylidyne cation, CH+, is a most useful molecule for such studies because it cannot form in cold gas without suprathermal energy input, so its presence indicates dissipation of mechanical energy(7-9) or strong ultraviolet irradiation(10,11). Here we report the detection of CH+ (J = 1-0) emission and absorption lines in the spectra of six lensed starburst galaxies(12-15) at redshifts near 2.5. This line has such a high critical density for excitation that it is emitted only in very dense gas, and is absorbed in low-density gas(10). We find that the CH+ emission lines, which are broader than 1,000 kilometres per second, originate in dense shock waves powered by hot galactic winds. The CH+ absorption lines reveal highly turbulent reservoirs of cool (about 100 kelvin), low-density gas, extending far (more than 10 kiloparsecs) outside the starburst galaxies (which have radii of less than 1 kiloparsec). We show that the galactic winds sustain turbulence in the 10-kiloparsec-scale environments of the galaxies, processing these environments into multiphase, gravitationally bound reservoirs. However, the mass outflow rates are found to be insufficient to balance the star-formation rates. Another mass input is therefore required for these reservoirs, which could be provided by ongoing mergers(16) or cold-stream accretion(17,18). Our results suggest that galactic feedback, coupled jointly to turbulence and gravity, extends the starburst phase of a galaxy instead of quenching it.	[Falgarone, E.; Odard, B. G.] UPMC Univ Paris 06, LERMA LRA, Observ Paris, PSL Res Univ,CNRS,Sorbonne Univ,Ecole Normale Sup, F-75005 Paris, France; [Zwaan, M. A.; Ivison, R. J.; Andreani, P. M.; Oteo, I.] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Bergin, E.] Univ Michigan, Ann Arbor, MI 48109 USA; [Ivison, R. J.; Oteo, I.] Univ Edinburgh, Inst Astron, Blackford Hill, Edinburgh EH9 3HJ, Midlothian, Scotland; [Bournaud, F.; Elbaz, D.] CEA AIM, Saclay, France; [Bussmann, R. S.] Cornell Univ, Cornell, NY USA; [Omont, A.] UPMC Univ Paris 06, Sorbonne Univ, CNRS, IAP, F-75014 Paris, France; [Walter, F.] Max Planck Inst Astron, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Observatoire de Paris; Sorbonne Universite; European Southern Observatory; University of Michigan System; University of Michigan; University of Edinburgh; UDICE-French Research Universities; Universite Paris Cite; Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society	Falgarone, E (corresponding author), UPMC Univ Paris 06, LERMA LRA, Observ Paris, PSL Res Univ,CNRS,Sorbonne Univ,Ecole Normale Sup, F-75005 Paris, France.	edith.falgarone@ens.fr	Elbaz, David/AAB-4141-2020	Elbaz, David/0000-0002-7631-647X; Ivison, Rob/0000-0001-5118-1313; Andreani, Paola Michela/0000-0001-9493-0169; Walter, Fabian/0000-0003-4793-7880; Zwaan, Martin/0000-0003-0101-1804	ERC [321302]; national CNRS programme Physique et Chimie du Milieu Interstellaire (PCMI)	ERC(European Research Council (ERC)European Commission); national CNRS programme Physique et Chimie du Milieu Interstellaire (PCMI)	ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. R.J.I. acknowledges support from the ERC in the form of the Advanced Investigator Programme, 321302, COSMICISM. E.F. and B.G. acknowledge support from the national CNRS programme Physique et Chimie du Milieu Interstellaire (PCMI).	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Appleton PN, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/66; Borisova E, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/1/39; Bothwell MS, 2016, MON NOT R ASTRON SOC, V455, P1156, DOI 10.1093/mnras/stv2121; Bouche N, 2010, ASTROPHYS J, V718, P1001, DOI 10.1088/0004-637X/718/2/1001; Bussmann RS, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/25; Calanog JA, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/138; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Danielson ALR, 2011, MON NOT R ASTRON SOC, V410, P1687, DOI 10.1111/j.1365-2966.2010.17549.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Douglas AE, 1941, ASTROPHYS J, V94, P381, DOI 10.1086/144342; Eales S, 2010, PUBL ASTRON SOC PAC, V122, P499, DOI 10.1086/653086; Engel H, 2010, ASTROPHYS J, V724, P233, DOI 10.1088/0004-637X/724/1/233; Falgarone E, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015109; Falgarone E, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014671; Flower DR, 1998, MON NOT R ASTRON SOC, V297, P1182, DOI 10.1046/j.1365-8711.1998.01574.x; George RD, 2014, MON NOT R ASTRON SOC, V442, P1877, DOI 10.1093/mnras/stu967; Gerin M, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424349; Godard B, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423526; Godard B, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220151; Godard B, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117664; Gonzalez-Alfonso E, 2004, ASTROPHYS J, V613, P247, DOI 10.1086/422868; Guillard P, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/158; Harris AI, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/152; Hennebelle P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0055-y; HOLLENBACH D, 1989, ASTROPHYS J, V342, P306, DOI 10.1086/167595; Ivison RJ, 2011, MON NOT R ASTRON SOC, V412, P1913, DOI 10.1111/j.1365-2966.2010.18028.x; Kritsuk AG, 2013, MON NOT R ASTRON SOC, V436, P3247, DOI 10.1093/mnras/stt1805; Lesaffre P, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201219928; Lupu RE, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/135; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Martin CL, 2005, ASTROPHYS J, V621, P227, DOI 10.1086/427277; Narayanan D, 2015, NATURE, V525, P496, DOI 10.1038/nature15383; Naylor DA, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014656; Negrello M, 2014, MON NOT R ASTRON SOC, V440, P1999, DOI 10.1093/mnras/stu413; Negrello M, 2010, SCIENCE, V330, P800, DOI 10.1126/science.1193420; Omont A, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220811; Omont A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116921; Rangwala N, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/94; Ritchey AM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/197; Schreiber C, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425017; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Shull JM, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/162; Spinoglio L, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/108; Swinbank AM, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/11; Swinbank AM, 2010, NATURE, V464, P733, DOI 10.1038/nature08880; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; van der Werf PP, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014682; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Wisotzki L, 2016, ASTRON ASTROPHYS, V587, DOI 10.1051/0004-6361/201527384; Yang C, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201628160	53	51	51	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					430	+		10.1038/nature23298	http://dx.doi.org/10.1038/nature23298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28813416	Green Submitted			2022-12-28	WOS:000408279000033
J	Slomski, A				Slomski, Anita			Home Monitoring Fails to Improve Glycemic Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					690	690		10.1001/jama.2017.10991	http://dx.doi.org/10.1001/jama.2017.10991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829872				2022-12-28	WOS:000408095800007
J	Zheng, SY; Dhruva, SS; Redberg, RF				Zheng, Sarah Y.; Dhruva, Sanket S.; Redberg, Rita F.			Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURROGATE END-POINTS; PREMARKET APPROVAL; FDA; SAFETY; SYSTEM	IMPORTANCE High-risk medical devices often undergo modifications, which are approved by the US Food and Drug Administration (FDA) through various kinds of premarket approval (PMA) supplements. There have been multiple high-profile recalls of devices approved as PMA supplements. OBJECTIVE To characterize the quality of the clinical studies and data (strength of evidence) used to support FDA approval of panel-track supplements (a type of PMA supplement pathway that is used for significant changes in a device or indication for use and always requires clinical data). DESIGN AND SETTING Descriptive study of clinical studies supporting panel-track supplements approved by the FDA between April 19, 2006, and October 9, 2015. EXPOSURE Panel-track supplement approval. MAIN OUTCOMES AND MEASURES Methodological quality of studies including randomization, blinding, type of controls, clinical vs surrogate primary end points, use of post hoc analyses, and reporting of age and sex. RESULTS Eighty-three clinical studies supported the approval of 78 panel-track supplements, with 71 panel-track supplements (91%) supported by a single study. Of the 83 studies, 37 (45%) were randomized clinical trials and 25 (30%) were blinded. The median number of patients per study was 185 (interquartile range, 75-305), and the median follow-up duration was 180 days (interquartile range, 84-270 days). There were a total of 150 primary end points (mean [SD], 1.8 [1.2] per study), and 57 primary end points (38%) were compared with controls. Of primary end points with controls, 6 (11%) were retrospective controls and 51 (89%) were active controls. One hundred twenty-one primary end points (81%) were surrogate end points. Thirty-three studies (40%) did not report age and 25 (30%) did not report sex for all enrolled patients. The FDA required postapproval studies for 29 of 78 (37%) panel-track supplements. CONCLUSIONS AND RELEVANCE Among clinical studies used to support FDA approval of high-risk medical device modifications, fewer than half were randomized, blinded, or controlled, and most primary outcomes were based on surrogate end points. These findings suggest that the quality of studies and data evaluated to support approval by the FDA of modifications of high-risk devices should be improved.	[Zheng, Sarah Y.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Dhruva, Sanket S.] Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT USA; [Dhruva, Sanket S.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Robert Wood Johnson Foundation (RWJF); Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Div Cardiol, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	rita.redberg@ucsf.edu			Robert Wood Johnson Foundation Clinical Scholars Program; US Department of Veterans Affairs	Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); US Department of Veterans Affairs(US Department of Veterans Affairs)	Dr Dhruva is supported by the Robert Wood Johnson Foundation Clinical Scholars Program and the US Department of Veterans Affairs.	Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Food and Drug Administration, FDA SUMM SAF EFF DAT, Patent No. [PMAP130001, 130001]; Gostin LO, 2008, JAMA-J AM MED ASSOC, V299, P2313, DOI 10.1001/jama.299.19.2313; Hauser RG, 2012, HEART RHYTHM, V9, P1227, DOI 10.1016/j.hrthm.2012.03.048; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ibrahim AM, 2017, JAMA SURG, V152, P835, DOI 10.1001/jamasurg.2017.1093; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; Meier B, 2009, NY TIMES; Rathi VK, 2017, OTOLARYNG HEAD NECK, V156, P285, DOI 10.1177/0194599816684094; Rathi VK, 2015, OTOLARYNG HEAD NECK, V153, P400, DOI 10.1177/0194599815587508; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Redberg RF, 2017, JAMA-J AM MED ASSOC, V318, P325, DOI 10.1001/jama.2017.7704; Redberg RF, 2014, NEW ENGL J MED, V371, P892, DOI 10.1056/NEJMp1406388; Redberg RF, 2011, NEW ENGL J MED, V365, P958, DOI 10.1056/NEJMc1108223; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Rising J, 2014, JAMA INTERN MED, V174, P1719, DOI 10.1001/jamainternmed.2014.4195; Robb MA, 2016, JAMA-J AM MED ASSOC, V315, P1107, DOI 10.1001/jama.2016.2240; Rome BN, 2014, JAMA-J AM MED ASSOC, V311, P385, DOI 10.1001/jama.2013.284986; Samuel AM, 2016, CLIN ORTHOP RELAT R, V474, P1053, DOI 10.1007/s11999-015-4634-x; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; U.S. Food and Drug Administration, PMA APPL CONT; US Food and Drug Administration, MOD DEV SUBJ PREM AP; US Food and Drug Administration, 2013, FDA SUMM SAF EFF DAT; US Food and Drug Administration, PREM APPR PMA; US Food and Drug Administration, 2013, FDA SUMM SAF EFF DAT; US Food and Drug Administration, FDA CLASS VOL PHYS A; US Food and Drug Administration, CLASS 1 DEV REC DEXC; US Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) US Department of Health and Human Services, NONINF CLIN TRAILS E; US Food and Drug Administration Office of Device Evaluation, 1995, OFF DEV EV ANN REP F; US Government Accountability Office, 2009, US GOV ACC OFF PUBL; Zheng SY, 2014, ANN INTERN MED, V160, P798, DOI 10.7326/M13-2931	35	13	13	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					619	625		10.1001/jama.2017.9414	http://dx.doi.org/10.1001/jama.2017.9414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810022	Green Published			2022-12-28	WOS:000407616000016
J	Santos-Lozano, A; Lucia, A; Ruilope, L; Pitsiladis, YP				Santos-Lozano, Alejandro; Lucia, Alejandro; Ruilope, Luis; Pitsiladis, Yannis P.			Born to run: our future depends on it	LANCET			English	Editorial Material							MEASURED PHYSICAL-ACTIVITY; KENYAN; CHILDREN; ADOLESCENTS		[Santos-Lozano, Alejandro] European Univ Miguel de Cervantes, I HeALTH, Valladolid, Spain; [Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Ruilope, Luis] Res Inst Hosp 12 Octubre I 12, Cardiovasc Risk & Cardiovasc Risk Grp, Madrid, Spain; [Pitsiladis, Yannis P.] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Eastbourne BN20 7SN, England	Miguel de Cervantes European University (UEMC); European University of Madrid; University of Brighton	Pitsiladis, YP (corresponding author), Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Eastbourne BN20 7SN, England.	y.pitsiladis@brighton.ac.uk	Santos-Lozano, Alejandro/L-3948-2017	Santos-Lozano, Alejandro/0000-0002-2309-3583; Lucia, Alejandro/0000-0002-5565-0997; Ruilope, Luis M/0000-0001-6278-7951; Pitsiladis, Yannis/0000-0001-6210-2449				Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; Gibson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066552; Gurven M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055679; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Kaplan H, 2017, LANCET, V389, P1730, DOI 10.1016/S0140-6736(17)30752-3; Kleinert S, 2016, LANCET, V388, P2848, DOI 10.1016/S0140-6736(16)31578-1; Konstabel K, 2014, INT J OBESITY, V38, pS135, DOI 10.1038/ijo.2014.144; Mulkeen J., 2017, MONZA; Ojiambo R, 2013, ANN HUM BIOL, V40, P318, DOI 10.3109/03014460.2013.775344; Ojiambo RM, 2012, J PHYS ACT HEALTH, V9, P115, DOI 10.1123/jpah.9.1.115; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; Rankinen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147330; Telford RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150041; Tucker R, 2015, INT J SPORT PHYSIOL, V10, P285, DOI 10.1123/ijspp.2014-0247; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92	17	5	5	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					635	636		10.1016/S0140-6736(17)32103-7	http://dx.doi.org/10.1016/S0140-6736(17)32103-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28816127	Green Submitted			2022-12-28	WOS:000407456200008
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			BIOETHICS Call to halt heart trial raises vexing questions	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					538	539		10.1126/science.357.6351.538	http://dx.doi.org/10.1126/science.357.6351.538			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798111				2022-12-28	WOS:000407324800018
J	Fu, NK; Sauer, GS; Saha, A; Loo, A; Lin, S				Fu, Niankai; Sauer, Gregory S.; Saha, Ambarneil; Loo, Aaron; Lin, Song			Metal-catalyzed electrochemical diazidation of alkenes	SCIENCE			English	Article							ORGANIC ELECTROCHEMISTRY; VICINAL DIAMINATION; CONVENIENT ACCESS; OXO COMPLEXES; ALKYL AZIDES; OLEFINS; OXIDATION; AMINATION; FUNCTIONALIZATION; 1,2-DIAMINATION	Vicinal diamines are a common structural motif in bioactive natural products, therapeutic agents, and molecular catalysts, motivating the continuing development of efficient, selective, and sustainable technologies for their preparation. We report an operationally simple and environmentally friendly protocol that converts alkenes and sodium azide-both readily available feedstocks-to 1,2-diazides. Powered by electricity and catalyzed by Earth-abundant manganese, this transformation proceeds under mild conditions and exhibits exceptional substrate generality and functional group compatibility. Using standard protocols, the resultant 1,2-diazides can be smoothly reduced to vicinal diamines in a single step, with high chemoselectivity. Mechanistic studies are consistent with metal-mediated azidyl radical transfer as the predominant pathway, enabling dual carbon-nitrogen bond formation.	[Fu, Niankai; Sauer, Gregory S.; Saha, Ambarneil; Loo, Aaron; Lin, Song] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University	Lin, S (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	songlin@cornell.edu	Lin, Song/F-5472-2014; Lin, Song/ABD-5785-2021	Lin, Song/0000-0002-8880-6476; Lin, Song/0000-0002-8880-6476; Saha, Ambarneil/0000-0002-6548-5403; Loo, Aaron/0000-0003-1618-5858; Fu, Niankai/0000-0002-7453-3569	Cornell University; NSF MRSEC (Materials Research Science and Engineering Centers) program [DMR-1120296]; NSF [CHE-1531632, DGE-1650441]	Cornell University; NSF MRSEC (Materials Research Science and Engineering Centers) program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The authors declare no competing financial interests. Complete experimental and characterization data are provided in the supplementary materials. Financial support was provided by Cornell University. This study made use of the Cornell Center for Materials Research Shared Facilities, supported by the NSF MRSEC (Materials Research Science and Engineering Centers) program (grant DMR-1120296), and a nuclear magnetic resonance facility supported by the NSF (grant CHE-1531632). G.S.S. is grateful for an NSF Graduate Fellowship (DGE-1650441). We thank K. L. Carpenter and W. Hao for providing substrates 19a and 43a, respectively; K. M. Lancaster for access to an ultraviolet-visible spectrometer; and D. B. Collum and B. Ganem for assistance with manuscript preparation. S.L., N.F., and G.S.S. are inventors on U.S. patent application 62/513,646 submitted by Cornell University that covers the electrochemical alkene diazidation.	Badalyan A, 2016, NATURE, V535, P406, DOI 10.1038/nature18008; Baffert C, 2001, J ELECTROANAL CHEM, V506, P99, DOI 10.1016/S0022-0728(01)00488-0; BECKER PN, 1980, J AM CHEM SOC, V102, P5676, DOI 10.1021/ja00537a046; Brase S, 2005, ANGEW CHEM INT EDIT, V44, P5188, DOI 10.1002/anie.200400657; Cardona F, 2009, NAT CHEM, V1, P269, DOI [10.1038/NCHEM.256, 10.1038/nchem.256]; Chiba K, 2001, J AM CHEM SOC, V123, P11314, DOI 10.1021/ja016885b; CHONG AO, 1977, J AM CHEM SOC, V99, P3420, DOI 10.1021/ja00452a039; DAVID SJ, 1986, J PHYS CHEM-US, V90, P3260, DOI 10.1021/j100405a041; Francke R, 2014, CHEM SOC REV, V43, P2492, DOI 10.1039/c3cs60464k; FRISTAD WE, 1985, J ORG CHEM, V50, P3647, DOI 10.1021/jo00219a049; Hennessy ET, 2013, SCIENCE, V340, P591, DOI 10.1126/science.1233701; Horn EJ, 2016, ACS CENTRAL SCI, V2, P302, DOI 10.1021/acscentsci.6b00091; Horn EJ, 2016, NATURE, V533, P77, DOI 10.1038/nature17431; Huang XY, 2015, J AM CHEM SOC, V137, P5300, DOI 10.1021/jacs.5b01983; Kirste A, 2010, ANGEW CHEM INT EDIT, V49, P971, DOI 10.1002/anie.200904763; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Leggans EK, 2012, ORG LETT, V14, P1428, DOI 10.1021/ol300173v; Li LJ, 2015, J ORG CHEM, V80, P11021, DOI 10.1021/acs.joc.5b02222; Little RD, 1997, TOP CURR CHEM, V185, P1; Lucet D, 1998, ANGEW CHEM INT EDIT, V37, P2581, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2580::AID-ANIE2580>3.0.CO;2-L; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; MINISCI F, 1975, ACCOUNTS CHEM RES, V8, P165, DOI 10.1021/ar50089a004; Moeller KD, 2000, TETRAHEDRON, V56, P9527, DOI 10.1016/S0040-4020(00)00840-1; MOELLER KD, 1990, J AM CHEM SOC, V112, P6123, DOI 10.1021/ja00172a035; Morofuji T, 2013, J AM CHEM SOC, V135, P5000, DOI 10.1021/ja402083e; Muniz K, 2017, J AM CHEM SOC, V139, P4354, DOI 10.1021/jacs.7b01443; Nguyen BH, 2014, GREEN CHEM, V16, P69, DOI 10.1039/c3gc41650j; Olson DE, 2014, J AM CHEM SOC, V136, P13506, DOI 10.1021/ja506532h; Palacios F, 2007, TETRAHEDRON, V63, P523, DOI 10.1016/j.tet.2006.09.048; Rosen BR, 2014, J AM CHEM SOC, V136, P5571, DOI 10.1021/ja5013323; SCHAFER H, 1970, ANGEW CHEM INT EDIT, V9, P158, DOI 10.1002/anie.197001582; Schilling CI, 2011, CHEM SOC REV, V40, P4840, DOI 10.1039/c0cs00123f; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Sharma A, 2015, NATURE, V517, P600, DOI 10.1038/nature14127; SHONO T, 1986, J AM CHEM SOC, V108, P4676, DOI 10.1021/ja00275a084; Simmons B, 2009, ANGEW CHEM INT EDIT, V48, P4349, DOI 10.1002/anie.200900220; Sperry JB, 2005, J AM CHEM SOC, V127, P8034, DOI 10.1021/ja051826+; Wang F, 2014, ANGEW CHEM INT EDIT, V53, P1881, DOI 10.1002/anie.201309991; Waser J, 2005, J AM CHEM SOC, V127, P8294, DOI 10.1021/ja052164r; Xiong P, 2017, J AM CHEM SOC, V139, P2956, DOI 10.1021/jacs.7b01016; Xu HC, 2008, J AM CHEM SOC, V130, P13542, DOI 10.1021/ja806259z; Yoshida J, 2008, CHEM REV, V108, P2265, DOI 10.1021/cr0680843; Yuan YA, 2016, ANGEW CHEM INT EDIT, V55, P534, DOI 10.1002/anie.201507550; Zhang B, 2014, ORG LETT, V16, P1790, DOI 10.1021/ol500513b; Zhu R, 2015, J AM CHEM SOC, V137, P8069, DOI 10.1021/jacs.5b04821; Zhu YG, 2014, ACCOUNTS CHEM RES, V47, P3665, DOI 10.1021/ar500344t	47	396	396	19	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					575	579		10.1126/science.aan6206	http://dx.doi.org/10.1126/science.aan6206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798126				2022-12-28	WOS:000407324800037
J	Crow, D				Crow, Diana			Biology Gone Wild (vol 170, pg 219, 2017)	CELL			English	Correction							CELLULAR SENESCENCE								ANR-BMFT; Fondation ARC pour la recherche sur le Cancer; Association La Ligue National Contre le Cancer LNCC; INSERM; National Cancer Institute of the National Institutes of Health [R01CA136533]	ANR-BMFT(French National Research Agency (ANR)); Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association La Ligue National Contre le Cancer LNCC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, Association La Ligue National Contre le Cancer LNCC, INSERM, and the National Cancer Institute of the National Institutes of Health under Award Number R01CA136533. R.I.M.-Z. is a member of the Mexican National Investigator System (SNI). O.B. is a CNRS fellow.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Crow D, 2017, CELL, V170, P219, DOI 10.1016/j.cell.2017.06.043; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X	6	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					815	+		10.1016/j.cell.2017.07.047	http://dx.doi.org/10.1016/j.cell.2017.07.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802048	Bronze			2022-12-28	WOS:000407445700020
J	Morgan, B; McGilvray, A				Morgan, Branwen; McGilvray, Annabel			GAME-CHANGERS	NATURE			English	Editorial Material													Morgan, Branwen/ABG-1328-2021	Morgan, Branwen/0000-0001-5318-1675				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0	3	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S9	S11		10.1038/548S9a	http://dx.doi.org/10.1038/548S9a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792918				2022-12-28	WOS:000407284300004
J	Hoogstraten, CG				Hoogstraten, Charles G.			Fighting through the darkness	SCIENCE			English	Editorial Material									[Hoogstraten, Charles G.] Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Hoogstraten, CG (corresponding author), Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA.								0	0	0	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					522	522		10.1126/science.357.6350.522	http://dx.doi.org/10.1126/science.357.6350.522			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774931				2022-12-28	WOS:000406840100041
J	Maxmen, A				Maxmen, Amy			MIDDLE EAST Jordan stakes its future on	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					14	15		10.1038/548014a	http://dx.doi.org/10.1038/548014a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770858	Bronze			2022-12-28	WOS:000406831700007
J	Jaffe, S				Jaffe, Susan			Dismantling the ACA without help from Congress	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					441	442		10.1016/S0140-6736(17)31991-8	http://dx.doi.org/10.1016/S0140-6736(17)31991-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792400				2022-12-28	WOS:000406463400011
J	Jasienska, G; Bribiescas, RG; Furberg, AS; Helle, S; Nunez-de la Mora, A				Jasienska, Grazyna; Bribiescas, Richard G.; Furberg, Anne-Sofie; Helle, Samuli; Nunez-de la Mora, Alejandra			Human reproduction and health: an evolutionary perspective	LANCET			English	Article							BREAST-CANCER RISK; EARLY PUBERTAL DEVELOPMENT; POPULATION VARIATION; PRECOCIOUS PUBERTY; OVARIAN-FUNCTION; LIFE-HISTORY; SOCIOECONOMIC-STATUS; PROGESTERONE LEVELS; TESTOSTERONE LEVELS; FOOD AVAILABILITY	According to life history theory, increased investment in reproductive function (physiology and behaviour) at different times throughout the life course affects the risk of many diseases and, ultimately, longevity. Although genetic factors contribute to interindividual and interpopulation variation in reproductive traits, the dominant source of variability is phenotypic plasticity during development and adult life. Reproductive traits in both sexes evolved sensitivity to ecological conditions, as reflected in contemporary associations of hormone concentrations with geographical setting, nutritional status, and physical activity level. Lifetime exposure to increased concentrations of sex hormones is associated with the risk of some cancers, hence decreasing fertility patterns contribute to secular increases in their incidence. Conversely, increased investment in reproductive function might compromise somatic investment in health, such that faster sexual maturation and higher parity increases risk of diabetes and cardiovascular disease. An evolutionary perspective on reproductive biology could improve the efficacy of public health efforts to reduce the risk of hormone-sensitive cancers and other non-communicable diseases.	[Jasienska, Grazyna] Jagiellonian Univ, Med Coll, Dept Environm Hlth, Fac Hlth Sci, PL-31531 Krakow, Poland; [Bribiescas, Richard G.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Furberg, Anne-Sofie] Arctic Univ Norway, Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Furberg, Anne-Sofie] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Helle, Samuli] Univ Turku, Dept Biol, Sect Ecol, Turku, Finland; [Nunez-de la Mora, Alejandra] Univ Veracruzana, Inst Invest Psicol, Xalapa, Veracruz, Mexico	Jagiellonian University; Collegium Medicum Jagiellonian University; Yale University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Turku; Universidad Veracruzana	Jasienska, G (corresponding author), Jagiellonian Univ, Med Coll, Dept Environm Hlth, Fac Hlth Sci, PL-31531 Krakow, Poland.	jasienska@post.harvard.edu	Jasienska, Grazyna/E-4901-2011	Jasienska, Grazyna/0000-0001-8716-6342; Furberg, Anne-Sofie/0000-0002-6311-166X	Ministry of Science and Higher Education [IdP2011 000161]; CONACYT Mexico [I0007-2014-01]; Kone Foundation	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Kone Foundation	Preparation of this paper was facilitated by support that the Arizona State University Center for Evolution and Medicine provided for an authors' meeting, by Ministry of Science and Higher Education grant IdP2011 000161 (GJ), CONACYT Mexico Programa de Retencion Convocatoria 2014-Proyecto I0007-2014-01 (ANM), and the Kone Foundation (SH). We thank Jonathan Wells (University College London).	ADOLFSSON S, 1981, PEDIATR RES, V15, P82, DOI 10.1203/00006450-198101000-00068; Aktipis C. Athena, 2015, Evolution Medicine and Public Health, P52, DOI 10.1093/emph/eou028; Alvarado LC, 2010, AM J HUM BIOL, V22, P449, DOI 10.1002/ajhb.21016; [Anonymous], 2006, MENOPAUSE BIOCULTURA; APTER D, 1983, J CLIN ENDOCR METAB, V57, P82, DOI 10.1210/jcem-57-1-82; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Baird DT, 2006, HUM REPROD UPDATE, V12, P193, DOI 10.1093/humupd/dmk003; Baron S, 2000, ARCH PEDIATRIE, V7, P809, DOI 10.1016/S0929-693X(00)80189-X; Begum K, 2016, FERTIL STERIL, V105, P744, DOI 10.1016/j.fertnstert.2015.11.024; Bentley GR, 1998, EUR J CLIN NUTR, V52, P261, DOI 10.1038/sj.ejcn.1600547; BENTLEY GR, 1994, ANN NY ACAD SCI, V709, P201, DOI 10.1111/j.1749-6632.1994.tb30401.x; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bribiescas RG, 2001, FOUND HUM B, P107; Bribiescas RG, 1996, HUM NATURE-INT BIOS, V7, P163, DOI 10.1007/BF02692109; Bribiescas RG, 2006, MEN EVOLUTIONARY LIF; Bukowski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040199; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Colditz GA, 2014, BREAST CANCER RES TR, V145, P567, DOI 10.1007/s10549-014-2993-8; Corbo RM, 2008, BIOGERONTOLOGY, V9, P317, DOI 10.1007/s10522-008-9143-9; De Souza MJ, 2010, HUM REPROD, V25, P491, DOI 10.1093/humrep/dep411; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dribe M, 2004, POP STUD-J DEMOG, V58, P297, DOI 10.1080/0032472042000272357; ELLISON PT, 1986, AM J OBSTET GYNECOL, V154, P1000, DOI 10.1016/0002-9378(86)90737-4; ELLISON PT, 1993, LANCET, V342, P433, DOI 10.1016/0140-6736(93)92845-K; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Ellison PT, 2003, FERTILE GROUND; Emaus A, 2008, HUM REPROD, V23, P919, DOI 10.1093/humrep/dem432; Faupel-Badger JM, 2013, JNCI-J NATL CANCER I, V105, P166, DOI 10.1093/jnci/djs505; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Folkerd E, 2013, BREAST, V22, pS38, DOI 10.1016/j.breast.2013.07.007; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Harris HE, 1997, NUTR RES REV, V10, P57, DOI 10.1079/NRR19970005; Hildreth KL, 2013, J CLIN ENDOCR METAB, V98, P1891, DOI 10.1210/jc.2012-3695; Hill J, 2014, J ENVIRON PATHOL TOX, V33, P239, DOI 10.1615/JEnvironPatholToxicolOncol.2014011005; Hinkula M, 2006, AM J EPIDEMIOL, V163, P367, DOI 10.1093/aje/kwj048; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Houghton LC, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0469-8; Houghton LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109200; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Ibanez L, 2006, PEDIATRICS, V117, P117, DOI 10.1542/peds.2005-0664; Iversen A, 2012, J CLIN ENDOCR METAB, V97, pE852, DOI 10.1210/jc.2011-2577; Jasienska G, 2006, AM J HUM BIOL, V18, P422, DOI 10.1002/ajhb.20497; Jasienska G, 2004, AM J HUM BIOL, V16, P563, DOI 10.1002/ajhb.20063; Jasienska G, 1998, P ROY SOC B-BIOL SCI, V265, P1847, DOI 10.1098/rspb.1998.0511; Jasienska G., 2013, FRAGILE WISDOM EVOLU; JASIENSKA G, 2015, P ROY SOC B-BIOL SCI, V282, DOI DOI 10.1098/RSPB.2014.2395; Jasienska G, 2008, AM J HUM BIOL, V20, P35, DOI 10.1002/ajhb.20686; Jasienska G, 2006, P NATL ACAD SCI USA, V103, P12759, DOI 10.1073/pnas.0605488103; Jasienska G, 2006, EUR J CANCER PREV, V15, P439, DOI 10.1097/00008469-200610000-00009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kauppila A, 2012, CANCER CAUSE CONTROL, V23, P187, DOI 10.1007/s10552-011-9868-7; Kington R, 1997, AM J PUBLIC HEALTH, V87, P33, DOI 10.2105/AJPH.87.1.33; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Kossman DA, 2011, J APPL PHYSIOL, V111, P1687, DOI 10.1152/japplphysiol.00319.2011; Kuzawa CW, 2010, P NATL ACAD SCI USA, V107, P16800, DOI 10.1073/pnas.1006008107; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LIPSON SF, 1992, J BIOSOC SCI, V24, P233, DOI 10.1017/S0021932000019751; Lumey LH, 1998, P NUTR SOC, V57, P129, DOI 10.1079/PNS19980019; LUNN PG, 1984, AM J CLIN NUTR, V39, P227, DOI 10.1093/ajcn/39.2.227; Lycett JE, 2000, P ROY SOC B-BIOL SCI, V267, P31, DOI 10.1098/rspb.2000.0962; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Manor O, 2000, SOC SCI MED, V51, P1175, DOI 10.1016/S0277-9536(00)00024-1; Mason P., 2002, CURRENT OPINION ENDO, V9, P26; Mokkonen M, 2015, EVOL APPL, V8, P307, DOI 10.1111/eva.12244; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Neilson Heather K, 2014, Curr Nutr Rep, V3, P22; Nenko I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2319; NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; Ng Marie, 2014, Lancet, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; la Mora AND, 2008, AM J HUM BIOL, V20, P2, DOI 10.1002/ajhb.20698; Nunez-de la Mora A, 2007, PLOS MED, V4, P813, DOI 10.1371/journal.pmed.0040167; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Pettay JE, 2005, P NATL ACAD SCI USA, V102, P2838, DOI 10.1073/pnas.0406709102; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Pollard TM, 2006, AM J HUM BIOL, V18, P741, DOI 10.1002/ajhb.20526; Proos L A, 1991, Indian J Pediatr, V58, P105, DOI 10.1007/BF02810420; PROOS LA, 1993, ACTA PAEDIATR, V82, P641, DOI 10.1111/j.1651-2227.1993.tb18031.x; Proos LA, 2009, INDIAN J MED RES, V130, P646; Qureshi AI, 1997, ARCH NEUROL-CHICAGO, V54, P203, DOI 10.1001/archneur.1997.00550140073015; Ramakrishnan U, 1999, J NUTR, V129, P2196, DOI 10.1093/jn/129.12.2196; Rickard IJ, 2010, ECOLOGY, V91, P3515, DOI 10.1890/10-0019.1; Rook G, 2017, LANCET, V390, P521, DOI 10.1016/S0140-6736(17)30566-4; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; Shi LJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE990, DOI 10.1152/ajpendo.00374.2010; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Simmons D, 2006, DIABETOLOGIA, V49, P1522, DOI 10.1007/s00125-006-0276-6; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Sonneveldt E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S7; Soriano-Guillen L, 2010, J CLIN ENDOCR METAB, V95, P4305, DOI 10.1210/jc.2010-1025; Stearns SC, 2012, P ROY SOC B-BIOL SCI, V279, P4836, DOI 10.1098/rspb.2012.2024; Stewart B. W., 2003, World Cancer Report; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Teilmann G, 2007, J CLIN ENDOCR METAB, V92, P2538, DOI 10.1210/jc.2006-2096; Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939; Tom SE, 2010, HUM REPROD, V25, P791, DOI 10.1093/humrep/dep451; TUVEMO T, 1993, ANN MED, V25, P217, DOI 10.3109/07853899309147867; Uchida A, 2006, AGING MALE, V9, P207, DOI 10.1080/13685530601060461; Villanueva M Teresa, 2014, Nat Rev Clin Oncol, V11, P501, DOI 10.1038/nrclinonc.2014.130; Virdis R, 1998, ARCH DIS CHILD, V78, P152, DOI 10.1136/adc.78.2.152; Vitzthum V J, 2000, High Alt Med Biol, V1, P39, DOI 10.1089/152702900320676; Wang Xiaofei, 2013, Evolution Medicine and Public Health, P241, DOI 10.1093/emph/eot013; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Wells JCK, 2017, LANCET, V390, P500, DOI 10.1016/S0140-6736(17)30572-X; Yue W, 2013, STEROIDS, V78, P161, DOI 10.1016/j.steroids.2012.11.001; Ziomkiewicz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145753	113	95	97	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					510	520		10.1016/S0140-6736(17)30573-1	http://dx.doi.org/10.1016/S0140-6736(17)30573-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792413				2022-12-28	WOS:000406463400032
J	Schiff, D				Schiff, David			Benefit with adjuvant chemotherapy in anaplastic astrocytoma	LANCET			English	Editorial Material							PROCARBAZINE; VINCRISTINE; GLIOMAS; GRADE; GLIOBLASTOMA; TEMOZOLOMIDE; LOMUSTINE; MUTATION; IDH		[Schiff, David] Hosp West, Neurooncol Ctr, Room 6225, Charlottesville, VA 22908 USA		Schiff, D (corresponding author), Hosp West, Neurooncol Ctr, Room 6225, Charlottesville, VA 22908 USA.	ds4jd@virginia.edu						Blumenthal DT, 2017, NEURO-ONCOLOGY, V19, P1119, DOI 10.1093/neuonc/nox025; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Gramatzki D, 2017, NEUROLOGY, V88, P1422, DOI 10.1212/WNL.0000000000003809; Olar A, 2015, ACTA NEUROPATHOL, V129, P585, DOI 10.1007/s00401-015-1398-z; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van den Bent MJ, 2017, LANCET; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	12	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1625	1626		10.1016/S0140-6736(17)31477-0	http://dx.doi.org/10.1016/S0140-6736(17)31477-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI9TS	28801187				2022-12-28	WOS:000412352800005
J	Gulick, RM; Wilkin, TJ; Chen, YQ; Landovitz, RJ; Amico, KR; Young, AM; Richardson, P; Marzinke, MA; Hendrix, CW; Eshleman, SH; McGowan, I; Cottle, LM; Andrade, A; Marcus, C; Klingman, KL; Chege, W; Rinehart, AR; Rooney, JF; Andrew, P; Salata, RA; Siegel, M; Manabe, YC; Frank, I; Ho, K; Santana, J; Stekler, JD; Swaminathan, S; McCauley, M; Hodder, S; Mayer, KH				Gulick, Roy M.; Wilkin, Timothy J.; Chen, Ying Q.; Landovitz, Raphael J.; Amico, K. Rivet; Young, Alicia M.; Richardson, Paul; Marzinke, Mark A.; Hendrix, Craig W.; Eshleman, Susan H.; McGowan, Ian; Cottle, Leslie M.; Andrade, Adriana; Marcus, Cheryl; Klingman, Karin L.; Chege, Wairimu; Rinehart, Alex R.; Rooney, James F.; Andrew, Philip; Salata, Robert A.; Siegel, Marc; Manabe, Yukari C.; Frank, Ian; Ho, Ken; Santana, Jorge; Stekler, Joanne D.; Swaminathan, Shobha; McCauley, Marybeth; Hodder, Sally; Mayer, Kenneth H.			Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women A Phase 2 Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; PREEXPOSURE PROPHYLAXIS; DOSE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; VAGINAL TISSUE; AFRICAN WOMEN; MEN; EMTRICITABINE; ADHERENCE; PLASMA	Background: Maraviroc (MVC) is a candidate drug for HIV preexposure prophylaxis (PrEP). Objective: To assess the safety and tolerability of MVCcontaining PrEP over 48 weeks in U.S. women at risk for HIV infection. Design: Phase 2 randomized, controlled, double-blinded study of 4 antiretroviral regimens used as PrEP. (ClinicalTrials. gov: NCT01505114) Setting: 12 clinical research sites of the HIV Prevention Trials Network and AIDS Clinical Trials Group. Participants: HIV-uninfected women reporting condomless vaginal or anal intercourse with at least 1 man with HIV infection or unknown serostatus within 90 days. Intervention: MVC only, MVC-emtricitabine (FTC), MVC-tenofovir disoproxil fumarate (TDF), and TDF-FTC (control). Measurements: At each visit, clinical and laboratory (including HIV) assessments were done. Primary outcomes were grade 3 and 4 adverse events and time to permanent discontinuation of the study regimen. All randomly assigned participants were analyzed according to their original assignment. Results: Among 188 participants, 85% completed follow-up, 11% withdrew early, and 4% were lost to follow-up; 19% discontinued their regimen prematurely. The number discontinuing and the time to discontinuation did not differ among regimens. Grade 3 or 4 adverse events occurred in 5 (MVC), 13 (MVC-FTC), 9 (MVC-TDF), and 8 (TDF-FTC) participants; rates did not differ among regimens. One death (by suicide) occurred in the MVC-TDF group but was judged not to be related to study drugs. Of available plasma samples at week 48 (n = 126), 60% showed detectable drug concentrations. No new HIV infections occurred. Limitations: Participants were not necessarily at high risk for HIV infection. The regimen comprised 3 pills taken daily. The study was not powered for efficacy. Conclusion: Maraviroc-containing PrEP regimens were safe and well-tolerated compared with TDF-FTC in U.S. women. No new HIV infections occurred, although whether this was due to study drugs or low risk in the population is uncertain. Maraviroc-containing PrEP for women may warrant further study.	[Gulick, Roy M.] Weill Cornell Med, Div Infect Dis, Box 125,1300 York Ave, New York, NY 10065 USA; [Wilkin, Timothy J.] Weill Cornell Med, Div Infect Dis, 53 West 23rd St,6th Floor, New York, NY 10010 USA; [Stekler, Joanne D.] Univ Washington, Harborview Med Ctr, Box 359931,325 Ninth Ave, Seattle, WA 98104 USA; [Chen, Ying Q.; Young, Alicia M.; Cottle, Leslie M.] Fred Hutchinson Canc Res Ctr, SCHARP, 1100 Fairview Ave N,M2-C200, Seattle, WA 98109 USA; [Landovitz, Raphael J.] Univ Calif Los Angeles, 11075 Santa Monica Blvd,Suite 100, Los Angeles, CA 90025 USA; [Amico, K. Rivet] Univ Michigan, Dept Hlth Behavior & Hlth Educ, Sch Publ Hlth 3830, 1415 Washington Hts, Ann Arbor, MI 48109 USA; [Marzinke, Mark A.] Johns Hopkins Univ, Sch Med, Sheikh Zayed Tower,1800 Orleans St,B1-1020G, Baltimore, MD 21287 USA; [Hendrix, Craig W.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Blalock 569,600 North Wolfe St, Baltimore, MD 21287 USA; [Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Ross Bldg,Room 646,720 Rutland Ave, Baltimore, MD 21205 USA; [McGowan, Ian] Univ Pittsburgh, Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ North Carolina Chapel Hill, Chapel Hill, NC USA; NIH, Natl Inst Allergy & Infect Dis, Bldg 10, Bethesda, MD 20892 USA; [Rinehart, Alex R.] ViiV Healthcare, 5 Moore Dr, Durham, NC 27709 USA; [Rooney, James F.] Gilead Sci, 333 Lakeside Dr, Foster City, CA USA; [Salata, Robert A.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, 1100 Euclid Ave,Lakeside Bldg,Room 3563, Cleveland, OH 44106 USA; George Washington Univ, Washington, DC USA; [McCauley, Marybeth] FHI 360, 1875 Connecticut Ave NW, Washington, DC 20009 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Santana, Jorge] Univ Puerto Rico, Sch Med, Proyecto ACTU Site 5401,POB 365067, San Juan, PR 00936 USA; [Swaminathan, Shobha] Rutgers New Jersey Med Sch, MSB I609 D, Newark, NJ 07103 USA; [Hodder, Sally] West Virginia Univ, Hlth Sci Ctr, West Virginia Clin & Translat Sci Inst, POB 9102, Morgantown, WV 26506 USA; Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Richardson, Paul] Johns Hopkins Med, Dept Pathol, HPTN Lab Ctr, Pathol 306,600 North Wolfe St, Baltimore, MD 21287 USA; [Andrade, Adriana] Johns Hopkins Univ, 600 North Wolfe St,Brady 522A, Baltimore, MD 21287 USA; [Marcus, Cheryl] UNC Inst Global Hlth & Infect Dis, UNC Global HIV Prevent & Treatment Clin Trials Un, Bioinformatics Bldg,130 Mason Farm Rd,2nd Floor, Chapel Hill, NC 27599 USA; [Klingman, Karin L.] Natl Inst Allergy & Infect Dis, Div Aids, Therapeut Res Program, 5601 Fishers Lane,MSC 9830, Bethesda, MD 20892 USA; [Chege, Wairimu] Natl Inst Allergy & Infect Dis, Div Aids, Prevent Sci Program, 5601 Fishers Lane,Room 8B38, Bethesda, MD 20892 USA; [Andrew, Philip] FHI 360, 359 Blackwell St,Suite 200, Durham, NC 27701 USA; [Siegel, Marc] George Washington Med Fac Associates, Div Infect Dis, 2150 Penn Ave NW,Suite 8-436, Washington, DC 20037 USA; [Manabe, Yukari C.] Johns Hopkins Univ, 1830 East Monument St,Room 443, Baltimore, MD 21205 USA; [Frank, Ian] Univ Penn, Div Infect Dis, 502 Johnson Pavilion,3610 Hamilton Walk, Philadelphia, PA 19104 USA; [Ho, Ken] Univ Pittsburgh, Div Infect Dis, 3520 Fifth Ave,Suite 533, Pittsburgh, PA 15213 USA; [Mayer, Kenneth H.] Fenway Inst, Fenway Hlth, 1340 Boylston St, Boston, MA 02215 USA	Cornell University; Cornell University; Harborview Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); GlaxoSmithKline; Gilead Sciences; Case Western Reserve University; Case Western Reserve University Hospital; George Washington University; University of Pennsylvania; Pennsylvania Medicine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Rutgers State University New Brunswick; Rutgers State University Medical Center; West Virginia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); FHI 360; Johns Hopkins University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fenway Health	Gulick, RM (corresponding author), Weill Cornell Med Coll, Div Infect Dis, Med, Box 125,1300 York Ave, New York, NY 10065 USA.	rgulick@med.cornell.edu	S, Swaminathan/AAC-4467-2020; /AAE-4700-2020; M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; Hendrix, Craig W/G-4182-2014	M, Ian/0000-0002-6470-8476; Hendrix, Craig W/0000-0002-5696-8665; Amico, K Rivet/0000-0002-4458-6934; Chen, Ying Qing/0000-0002-2726-3391	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384, UL1TR001111, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, U01AI069423, UM1AI068636, P30AI050410, UM1AI106701, UM1AI069494, U01AI068634, UM1AI069503, UM1AI069481, P30AI117970, UM1AI069465, UM1AI069466, UM1AI069424, UM1AI069501, UM1AI069415, UM1AI068634, UM1AI069423, UM1AI068619, UM1AI069419, UM1AI069412, UM1AI069534, UM1AI068613, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health.	Abel S, 2008, BRIT J CLIN PHARMACO, V65, P19, DOI 10.1111/j.1365-2125.2008.03132.x; Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Amico KR, 2012, CURR OPIN HIV AIDS, V7, P542, DOI 10.1097/COH.0b013e3283582d4a; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Antiretroviral Pregnancy Registry Steering Committee, 2016, ANT PREGN REG INT IN; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Brown KC, 2011, J INFECT DIS, V203, P1484, DOI 10.1093/infdis/jir059; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Cooperativecom, 2016, FLASHBACKS RURAL ELE; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Department of Health and Human Services, 2017, GUIDELINES USE ANTIR; Division of AIDS, 2009, TABL GRAD SEV AD PED; Dumond JB, 2009, JAIDS-J ACQ IMM DEF, V51, P546, DOI 10.1097/QAI.0b013e3181ae69c5; Emory JF, 2014, CLIN CHIM ACTA, V431, P198, DOI 10.1016/j.cca.2014.02.008; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gulick RM, 2017, J INFECT DIS, V215, P238, DOI 10.1093/infdis/jiw525; Gulick RM, 2014, JAIDS-J ACQ IMM DEF, V65, P78, DOI 10.1097/QAI.0b013e3182a7a97a; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Hendrix CW, 2013, CELL, V155, P515, DOI 10.1016/j.cell.2013.09.030; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004; Kasonde M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090111; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Mulligan K, 2015, CLIN INFECT DIS, V61, P572, DOI 10.1093/cid/civ324; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Taiwo BO, 2015, CLIN INFECT DIS, V61, P1179, DOI 10.1093/cid/civ455; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Viiv Healthcare, 2016, SELZ FULL PRESCR INF; World Health Organization, 2016, CONS GUID US ANT DRU	38	24	24	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					384	+		10.7326/M17-0520	http://dx.doi.org/10.7326/M17-0520			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828489	Green Accepted			2022-12-28	WOS:000411009900015
J	O'Neil, ME; Nugent, SM; Morasco, BJ; Freeman, M; Low, A; Kondo, K; Zakher, B; Elven, C; Motu'apuaka, M; Paynter, R; Kansagara, D				O'Neil, Maya E.; Nugent, Shannon M.; Morasco, Benjamin J.; Freeman, Michele; Low, Allison; Kondo, Karli; Zakher, Bernadette; Elven, Camille; Motu'apuaka, Makalapua; Paynter, Robin; Kansagara, Devan			Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							MEDICAL MARIJUANA; SYMPTOM SEVERITY; UNITED-STATES; MENTAL-HEALTH; PTSD; NIGHTMARES; VETERANS; PREVALENCE	Background: Cannabis is available from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet its efficacy in treating PTSD symptoms remains uncertain. Purpose: To identify ongoing studies and review existing evidence regarding the benefits and harms of plant-based cannabis preparations in treating PTSD in adults. Data Sources: MEDLINE, the Cochrane Library, and other sources from database inception to March 2017. Study Selection: English-language systematic reviews, trials, and observational studies with a control group that reported PTSD symptoms and adverse effects of plant-based cannabis use in adults with PTSD. Data Extraction: Study data extracted by 1 investigator was checked by a second reviewer; 2 reviewers independently assessed study quality, and the investigator group graded the overall strength of evidence by using standard criteria. Data Synthesis: Two systematic reviews, 3 observational studies, and no randomized trials were found. The systematic reviews reported insufficient evidence to draw conclusions about benefits and harms. The observational studies found that compared with nonuse, cannabis did not reduce PTSD symptoms. Studies had medium and high risk of bias, and overall evidence was judged insufficient. Two randomized trials and 6 other studies examining outcomes of cannabis use in patients with PTSD are ongoing and are expected to be completed within 3 years. Limitation: Very scant evidence with medium to high risk of bias. Conclusion: Evidence is insufficient to draw conclusions about the benefits and harms of plant-based cannabis preparations in patients with PTSD, but several ongoing studies may soon provide important results.	[O'Neil, Maya E.; Nugent, Shannon M.; Morasco, Benjamin J.] Vet Affairs Portland Hlth Care Syst, RD 66,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA; [Freeman, Michele; Low, Allison; Kondo, Karli; Motu'apuaka, Makalapua; Paynter, Robin] VA Portland Hlth Care Syst, RD 71,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA; [Zakher, Bernadette; Elven, Camille] Oregon Hlth & Sci Univ, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA; [Kansagara, Devan] VA Portland Hlth Care Syst, P3MED,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	O'Neil, ME (corresponding author), Vet Affairs Portland Hlth Care Syst, RD 66,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA.	maya.oneil@va.gov	Kondo, Karli/R-3994-2019	Kondo, Karli/0000-0002-4635-5056; Paynter, Robin/0000-0002-6969-4261	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative [PROSPERO: CRD42016033623]	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative. (PROSPERO: CRD42016033623)	Adler JN, 2013, NEW ENGL J MED, V368, pE30, DOI 10.1056/NEJMclde1305159; Atkins D, 2011, AHRQ PUBLICATION; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Boden MT, 2013, AM J ADDICTION, V22, P277, DOI 10.1111/j.1521-0391.2012.12018.x; Bonn-Miller MO, 2015, AM J DRUG ALCOHOL AB, V41, DOI 10.3109/00952990.2015.1043209; Bonn-Miller MO, 2014, DRUG ALCOHOL DEPEN, V136, P162, DOI 10.1016/j.drugalcdep.2013.12.008; Bonn-Miller MO, 2013, PSYCHOL TRAUMA-US, V5, P193, DOI 10.1037/a0026621; Bonn-Miller MO, 2017, MARIJUANA USE PTSD V; Bowles DW, 2012, J PALLIAT MED, V15, P9, DOI 10.1089/jpm.2011.0356; Butler M, 2016, MED CANNABIS NONCANC; Cameron C, 2014, J CLIN PSYCHOPHARM, V34, P559, DOI 10.1097/JCP.0000000000000180; Committee on Treatment of Posttraumatic Stress Disorder, 2014, TREATM POSTTR STRESS; Fraser GA, 2009, CNS NEUROSCI THER, V15, P84, DOI 10.1111/j.1755-5949.2008.00071.x; Greer GR, 2014, J PSYCHOACTIVE DRUGS, V46, P73, DOI 10.1080/02791072.2013.873843; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Jetly R, 2015, PSYCHONEUROENDOCRINO, V51, P585, DOI 10.1016/j.psyneuen.2014.11.002; Johnson MJ, 2016, J AFFECT DISORDERS, V190, P439, DOI 10.1016/j.jad.2015.10.048; Kansagara D, 2016, CANNABIS MANAGEMENT; Kansagara D, 2016, 05225 VA ESP; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; Mashiah M., 2012, PAT OUT TIM C TUCS A; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; National Conference of State Legislatures, 2017, MAR OV; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; Reznik I., 2011, INT C INT MED JER IS; Roitman P, 2014, CLIN DRUG INVEST, V34, P587, DOI 10.1007/s40261-014-0212-3; Ruglass LM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020014; Ryan-Ibarra S, 2015, DRUG ALCOHOL REV, V34, P141, DOI 10.1111/dar.12207; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; U.S. Department of Veterans Affairs; National Center for PTSD, 2017, COOCC COND PTSD; Viswanathan M AM, 2012, METHODS GUIDE EFFECT; Walsh Z, 2017, CLIN PSYCHOL REV, V51, P15, DOI 10.1016/j.cpr.2016.10.002; Wells G., 2014, NEWCASTLE OTTAWA SCA; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wilkinson ST, 2016, J CLIN PSYCHIAT, V77, P1050, DOI 10.4088/JCP.15r10036; Wilkinson ST, 2015, J CLIN PSYCHIAT, V76, P1174, DOI 10.4088/JCP.14m09475	37	41	41	1	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					332	+		10.7326/M17-0477	http://dx.doi.org/10.7326/M17-0477			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF6LC	28806794				2022-12-28	WOS:000409120400007
J	Wenger, HC; Cifu, AS				Wenger, Hannah C.; Cifu, Adam S.			Treatment of Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN-COLLEGE; PHYSICIANS; CARE		[Wenger, Hannah C.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Chou R, NONINVASIVE TREATMEN; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010	9	26	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					743	744		10.1001/jama.2017.9386	http://dx.doi.org/10.1001/jama.2017.9386			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829855				2022-12-28	WOS:000408095800026
J	Dobbek, H				Dobbek, Holger			Playing marble run to make methane	SCIENCE			English	Editorial Material									[Dobbek, Holger] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Dobbek, H (corresponding author), Humboldt Univ, Dept Biol, D-10115 Berlin, Germany.	holger.dobbek@biologie.hu-berlin.de						Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Szent-Gyorgyi A., 1960, INTRO SUBMOLECULAR B; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wagner T, 2017, SCIENCE, V357, P699, DOI 10.1126/science.aan0425	8	1	1	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					642	643		10.1126/science.aao2439	http://dx.doi.org/10.1126/science.aao2439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818927				2022-12-28	WOS:000407793600015
J	Pickrell, J				Pickrell, John			SCIENCE FUNDING Australia to ax support for long-term ecology sites	SCIENCE			English	News Item																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					632	633		10.1126/science.357.6352.632	http://dx.doi.org/10.1126/science.357.6352.632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818922				2022-12-28	WOS:000407793600010
J	Burclaff, J; Mills, JC				Burclaff, Joseph; Mills, Jason C.			CELL BIOLOGY Healthy skin rejects cancer	NATURE			English	Editorial Material							BETA-CATENIN; MUTATIONS; COMPETITION; METAPLASIA; TUMOR		[Burclaff, Joseph; Mills, Jason C.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Mills, Jason C.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Mills, Jason C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Burclaff, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA.	joseph.burclaff@wustl.edu; jmills@wustl.edu	Mills, Jason/AAA-6688-2021	Mills, Jason/0000-0002-0402-4662; Burclaff, Joseph/0000-0002-0325-5039	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA206419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067755, R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NCI NIH HHS [F31 CA206419] Funding Source: Medline; NIAMS NIH HHS [5R01AR063663-04, 1R01AR067755-01A1] Funding Source: Medline; NICHD NIH HHS [T32 HD007149] Funding Source: Medline; NIDDK NIH HHS [R01 DK105129] Funding Source: Medline; NIGMS NIH HHS [T32 GM007223] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown S, 2017, NATURE, V548, P334, DOI 10.1038/nature23304; Burclaff J, 2017, GASTROENTEROLOGY, V152, P762, DOI 10.1053/j.gastro.2016.12.001; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Kon S, 2017, NAT CELL BIOL, V19, P530, DOI 10.1038/ncb3509; Mills JC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa7540; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Yamamoto M, 2017, NATURE, V542, P246, DOI 10.1038/nature21033	11	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					289	290		10.1038/nature23534	http://dx.doi.org/10.1038/nature23534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28783724				2022-12-28	WOS:000407748400023
J	Cyranoski, D				Cyranoski, David			CHINA'S PUSH FOR BETTER BABIES	NATURE			English	News Item																		Tur-Kaspa I, 2010, REPROD BIOMED ONLINE, V21, P186, DOI 10.1016/j.rbmo.2010.04.031	1	9	11	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					272	274		10.1038/548272a	http://dx.doi.org/10.1038/548272a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816265	Bronze			2022-12-28	WOS:000407748400010
J	Harvie, D; Murfin, B				Harvie, David; Murfin, Brendan			CASE REVIEW Pregnant and nil by mouth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harvie, David; Murfin, Brendan] Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Harvie, David] Univ Hosp Southampton, Intens Care Unit, Southampton, Hants, England; [Murfin, Brendan] Guys & St Thomas Hosp, Intens Care Unit, London, England	Royal Melbourne Hospital; Guy's & St Thomas' NHS Foundation Trust	Harvie, D (corresponding author), Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia.; Harvie, D (corresponding author), Univ Hosp Southampton, Intens Care Unit, Southampton, Hants, England.	david.harvie@doctors.net.uk						Cullen MT, 1996, AM J PERINAT, V13, P449, DOI 10.1055/s-2007-994386; Frise CJ, 2013, EUR J OBSTET GYN R B, V167, P1, DOI 10.1016/j.ejogrb.2012.10.005; LIBERATORE SM, 1984, RESPIRATION, V46, P145, DOI 10.1159/000194683; LIM VS, 1976, AM J PHYSIOL, V231, P1764, DOI 10.1152/ajplegacy.1976.231.6.1764; Napoli A, 2011, EAT WEIGHT DISORD-ST, V16, pE146, DOI 10.1007/BF03325322; Nelson-Piercy C, 2002, HDB OBSTET MED; Nickson C., 2009, KETOACIDOSIS; PROWSE CM, 1965, ANESTHESIOLOGY, V26, P381, DOI 10.1097/00000542-196507000-00003	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2017	358								j3463	10.1136/bmj.j3463	http://dx.doi.org/10.1136/bmj.j3463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5CB	28818974				2022-12-28	WOS:000408228500002
J	Morgan, M; Much, C; DiGiacomo, M; Azzi, C; Ivanova, I; Vitsios, DM; Pistolic, J; Collier, P; Moreira, PN; Benes, V; Enright, AJ; O'Carroll, D				Morgan, Marcos; Much, Christian; DiGiacomo, Monica; Azzi, Chiara; Ivanova, Ivayla; Vitsios, Dimitrios M.; Pistolic, Jelena; Collier, Paul; Moreira, Pedro N.; Benes, Vladimir; Enright, Anton J.; O'Carroll, Donal			mRNA 3 ' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome	NATURE			English	Article							MOUSE OOCYTES; EXPRESSION; MATURATION; MICRORNA; RECOMBINASE; DEGRADATION; TRANSITION; TRIGGERS; REVEALS; GROWTH	A fundamental principle in biology is that the program for early development is established during oogenesis in the form of the maternal transcriptome(1,2). How the maternal transcriptome acquires the appropriate content and dosage of transcripts is not fully understood. Here we show that 3' terminal uridylation of mRNA mediated by TUT4 and TUT7 sculpts the mouse maternal transcriptome by eliminating transcripts during oocyte growth. Uridylation mediated by TUT4 and TUT7 is essential for both oocyte maturation and fertility. In comparison to somatic cells, the oocyte transcriptome has a shorter poly(A) tail and a higher relative proportion of terminal oligo-uridylation. Deletion of TUT4 and TUT7 leads to the accumulation of a cohort of transcripts with a high frequency of very short poly(A) tails, and a loss of 3' oligouridylation. By contrast, deficiency of TUT4 and TUT7 does not alter gene expression in a variety of somatic cells. In summary, we show that poly(A) tail length and 3' terminal uridylation have essential and specific functions in shaping a functional maternal transcriptome.	[Morgan, Marcos; Much, Christian; Ivanova, Ivayla; Moreira, Pedro N.; O'Carroll, Donal] Univ Edinburgh, Inst Stem Cell Res, Sch Biol Sci, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Morgan, Marcos; Much, Christian; DiGiacomo, Monica; Azzi, Chiara; Ivanova, Ivayla; Moreira, Pedro N.; O'Carroll, Donal] EMBL, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Vitsios, Dimitrios M.; Enright, Anton J.] EMBL, EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Pistolic, Jelena; Collier, Paul; Benes, Vladimir] EMBL, Genom Core Facil, D-69117 Heidelberg, Germany	University of Edinburgh; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	O'Carroll, D (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Sch Biol Sci, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.; O'Carroll, D (corresponding author), EMBL, Mouse Biol Unit, I-00015 Monterotondo, Italy.	donal.ocarroll@ed.ac.uk	Enright, Anton/F-3094-2011; Vitsios, Dimitrios/J-4281-2019	Enright, Anton/0000-0002-6090-3100; Vitsios, Dimitrios/0000-0002-8939-5445; Morgan, Marcos/0000-0002-3549-0375; Azzi, Chiara/0000-0002-2240-4618; Much, Christian/0000-0002-1644-8200; O'Carroll, Donal/0000-0002-8626-2217; Ivanova, Ivayla/0000-0003-2949-9610; Di Giacomo, Monica/0000-0002-4075-0725	Wellcome Trust [106144]; MRC [MR/K017047/1] Funding Source: UKRI; Medical Research Council [MR/K017047/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the Wellcome Trust (Award 106144). This study was technically supported by EMBL Monterotondo's genome engineering and microscopy core facilities.	Badea TC, 2003, J NEUROSCI, V23, P2314; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BROWER PT, 1981, DEV BIOL, V86, P373, DOI 10.1016/0012-1606(81)90195-0; Bryja V, 2006, STEM CELLS, V24, P844, DOI 10.1634/stemcells.2005-0444; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Eichhorn SW, 2016, ELIFE, V5, DOI 10.7554/eLife.16955; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lim J, 2016, GENE DEV, V30, P1671, DOI 10.1101/gad.284802.116; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Jun, 2015, Biol Reprod, V93, P48, DOI 10.1095/biolreprod.115.130344; Ma J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105312; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Ma JY, 2013, CELL CYCLE, V12, P1928, DOI 10.4161/cc.24991; Medvedev S, 2008, DEV BIOL, V321, P205, DOI 10.1016/j.ydbio.2008.06.016; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Svoboda P, 2015, CURR TOP DEV BIOL, V113, P305, DOI 10.1016/bs.ctdb.2015.06.004; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Vitsios DM, 2015, BIOINFORMATICS, V31, P3365, DOI 10.1093/bioinformatics/btv380	42	84	88	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					347	+		10.1038/nature23318	http://dx.doi.org/10.1038/nature23318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792939	Green Accepted, Green Submitted			2022-12-28	WOS:000407748400036
J	Popkin, G				Popkin, Gabriel			CLIMATE SCIENCE El Nino drove up carbon emissions	NATURE			English	News Item																		Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016	1	1	1	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					269	269		10.1038/nature.2017.22440	http://dx.doi.org/10.1038/nature.2017.22440			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816255	Bronze			2022-12-28	WOS:000407748400006
J	Robinson, DR; Wu, YM; Lonigro, RJ; Vats, P; Cobain, E; Everett, J; Cao, XH; Rabban, E; Kumar-Sinha, C; Raymond, V; Schuetze, S; Alva, A; Siddiqui, J; Chugh, R; Worden, F; Zalupski, MM; Innis, J; Mody, RJ; Tomlins, SA; Lucas, D; Baker, LH; Ramnath, N; Chott, AFS; Hayes, DF; Vijai, J; Offit, K; Stoffel, EM; Roberts, JS; Smith, DC; Kunju, LP; Talpaz, M; Cieslik, M; Chinnaiyan, AM				Robinson, Dan R.; Wu, Yi-Mi; Lonigro, Robert J.; Vats, Pankaj; Cobain, Erin; Everett, Jessica; Cao, Xuhong; Rabban, Erica; Kumar-Sinha, Chandan; Raymond, Victoria; Schuetze, Scott; Alva, Ajjai; Siddiqui, Javed; Chugh, Rashmi; Worden, Francis; Zalupski, Mark M.; Innis, Jeffrey; Mody, Rajen J.; Tomlins, Scott A. .; Lucas, David; Baker, Laurence H.; Ramnath, Nithya; Schott, Ann F.; Hayes, Daniel F.; Vijai, Joseph; Offit, Kenneth; Stoffel, Elena M.; Roberts, J. Scott; Smith, David C.; Kunju, Lakshmi P.; Talpaz, Moshe; Cieslik, Marcin; Chinnaiyan, Arul M.			Integrative clinical genomics of metastatic cancer	NATURE			English	Article							PROSTATE-CANCER; VARIANT FUSIONS; T-LYMPHOCYTES; EXPRESSION; REARRANGEMENTS; MELANOMA; THERAPY; KINASE; IMMUNOTHERAPY; DIAGNOSTICS	Metastasis is the primary cause of cancer-related deaths. Although The Cancer Genome Atlas has sequenced primary tumour types obtained from surgical resections, much less comprehensive molecular analysis is available from clinically acquired metastatic cancers. Here we perform whole-exome and -transcriptome sequencing of 500 adult patients with metastatic solid tumours of diverse lineage and biopsy site. The most prevalent genes somatically altered in metastatic cancer included TP53, CDKN2A, PTEN, PIK3CA, and RB1. Putative pathogenic germline variants were present in 12.2% of cases of which 75% were related to defects in DNA repair. RNA sequencing complemented DNA sequencing to identify gene fusions, pathway activation, and immune profiling. Our results show that integrative sequence analysis provides a clinically relevant, multi-dimensional view of the complex molecular landscape and microenvironment of metastatic cancers.	[Robinson, Dan R.; Wu, Yi-Mi; Lonigro, Robert J.; Vats, Pankaj; Cao, Xuhong; Rabban, Erica; Kumar-Sinha, Chandan; Siddiqui, Javed; Tomlins, Scott A. .; Kunju, Lakshmi P.; Cieslik, Marcin; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Wu, Yi-Mi; Kumar-Sinha, Chandan; Siddiqui, Javed; Tomlins, Scott A. .; Lucas, David; Kunju, Lakshmi P.; Cieslik, Marcin; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cobain, Erin; Everett, Jessica; Raymond, Victoria; Schuetze, Scott; Alva, Ajjai; Chugh, Rashmi; Worden, Francis; Zalupski, Mark M.; Baker, Laurence H.; Ramnath, Nithya; Schott, Ann F.; Hayes, Daniel F.; Stoffel, Elena M.; Smith, David C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Innis, Jeffrey; Mody, Rajen J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Vijai, Joseph; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Roberts, J. Scott] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Talpaz, Moshe; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	arul@umich.edu	Vats, Pankaj/AAL-1443-2020; Hayes, Daniel/ABE-1129-2020; Joseph, Vijai/J-9158-2013	Kumar, Chandan/0000-0002-8696-3400; Talpaz, Moshe/0000-0003-3361-3981; Joseph, Vijai/0000-0002-7933-151X; Smith, David/0000-0002-9465-988X; Everett, Jessica/0000-0002-4894-8891; Vats, Pankaj/0000-0001-8441-7732	National Institutes of Health (NIH) Clinical Sequencing Exploratory Research Award [NIH 1UM1HG006508]; Prostate Cancer Foundation, Stand Up 2 Cancer (SU2C)-Prostate Cancer Foundation Prostate Dream Team Grant [SU2C-AACR-DT0712]; Early Detection Research Network [U01 CA214170]; Prostate SPORE grant [P50 CA186786]; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA046592, U01CA214170, P50CA186786] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006508] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Clinical Sequencing Exploratory Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation, Stand Up 2 Cancer (SU2C)-Prostate Cancer Foundation Prostate Dream Team Grant; Early Detection Research Network; Prostate SPORE grant; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a National Institutes of Health (NIH) Clinical Sequencing Exploratory Research Award NIH 1UM1HG006508. Other sources of support included the Prostate Cancer Foundation, Stand Up 2 Cancer (SU2C)-Prostate Cancer Foundation Prostate Dream Team Grant SU2C-AACR-DT0712, Early Detection Research Network grant U01 CA214170, and Prostate SPORE grant P50 CA186786. A.M.C. is a Howard Hughes Medical Institute Investigator, A. Alfred Taubman Scholar, and American Cancer Society Professor. M.C. is supported by a PCF Young Investigator Award. We acknowledge Y. Ning, R. Wang, X. Dang, M. Davis, L. Hodges, J. Griggs, J. Athanikar, C. Brennan, C. Betts, J. Chen, S. Kalyana-Sundaram, K. Giles, and R. Mehra for their contributions to this study. Over 100 physicians referred patients to this study and we acknowledge the following: K. Cooney, M. Hussain, S. Urba, N. Henry, V. Sahai, D. Simeone, C. Lao, J. Smerage, M. Caram, M. Burness, G. Kalemkerian, C. Van Poznak, M. Wicha, R. Buckanovich, J. Bufill, P. Grivas, P. Hu, A. Morikawa, P. Palmbos, B. Redman, F. Feng, G. Hammer, S. Merajver, and A. Pearson. We thank S. Roychowdhury and K. Pienta for help in protocol development for the MI-ONCOSEQ program. Most importantly, we recognize the generosity and kindness of the cancer patients and their families for participating in this study.	Agaram NP, 2014, HUM PATHOL, V45, P1084, DOI 10.1016/j.humpath.2014.01.007; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Gagan J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0203-x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Leiserson MDM, 2015, NAT METHODS, V12, P483, DOI 10.1038/nmeth.3412; Liberzon A., BIOINFORMATICS; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mardis ER, 2014, GENOME MED, V6, DOI 10.1186/gm539; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mauer CB, 2014, GENET MED, V16, P407, DOI 10.1038/gim.2013.160; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; Nakano O, 2001, CANCER RES, V61, P5132; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Shen T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00215; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; van Houdt IS, 2008, INT J CANCER, V123, P609, DOI 10.1002/ijc.23543; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Weinreb I, 2014, GENE CHROMOSOME CANC, V53, P845, DOI 10.1002/gcc.22195; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	45	453	460	7	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					297	+		10.1038/nature23306	http://dx.doi.org/10.1038/nature23306			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28783718	Green Accepted			2022-12-28	WOS:000407748400025
J	Schaefer, GH				Schaefer, Gail H.			ASTRONOMY A turbulent stellar atmosphere in full view	NATURE			English	Editorial Material							1ST OVERTONE LINES; DYNAMICAL ATMOSPHERE; CONVECTION; SUPERGIANTS; VLTI/AMBER		[Schaefer, Gail H.] Georgia State Univ, CHARA Array, Mt Wilson, CA 91023 USA	University System of Georgia; Georgia State University	Schaefer, GH (corresponding author), Georgia State Univ, CHARA Array, Mt Wilson, CA 91023 USA.	schaefer@chara-array.org			Division Of Astronomical Sciences [1411654] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Arroyo-Torres B, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425212; CASSINELLI JP, 1979, ANNU REV ASTRON ASTR, V17, P275, DOI 10.1146/annurev.aa.17.090179.001423; Gilliland RL, 1996, ASTROPHYS J, V463, pL29, DOI 10.1086/310043; Lim J, 1998, NATURE, V392, P575, DOI 10.1038/33352; Marsh KA, 2001, ASTROPHYS J, V548, P861, DOI 10.1086/319035; Ohnaka K, 2017, NATURE, V548, P310, DOI 10.1038/nature23445; Ohnaka K, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321063; Ohnaka K, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016279; SCHWARZSCHILD M, 1975, ASTROPHYS J, V195, P137, DOI 10.1086/153313; Smith N, 2014, ANNU REV ASTRON ASTR, V52, P487, DOI 10.1146/annurev-astro-081913-040025; Tuthill PG, 1997, MON NOT R ASTRON SOC, V285, P529, DOI 10.1093/mnras/285.3.529; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357	12	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					288	289		10.1038/548288a	http://dx.doi.org/10.1038/548288a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816252				2022-12-28	WOS:000407748400022
J	Cai, J; Townsend, JP; Dodson, TC; Heiney, PA; Sweeney, AM				Cai, J.; Townsend, J. P.; Dodson, T. C.; Heiney, P. A.; Sweeney, A. M.			Eye patches: Protein assembly of index-gradient squid lenses	SCIENCE			English	Article							GLUTATHIONE-S-TRANSFERASE; CEPHALOPODS; CRYSTALLINS; SCATTERING; EVOLUTION; FISH; GELS	A parabolic relationship between lens radius and refractive index allows spherical lenses to avoid spherical aberration. We show that in squid, patchy colloidal physics resulted from an evolutionary radiation of globular S-crystallin proteins. Small-angle x-ray scattering experiments on lens tissue show colloidal gels of S-crystallins at all radial positions. Sparse lens materials form via low-valence linkages between disordered loops protruding from the protein surface. The loops are polydisperse and bind via a set of hydrogen bonds between disordered side chains. Peripheral lens regions with low particle valence form stable, volume-spanning gels at low density, whereas central regions with higher average valence gel at higher densities. The proteins demonstrate an evolved set of linkers for self-assembly of nanoparticles into volumetric materials.	[Cai, J.; Dodson, T. C.; Heiney, P. A.; Sweeney, A. M.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Townsend, J. P.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Sweeney, AM (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	alisonsw@physics.upenn.edu	Townsend, James/AAS-2329-2020	Townsend, James/0000-0002-4782-6083	National Science Foundation Materials Research Science and Engineering Center [DMR11-20901]; Packard Foundation; Sloan Foundation; Kaufman Foundation; University of Pennsylvania; Department of Defense;  [NSF-1351935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	National Science Foundation Materials Research Science and Engineering Center(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Kaufman Foundation; University of Pennsylvania; Department of Defense(United States Department of Defense); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Kamien and E. Eiser for useful discussions and to D. Fox for assistance with data visualization. S. Johnsen's comments improved the manuscript. We are also grateful to an anonymous reviewer whose thoughtful questions improved the work. Financial support was provided by the National Science Foundation Materials Research Science and Engineering Center DMR11-20901 to P.A.H.; by the Packard Foundation Fellowship for Science and Engineering, Sloan Foundation, NSF-1351935, Kaufman Foundation, and University of Pennsylvania to A.M.S.; and by the Department of Defense's National Defense Science and Engineering Graduate fellowship program to T.C.D. SAXS data are archived at Small Angle Scattering Biological Data Bank under accession numbers SASDCQ5 to U5, and RNA-seq data are archived at GenBank under SRR5528268-9.	BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bianchi E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168301; Bianchi E, 2015, FARADAY DISCUSS, V181, P123, DOI 10.1039/c4fd00271g; Camp PJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011503; Cardinaux F, 2011, J PHYS CHEM B, V115, P7227, DOI 10.1021/jp112180p; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Eildal JNN, 2013, J AM CHEM SOC, V135, P12998, DOI 10.1021/ja402875h; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gibaud T, 2012, FARADAY DISCUSS, V158, P267, DOI 10.1039/c2fd20048a; Gogelein C, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2951987; Jacobs WM, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905670; JAGGER WS, 1992, VISION RES, V32, P1271, DOI 10.1016/0042-6989(92)90222-5; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Land MF, 2012, OXF ANIMAL BIOL SER, P1; Malfois M, 1996, J CHEM PHYS, V105, P3290, DOI 10.1063/1.471843; Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Russo J, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3153843; Sciortino F, 2011, CURR OPIN SOLID ST M, V15, P246, DOI 10.1016/j.cossms.2011.07.003; Shibayama M, 1998, MACROMOL CHEM PHYSIC, V199, P1; SIVAK JG, 1994, VISION RES, V34, P2177, DOI 10.1016/0042-6989(94)90100-7; STAUFFER D, 1994, INTRO PERCOLATION TH; Sweeney AM, 2007, J R SOC INTERFACE, V4, P685, DOI 10.1098/rsif.2006.0210; TOMAREV SI, 1993, J BIOL CHEM, V268, P4534; TOMAREV SI, 1992, J BIOL CHEM, V267, P8604; TOMAREV SI, 1988, NATURE, V336, P86, DOI 10.1038/336086a0; Tomarev SI, 1995, J MOL EVOL, V41, P1048; Vanhoudt J, 2000, EUR J BIOCHEM, V267, P3848, DOI 10.1046/j.1432-1327.2000.01423.x; WEST JA, 1995, EXP EYE RES, V60, P19, DOI 10.1016/S0014-4835(05)80080-6	31	38	38	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					564	569		10.1126/science.aal2674	http://dx.doi.org/10.1126/science.aal2674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798124	Green Accepted			2022-12-28	WOS:000407324800035
J	Slater, LJ; Wilby, RL				Slater, Louise J.; Wilby, Robert L.			CLIMATE CHANGE Measuring the changing pulse of rivers	SCIENCE			English	Editorial Material							UNITED-STATES; DRIVERS		[Slater, Louise J.; Wilby, Robert L.] Loughborough Univ Technol, Dept Geog, Loughborough, Leics, England	Loughborough University	Slater, LJ (corresponding author), Loughborough Univ Technol, Dept Geog, Loughborough, Leics, England.	l.slater@lboro.ac.uk		Slater, Louise/0000-0001-9416-488X				Berghuijs WR, 2016, GEOPHYS RES LETT, V43, P4382, DOI 10.1002/2016GL068070; Bloschl G, 2017, SCIENCE, V357, P588, DOI 10.1126/science.aan2506; Field C.B., 2012, MANAGING RISKS EXTRE; Godsey SE, 2014, HYDROL PROCESS, V28, P5791, DOI 10.1002/hyp.10310; Hall J, 2015, P INT ASS HYDROL SCI, V370, P89, DOI 10.5194/piahs-370-89-2015; Harrigan S, 2014, HYDROL EARTH SYST SC, V18, P1935, DOI 10.5194/hess-18-1935-2014; Mallakpour I, 2016, ADV WATER RESOUR, V92, P159, DOI 10.1016/j.advwatres.2016.04.008; Merz R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001952; Painter TH, 2010, P NATL ACAD SCI USA, V107, P17125, DOI 10.1073/pnas.0913139107; Rojas R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017461; Sankarasubramanian A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001593; Slater LJ, 2015, GEOPHYS RES LETT, V42, P370, DOI 10.1002/2014GL062482; Wilby RL, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1209; Winsemius HC, 2016, NAT CLIM CHANGE, V6, P381, DOI [10.1038/nclimate2893, 10.1038/NCLIMATE2893]	14	11	13	6	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					552	552		10.1126/science.aao2441	http://dx.doi.org/10.1126/science.aao2441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798119	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000407324800026
J	Jackson, ML; Chung, JR; Jackson, LA; Phillips, CH; Benoit, J; Monto, AS; Martin, ET; Belongia, EA; McLean, HQ; Gaglani, M; Murthy, K; Zimmerman, R; Nowalk, MP; Fry, AM; Flannery, B				Jackson, Michael L.; Chung, Jessie R.; Jackson, Lisa A.; Phillips, C. Hallie; Benoit, Joyce; Monto, Arnold S.; Martin, Emily T.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Murthy, Kempapura; Zimmerman, Richard; Nowalk, Mary P.; Fry, Alicia M.; Flannery, Brendan			Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION PRACTICES ACIP; TEST-NEGATIVE DESIGN; ADVISORY-COMMITTEE; RECOMMENDATIONS; PREVENTION; VIRUS; PROTECTION; AGE	BACKGROUND The A(H1N1) pdm09 virus strain used in the live attenuated influenza vaccine was changed for the 2015-2016 influenza season because of its lack of effectiveness in young children in 2013-2014. The Influenza Vaccine Effectiveness Network evaluated the effect of this change as part of its estimates of influenza vaccine effectiveness in 2015-2016. METHODS We enrolled patients 6 months of age or older who presented with acute respiratory illness at ambulatory care clinics in geographically diverse U.S. sites. Using a test-negative design, we estimated vaccine effectiveness as (1 - OR) x 100, in which OR is the odds ratio for testing positive for influenza virus among vaccinated versus unvaccinated participants. Separate estimates were calculated for the inactivated vaccines and the live attenuated vaccine. RESULTS Among 6879 eligible participants, 1309 (19%) tested positive for influenza virus, predominantly for A(H1N1) pdm09 (11%) and influenza B (7%). The effectiveness of the influenza vaccine against any influenza illness was 48% (95% confidence interval [CI], 41 to 55; P<0.001). Among children 2 to 17 years of age, the inactivated influenza vaccine was 60% effective (95% CI, 47 to 70; P<0.001), and the live attenuated vaccine was not observed to be effective (vaccine effectiveness, 5%; 95% CI, -47 to 39; P = 0.80). Vaccine effectiveness against A(H1N1) pdm09 among children was 63% (95% CI, 45 to 75; P<0.001) for the inactivated vaccine, as compared with -19% (95% CI, -113 to 33; P = 0.55) for the live attenuated vaccine. CONCLUSIONS Influenza vaccines reduced the risk of influenza illness in 2015-2016. However, the live attenuated vaccine was found to be ineffective among children in a year with substantial inactivated vaccine effectiveness. Because the 2016-2017 A(H1N1) pdm09 strain used in the live attenuated vaccine was unchanged from 2015-2016, the Advisory Committee on Immunization Practices made an interim recommendation not to use the live attenuated influenza vaccine for the 2016-2017 influenza season. (Funded by the Centers for Disease Control and Prevention and the National Institutes of Health.)	[Jackson, Michael L.; Jackson, Lisa A.; Phillips, C. Hallie; Benoit, Joyce] Kaiser Permanente, Washington Hlth Res Inst, Grp Hlth Res Inst, Seattle, WA USA; [Chung, Jessie R.; Fry, Alicia M.; Flannery, Brendan] Ctr Dis Control & Prevent, Atlanta, GA USA; [Monto, Arnold S.; Martin, Emily T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Belongia, Edward A.; McLean, Huong Q.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Gaglani, Manjusha; Murthy, Kempapura] Texas A&M Coll Med, Baylor Scott & White Hlth, Temple, TX USA; [Zimmerman, Richard; Nowalk, Mary P.] Univ Pittsburgh, Pittsburgh, PA USA	Kaiser Permanente; Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jackson, ML (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA USA.	jackson.ml@ghc.org	Nowalk, Mary Patricia/ACU-4712-2022; Gaglani, Manjusha/AFQ-6802-2022	Gaglani, Manjusha/0000-0002-3952-9230; Belongia, Edward/0000-0001-7478-0415	Centers for Disease Control and Prevention; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001857, UL1TR000005] Funding Source: NIH RePORTER; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP000471, U01IP001034, U01IP000474, U01IP000473, U01IP000466, U01IP000467, U01IP001038, U01IP001037] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by the Centers for Disease Control and Prevention and the National Institutes of Health.	Ambrose CS, 2016, EUROSURVEILLANCE, V21, P45; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Caspard H, 2016, OPT 9 CONTR INFL C C; Caspard H, 2016, VACCINE, V34, P77, DOI 10.1016/j.vaccine.2015.11.010; Cost Angelia A, 2014, MSMR, V21, P15; De Serres G, 2013, EURO SURVEILL, V18, P37; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Ferdinands JM, 2012, CLIN INFECT DIS, V54, P25, DOI 10.1093/cid/cir750; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flannery B, 2016, INFLUENZA VACCINE EF; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Jackson ML, 2015, VACCINE, V33, P5181, DOI 10.1016/j.vaccine.2015.07.098; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647; Mishin VP, 2017, J CLIN MICROBIOL, V55, P145, DOI 10.1128/JCM.01840-16; Nohynek H, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.38.30346; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Pebody R, 2016, EUROSURVEILLANCE, V21, P41, DOI 10.2807/1560-7917.ES.2016.21.38.30348; Pebody R, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/ESE.18.05.20389-EN; Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176; Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064; Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zimmerman RK, 2016, CLIN INFECT DIS, V63, P1564, DOI 10.1093/cid/ciw635	33	169	182	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					534	543		10.1056/NEJMoa1700153	http://dx.doi.org/10.1056/NEJMoa1700153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28792867	Green Accepted, Bronze			2022-12-28	WOS:000407212600006
J	[Anonymous]				[Anonymous]			Walking Study: Women Outpace Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					511	511		10.1001/jama.2017.9722	http://dx.doi.org/10.1001/jama.2017.9722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787513				2022-12-28	WOS:000407160100008
J	Grant, PR				Grant, Peter R.			Evolution, climate change, and extreme events	SCIENCE			English	Editorial Material									[Grant, Peter R.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Grant, PR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	prgrant@princeton.edu	Grant, Peter/HIR-3733-2022					Buckley LB, 2016, INTEGR COMP BIOL, V56, P98, DOI 10.1093/icb/icw004; Bumpus H.C., 1899, BIOL LECT WOODS HOLE, P209; BUTTEMER WA, 1992, CONDOR, V94, P944, DOI 10.2307/1369291; Campbell-Staton SC, 2016, J EVOLUTION BIOL, V29, P2168, DOI 10.1111/jeb.12935; Campbell-Staton SC, 2017, SCIENCE, V357, P495, DOI 10.1126/science.aam5512; Chevin LM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0138; Drijfhout S, 2015, P NATL ACAD SCI USA, V112, pE5777, DOI 10.1073/pnas.1511451112; Franks SJ, 2016, MOL ECOL, V23, P3938; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Grant PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0146; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Stott PA, 2014, B AM METEOROL SOC, V95, pS1	12	21	22	5	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					451	452		10.1126/science.aao2067	http://dx.doi.org/10.1126/science.aao2067			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774914				2022-12-28	WOS:000406840100019
J	Hardie, DG				Hardie, D. Grahame			Targeting an energy sensor to treat diabetes	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; METFORMIN; MECHANISM; MICE		[Hardie, D. Grahame] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Hardie, DG (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Hardie, David/Z-1979-2019		Wellcome Trust [204766/Z/16/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Langendorf CG, 2015, CELL RES, V25, P5, DOI 10.1038/cr.2014.163; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Salatto CT, 2017, J PHARMACOL EXP THER, V361, P303, DOI 10.1124/jpet.116.237925; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	14	16	16	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					455	456		10.1126/science.aao1913	http://dx.doi.org/10.1126/science.aao1913			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774917	Green Submitted			2022-12-28	WOS:000406840100022
J	Vetrone, F; Rosei, F				Vetrone, Fiorenzo; Rosei, Federico			A low-loss origami plasmonic waveguide	SCIENCE			English	Editorial Material							DNA; NANOSTRUCTURES; PATTERNS; SHAPES		[Rosei, Federico] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, 4 Sect 2,N Jianshe Rd, Chengdu 610051, Sichuan, Peoples R China; Univ Quebec, Ctr Energie, Inst Natl Rech Sci, Varennes, PQ J3X 1S2, Canada	University of Electronic Science & Technology of China; University of Quebec; Institut national de la recherche scientifique (INRS)	Rosei, F (corresponding author), Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, 4 Sect 2,N Jianshe Rd, Chengdu 610051, Sichuan, Peoples R China.	rosei@emt.inrs.ca	Vetrone, Fiorenzo/Q-3478-2017; Rosei, Federico/AAH-1159-2021	Vetrone, Fiorenzo/0000-0002-3222-3052; Rosei, Federico/0000-0001-8479-6955	Canada Research Chairs Program; government of China; Sichuan province	Canada Research Chairs Program(Canada Research Chairs); government of China; Sichuan province	F.R. thanks the Canada Research Chairs Program for partial salary support, the government of China for a Chang Jiang Chair Professorship, and Sichuan province for a Thousand Talents short-term award.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Devaux E, 2003, APPL PHYS LETT, V83, P4936, DOI 10.1063/1.1634379; Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Hamblin GD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8065; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Roller EM, 2017, NAT PHYS, V13, P761, DOI [10.1038/NPHYS4120, 10.1038/nphys4120]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244	12	4	4	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					452	453		10.1126/science.aan6488	http://dx.doi.org/10.1126/science.aan6488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774915				2022-12-28	WOS:000406840100020
J	Elsasser, SJ; Noh, KM; Diaz, N; Allis, CD; Banaszynski, LA				Elsasser, Simon J.; Noh, Kyung-Min; Diaz, Nichole; Allis, C. David; Banaszynski, Laura A.			On the role of H3.3 in retroviral silencing reply	NATURE			English	Letter							HISTONE H3.3; LOCI		[Elsasser, Simon J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden; [Noh, Kyung-Min; Diaz, Nichole; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA; [Banaszynski, Laura A.] UT Southwestern Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Banaszynski, Laura A.] UT Southwestern Med Ctr, Childrens Med Ctr, Res Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Karolinska Institutet; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Elsasser, SJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden.	simon.elsasser@scilifelab.se; laura.banaszynski@utsouthwestern.edu	Elsässer, Simon/AAM-3986-2020; Elsässer, Simon/B-8911-2014	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Noh, Kyung-Min/0000-0002-0708-787X				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036; Wolf G, 2017, NATURE, V548, pE1, DOI 10.1038/nature23277; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	12	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					E7	E12		10.1038/nature23278	http://dx.doi.org/10.1038/nature23278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770850				2022-12-28	WOS:000406831700002
J	Mezzadra, R; Sun, C; Jae, LT; Gomez-Eerland, R; de Vries, E; Wu, W; Logtenberg, MEW; Slagter, M; Rozeman, EA; Hofland, I; Broeks, A; Horlings, HM; Wessels, LFA; Blank, CU; Xiao, YL; Heck, AJR; Borst, J; Brummelkamp, TR; Schumacher, TNM				Mezzadra, Riccardo; Sun, Chong; Jae, Lucas T.; Gomez-Eerland, Raquel; de Vries, Evert; Wu, Wei; Logtenberg, Meike E. W.; Slagter, Maarten; Rozeman, Elisa A.; Hofland, Ingrid; Broeks, Annegien; Horlings, Hugo M.; Wessels, Lodewyk F. A.; Blank, Christian U.; Xiao, Yanling; Heck, Albert J. R.; Borst, Jannie; Brummelkamp, Thijn R.; Schumacher, Ton N. M.			Identification of CMTM6 and CMTM4 as PD-L1 protein regulators	NATURE			English	Article							CELL CARCINOMA; ANTI-PD-L1 ANTIBODY; CANCER; EXPRESSION; NIVOLUMAB; BLOCKADE; PEMBROLIZUMAB; DISRUPTION; MPDL3280A; MELANOMA	The clinical benefit for patients with diverse types of metastatic cancers that has been observed upon blockade of the interaction between PD-1 and PD-L1 has highlighted the importance of this inhibitory axis in the suppression of tumour-specific T-cell responses(1-9). Notwithstanding the key role of PD-L1 expression by cells within the tumour micro-environment, our understanding of the regulation of the PD-L1 protein is limited(10-15). Here we identify, using a haploid genetic screen, CMTM6, a type-3 transmembrane protein of previously unknown function, as a regulator of the PD-L1 protein. Interference with CMTM6 expression results in impaired PD-L1 protein expression in all human tumour cell types tested and in primary human dendritic cells. Furthermore, through both a haploid genetic modifier screen in CMTM6-deficient cells and genetic complementation experiments, we demonstrate that this function is shared by its closest family member, CMTM4, but not by any of the other CMTM members tested. Notably, CMTM6 increases the PD-L1 protein pool without affecting PD-L1 (also known as CD274) transcription levels. Rather, we demonstrate that CMTM6 is present at the cell surface, associates with the PD-L1 protein, reduces its ubiquitination and increases PD-L1 protein half-life. Consistent with its role in PD-L1 protein regulation, CMTM6 enhances the ability of PD-L1-expressing tumour cells to inhibit T cells. Collectively, our data reveal that PD-L1 relies on CMTM6/4 to efficiently carry out its inhibitory function, and suggest potential new avenues to block this pathway.	[Mezzadra, Riccardo; Sun, Chong; Gomez-Eerland, Raquel; Logtenberg, Meike E. W.; Slagter, Maarten; Rozeman, Elisa A.; Blank, Christian U.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Jae, Lucas T.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [de Vries, Evert; Xiao, Yanling; Borst, Jannie] Netherlands Canc Inst, Div Tumor Biol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Wu, Wei; Heck, Albert J. R.] Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Wu, Wei; Heck, Albert J. R.] Utrecht Inst Pharmaceut Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Wu, Wei; Heck, Albert J. R.] Netherlands Prote Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Slagter, Maarten; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Rozeman, Elisa A.; Blank, Christian U.] Netherlands Canc Inst, Div Med Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Hofland, Ingrid; Broeks, Annegien] Netherlands Canc Inst, Core Facil Mol Pathol & Biobanking, Div Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Horlings, Hugo M.] Netherlands Canc Inst, Div Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Brummelkamp, Thijn R.] Cancergen Nl, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany; [Jae, Lucas T.] Ludwig Maximilians Univ Munchen, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Munich; University of Munich	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Brummelkamp, TR (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.; Brummelkamp, TR (corresponding author), Cancergen Nl, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.brummelkamp@nki.nl; t.schumacher@nki.nl	Jae, Lucas/AAH-5342-2020; Sun, Chong/AAB-4859-2021; Jae, Lucas/AAY-3438-2021; Wu, Wei/GYR-2981-2022; Schumacher, Ton/Y-2432-2019; 高, 雨莉/HGU-8187-2022; Heck, Albert/D-7098-2011	Jae, Lucas/0000-0002-3531-1760; Sun, Chong/0000-0001-9008-2158; Wu, Wei/0000-0002-1092-603X; Schumacher, Ton/0000-0003-0517-8804; Heck, Albert/0000-0002-2405-4404; Mezzadra, Riccardo/0000-0002-7737-8461; Logtenberg, Meike/0000-0002-8981-1189; Borst, Jannie/0000-0002-8043-5009; Xiao, Yanling/0000-0003-1755-1709	Queen Wilhelmina Cancer Research Award; European Research Council (ERC) Advanced Grant SENSIT; NWO Vici Grant [016.Vici.170.033]; Cancer Genomics Center; Ammodo KNAW Award for Biomedical Sciences; Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship; Landsteiner Foundation for Blood Research [1355]; Proteins@Work; Netherlands Proteomics Centre - NWO; Netherlands Organisation for Scientific Research; Institute for Chemical Immunology, an NWO Gravitation project	Queen Wilhelmina Cancer Research Award; European Research Council (ERC) Advanced Grant SENSIT(European Research Council (ERC)); NWO Vici Grant(Netherlands Organization for Scientific Research (NWO)); Cancer Genomics Center; Ammodo KNAW Award for Biomedical Sciences; Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship; Landsteiner Foundation for Blood Research; Proteins@Work; Netherlands Proteomics Centre - NWO; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institute for Chemical Immunology, an NWO Gravitation project	We thank F. Scheeren, E. Stickel, V. Blomen, M. Brockmann and the other members of the Schumacher and Brummelkamp laboratories for discussions, J. Grabowska for technical assistance, K. Kemper and D. Peeper for sharing melanoma PDX models and the NKI-AVL flow facility, the NKI-AVL Core Facility Molecular Pathology & Biobanking (CFMPB) for supplying NKI-AVL Biobank material and/or laboratory support. This work was supported by The Queen Wilhelmina Cancer Research Award and European Research Council (ERC) Advanced Grant SENSIT (to T.N.M.S.), NWO Vici Grant (016.Vici.170.033), the Cancer Genomics Center (CGC.nl), and Ammodo KNAW Award 2015 for Biomedical Sciences (to T.R.B.), The Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship (to C.S.), The Landsteiner Foundation for Blood Research, grant 1355 (to J.B.), Proteins@Work, a program of the Netherlands Proteomics Centre financed by NWO, the Netherlands Organisation for Scientific Research (to A.J.R.H.) and The Institute for Chemical Immunology, an NWO Gravitation project (to T.N.M.S. and A.J.R.H.).	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dorand RD, 2016, SCIENCE, V353, P399, DOI 10.1126/science.aae0477; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Miyazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031829; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ribas A, 2016, J EXP MED, V213, P2835, DOI 10.1084/jem.20161462; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Xiao YL, 2015, STEM CELL REP, V4, P984, DOI 10.1016/j.stemcr.2015.04.012	31	343	374	8	111	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					106	+		10.1038/nature23669	http://dx.doi.org/10.1038/nature23669			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28813410	Green Accepted			2022-12-28	WOS:000409388700042
J	Felker, GM; Anstrom, KJ; Adams, KF; Ezekowitz, JA; Fiuzat, M; Houston-Miller, N; Januzzi, JL; Mark, DB; Pina, IL; Passmore, G; Whellan, DJ; Yang, HQ; Cooper, LS; Leifer, ES; Desvigne-Nickens, P; O'Connor, CM				Felker, G. Michael; Anstrom, Kevin J.; Adams, Kirkwood F.; Ezekowitz, Justin A.; Fiuzat, Mona; Houston-Miller, Nancy; Januzzi, James L., Jr.; Mark, Daniel B.; Pina, Ileana L.; Passmore, Gayle; Whellan, David J.; Yang, Hongqiu; Cooper, Lawton S.; Leifer, Eric S.; Desvigne-Nickens, Patrice; O'Connor, Christopher M.			Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGEMENT; MORBIDITY; IMPROVE; TIME; CARE	IMPORTANCE The natriuretic peptides are biochemical markers of heart failure (HF) severity and predictors of adverse outcomes. Smaller studies have evaluated adjusting HF therapy based on natriuretic peptide levels ("guided therapy") with inconsistent results. OBJECTIVE To determine whether an amino-terminal pro-B-type natriuretic peptide (NT-proBNP)-guided treatment strategy improves clinical outcomes vs usual care in high-risk patients with HF and reduced ejection fraction (HFrEF). DESIGN, SETTINGS, AND PARTICIPANTS The Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study was a randomized multicenter clinical trial conducted between January 16, 2013, and September 20, 2016, at 45 clinical sites in the United States and Canada. This study planned to randomize 1100 patients with HFrEF (ejection fraction <= 40%), elevated natriuretic peptide levels within the prior 30 days, and a history of a prior HF event (HF hospitalization or equivalent) to either an NT-proBNP-guided strategy or usual care. INTERVENTIONS Patients were randomized to either an NT-proBNP-guided strategy or usual care. Patients randomized to the guided strategy (n = 446) had HF therapy titrated with the goal of achieving a target NT-proBNP of less than 1000 pg/mL. Patients randomized to usual care (n = 448) had HF care in accordance with published guidelines, with emphasis on titration of proven neurohormonal therapies for HF. Serial measurement of NT-proBNP testing was discouraged in the usual care group. MAIN OUTCOMES AND MEASURES The primary end point was the composite of time-to-first HF hospitalization or cardiovascular mortality. Prespecified secondary end points included all-cause mortality, total hospitalizations for HF, days alive and not hospitalized for cardiovascular reasons, the individual components on the primary end point, and adverse events. RESULTS The data and safety monitoring board recommended stopping the study for futility when 894 (median age, 63 years; 286 [32%] women) of the planned 1100 patients had been enrolled with follow-up for a median of 15 months. The primary end point occurred in 164 patients (37%) in the biomarker-guided group and 164 patients (37%) in the usual care group (adjusted hazard ratio [HR], 0.98; 95% CI, 0.79-1.22; P = .88). Cardiovascular mortality was 12% (n = 53) in the biomarker-guided group and 13% (n = 57) in the usual care group (HR, 0.94; (95% CI, 0.65-1.37; P = .75). None of the secondary end points nor the decreases in the NT-proBNP levels achieved differed significantly between groups. CONCLUSIONS AND RELEVANCE In high-risk patients with HFrEF, a strategy of NT-proBNP guided therapy was not more effective than a usual care strategy in improving outcomes.	[Felker, G. Michael; Anstrom, Kevin J.; Fiuzat, Mona; Mark, Daniel B.; Passmore, Gayle; Yang, Hongqiu; O'Connor, Christopher M.] Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA; [Adams, Kirkwood F.] Univ N Carolina, Chapel Hill, NC USA; [Ezekowitz, Justin A.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Houston-Miller, Nancy] LifeCare Co, Menlo Pk, CA USA; [Januzzi, James L., Jr.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Pina, Ileana L.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Whellan, David J.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Cooper, Lawton S.; Leifer, Eric S.; Desvigne-Nickens, Patrice] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [O'Connor, Christopher M.] Inova Heart & Vasc Ctr, Fairfax, VA USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Alberta; Harvard University; Massachusetts General Hospital; Yeshiva University; Albert Einstein College of Medicine; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Inova Fairfax Hospital	Felker, GM (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	michael.felker@duke.edu	Januzzi, James/Y-2436-2019; Felker, Michael/AAX-2288-2021		National Institutes of Health [HL105448, HL105451, HL105457]; Roche Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105457, R01HL105448, R01HL105451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The GUIDE-IT study was funded by grants HL105448, HL105451 and HL105457 from the National Institutes of Health, and Roche Diagnostics provided support for NT-proBNP testing.	Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Berger R, 2010, J AM COLL CARDIOL, V55, P645, DOI 10.1016/j.jacc.2009.08.078; Eurlings LWM, 2010, J AM COLL CARDIOL, V56, P2090, DOI 10.1016/j.jacc.2010.07.030; Felker GM, 2014, JACC-HEART FAIL, V2, P457, DOI 10.1016/j.jchf.2014.05.007; Felker GM, 2009, AM HEART J, V158, pS37, DOI 10.1016/j.ahj.2009.07.011; Felker GM, 2009, AM HEART J, V158, P422, DOI 10.1016/j.ahj.2009.06.018; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Januzzi JL, 2011, J AM COLL CARDIOL, V58, P1881, DOI 10.1016/j.jacc.2011.03.072; Januzzi JL, 2006, ARCH INTERN MED, V166, P315, DOI 10.1001/archinte.166.3.315; Lainchbury JG, 2009, J AM COLL CARDIOL, V55, P53, DOI 10.1016/j.jacc.2009.02.095; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	20	271	278	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					713	720		10.1001/jama.2017.10565	http://dx.doi.org/10.1001/jama.2017.10565			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829876	Green Accepted			2022-12-28	WOS:000408095800022
J	Frakt, AB; Bagley, N				Frakt, Austin B.; Bagley, Nicholas			Why It's So Hard for Insurers to Compete Over Technology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Frakt, Austin B.] Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, Washington, DC 20571 USA; [Frakt, Austin B.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Frakt, Austin B.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Frakt, Austin B.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bagley, Nicholas] Univ Michigan, Law, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan	Frakt, AB (corresponding author), Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, Washington, DC 20571 USA.; Frakt, AB (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Frakt, AB (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.; Frakt, AB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	afrakt@gmail.com		Frakt, Austin/0000-0002-0795-5462					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					687	688		10.1001/jama.2017.9971	http://dx.doi.org/10.1001/jama.2017.9971			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28829860				2022-12-28	WOS:000408095800002
J	Bock, D; Medeiros, JM; Tsao, HF; Penz, T; Weiss, GL; Aistleitner, K; Horn, M; Pilhofer, M				Bock, Desiree; Medeiros, Joao M.; Tsao, Han-Fei; Penz, Thomas; Weiss, Gregor L.; Aistleitner, Karin; Horn, Matthias; Pilhofer, Martin			In situ architecture, function, and evolution of a contractile injection system	SCIENCE			English	Article							CANDIDATUS AMOEBOPHILUS ASIATICUS; REVEALS COMMON MECHANISMS; AMEBA-ASSOCIATED BACTERIA; HOST-CELL INTERACTION; VI SECRETION; PROPHAGE AFP; BASEPLATE; GENOME; SHEATH; LENGTH	Contractile injection systems mediate bacterial cell-cell interactions by a bacteriophage tail-like structure. In contrast to extracellular systems, the type 6 secretion system (T6SS) is defined by intracellular localization and attachment to the cytoplasmic membrane. Here we used cryo-focused ion beam milling, electron cryotomography, and functional assays to study a T6SS in Amoebophilus asiaticus. The in situ architecture revealed three modules, including a contractile sheath-tube, a baseplate, and an anchor. All modules showed conformational changes upon firing. Lateral baseplate interactions coordinated T6SSs in hexagonal arrays. The system mediated interactions with host membranes and may participate in phagosome escape. Evolutionary sequence analyses predicted that T6SSs are more widespread than previously thought. Our insights form the basis for understanding T6SS key concepts and exploring T6SS diversity.	[Bock, Desiree; Medeiros, Joao M.; Weiss, Gregor L.; Pilhofer, Martin] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Tsao, Han-Fei; Penz, Thomas; Aistleitner, Karin; Horn, Matthias] Univ Vienna, Div Microbial Ecol, A-1090 Vienna, Austria; [Penz, Thomas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Aistleitner, Karin] NIAID, Hamilton, MT 59840 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pilhofer, M (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.; Horn, M (corresponding author), Univ Vienna, Div Microbial Ecol, A-1090 Vienna, Austria.	horn@microbial-ecology.net; pilhofer@biol.ethz.ch	Horn, Matthias/G-1136-2011	Horn, Matthias/0000-0002-8309-5855; Tsao, Han-Fei/0000-0002-9829-1576; Medeiros, Joao/0000-0001-9075-548X; Boeck, Desiree/0000-0001-8142-0629	European Research Council; Swiss National Science Foundation; Helmut Horten Foundation; European Research Council (ERC StG) [281633]; Austrian Science Fund [I 1628-B22]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation; European Research Council (ERC StG)(European Research Council (ERC)); Austrian Science Fund(Austrian Science Fund (FWF))	We thank F. Bosia, A. Harreither, P. Gasser, S. Rutz, P. Szwedziak, P. Tittmann, R. Wepf, and C. Zaubitzer for technical support. ScopeM is acknowledged for instrument access at ETH Zurich. We thank O. Medalia for microscope access at the University of Zurich. T. Ishikawa, R. Wepf, and Pilhofer Lab members are acknowledged for discussions. R. Kostanjsek is acknowledged for generating preliminary data. W.-D. Hardt, H. Hilbi, R. Kooger, V. Panse, N. Shikuma, M. Swulius, and E. Tocheva are acknowledged for comments on the manuscript. We thank N. Taylor for providing us with the T4 model shown in Fig. 2B. Preliminary observations were made in the lab of G. J. Jensen. M. P. is supported by the European Research Council, the Swiss National Science Foundation, and the Helmut Horten Foundation. M.H. is supported by the European Research Council (ERC StG, no. 281633) and Austrian Science Fund (I 1628-B22). Subtomogram averages and tomograms were deposited in the Electron Microscopy Data Bank (accession numbers EMD-3791 and EMD-3793 to EMD-3801).	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0021; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Buttner CR, 2016, P NATL ACAD SCI USA, V113, P10174, DOI 10.1073/pnas.1607966113; Chang YW, 2017, EMBO REP, V18, P1090, DOI 10.15252/embr.201744072; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Horn M, 2001, ENVIRON MICROBIOL, V3, P440, DOI 10.1046/j.1462-2920.2001.00210.x; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; Penz T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003012; Penz T, 2010, VIRULENCE, V1, P541, DOI 10.4161/viru.1.6.13800; Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Rybakova D, 2015, MOL MICROBIOL, V96, P815, DOI 10.1111/mmi.12974; Rybakova D, 2013, MOL MICROBIOL, V89, P702, DOI 10.1111/mmi.12305; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Shikuma NJ, 2014, SCIENCE, V343, P529, DOI 10.1126/science.1246794; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Taylor NMI, 2016, NATURE, V533, P346, DOI 10.1038/nature17971; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799	24	80	81	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					713	+		10.1126/science.aan7904	http://dx.doi.org/10.1126/science.aan7904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818949	Green Accepted			2022-12-28	WOS:000407793600041
J	Mu, D; Deng, J; Liu, KF; Wu, ZY; Shi, YF; Guo, WM; Mao, QQ; Liu, XJ; Li, H; Sun, YG				Mu, Di; Deng, Juan; Liu, Ke-Fei; Wu, Zhen-Yu; Shi, Yu-Feng; Guo, Wei-Min; Mao, Qun-Quan; Liu, Xing-Jun; Li, Hui; Sun, Yan-Gang			A central neural circuit for itch sensation	SCIENCE			English	Article							LAMINA-I NEURONS; SPINAL-CORD; TRACT NEURONS; INTERNEURONS; PAIN; PROJECTION; RECEPTORS; HISTAMINE; MONKEY; CELLS	Although itch sensation is an important protective mechanism for animals, chronic itch remains a challenging clinical problem. Itch processing has been studied extensively at the spinal level. However, how itch information is transmitted to the brain and what central circuits underlie the itch-induced scratching behavior remain largely unknown. We found that the spinoparabrachial pathway was activated during itch processing and that optogenetic suppression of this pathway impaired itch-induced scratching behaviors. Itch-mediating spinal neurons, which express the gastrin-releasing peptide receptor, are disynaptically connected to the parabrachial nucleus via glutamatergic spinal projection neurons. Blockade of synaptic output of glutamatergic neurons in the parabrachial nucleus suppressed pruritogen-induced scratching behavior. Thus, our studies reveal a central neural circuit that is critical for itch signal processing.	[Mu, Di; Deng, Juan; Liu, Ke-Fei; Shi, Yu-Feng; Guo, Wei-Min; Mao, Qun-Quan; Liu, Xing-Jun; Sun, Yan-Gang] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Mu, Di; Deng, Juan] Univ Chinese Acad Sci, 19A Yu Quan Rd, Beijing 100049, Peoples R China; [Wu, Zhen-Yu; Li, Hui] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Shaanxi, Peoples R China; [Liu, Ke-Fei] Yale Univ, Sch Med, Dept Psychiat, 333 Cedar St, New Haven, CT 06511 USA; [Liu, Xing-Jun] Xuzhou Med Univ, Sch Anesthesiol, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Air Force Military Medical University; Yale University; Xuzhou Medical University	Sun, YG (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yangang.sun@ion.ac.cn	Liu, Xing-Jun/Z-2020-2019; 穆, 迪/AEZ-5082-2022	Liu, Xing-Jun/0000-0002-5496-541X; 穆, 迪/0000-0003-1209-9311; Liu, Kefei/0000-0002-0807-9652; Qu, Yi/0000-0002-9993-8810; Li, Hui/0000-0001-9083-7776; sun, yan gang/0000-0003-0768-7733	National Natural Science Foundation of China [31371122, 31371211, 81322015]; Chinese Academy of Sciences Hundreds of Talents Program; Youth Thousand Plan; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB02010000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Hundreds of Talents Program(Chinese Academy of Sciences); Youth Thousand Plan; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank M. M. Poo and M. Beierlein for comments on the manuscript. We thank C. Luo, X. H. Xu, H. L. Hu, J. Yan, L. Yuan, X. J. Chen, Z. Li, J. Pan, K. Yang, and Y. J. Zhu for their technical support and all the laboratory members of Y.G.S. for helpful discussion. All data to understand and assess the conclusions of this study are available in the main text or supplementary materials. This work was supported by the National Natural Science Foundation of China (grants 31371122, 31371211, and 81322015), the Chinese Academy of Sciences Hundreds of Talents Program (to Y.G.S.), the Youth Thousand Plan (to Y.G.S.), and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDB02010000).	Akiyama T, 2015, PAIN, V156, P1240, DOI 10.1097/j.pain.0000000000000172; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Bourane S, 2015, SCIENCE, V350, P550, DOI 10.1126/science.aac8653; Cameron D, 2015, PAIN, V156, P2061, DOI 10.1097/j.pain.0000000000000270; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; GISZTER SF, 1989, J NEUROPHYSIOL, V62, P750, DOI 10.1152/jn.1989.62.3.750; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Herde L, 2007, J NEUROPHYSIOL, V98, P2347, DOI 10.1152/jn.00475.2007; Hyndman OR, 1943, ARCH NEURO PSYCHIATR, V50, P129, DOI 10.1001/archneurpsyc.1943.02290200029002; Jansen NA, 2015, J NEUROPHYSIOL, V113, P58, DOI 10.1152/jn.00596.2014; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mochizuki H, 2015, CLIN NEUROPHYSIOL, V126, P1650, DOI 10.1016/j.clinph.2014.11.019; Oaklander AL, 2002, PAIN, V96, P9, DOI 10.1016/S0304-3959(01)00400-6; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Weiss MS, 2014, J NEUROPHYSIOL, V111, P1655, DOI 10.1152/jn.00643.2013; WIBERG M, 1987, J COMP NEUROL, V264, P92, DOI 10.1002/cne.902640108; Yosipovitch G, 2008, J INVEST DERMATOL, V128, P1806, DOI 10.1038/jid.2008.3; Zhao ZQ, 2014, J NEUROSCI, V34, P12402, DOI 10.1523/JNEUROSCI.1709-14.2014	30	117	128	6	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					695	698		10.1126/science.aaf4918	http://dx.doi.org/10.1126/science.aaf4918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818946				2022-12-28	WOS:000407793600037
J	Cohen, JF; Korevaar, DA; Gatsonis, CA; Glasziou, PP; Hooft, L; Moher, D; Reitsma, JB; de Vet, HCW; Bossuyt, PM				Cohen, Jeremie F.; Korevaar, Daniel A.; Gatsonis, Constantine A.; Glasziou, Paul P.; Hooft, Lotty; Moher, David; Reitsma, Johannes B.; de Vet, Henrica C. W.; Bossuyt, Patrick M.			STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UPDATED LIST; BIAS; PUBLICATION	Many abstracts of diagnostic accuracy studies are currently insufficiently informative. We extended the STARD (Standards for Reporting Diagnostic Accuracy) statement by developing a list of essential items that authors should consider when reporting diagnostic accuracy studies in journal or conference abstracts. After a literature review of published guidance for reporting biomedical studies, we identified 39 items potentially relevant to report in an abstract. We then selected essential items through a two round web based survey among the 85 members of the STARD Group, followed by discussions within an executive committee. Seventy three STARD Group members responded (86%), with 100% completion rate. STARD for Abstracts is a list of 11 quintessential items, to be reported in every abstract of a diagnostic accuracy study. We provide examples of complete reporting, and developed template text for writing informative abstracts.	[Cohen, Jeremie F.; Korevaar, Daniel A.; Bossuyt, Patrick M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Cohen, Jeremie F.] INSERM, UMR 1153, Paris, France; [Cohen, Jeremie F.] Paris Descartes Univ, Necker Enfants Malad Hosp, AP HP, Dept Pediat, Paris, France; [Gatsonis, Constantine A.] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Glasziou, Paul P.] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [Hooft, Lotty] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dutch Cochrane Ctr, Utrecht, Netherlands; [Moher, David] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Reitsma, Johannes B.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Vet, Henrica C. W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Brown University; Bond University; Utrecht University; Utrecht University Medical Center; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Cohen, JF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands.; Cohen, JF (corresponding author), INSERM, UMR 1153, Paris, France.; Cohen, JF (corresponding author), Paris Descartes Univ, Necker Enfants Malad Hosp, AP HP, Dept Pediat, Paris, France.	jeremie.cohen@inserm.fr	Knottnerus, Johannes A/A-3829-2009; Korevaar, Daniël A./O-5809-2019; Deeks, Jon/AAV-5745-2020; Simera, Iveta/AFN-5638-2022; Glasziou, Paul/A-7832-2008; Cohen, Jérémie/H-4707-2019; Petersen, Steffen E/A-8389-2011; Rutjes, Anne/L-8750-2017; Moher, David/I-3408-2019; Bossuyt, Patrick M./B-4557-2016; Dinnes, Jacqueline/Y-3673-2018; Bossuyt, Patrick M/AAR-1183-2021; Virgili, Gianni/P-6607-2014	Deeks, Jon/0000-0002-8850-1971; Simera, Iveta/0000-0001-5785-6756; Glasziou, Paul/0000-0001-7564-073X; Cohen, Jérémie/0000-0003-3572-8985; Petersen, Steffen E/0000-0003-4622-5160; Rutjes, Anne/0000-0001-9782-779X; Moher, David/0000-0003-2434-4206; Bossuyt, Patrick M./0000-0003-4427-0128; Dinnes, Jacqueline/0000-0003-1343-7335; Bossuyt, Patrick M/0000-0003-4427-0128; de Vet, Henrica/0000-0002-5454-2804; Ravaud, Philippe/0000-0001-8264-9206; Lumbreras, Blanca/0000-0003-1665-0860; Boutron, Isabelle/0000-0002-5263-6241; Reitsma, Johannes/0000-0003-4026-4345; Fleming, Kenneth/0000-0002-3200-1302; Christopher, Hyde/0000-0002-7349-0616; Onderdonk, Andrew/0000-0001-8998-8972; Mallett, Sue/0000-0002-0596-8200; Ioannidis, John P./0000-0003-3118-6859; Azuara-Blanco, Augusto/0000-0002-4805-9322; Takwoingi, Yemisi/0000-0002-5828-9746; Schunemann, Holger/0000-0003-3211-8479; Whiting, Penny/0000-0003-1138-5682; Virgili, Gianni/0000-0002-9960-2989; Morris, Katie/0000-0003-1247-429X				[Anonymous], 2000, J GEN INTERN MED, P1525; Begley CG, 2015, NATURE, V525, P25, DOI 10.1038/525025a; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brazzelli M, 2009, J CLIN EPIDEMIOL, V62, P425, DOI 10.1016/j.jclinepi.2008.06.018; Cohen JD, 2016, ANN RHEUM DIS, V75, P1266, DOI 10.1136/annrheumdis-2016-eular.2668; Cohen JF, 2015, DEV STARD ABSTRACTS; Estrada CA, 2000, J GEN INTERN MED, V15, P183, DOI 10.1046/j.1525-1497.2000.03189.x; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Korevaar DA, 2017, CLIN CHEM, V63, P1331, DOI 10.1373/clinchem.2017.272765; Korevaar DA, 2016, J CLIN EPIDEMIOL, V79, P96, DOI 10.1016/j.jclinepi.2016.06.002; Korevaar DA, 2015, JAMA OPHTHALMOL, V133, P1464, DOI 10.1001/jamaophthalmol.2015.3577; Korevaar DA, 2015, J CLIN EPIDEMIOL, V68, P708, DOI 10.1016/j.jclinepi.2015.01.014; Korevaar DA, 2015, RADIOLOGY, V274, P781, DOI 10.1148/radiol.14141160; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Moher D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001864; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Wilson C, 2015, INT J GERIATR PSYCH, V30, P1250, DOI 10.1002/gps.4283	22	36	37	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2017	358								j3751	10.1136/bmj.j3751	http://dx.doi.org/10.1136/bmj.j3751			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5CB	28819063	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000408228500004
J	Micali, G; Lacarrubba, F				Micali, Giuseppe; Lacarrubba, Francesco			Eczema Herpeticum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Micali, Giuseppe; Lacarrubba, Francesco] Univ Catania, Catania, Italy	University of Catania	Micali, G (corresponding author), Univ Catania, Catania, Italy.	cldermct@gmail.com		MICALI, Giuseppe/0000-0002-5157-3939					0	9	9	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					E9	E9		10.1056/NEJMicm1701668	http://dx.doi.org/10.1056/NEJMicm1701668			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813215				2022-12-28	WOS:000407691400011
J	Cornell, JE; Liao, JM; Stack, CB; Mulrow, CD				Cornell, John E.; Liao, Joshua M.; Stack, Catharine B.; Mulrow, Cynthia D.			Annals Understanding Clinical Research: Evaluating the Meaning of a Summary Estimate in a Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AORTIC-VALVE-REPLACEMENT; INTERMEDIATE-RISK PATIENTS; TRANSCATHETER		[Cornell, John E.] Univ Texas Hlth Sci Ctr San Antonio, 7703 Merton Minter Blvd, San Antonio, TX 78299 USA; [Liao, Joshua M.] Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Stack, Catharine B.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Mulrow, Cynthia D.] Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Pennsylvania; American College of Physicians; University of Texas System; University of Texas Health San Antonio	Cornell, JE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, 7703 Merton Minter Blvd, San Antonio, TX 78299 USA.	cornell@uthscsa.edu						Gargiulo G, 2016, ANN INTERN MED, V165, P334, DOI 10.7326/M16-0060; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3	4	14	14	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					275	+		10.7326/M17-1454	http://dx.doi.org/10.7326/M17-1454			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28785763				2022-12-28	WOS:000407797500016
J	Rabi, DM; Daskalopoulou, SS; Leung, AA; Dresser, G; Padwal, R; Khan, N				Rabi, Doreen M.; Daskalopoulou, Stella S.; Leung, Alexander A.; Dresser, George; Padwal, Raj; Khan, Nadia			Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Letter									[Rabi, Doreen M.; Daskalopoulou, Stella S.; Leung, Alexander A.; Dresser, George; Padwal, Raj; Khan, Nadia] Hypertens Canada, Markham, ON, Canada		Rabi, DM (corresponding author), Hypertens Canada, Markham, ON, Canada.		Leung, Alexander/L-9856-2018; Padwal, Raj/G-6903-2016	Leung, Alexander/0000-0002-7536-8497; Padwal, Raj/0000-0003-3541-2817				Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					289	290		10.7326/L17-0285	http://dx.doi.org/10.7326/L17-0285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806806				2022-12-28	WOS:000407797500024
J	Eichler, K; Li, F; Litwin-Kumar, A; Park, Y; Andrade, I; Chneider-Mizell, CMS; Saumweber, T; Huser, A; Eschbach, C; Gerber, B; Fetter, RD; Truman, JW; Priebe, CE; Abbott, LF; Thum, AS; Zlatic, M; Cardona, A				Eichler, Katharina; Li, Feng; Litwin-Kumar, Ashok; Park, Youngser; Andrade, Ingrid; Chneider-Mizell, Casey M. S.; Saumweber, Timo; Huser, Annina; Eschbach, Claire; Gerber, Bertram; Fetter, Richard D.; Truman, James W.; Priebe, Carey E.; Abbott, L. F.; Thum, Andreas S.; Zlatic, Marta; Cardona, Albert			The complete connectome of a learning and memory centre in an insect brain	NATURE			English	Article							DROSOPHILA MUSHROOM BODIES; DOPAMINERGIC-NEURONS; EMBRYONIC-DEVELOPMENT; IDENTIFIED NEURONS; BEHAVIORAL CHOICE; CIRCUIT; COMPONENTS; SPARSE; REWARD; INTEGRATION	Associating stimuli with positive or negative reinforcement is essential for survival, but a complete wiring diagram of a higher-order circuit supporting associative memory has not been previously available. Here we reconstruct one such circuit at synaptic resolution, the Drosophila larval mushroom body. We find that most Kenyon cells integrate random combinations of inputs but that a subset receives stereotyped inputs from single projection neurons. This organization maximizes performance of a model output neuron on a stimulus discrimination task. We also report a novel canonical circuit in each mushroom body compartment with previously unidentified connections: reciprocal Kenyon cell to modulatory neuron connections, modulatory neuron to output neuron connections, and a surprisingly high number of recurrent connections between Kenyon cells. Stereotyped connections found between output neurons could enhance the selection of learned behaviours. The complete circuit map of the mushroom body should guide future functional studies of this learning and memory centre.	[Eichler, Katharina; Li, Feng; Andrade, Ingrid; Chneider-Mizell, Casey M. S.; Eschbach, Claire; Fetter, Richard D.; Truman, James W.; Zlatic, Marta; Cardona, Albert] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA; [Eichler, Katharina; Huser, Annina; Thum, Andreas S.] Univ Konstanz, Dept Biol, Univ Str 10, D-78464 Constance, Germany; [Litwin-Kumar, Ashok; Abbott, L. F.] Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Brain Behav Inst, 3227 Broadway, New York, NY 10027 USA; [Park, Youngser; Priebe, Carey E.] Johns Hopkins Univ, Dept Appl Math & Stat, Whiting Sch Engn, 100 Whitehead Hall,3400 North Charles St, Baltimore, MD 21218 USA; [Saumweber, Timo; Gerber, Bertram] Leibniz Inst Neurobiol, Abt Genet von Lernen & Gedachtnis, D-39118 Magdeburg, Germany; [Gerber, Bertram] Otto von Guericke Univ, Inst Biol, Verhaltensgenet, Univ Pl 2, D-39106 Magdeburg, Germany; [Gerber, Bertram] Otto von Guericke Univ, Ctr Behav Brain Sci, Univ Pl 2, D-39106 Magdeburg, Germany; [Abbott, L. F.] Columbia Univ, Dept Physiol & Cellular Biophys, Russ Berrie Pavil,1150 St Nicholas Ave, New York, NY 10032 USA; [Zlatic, Marta] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Cardona, Albert] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Thum, Andreas S.] Univ Leipzig, Dept Genet, Talstr 33, D-04103 Leipzig, Germany	Howard Hughes Medical Institute; University of Konstanz; Columbia University; Johns Hopkins University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Columbia University; University of Cambridge; University of Cambridge; Leipzig University	Zlatic, M; Cardona, A (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.; Thum, AS (corresponding author), Univ Konstanz, Dept Biol, Univ Str 10, D-78464 Constance, Germany.; Abbott, LF (corresponding author), Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Brain Behav Inst, 3227 Broadway, New York, NY 10027 USA.; Abbott, LF (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Russ Berrie Pavil,1150 St Nicholas Ave, New York, NY 10032 USA.; Zlatic, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.; Cardona, A (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.; Thum, AS (corresponding author), Univ Leipzig, Dept Genet, Talstr 33, D-04103 Leipzig, Germany.	lfa2103@columbia.edu; andreas.thum@uni-leipzig.de; zlaticm@hhmi.org; cardonaa@hhmi.org	Eschbach, Claire/AAA-9165-2022; Thum, Andreas S/B-1083-2013	Thum, Andreas/0000-0002-3830-6596; Park, Youngser/0000-0002-3978-5533; Cardona, Albert/0000-0003-4941-6536; Zlatic, Marta/0000-0002-3149-2250	National Institutes of Health [F32DC014387]; Simons Collaboration on the Global Brain; Gatsby Foundation; Mathers Foundation; Kavli Foundation; Defense Advanced Research Projects Agency XDATA program (Air Force Research Laboratory) [FA8750-12-2-0303]; National Science Foundation BRAIN EAGER award [DBI-1451081]; Deutsche Forschungsgemeinschaft [TH1584/1-1, TH1584/3-1, CRC 779, GE 1091/4-1]; Swiss National Science Foundation [31003A_132812/1]; Baden Wurttemberg Stiftung; Zukunftskolleg of the University of Konstanz; Deutscher Akademischer Austauschdienst; European Commission, FP7-ICT MINIMAL; Janelia Visiting Scientist program; HHMI visa office; HHMI Janelia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC014387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Collaboration on the Global Brain; Gatsby Foundation; Mathers Foundation; Kavli Foundation; Defense Advanced Research Projects Agency XDATA program (Air Force Research Laboratory); National Science Foundation BRAIN EAGER award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden Wurttemberg Stiftung; Zukunftskolleg of the University of Konstanz; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); European Commission, FP7-ICT MINIMAL; Janelia Visiting Scientist program; HHMI visa office; HHMI Janelia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Khandelwal, J. Lovick, J. Valdes-Aleman, I. Larderet, V. Hartenstein, A. Fushiki, B. Afonso, P. Schlegel and M. Berck for reconstructing 31% of arbor cable and 19% of synapses. We thank R. Axel, G. M. Rubin and Y. Aso for their comments on the manuscript. A. L.-K. was supported by National Institutes of Health grant number F32DC014387. A. L.-K. and L.F.A. were supported by the Simons Collaboration on the Global Brain. L.F.A. was also supported by the Gatsby, Mathers, and Kavli Foundations. C.E.P. and Y. P. were supported by the Defense Advanced Research Projects Agency XDATA program (Air Force Research Laboratory contract FA8750-12-2-0303) and National Science Foundation BRAIN EAGER award DBI-1451081. K.E. and A.S.T. thank the Deutsche Forschungsgemeinschaft, TH1584/1-1, TH1584/3-1; the Swiss National Science Foundation, 31003A_132812/1; the Baden Wurttemberg Stiftung; Zukunftskolleg of the University of Konstanz; and Deutscher Akademischer Austauschdienst. B. G. and T.S. thank the Deutsche Forschungsgemeinschaft, CRC 779, GE 1091/4-1; the European Commission, FP7-ICT MINIMAL. We thank the Fly EM Project Team at Howard Hughes Medical Institute (HHMI) Janelia for the gift of the electron microscopy volume, the Janelia Visiting Scientist program, the HHMI visa office, and HHMI Janelia for funding.	Almeida-Carvalho MJ, 2017, J EXP BIOL, V220, P2452, DOI 10.1242/jeb.156646; Aso Y, 2016, ELIFE, V5, DOI [DOI 10.7554/ELIFE.16135, 10.7554/eLife.16135]; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Babadi B, 2014, NEURON, V83, P1213, DOI 10.1016/j.neuron.2014.07.035; Bang S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001346; Barnstedt O, 2016, NEURON, V89, P1237, DOI 10.1016/j.neuron.2016.02.015; BATE M, 1981, J NEUROSCI, V1, P103, DOI 10.1523/JNEUROSCI.01-01-00103.1981; Berck ME, 2016, ELIFE, V5, DOI 10.7554/eLife.14859; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bouzaiane E, 2015, CELL REP, V11, P1280, DOI 10.1016/j.celrep.2015.04.044; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Cohn R, 2015, CELL, V163, P1742, DOI 10.1016/j.cell.2015.11.019; Costa M, 2016, NEURON, V91, P293, DOI 10.1016/j.neuron.2016.06.012; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Das G, 2014, CURR BIOL, V24, P1723, DOI 10.1016/j.cub.2014.05.078; Diegelmann S, 2013, J EXP BIOL, V216, P939, DOI 10.1242/jeb.076208; Drobysheva D, 2008, J HISTOCHEM CYTOCHEM, V56, P1049, DOI 10.1369/jhc.2008.951137; Farris SM, 2011, ARTHROPOD STRUCT DEV, V40, P368, DOI 10.1016/j.asd.2011.02.004; Fushiki A, 2016, ELIFE, V5, DOI 10.7554/eLife.13253; Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062; GOODMAN CS, 1981, J NEUROSCI, V1, P94, DOI 10.1523/JNEUROSCI.01-01-00094.1981; Gruntman E, 2013, NAT NEUROSCI, V16, P1821, DOI 10.1038/nn.3547; Heckscher ES, 2015, NEURON, V88, P314, DOI 10.1016/j.neuron.2015.09.009; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hige T, 2015, NEURON, V88, P985, DOI 10.1016/j.neuron.2015.11.003; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Huetteroth W, 2015, CURR BIOL, V25, P751, DOI 10.1016/j.cub.2015.01.036; Ichinose T, 2015, ELIFE, V4, DOI 10.7554/eLife.10719; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jovanic T, 2016, CELL, V167, P858, DOI 10.1016/j.cell.2016.09.009; Klein M, 2015, P NATL ACAD SCI USA, V112, pE220, DOI 10.1073/pnas.1416212112; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kunz T, 2012, DEVELOPMENT, V139, P2510, DOI 10.1242/dev.077883; Kurusu M, 2002, DEVELOPMENT, V129, P409; Larderet I., 2017, PREPRINT; Lee T, 1999, DEVELOPMENT, V126, P4065; Lewis LPC, 2015, CURR BIOL, V25, P2203, DOI 10.1016/j.cub.2015.07.015; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Litwin-Kumar A, 2017, NEURON, V93, P1153, DOI 10.1016/j.neuron.2017.01.030; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Lorenz K, 1973, LES PRIX NOBEL; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Masuda-Nakagawa LM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00035; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Mishra D, 2010, J NEUROGENET, V24, P168, DOI 10.3109/01677063.2010.498066; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Owald D, 2015, CURR OPIN NEUROBIOL, V35, P178, DOI 10.1016/j.conb.2015.10.002; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Perisse E, 2016, NEURON, V90, P1086, DOI 10.1016/j.neuron.2016.04.034; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rohwedder A, 2016, CURR BIOL, V26, P661, DOI 10.1016/j.cub.2016.01.012; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider-Mizell CM, 2016, ELIFE, V5, DOI 10.7554/eLife.12059; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; Selcho M, 2014, J COMP NEUROL, V522, P3485, DOI 10.1002/cne.23616; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Slater G, 2015, J NEUROSCI, V35, P1831, DOI 10.1523/JNEUROSCI.2331-14.2015; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Takemura S, 2017, ELIFE, V6, DOI 10.7554/eLife.26975; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Zwart MF, 2016, NEURON, V91, P615, DOI 10.1016/j.neuron.2016.06.031	80	235	240	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					175	+		10.1038/nature23455	http://dx.doi.org/10.1038/nature23455			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796202	Green Submitted, Green Accepted			2022-12-28	WOS:000407284300036
J	Friedman, DA; Gordon, DM; Luo, LQ				Friedman, Daniel A.; Gordon, Deborah M.; Luo, Liqun			The MutAnts Are Here	CELL			English	Editorial Material							EVOLUTION; BEHAVIOR		[Friedman, Daniel A.; Gordon, Deborah M.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Friedman, DA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dfri@stanford.edu		Luo, Liqun/0000-0001-5467-9264				Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; Friedman DA, 2016, ANNU REV NEUROSCI, V39, P41, DOI 10.1146/annurev-neuro-070815-013927; Gordon DM, 2016, CELL SYST, V3, P514, DOI 10.1016/j.cels.2016.10.013; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Tsutsui ND, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0416; Ward PS, 2014, ANNU REV ECOL EVOL S, V45, P23, DOI 10.1146/annurev-ecolsys-120213-091824; Yan H, 2014, NAT REV GENET, V15, P677, DOI 10.1038/nrg3787	9	4	4	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					601	602		10.1016/j.cell.2017.07.046	http://dx.doi.org/10.1016/j.cell.2017.07.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802035	Bronze			2022-12-28	WOS:000407445700003
J	Cutler, DM				Cutler, David M.			Rising Medical Costs Mean More Rough Times Ahead	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Cutler, David M.] Harvard Univ, Dept Econ, Appl Econ, Cambridge, MA 02138 USA; [Cutler, David M.] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA; [Cutler, David M.] Inst Med, Cambridge, MA USA	Harvard University; Harvard University	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, Appl Econ, Cambridge, MA 02138 USA.; Cutler, DM (corresponding author), Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA.; Cutler, DM (corresponding author), Inst Med, Cambridge, MA USA.	dcutler@fas.harvard.edu		Cutler, David/0000-0002-4949-8917					0	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					508	509		10.1001/jama.2017.8931	http://dx.doi.org/10.1001/jama.2017.8931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787495				2022-12-28	WOS:000407160100003
J	Browder, T; Passaleva, G; Roney, M				Browder, Tom; Passaleva, Giovanni; Roney, Michael			BaBar Collaboration first to see anomaly	NATURE			English	Letter									[Browder, Tom] Univ Hawaii Manoa, Belle Collaborat 2, Honolulu, HI 96822 USA; [Passaleva, Giovanni] Ist Nazl Fis Nucl, LHCb Collaborat, Florence, Italy; [Roney, Michael] Univ Victoria, BaBar Collaborat, Victoria, BC, Canada	University of Hawaii System; University of Hawaii Manoa; Istituto Nazionale di Fisica Nucleare (INFN); University of Victoria	Roney, M (corresponding author), Univ Victoria, BaBar Collaborat, Victoria, BC, Canada.	mroney@uvic.ca	Passaleva, Giovanni/ABF-5558-2021	Passaleva, Giovanni/0000-0002-8077-8378				Lees JP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.101802; 2017, NATURE, V546, P185	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					31	31		10.1038/548031d	http://dx.doi.org/10.1038/548031d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770845				2022-12-28	WOS:000406831700024
J	Schachter, J; Ribas, A; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, C; Petrella, TM; Hamid, O; Zhou, HH; Ebbinghaus, S; Ibrahim, N; Robert, C				Schachter, Jacob; Ribas, Antoni; Long, Georgina V.; Arance, Ana; Grob, Jean-Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S.; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian; Petrella, Teresa M.; Hamid, Omid; Zhou, Honghong; Ebbinghaus, Scot; Ibrahim, Nageatte; Robert, Caroline			Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)	LANCET			English	Article							COMBINED NIVOLUMAB; ANTI-PD-1; MONOTHERAPY; TOXICITIES; MANAGEMENT; BLOCKADE	Background Interim analyses of the phase 3 KEYNOTE-006 study showed superior overall and progression-free survival of pembrolizumab versus ipilimumab in patients with advanced melanoma. We present the final protocol-specified survival analysis. Methods In this multicentre, open-label, randomised, phase 3 trial, we recruited patients from 87 academic institutions, hospitals, and cancer centres in 16 countries (Australia, Austria, Belgium, Canada, Chile, Colombia, France, Germany, Israel, Netherlands, New Zealand, Norway, Spain, Sweden, UK, and USA). We randomly assigned participants (1: 1: 1) to one of two dose regimens of pembrolizumab, or one regimen of ipilimumab, using a centralised, computer-generated allocation schedule. Treatment assignments used blocked randomisation within strata. Eligible patients were at least 18 years old, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, at least one measurable lesion per Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST v1.1), unresectable stage III or IV melanoma (excluding ocular melanoma), and up to one previous systemic therapy (excluding anti-CTLA-4, PD-1, or PD-L1 agents). Secondary eligibility criteria are described later. Patients were excluded if they had active brain metastases or active autoimmune disease requiring systemic steroids. The primary outcome was overall survival (defined as the time from randomisation to death from any cause). Response was assessed per RECIST v1.1 by independent central review at week 12, then every 6 weeks up to week 48, and then every 12 weeks thereafter. Survival was assessed every 12 weeks, and final analysis occurred after all patients were followed up for at least 21 months. Primary analysis was done on the intention-to-treat population (all randomly assigned patients) and safety analyses were done in the treated population (all randomly assigned patients who received at least one dose of study treatment). Data cutoff date for this analysis was Dec 3, 2015. This study was registered with ClinicalTrials.gov, number NCT01866319. Findings Between Sept 18, 2013, and March 3, 2014, 834 patients with advanced melanoma were enrolled and randomly assigned to receive intravenous pembrolizumab every 2 weeks (n=279), intravenous pembrolizumab every 3 weeks (n=277), or intravenous ipilimumab every 3 weeks (ipilimumab for four doses; n=278). One patient in the pembrolizumab 2 week group and 22 patients in the ipilimumab group withdrew consent and did not receive treatment. A total of 811 patients received at least one dose of study treatment. Median follow-up was 22.9 months; 383 patients died. Median overall survival was not reached in either pembrolizumab group and was 16.0 months with ipilimumab (hazard ratio [HR] 0.68, 95% CI 0.53-0.87 for pembrolizumab every 2 weeks vs ipilimumab; p=0.0009 and 0.68, 0.53-0.86 for pembrolizumab every 3 weeks vs ipilimumab; p=0.0008). 24-month overall survival rate was 55% in the 2-week group, 55% in the 3-week group, and 43% in the ipilimumab group. Interpretation Substantiating the results of the interim analyses of KEYNOTE-006, pembrolizumab continued to provide superior overall survival versus ipilimumab, with no difference between pembrolizumab dosing schedules. These conclusions further support the use of pembrolizumab as a standard of care for advanced melanoma.	[Schachter, Jacob] Sheba Med Ctr, Div Oncol, Ella Lemelbaum Inst Melanoma, Tel Hashomer, Israel; [Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Long, Georgina V.] Univ Sydney, Mater Hosp, Melanoma Inst Australia, Dept Med Oncol & Translat Res, Sydney, NSW, Australia; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Arance, Ana] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Grob, Jean-Jacques] Aix Marseille Univ, Dept Dermatol & Skin Canc, Hop Timone, Marseille, France; [Mortier, Laurent] Univ Lille, CHU Lille, Dept Dermatol, INSERM,U1189, F-59000 Lille, France; [Daud, Adil] Univ Calif San Francisco, Dept Hematol Oncol, San Francisco, CA 94143 USA; [Carlino, Matteo S.] Melanoma Inst Australia, Westmead Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Carlino, Matteo S.] Melanoma Inst Australia, Blacktown Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Carlino, Matteo S.] Univ Sydney, Sydney, NSW, Australia; [McNeil, Catriona] Royal Prince Alfred Hosp, Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia; [McNeil, Catriona] Melanoma Inst Australia, Camperdown, NSW, Australia; [Lotem, Michal] Hadassah Hebrew Univ Med Ctr, Sharett Inst Oncol, Dept Melanoma & Canc Immunotherapy, Jerusalem, Israel; [Larkin, James] Royal Marsden Hosp, Dept Med Oncol, London, England; [Lorigan, Paul] Univ Manchester, Dept Med Oncol, Manchester, Lancs, England; [Lorigan, Paul] Christie NHS Fdn Trust, Manchester, Lancs, England; [Neyns, Bart] Univ Ziekenhuis Brussel, Dept Med Oncol, Brussels, Belgium; [Blank, Christian] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Petrella, Teresa M.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Med Oncol Hematol, Toronto, ON, Canada; [Hamid, Omid] Angeles Clin & Res Inst, Dept Hematol Oncol, Los Angeles, CA USA; [Ebbinghaus, Scot; Ibrahim, Nageatte] Merck & Co Inc, Dept Clin Oncol, Kenilworth, NJ USA; [Zhou, Honghong] Merck & Co Inc, BARDS, Kenilworth, NJ USA; [Zhou, Honghong; Ebbinghaus, Scot; Ibrahim, Nageatte] Merck & Co Inc, Kenilworth, NJ USA; [Robert, Caroline] Gustave Roussy, Dept Oncol, Villejuif, France; [Robert, Caroline] Paris Sud Univ, Villejuif, France	Chaim Sheba Medical Center; University of California System; University of California Los Angeles; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital; University of Barcelona; Hospital Clinic de Barcelona; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of California System; University of California San Francisco; Melanoma Institute Australia; University of Sydney; Blacktown & Mount Druitt Hospital; Melanoma Institute Australia; University of Sydney; University of Sydney; Melanoma Institute Australia; Hebrew University of Jerusalem; Royal Marsden NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; University Hospital Brussels; Vrije Universiteit Brussel; Netherlands Cancer Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Angeles Clinic & Research Institute; Merck & Company; Merck & Company; Merck & Company; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Schachter, J (corresponding author), Sheba Med Ctr, Ella Lemelbaum Inst Melanoma, Tel Hashomer, Israel.	jacob.schachter@sheba.health.gov.il	Robert, Caroline/G-6157-2018; Neyns, Bart/AAA-8267-2021; Neyns, Bart/ABG-3145-2021; Long, Georgina V/C-1771-2013; Carlino, Matteo/GRS-7198-2022; Daud, Adil/T-3079-2019; Lorigan, Paul/J-6898-2015	Robert, Caroline/0000-0002-9493-0238; Neyns, Bart/0000-0003-0658-5903; Long, Georgina V/0000-0001-8894-3545; Daud, Adil/0000-0002-6617-8421; Larkin, James/0000-0001-5569-9523; Lorigan, Paul/0000-0002-8875-2164; MORTIER, Laurent/0000-0002-2644-1790; Arance, Ana/0000-0003-2896-1957; Carlino, Matteo/0000-0002-7861-4104	Merck Co	Merck Co(Merck & Company)	Merck & Co.	Ackerman A, 2014, CANCER; [Anonymous], 2016, KEYTR; [Anonymous], 2015, YERV; [Anonymous], 2016, OPD; Aya F, 2017, CLIN TRANSL ONCOL, V19, P119, DOI 10.1007/s12094-016-1514-0; Callahan MK, 2013, CLIN DERMATOL, V31, P191, DOI 10.1016/j.clindermatol.2012.08.006; COX DR, 1972, J R STAT SOC B, V34, P187; Farolfi A, 2012, MELANOMA RES, V22, P263, DOI 10.1097/CMR.0b013e328353e65c; Gangadhar TC, 2016, EUROPEAN SOC MED ONC; Gangadhar TC, 2015, J IMMUNOTHER CANCER, V3, pO7, DOI DOI 10.1186/2051-1426-3-S2-O7; Hamid O, 2015, 12 INT C SOC MEL RES; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hodi FS, 2016, LANCET ONCOL, V17, P1558, DOI 10.1016/S1470-2045(16)30366-7; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johnson DB, 2017, J IMMUNOTHER, V40, P31, DOI 10.1097/CJI.0000000000000148; Kahler KC, 2016, J DTSCH DERMATOL GES, V14, P662, DOI [10.1111/ddg.13047_g, 10.1111/ddg.13047]; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Larkin J, 2017, OVERALL SURVIVAL RES; Long B, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS5609; Long GV, 2015 EUR CANC C SEPT; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Naidoo J, 2015, ANN ONCOL, V26, P2375, DOI 10.1093/annonc/mdv383; O'Day SJ, 2010, ANN ONCOL, V21, P1712, DOI 10.1093/annonc/mdq013; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow Michael A, 2015, Am Soc Clin Oncol Educ Book, P76, DOI 10.14694/EdBook_AM.2015.35.76; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; ROBERT C, 2016, J CLIN ONCOL S, V34; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Schachter J, 2015, SOC MEL RES 2015 C N; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spain L, 2016, CANCER TREAT REV, V44, P51, DOI 10.1016/j.ctrv.2016.02.001; Sznol M, 2013, J CLIN ONCOL, V31	33	734	762	2	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1853	1862		10.1016/S0140-6736(17)31601-X	http://dx.doi.org/10.1016/S0140-6736(17)31601-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LY	28822576				2022-12-28	WOS:000413244500026
J	Athauda, D; Maclagan, K; Skene, SS; Bajwa-Joseph, M; Letchford, D; Chowdhury, K; Hibbert, S; Budnik, N; Zampedri, L; Dickson, J; Li, YZ; Aviles-Olmos, I; Warner, TT; Limousin, P; Lees, AJ; Greig, NH; Tebbs, S; Foltynie, T				Athauda, Dilan; Maclagan, Kate; Skene, Simon S.; Bajwa-Joseph, Martha; Letchford, Dawn; Chowdhury, Kashfia; Hibbert, Steve; Budnik, Natalia; Zampedri, Luca; Dickson, John; Li, Yazhou; Aviles-Olmos, Iciar; Warner, Thomas T.; Limousin, Patricia; Lees, Andrew J.; Greig, Nigel H.; Tebbs, Susan; Foltynie, Thomas			Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; CLINICAL-TRIALS; ANIMAL-MODEL; MOUSE MODEL; OPEN-LABEL; EXENDIN-4; THERAPIES	Background Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has neuroprotective effects in preclinical models of Parkinson's disease. We investigated whether these effects would be apparent in a clinical trial. Methods In this single-centre, randomised, double-blind, placebo-controlled trial, patients with moderate Parkinson's disease were randomly assigned (1:1) to receive subcutaneous injections of exenatide 2 mg or placebo once weekly for 48 weeks in addition to their regular medication, followed by a 12-week washout period. Eligible patients were aged 25-75 years, had idiopathic Parkinson's disease as measured by Queen Square Brain Bank criteria, were on dopaminergic treatment with wearing-off effects, and were at Hoehn and Yahr stage 2.5 or less when on treatment. Randomisation was by web-based randomisation with a two strata block design according to disease severity. Patients and investigators were masked to treatment allocation. The primary outcome was the adjusted difference in the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor subscale (part 3) in the practically defined off-medication state at 60 weeks. All efficacy analyses were based on a modified intention-to-treat principle, which included all patients who completed any post-randomisation follow-up assessments. The study is registered at ClinicalTrials.gov (NCT01971242) and is completed. Findings Between June 18, 2014, and March 13, 2015, 62 patients were enrolled and randomly assigned, 32 to exenatide and 30 to placebo. Our primary analysis included 31 patients in the exenatide group and 29 patients in the placebo group. At 60 weeks, off-medication scores on part 3 of the MDS-UPDRS had improved by 1.0 points (95% CI -2.6 to 0.7) in the exenatide group and worsened by 2.1 points (-0.6 to 4.8) in the placebo group, an adjusted mean difference of -3.5 points (-6.7 to -0.3; p=0.0318). Injection site reactions and gastrointestinal symptoms were common adverse events in both groups. Six serious adverse events occurred in the exenatide group and two in the placebo group, although none in either group were judged to be related to the study interventions. Interpretation Exenatide had positive effects on practically defined off-medication motor scores in Parkinson's disease, which were sustained beyond the period of exposure. Whether exenatide affects the underlying disease pathophysiology or simply induces long-lasting symptomatic effects is uncertain. Exenatide represents a major new avenue for investigation in Parkinson's disease, and effects on everyday symptoms should be examined in longer-term trials. Funding Michael J Fox Foundation for Parkinson's Research.	[Athauda, Dilan; Aviles-Olmos, Iciar; Limousin, Patricia; Lees, Andrew J.; Foltynie, Thomas] UCL, Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England; [Athauda, Dilan; Aviles-Olmos, Iciar; Limousin, Patricia; Lees, Andrew J.; Foltynie, Thomas] Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England; [Maclagan, Kate; Skene, Simon S.; Bajwa-Joseph, Martha; Letchford, Dawn; Chowdhury, Kashfia; Hibbert, Steve; Tebbs, Susan] UCL, Comprehens Clin Trials Unit, London, England; [Budnik, Natalia; Zampedri, Luca] Leonard Wolfson Expt Neurosci Ctr, London, England; [Dickson, John] Univ Coll London Hosp NHS Trust, Inst Nucl Med, London, England; [Li, Yazhou; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Warner, Thomas T.] Queen Sq Brain Bank, London, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London	Foltynie, T (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.; Foltynie, T (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	t.foltynie@ucl.ac.uk	Skene, Simon S/L-6239-2015; Warner, Thomas T/A-1454-2013; AVILES-OLMOS, ICIAR/AAG-5965-2019; Lees, Andrew J/A-6605-2009; Dickson, John/AAA-5261-2021; AVILES-OLMOS, ICIAR/E-3065-2018	Skene, Simon S/0000-0002-7828-3122; Warner, Thomas T/0000-0001-6195-6995; AVILES-OLMOS, ICIAR/0000-0002-1645-7406; Lees, Andrew J/0000-0002-2476-4385; Dickson, John/0000-0002-1793-3822; AVILES-OLMOS, ICIAR/0000-0002-1645-7406; Maclagan, Kate/0000-0003-0686-3053	Michael J Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [ZIAAG000333] Funding Source: NIH RePORTER	Michael J Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michael J Fox Foundation for Parkinson's Research.	Abuirmeileh A, 2012, J PHARM PHARMACOL, V64, P637, DOI 10.1111/j.2042-7158.2011.01394.x; Athauda D, 2016, PROG NEUROBIOL, V145, P98, DOI 10.1016/j.pneurobio.2016.10.001; Athauda D, 2016, PARKINSONISM RELAT D, V32, P1, DOI 10.1016/j.parkreldis.2016.07.019; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Azoulay L, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i581; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chen YM, 2015, EUR J PHARMACOL, V768, P21, DOI 10.1016/j.ejphar.2015.09.029; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; ENG J, 1992, J BIOL CHEM, V267, P7402; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Kang MY, 2015, ENDOCRINOL METAB, V30, P216, DOI 10.3803/EnM.2015.30.2.216; Kas A, 2007, J NUCL MED, V48, P1459, DOI 10.2967/jnumed.106.038646; Kieburtz K, 2015, MOVEMENT DISORD, V30, P1580, DOI 10.1002/mds.26371; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liu W, 2015, NEUROSCIENCE, V303, P42, DOI 10.1016/j.neuroscience.2015.06.054; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; MacConell L, 2015, DIABETES METAB SYNDR, V8, P241, DOI 10.2147/DMSO.S77290; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Pirker W, 2002, MOVEMENT DISORD, V17, P45, DOI 10.1002/mds.1265; Rampersaud N, 2012, NEUROPEPTIDES, V46, P183, DOI 10.1016/j.npep.2012.07.004; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; WARD CD, 1994, J NEUROL NEUROSUR PS, V57, P217, DOI 10.1136/jnnp.57.2.217; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609	36	377	384	4	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1664	1675		10.1016/S0140-6736(17)31585-4	http://dx.doi.org/10.1016/S0140-6736(17)31585-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI9TS	28781108	Green Accepted, Green Submitted			2022-12-28	WOS:000412352800026
J	Lipner, RS; Brossman, BG; Samonte, KM; Durning, SJ				Lipner, Rebecca S.; Brossman, Bradley G.; Samonte, Kelli M.; Durning, Steven J.			Effect of Access to an Electronic Medical Resource on Performance Characteristics of a Certification Examination A Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ITEM RESPONSE THEORY; EDUCATION; MAINTENANCE; ASSESSMENTS	Background: Electronic resources are increasingly used in medical practice. Their use during high-stakes certification examinations has been advocated by many experts, but whether doing so would affect the capacity to differentiate between high and low abilities is unknown. Objective: To determine the effect of electronic resources on examination performance characteristics. Design: Randomized controlled trial. Setting: Medical certification program. Participants: 825 physicians initially certified by the American Board of Internal Medicine (ABIM) who passed the Internal Medicine Certification examination or sat for the Internal Medicine Maintenance of Certification (IM-MOC) examination in 2012 to 2015. Intervention: Participants were randomly assigned to 1 of 4 conditions: closed book using typical or additional time, or open book (that is, UpToDate [Wolters Kluwer]) using typical or additional time. All participants took the same modified version of the IM-MOC examination. Measurements: Primary outcomes included item difficulty (how easy or difficult the question was), item discrimination (how well the question differentiated between high and low abilities), and average question response time. Secondary outcomes included examination dimensionality (that is, the number of factors measured) and test-taking strategy. Item response theory was used to calculate question characteristics. Analysis of variance compared differences among conditions. Results: Closed-book conditions took significantly less time than open-book conditions (mean, 79.2 seconds [95% CI, 78.5 to 79.9 seconds] vs. 110.3 seconds [CI, 109.2 to 111.4 seconds] per question). Mean discrimination was statistically significantly higher for open-book conditions (0.34 [CI, 0.32 to 0.35] vs. 0.39 [CI, 0.37 to 0.41] per question). A strong single dimension showed that the examination measured the same factor with or without the resource. Limitation: Only 1 electronic resource was evaluated. Conclusion: Inclusion of an electronic resource with time constraints did not adversely affect test performance and did not change the specific skill or factor targeted by the examination. Further study on the effect of resource inclusion on other examinations is warranted.	[Lipner, Rebecca S.; Brossman, Bradley G.; Samonte, Kelli M.] Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA; [Durning, Steven J.] Uniformed Serv Univ Hlth Sci, Div Hlth Profess Educ MED, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	American Board of Internal Medicine; Uniformed Services University of the Health Sciences - USA	Lipner, RS (corresponding author), Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.	rlipner@abim.org			ABIM Foundation	ABIM Foundation	ABIM Foundation.	American Board of Internal Medicine, 2017, INT MED CERT BLUEPR; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Centor RM, 2014, ANN INTERN MED, V161, P226, DOI 10.7326/M14-1014; Clarke MA, 2013, HEALTH INFO LIBR J, V30, P178, DOI 10.1111/hir.12036; Clauser B.E., 1998, EDUC MEAS-ISSUES PRA, V17, P31, DOI [10.1111/j.1745-3992.1998.tb00619.x, DOI 10.1111/J.1745-3992.1998.TB00619.X]; De Champlain AF, 2010, MED EDUC, V44, P109, DOI 10.1111/j.1365-2923.2009.03425.x; Downing SM, 2003, MED EDUC, V37, P739, DOI 10.1046/j.1365-2923.2003.01587.x; Durning SJ, 2016, ACAD MED, V91, P583, DOI 10.1097/ACM.0000000000000977; Epocrates, 2014, 2014 EP MOB TRENDS R; Hussey PS, 2015, JAMA-J AM MED ASSOC, V313, P2181, DOI 10.1001/jama.2015.5089; Jodoin MG, 2001, APPL MEAS EDUC, V14, P329, DOI 10.1207/S15324818AME1404_2; Kantar Media, 2015, OFTEN DOCTORS CONSUL; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lipner RS, 2010, JAMA-J AM MED ASSOC, V304, P1379, DOI 10.1001/jama.2010.1378; Lipner RS, 2015, ATP INN TEST C PALM; Middleton B, 2016, Yearb Med Inform, VSuppl 1, pS103, DOI 10.15265/IYS-2016-s034; Reed DA, 2012, J GEN INTERN MED, V27, P917, DOI 10.1007/s11606-012-2017-5; Sireci SG, 1992, AM PSYCH ASS 1992 AN; UpToDate, 2017, EV BAS CLIN SUPP POI	19	7	7	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					302	+		10.7326/M16-2843	http://dx.doi.org/10.7326/M16-2843			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28806791				2022-12-28	WOS:000409120400004
J	Pronovost, PJ; Wu, AW; Austin, JM				Pronovost, Peter J.; Wu, Albert W.; Austin, J. Matthew			Time for Transparent Standards in Quality Reporting by Health Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SAFETY		[Pronovost, Peter J.] Johns Hopkins Med, Patient Safety & Qual, Baltimore, MD 21202 USA; [Pronovost, Peter J.; Austin, J. Matthew] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA; [Wu, Albert W.] Johns Hopkins Univ, Hlth Policy & Management, Ctr Hlth Serv & Outcomes Res, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Austin, J. Matthew] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Austin, JM (corresponding author), Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA.	jmaustin@jhmi.edu	Wu, Albert/AAJ-4780-2021		Patient-Centered Outcomes Research Institute; Agency for Healthcare Research and Quality; Greenwall Foundation; American International Group; Gilead; Leapfrog	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Foundation; American International Group; Gilead(Gilead Sciences); Leapfrog	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wu reported that he has received grants from Patient-Centered Outcomes Research Institute, the Agency for Healthcare Research and Quality, Greenwall Foundation, and American International Group and personal fees from Gilead. Dr Austin reported that he has received grants from the Agency for Healthcare Research and Quality and Leapfrog. No other disclosures were reported.	Austin JM, 2016, JAMA-J AM MED ASSOC, V316, P1661, DOI 10.1001/jama.2016.14039; Austin JM, 2014, J PATIENT SAF, V10, P64, DOI 10.1097/PTS.0b013e3182952644; Dzau VJ, 2016, JAMA-J AM MED ASSOC, V316, P711, DOI 10.1001/jama.2016.10692; Jha AK, 2016, JAMA-J AM MED ASSOC, V315, P2265, DOI 10.1001/jama.2016.5638; Mitchell E, 2016, AM J MANAG CARE, V22, pS342; Pronovost PJ, 2007, JAMA-J AM MED ASSOC, V298, P1800, DOI 10.1001/jama.298.15.1800	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					701	702		10.1001/jama.2017.10124	http://dx.doi.org/10.1001/jama.2017.10124			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28783820				2022-12-28	WOS:000408095800016
J	McCall, C				McCall, Chris			The cost of complacency-black lung in Australia	LANCET			English	Editorial Material																			0	3	3	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					727	729		10.1016/S0140-6736(17)32237-7	http://dx.doi.org/10.1016/S0140-6736(17)32237-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28831984				2022-12-28	WOS:000407858900009
J	Zhao, F; Franco, HL; Rodriguez, KF; Brown, PR; Tsai, MJ; Tsai, SY; Yao, HHC				Zhao, Fei; Franco, Heather L.; Rodriguez, Karina F.; Brown, Paula R.; Tsai, Ming-Jer; Tsai, Sophia Y.; Yao, Humphrey H. -C.			Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice	SCIENCE			English	Article							MESENCHYMAL EPITHELIAL INTERACTIONS; WOLFFIAN DUCT DEVELOPMENT; PROSTATE-CANCER; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION	The sexual differentiation paradigm contends that the female pattern of the reproductive system is established by default because the male reproductive tracts (Wolffian ducts) in the female degenerate owing to a lack of androgen. Here, we discovered that female mouse embryos lacking Coup-tfII (chicken ovalbumin upstream promoter transcription factor II) in the Wolffian duct mesenchyme became intersex-possessing both female and male reproductive tracts. Retention of Wolffian ducts was not caused by ectopic androgen production or action. Instead, enhanced phosphorylated extracellular signal-regulated kinase signaling in Wolffian duct epithelium was responsible for the retention of male structures in an androgen-independent manner. We thus suggest that elimination of Wolffian ducts in female embryos is actively promoted by COUP-TFII, which suppresses a mesenchyme-epithelium cross-talk responsible for Wolffian duct maintenance.	[Zhao, Fei; Franco, Heather L.; Rodriguez, Karina F.; Brown, Paula R.; Yao, Humphrey H. -C.] NIEHS, Reprod Dev Biol Grp, POB 12233, Res Triangle Pk, NC 27709 USA; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Yao, HHC (corresponding author), NIEHS, Reprod Dev Biol Grp, POB 12233, Res Triangle Pk, NC 27709 USA.	humphrey.yao@nih.gov	Yao, Hung-Chang Humphrey/B-4795-2010	Yao, Hung-Chang Humphrey/0000-0003-2944-8469; Rodriguez, Karina/0000-0002-8465-1972; Zhao, Fei/0000-0002-0958-3981	NIH [Z01-ES102965, DK59820, HL114539, DK45641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114539, R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045641, P01DK059820, R01DK045641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank B. Mclntyre, L. Roberts, and D. McClain for AGD measurement instruction, Wolffian duct culture instruction, and colony maintenance, respectively. This research was supported by the NIH Intramural Research Fund Z01-ES102965 to H.H.-C.Y., extramural research fund DK59820 and HL114539 to S.Y.T. and M.-J.T., and DK45641 to M.-J.T. Microarray data have been deposited in Gene Expression Omnibus under accession no. GSE100015.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; CUNHA GR, 1992, J ANDROL, V13, P465; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; GUPTA C, 1991, DEV BIOL, V146, P106, DOI 10.1016/0012-1606(91)90451-8; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; HIGGINS SJ, 1989, DEVELOPMENT, V106, P235; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; JOST A, 1953, RECENT PROG HORM RES, V8, P379; JOST A, 1947, ARCH ANAT MICROSC MO, V36, P244; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Liu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7934; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; Mostaghel EA, 2010, CANCER RES, V70, P1286, DOI 10.1158/0008-5472.CAN-09-2509; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Okazawa M, 2015, DEV BIOL, V400, P139, DOI 10.1016/j.ydbio.2015.01.023; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Renfree MB, 2009, DEV BIOL, V334, P429, DOI 10.1016/j.ydbio.2009.07.040; Snyder EM, 2009, BIOL REPROD, V81, P707, DOI 10.1095/biolreprod.109.079053; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Welsh M, 2006, ENDOCRINOLOGY, V147, P4820, DOI 10.1210/en.2006-0149	23	46	46	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					717	+		10.1126/science.aai9136	http://dx.doi.org/10.1126/science.aai9136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818950	Green Accepted			2022-12-28	WOS:000407793600042
J	Bilham, R				Bilham, Roger			Quake news from America	NATURE			English	Editorial Material									[Bilham, Roger] Univ Colorado Boulder, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bilham, R (corresponding author), Univ Colorado Boulder, Boulder, CO 80309 USA.	roger.bilham@colorado.edu							0	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					278	280		10.1038/548278a	http://dx.doi.org/10.1038/548278a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28816247	Bronze			2022-12-28	WOS:000407748400012
J	Wenzel, RP				Wenzel, Richard P.			Medical Education in the Era of Alternative Facts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wenzel, Richard P.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Wenzel, RP (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA.							Benston K., 2017, HAVERFORD MAGAZINE, P5; Brecht B., LIFE GALILEO SCENE 9; Edmond Michael B, 2010, Ann Intern Med, V153, P845, DOI 10.7326/0003-4819-153-12-201012210-00288; Hartzband P, 2016, NEW ENGL J MED, V374, P106, DOI 10.1056/NEJMp1512402; Wenzel RP, 2015, INFECTION, V43, P141, DOI 10.1007/s15010-015-0744-3	5	12	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					607	609		10.1056/NEJMp1706528	http://dx.doi.org/10.1056/NEJMp1706528			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813227				2022-12-28	WOS:000407691400002
J	Wade, L				Wade, Lizzie			ON THE TRAIL OF ANCIENT MARINERS	SCIENCE			English	Editorial Material																			0	7	8	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					542	545		10.1126/science.357.6351.542	http://dx.doi.org/10.1126/science.357.6351.542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FD1VM	28798114				2022-12-28	WOS:000407324800021
J	Bertram, K; Agafonov, DE; Dybkov, O; Haselbach, D; Leelaram, MN; Will, CL; Urlaub, H; Kastner, B; Luhrmann, R; Stark, H				Bertram, Karl; Agafonov, Dmitry E.; Dybkov, Olexandr; Haselbach, David; Leelaram, Majety N.; Will, Cindy L.; Urlaub, Henning; Kastner, Berthold; Luehrmann, Reinhard; Stark, Holger			Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation	CELL			English	Article							U4/U6.U5 TRI-SNRNP; CRYSTAL-STRUCTURE; MOLECULAR ARCHITECTURE; PROTEIN; SITE; U4; BINDING; STEP; COMPLEX; DOMAIN	Little is known about the spliceosome's structure before its extensive remodeling into a catalytically active complex. Here, we report a 3D cryo-EM structure of a pre-catalytic human spliceosomal B complex. The U2 snRNP-containing head domain is connected to the B complex main body via three main bridges. U4/U6. U5 tri-snRNP proteins, which are located in the main body, undergo significant rearrangements during tri-snRNP integration into the B complex. These include formation of a partially closed Prp8 conformation that creates, together with Dim1, a 5' splice site (ss) binding pocket, displacement of Sad1, and rearrangement of Brr2 such that it contacts its U4/U6 substrate and is poised for the subsequent spliceosome activation step. The molecular organization of several B-specific proteins suggests that they are involved in negatively regulating Brr2, positioning the U6/5'ss helix, and stabilizing the B complex structure. Our results indicate significant differences between the early activation phase of human and yeast spliceosomes.	[Bertram, Karl; Haselbach, David; Stark, Holger] MPI Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany; [Agafonov, Dmitry E.; Dybkov, Olexandr; Leelaram, Majety N.; Will, Cindy L.; Kastner, Berthold; Luehrmann, Reinhard] MPI Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany; [Urlaub, Henning] MPI Biophys Chem, Bioanalyt Mass Spectrometry, Fassberg 11, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Bioanalyt Grp, Inst Clin Chem, Robert Koch Str 40, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen	Stark, H (corresponding author), MPI Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany.; Kastner, B; Luhrmann, R (corresponding author), MPI Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	b.kastner@mpibpc.mpg.de; reinhard.luehrmann@mpibpc.mpg.de; hstark1@gwdg.de		Haselbach, David/0000-0002-5276-5633; Bertram, Karl/0000-0003-1528-9911; Majety, Naga Leelaram/0000-0003-2884-4654	Alexander von Humboldt Stiftung; Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 860, LU294/15-1]	Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Conrad for HeLa cell production in a bioreactor; H. Kohansal for preparing HeLa cell nuclear extract; U. Steuerwald, W. Lendeckel, M. Raabe, and U. Plessmann for excellent technical assistance; and K. Hartmuth for advice and discussions. Majety N. Leelaram was supported by a fellowship from the Alexander von Humboldt Stiftung. This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (grants SFB 860 to R.L., H.S., and H.U. and LU294/15-1 to R.L.)	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; Boesler C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11997; Boesler C, 2015, RNA, V21, P1993, DOI 10.1261/rna.053991.115; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Huang YH, 2014, MOL CELL BIOL, V34, P210, DOI 10.1128/MCB.00837-13; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; Liu SB, 2011, RNA, V17, P1655, DOI 10.1261/rna.2690611; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Reyes JL, 1999, RNA, V5, P167, DOI 10.1017/S1355838299981785; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Schellenberg MJ, 2013, NAT STRUCT MOL BIOL, V20, P728, DOI 10.1038/nsmb.2556; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Schutze T, 2016, RNA, V22, P265, DOI 10.1261/rna.054296.115; Sidarovich A, 2017, ELIFE, V6, DOI 10.7554/eLife.23533; Singer A, 2010, J STRUCT BIOL, V169, P312, DOI 10.1016/j.jsb.2009.11.003; Spartz AK, 2004, MOL CELL BIOL, V24, P6811, DOI 10.1128/MCB.24.15.6811-6823.2004; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Ulrich AKC, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0923-1; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; Ulrich AKC, 2016, STRUCTURE, V24, P762, DOI 10.1016/j.str.2016.03.016; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	62	136	145	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					701	+		10.1016/j.cell.2017.07.011	http://dx.doi.org/10.1016/j.cell.2017.07.011			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28781166	Bronze			2022-12-28	WOS:000407445700011
J	Swarts, K; Gutaker, RM; Benz, B; Blake, M; Bukowski, R; Holland, J; Kruse-Peeples, M; Lepak, N; Prim, L; Romay, MC; Ross-Ibarra, J; Sanchez-Gonzalez, JD; Schmidt, C; Schuenemann, VJ; Krause, J; Matson, RG; Weigel, D; Buckler, ES; Burbano, HA				Swarts, Kelly; Gutaker, Rafal M.; Benz, Bruce; Blake, Michael; Bukowski, Robert; Holland, James; Kruse-Peeples, Melissa; Lepak, Nicholas; Prim, Lynda; Romay, M. Cinta; Ross-Ibarra, Jeffrey; de Jesus Sanchez-Gonzalez, Jose; Schmidt, Chris; Schuenemann, Verena J.; Krause, Johannes; Matson, R. G.; Weigel, Detlef; Buckler, Edward S.; Burbano, Hernan A.			Genomic estimation of complex traits reveals ancient maize adaptation to temperate North America	SCIENCE			English	Article							FLOWERING-TIME; DOMESTICATION; ORIGIN; CORN	By 4000 years ago, people had introduced maize to the southwestern United States; full agriculture was established quickly in the lowland deserts but delayed in the temperate highlands for 2000 years. We test if the earliest uplandmaize was adapted for early flowering, a characteristic of modern temperate maize. We sequenced fifteen 1900-year-old maize cobs from Turkey Pen Shelter in the temperate Southwest. Indirectly validated genomic models predicted that Turkey Pen maize was marginally adapted with respect to flowering, as well as short, tillering, and segregating for yellow kernel color. Temperate adaptation drove modern population differentiation and was selected in situ from ancient standing variation. Validated prediction of polygenic traits improves our understanding of ancient phenotypes and the dynamics of environmental adaptation.	[Swarts, Kelly; Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, 175 Biotechnology Bldg, Ithaca, NY 14853 USA; [Swarts, Kelly; Gutaker, Rafal M.; Burbano, Hernan A.] Max Planck Inst Dev Biol, Dept Mol Biol, Res Grp Ancient Genom & Evolut, Spemannstr. 35, D-72076 Tubingen, Germany; [Benz, Bruce] Texas Wesleyan Univ, Dept Biol, Schollmaier Sci & Technol Ctr, Room 109, Ft Worth, TX 76105 USA; [Blake, Michael; Matson, R. G.] Univ British Columbia, Dept Anthropol, 6303 Northwest Marine Dr, Vancouver, BC V6T IZ1, Canada; [Bukowski, Robert] Cornell Univ, Bioinformat Facil, Inst Biotechnol, Ithaca, NY 14853 USA; [Holland, James] USDA ARS, POB 7620, Raleigh, NC 27695 USA; [Holland, James] North Carolina State Univ, Dept Crop & Soil Sci, POB 7620, Raleigh, NC 27695 USA; [Kruse-Peeples, Melissa; Prim, Lynda; Schmidt, Chris] Nat Seeds SEARCH, 3584 East River Rd, Tucson, AZ 85718 USA; [Lepak, Nicholas; Buckler, Edward S.] Cornell Univ, USDA ARS, Biotechnol Bldg, Ithaca, NY 14853 USA; [Romay, M. Cinta] Cornell Univ, Inst Biotechnol 175, Gen Div Facil, Ithaca, NY 14853 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Dept Plant Sci, 1 Shields Ave, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [de Jesus Sanchez-Gonzalez, Jose] Univ Guadalajara, Ctr Univ Ciencias Biol & Agropecuarias, Zapopan CP45110, Jalisco, Mexico; [Schuenemann, Verena J.; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72076 Tubingen, Germany; [Schuenemann, Verena J.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, D-72076 Tubingen, Germany; [Krause, Johannes] Max Planck Inst Sci Human Hist, Dept Archaeogenet, Kahlaische Str 10, D-07745 Jena, Germany; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Cornell University; Max Planck Society; University of British Columbia; Cornell University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Cornell University; United States Department of Agriculture (USDA); Cornell University; University of California System; University of California Davis; University of California System; University of California Davis; Universidad de Guadalajara; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society	Swarts, K (corresponding author), Cornell Univ, Dept Plant Breeding & Genet, 175 Biotechnology Bldg, Ithaca, NY 14853 USA.; Swarts, K; Burbano, HA (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Res Grp Ancient Genom & Evolut, Spemannstr. 35, D-72076 Tubingen, Germany.	kelly.swarts@tuebingen.mpg.de; hernan.burbano@tuebingen.mpg.de	Romay, Cinta/ABE-8340-2020; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Ross-Ibarra, Jeffrey/D-7782-2011; Krause, Johannes/AFP-2642-2022; Weigel, Detlef/GSJ-0799-2022	Romay, Cinta/0000-0001-9309-1586; Buckler, Edward/0000-0002-3100-371X; Weigel, Detlef/0000-0002-2114-7963; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Krause, Johannes/0000-0001-9144-3920; Weigel, Detlef/0000-0002-2114-7963; Lepak, Nick/0000-0003-2653-6367; Blake, Michael/0000-0001-6292-0927; Holland, James/0000-0002-4341-9675; Swarts, Kelly/0000-0002-0578-7426; SANCHEZ-GONZALEZ, JOSE DE JESUS/0000-0002-1611-3603; Gutaker, Rafal/0000-0001-9226-879X	NSF [0922493, 1238014, GS33413X, GS-33413X]; USDA-ARS; Max Planck Society; Direct For Biological Sciences [1238014] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Max Planck Society(Max Planck SocietyFoundation CELLEX); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by NSF grants 0922493 (E.S.B.), 1238014 (E.S.B.), and GS33413X (R.G.M.); USDA-ARS (E.S.B.); and the Max Planck Society (D.W., J.K., and H.A.B.) and its Presidential Innovation Fund (H.A.B.). The corncobs excavated from the Turkey Pen site (42Sa3714) that yielded the DNA were excavated in August 1972 from federal lands in Utah (administered by the Bureau of Land Management) as part of the Cedar Mesa Archaeological Project, codirected by W. D. Lipe and R. G. Matson, funded by NSF grant GS-33413X to the Museum of Northern Arizona, and under Antiquities Act permit 72-AZ-040. The authors declare no conflicts of interest. The authors thank Native Seeds/SEARCH for the southwestern landrace germ plasm and hybrid experiment, especially E. Sofro and the interns at the farm in Patagonia, Arizona, in 2013, and D. Johnson, M. Franz, T. Gerckens, and F. Claverie. C. Urban prepped uracil glycosylase libraries and L. Morales, C. Hulbert, A. Stanley, K. C. Randall, R. Antone, and C. Honahnie helped phenotype the landrace hybrid panel in 2015. We thank J. Wallace for contributing genotyping-by-sequencing data for the Northern Flint landraces. We also thank C. Aquadro, J.-L. Jannink, W. D. Lipe, L. Morales, P. Lang, and M. Exposito-Alonso for reading early versions of the manuscript; K. Pruefer, R. da Fonseca, T. Lamnidis, and S. Schiffels for input on population genetic analyses; and T. Gilbert and N. Wales for early access to Tehuacan sequencing data. K.S., H.A.B., D.W., and E.S.B. conceived and designed the study. K.S. designed and led the landrace hybrid experiment with statistical input from J.H., which was managed by N. L. in New York, J.H. in North Carolina, and L. P. in Arizona. B.B., M.B., and R.G.M. contributed the Turkey Pen samples and archaeological analyses from the Turkey Pen site; V.J.S., J.K., and H.A.B. coordinated the molecular work with archaeological samples; V.J.S. carried out the molecular work with archaeological samples; J.R.-I., J.S., and M.C.R. contributed the Pan-American, teosinte, and Ames Inbred Diversity data sets, respectively; C.S. and M.K.-P. contributed the southwestern panel from the Native Seeds/SEARCH core collection; K.S., R.M.G., R.B., and H.A.B. preprocessed ancient and modern sequencing reads; R.B. performed SNP calling and K.S. filtered final data sets; K.S. led and carried out the quantitative genetics analyses with input from E.S.B. and J.H.; K.S. and R.M.G. carried out the population genetics analyses with input from E.S.B. and H.A.B.; J.R.-I., M.C.R., and D.W. contributed to the interpretation of the data; K.S. led the writing of the manuscript together with R.M.G., E.S.B., and H.A.B. All authors read and approved the manuscript. Sequencing data generated in this study are available in the European Nucleotide Archive (ENA) under accession number PRJEB20529 and the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) under accession number PRJNA386191.	Anderson E., 1942, ANN MISSOURI BOT GARD, V29, P69, DOI 10.2307/2394331; [Anonymous], 2006, HIST MAIZE MULTIDISC; [Anonymous], 1991, ORIGINS SW AGR; Bellorado BA, 2013, KIVA, V78, P377, DOI 10.1179/0023194013Z.0000000007; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Bukowski R., 2016, BIORXIV         0916; Cordell L., 2012, ARCHAEOLOGY SW; da Fonseca RR, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.3, 10.1038/NPLANTS.2014.3]; DOEBLEY J, 1988, ECON BOT, V42, P120, DOI 10.1007/BF02859042; DOEBLEY JF, 1983, MAYDICA, V28, P97; DOEBLEY JF, 1986, AM J BOT, V73, P64, DOI 10.2307/2444278; Ford R. I., 1980, DISCOVERY, P17; GALINAT WALTON C., 1963, BOT MUS LEAFL HARVARD UNIV, V20, P117; Gregory D.A., 2007, EXCAVATIONS SANTA CR; Huber E. K., 2005, FENCE LAKE PROJECT A; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Lipe WD, 2016, AM ANTIQUITY, V81, P97, DOI 10.7183/0002-7316.81.1.97; Marlay S., 2011, EXTERNAL PUBLICATION; Navarro JAR, 2017, NAT GENET, V49, P476, DOI 10.1038/ng.3784; Ramos-Madrigal J, 2016, CURR BIOL, V26, P3195, DOI 10.1016/j.cub.2016.09.036; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Troyer AF, 2007, CROP SCI, V47, P905, DOI 10.2135/cropsci2006.10.0651; Utah State University Extension, FAQ DO YOU HAV INF A; Vierra Bradley J., 2005, LATE ARCHAIC BORDERL; Wills W. H., 1988, EARLY PREHISTORIC AG	28	85	88	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					512	515		10.1126/science.aam9425	http://dx.doi.org/10.1126/science.aam9425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774930				2022-12-28	WOS:000406840100040
J	Poewe, W; Seppi, K				Poewe, Werner; Seppi, Klaus			Insulin signalling: new target for Parkinson's treatments?	LANCET			English	Editorial Material							EXENATIDE; DISEASE		[Poewe, Werner] Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Poewe, W (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	werner.poewe@i-med.ac.at		Seppi, Klaus/0000-0001-6503-1455	AbbVie; AstraZeneca; BIAL; Biogen; Cynapsus; Britannia; Grunenthal; Intec; Ipsen; Lundbeck; Merz; Novartis; Neuroderm; Orion; Prexton; Teva; UCB; Zambon; Austrian Science Fund (FWF); Michael J Fox Foundation; International Parkinson and Movement Disorder Society; AOP Orphan Pharmaceuticals; Roche	AbbVie(AbbVie); AstraZeneca(AstraZeneca); BIAL(Bial Group); Biogen(Biogen); Cynapsus; Britannia; Grunenthal(HAL Allergy Group); Intec(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ipsen(Ipsen); Lundbeck(Lundbeck Corporation); Merz; Novartis(Novartis); Neuroderm; Orion; Prexton; Teva(Teva Pharmaceutical Industries); UCB(UCB Pharma SA); Zambon; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Michael J Fox Foundation; International Parkinson and Movement Disorder Society; AOP Orphan Pharmaceuticals; Roche(Roche Holding)	WP reports personal, consultancy, and lecture fees in relation to clinical drug programmes for Parkinson's disease from AbbVie, AstraZeneca, BIAL, Biogen, Cynapsus, Britannia, Grunenthal, Intec, Ipsen, Lundbeck, Merz, Novartis, Neuroderm, Orion, Prexton, Teva, UCB, and Zambon. KS reports grants from Austrian Science Fund (FWF), the Michael J Fox Foundation, and the International Parkinson and Movement Disorder Society, lecture fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals, and AbbVie, and consultancy fees from AbbVie and Roche.	Athauda D, 2016, PROG NEUROBIOL, V145, P98, DOI 10.1016/j.pneurobio.2016.10.001; Athauda D., 2017, LANCET; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Calsolaro V, 2015, CNS DRUGS, V29, P1023, DOI 10.1007/s40263-015-0301-8; de la Monte SM, 2017, DRUGS, V77, P47, DOI 10.1007/s40265-016-0674-0; Hughes R, 2016, FRONTIER NEUROSCI, V25, P177; Kim DS, 2017, CELL TRANSPLANT, DOI [10.3727/096368917X695669, DOI 10.3727/096368917X695669]; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; MacConell L, 2015, DIABETES METAB SYNDR, V8, P241, DOI 10.2147/DMSO.S77290; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Reddy IA, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.86	11	3	3	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1628	1630		10.1016/S0140-6736(17)32101-3	http://dx.doi.org/10.1016/S0140-6736(17)32101-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI9TS	28781109				2022-12-28	WOS:000412352800007
J	Brocks, JJ; Jarrett, AJM; Sirantoine, E; Hallmann, C; Hoshino, Y; Liyanage, T				Brocks, Jochen J.; Jarrett, Amber J. M.; Sirantoine, Eva; Hallmann, Christian; Hoshino, Yosuke; Liyanage, Tharika			The rise of algae in Cryogenian oceans and the emergence of animals	NATURE			English	Article							NEOPROTEROZOIC SNOWBALL EARTH; HYDROCARBON BIOMARKERS; ATMOSPHERIC OXYGEN; EVOLUTION; RECORD; CONTAMINANTS; APPEARANCE; SYNGENEITY; PROTISTS; EVENTS	The transition from dominant bacterial to eukaryotic marine primary productivity was one of the most profound ecological revolutions in the Earth's history, reorganizing the distribution of carbon and nutrients in the water column and increasing energy flow to higher trophic levels. But the causes and geological timing of this transition, as well as possible links with rising atmospheric oxygen levels(1) and the evolution of animals(2), remain obscure. Here we present a molecular fossil record of eukaryotic steroids demonstrating that bacteria were the only notable primary producers in the oceans before the Cryogenian period (720-635 million years ago). Increasing steroid diversity and abundance marks the rapid rise of marine planktonic algae (Archaeplastida) in the narrow time interval between the Sturtian and Marinoan 'snowball Earth' glaciations, 659-645 million years ago. We propose that the incumbency of cyanobacteria was broken by a surge of nutrients supplied by the Sturtian deglaciation(3). The 'Rise of Algae' created food webs with more efficient nutrient and energy transfers(4), driving ecosystems towards larger and increasingly complex organisms. This effect is recorded by the concomitant appearance of biomarkers for sponges(5) and predatory rhizarians, and the subsequent radiation of eumetazoans in the Ediacaran period(2).	[Brocks, Jochen J.; Jarrett, Amber J. M.; Sirantoine, Eva; Liyanage, Tharika] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Hallmann, Christian; Hoshino, Yosuke] Max Planck Inst Biogeochem, Hans Knoell Str 10, D-07745 Jena, Germany; [Hallmann, Christian] Univ Bremen, MARUM Ctr Marine Environm Sci, Leobener Str 8, D-28359 Bremen, Germany; [Hoshino, Yosuke] Georgia Inst Technol, Sch Biol Sci, 310 Ferst Dr NW, Atlanta, GA 30322 USA	Australian National University; Max Planck Society; University of Bremen; University System of Georgia; Georgia Institute of Technology	Brocks, JJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia.	jochen.brocks@anu.edu.au	Brocks, Jochen/E-3920-2012	Brocks, Jochen/0000-0002-8430-8744; Hoshino, Yosuke/0000-0002-6335-1815; Sirantoine, Eva/0000-0003-2394-9342; Hallmann, Christian/0000-0003-3696-7371	Australian Research Council (ARC) [DP0557499, DP1095247, DP160100607, DP170100556]	Australian Research Council (ARC)(Australian Research Council)	Funding support for this work came from Australian Research Council (ARC) grants DP0557499, DP1095247, DP160100607 and DP170100556. We thank the Geological Survey of Western Australia (GSWA), the Northern Territory Geological Survey (NTGS), and S. Porter and M. Moczydlowska for access to samples. J. M. Hope provided technical assistance, including the maintenance of mass spectrometers at The Australian National University.	Aguilera Angeles, 2013, Life-Basel, V3, P363, DOI 10.3390/life3030363; Brocks JJ, 2016, GEOBIOLOGY, V14, P129, DOI 10.1111/gbi.12165; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P871, DOI 10.1016/j.gca.2007.11.028; Brocks JJ, 2014, J CHROMATOGR SCI, V52, P471, DOI 10.1093/chromsci/bmt068; Brocks JJ, 2011, GEOCHIM COSMOCHIM AC, V75, P3196, DOI 10.1016/j.gca.2011.03.014; Butterfield NJ, 2015, PALAEONTOLOGY, V58, P953, DOI 10.1111/pala.12211; Butterfield NJ, 2009, GEOL SOC SPEC PUBL, V326, P55, DOI 10.1144/SP326.3; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Cohen PA, 2015, PALEOBIOLOGY, V41, P610, DOI 10.1017/pab.2015.25; Cox GM, 2016, EARTH PLANET SC LETT, V446, P89, DOI 10.1016/j.epsl.2016.04.016; Derry LA, 2015, GEOPHYS RES LETT, V42, P8538, DOI 10.1002/2015GL065333; French KL, 2015, P NATL ACAD SCI USA, V112, P5915, DOI 10.1073/pnas.1419563112; Grabenstatter J, 2013, ORG GEOCHEM, V63, P145, DOI 10.1016/j.orggeochem.2013.08.010; GRANTHAM PJ, 1988, ORG GEOCHEM, V12, P61, DOI 10.1016/0146-6380(88)90115-5; Grosjean E, 2009, ORG GEOCHEM, V40, P87, DOI 10.1016/j.orggeochem.2008.09.011; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jarrett AJM, 2013, ORG GEOCHEM, V61, P57, DOI 10.1016/j.orggeochem.2013.06.005; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll Andrew H., 2007, P133; Knoll AH, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1755; Kodner RB, 2008, GEOBIOLOGY, V6, P411, DOI 10.1111/j.1472-4669.2008.00167.x; Krissansen-Totton J, 2015, AM J SCI, V315, P275, DOI 10.2475/04.2015.01; Laakso TA, 2014, EARTH PLANET SC LETT, V388, P81, DOI 10.1016/j.epsl.2013.11.049; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Mills B, 2011, NAT GEOSCI, V4, P861, DOI [10.1038/NGEO1305, 10.1038/ngeo1305]; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Pu JP, 2016, GEOLOGY, V44, P955, DOI 10.1130/G38284.1; Reinhard CT, 2017, NATURE, V541, P386, DOI 10.1038/nature20772; Riedman LA, 2014, GEOLOGY, V42, P1011, DOI 10.1130/G35901.1; Sahoo SK, 2016, GEOBIOLOGY, V14, P457, DOI 10.1111/gbi.12182; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; Schinteie R, 2014, ORG GEOCHEM, V72, P46, DOI 10.1016/j.orggeochem.2014.04.009; Schwark L, 2006, PALAEOGEOGR PALAEOCL, V240, P225, DOI 10.1016/j.palaeo.2006.03.050; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P2625, DOI 10.1016/0016-7037(88)90031-2; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; von Strandmann PAEP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10157; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684; Yang J, 2017, GEOLOGY, V45, P615, DOI 10.1130/G38920.1; Ye Q, 2015, GEOLOGY, V43, P507, DOI 10.1130/G36640.1	42	270	283	9	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					578	+		10.1038/nature23457	http://dx.doi.org/10.1038/nature23457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28813409				2022-12-28	WOS:000408703100037
J	Augustin, HG; Koh, GY				Augustin, Hellmut G.; Koh, Gou Young			Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology	SCIENCE			English	Review							BLOOD-BRAIN-BARRIER; CEREBRAL CAVERNOUS MALFORMATIONS; ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; PROTEIN-COUPLED RECEPTOR; FATTY-ACID TRANSPORT; SMOOTH-MUSCLE-CELLS; FLUID SHEAR-STRESS; CORONARY-ARTERIES; BONE-DEVELOPMENT	Blood vessels form one of the body's largest surfaces, serving as a critical interface between the circulation and the different organ environments. They thereby exert gatekeeper functions on tissue homeostasis and adaptation to pathologic challenge. Vascular control of the tissuemicroenvironment is indispensable in development, hemostasis, inflammation, and metabolism, as well as in cancer and metastasis. This multitude of vascular functions is mediated by organ-specifically differentiated endothelial cells (ECs), whose cellular and molecular heterogeneity has long been recognized. Yet distinct organotypic functional attributes and the molecular mechanisms controlling EC differentiation and vascular bed-specific functions have only become known in recent years. Considering the involvement of vascular dysfunction in numerous chronic and life-threatening diseases, a better molecular understanding of organotypic vasculatures may pave the way toward novel angiotargeted treatments to cure hitherto intractable diseases. This Review summarizes recent progress in the understanding of organotypic vascular differentiation and function.	[Augustin, Hellmut G.] German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, D-69121 Heidelberg, Germany; [Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-67167 Mannheim, Germany; [Koh, Gou Young] Inst for Basic Sci Korea, Ctr Vasc Res, Daejeon, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST)	Augustin, HG (corresponding author), German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, D-69121 Heidelberg, Germany.; Augustin, HG (corresponding author), Heidelberg Univ, Med Fac Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-67167 Mannheim, Germany.; Koh, GY (corresponding author), Inst for Basic Sci Korea, Ctr Vasc Res, Daejeon, South Korea.; Koh, GY (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.	augustin@angiogenese.de; gykoh@kaist.ac.kr	Koh, Gou Young/C-1615-2011; Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242	Deutsche Forschungsgemeinschaft; Helmholtz Association; European Union; Fondation Leducq; Institute for Basic Science - Ministry of Science, ICT and Future Planning, Korea [IBS-R025-D1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); European Union(European Commission); Fondation Leducq(Leducq Foundation); Institute for Basic Science - Ministry of Science, ICT and Future Planning, Korea	We regret that, because of space limitations, we were not able to cite all of the original research articles and related references on this topic. Work in the authors' laboratories is supported by funds from the Deutsche Forschungsgemeinschaft, the Helmholtz Association, the European Union, the Fondation Leducq, and the Institute for Basic Science funded by the Ministry of Science, ICT and Future Planning, Korea (grant IBS-R025-D1).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Aspelund A, 2016, CIRC RES, V118, P515, DOI 10.1161/CIRCRESAHA.115.306544; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Aspelund A, 2014, J CLIN INVEST, V124, P3975, DOI 10.1172/JCI75395; Baeyens N, 2016, J CLIN INVEST, V126, P821, DOI 10.1172/JCI83083; Baltrunaite K, 2017, ANGIOGENESIS, V20, P307, DOI 10.1007/s10456-017-9539-8; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cano E, 2016, P NATL ACAD SCI USA, V113, P656, DOI 10.1073/pnas.1509834113; Cao YH, 2014, NAT REV ENDOCRINOL, V10, P530, DOI 10.1038/nrendo.2014.114; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Cao ZW, 2017, CANCER CELL, V31, P110, DOI 10.1016/j.ccell.2016.11.010; Chen HI, 2014, DEVELOPMENT, V141, P4500, DOI 10.1242/dev.113639; Cheng C, 2012, CIRCULATION, V125, P3142, DOI 10.1161/CIRCULATIONAHA.111.064030; Chistiakov DA, 2017, ACTA PHYSIOL, V219, P382, DOI 10.1111/apha.12725; Chu M, 2016, ELIFE, V5, DOI 10.7554/eLife.21032; Clarkin C, 2010, CELL METAB, V12, P314, DOI 10.1016/j.cmet.2010.09.009; Condren AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053386; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; Corada M, 2014, ARTERIOSCL THROM VAS, V34, P2372, DOI 10.1161/ATVBAHA.114.303218; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; Dessapt-Baradez C, 2014, J AM SOC NEPHROL, V25, P33, DOI 10.1681/ASN.2012121218; Dimke H, 2015, J AM SOC NEPHROL, V26, P1027, DOI 10.1681/ASN.2014010060; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Doddaballapur A, 2015, ARTERIOSCL THROM VAS, V35, P137, DOI 10.1161/ATVBAHA.114.304277; Duan XC, 2015, DEVELOPMENT, V142, P1984, DOI 10.1242/dev.117952; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Escobedo N, 2016, ANNU REV CELL DEV BI, V32, P677, DOI 10.1146/annurev-cellbio-111315-124944; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferland-McCollough D, 2017, PHARMACOL THERAPEUT, V171, P30, DOI 10.1016/j.pharmthera.2016.11.008; Fong LG, 2016, TRENDS ENDOCRIN MET, V27, P455, DOI 10.1016/j.tem.2016.04.013; Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Geraud C, 2017, J CLIN INVEST, V127, P1099, DOI 10.1172/JCI90086; Geraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hen G, 2015, DEVELOPMENT, V142, P4266, DOI 10.1242/dev.129247; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Hong KY, 2015, DEVELOPMENT, V142, P2623, DOI 10.1242/dev.125336; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jang JY, 2017, EMBO MOL MED, V9, P750, DOI 10.15252/emmm.201607341; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jin J, 2012, CELL, V151, P384, DOI 10.1016/j.cell.2012.08.037; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Kizhatil K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001912; Knolle PA, 2016, CELL MOL IMMUNOL, V13, P347, DOI 10.1038/cmi.2016.5; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Kolka CM, 2012, PHYSIOLOGY, V27, P237, DOI 10.1152/physiol.00012.2012; Korn C, 2014, DEVELOPMENT, V141, P1757, DOI 10.1242/dev.104422; Kostallari E, 2016, AM J PHYSIOL-GASTR L, V311, pG246, DOI 10.1152/ajpgi.00118.2016; Kumar P, 2017, DEVELOPMENT, V144, P17, DOI 10.1242/dev.133058; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Ling ITC, 2017, DEV BIOL, V421, P219, DOI 10.1016/j.ydbio.2016.11.016; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Maes C, 2012, NAT REV RHEUMATOL, V8, P358, DOI 10.1038/nrrheum.2012.36; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McSweeney SR, 2016, HYPERTENSION, V67, P20, DOI 10.1161/HYPERTENSIONAHA.115.06146; Mehrotra D, 2014, TRENDS ENDOCRIN MET, V25, P99, DOI 10.1016/j.tem.2013.11.001; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Mogler C, 2017, EMBO MOL MED, V9, P741, DOI 10.15252/emmm.201607222; Mogler C, 2015, EMBO MOL MED, V7, P332, DOI 10.15252/emmm.201404246; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Park DY, 2014, J CLIN INVEST, V124, P3960, DOI 10.1172/JCI75392; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Pircher A, 2016, ATHEROSCLEROSIS, V253, P247, DOI 10.1016/j.atherosclerosis.2016.08.011; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; Rantakari P, 2016, NATURE, V538, P392, DOI 10.1038/nature19814; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Robciuc MR, 2016, CELL METAB, V23, P712, DOI 10.1016/j.cmet.2016.03.004; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Rosenberg G A, 2014, J Prev Alzheimers Dis, V1, P138; Sangwung P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91700; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Scholz B, 2016, DEV CELL, V36, P79, DOI 10.1016/j.devcel.2015.12.015; Semo J, 2016, DEVELOPMENT, V143, P924, DOI 10.1242/dev.132431; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Singh N, 2013, BLOOD, V121, P4242, DOI 10.1182/blood-2012-08-453043; Sivaskandarajah GA, 2012, DIABETES, V61, P2958, DOI 10.2337/db11-1655; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Sriram G, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0260-5; Strauss O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44356; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Tang AT, 2017, NATURE, V545, P305, DOI 10.1038/nature22075; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Thomson BR, 2014, J CLIN INVEST, V124, P4320, DOI 10.1172/JCI77162; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Viswambharan H, 2017, CIRC RES, V120, P784, DOI 10.1161/CIRCRESAHA.116.309678; Volz KS, 2015, ELIFE, V4, DOI 10.7554/eLife.10036; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang H, 2006, CIRC RES, V98, P1331, DOI 10.1161/01.RES.0000220650.26555.1d; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Woik N, 2015, CELL MOL LIFE SCI, V72, P2709, DOI 10.1007/s00018-015-1907-1; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yanga YL, 2013, P NATL ACAD SCI USA, V110, P12018, DOI 10.1073/pnas.1301331110; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	160	318	323	6	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaal2379	10.1126/science.aal2379	http://dx.doi.org/10.1126/science.aal2379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28775214				2022-12-28	WOS:000408327900034
J	Solis, GP; Bilousov, O; Koval, A; Luchtenborg, AM; Lin, C; Katanaev, VL				Solis, Gonzalo P.; Bilousov, Oleksii; Koval, Alexey; Luechtenborg, Anne-Marie; Lin, Chen; Katanaev, Vladimir L.			Golgi-Resident G alpha o Promotes Protrusive Membrane Dynamics	CELL			English	Article							PLASMA-MEMBRANE; RAB PROTEINS; ENDOPLASMIC-RETICULUM; KDEL RECEPTOR; TRANSPORT; BINDING; COMPLEXES; CELLS; OVEREXPRESSION; TRANSLOCATION	To form protrusions like neurites, cells must coordinate their induction and growth. The first requires cytoskeletal rearrangements at the plasma membrane (PM), the second requires directed material delivery from cell's insides. We find that the G alpha o-subunit of heterotrimeric G proteins localizes dually to PM and Golgi across phyla and cell types. The PM pool of G alpha o induces, and the Golgi pool feeds, the growing protrusions by stimulated trafficking. Golgi-residing KDELR binds and activates monomeric G alpha o, atypically for G protein-coupled receptors that normally act on heterotrimeric G proteins. Through multidimensional screenings identifying > 250 G alpha o interactors, we pinpoint several basic cellular activities, including vesicular trafficking, as being regulated by G alpha o. We further find small Golgi-residing GTPases Rab1 and Rab3 as direct effectors of G alpha o. This KDELR -> G alpha o -> Rab1/3 signaling axis is conserved from insects to mammals and controls material delivery from Golgi to PM in various cells and tissues.	[Solis, Gonzalo P.; Bilousov, Oleksii; Koval, Alexey; Luechtenborg, Anne-Marie; Lin, Chen; Katanaev, Vladimir L.] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1011 Lausanne, Switzerland; [Katanaev, Vladimir L.] Far Eastern Fed Univ, Sch Biomed, Vladivostok 690950, Russia	University of Lausanne; Far Eastern Federal University	Solis, GP; Katanaev, VL (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, CH-1011 Lausanne, Switzerland.; Katanaev, VL (corresponding author), Far Eastern Fed Univ, Sch Biomed, Vladivostok 690950, Russia.	gonzalo.solis@unil.ch; vladimir.katanaev@unil.ch	Koval, Alexey/AAU-4766-2020; Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617; Solis, Gonzalo P./0000-0002-2359-3780; Bilousov, Oleksii/0000-0001-5783-6325	Deutsche Forschungsgemeinschaft [SFB-TR11]; Swiss National Science Foundation [31003A_138350, 31003A_156762]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Alina Titova, Anke Ruedel, Birgit Gogol, Nadine Woessner, and Diane Egger-Adam for technical help in genetic screens, Pablo Serrano de Toro and Anne-Lise Maury Fraering for technical assistance, Valerie Franzen in cloning small GTPase mutants, Dmitry Ivankov and Natalya Bogatyreva for discussions on bioinformatics analysis, and Andrew Tomlinson for comments on the manuscript. This work was funded by Deutsche Forschungsgemeinschaft (SFB-TR11) and the Swiss National Science Foundation (31003A_138350 and 31003A_156762) to V.L.K.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Beltrao P, 2012, ADV EXP MED BIOL, V751, P139, DOI 10.1007/978-1-4614-3567-9_7; Bromberg KD, 2008, FRONT BIOSCI-LANDMRK, V13, P4544, DOI 10.2741/3022; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dumaresq-Doiron K, 2010, J CELL SCI, V123, P2273, DOI 10.1242/jcs.055798; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; Fukuda M, 2004, GENES CELLS, V9, P831, DOI 10.1111/j.1365-2443.2004.00767.x; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; Karunarathne WKA, 2012, BIOCHEM BIOPH RES CO, V421, P605, DOI 10.1016/j.bbrc.2012.04.054; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee MS, 2006, STEM CELLS, V24, P1946, DOI 10.1634/stemcells.2005-0325; Lin C, 2014, MOL CELL, V53, P663, DOI 10.1016/j.molcel.2014.01.014; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Luchtenborg AM, 2014, DEVELOPMENT, V141, P3399, DOI 10.1242/dev.106773; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Maltese WA, 1996, BIOCHEM SOC T, V24, P703, DOI 10.1042/bst0240703; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Purvanov V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000877; Romero N, 2013, MOL BIOL CELL, V24, P617, DOI 10.1091/mbc.E12-07-0530; Shao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009938; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; YANG CZ, 1994, J BIOL CHEM, V269, P31891	48	32	33	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					939	+	955.e24	10.1016/j.cell.2017.07.015	http://dx.doi.org/10.1016/j.cell.2017.07.015			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28803726	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000408372400013
J	Apai, D; Karalidi, T; Marley, MS; Yang, H; Flateau, D; Metchev, S; Cowan, NB; Buenzli, E; Burgasser, AJ; Radigan, J; Artigau, E; Lowrance, P				Apai, D.; Karalidi, T.; Marley, M. S.; Yang, H.; Flateau, D.; Metchev, S.; Cowan, N. B.; Buenzli, E.; Burgasser, A. J.; Radigan, J.; Artigau, E.; Lowrance, P.			Zones, spots, and planetary-scale waves beating in brown dwarf atmospheres	SCIENCE			English	Article								Brown dwarfs are massive analogs of extrasolar giant planets and may host types of atmospheric circulation not seen in the solar system. We analyzed a long-term Spitzer Space Telescope infrared monitoring campaign of brown dwarfs to constrain cloud cover variations over a total of 192 rotations. The infrared brightness evolution is dominated by beat patterns caused by planetary-scale wave pairs and by a small number of bright spots. The beating waves have similar amplitudes but slightly different apparent periods because of differing velocities or directions. The power spectrum of intermediate-temperature brown dwarfs resembles that of Neptune, indicating the presence of zonal temperature and wind speed variations. Our findings explain three previously puzzling behaviors seen in brown dwarf brightness variations.	[Apai, D.; Karalidi, T.; Yang, H.; Flateau, D.] Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA; [Apai, D.] Univ Arizona, Lunar & Planetary Lab, 1640 E Univ Blvd, Tucson, AZ 85721 USA; [Marley, M. S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Flateau, D.] Univ Cincinnati, Dept Phys, 2600 Clifton Ave, Cincinnati, OH 45221 USA; [Metchev, S.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Metchev, S.] Univ Western Ontario, Ctr Planetary Sci & Explorat, London, ON N6A 3K7, Canada; [Metchev, S.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11795 USA; [Cowan, N. B.] McGill Univ, Dept Earth & Planetary Sci, 3450 Rue Univ, Montreal, PQ H3A 2A7, Canada; [Cowan, N. B.] McGill Space Inst, 3550 Rue Univ, Montreal, PQ H3A 2A7, Canada; [Cowan, N. B.; Artigau, E.] Univ Montreal, Dept Phys, Inst Rech Exoplanetes IREx, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Buenzli, E.] ETH, Inst Astron, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland; [Burgasser, A. J.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Radigan, J.] Utah Valley Univ, Dept Phys, 800 West Univ Pkwy, Orem, UT 84058 USA; [Lowrance, P.] CALTECH, Ctr Infrared Proc & Anal, MS 314-5,1200 E Calif Blvd, Pasadena, CA 91125 USA	University of Arizona; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Ohio; University of Cincinnati; Western University (University of Western Ontario); Western University (University of Western Ontario); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; McGill University; Universite de Montreal; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Diego; Utah System of Higher Education; Utah Valley University; California Institute of Technology	Apai, D (corresponding author), Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA.; Apai, D (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1640 E Univ Blvd, Tucson, AZ 85721 USA.	apai@arizona.edu	Karalidi, Theodora/AAN-1384-2020; Yang, Hao/F-8396-2014	Burgasser, Adam J./0000-0002-6523-9536; Yang, Hao/0000-0002-9423-2333; Apai, Daniel/0000-0003-3714-5855; Cowan, Nicolas/0000-0001-6129-5699; Marley, Mark/0000-0002-5251-2943; Karalidi, Theodora/0000-0001-7356-6652; Metchev, Stanimir/0000-0003-3050-8203; Lowrance, Patrick/0000-0001-8014-0270	NASA; Universities for Research in Astronomy under NASA [13176, NAS5-26555]; NASA's Science Mission Directorate; National Science Foundation [AST-1517177]	NASA(National Aeronautics & Space Administration (NASA)); Universities for Research in Astronomy under NASA; NASA's Science Mission Directorate; National Science Foundation(National Science Foundation (NSF))	Individual author contributions are listed in the supplementary materials. We acknowledge discussions with G. Mulders, V. Parmentier, and X. Zhang on atmospheric dynamics and the interpretation of our observations. This work is part of the Spitzer Cycle-9 Exploration Program "Extrasolar Storms" and based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory (JPL), California Institute of Technology, under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/California Institute of Technology. Support for the Hubble Space Telescope GO program 13176 was provided by Universities for Research in Astronomy, under NASA contract NAS5-26555. This research has benefitted from the SpeX Prism Spectral Libraries, maintained by A.J.B. at http://pono.ucsd.edu/similar to adam/browndwarfs/spexprism, and the M, L, T, and Y dwarf compendium at http://DwarfArchives.org. This research benefitted from the workshop "Solving the Exocartography Inverse Problem" held at the International Space Science Institute in Bern. The results reported here benefitted from collaborations and/or information exchange within NASA's Nexus for Exoplanet System Science (NExSS) research coordination network sponsored by NASA's Science Mission Directorate. An allocation of computer time from the University of Arizona Research Computing High Performance Computing and High Throughput Computing (HTC) is gratefully acknowledged. A.J.B. acknowledges funding support from the National Science Foundation under award AST-1517177. The raw observations are available from the Spitzer Heritage Archive at http://sha.ipac.caltech.edu under program 90063. Light curves for all of our targets, along with our model fits for each, are included in the supplementary file Data S1. Our adapted version of the Aeolus software is available at https://github.com/Dot83/Aeolus.	Apai D, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/121; Artigau E, 2009, ASTROPHYS J, V701, P1534, DOI 10.1088/0004-637X/701/2/1534; Biller BA, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L10; Buenzli E, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/127; Buenzli E, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/77; Buenzli E, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L31; Burgasser AJ, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/48; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; de Pater I, 2014, ICARUS, V237, P211, DOI 10.1016/j.icarus.2014.02.030; Gillon M, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321620; Karalidi T, 2016, ASTROPHYS J, V825, DOI 10.3847/0004-637X/825/2/90; Karalidi T, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/1/65; Kaspi Y, 2013, NATURE, V497, P344, DOI 10.1038/nature12131; Metchev SA, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/154; Radigan J, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/2/75; Radigan J, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/105; Showman AP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/85; STAUFFER J, 2016, ASTRON J, V152; Wagner K, 2016, SCIENCE, V353, P673, DOI 10.1126/science.aaf9671; Yang H, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/1/8; Zhang X, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/1/L6	23	58	58	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					683	+		10.1126/science.aam9848	http://dx.doi.org/10.1126/science.aam9848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818943				2022-12-28	WOS:000407793600034
J	Cousins, S				Cousins, Sophie			HIV/AIDS Could cancer research hold the key to a cure for HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophcousins@gmail.com						Kaiser Family Foundation, DON GOV FUND HIV LOW	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2017	358								j3905	10.1136/bmj.j3905	http://dx.doi.org/10.1136/bmj.j3905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE5CD	28821488				2022-12-28	WOS:000408228700003
J	Haas, WR; Aldenderfer, MS; Meyer, MC				Haas, W. R.; Aldenderfer, M. S.; Meyer, M. C.			Response to Comment on "Permanent human occupation of the central Tibetan Plateau in the early Holocene"	SCIENCE			English	Editorial Material								Zhang et al. contest that Chusang was part of an annual mobility round that "more likely" included seasonal use of high-elevation environments than permanent use. We show that their probabilistic statement hinges on indefensible claims about hunter-gatherer mobility. In the context of quantitative data from hunter-gatherer ethnography, our travel model shows that seasonal-use models are highly unlikely to explain Chusang.	[Haas, W. R.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Aldenderfer, M. S.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95343 USA; [Meyer, M. C.] Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria	University of California System; University of California Davis; University of California System; University of California Merced; University of Innsbruck	Haas, WR (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.; Aldenderfer, MS (corresponding author), Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95343 USA.; Meyer, MC (corresponding author), Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria.	wrhaas@ucdavis.edu; maldenderfer@ucmerced.edu; michael.meyer@uibk.ac.at	Meyer, Michael C/S-8214-2016	Meyer, Michael C/0000-0001-6677-7419; Haas, Randall/0000-0002-7742-2127				BRAIDWOOD RJ, 1960, SCI AM, V203, P130, DOI 10.1038/scientificamerican0960-130; Chamberlin TC, 1944, SCI MON, V59, P357; Fogelin L, 2007, AM ANTIQUITY, V72, P603, DOI 10.2307/25470436; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Marquet PA, 2014, BIOSCIENCE, V64, P701, DOI 10.1093/biosci/biu098; McElreath R, 2016, TEXT STAT SCI, pXI; Meyer MC, 2017, SCIENCE, V355, P64, DOI 10.1126/science.aag0357; WOBST HM, 1978, AM ANTIQUITY, V43, P303, DOI 10.2307/279256; Zhang DJ, 2017, SCIENCE, V357, DOI 10.1126/science.aam8273	9	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351								10.1126/science.aam9444	http://dx.doi.org/10.1126/science.aam9444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FD1VM	28798105				2022-12-28	WOS:000407324800003
J	Dolgin, E				Dolgin, Elie			A LEGACY OF GREATER KNOWLEDGE	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					S16	S18		10.1038/548S16a	http://dx.doi.org/10.1038/548S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28792919	Bronze			2022-12-28	WOS:000407284300007
J	Pontes-Quero, S; Heredia, L; Casquero-Garcia, V; Fernandez-Chacon, M; Luo, W; Hermoso, A; Bansal, M; Garcia-Gonzalez, I; Sanchez-Munoz, MS; Perea, JR; Galiana-Simal, A; Rodriguez-Arabaolaza, I; Del Olmo-Cabrera, S; Rocha, SF; Criado-Rodriguez, LM; Giovinazzo, G; Benedito, R				Pontes-Quero, Samuel; Heredia, Luis; Casquero-Garcia, Veronica; Fernandez-Chacon, Macarena; Luo, Wen; Hermoso, Ana; Bansal, Mayank; Garcia-Gonzalez, Irene; Sanchez-Munoz, Maria S.; Perea, Juan R.; Galiana-Simal, Adrian; Rodriguez-Arabaolaza, Iker; Del Olmo-Cabrera, Sergio; Rocha, Susana F.; Criado-Rodriguez, Luis M.; Giovinazzo, Giovanna; Benedito, Rui			Dual ifgMosaic: A Versatile Method for Multispectral and Combinatorial Mosaic Gene-Function Analysis	CELL			English	Article							CRE-LOXP; IN-VIVO; MOUSE; MICE; EXPRESSION; RECOMBINATION; SYSTEM	Improved methods for manipulating and analyzing gene function have provided a better understanding of how genes work during organ development and disease. Inducible functional genetic mosaics can be extraordinarily useful in the study of biological systems; however, this experimental approach is still rarely used in vertebrates. This is mainly due to technical difficulties in the assembly of large DNA constructs carrying multiple genes and regulatory elements and their targeting to the genome. In addition, mosaic phenotypic analysis, unlike classical single gene-function analysis, requires clear labeling and detection of multiple cell clones in the same tissue. Here, we describe several methods for the rapid generation of transgenic or gene-targeted mice and embryonic stem (ES) cell lines containing all the necessary elements for inducible, fluorescent, and functional genetic mosaic (ifgMosaic) analysis. This technology enables the interrogation of multiple and combinatorial gene function with high temporal and cellular resolution.	[Pontes-Quero, Samuel; Heredia, Luis; Casquero-Garcia, Veronica; Fernandez-Chacon, Macarena; Luo, Wen; Hermoso, Ana; Bansal, Mayank; Garcia-Gonzalez, Irene; Sanchez-Munoz, Maria S.; Perea, Juan R.; Galiana-Simal, Adrian; Rodriguez-Arabaolaza, Iker; Del Olmo-Cabrera, Sergio; Rocha, Susana F.; Benedito, Rui] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Mol Genet Angiogenesis Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain; [Criado-Rodriguez, Luis M.] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Transgenesis Unit, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain; [Giovinazzo, Giovanna] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Pluripotent Cell Technol Unit, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Benedito, R (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Mol Genet Angiogenesis Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	rui.benedito@cnic.es	Galiana, Adrián/GZG-8250-2022; Benedito, Rui/G-8295-2012; Giovinazzo, Giovanna/I-1283-2015; Benedito, Rui/AAQ-8096-2020; Arabaolaza, Iker Rodríguez/AAC-3773-2020; Galiana, Adrian/AAF-2273-2020; Perea, Juan Ramón/Y-2742-2018	Benedito, Rui/0000-0003-2458-3055; Giovinazzo, Giovanna/0000-0002-5391-0441; Benedito, Rui/0000-0003-2458-3055; Galiana, Adrian/0000-0002-6779-009X; Perea, Juan Ramón/0000-0001-7607-8814; Pontes, Samuel/0000-0002-4061-2365; Fernandez-Chacon, Macarena/0000-0001-5831-0923; Garcia-Gonzalez, Irene/0000-0001-8508-8344	Spanish Ministry of Economy, Industry and Competitiveness [SAF2013-44329-P, SAF2013-42359-ERC, RYC-2013-13209]; European Research Council [ERC-2014-StG - 638028]; Fundacion La Caixa [CX-SO-2013-02, CX_E-2015-01, CX-SO-16-1]; FP7-PEOPLE-COFUND [GA600396]; MEIC/MINECO; Pro CNIC Foundation	Spanish Ministry of Economy, Industry and Competitiveness; European Research Council(European Research Council (ERC)European Commission); Fundacion La Caixa(La Caixa Foundation); FP7-PEOPLE-COFUND; MEIC/MINECO; Pro CNIC Foundation	This work was supported by grants to the PI R.B. from the Spanish Ministry of Economy, Industry and Competitiveness (SAF2013-44329-P, SAF2013-42359-ERC, and RYC-2013-13209) and European Research Council (ERC-2014-StG - 638028). S.P.-Q., M.F.-C., and I.G.-G. were supported by PhD fellowships from Fundacion La Caixa (CX-SO-2013-02, CX_E-2015-01, and CX-SO-16-1, respectively). W.L. by a FP7-PEOPLE-2012-COFUND GA600396 postdoctoral contract. We thank Simon Bartlett for English editing, Ralf H. Adams for sharing the Cdh5(PAC)-CreERT2 mice, Jose Luis de La Pompa for comments throughout the project and for sharing the Tie2-Cre mice, Gonzalo Gancedo for the help with the mouse colony, Valeria Caiolfa for the help with the microscopy, and all the members of the CNIC gene targeting, transgenesis, cellomics, and microscopy units. The CNIC is supported by MEIC/MINECO and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Briscoe J, 2015, DEVELOPMENT, V142, P3996, DOI 10.1242/dev.129452; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lao ZM, 2012, CELL REP, V2, P386, DOI 10.1016/j.celrep.2012.07.004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee YB, 2005, EXP PHYSIOL, V90, P33, DOI 10.1113/expphysiol.2004.028209; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Liu J, 2013, GENESIS, V51, P436, DOI 10.1002/dvg.22384; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zong H, 2014, METHODS MOL BIOL, V1194, P187, DOI 10.1007/978-1-4939-1215-5_10	33	34	34	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					800	+		10.1016/j.cell.2017.07.031	http://dx.doi.org/10.1016/j.cell.2017.07.031			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802047	Green Published, hybrid			2022-12-28	WOS:000407445700019
J	Sacristan, C				Sacristan, Catarina			Formidable Defenses In Utero	CELL			English	Editorial Material														Sacristan, Catarina/0000-0001-9643-7650				Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Prahl M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1545-6	6	0	0	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					595	596		10.1016/j.cell.2017.07.048	http://dx.doi.org/10.1016/j.cell.2017.07.048			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802033	Bronze			2022-12-28	WOS:000407445700001
J	Shi, HJ; Enriquez, A; Rapadas, M; Martin, EMMA; Wang, R; Moreau, J; Lim, CK; Szot, JO; Ip, E; Hughes, JN; Sugimoto, K; Humphreys, DT; McInerney-Leo, AM; Leo, PJ; Maghzal, GJ; Halliday, J; Smith, J; Colley, A; Mark, PR; Collins, F; Sillence, DO; Winlaw, DS; Ho, JWK; Guillemin, GJ; Brown, MA; Kikuchi, K; Thomas, PQ; Stocker, R; Giannoulatou, E; Chapman, G; Duncan, EL; Sparrow, DB; Dunwoodie, SL				Shi, Hongjun; Enriquez, Annabelle; Rapadas, Melissa; Martin, Ella M. M. A.; Wang, Roni; Moreau, Julie; Lim, Chai K.; Szot, Justin O.; Ip, Eddie; Hughes, James N.; Sugimoto, Kotaro; Humphreys, David T.; McInerney-Leo, Aideen M.; Leo, Paul J.; Maghzal, Ghassan J.; Halliday, Jake; Smith, Janine; Colley, Alison; Mark, Paul R.; Collins, Felicity; Sillence, David O.; Winlaw, David S.; Ho, Joshua W. K.; Guillemin, Gilles J.; Brown, Matthew A.; Kikuchi, Kazu; Thomas, Paul Q.; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Duncan, Emma L.; Sparrow, Duncan B.; Dunwoodie, Sally L.			NAD Deficiency, Congenital Malformations, and Niacin Supplementation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; METABOLISM; MUTATIONS; DEFECTS; HUMANS; ASSOCIATION; KYNURENINE; TRYPTOPHAN; VARIANTS; SIRTUINS	BACKGROUND Congenital malformations can be manifested as combinations of phenotypes that co-occur more often than expected by chance. In many such cases, it has proved difficult to identify a genetic cause. We sought the genetic cause of cardiac, vertebral, and renal defects, among others, in unrelated patients. METHODS We used genomic sequencing to identify potentially pathogenic gene variants in families in which a person had multiple congenital malformations. We tested the function of the variant by using assays of in vitro enzyme activity and by quantifying metabolites in patient plasma. We engineered mouse models with similar variants using the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 system. RESULTS Variants were identified in two genes that encode enzymes of the kynurenine pathway, 3-hydroxyanthranilic acid 3,4-dioxygenase (HAAO) and kynureninase (KYNU). Three patients carried homozygous variants predicting loss-of-function changes in the HAAO or KYNU proteins (HAAO p.D162*, HAAO p.W186*, or KYNU p.V57Efs*21). Another patient carried heterozygous KYNU variants (p.Y156* and p.F349Kfs*4). The mutant enzymes had greatly reduced activity in vitro. Nicotinamide adenine dinucleotide (NAD) is synthesized de novo from tryptophan through the kynurenine pathway. The patients had reduced levels of circulating NAD. Defects similar to those in the patients developed in the embryos of Haao-null or Kynu-null mice owing to NAD deficiency. In null mice, the prevention of NAD deficiency during gestation averted defects. CONCLUSIONS Disruption of NAD synthesis caused a deficiency of NAD and congenital malformations in humans and mice. Niacin supplementation during gestation prevented the malformations in mice. (Funded by the National Health and Medical Research Council of Australia and others.)	[Shi, Hongjun; Enriquez, Annabelle; Rapadas, Melissa; Martin, Ella M. M. A.; Wang, Roni; Moreau, Julie; Szot, Justin O.; Ip, Eddie; Sugimoto, Kotaro; Halliday, Jake; Kikuchi, Kazu; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Div Dev & Stem Cell Biol, Sydney, NSW, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Div Vasc Biol, Sydney, NSW, Australia; [Humphreys, David T.; Ho, Joshua W. K.; Giannoulatou, Eleni] Victor Chang Cardiac Res Inst, Div Mol Struct & Computat Biol, Sydney, NSW, Australia; [Shi, Hongjun; Enriquez, Annabelle; Szot, Justin O.; Ip, Eddie; Humphreys, David T.; Maghzal, Ghassan J.; Ho, Joshua W. K.; Kikuchi, Kazu; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Shi, Hongjun; Enriquez, Annabelle; Szot, Justin O.; Ip, Eddie; Humphreys, David T.; Maghzal, Ghassan J.; Ho, Joshua W. K.; Kikuchi, Kazu; Stocker, Roland; Giannoulatou, Eleni; Chapman, Gavin; Sparrow, Duncan B.; Dunwoodie, Sally L.] Univ New South Wales, Fac Sci, Sydney, NSW, Australia; [Enriquez, Annabelle; Colley, Alison] Liverpool Hosp, Dept Clin Genet, Sydney, NSW, Australia; [Enriquez, Annabelle; Smith, Janine; Collins, Felicity; Sillence, David O.] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Winlaw, David S.] Childrens Hosp Westmead, Heart Ctr Children, Sydney, NSW, Australia; [Enriquez, Annabelle; Smith, Janine; Collins, Felicity; Sillence, David O.] Univ Sydney, Discipline Genet Med, Sydney, NSW, Australia; [Winlaw, David S.] Univ Sydney, Med Sch, Sydney, NSW, Australia; [Lim, Chai K.; Guillemin, Gilles J.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Hughes, James N.; Thomas, Paul Q.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [McInerney-Leo, Aideen M.; Leo, Paul J.; Brown, Matthew A.; Duncan, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [McInerney-Leo, Aideen M.; Leo, Paul J.; Brown, Matthew A.; Duncan, Emma L.] Royal Brisbane & Womens Hosp, Translat Res Inst, Brisbane, Qld, Australia; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Brisbane, Qld, Australia; [Duncan, Emma L.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Mark, Paul R.] Spectrum Hlth Med Grp, Med Genet, Grand Rapids, MI USA	Victor Chang Cardiac Research Institute; Victor Chang Cardiac Research Institute; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; Liverpool Hospital; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Macquarie University; University of Adelaide; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; University of Queensland; Spectrum Health Medical Group	Dunwoodie, SL (corresponding author), Victor Chang Cardiac Res Inst, Lowy Packer Bldg,405 Liverpool St, Sydney, NSW 2010, Australia.	s.dunwoodie@victorchang.edu.au	Guillemin, Gilles J/C-3878-2015; Sugimoto, Kotaro/AAE-9873-2020; Dunwoodie, Sally L/M-4019-2018; Stocker, Roland/L-9157-2019; Ho, Joshua W. K./AAK-7759-2020; Stocker, Roland/AAV-4489-2021; Sparrow, Duncan/B-3994-2008; Chapman, Gavin/A-9534-2012; Mark, Paul/AAK-2153-2020; McInerney-Leo, Aideen M/D-8302-2016; Brown, Matthew A/E-5749-2010; Leo, Paul/R-4464-2019; Lim, Edwin/R-5001-2019; Winlaw, David/B-9405-2019; McInerney-Leo, Aideen M/E-1788-2018; Duncan, Emma/L-1224-2013	Guillemin, Gilles J/0000-0001-8105-4470; Dunwoodie, Sally L/0000-0002-2069-7349; Ho, Joshua W. K./0000-0003-2331-7011; Sparrow, Duncan/0000-0002-1141-6613; Chapman, Gavin/0000-0002-3513-723X; McInerney-Leo, Aideen M/0000-0002-0059-5732; Brown, Matthew A/0000-0003-0538-8211; Lim, Edwin/0000-0003-3526-8405; Winlaw, David/0000-0001-8005-3361; Moreau, Julie Liliane Marguerite/0000-0003-1559-7703; Duncan, Emma/0000-0002-8143-4403; Sugimoto, Kotaro/0000-0002-5299-7610; Mark, Paul R./0000-0002-1020-888X; Szot, Justin/0000-0001-6513-2352; Giannoulatou, Eleni/0000-0002-7084-6736; Ip, Eddie K.K./0000-0002-4767-7583; Enriquez, Annabelle/0000-0003-4684-9889	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia and others.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Allegri G, 2003, ADV EXP MED BIOL, V527, P387; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Baker H, 2002, J AM COLL NUTR, V21, P33, DOI 10.1080/07315724.2002.10719191; Blue GM, 2014, J AM COLL CARDIOL, V64, P2498, DOI 10.1016/j.jacc.2014.09.048; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen YX, 2016, J MED GENET, V53, P431, DOI 10.1136/jmedgenet-2015-103554; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Christensen M, 2007, J INHERIT METAB DIS, V30, P248, DOI 10.1007/s10545-007-0396-2; Correia M, 2017, BBA-GEN SUBJECTS, V1861, P3444, DOI 10.1016/j.bbagen.2016.09.008; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; HOLLIDAY MA, 1967, PEDIATR RES, V1, P185, DOI 10.1203/00006450-196705000-00005; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jacobson EL, 1999, MOL CELL BIOCHEM, V193, P69, DOI 10.1023/A:1006960126369; Kirkland JB, 2012, MUTAT RES-FUND MOL M, V733, P14, DOI 10.1016/j.mrfmmm.2011.11.008; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; McInerney-Leo AM, 2015, HUM MOL GENET, V24, P1234, DOI 10.1093/hmg/ddu534; Mohamed JY, 2013, AM J HUM GENET, V92, P157, DOI 10.1016/j.ajhg.2012.11.016; Oxenkrug G, 2013, MOL NEUROBIOL, V48, P294, DOI 10.1007/s12035-013-8497-4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosa Rosana Cardoso M., 2013, Rev. paul. pediatr., V31, P243; Sasaki Y, 2015, J BIOL CHEM, V290, P17228, DOI 10.1074/jbc.M115.637850; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Solomon BD, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-56; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Terakata M, 2012, J NUTR, V142, P2148, DOI 10.3945/jn.112.167569; Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3; Wan P, 2011, BRIT J DERMATOL, V164, P1188, DOI 10.1111/j.1365-2133.2010.10163.x; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053	33	121	126	4	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					544	552		10.1056/NEJMoa1616361	http://dx.doi.org/10.1056/NEJMoa1616361			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28792876	Bronze, Green Published			2022-12-28	WOS:000407212600007
J	Bergeron, A; Chevret, S; Granata, A; Chevallier, P; Vincent, L; Huynh, A; Tabrizi, R; Labussiere-Wallet, H; Bernard, M; Chantepie, S; Bay, JO; Thiebaut-Bertrand, A; Thepot, S; Contentin, N; Fornecker, LM; Maillard, N; Risso, K; Berceanu, A; Blaise, D; de La Tour, RP; Chien, J; Coiteux, V; Socie, G				Bergeron, Anne; Chevret, Sylvie; Granata, Angela; Chevallier, Patrice; Vincent, Laure; Huynh, Anne; Tabrizi, Reza; Labussiere-Wallet, Helene; Bernard, Marc; Chantepie, Sylvain; Bay, Jacques-Olivier; Thiebaut-Bertrand, Anne; Thepot, Sylvain; Contentin, Nathalie; Fornecker, Luc-Matthieu; Maillard, Natacha; Risso, Karine; Berceanu, Ana; Blaise, Didier; de La Tour, Regis Peffault; Chien, Jason W.; Coiteux, Valerie; Socie, Gerard		ALLOZITHRO Study Investigators	Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant The ALLOZITHRO Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; VERSUS-HOST-DISEASE; LUNG TRANSPLANTATION; PULMONARY COMPLICATIONS; MICROBIOTA; REJECTION; LEUKEMIA; EFFICACY; THERAPY; RISK	IMPORTANCE Bronchiolitis obliterans syndrome has been associated with increased morbidity and mortality after allogeneic hematopoietic stem cell transplant (HSCT). Previous studies have suggested that azithromycin may reduce the incidence of post-lung transplant bronchiolitis obliterans syndrome. OBJECTIVE To evaluate if the early administration of azithromycin can improve airflow decline-free survival after allogeneic HSCT. DESIGN, SETTING, AND PARTICIPANTS The ALLOZITHRO parallel-group trial conducted in 19 French academic transplant centers and involving participants who were at least 16 years old, had undergone allogeneic HSCT for a hematological malignancy, and had available pretransplant pulmonary function test results. Enrollment was from February 2014 to August 2015 with follow-up through April 26, 2017. INTERVENTIONS Patients were randomly assigned to receive 3 times a week either 250mg of azithromycin (n= 243) or placebo (n= 237) for 2 years, starting at the time of the conditioning regimen. MAIN OUTCOMES AND MEASURES The primary efficacy end pointwas airflow decline-free survival at 2 years after randomization. Main secondary end points were overall survival and bronchiolitis obliterans syndrome at 2 years. RESULTS Thirteen months after enrollment, the independent data and safety monitoring board detected an unanticipated imbalance across blinded groups in the number of hematological relapses, and the treatment was stopped December 26, 2016. Among 480 randomized participants, 465 (97%) were included in the modified intention-to-treat analysis (mean age, 52 [SD, 14] years; 75women [35%]). At the time of data cutoff, 104 patients (22%; 54 azithromycin vs 50 placebo) had experienced an airflow decline; 138 patients (30%) died (78 azithromycin vs 60 placebo). Two-year airflow decline-free survival was 32.8%(95% CI, 25.9%-41.7%) with azithromycin and 41.3%(95% CI, 34.1%-50.1%) with placebo (unadjusted hazard ratio [HR], 1.3; 95% CI, 1.02-1.70; P=.03). Of the 22 patients (5%) who experienced bronchiolitis obliterans syndrome, 15 (6%) were in the azithromycin group and 7 (3%) in the placebo group (P=.08). The azithromycin group had increased mortality, with a 2-year survival of 56.6%(95% CI, 50.2%-63.7%) vs 70.1%(95% CI, 64.2%-76.5%) in the placebo group (unadjusted HR, 1.5; 95% CI, 1.1-2.0; P=.02). In a post hoc analysis, the 2-year cumulative incidence of hematological relapsewas 33.5%(95% CI, 27.3%-39.7%) with azithromycin vs 22.3%(95% CI, 16.4%-28.2%) with placebo (unadjusted cause-specific HR, 1.7; 95% CI, 1.2-2.4; P=.002). CONCLUSIONS AND RELEVANCE Among patients undergoing allogeneic HSCT for hematological malignancy, early administration of azithromycin resulted in worse airflow decline-free survival than did placebo; these findings are limited by early trial termination. The potential for harm related to relapse requires further investigation.	[Bergeron, Anne] Hop St Louis, AP HP, Serv Pneumol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France; [Bergeron, Anne; Chevret, Sylvie] Univ Paris Diderot, Biostat & Clin Epidemiol Res Team, Sorbonne Paris Cite, UMR CRESS 1153, Paris, France; [Chevret, Sylvie] Hop St Louis, AP HP, Serv Biostat & Informat Med, Paris, France; [Granata, Angela] Inst Paoli Calmettes, Marseille, France; [Chevallier, Patrice] CHU Nantes, Serv Hematol, Nantes, France; [Vincent, Laure] CHU Montpellier, Dept Hematol Clin, Montpellier, France; [Huynh, Anne] CHU Oncopole, Sect Greffe, Toulouse, France; [Tabrizi, Reza] CHU Bordeaux, Serv Hematol & Therapie Cellulaire, Bordeaux, France; [Labussiere-Wallet, Helene] Lyon Sud Hosp, Hospices Civils Lyon, Dept Hematol, Pierre Benite, Lyon, France; [Bernard, Marc] CHU Pontchaillou, Hematol Clin, Rennes, France; [Chantepie, Sylvain] CHU Caen, Inst Hematol Basse Normandie, Ave Cote Nacre, Caen, France; [Bay, Jacques-Olivier] Univ Auvergne, CHU Clermont Ferrand Hop Estaing, Serv Therapie Cellulaire & Hematol Clin Adulte, CIC 501, Clermont Ferrand, France; [Thiebaut-Bertrand, Anne] Univ Grenoble Alpes, Clin Univ Hematol, CHU Grenoble Alpes, CS 10217, Grenoble, France; [Thepot, Sylvain] CHU Angers, Serv Hematol Malad Sang, Angers, France; [Thepot, Sylvain] Univ Angers, INSERM, Unit 1232, LabEx IGO, Angers, France; [Contentin, Nathalie] Ctr Henri Becquerel, Serv Hematol, Rouen, France; [Fornecker, Luc-Matthieu] CHU Strasbourg, Serv Hematol, Strasbourg, France; [Maillard, Natacha] CHU Poitiers, Serv Hematol, Poitiers, France; [Risso, Karine] Ctr Hosp Univ Nice, Serv Hematol, Nice, France; [Berceanu, Ana] CHRU Besancon, Hematol, Besancon, France; [Blaise, Didier] Aix Marseille Univ, CNRS, Inst Paoli Calmettes,CRCM, INSERM, Marseille, France; [de La Tour, Regis Peffault] SFGM TC, Pierre Benite, France; [Chien, Jason W.] Gilead Sci Inc, Foster City, CA USA; [Coiteux, Valerie] CHRU Lille, Sect Allogreffe Cellules Souches Hematopoiet, Serv Malad Sang, Lille, France; [Socie, Gerard] Univ Paris 07, Hematol Transplantat Hop St Louis, APHP, Paris, France; [Socie, Gerard] INSERM, UMR 1160, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; CHU Bordeaux; CHU Lyon; CHU Rennes; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UNICANCER; Centre Henri Becquerel; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Poitiers; Universite de Poitiers; CHU Nice; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Gilead Sciences; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bergeron, A (corresponding author), Hop St Louis, AP HP, Serv Pneumol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	anne.bergeron-lafaurie@aphp.fr	Blaise, Didier/R-2483-2016	Blaise, Didier/0000-0002-5684-9447; thepot, sylvain/0000-0003-3492-2778; Bergeron, Anne/0000-0003-2156-254X; Thiebaut-Bertrand, Anne/0000-0002-3984-0934; chevret, sylvie/0000-0001-6449-4730; Vincent, Laure/0000-0001-5904-1286	French Cancer Institute under the authority of the French Ministry of Health (PHRC) [AOM12, CRC16]; SOS Oxygene; SFGM-TC Capucine	French Cancer Institute under the authority of the French Ministry of Health (PHRC); SOS Oxygene; SFGM-TC Capucine	This trial was funded by the French Cancer Institute under the authority of the French Ministry of Health (PHRC 2012 code AOM12 and CRC16) and by additional grants from SOS Oxygene and SFGM-TC Capucine.	Abedin S, 2015, BIOL BLOOD MARROW TR, V21, P1127, DOI 10.1016/j.bbmt.2015.02.006; Armand P, 2012, BLOOD, V120, P905, DOI 10.1182/blood-2012-03-418202; Au BKC, 2011, BIOL BLOOD MARROW TR, V17, P1072, DOI 10.1016/j.bbmt.2010.11.018; Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664; Bergeron A, 2013, BONE MARROW TRANSPL, V48, P819, DOI 10.1038/bmt.2012.241; Bergeron A, 2017, CLIN CHEST MED, V38, P249, DOI 10.1016/j.ccm.2016.12.013; Bergeron A, 2015, AM J RESP CRIT CARE, V191, P1242, DOI 10.1164/rccm.201410-1818OC; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Cheng GS, 2016, ANN AM THORAC SOC, V13, P1932, DOI 10.1513/AnnalsATS.201604-262OC; Chien JW, 2003, AM J RESP CRIT CARE, V168, P208, DOI 10.1164/rccm.200212-1468OC; Corris PA, 2015, THORAX, V70, P442, DOI 10.1136/thoraxjnl-2014-205998; COX DR, 1972, J R STAT SOC B, V34, P187; Cramer CL, 2017, POSTGRAD MED, V129, P493, DOI 10.1080/00325481.2017.1285677; Dhedin N, 2015, BLOOD, V125, P2486, DOI 10.1182/blood-2014-09-599894; Diab M, 2016, EXP CLIN TRANSPLANT, V14, P259, DOI 10.6002/ect.2015.0275; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Genolini C, 2011, COMPUT METH PROG BIO, V104, pE112, DOI 10.1016/j.cmpb.2011.05.008; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Holbro A, 2013, BIOL BLOOD MARROW TR, V19, P973, DOI 10.1016/j.bbmt.2013.03.017; HOROWITZ MM, 1990, BLOOD, V75, P555; Ishimatsu Y, 2004, INT J ANTIMICROB AG, V24, P247, DOI 10.1016/j.ijantimicag.2004.03.022; Iwamoto S, 2013, CLIN EXP IMMUNOL, V171, P338, DOI 10.1111/cei.12023; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; Lin SJ, 2016, INT IMMUNOPHARMACOL, V40, P318, DOI 10.1016/j.intimp.2016.09.012; Lin SJ, 2012, INT IMMUNOPHARMACOL, V13, P8, DOI 10.1016/j.intimp.2012.02.013; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Radhakrishnan SV, 2015, BIOL BLOOD MARROW TR, V21, P30, DOI 10.1016/j.bbmt.2014.09.025; Ruttens D, 2016, AM J TRANSPLANT, V16, P254, DOI 10.1111/ajt.13417; Schlemmer F, 2014, RESP MED, V108, P1525, DOI 10.1016/j.rmed.2014.09.006; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Uhlving HH, 2015, BIOL BLOOD MARROW TR, V21, P531, DOI 10.1016/j.bbmt.2014.12.004; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vieira AG, 2014, BONE MARROW TRANSPL, V49, P812, DOI 10.1038/bmt.2014.25; Vos R, 2011, EUR RESPIR J, V37, P164, DOI 10.1183/09031936.00068310; Vos R, 2012, TRANSPLANTATION, V94, P101, DOI 10.1097/TP.0b013e31824db9da; Weatherall M, 2009, EUR RESPIR J, V33, P1025, DOI 10.1183/09031936.00116808; Williams KM, 2017, BLOOD, V129, P448, DOI 10.1182/blood-2016-08-693507; Williams KM, 2016, BIOL BLOOD MARROW TR, V22, P710, DOI 10.1016/j.bbmt.2015.10.009; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yanik G, 2006, SEMIN HEMATOL, V43, P42, DOI 10.1053/j.seminhematol.2005.09.004	44	57	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					557	566		10.1001/jama.2017.9938	http://dx.doi.org/10.1001/jama.2017.9938			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787506	Green Published			2022-12-28	WOS:000407160100018
J	Evans, TM; Sing, DK; Kataria, T; Oyal, JG; Nikolov, N; Wakeford, HR; Deming, D; Marley, MS; Amundsen, DS; Ballester, GE; Barstow, JK; Ben-Jaffel, L; Bourrier, V; Buchhave, LA; Cohen, O; Ehrenreich, D; Munoz, AG; Henry, GW; Knutson, H; Lavvas, P; des Etangs, AL; Lewis, NK; Lopez-Morales, M; Mandell, AM; Sanz-Forcada, J; Tremblin, P; Lupu, R				Evans, Thomas M.; Sing, David K.; Kataria, Tiffany; Oyal, Jayesh G.; Nikolov, Nikolay; Wakeford, Hannah R.; Deming, Drake; Marley, Mark S.; Amundsen, David S.; Ballester, Gilda E.; Barstow, Joanna K.; Ben-Jaffel, Lotfi; Bourrier, Vincent; Buchhave, Lars A.; Cohen, Ofer; Ehrenreich, David; Munoz, Antonio Garcia; Henry, Gregory W.; Knutson, Heather; Lavvas, Panayotis; des Etangs, Alain Lecavelier; Lewis, Nikole K.; Lopez-Morales, Mercedes; Mandell, Avi M.; Sanz-Forcada, Jorge; Tremblin, Pascal; Lupu, Roxana			An ultrahot gas-giant exoplanet with a stratosphere	NATURE			English	Article							THERMAL STRUCTURE; HOT JUPITERS; HD 209458B; EMISSION-SPECTRUM; WATER ABUNDANCE; LIGHT CURVES; BROWN DWARF; TEMPERATURE; ATMOSPHERES; INVERSION	Infrared radiation emitted from a planet contains information about the chemical composition and vertical temperature profile of its atmosphere(1-3). If upper layers are cooler than lower layers, molecular gases will produce absorption features in the planetary thermal spectrum(4,5). Conversely, if there is a stratosphere-where temperature increases with altitude-these molecular features will be observed in emission(6-8). It has been suggested that stratospheres could form in highly irradiated exoplanets(9,10), but the extent to which this occurs is unresolved both theoretically(11,12) and observationally(3,13-15). A previous claim for the presence of a stratosphere(14) remains open to question, owing to the challenges posed by the highly variable host star and the low spectral resolution of the measurements(3). Here we report a near-infrared thermal spectrum for the ultrahot gas giant WASP-121b, which has an equilibrium temperature of approximately 2,500 kelvin. Water is resolved in emission, providing a detection of an exoplanet stratosphere at 5 sigma confidence. These observations imply that a substantial fraction of incident stellar radiation is retained at high altitudes in the atmosphere, possibly by absorbing chemical species such as gaseous vanadium oxide and titanium oxide.	[Evans, Thomas M.; Sing, David K.; Oyal, Jayesh G.; Nikolov, Nikolay] Univ Exeter, Sch Phys, Astrophys Grp, Stocker Rd, Exeter EX4 4QL, Devon, England; [Kataria, Tiffany] NASA, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Wakeford, Hannah R.; Mandell, Avi M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Marley, Mark S.] NASA, Ames Res Ctr, MS 245-5, Moffett Field, CA 94035 USA; [Amundsen, David S.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10025 USA; [Amundsen, David S.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Ballester, Gilda E.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Barstow, Joanna K.] UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England; [Ben-Jaffel, Lotfi; des Etangs, Alain Lecavelier] UPMC Univ Paris 6, Sorbonne Univ, 98 Bis Blvd Arago, F-75014 Paris, France; [Ben-Jaffel, Lotfi; des Etangs, Alain Lecavelier] CNRS, UMR 7095, Inst Astrophys Paris, 98 Bis Blvd Arago, F-75014 Paris, France; [Bourrier, Vincent; Ehrenreich, David] Observ Univ Geneve, 51 Chemin Maillettes, CH-1290 Sauverny, Switzerland; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum, DK-1350 Copenhagen, Denmark; [Cohen, Ofer] Univ Massachusetts, Lowell Ctr Space Sci & Technol, Lowell, MA 01854 USA; [Munoz, Antonio Garcia] Tech Univ Berlin, Zentrum Astron & Astrophys, D-10623 Berlin, Germany; [Henry, Gregory W.] Tennessee State Univ, Ctr Excellence Informat Syst, Nashville, TN 37209 USA; [Knutson, Heather] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lavvas, Panayotis] Univ Reims, CNRS, UMR 7331, Grp Spectrometrie Mol & Atmospher, F-51687 Reims, France; [Lewis, Nikole K.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Lopez-Morales, Mercedes] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Sanz-Forcada, Jorge] Ctr Astrobiol CSIC INTA, ESAC Campus, E-28692 Madrid, Spain; [Tremblin, Pascal] Univ Paris Saclay, Univ Paris Sud, UVSQ, Maison Simulat,CEA,CNRS, F-91191 Gif Sur Yvette, France; [Lupu, Roxana] Bay Area Environm Res Inst, Moffett Field, CA 94035 USA	University of Exeter; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of London; University College London; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Geneva; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of Massachusetts System; University of Massachusetts Lowell; Technical University of Berlin; Tennessee State University; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Reims Champagne-Ardenne; Space Telescope Science Institute; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Evans, TM (corresponding author), Univ Exeter, Sch Phys, Astrophys Grp, Stocker Rd, Exeter EX4 4QL, Devon, England.	tevans@astro.ex.ac.uk	Mandell, Avi M/F-9361-2012; Buchhave, Lars A./ABF-2000-2020; Wakeford, Hannah/H-7883-2018; Lecavelier des Etangs, Alain/GLU-6503-2022; Nikolov, Nikolay/H-6183-2015	Mandell, Avi M/0000-0002-8119-3355; Buchhave, Lars A./0000-0003-1605-5666; Wakeford, Hannah/0000-0003-4328-3867; Lecavelier des Etangs, Alain/0000-0002-5637-5253; Garcia Munoz, Antonio/0000-0003-1756-4825; Barstow, Joanna/0000-0003-3726-5419; Tremblin, Pascal/0000-0001-6172-3403; Nikolov, Nikolay/0000-0002-6500-3574; Goyal, Jayesh/0000-0002-8515-7204; Evans, Thomas/0000-0001-5442-1300; Lavvas, Panayotis/0000-0002-5360-3660; Sing, David/0000-0001-6050-7645	NASA; European Research Council under the European Union [336792]; ERC [724427]; NASA [HST-GO-14767]; NASA Postdoctoral Program; NASA Exoplanets Research Program; Royal Astronomical Society Fellowship; National Centre for Competence in Research "PlanetS" by the Swiss National Science Foundation (SNSF); CNES; French Agence Nationale de la Recherche (ANR) [ANR-12-BS05-0012]; Spanish MINECO [AYA2014-54348-C3-2-R]; NSF; Tennessee State University; State of Tennessee through its Centers of Excellence programme; CNES (France)	NASA(National Aeronautics & Space Administration (NASA)); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); NASA(National Aeronautics & Space Administration (NASA)); NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); NASA Exoplanets Research Program; Royal Astronomical Society Fellowship; National Centre for Competence in Research "PlanetS" by the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); CNES(Centre National D'etudes Spatiales); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Spanish MINECO(Spanish Government); NSF(National Science Foundation (NSF)); Tennessee State University; State of Tennessee through its Centers of Excellence programme; CNES (France)(Centre National D'etudes Spatiales)	This work is based on observations with the NASA/ESA HST, obtained at the Space Telescope Science Institute (STScI) operated by AURA, Inc. This work is also based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 336792 and is supported by the ERC Horizon 2020 research and innovation programme (grant agreement no. 724427). Support for this work was provided by NASA through grants under the HST-GO-14767 "Panchromatic Comparative Exoplanetary Treasury (PanCET)" programme from the STScI. J.G. acknowledges support from a Leverhulme Trust Research Project Grant. H.R.W acknowledges support from the NASA Postdoctoral Program, administered by Universities Space Research Association through a contract with NASA. M.S.M. acknowledges support from the NASA Exoplanets Research Program. J.K.B. acknowledges support from a Royal Astronomical Society Fellowship. D.E. and V.B. acknowledge the financial support of the National Centre for Competence in Research "PlanetS" supported by the Swiss National Science Foundation (SNSF). A.L.E. acknowledges support from CNES and the French Agence Nationale de la Recherche (ANR), under programme ANR-12-BS05-0012 "Exo-Atmos". J.S.-F. acknowledges support from the Spanish MINECO through grant AYA2014-54348-C3-2-R. G.W.H. acknowledges support from NASA, NSF, Tennessee State University, and the State of Tennessee through its Centers of Excellence programme. L.B.-J. and P.L. acknowledge support from CNES (France) under project PACES. P.T. and D.S.A. acknowledge funding from the European Research Council under the European Union Seventh Framework Program: grant 247060-PEPS.	Amundsen DS, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629322; Amundsen DS, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201323169; Beatty T. G., 2016, EVIDENCE ATMOSPHERIC; Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Cartier KMS, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/1/34; Delrez L, 2016, MON NOT R ASTRON SOC, V458, P4025, DOI 10.1093/mnras/stw522; Deming D, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/132; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Drummond B, 2016, ASTRON ASTROPHYS, V594, DOI [10.1051/0004-6361/20162.8799, 10.1051/0004-6361/201628799]; Evans TM, 2016, ASTROPHYS J LETT, V822, DOI 10.3847/2041-8205/822/1/L4; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GILLETT FC, 1969, ASTROPHYS J, V157, P925, DOI 10.1086/150124; Guillot T, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913396; Hauschildt PH, 1999, ASTROPHYS J, V512, P377, DOI 10.1086/306745; Haynes K, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/146; Heng KV, 2012, MON NOT R ASTRON SOC, V420, P20, DOI 10.1111/j.1365-2966.2011.19943.x; Hickey MP, 2000, ICARUS, V148, P266, DOI 10.1006/icar.2000.6472; Hubeny I, 2003, ASTROPHYS J, V594, P1011, DOI 10.1086/377080; Jones E., 2001, SCIPY OPEN SOURCE SC; Kirkpatrick JD, 2010, ASTROPHYS J SUPPL S, V190, P100, DOI 10.1088/0067-0049/190/1/100; Kreidberg L, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L27; Lewis NK, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/95; Line MR, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/137; Lodders K, 2002, ASTROPHYS J, V577, P974, DOI 10.1086/342241; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Marley MS, 1999, ICARUS, V138, P268, DOI 10.1006/icar.1998.6071; Matcheva KI, 1999, ICARUS, V140, P328, DOI 10.1006/icar.1999.6151; RIDGWAY ST, 1974, ASTROPHYS J, V187, pL41, DOI 10.1086/181388; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Sharp CM, 2007, ASTROPHYS J SUPPL S, V168, P140, DOI 10.1086/508708; Spiegel DS, 2009, ASTROPHYS J, V699, P1487, DOI 10.1088/0004-637X/699/2/1487; Stevenson KB, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/2/68; Stevenson KB, 2014, SCIENCE, V346, P838, DOI 10.1126/science.1256758; Tennyson J, 2016, J MOL SPECTROSC, V327, P73, DOI 10.1016/j.jms.2016.05.002; Tremblin P, 2016, ASTROPHYS J LETT, V817, DOI 10.3847/2041-8205/817/2/L19; Tremblin P, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/1/L17; Wakeford HR, 2017, ASTROPHYS J LETT, V835, DOI 10.3847/2041-8213/835/1/L12; Wakeford HR, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424207; Wakeford HR, 2017, SCIENCE, V356, P628, DOI 10.1126/science.aah4668; WALLACE L, 1974, ASTROPHYS J, V193, P481, DOI 10.1086/153184; Wilkins AN, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/113; Wong I, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/2/122	51	159	159	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					58	+		10.1038/nature23266	http://dx.doi.org/10.1038/nature23266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770846	Green Submitted, Green Accepted			2022-12-28	WOS:000406831700035
J	Mani, RG; Kriisa, A				Mani, Ramesh G.; Kriisa, Annika			Improve contactless sensing technology	NATURE			English	Letter									[Mani, Ramesh G.; Kriisa, Annika] Georgia State Univ, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Mani, RG (corresponding author), Georgia State Univ, Atlanta, GA 30303 USA.	mani.rg@gmail.com						Briane M, 2009, ARCH RATION MECH AN, V193, P715, DOI 10.1007/s00205-008-0200-y; Kern C, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.016601; MANI RG, 1994, APPL PHYS LETT, V64, P1262, DOI 10.1063/1.110859	3	0	0	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					31	31		10.1038/548031e	http://dx.doi.org/10.1038/548031e			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770847	Bronze			2022-12-28	WOS:000406831700025
J	Horton, R				Horton, Richard			Offline: Medicines leadership-Britain's loss, Europe's gain	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					440	440		10.1016/S0140-6736(17)31995-5	http://dx.doi.org/10.1016/S0140-6736(17)31995-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28792399	Bronze			2022-12-28	WOS:000406463400010
J	Dilnot, A				Dilnot, Andrew			The burden of triumph: meeting health and social care needs	LANCET			English	Editorial Material									[Dilnot, Andrew] Univ Oxford, Nuffield Coll, Oxford OX1 1NF, England	University of Oxford	Dilnot, A (corresponding author), Univ Oxford, Nuffield Coll, Oxford OX1 1NF, England.	andrew.dilnot@nuffield.ox.ac.uk			UK Government's commission	UK Government's commission	I was from 2010 to 2011 the chair of the UK Government's commission on the funding of care and support. I declare no other competing interests.	[Anonymous], 2015, HAS LIF EXP CHANG TI; Barr N, 2010, SOC POLICY ADMIN, V44, P359, DOI 10.1111/j.1467-9515.2010.00718.x; Kingston A, 2017, LANCET; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Muir T, 2017, OECD HLTH WORKING PA, DOI 10.1787/a411500aen; National Archives, 2011, FAIR CAR FUND REP CO	6	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1630	1631		10.1016/S0140-6736(17)31938-4	http://dx.doi.org/10.1016/S0140-6736(17)31938-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI9TS	28821409	hybrid			2022-12-28	WOS:000412352800008
J	Merli, GJ; Weitz, HH				Merli, Geno J.; Weitz, Howard H.			Venous Thrombosis and Cancer: What Would Dr. Trousseau Teach Today?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Merli, Geno J.; Weitz, Howard H.] Thomas Jefferson Univ Hosp, Suite 2210 Gibbon,111 South 11th St, Philadelphia, PA 19107 USA; [Weitz, Howard H.] Jefferson Heart Inst, 925 Chestnut St,Suite 200, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Merli, GJ (corresponding author), Thomas Jefferson Univ Hosp, Suite 2210 Gibbon,111 South 11th St, Philadelphia, PA 19107 USA.	geno.merli@jefferson.edu						ACKERMAN RF, 1951, ANN INTERN MED, V34, P902, DOI 10.7326/0003-4819-34-4-902; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Khorana AA, 2003, J THROMB HAEMOST, V1, P2463, DOI 10.1111/j.1538-7836.2003.00501.x; TROUSSEAU A, 1963, CLIN MED HOTEL DIEU; Trousseau A., 1868, LECT CLIN MED DELIVE; van Es N, 2017, ANN INTERN MED, V167, P410, DOI 10.7326/M17-0868	6	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					440	+		10.7326/M17-2030	http://dx.doi.org/10.7326/M17-2030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28828491				2022-12-28	WOS:000411009900024
J	Falk, AL				Falk, Abram L.			Addressing spin states with infrared light	SCIENCE			English	Editorial Material							SILICON-CARBIDE; ROOM-TEMPERATURE; COHERENT CONTROL; SINGLE SPINS; QUBITS		[Falk, Abram L.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Falk, AL (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	alfalk@us.ibm.com						Baranov PG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125203; Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Christle DJ, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021046; Christle DJ, 2015, NAT MATER, V14, P160, DOI [10.1038/NMAT4144, 10.1038/nmat4144]; Dobrovitski VV, 2013, ANNU REV CONDEN MA P, V4, P23, DOI 10.1146/annurev-conmatphys-030212-184238; Falk AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2854; Koehl WF, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.035207; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Siyushev P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4895; Toyli DM, 2010, NANO LETT, V10, P3168, DOI 10.1021/nl102066q; Widmann M, 2015, NAT MATER, V14, P164, DOI [10.1038/NMAT4145, 10.1038/nmat4145]	12	1	1	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					649	649		10.1126/science.aan8807	http://dx.doi.org/10.1126/science.aan8807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818932				2022-12-28	WOS:000407793600020
J	Wirka, RC; Quertermous, T				Wirka, Robert C.; Quertermous, Thomas			Circulating peptide prevents preeclampsia	SCIENCE			English	Editorial Material							APELIN		[Wirka, Robert C.; Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Quertermous, T (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	tomq1@stanford.edu		Quertermous, Thomas/0000-0002-7645-9067				Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Schreiber CA, 2016, CURR GENE THER, V16, P349, DOI 10.2174/1566523217666161121111906; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yang PR, 2015, TRENDS PHARMACOL SCI, V36, P560, DOI 10.1016/j.tips.2015.06.002	6	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					643	644		10.1126/science.aao2642	http://dx.doi.org/10.1126/science.aao2642			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818928				2022-12-28	WOS:000407793600016
J	Lee, H; Macpherson, LJ; Parada, CA; Zuker, CS; Ryba, NJP				Lee, Hojoon; Macpherson, Lindsey J.; Parada, Camilo A.; Zuker, Charles S.; Ryba, Nicholas J. P.			Rewiring the taste system	NATURE			English	Article							SELF-AVOIDANCE; SEMAPHORIN 7A; RECEPTORS; GROWTH; PROTOCADHERINS; CHEMOAFFINITY; SPECIFICITY; RESPONSES; PATHWAYS; CIRCUITS	In mammals, taste buds typically contain 50-100 tightly packed taste-receptor cells (TRCs), representing all five basic qualities: sweet, sour, bitter, salty and umami(1,2). Notably, mature taste cells have life spans of only 5-20 days and, consequently, are constantly replenished by differentiation of taste stem cells(3). Given the importance of establishing and maintaining appropriate connectivity between TRCs and their partner ganglion neurons (that is, ensuring that a labelled line from sweet TRCs connects to sweet neurons, bitter TRCs to bitter neurons, sour to sour, and so on), we examined how new connections are specified to retain fidelity of signal transmission. Here we show that bitter and sweet TRCs provide instructive signals to bitter and sweet target neurons via different guidance molecules (SEMA3A and SEMA7A)(4-6). We demonstrate that targeted expression of SEMA3A or SEMA7A in different classes of TRCs produces peripheral taste systems with miswired sweet or bitter cells. Indeed, we engineered mice with bitter neurons that now responded to sweet tastants, sweet neurons that responded to bitter or sweet neurons responding to sour stimuli. Together, these results uncover the basic logic of the wiring of the taste system at the periphery, and illustrate how a labelled-line sensory circuit preserves signalling integrity despite rapid and stochastic turnover of receptor cells.	[Lee, Hojoon; Macpherson, Lindsey J.; Parada, Camilo A.; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Lee, Hojoon; Macpherson, Lindsey J.; Parada, Camilo A.; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.; Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	cz2195@columbia.edu		Ryba, Nicholas/0000-0002-2060-8393; Macpherson, Lindsey/0000-0002-1089-3733; Lee, Hojoon/0000-0001-6214-629X	National Institute On Drug Abuse of the National Institutes of Health [R01DA035025]; Intramural Research Program of the NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035025] Funding Source: NIH RePORTER	National Institute On Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Intramural Research Program of the NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Yagi for providing the floxed Sema3a mice, R. Barretto and D. Yarmolinsky for help with in vivo imaging and analysis, and Z. Wu, I. Schieren and S. O'Keeffe for advice and expert technical support. We also thank N. Balaskas and the members of the Zuker laboratory for helpful comments and suggestions. Research reported in this publication was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R01DA035025 (C.S.Z.) and in part by the Intramural Research Program of the NIH, NIDCR (N.J.P.R.). L.J.M. was an HHMI Fellow of the Jane Coffin Childs Memorial Fund. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farm Research Campus.	Barlow LA, 2015, CURR TOP DEV BIOL, V111, P401, DOI 10.1016/bs.ctdb.2014.11.012; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Carcea I, 2014, P NATL ACAD SCI USA, V111, P13978, DOI 10.1073/pnas.1408680111; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Coate TM, 2015, ELIFE, V4, DOI 10.7554/eLife.07830; Hayashi S, 2015, J CELL SCI, V128, P1455, DOI 10.1242/jcs.166306; Koropouli E, 2014, CURR OPIN NEUROBIOL, V27, P1, DOI 10.1016/j.conb.2014.02.005; Langley J N, 1895, J Physiol, V18, P280; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Telley L, 2016, NEURON, V91, P1276, DOI 10.1016/j.neuron.2016.08.015; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vandenbeuch A, 2015, J PHYSIOL-LONDON, V593, P1113, DOI 10.1113/jphysiol.2014.281014; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9171; Yarmolinsky DA, 2016, NEURON, V92, P1079, DOI 10.1016/j.neuron.2016.10.021; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshida Y, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmo1.2012.00071, 10.3389/fnmol.2012.00071]; Zaidi FN, 2006, J NEUROSCI, V26, P8243, DOI 10.1523/JNEUROSCI.5142-05.2006; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	35	61	65	7	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					330	+		10.1038/nature23299	http://dx.doi.org/10.1038/nature23299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792937	Green Accepted			2022-12-28	WOS:000407748400032
J	Westaway, KE; Louys, J; Awe, RD; Morwood, MJ; Price, GJ; Zhao, JX; Aubert, M; Joannes-Boyau, R; Smith, TM; Skinner, MM; Compton, T; Bailey, RM; van den Bergh, GD; de Vos, J; Pike, AWG; Stringer, C; Saptomo, EW; Rizal, Y; Zaim, J; Santoso, WD; Trihascaryo, A; Kinsley, L; Sulistyanto, B				Westaway, K. E.; Louys, J.; Awe, R. Due; Morwood, M. J.; Price, G. J.; Zhao, J. -X.; Aubert, M.; Joannes-Boyau, R.; Smith, T. M.; Skinner, M. M.; Compton, T.; Bailey, R. M.; van den Bergh, G. D.; de Vos, J.; Pike, A. W. G. .; Stringer, C.; Saptomo, E. W.; Rizal, Y.; Zaim, J.; Santoso, W. D.; Trihascaryo, A.; Kinsley, L.; Sulistyanto, B.			An early modern human presence in Sumatra 73,000-63,000 years ago	NATURE			English	Article							REGENERATIVE-DOSE PROTOCOL; U-SERIES; ENAMEL THICKNESS; TOOTH ENAMEL; SINGLE-ALIQUOT; HOMO-SAPIENS; LOWER MOLARS; QUARTZ; LUMINESCENCE; INDONESIA	Genetic evidence for anatomically modern humans (AMH) out of Africa before 75 thousand years ago (ka)(1) and in island southeast Asia (ISEA) before 60 ka (93-61 ka)(2) predates accepted archaeological records of occupation in the region(3). Claims that AMH arrived in ISEA before 60 ka (ref. 4) have been supported only by equivocal(5) or non-skeletal evidence(6). AMH evidence from this period is rare and lacks robust chronologies owing to a lack of direct dating applications(7), poor preservation and/or excavation strategies(8) and questionable taxonomic identifications(9). Lida Ajer is a Sumatran Pleistocene cave with a rich rainforest fauna associated with fossil human teeth(7,10). The importance of the site is unclear owing to unsupported taxonomic identification of these fossils and uncertainties regarding the age of the deposit, therefore it is rarely considered in models of human dispersal. Here we reinvestigate Lida Ajer to identify the teeth confidently and establish a robust chronology using an integrated dating approach. Using enamel-dentine junction morphology, enamel thickness and comparative morphology, we show that the teeth are unequivocally AMH. Luminescence and uranium-series techniques applied to bone-bearing sediments and speleothems, and coupled uranium-series and electron spin resonance dating of mammalian teeth, place modern humans in Sumatra between 73 and 63 ka. This age is consistent with biostratigraphic estimations(7), palaeoclimate and sea-level reconstructions, and genetic evidence for a pre-60 ka arrival of AMH into ISEA(2). Lida Ajer represents, to our knowledge, the earliest evidence of rainforest occupation by AMH, and underscores the importance of reassessing the timing and environmental context of the dispersal of modern humans out of Africa.	[Westaway, K. E.] Macquarie Univ, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW 2109, Australia; [Louys, J.] Australian Natl Univ, Sch Culture Hist & Languages, ANU Coll Asia & Pacific, Canberra, ACT, Australia; [Awe, R. Due; Saptomo, E. W.; Sulistyanto, B.] Indonesian Ctr Archaeol, Jl Raya Condet Pejaten 4, Jakarta 12001, Indonesia; [Morwood, M. J.; van den Bergh, G. D.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Price, G. J.; Zhao, J. -X.] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld 4072, Australia; [Aubert, M.] Griffith Univ, PERAHU, Gold Coast, Australia; [Joannes-Boyau, R.] Southern Cross Univ, Southern Cross GeoSci, Mil Rd, Lismore, NSW 2480, Australia; [Smith, T. M.] Griffith Univ, Australian Res Ctr Human Evolut, Environm Futures Res Inst, 170 Kessels Rd, Nathan, Qld 4111, Australia; [Smith, T. M.] Harvard Univ, Dept Human Evolutionary Biol, 11 Divinity Ave, Cambridge, MA 02138 USA; [Skinner, M. M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Skinner, M. M.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany; [Compton, T.] Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England; [Bailey, R. M.] Univ Oxford, Sch Geog & Environm, Oxford OX1 2JD, England; [de Vos, J.] Nat Biodivers Ctr, Dept Geol, Leiden, Netherlands; [Pike, A. W. G. .] Univ Southampton, Dept Archaeol, Highfield Rd, Southampton SO17 1BF, Hants, England; [Rizal, Y.; Zaim, J.; Santoso, W. D.; Trihascaryo, A.] Inst Teknologi Bandung, Geol Study Program, Java, Indonesia; [Trihascaryo, A.] Australian Natl Univ, Sch Earth Sci, Canberra, ACT, Australia	Macquarie University; Australian National University; University of Wollongong; University of Queensland; Griffith University; Southern Cross University; Griffith University; Harvard University; University of Kent; Max Planck Society; Natural History Museum London; University of Oxford; Naturalis Biodiversity Center; University of Southampton; Institute Technology of Bandung; Australian National University	Westaway, KE (corresponding author), Macquarie Univ, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW 2109, Australia.	kira.westaway@mq.edu.au	Louys, Julien/GLN-6714-2022; Joannes-Boyau, Renaud/D-6058-2012; Aubert, Maxime/AAT-6198-2020; Price, Gilbert J/N-3282-2013; van den Bergh, Gerrit D/I-7670-2016; Zhao, Jian-xin/A-5938-2008; Skinner, Matthew/D-1104-2010	Joannes-Boyau, Renaud/0000-0002-0452-486X; Aubert, Maxime/0000-0002-4189-531X; Price, Gilbert J/0000-0001-8406-4594; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Zhao, Jian-xin/0000-0002-2413-6178; Smith, Tanya M./0000-0001-8175-8208; Westaway, Kira/0000-0001-5315-778X; Skinner, Matthew/0000-0001-8321-3543; Louys, Julien/0000-0001-7539-0689	Australian Research Council [DP1093049, DP140100919, DP120101752]; Leaky Foundation grant; Research School of Asia; Human Origins Research Fund; Calleva Foundation; Max Planck Society; Pacific Grant Development Support grant	Australian Research Council(Australian Research Council); Leaky Foundation grant; Research School of Asia; Human Origins Research Fund; Calleva Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Pacific Grant Development Support grant	This research was funded by Australian Research Council Discovery grants (DP1093049, DP140100919, and DP120101752 to K.E.W., R.J.-B., and G.J.P. et al., respectively) and a Leaky Foundation grant and Research School of Asia and the Pacific Grant Development Support grant to J.L.C.S.'s research is supported by the Human Origins Research Fund and the Calleva Foundation. We acknowledge the Max Planck Society for funding micro-CT scanning of the teeth, A. Olejnicak and J. P. Zermeno for assistance with section preparation, and support provided by the Centre from Archaeology in Padang Sumatra and ARKENAS in Jakarta and for allowing access to the site and four fossil faunal teeth for dating. We thank the Department of Geology, Naturalis Biodiversity Center in Leiden, The Netherlands for providing access to Dubois's fieldnote book, excavation details, the two modern human teeth for scanning and the Pongo tooth for dating, and we thank C. Bronk Ramsey for assistance with age modelling.	Barker G., 2016, ARCHAEOLOGICAL INVES, V2; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Clark TR, 2014, GEOCHIM COSMOCHIM AC, V138, P57, DOI 10.1016/j.gca.2014.04.022; de Vos J, 2007, ENCY QUATERNARY SCI, P3232, DOI [10.1016/B0-44-452747-8/00256-8, DOI 10.1016/B0-44-452747-8/00256-8]; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; DEVOS J, 1983, P K NED AKAD B PHYS, V86, P417; Drawhorn GM, 1994, THESIS; Dubois E, 1891, NATUURKUNDIG TIJDSCH, V51, P93; Duval M, 2016, QUAT GEOCHRONOL, V31, P19, DOI 10.1016/j.quageo.2015.09.007; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Erlandson JM, 2015, QUATERN INT, V382, P31, DOI 10.1016/j.quaint.2015.03.046; Feathers JK, 2001, QUATERNARY SCI REV, V20, P961, DOI 10.1016/S0277-3791(00)00041-X; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R, 1998, J HUM EVOL, V34, P555, DOI 10.1006/jhev.1997.0211; Guerin G., 2011, ANCIENT TL, V29, P5; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley D.J., 1997, ANCIENT TL, V15, P11; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Huot S, 2006, RADIAT MEAS, V41, P796, DOI 10.1016/j.radmeas.2006.05.001; Indriati E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021562; Joannes-Boyau R, 2013, GEOCHRONOMETRIA, V40, P322, DOI 10.2478/s13386-013-0132-7; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Louys J, 2012, CR PALEVOL, V11, P203, DOI 10.1016/j.crpv.2011.03.003; Louys J, 2010, J BIOGEOGR, V37, P1432, DOI 10.1111/j.1365-2699.2010.02297.x; Ludwig K.R, 2003, USERS MANUAL ISOPLOT; Ludwig K.R., 2012, USERS MANUAL ISOPLOT, V5, P1, DOI DOI 10.1016/S0016-7037(98)00059-3; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin L.B., 1983, THESIS; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Moorrees C. F. A., 1957, THE ALEUT DENTITION; Morwood MJ, 2008, J ARCHAEOL SCI, V35, P1776, DOI 10.1016/j.jas.2007.11.025; Morwood MJ, 2009, J HUM EVOL, V57, P437, DOI 10.1016/j.jhevol.2009.07.003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Murray AS, 2009, RADIAT MEAS, V44, P554, DOI 10.1016/j.radmeas.2009.02.004; Murray AS, 1999, QUATERNARY SCI REV, V18, P223, DOI 10.1016/S0277-3791(98)00055-9; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; NEWSOME J, 1988, J BIOGEOGR, V15, P555, DOI 10.2307/2845436; Oppenheimer S, 2012, QUATERN INT, V258, P88, DOI 10.1016/j.quaint.2011.07.049; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Petraglia M. D., QUAT INT, V258, P119; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Rasband W. S, 2008, IMAGEJ; Roberts P, 2015, WORLD ARCHAEOL, V47, P718, DOI 10.1080/00438243.2015.1073119; Roberts RG, 2009, J HUM EVOL, V57, P484, DOI 10.1016/j.jhevol.2009.01.003; Schwartz Jeffrey H., 1995, Anthropological Papers of the American Museum of Natural History, V76, P1; Shackelford L., 2017, QUAT INT; Shao QF, 2012, QUAT GEOCHRONOL, V10, P406, DOI 10.1016/j.quageo.2012.02.009; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith T., 2011, HUMAN ORIGINS RES, V1, pe1, DOI [10.4081/hor.2011.e1, DOI 10.4081/HOR.2011.E1]; Smith TM, 2006, ARCH ORAL BIOL, V51, P974, DOI 10.1016/j.archoralbio.2006.04.012; Smith TM, 2012, AM J PHYS ANTHROPOL, V147, P417, DOI 10.1002/ajpa.22009; Spooner NA, 2002, RADIAT MEAS, V35, P59, DOI 10.1016/S1350-4487(01)00109-3; St Pierre EJ, 2013, J ARCHAEOL SCI, V40, P148, DOI 10.1016/j.jas.2012.07.007; Stokes S, 2003, QUATERNARY SCI REV, V22, P925, DOI 10.1016/S0277-379(03)00243-3; Storm P, 2013, J HUM EVOL, V64, P356, DOI 10.1016/j.jhevol.2012.11.002; Thiel C, 2011, QUATERN INT, V234, P23, DOI 10.1016/j.quaint.2010.05.018; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; Thomsen KJ, 2011, GEOCHRONOMETRIA, V38, P1, DOI 10.2478/s13386-011-0003-z; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; van der Kaars S, 2012, QUATERN INT, V258, P45, DOI 10.1016/j.quaint.2011.09.006; Weidenreich F., 1937, DENTITION SINANTHROP; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Westaway KE, 2006, QUATERNARY SCI REV, V25, P2513, DOI 10.1016/j.quascirev.2005.06.010; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Zhao JX, 2001, GEOLOGY, V29, P27, DOI 10.1130/0091-7613(2001)029<0027:TIMSUS>2.0.CO;2; Zhou HY, 2011, J QUATERNARY SCI, V26, P781, DOI 10.1002/jqs.1506	73	131	137	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					322	+		10.1038/nature23452	http://dx.doi.org/10.1038/nature23452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28792933	Green Accepted, Green Submitted			2022-12-28	WOS:000407748400030
J	[Anonymous]				[Anonymous]			Faster Orphan Drug Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					604	604		10.1001/jama.2017.10130	http://dx.doi.org/10.1001/jama.2017.10130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810007				2022-12-28	WOS:000407616000006
J	Schwalm, CR; Anderegg, WRL; Michalak, AM; Fisher, JB; Biondi, F; Koch, G; Litvak, M; Ogle, K; Shaw, JD; Wolf, A; Huntzinger, DN; Schaefer, K; Cook, R; Wei, YX; Fang, YY; Hayes, D; Huang, MY; Jain, A; Tian, HQ				Schwalm, Christopher R.; Anderegg, William R. L.; Michalak, Anna M.; Fisher, Joshua B.; Biondi, Franco; Koch, George; Litvak, Marcy; Ogle, Kiona; Shaw, John D.; Wolf, Adam; Huntzinger, Deborah N.; Schaefer, Kevin; Cook, Robert; Wei, Yaxing; Fang, Yuanyuan; Hayes, Daniel; Huang, Maoyi; Jain, Atul; Tian, Hanqin			Global patterns of drought recovery	NATURE			English	Article							MODEL INTERCOMPARISON PROJECT; PROGRAM MULTISCALE SYNTHESIS; LAND-COVER CHANGE; FOREST ECOSYSTEMS; CLIMATE EXTREMES; CARBON; BIODIVERSITY; RESISTANCE; REDUCTION; DIVERSITY	Drought, a recurring phenomenon with major impacts on both human and natural systems(1-3), is the most widespread climatic extreme that negatively affects the land carbon sink(2,4). Although twentieth-century trends in drought regimes are ambiguous(5-7), across many regions more frequent and severe droughts are expected in the twenty-first century(3,7-9). Recovery time-how long an ecosystem requires to revert to its pre-drought functional state-is a critical metric of drought impact. Yet the factors influencing drought recovery and its spatiotemporal patterns at the global scale are largely unknown. Here we analyse three independent datasets of gross primary productivity and show that, across diverse ecosystems, drought recovery times are strongly associated with climate and carbon cycle dynamics, with biodiversity and CO2 fertilization as secondary factors. Our analysis also provides two key insights into the spatiotemporal patterns of drought recovery time: first, that recovery is longest in the tropics and high northern latitudes (both vulnerable areas of Earth's climate system(10)) and second, that drought impacts(11) (assessed using the area of ecosystems actively recovering and time to recovery) have increased over the twentieth century. If droughts become more frequent, as expected, the time between droughts may become shorter than drought recovery time, leading to permanently damaged ecosystems and widespread degradation of the land carbon sink.	[Schwalm, Christopher R.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Schwalm, Christopher R.; Koch, George] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Anderegg, William R. L.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Michalak, Anna M.; Fang, Yuanyuan] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Fisher, Joshua B.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Biondi, Franco] Univ Nevada, EECB, DendroLab & Grad Program, Reno, NV 89557 USA; [Litvak, Marcy] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Ogle, Kiona] No Arizona Univ, Informat & Comp Program, Flagstaff, AZ 86011 USA; [Shaw, John D.] US Forest Serv, Rocky Mt Res Stn, Ogden, UT 84401 USA; [Wolf, Adam] Arable Labs Inc, 40 North Tulane St, Princeton, NJ 08542 USA; [Huntzinger, Deborah N.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Schaefer, Kevin] Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Cook, Robert; Wei, Yaxing] Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN 37831 USA; [Hayes, Daniel] Univ Maine, Sch Forest Resources, Orono, ME 04469 USA; [Huang, Maoyi] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Jain, Atul] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Tian, Hanqin] Auburn Univ, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Tian, Hanqin] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	Woods Hole Research Center; Northern Arizona University; Utah System of Higher Education; University of Utah; Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of New Mexico; Northern Arizona University; United States Department of Agriculture (USDA); United States Forest Service; Northern Arizona University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Maine System; University of Maine Orono; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Illinois System; University of Illinois Urbana-Champaign; Auburn University System; Auburn University; Auburn University System; Auburn University	Schwalm, CR (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.; Schwalm, CR (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	schwalm.christopher@gmail.com	Fang, Yuanyuan/F-1308-2011; Huang, Maoyi/I-8599-2012; Tian, Hanqin/A-6484-2012; Jain, Atul/D-2851-2016; Biondi, Franco/G-2536-2010; Wei, Yaxing/K-1507-2013	Fang, Yuanyuan/0000-0001-7067-7103; Huang, Maoyi/0000-0001-9154-9485; Tian, Hanqin/0000-0002-1806-4091; Jain, Atul/0000-0002-4051-3228; Biondi, Franco/0000-0003-0651-104X; Hayes, Daniel/0000-0002-3011-7934; Wei, Yaxing/0000-0001-6924-0078; Schwalm, Christopher/0000-0002-5035-5681	National Science Foundation (NSF) [DEB EF-1340270]; National Aeronautics and Space Administration (NASA) [NNX12AK12G, NNX12AP74G, NNX10AG01A, NNX11AO08A]; NASA; NASA [NNX10AG01A, NNN13D504T, NNN13D202T, NNN13D503T, NNH10AN681]; Directorate For Geosciences [1243071] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by the National Science Foundation (NSF) grant DEB EF-1340270. C.R.S. was also supported by National Aeronautics and Space Administration (NASA) grants NNX12AK12G, NNX12AP74G, NNX10AG01A and NNX11AO08A. J.B.F. contributed to this paper from the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Government sponsorship acknowledged. Support was provided to J.B.F. by NASA grants NNN13D504T (CARBON), NNN13D202T (INCA), and NNN13D503T (SUSMAP). Funding for the MsTMIP activity was provided through NASA grant NNX10AG01A. Data management support for preparing, documenting and distributing model driver and output data was performed by the Modeling and Synthesis Thematic Data Center at Oak Ridge National Laboratory (http://nacp.ornl.gov), with funding through NASA grant NNH10AN681. Finalized MsTMIP datasets are archived at the Oak Ridge National Laboratory Distributed Active Archive Center (http://daac.ornl.gov). This is MsTMIP contribution number 10.	Alexander LV, 2009, INT J CLIMATOL, V29, P317, DOI 10.1002/joc.1861; Anderegg WRL, 2015, SCIENCE, V349, P528, DOI 10.1126/science.aab1833; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Banerjee O, 2013, ECOL ECON, V91, P19, DOI 10.1016/j.ecolecon.2013.03.022; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; DeChant CM, 2015, J HYDROL, V526, P89, DOI 10.1016/j.jhydrol.2014.10.021; Ellis EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030535; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Grossiord C, 2014, P NATL ACAD SCI USA, V111, P14812, DOI 10.1073/pnas.1411970111; Grossiord C, 2014, ECOSYSTEMS, V17, P394, DOI 10.1007/s10021-013-9729-1; Hacke UG, 2001, PLANT PHYSIOL, V125, P779, DOI 10.1104/pp.125.2.779; Haines A, 2006, PUBLIC HEALTH, V120, P585, DOI 10.1016/j.puhe.2006.01.002; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hayes DJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003813; Huntzinger DN, 2013, GEOSCI MODEL DEV, V6, P2121, DOI 10.5194/gmd-6-2121-2013; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Jain AK, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002349; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Lei HM, 2014, J ADV MODEL EARTH SY, V6, P658, DOI 10.1002/2013MS000252; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Luo YQ, 2015, GLOBAL CHANGE BIOL, V21, P1737, DOI 10.1111/gcb.12766; Mao JF, 2012, J CLIMATE, V25, P5327, DOI 10.1175/JCLI-D-11-00401.1; Martorell S, 2014, PLANT CELL ENVIRON, V37, P617, DOI 10.1111/pce.12182; Meiyappan P, 2012, FRONT EARTH SCI-PRC, V6, P122, DOI 10.1007/s11707-012-0314-2; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Pan M, 2013, GEOPHYS RES LETT, V40, P3637, DOI 10.1002/grl.50728; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Schwalm CR, 2012, NAT GEOSCI, V5, P551, DOI [10.1038/NGEO1529, 10.1038/ngeo1529]; Secchi F, 2014, PLANT PHYSIOL, V164, P1789, DOI 10.1104/pp.114.237511; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Tian HQ, 2012, ECOSYSTEMS, V15, P674, DOI 10.1007/s10021-012-9539-x; Tobner CM, 2014, OECOLOGIA, V174, P609, DOI 10.1007/s00442-013-2815-4; Touma D, 2015, J HYDROL, V526, P196, DOI 10.1016/j.jhydrol.2014.12.011; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Wei Y, 2014, GEOSCI MODEL DEV, V7, P2875, DOI 10.5194/gmd-7-2875-2014; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	44	377	406	72	559	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					202	+		10.1038/nature23021	http://dx.doi.org/10.1038/nature23021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28796213	Green Submitted			2022-12-28	WOS:000407284300041
J	Verma, R				Verma, Rajanshu			Insulin-Mediated Lipohypertrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Verma, Rajanshu] Augusta Hlth, Fishersville, VA 22939 USA		Verma, R (corresponding author), Augusta Hlth, Fishersville, VA 22939 USA.	rajanshu@gmail.com							0	2	2	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					573	573		10.1056/NEJMicm1701235	http://dx.doi.org/10.1056/NEJMicm1701235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28792866				2022-12-28	WOS:000407212600010
J	[Anonymous]				[Anonymous]			Medical Writing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					579	579		10.1001/jama.2017.8600	http://dx.doi.org/10.1001/jama.2017.8600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787496				2022-12-28	WOS:000407160100028
J	Creed, MC				Creed, Meaghan C.			Toward a targeted treatment for addiction	SCIENCE			English	Editorial Material									[Creed, Meaghan C.] Univ Maryland, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Creed, MC (corresponding author), Univ Maryland, Dept Pharmacol, Baltimore, MD 21201 USA.	mcreed@som.umaryland.edu	Creed, Meaghan/AAW-8136-2021	Creed, Meaghan/0000-0002-9658-2601				Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Creed M, 2016, NEURON, V92, P214, DOI 10.1016/j.neuron.2016.09.001; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Spagnolo PA, 2017, BRAIN, V140, P1183, DOI 10.1093/brain/aww284	6	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					464	465		10.1126/science.aao1197	http://dx.doi.org/10.1126/science.aao1197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4VW	28774920				2022-12-28	WOS:000406840100027
J	Ahmadi, M; Alves, BXR; Baker, CJ; Bertsche, W; Butler, E; Capra, A; Carruth, C; Cesar, CL; Charlton, M; Cohen, S; Collister, R; Eriksson, S; Evans, A; Evetts, N; Fajans, J; Friesen, T; Fujiwara, MC; Gill, DR; Gutierrez, A; Hangst, JS; Hardy, WN; Hayden, ME; Isaac, CA; Ishida, A; Johnson, MA; Jones, SA; Jonsell, S; Kurchaninov, L; Madsen, N; Mathers, M; Maxwell, D; McKenna, JTK; Menary, S; Michan, JM; Momose, T; Munich, JJ; Nolan, P; Olchanski, K; Olin, A; Pusa, P; Rasmussen, CO; Robicheaux, F; Sacramento, RL; Sameed, M; Sarid, E; Silveira, DM; Stracka, S; Stutter, G; So, C; Tharp, TD; Thompson, JE; Thompson, RI; Van der Werf, DP; Wurtele, JS				Ahmadi, M.; Alves, B. X. R.; Baker, C. J.; Bertsche, W.; Butler, E.; Capra, A.; Carruth, C.; Cesar, C. L.; Charlton, M.; Cohen, S.; Collister, R.; Eriksson, S.; Evans, A.; Evetts, N.; Fajans, J.; Friesen, T.; Fujiwara, M. C.; Gill, D. R.; Gutierrez, A.; Hangst, J. S.; Hardy, W. N.; Hayden, M. E.; Isaac, C. A.; Ishida, A.; Johnson, M. A.; Jones, S. A.; Jonsell, S.; Kurchaninov, L.; Madsen, N.; Mathers, M.; Maxwell, D.; McKenna, J. T. K.; Menary, S.; Michan, J. M.; Momose, T.; Munich, J. J.; Nolan, P.; Olchanski, K.; Olin, A.; Pusa, P.; Rasmussen, C. O.; Robicheaux, F.; Sacramento, R. L.; Sameed, M.; Sarid, E.; Silveira, D. M.; Stracka, S.; Stutter, G.; So, C.; Tharp, T. D.; Thompson, J. E.; Thompson, R. I.; Van der Werf, D. P.; Wurtele, J. S.			Observation of the hyperfine spectrum of antihydrogen	NATURE			English	Article							TRAPPED ANTIHYDROGEN; MAGNETIC-MOMENT; ATOMIC-HYDROGEN; DEUTERIUM; MASER	The observation of hyperfine structure in atomic hydrogen by Rabi and co-workers(1-3) and the measurement(4) of the zero-field ground-state splitting at the level of seven parts in 10(13) are important achievements of mid-twentieth-century physics. The work that led to these achievements also provided the first evidence for the anomalous magnetic moment of the electron(5-8), inspired Schwinger's relativistic theory of quantum electrodynamics(9,10) and gave rise to the hydrogen maser(11), which is a critical component of modern navigation, geo-positioning and very-long-baseline interferometry systems. Research at the Antiproton Decelerator at CERN by the ALPHA collaboration extends these enquiries into the antimatter sector. Recently, tools have been developed that enable studies of the hyperfine structure of antihydrogen(12)-the antimatter counterpart of hydrogen. The goal of such studies is to search for any differences that might exist between this archetypal pair of atoms, and thereby to test the fundamental principles on which quantum field theory is constructed. Magnetic trapping of antihydrogen atoms(13,14) provides a means of studying them by combining electromagnetic interaction with detection techniques that are unique to antimatter(12,15). Here we report the results of a microwave spectroscopy experiment in which we probe the response of antihydrogen over a controlled range of frequencies. The data reveal clear and distinct signatures of two allowed transitions, from which we obtain a direct, magnetic-field-independent measurement of the hyperfine splitting. From a set of trials involving 194 detected atoms, we determine a splitting of 1,420.4 +/- 0.5 megahertz, consistent with expectations for atomic hydrogen at the level of four parts in 10(4). This observation of the detailed behaviour of a quantum transition in an atom of antihydrogen exemplifies tests of fundamental symmetries such as charge-parity-time in antimatter, and the techniques developed here will enable more-precise such tests.	[Ahmadi, M.; Nolan, P.; Pusa, P.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Alves, B. X. R.; Friesen, T.; Hangst, J. S.; Rasmussen, C. O.; Stutter, G.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Baker, C. J.; Charlton, M.; Eriksson, S.; Isaac, C. A.; Jones, S. A.; Madsen, N.; Maxwell, D.; Sameed, M.; Van der Werf, D. P.] Swansea Univ, Coll Sci, Dept Phys, Swansea SA2 8PP, W Glam, Wales; [Bertsche, W.; Johnson, M. A.] Univ Manchester, Sch Phys & Astron, Manchester M12 9PL, Lancs, England; [Bertsche, W.; Johnson, M. A.] Sci Tech Daresbury, Cockcroft Inst, Warrington WA4 4AD, Cheshire, England; [Butler, E.] CERN, Dept Phys, CH-1211 Geneva 23, Switzerland; [Capra, A.; Collister, R.; Fujiwara, M. C.; Gill, D. R.; Kurchaninov, L.; McKenna, J. T. K.; Michan, J. M.; Olchanski, K.; Olin, A.; Stracka, S.] TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada; [Carruth, C.; Fajans, J.; Wurtele, J. S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Cesar, C. L.; Sacramento, R. L.; Silveira, D. M.] Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, Brazil; [Cohen, S.] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Evans, A.; Thompson, R. I.] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [Evetts, N.; Gutierrez, A.; Hardy, W. N.; Momose, T.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Gutierrez, A.] UCL, Dept Med Phys & Biomed Engn, London WC1E 6BT, England; [Hayden, M. E.; Munich, J. J.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Ishida, A.] Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Jonsell, S.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Mathers, M.; Menary, S.; Thompson, J. E.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Michan, J. M.] Ecole Polytech Fed Lausanne, Swiss Plasma Ctr, CH-1015 Lausanne, Switzerland; [Olin, A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Robicheaux, F.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Sarid, E.] Soreq NRC, IL-81800 Yavne, Israel; [Stracka, S.] Univ Pisa, Largo Pontecorvo 3, I-56127 Pisa, Italy; [Stracka, S.] Sez INFN Pisa, Largo Pontecorvo 3, I-56127 Pisa, Italy; [Tharp, T. D.] Marquette Univ, Dept Phys, POB 1881, Milwaukee, WI 53201 USA; [Van der Werf, D. P.] CEA Saclay, IRFU, F-91191 Gif Sur Yvette, France	University of Liverpool; Aarhus University; Swansea University; University of Manchester; STFC Daresbury Laboratory; European Organization for Nuclear Research (CERN); University of Geneva; University of British Columbia; University of California System; University of California Berkeley; Universidade Federal do Rio de Janeiro; Ben Gurion University; University of Calgary; University of British Columbia; University of London; University College London; Simon Fraser University; University of Tokyo; Stockholm University; York University - Canada; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Victoria; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Marquette University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Friesen, T; Hangst, JS (corresponding author), Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark.; Hayden, ME (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	Tim.Friesen@cern.ch; jeffrey.hangst@cern.ch; mhayden@sfu.ca	Wurtele, Jonathan S/J-6278-2016; Cesar, Claudio/AAH-4612-2021; Maxwell, Daniel/B-5730-2018; Hardy, Walter Newbold/AAN-7827-2020; Madsen, Niels/I-2314-2019; Bertsche, William/A-3678-2012; ISHIDA, AKIRA/G-4990-2014; Jonsell, Svante/J-2251-2016; Robicheaux, Francis/F-4343-2014	Wurtele, Jonathan S/0000-0001-8401-0297; Maxwell, Daniel/0000-0001-5178-9492; Madsen, Niels/0000-0002-7372-0784; Bertsche, William/0000-0002-6565-9282; ISHIDA, AKIRA/0000-0002-9880-6517; Jonsell, Svante/0000-0003-4969-1714; Johnson, Mark/0000-0002-0654-2658; Capra, Andrea/0000-0001-9499-0380; Stutter, Graham/0000-0002-1629-7588; Cohen, Snir/0000-0002-4240-0702; Robicheaux, Francis/0000-0002-8054-6040; Rasmussen, Chris Orum/0000-0002-6029-1730; van der Werf, Dirk/0000-0001-5436-5214; Eriksson, Stefan/0000-0002-5390-1879; McKenna, Joseph/0000-0002-7838-4230; Sameed, Muhammed/0000-0002-9706-8970; Jones, Steven/0000-0001-8205-2186; Munich, Justine/0000-0001-7475-3070; Kurchaninov, Leonid/0000-0001-9392-3936; Friesen, Timothy/0000-0002-7017-9662	European Research Council; CNPq (Brazil); FAPERJ (Brazil); RENAFAE (Brazil); NSERC (Canada); NRC/TRIUMF (Canada); EHPDS/EHDRS (Canada); FQRNT (Canada); FNU (NICE Centre) (Denmark); Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC (UK); EPSRC (UK); Royal Society (UK); Leverhulme Trust (UK); DOE (USA); NSF (USA); VR (Sweden); Direct For Mathematical & Physical Scien [1500538] Funding Source: National Science Foundation; Division Of Physics [1500470] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/D040108/1, EP/L014718/1, 1422853, EP/L014734/1, EP/F019785/1, EP/P024785/1, EP/H026932/1, EP/P024734/1, EP/K040235/1, EP/K017373/1, EP/E048951/1, EP/H02431X/1, EP/L014769/1, EP/P024769/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/P002056/1, 1686188] Funding Source: researchfish; EPSRC [EP/D040108/1, EP/L014769/1, EP/P024734/1, EP/L014718/1, EP/K040235/1, EP/L014734/1, EP/F019785/1, EP/H026932/1, EP/E048951/1, EP/P024785/1, EP/K017373/1, EP/P024769/1, EP/H02431X/1] Funding Source: UKRI; STFC [ST/P002056/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); RENAFAE (Brazil); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC/TRIUMF (Canada); EHPDS/EHDRS (Canada); FQRNT (Canada)(FQRNT); FNU (NICE Centre) (Denmark); Carlsberg Foundation (Denmark)(Carlsberg Foundation); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel)(Israel Science Foundation); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society (UK)(Royal Society of London); Leverhulme Trust (UK)(Leverhulme Trust); DOE (USA)(United States Department of Energy (DOE)); NSF (USA)(National Science Foundation (NSF)); VR (Sweden)(Swedish Research Council); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	All authors are members of the ALPHA Collaboration. This work was supported by: the European Research Council through its Advanced Grant programme (J.S.H.); CNPq, FAPERJ and RENAFAE (Brazil); NSERC, NRC/TRIUMF, EHPDS/EHDRS and FQRNT (Canada); FNU (NICE Centre) and Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC, EPSRC, the Royal Society and the Leverhulme Trust (UK); DOE and NSF (USA); and VR (Sweden). We are grateful for the efforts of the CERN Antiproton Decelerator team. We thank J. Tonoli (CERN) and his staff for help with machining work. We thank the staff of the Superconducting Magnet Division at Brookhaven National Laboratory for collaboration and fabrication of the trapping magnets. We thank C. Marshall (TRIUMF) for his work on the ALPHA-2 cryostat. We thank F. Besenbacher (Aarhus) for support in procuring the ALPHA-2 external solenoid.	Ahmadi M, 2017, NATURE, V541, P506, DOI 10.1038/nature21040; Amole C, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013037; Amole C, 2013, NUCL INSTRUM METH A, V732, P134, DOI 10.1016/j.nima.2013.05.188; Amole C, 2014, NUCL INSTRUM METH A, V735, P319, DOI 10.1016/j.nima.2013.09.043; Amole C, 2012, HYPERFINE INTERACT, V212, P101, DOI 10.1007/s10751-012-0588-5; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; Andresen GB, 2011, NAT PHYS, V7, P558, DOI [10.1038/NPHYS2025, 10.1038/nphys2025]; Andresen GB, 2010, NATURE, V468, P673, DOI 10.1038/nature09610; GOLDENBERG HM, 1960, PHYS REV LETT, V5, P361, DOI 10.1103/PhysRevLett.5.361; Kellogg JMB, 1936, PHYS REV, V50, P472, DOI 10.1103/PhysRev.50.472; Kostelecky VA, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.056002; Kuroda N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4089; Maury S, 1997, HYPERFINE INTERACT, V109, P43, DOI 10.1023/A:1012632812327; MURPHY TJ, 1992, PHYS REV A, V46, P5696, DOI 10.1103/PhysRevA.46.5696; NAFE JE, 1948, PHYS REV, V73, P718, DOI 10.1103/PhysRev.73.718; NAFE JE, 1947, PHYS REV, V71, P914, DOI 10.1103/PhysRev.71.914; Narsky I., 2005, PREPRINT; NELSON EB, 1949, PHYS REV, V76, P1858, DOI 10.1103/PhysRev.76.1858; NELSON EB, 1949, PHYS REV, V75, P1194, DOI 10.1103/PhysRev.75.1194; PETIT P, 1980, METROLOGIA, V16, P7, DOI 10.1088/0026-1394/16/1/003; Rabi II, 1934, PHYS REV, V46, P0157, DOI 10.1103/PhysRev.46.157; Rabi II, 1934, PHYS REV, V46, P0163, DOI 10.1103/PhysRev.46.163; SCHWINGER J, 1949, PHYS REV, V76, P790, DOI 10.1103/PhysRev.76.790; SCHWINGER J, 1948, PHYS REV, V73, P416, DOI 10.1103/PhysRev.73.416	25	75	75	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					66	+		10.1038/nature23446	http://dx.doi.org/10.1038/nature23446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770838	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000406831700037
J	Appleby, J; Gershlick, B				Appleby, John; Gershlick, Ben			Keeping up with the Johanssons: How does UK health spending compare internationally?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, Res, London, England; [Appleby, John] Nuffield Trust, London, England; [Gershlick, Ben] Hlth Fdn, London, England		Appleby, J (corresponding author), Nuffield Trust, Res, London, England.; Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						Appleby J, 2017, BMJ; Appleby J., 2013, SPENDING HLTH SOCIAL; Appleby J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3094; Gershlick B., 2016, ACCOUNTING FOR CARE; Monitor, 2015, MOV HEALTHC CLOS HOM; NHS Digital, 2016, PERS SOC SERV EXP UN; OECD, 2011, HLTH REF; OECD, 2016, BETT WAYS PAY HLTH C, DOI DOI 10.1787/9789264258211-EN; OECD, HLTH STAT 2017; OECD EaWHO, 2017, SYST HLTH ACC 2022, DOI [10.1787/9789264270985-en, DOI 10.1787/9789264270985-EN]; Office for National Statistics, 2016, UK HLTH ACC 2014; Watt N., 2000, GUARDIAN	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2017	358								j3568	10.1136/bmj.j3568	http://dx.doi.org/10.1136/bmj.j3568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CI	28774962				2022-12-28	WOS:000407207000005
J	Victor, DG; Akimoto, K; Kaya, Y; Yamaguchi, M; Cullenward, D; Hepburn, C				Victor, David G.; Akimoto, Keigo; Kaya, Yoichi; Yamaguchi, Mitsutsune; Cullenward, Danny; Hepburn, Cameron			Prove Paris was more than paper promises	NATURE			English	Editorial Material							POLICY		[Victor, David G.] Univ Calif San Diego, Int Relat, Sch Global Policy & Strategy, San Diego, CA 92103 USA; [Victor, David G.] Brookings Inst, Energy Secur & Climate Initiat, Washington, DC 20036 USA; [Akimoto, Keigo] Res Inst Innovat Technol Earth RITE, Syst Anal Grp, Kyoto, Japan; [Kaya, Yoichi; Yamaguchi, Mitsutsune] RITE, Tokyo, Japan; [Cullenward, Danny] Near Zero, Santa Monica, CA USA; [Hepburn, Cameron] Univ Oxford, Environm Econ, Oxford, England	University of California System; University of California San Diego; Brookings Institution; Research Institute of Innovative Technology for the Earth; University of Oxford	Victor, DG (corresponding author), Univ Calif San Diego, Int Relat, Sch Global Policy & Strategy, San Diego, CA 92103 USA.; Victor, DG (corresponding author), Brookings Inst, Energy Secur & Climate Initiat, Washington, DC 20036 USA.	david.victor@ucsd.edu		Hepburn, Cameron/0000-0003-0467-7441; kaya, yoichi/0000-0001-5213-1027; Cullenward, Danny/0000-0002-6803-9572				Akimoto K, 2017, EVOL INST ECON REV, V14, P193, DOI 10.1007/s40844-016-0049-y; Aldy J, 2016, NAT CLIM CHANGE, V6, P1000, DOI [10.1038/nclimate3106, 10.1038/NCLIMATE3106]; Aldy JE, 2016, REV ENV ECON POLICY, V10, P3, DOI 10.1093/reep/rev013; Commonwealth of Australia, 2017, BLUEPR FUT IND REV F; Drummond P, 2017, CLIM POLICY, V17, pS51, DOI 10.1080/14693062.2016.1258634; European Commission, 2016, PROP DIR EUR PARL CO; Hepburn C, 2017, OXFORD REV ECON POL, V33, pS144, DOI 10.1093/oxrep/grx004; Larsen J., 2016, TAKING STOCK PROGR M; Larsen K, 2017, TAKING STOCK 2017 AD; Victor D. G., 2017, YALE ENV 360	10	77	77	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					25	27		10.1038/548025a	http://dx.doi.org/10.1038/548025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770856	Bronze			2022-12-28	WOS:000406831700012
J	Wolf, G; Rebollo, R; Karimi, MM; Ewing, AD; Kamada, R; Wu, W; Wu, B; Bachu, M; Ozato, K; Faulkner, GJ; Mager, DL; Lorincz, MC; Macfarlan, TS				Wolf, Gernot; Rebollo, Rita; Karimi, Mohammad M.; Ewing, Adam D.; Kamada, Rui; Wu, Warren; Wu, Brenda; Bachu, Mahesh; Ozato, Keiko; Faulkner, Geoffrey J.; Mager, Dixie L.; Lorincz, Matthew C.; Macfarlan, Todd S.			On the role of H3.3 in retroviral silencing	NATURE			English	Letter									[Wolf, Gernot; Kamada, Rui; Wu, Warren; Wu, Brenda; Bachu, Mahesh; Ozato, Keiko; Macfarlan, Todd S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Rebollo, Rita; Karimi, Mohammad M.; Mager, Dixie L.; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Rebollo, Rita; Mager, Dixie L.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Ewing, Adam D.; Faulkner, Geoffrey J.] Univ Queensland, Mater Res Inst, TRI Bldg, Woolloongabba, Qld 4102, Australia; [Rebollo, Rita] Univ Lyon, INSA Lyon, INRA, UMR203 BF2i,Biol Fonct Insectes & Interact, F-69621 Villeurbanne, France; [Karimi, Mohammad M.] Univ Strasbourg, CNRS, INSERM, Dept Genom Fonct & Canc,IGBMC, F-67404 Illkirch Graffenstaden, France; [Kamada, Rui] Hokkaido Univ, Biol Chem Lab, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of British Columbia; British Columbia Cancer Agency; Mater Research; University of Queensland; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hokkaido University	Macfarlan, TS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	todd.macfarlan@nih.gov	Faulkner, Geoffrey J/M-3168-2014; Kamada, Rui/P-9714-2019; Macfarlan, Todd/S-3750-2017; Bachu, Mahesh/I-4343-2015; Ewing, Adam D/M-3164-2014	Faulkner, Geoffrey J/0000-0001-5769-4494; Macfarlan, Todd/0000-0003-2495-9809; Bachu, Mahesh/0000-0002-6494-6642; Ewing, Adam D/0000-0002-4544-994X; Mager, Dixie/0000-0002-5955-2550; Karimi, Mohammad Mahdi/0000-0001-5017-1252; Wolf, Gernot/0000-0002-3943-8662; Kamada, Rui/0000-0002-6118-5091; Rebollo, Rita/0000-0002-8138-5082; Lorincz, Matthew/0000-0003-0885-0467	Intramural NIH HHS [ZIA HD008933-04, ZIA HD008933-03] Funding Source: Medline; Grants-in-Aid for Scientific Research [17K17565] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008933] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Li JF, 2012, GENOME RES, V22, P870, DOI 10.1101/gr.130740.111; LUEDERS KK, 1993, MAMM GENOME, V4, P69, DOI 10.1007/BF00290429; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	8	12	13	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					E1	E6		10.1038/nature23277	http://dx.doi.org/10.1038/nature23277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770848	Green Accepted			2022-12-28	WOS:000406831700001
J	Moor, AE; Golan, M; Massasa, EE; Lemze, D; Weizman, T; Shenhav, R; Baydatch, S; Mizrahi, O; Winkler, R; Golani, O; Stern-Ginossar, N; Itzkovitz, S				Moor, Andreas E.; Golan, Matan; Massasa, Efi E.; Lemze, Doron; Weizman, Tomer; Shenhav, Rom; Baydatch, Shaked; Mizrahi, Orel; Winkler, Roni; Golani, Ofra; Stern-Ginossar, Noam; Itzkovitz, Shalev			Global mRNA polarization regulates translation efficiency in the intestinal epithelium	SCIENCE			English	Article							PROTEIN-SYNTHESIS; LOCALIZATION; CELLS; ENTEROCYTES; REVEALS; GROWTH; TIME	Asymmetric messenger RNA (mRNA) localization facilitates efficient translation in cells such as neurons and fibroblasts. However, the extent and importance of mRNA polarization in epithelial tissues are unclear. Here, we used single-molecule transcript imaging and subcellular transcriptomics to uncover global apical-basal intracellular polarization of mRNA in the mouse intestinal epithelium. The localization of mRNAs did not generally overlap protein localization. Instead, ribosomes were more abundant on the apical sides, and apical transcripts were consequently more efficiently translated. Refeeding of fasted mice elicited a basal-toapical shift in polarization of mRNAs encoding ribosomal proteins, which was associated with a specific boost in their translation. This led to increased protein production, required for efficient nutrient absorption. These findings reveal a posttranscriptional regulatory mechanism involving dynamic polarization of mRNA and polarized translation.	[Moor, Andreas E.; Golan, Matan; Massasa, Efi E.; Lemze, Doron; Weizman, Tomer; Shenhav, Rom; Baydatch, Shaked; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Mizrahi, Orel; Winkler, Roni; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Golani, Ofra] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Itzkovitz, S (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	shalev.itzkovitz@weizmann.ac.il		Mizrahi, Orel/0000-0003-2189-5731; Moor, Andreas/0000-0001-8715-8449	Swiss National Science Foundation [158999]; European Molecular Biology Organization (EMBO) [ALTF 306-2016]; European Research Council [StG-2014-638142]; Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; Leir Charitable Foundations; Richard Jakubskind Laboratory of Systems Biology; Lord Sieff of Brimpton Memorial Fund; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [1902/12, 1796/12, 1486/16]; EMBO; European Research Council under the European Union-ERC [335122]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; Leir Charitable Foundations; Richard Jakubskind Laboratory of Systems Biology; Lord Sieff of Brimpton Memorial Fund; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); EMBO(European Molecular Biology Organization (EMBO)); European Research Council under the European Union-ERC(European Research Council (ERC))	We thank K. Bahar Halpern, B. Toth, and S. Ben-Moshe for valuable comments on the manuscript. We thank the L Lokey animal facility (Weizmann Institute of Science, Rehovot, Israel), the Crown Institute for Genomics (Weizmann Institute of Science, Rehovot, Israel), and the Smoler Protein Research Center (Technion, Haifa, Israel) for help with experimental procedures. A.E.M. is supported by the Swiss National Science Foundation (grant 158999) and the European Molecular Biology Organization (EMBO) Long-Term Fellowship program (ALTF 306-2016). N.S.-G. research is funded by the European Research Council starting grant (StG-2014-638142). N.S.-G. is incumbent of the Skirball Career Development Chair in New Scientists. S.I. is supported by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, The Leir Charitable Foundations, Richard Jakubskind Laboratory of Systems Biology, Cymerman-Jakubskind Prize, The Lord Sieff of Brimpton Memorial Fund, the I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation (grants 1902/12 and 1796/12), the Israel Science Foundation grant no. 1486/16, the EMBO Young Investigator Program, and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)-ERC grant agreement no. 335122. S.I. is the incumbent of the Philip Harris and Gerald Ronson Career Development Chair. All data supporting the findings of this study and all analysis codes are available within the article and its supplementary materials or from the corresponding author upon request. The generated sequencing data have been deposited in the GenBank Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/geo/) under accession code GSE95416.	Barth JA, 1998, J HISTOCHEM CYTOCHEM, V46, P335, DOI 10.1177/002215549804600307; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Frayn K. N., 2010, METABOLIC REGULATION; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Jambor H, 2015, ELIFE, V4, DOI 10.7554/eLife.05003; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li W, 1998, GASTROENTEROLOGY, V115, P86, DOI 10.1016/S0016-5085(98)70368-3; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Madar D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-136; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Nichterwitz S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12139; Pratt CA, 2013, CURR OPIN CELL BIOL, V25, P99, DOI 10.1016/j.ceb.2012.08.015; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; RINGS EHHM, 1992, FEBS LETT, V300, P183, DOI 10.1016/0014-5793(92)80192-J; Rodriguez AJ, 2008, CURR OPIN CELL BIOL, V20, P144, DOI 10.1016/j.ceb.2008.02.004; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003	26	84	84	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357					1299	+		10.1126/science.aan2399	http://dx.doi.org/10.1126/science.aan2399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7BX	28798045	Green Accepted			2022-12-28	WOS:000411337700047
J	Coles, CE; Griffin, CL; Kirby, AM; Titley, J; Agrawal, RK; Alhasso, A; Bhattacharya, IS; Brunt, AM; Ciurlionis, L; Chan, C; Donovan, EM; Emson, MA; Harnett, AN; Haviland, JS; Hopwood, P; Jefford, ML; Kaggwa, R; Sawyer, EJ; Syndikus, I; Tsang, YM; Wheatley, DA; Wilcox, M; Yarnold, JR; Bliss, JM				Coles, Charlotte E.; Griffin, Clare L.; Kirby, Anna M.; Titley, Jenny; Agrawal, Rajiv K.; Alhasso, Abdulla; Bhattacharya, Indrani S.; Brunt, Adrian M.; Ciurlionis, Laura; Chan, Charlie; Donovan, Ellen M.; Emson, Marie A.; Harnett, Adrian N.; Haviland, Joanne S.; Hopwood, Penelope; Jefford, Monica L.; Kaggwa, Ronald; Sawyer, Elinor J.; Syndikus, Isabel; Tsang, Yat M.; Wheatley, Duncan A.; Wilcox, Maggie; Yarnold, John R.; Bliss, Judith M.		IMPORT Trialist	Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial	LANCET			English	Article							INTENSITY-MODULATED RADIOTHERAPY; CONSERVING SURGERY; CONSENSUS STATEMENT; START TRIALS; IRRADIATION; WHOLE; STANDARDIZATION; BRACHYTHERAPY; THERAPY; SOCIETY	Background Local cancer relapse risk after breast conservation surgery followed by radiotherapy has fallen sharply in many countries, and is influenced by patient age and clinicopathological factors. We hypothesise that partial-breast radiotherapy restricted to the vicinity of the original tumour in women at lower than average risk of local relapse will improve the balance of beneficial versus adverse effects compared with whole-breast radiotherapy. Methods IMPORT LOW is a multicentre, randomised, controlled, phase 3, non-inferiority trial done in 30 radiotherapy centres in the UK. Women aged 50 years or older who had undergone breast-conserving surgery for unifocal invasive ductal adenocarcinoma of grade 1-3, with a tumour size of 3 cm or less (pT1-2), none to three positive axillary nodes (pN0-1), and minimum microscopic margins of non-cancerous tissue of 2 mm or more, were recruited. Patients were randomly assigned (1:1:1) to receive 40 Gy whole-breast radiotherapy (control), 36 Gy whole-breast radiotherapy and 40 Gy to the partial breast (reduced-dose group), or 40 Gy to the partial breast only (partial-breast group) in 15 daily treatment fractions. Computer-generated random permuted blocks (mixed sizes of six and nine) were used to assign patients to groups, stratifying patients by radiotherapy treatment centre. Patients and clinicians were not masked to treatment allocation. Field-in-field intensity-modulated radiotherapy was delivered using standard tangential beams that were simply reduced in length for the partial-breast group. The primary endpoint was ipsilateral local relapse (80% power to exclude a 2.5% increase [non-inferiority margin] at 5 years for each experimental group; non-inferiority was shown if the upper limit of the two-sided 95% CI for the local relapse hazard ratio [HR] was less than 2.03), analysed by intention to treat. Safety analyses were done in all patients for whom data was available (ie, a modified intention-to-treat population). This study is registered in the ISRCTN registry, number ISRCTN12852634. Findings Between May 3, 2007, and Oct 5, 2010, 2018 women were recruited. Two women withdrew consent for use of their data in the analysis. 674 patients were analysed in the whole-breast radiotherapy (control) group, 673 in the reduced-dose group, and 669 in the partial-breast group. Median follow-up was 72.2 months (IQR 61.7-83.2), and 5-year estimates of local relapse cumulative incidence were 1.1% (95% CI 0.5-2.3) of patients in the control group, 0.2% (0.02-1.2) in the reduced-dose group, and 0.5% (0.2-1.4) in the partial-breast group. Estimated 5-year absolute differences in local relapse compared with the control group were -0.73% (-0.99 to 0.22) for the reduced-dose and -0.38% (-0.84 to 0.90) for the partial-breast groups. Non-inferiority can be claimed for both reduced-dose and partial-breast radiotherapy, and was confirmed by the test against the critical HR being more than 2.03 (p=0.003 for the reduced-dose group and p=0.016 for the partial-breast group, compared with the whole-breast radiotherapy group). Photographic, patient, and clinical assessments recorded similar adverse effects after reduced-dose or partial-breast radiotherapy, including two patient domains achieving statistically significantly lower adverse effects (change in breast appearance [p=0.007 for partial-breast] and breast harder or firmer [p=0.002 for reduced-dose and p<0.0001 for partial-breast]) compared with whole-breast radiotherapy. Interpretation We showed non-inferiority of partial-breast and reduced-dose radiotherapy compared with the standard whole-breast radiotherapy in terms of local relapse in a cohort of patients with early breast cancer, and equivalent or fewer late normal-tissue adverse effects were seen. This simple radiotherapy technique is implementable in radiotherapy centres worldwide. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Coles, Charlotte E.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Griffin, Clare L.; Titley, Jenny; Bhattacharya, Indrani S.; Emson, Marie A.; Haviland, Joanne S.; Hopwood, Penelope; Kaggwa, Ronald; Bliss, Judith M.] Inst Canc Res, Clin Trials & Stat Unit, London, England; [Yarnold, John R.] Inst Canc Res, Dept Radiotherapy & Imaging, London, England; [Kirby, Anna M.] Royal Marsden NHS Fdn Trust, Dept Radiotherapy & Imaging, London, England; [Kirby, Anna M.] Inst Canc Res, London, England; [Agrawal, Rajiv K.] Shrewsbury & Telford Hosp NHS Trust, Dept Oncol, Shrewsbury, Salop, England; [Alhasso, Abdulla] Beatson West Scotland Canc Ctr, Dept Clin Oncol, Glasgow, Lanark, Scotland; [Brunt, Adrian M.] Univ Hosp North Midlands, Canc Ctr, Stoke On Trent, Staffs, England; [Brunt, Adrian M.] Keele Univ, Stoke On Trent, Staffs, England; [Ciurlionis, Laura] Auckland City Hosp, Dept Radiat Oncol, Auckland, New Zealand; [Chan, Charlie] Nuffield Hlth Cheltenham Hosp, Dept Breast Surg, Cheltenham, Glos, England; [Donovan, Ellen M.] Univ Surrey, Dept Hlth & Med Sci, Guildford, Surrey, England; [Harnett, Adrian N.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Dept Oncol, Norwich, Norfolk, England; [Jefford, Monica L.; Wilcox, Maggie] Patient Advocate, London, England; [Sawyer, Elinor J.] Kings Coll London, Dept Res Oncol, London, England; [Syndikus, Isabel] Clatterbridge Canc Ctr NHS Fdn Trust, Canc Ctr, Bebington, England; [Tsang, Yat M.] Mt Vernon Canc Ctr Northwood, Dept Radiotherapy, Northwood, Middx, England; [Wheatley, Duncan A.] Royal Cornwall Hosp NHS Trust, Dept Oncol, Truro, England	University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Beatson Oncology Centre; Keele University; Auckland City Hospital; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; University of Surrey; Norfolk & Norwich University Hospitals NHS Foundation Trust; University of London; King's College London; Mount Vernon Cancer Centre; Royal Cornwall Hospital	Coles, CE (corresponding author), Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England.	colesc@doctors.org.uk	; Evans, Philip/A-6257-2009	Tutt, Andrew/0000-0001-8715-2901; Bliss, Judith/0000-0001-7957-7424; Ellis, Ian/0000-0001-5292-8474; Sawyer, Elinor/0000-0001-8285-4111; Kirwan, Cliona/0000-0002-1725-4790; Haviland, Joanne/0000-0001-5728-3636; Bhattacharya, Indrani/0000-0002-2983-1305; Wheatley, Duncan/0000-0002-1919-5114; Brunt, Adrian Murray/0000-0002-4797-5097; Evans, Philip/0000-0002-8102-6581; Sculpher, Mark/0000-0003-3746-9913	Cancer Research UK; Cancer Research UK [6035, 10588, 19727, 21752] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-011-014, NF-SI-0510-10026, NF-SI-0616-10107] Funding Source: researchfish; MRC [MC_PC_14105] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK.	Belkacemi Y, 2015, ANN ONCOL, V26, P529, DOI 10.1093/annonc/mdu561; Ben Wilkinson J, 2013, INT J RADIAT ONCOL, V85, P1179, DOI 10.1016/j.ijrobp.2012.10.010; Breast radiotherapy after breast-conserving surgery, 1998, CMAJ S3, V158, pS35; Coles CE, 2013, CLIN ONCOL-UK, V25, P215, DOI 10.1016/j.clon.2012.11.003; Coles CE, 2009, EJSO-EUR J SURG ONC, V35, P578, DOI 10.1016/j.ejso.2008.09.005; Csaba P, 2010, RADIOTHER ONCOL, V94, P264, DOI 10.1016/j.radonc.2010.01.014; Csaba P, 2010, RADIOTHER ONCOL, V94, P274, DOI 10.1016/j.radonc.2010.01.019; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Donovan EM, 2012, MED PHYS, V39, P5814, DOI 10.1118/1.4748332; Dundas KL, 2015, J MED IMAG RADIAT ON, V59, P736, DOI 10.1111/1754-9485.12348; Gentilini O, 2017, RADIOTHER ONCOL, V122, P37, DOI 10.1016/j.radonc.2016.12.021; Harris EJ, INT J RAD ONCOL BIOL; Haviland JS, 2008, CLIN ONCOL-UK, V20, P497, DOI 10.1016/j.clon.2008.03.017; Haviland JS, 2016, CLIN ONCOL-UK, V28, P345, DOI 10.1016/j.clon.2016.01.011; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Kirby AM, 2010, RADIOTHER ONCOL, V96, P178, DOI 10.1016/j.radonc.2010.05.014; Livi L, 2015, EUR J CANCER, V51, P451, DOI 10.1016/j.ejca.2014.12.013; Mannino M, 2009, RADIOTHER ONCOL, V90, P14, DOI 10.1016/j.radonc.2008.05.002; Marta GN, 2015, RADIOTHER ONCOL, V114, P42, DOI 10.1016/j.radonc.2014.11.014; Olivotto IA, 2013, J CLIN ONCOL, V31, P4038, DOI 10.1200/JCO.2013.50.5511; Salvadori B, 1999, BRIT J SURG, V86, P84, DOI 10.1046/j.1365-2168.1999.00961.x; Schaverien MV, 2013, EJSO-EUR J SURG ONC, V39, P1179, DOI 10.1016/j.ejso.2013.07.240; Sedlmayer F, 2013, STRAHLENTHER ONKOL, V189, P825, DOI 10.1007/s00066-013-0437-8; Shah C, 2013, BRACHYTHERAPY, V12, P267, DOI 10.1016/j.brachy.2013.02.001; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Strnad V, 2016, LANCET, V387, P229, DOI 10.1016/S0140-6736(15)00471-7; Theberge V, 2011, SEMIN RADIAT ONCOL, V21, P55, DOI 10.1016/j.semradonc.2010.08.007; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005	29	293	302	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1048	1060		10.1016/S0140-6736(17)31145-5	http://dx.doi.org/10.1016/S0140-6736(17)31145-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG1BW	28779963	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000409528600023
J	Jin, EQ; Asada, M; Xu, Q; Dalapati, S; Addicoat, MA; Brady, MA; Xu, H; Nakamura, T; Heine, T; Chen, QH; Jiang, DL				Jin, Enquan; Asada, Mizue; Xu, Qing; Dalapati, Sasanka; Addicoat, Matthew A.; Brady, Michael A.; Xu, Hong; Nakamura, Toshikazu; Heine, Thomas; Chen, Qiuhong; Jiang, Donglin			Two-dimensional sp(2) carbon-conjugated covalent organic frameworks	SCIENCE			English	Article							POLARONS; ELECTROLUMINESCENT; CONDENSATION; BIPOLARONS; POLYMERS	We synthesized a two-dimensional (2D) crystalline covalent organic framework (sp(2)c-COF) that was designed to be fully pi-conjugated and constructed from all sp(2) carbons by C=C condensation reactions of tetrakis(4-formylphenyl)pyrene and 1,4-phenylenediacetonitrile. The C=C linkages topologically connect pyrene knots at regular intervals into a 2D lattice with pi conjugations extended along both x and y directions and develop an eclipsed layer framework rather than the more conventionally obtained disordered structures. The sp(2)c-COF is a semiconductor with a discrete band gap of 1.9 electron volts and can be chemically oxidized to enhance conductivity by 12 orders of magnitude. The generated radicals are confined on the pyrene knots, enabling the formation of a paramagnetic carbon structure with high spin density. The sp(2) carbon framework induces ferromagnetic phase transition to develop spin-spin coherence and align spins unidirectionally across the material.	[Jin, Enquan; Xu, Qing; Dalapati, Sasanka; Xu, Hong; Chen, Qiuhong; Jiang, Donglin] Japan Adv Inst Sci & Technol, Sch Mat Sci, Field Energy & Environm, 1-1 Asahidai, Nomi 9231292, Japan; [Asada, Mizue; Xu, Hong; Nakamura, Toshikazu] Inst Mol Sci, Dept Mat Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Addicoat, Matthew A.] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England; [Brady, Michael A.] Lawrence Berkeley Natl Lab, Mol Foundry & Adv Light Source, 1 Cyclotron Rd,Mailstop 15R0317, Berkeley, CA 94720 USA; [Heine, Thomas] Univ Leipzig, Wilhelm Ostwald Inst Phys & Theoret Chem, Linnestr 2, D-04103 Leipzig, Germany	Japan Advanced Institute of Science & Technology (JAIST); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Nottingham Trent University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Leipzig University	Jiang, DL (corresponding author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Field Energy & Environm, 1-1 Asahidai, Nomi 9231292, Japan.	djiang@jaist.ac.jp	徐, 庆/HGB-3100-2022; Heine, Thomas/H-5446-2011; Xu, Hong/I-1475-2015; Jiang, Donglin/E-6696-2017; Chen, QH/GXH-3158-2022	徐, 庆/0000-0002-9066-9837; Heine, Thomas/0000-0003-2379-6251; Xu, Hong/0000-0001-7918-1454; Jiang, Donglin/0000-0002-3785-1330; Nakamura, Toshikazu/0000-0001-8672-0946; Asada, Mizue/0000-0003-0837-7753; DALAPATI, SASANKA/0000-0001-5022-561X	Chinese Scholarship Concert; Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-AC02-05CH11231]; European Research Council [ERC-StG 256962 C3ENV]; VolkswagenStiftung; Ministry of Education, Culture, Sports, Science and Technology, Japan [17H01218]; ENEOS Hydrogen Trust Fund; Ogasawara Foundation for the Promotion of Science and Engineering	Chinese Scholarship Concert; Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); VolkswagenStiftung(Volkswagen); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ENEOS Hydrogen Trust Fund; Ogasawara Foundation for the Promotion of Science and Engineering	E.J. acknowledges Chinese Scholarship Concert for financial support for his study in Japan. S.D. is now an international research fellow of the Japan Society for the Promotion of Science. M.A.B. acknowledges the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. T.H. and M.A. acknowledge supercomputer time at ZIH Dresden and financial support by the European Research Council (grant ERC-StG 256962 C3ENV) and the VolkswagenStiftung. D.J. acknowledges a Grant-in-Aid for Scientific Research (A) (17H01218) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and support from the ENEOS Hydrogen Trust Fund and the Ogasawara Foundation for the Promotion of Science and Engineering. D.J. conceived and designed the project. E.J., Q.X., S.D., H.X., and Q.C. conducted the experiments. M.A. A. and T.H. conducted DFTB calculations and structure simulations. M.A. and T.N. conducted ESR and SQUID measurements. M.A.B. conducted WAXS measurements. D.J., E.J., Q.C., and S.D. wrote the manuscript and discussed the results with all authors. All data are reported in the main text and supplementary materials.	Aradi B, 2007, J PHYS CHEM A, V111, P5678, DOI 10.1021/jp070186p; Ascherl L, 2016, NAT CHEM, V8, P310, DOI 10.1038/NCHEM.2444; BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005; CHANCE RR, 1984, PHYS REV B, V29, P4491, DOI 10.1103/PhysRevB.29.4491; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Egbe DAM, 2004, MACROMOLECULES, V37, P8863, DOI 10.1021/ma048219b; Hexemer A, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012007; Huang N, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.68; Ilavsky J, 2012, J APPL CRYSTALLOGR, V45, P324, DOI 10.1107/S0021889812004037; Jiang JX, 2007, ANGEW CHEM INT EDIT, V46, P8574, DOI 10.1002/anie.200701595; Kandambeth S, 2012, J AM CHEM SOC, V134, P19524, DOI 10.1021/ja308278w; Kuroda S, 2001, THIN SOLID FILMS, V393, P304, DOI 10.1016/S0040-6090(01)01100-2; Liu XH, 2013, J AM CHEM SOC, V135, P10470, DOI 10.1021/ja403464h; MOWRY DT, 1945, J AM CHEM SOC, V67, P1050, DOI 10.1021/ja01223a002; Orion I, 1998, PHYS REV B, V57, P7050, DOI 10.1103/PhysRevB.57.7050; PATAI S, 1960, J CHEM SOC, P2025, DOI 10.1039/jr9600002025; Rao MR, 2017, J AM CHEM SOC, V139, P2421, DOI 10.1021/jacs.6b12005; SAKAMOTO A, 1994, J PHYS CHEM-US, V98, P4635, DOI 10.1021/j100068a025; Salaneck WR, 1999, PHYS REP, V319, P232; Thompson BC, 2006, J AM CHEM SOC, V128, P12714, DOI 10.1021/ja061274a; Waller PJ, 2015, ACCOUNTS CHEM RES, V48, P3053, DOI 10.1021/acs.accounts.5b00369; Xu YH, 2013, CHEM SOC REV, V42, P8012, DOI 10.1039/c3cs60160a; Zhuang XD, 2016, POLYM CHEM-UK, V7, P4176, DOI 10.1039/c6py00561f; ZIMMERMAN HE, 1959, J AM CHEM SOC, V81, P2086, DOI 10.1021/ja01518a015	24	568	582	108	1150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					673	676		10.1126/science.aan0202	http://dx.doi.org/10.1126/science.aan0202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28818940	Green Submitted, Green Accepted			2022-12-28	WOS:000407793600031
J	Kean, S				Kean, Sam			ON THE TRAIL OF YELLOW FEVER	SCIENCE			English	Editorial Material																			0	4	4	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					637	641		10.1126/science.357.6352.637	http://dx.doi.org/10.1126/science.357.6352.637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818926				2022-12-28	WOS:000407793600014
J	Kanneganti, TD				Kanneganti, Thirumala-Devi			Inflammatory Bowel Disease and the NLRP3 Inflammasome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Nielsen OH, 2014, FRONT MED-LAUSANNE, V1, DOI 10.3389/fmed.2014.00003; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	6	48	54	6	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					694	696		10.1056/NEJMcibr1706536	http://dx.doi.org/10.1056/NEJMcibr1706536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD7FG	28813221				2022-12-28	WOS:000407691400015
J	Weiss, J; Kansagara, D				Weiss, Jessica; Kansagara, Devan			Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							NURSING-HOME RESIDENTS		[Weiss, Jessica] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kansagara, Devan] Vet Affairs Portland Hlth Care Syst, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Weiss, J (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Fougere B, 2016, J GERONTOL A-BIOL, V71, P420, DOI 10.1093/gerona/glv098; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Weiss J, 2015, 05225 VA ESP US DEP	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					288	289		10.7326/L17-0288	http://dx.doi.org/10.7326/L17-0288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28806809				2022-12-28	WOS:000407797500023
J	[Anonymous]				[Anonymous]			Lethal Heat Waves Expected to Increase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					603	603		10.1001/jama.2017.10120	http://dx.doi.org/10.1001/jama.2017.10120			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28810031				2022-12-28	WOS:000407616000003
J	Abritis, A; McCook, A				Abritis, Alison; McCook, Alison			SCIENTIFIC COMMUNITY Cash incentives for papers go global	SCIENCE			English	News Item																			0	25	25	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					541	541		10.1126/science.357.6351.541	http://dx.doi.org/10.1126/science.357.6351.541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28798113				2022-12-28	WOS:000407324800020
J	Bamber, J; Eckersley, R; Harvey, C; Lim, A; Sidhu, P; Tang, MX				Bamber, Jeff; Eckersley, Robert; Harvey, Chris; Lim, Adrian; Sidhu, Paul; Tang, Meng Xing			David Cosgrove OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item													Bamber, Jeffrey C/B-8839-2014	Bamber, Jeffrey C/0000-0001-9436-1832; Sidhu, Paul/0000-0003-1928-4077				COSGROVE D, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2017	358								j3854	10.1136/bmj.j3854	http://dx.doi.org/10.1136/bmj.j3854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7YF	28801356				2022-12-28	WOS:000407741300002
J	Lin, YL; Pasero, P				Lin, Yea-Lih; Pasero, Philippe			Transcription-Replication Conflicts: Orientation Matters	CELL			English	Editorial Material							FORK PROGRESSION		[Lin, Yea-Lih; Pasero, Philippe] CNRS UMR9002, Inst Human Genet, F-34090 Montpellier, France; [Lin, Yea-Lih; Pasero, Philippe] Univ Montpellier, Equipe Labellise Ligue Canc, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Pasero, P (corresponding author), CNRS UMR9002, Inst Human Genet, F-34090 Montpellier, France.; Pasero, P (corresponding author), Univ Montpellier, Equipe Labellise Ligue Canc, F-34090 Montpellier, France.	philippe.pasero@igh.cnrs.fr	Pasero, Philippe/O-2340-2018	Pasero, Philippe/0000-0001-5891-0822				[Anonymous], TITLE ERROR; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Merrikh H., 2017, NATURE, V25, P515; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006	8	12	12	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					603	604		10.1016/j.cell.2017.07.040	http://dx.doi.org/10.1016/j.cell.2017.07.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802036	Bronze			2022-12-28	WOS:000407445700004
J	Wilkinson, D; Savulescu, J				Wilkinson, Dominic; Savulescu, Julian			After Charlie Gard: ethically ensuring access to innovative treatment	LANCET			English	Editorial Material									[Wilkinson, Dominic; Savulescu, Julian] Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England; [Wilkinson, Dominic] John Radcliffe Hosp, Dept Newborn Care, Oxford, England; [Savulescu, Julian] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Oxford; University of Oxford; Murdoch Children's Research Institute	Wilkinson, D (corresponding author), Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.; Wilkinson, D (corresponding author), John Radcliffe Hosp, Dept Newborn Care, Oxford, England.	dominic.wilkinson@philosophy.ox.ac.uk			Wellcome Trust [WT106587/Z/14/Z, WT104848Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	DW and JS are both Editors of the Journal of Medical Ethics. DW was supported for this work by a grant from the Wellcome Trust WT106587/Z/14/Z. JS was supported by a grant from the Wellcome Trust WT104848Z/14/Z. The authors declare no other competing interests.	Brierley J, BIOETHICS IN PRESS; Brierley J, 2009, ARCH DIS CHILD, V94, P651, DOI 10.1136/adc.2008.155317; Gillam L., 2015, CLIN ETHICS, V11, P1; Mendick R., TELEGRAPH; Parfit Derek., 1984, REASONS PERSONS; Savulescu J, 2001, J MED ETHICS, V27, P148, DOI 10.1136/jme.27.3.148; Savulescu J, 2017, LANCET, V389, P1868, DOI 10.1016/S0140-6736(17)31204-7; Truog RD, 2017, JAMA-J AM MED ASSOC, V318, P1001, DOI 10.1001/jama.2017.10410; WIlkinson D, J MED ETHIC IN PRESS; Wilkinson D, 2018, HEALTH CARE ANAL, V26, P287, DOI 10.1007/s10728-016-0337-z; Wilkinson D, 2017, LANCET, V389, P1866, DOI 10.1016/S0140-6736(17)31205-9; Wilkinson D, 2016, BIOETHICS, V30, P109, DOI 10.1111/bioe.12162	12	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					540	542		10.1016/S0140-6736(17)32125-6	http://dx.doi.org/10.1016/S0140-6736(17)32125-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28792386	Green Submitted			2022-12-28	WOS:000406855800008
J	Campbell-Staton, SC; Cheviron, ZA; Rochette, N; Catchen, J; Losos, JB; Edwards, SV				Campbell-Staton, Shane C.; Cheviron, Zachary A.; Rochette, Nicholas; Catchen, Julian; Losos, Jonathan B.; Edwards, Scott V.			Winter storms drive rapid phenotypic, regulatory, and genomic shifts in the green anole lizard	SCIENCE			English	Article							NATURAL-SELECTION; EVOLUTION; CAROLINENSIS; FINCHES	Extreme environmental perturbations offer opportunities to observe the effects of natural selection in wild populations. During the winter of 2013-2014, the southeastern United States endured an extreme cold event. We used thermal performance, transcriptomics, and genome scans to measure responses of lizard populations to storm-induced selection. We found significant increases in cold tolerance at the species' southern limit. Gene expression in southern survivors shifted toward patterns characteristic of northern populations. Comparing samples before and after the extreme winter, 14 genomic regions were differentiated in the surviving southern population; four also exhibited signatures of local adaptation across the latitudinal gradient and implicate genes involved in nervous system function. Together, our results suggest that extreme winter events can rapidly produce strong selection on natural populations at multiple biological levels that recapitulate geographic patterns of local adaptation.	[Campbell-Staton, Shane C.; Rochette, Nicholas; Catchen, Julian] Univ Illinois, Champaign, IL 61820 USA; [Campbell-Staton, Shane C.; Cheviron, Zachary A.] Univ Montana, Missoula, MT 59812 USA; [Losos, Jonathan B.; Edwards, Scott V.] Harvard Univ, Cambridge, MA 02138 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Montana System; University of Montana; Harvard University	Campbell-Staton, SC (corresponding author), Univ Illinois, Champaign, IL 61820 USA.; Campbell-Staton, SC (corresponding author), Univ Montana, Missoula, MT 59812 USA.	shane.campbellstaton@gmail.com	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217; Catchen, Julian/0000-0002-4798-660X	National Science Foundation; Harvard University; University of Illinois	National Science Foundation(National Science Foundation (NSF)); Harvard University; University of Illinois	M. Fujita, Y. Stuart, and A. Jaffe provided assistance in collecting samples. National Science Foundation, Harvard University, and University of Illinois provided funding. Sequence data are available from the National Center for Biotechnology Information: SAMN06042490 to SAMN06042537. Cold tolerance data are available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.g500m. Samples are accessioned in the Harvard Museum of Comparative Zoology (MCZ Cryogenic 4448-4586).	Brown CR, 1998, EVOLUTION, V52, P1461, DOI 10.1111/j.1558-5646.1998.tb02027.x; Bumpus H., 1898, BIOL LECT DELIV MAR, V1898, P209; Campbell-Staton SC, 2016, J EVOLUTION BIOL, V29, P2168, DOI 10.1111/jeb.12935; Cowles RB, 1944, B AM MUS NAT HIST, V83, P263; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Grant PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0146; HAIRSTON NG, 1986, P NATL ACAD SCI USA, V83, P4831, DOI 10.1073/pnas.83.13.4831; Hegerl GC, 2011, NAT GEOSCI, V4, P142, DOI 10.1038/ngeo1090; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; NACHMANSOHN D, 1968, P NATL ACAD SCI USA, V61, P1034, DOI 10.1073/pnas.61.3.1034; ODONALD P, 1973, EVOLUTION, V27, P398, DOI 10.1111/j.1558-5646.1973.tb00686.x; Portner HO, 2000, ANTARCTIC ECOSYSTEMS, P109; Rodriguez-Trelles F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0228; WILSON MA, 1987, COMP BIOCHEM PHYS A, V87, P757, DOI 10.1016/0300-9629(87)90395-1	16	121	121	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					495	497		10.1126/science.aam5512	http://dx.doi.org/10.1126/science.aam5512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28774927				2022-12-28	WOS:000406840100036
J	Foster, KR; Chluter, JS; Oyte, KZC; Rakoff-Nahoum, S				Foster, Kevin R.; Chluter, Jonas S.; Oyte, Katharine Z. C.; Rakoff-Nahoum, Seth			The evolution of the host microbiome as an ecosystem on a leash	NATURE			English	Article							TOLL-LIKE RECEPTORS; GUT MICROBIOTA; MUTUALISM; COOPERATION; COMPETITION; COEVOLUTION; SEGREGATION; METABOLITES; RESILIENCE; DIVERSITY	The human body carries vast communities of microbes that provide many benefits. Our microbiome is complex and challenging to understand, but evolutionary theory provides a universal framework with which to analyse its biology and health impacts. Here we argue that to understand a given microbiome feature, such as colonization resistance, host nutrition or immune development, we must consider how hosts and symbionts evolve. Symbionts commonly evolve to compete within the host ecosystem, while hosts evolve to keep the ecosystem on a leash. We suggest that the health benefits of the microbiome should be understood, and studied, as an interplay between microbial competition and host control.	[Foster, Kevin R.; Oyte, Katharine Z. C.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Chluter, Jonas S.; Oyte, Katharine Z. C.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Oyte, Katharine Z. C.; Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Med, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA; [Oyte, Katharine Z. C.; Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Med, Div Gastroenterol, 300 Longwood Ave, Boston, MA 02115 USA; [Oyte, Katharine Z. C.; Rakoff-Nahoum, Seth] Harvard Med Sch, 300 Longwood Ave, Boston, MA 02115 USA	University of Oxford; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Foster, KR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.; Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Dept Med, Div Gastroenterol, 300 Longwood Ave, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Harvard Med Sch, 300 Longwood Ave, Boston, MA 02115 USA.	kevin.foster@zoo.ox.ac.uk; seth.rakoff-nahoum@childrens.harvard.edu		Schluter, Jonas/0000-0002-6214-9367; Foster, Kevin/0000-0003-4687-6633	European Research Council [242670]; Calleva Research Centre for Evolution and Human Science (Magdalen College, Oxford); Sir Henry Wellcome Postdoctoral Research Fellowship [201341/Z/16/Z]; NIH [1U01AI124275-01, 1K08AI130392-01]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI130392, U01AI124275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Calleva Research Centre for Evolution and Human Science (Magdalen College, Oxford); Sir Henry Wellcome Postdoctoral Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Boomsma, J. Thompson, S. Knowles and N. Ruby for discussions and comments on the manuscript, and D. Hughes, A. Wilson, M. McFall-Ngai for providing images for Fig. 2. K.R.F. is funded by European Research Council grant 242670 and a Calleva Research Centre for Evolution and Human Science (Magdalen College, Oxford) grant. K.Z.C. is funded by a Sir Henry Wellcome Postdoctoral Research Fellowship (grant 201341/Z/16/Z). J. S. is funded by an NIH grant to E. Pamer and J. Xavier (project number 1U01AI124275-01). S.R.-N. is funded by NIH grant 1K08AI130392-01 and a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Adlassnig W, 2011, ANN BOT-LONDON, V107, P181, DOI 10.1093/aob/mcq238; Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arpaia N, 2014, P NATL ACAD SCI USA, V111, P2058, DOI 10.1073/pnas.1323183111; Ayres JS, 2016, CELL, V165, P1323, DOI 10.1016/j.cell.2016.05.049; Barroso-Batista J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9945; Barroso-Batista J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004182; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Chatzidaki-Livanis M, 2016, P NATL ACAD SCI USA, V113, P3627, DOI 10.1073/pnas.1522510113; Correa CC, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00153; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; De Mazancourt C, 2005, J ECOL, V93, P305, DOI 10.1111/j.0022-0477.2004.00952.x; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Douglas AE, 2016, MBIO, V7, DOI [10.1128/mBio.02099-15, 10.1128/mBio.02099]; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Foster KR, 2011, NAT REV GENET, V12, P193, DOI 10.1038/nrg2903; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Glasl B, 2016, ISME J, V10, P2280, DOI 10.1038/ismej.2016.9; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang JY, 2011, ANAEROBE, V17, P137, DOI 10.1016/j.anaerobe.2011.05.017; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Ji BY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00219; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaltenpoth M, 2014, P NATL ACAD SCI USA, V111, P6359, DOI 10.1073/pnas.1400457111; Kato LM, 2014, IMMUNOL REV, V260, P67, DOI 10.1111/imr.12185; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; King KC, 2016, ISME J, V10, P1915, DOI 10.1038/ismej.2015.259; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; Louca S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0015; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McInerney JO, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.40; McLoughlin K, 2016, CELL HOST MICROBE, V19, P550, DOI 10.1016/j.chom.2016.02.021; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Mushegian AA, 2016, BIOESSAYS, V38, P100, DOI 10.1002/bies.201500074; Nadell CD, 2016, NAT REV MICROBIOL, V14, P589, DOI 10.1038/nrmicro.2016.84; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; Niehus R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9924; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2016, NATURE, V533, P255, DOI 10.1038/nature17626; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Rivera-Chavez F, 2015, ANNU REV MICROBIOL, V69, P31, DOI 10.1146/annurev-micro-091014-104108; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Schluter J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004848; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Schwartzman JA, 2016, MICROBES INFECT, V18, P1, DOI 10.1016/j.micinf.2015.08.016; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049; Thompson JN, 2014, INTERACTION COEVOLUT; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Waller AS, 2014, ISME J, V8, P1391, DOI 10.1038/ismej.2014.30; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Williams G. C., 1966, P307; Williams HTP, 2008, P NATL ACAD SCI USA, V105, P10432, DOI 10.1073/pnas.0800244105; Wilson DS, 1997, ECOLOGY, V78, P2018, DOI 10.2307/2265941; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	103	375	385	19	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					43	51		10.1038/nature23292	http://dx.doi.org/10.1038/nature23292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770836	Green Accepted, Green Submitted			2022-12-28	WOS:000406831700033
J	Gurib-Fakim, A				Gurib-Fakim, Ameenah			Capitalize on African biodiversity	NATURE			English	Editorial Material												president@govmu.org							0	10	10	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					7	7		10.1038/548007a	http://dx.doi.org/10.1038/548007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28770865	Bronze			2022-12-28	WOS:000406831700005
J	Sinclair, C; Bommakanti, G; Gardinassi, L; Loebbermann, J; Johnson, MJ; Hakimpour, P; Hagan, T; Benitez, L; Todor, A; Machiah, D; Oriss, T; Ray, A; Bosinger, S; Ravindran, R; Li, SZ; Pulendran, B				Sinclair, Charles; Bommakanti, Gayathri; Gardinassi, Luiz; Loebbermann, Jens; Johnson, Matthew Joseph; Hakimpour, Paul; Hagan, Thomas; Benitez, Lydia; Todor, Andrei; Machiah, Deepa; Oriss, Timothy; Ray, Anuradha; Bosinger, Steven; Ravindran, Rajesh; Li, Shuzhao; Pulendran, Bali			mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation	SCIENCE			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; CONVENTIONAL DENDRITIC CELLS; MECHANISTIC TARGET; MAMMALIAN TARGET; INFLUENZA-VIRUS; SENSOR GCN2; FLT3 LIGAND; RAPAMYCIN; DIFFERENTIATION; HOMEOSTASIS	Antigen-presenting cells (APCs) occupy diverse anatomical tissues, but their tissue-restricted homeostasis remains poorly understood. Here, working with mouse models of inflammation, we found that mechanistic target of rapamycin (mTOR)-dependent metabolic adaptation was required at discrete locations. mTOR was dispensable for dendritic cell (DC) homeostasis in secondary lymphoid tissues but necessary to regulate cellular metabolism and accumulation of CD103(+) DCs and alveolar macrophages in lung. Moreover, while numbers of mTOR-deficient lung CD11b(+) DCs were not changed, they were metabolically reprogrammed to skew allergic inflammation from eosinophilic T helper cell 2 (T(H)2) to neutrophilic T(H)17 polarity. The mechanism for this change was independent of translational control but dependent on inflammatory DCs, which produced interleukin-23 and increased fatty acid oxidation. mTOR therefore mediates metabolic adaptation of APCs in distinct tissues, influencing the immunological character of allergic inflammation.	[Sinclair, Charles; Bommakanti, Gayathri; Loebbermann, Jens; Johnson, Matthew Joseph; Hakimpour, Paul; Hagan, Thomas; Benitez, Lydia; Ravindran, Rajesh; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Gardinassi, Luiz; Todor, Andrei; Li, Shuzhao] Emory Univ, Dept Med, Atlanta, GA 30329 USA; [Johnson, Matthew Joseph] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Machiah, Deepa] Yerkes Natl Primate Res Ctr, Yerkes Mol Pathol Core Lab, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Oriss, Timothy; Ray, Anuradha] Univ Pittsburgh, UPMC, Div Pulm Allergy & Crit Care Med, Dept Immunol,Sch Med,Asthma Inst, Pittsburgh, PA USA; [Bosinger, Steven] Yerkes Natl Primate Res Ctr, Primate Genom Core, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Pulendran, Bali] Stanford Univ, Dept Microbiol & Immunol, Dept Pathol, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Sinclair, Charles] Univ Cambridge, AstraZeneca Canc Res UK CRUK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England; [Ravindran, Rajesh] Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA	Emory University; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Stanford University; CRUK Cambridge Institute; University of Cambridge; Novartis	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.; Pulendran, B (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Dept Pathol, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	bpulend@emory.edu	Gardinassi, Luiz Gustavo Araujo/K-6276-2012; Sinclair, Charles/AAP-3976-2020; Pulendran, Bali/AAW-9550-2021; Gardinassi, Luiz/V-2225-2019	Gardinassi, Luiz Gustavo Araujo/0000-0002-9027-2688; Gardinassi, Luiz/0000-0002-9027-2688; Li, Shuzhao/0000-0002-7386-2539; Hakimata, Paul/0000-0002-2526-6003; Pulendran, Bali/0000-0001-6517-4333	Action Cycling Atlanta; European Union; U.S. National Institutes of Health [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, U19AI057266, R37AI048638, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Action Cycling Atlanta; European Union(European Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank V. Bliss and P. Sharma for histological support, G. Tharp and N. Patel for genomics analysis, V. Tran for metabolomics, B. Cervasi and K. Gill for fluorescence-activated cell sorting (FACS), and H. Hartweger (The Rockefeller University) and E. Schweighoffer (Francis Crick Institute) for advice on B cell FACS staining. We also thank C. Wongtrakool for advice and discussion on lung inflammation models and readouts. Finally, we thank Pulendran laboratory members for discussion and M. Sinclair for proofreading the manuscript. This work was supported by funding from Action Cycling Atlanta and from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) (C.S.) and from the U.S. National Institutes of Health (grants R37 DK057665, R37 AI048638, U19 AI090023, and U19 AI057266) (B.P.). We are not aware of any conflicts of interest. Additional data presented in this manuscript are available in the supplementary materials.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kellersch B, 2013, BLOOD, V121, P298, DOI 10.1182/blood-2012-06-439786; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Mathie SA, 2015, ALLERGY, V70, P80, DOI 10.1111/all.12536; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; Nobs SP, 2015, IMMUNITY, V43, P674, DOI 10.1016/j.immuni.2015.09.006; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Shah PL, 2000, THORAX, V55, P67, DOI 10.1136/thorax.55.1.67; Sukhbaatar N, 2016, TRENDS IMMUNOL, V37, P778, DOI 10.1016/j.it.2016.08.009; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012	42	66	67	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1014	+		10.1126/science.aaj2155	http://dx.doi.org/10.1126/science.aaj2155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28798047	Green Accepted			2022-12-28	WOS:000409455700039
J	Zehr, JP; Weitz, JS; Joint, I				Zehr, Jonathan P.; Weitz, Joshua S.; Joint, Ian			How microbes survive in the open ocean	SCIENCE			English	Editorial Material							MARINE-BACTERIA; PHYTOPLANKTON; GROWTH; ECOSYSTEMS; WATERS; SEA		[Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Joint, Ian] Marine Biol Assoc UK, Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England	University of California System; University of California Santa Cruz; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Marine Biological Association United Kingdom	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu; jsweitz@gatech.edu; ianjoi@mba.ac.uk			Simons Foundation (SCOPE) [329108]	Simons Foundation (SCOPE)	We greatly appreciate the input and review of this manuscript by R. Braakman, S. J. Beckett, D. Caron, S. W. Chisholm, C. Edwards, M. Follows, D. Muratore, F. Ribalet, L. Riemann, D. A. Siegel, and two anonymous reviewers. We thank A. Dingeldein for help in illustration. This work was supported by grants from the Simons Foundation (SCOPE Award ID 329108 to J.P.Z. and J.S.W.).	Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Braakman R, 2017, P NATL ACAD SCI USA, V114, pE3091, DOI 10.1073/pnas.1619573114; Dusenbery DB, 1997, P NATL ACAD SCI USA, V94, P10949, DOI 10.1073/pnas.94.20.10949; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; JACKSON GA, 1980, NATURE, V284, P439, DOI 10.1038/284439a0; MCCARTHY JJ, 1979, SCIENCE, V203, P670, DOI 10.1126/science.203.4381.670; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Seymour JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.65; Smriga S, 2016, P NATL ACAD SCI USA, V113, P1576, DOI 10.1073/pnas.1512307113; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359	15	18	19	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					646	647		10.1126/science.aan5764	http://dx.doi.org/10.1126/science.aan5764			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD8SE	28818930	Green Accepted			2022-12-28	WOS:000407793600018
J	Scheufele, DA; Xenos, MA; Howell, EL; Rose, KM; Brossard, D; Hardy, BW				Scheufele, Dietram A.; Xenos, Michael A.; Howell, Emily L.; Rose, Kathleen M.; Brossard, Dominique; Hardy, Bruce W.			SCIENCE AND SOCIETY U.S. attitudes on human genome editing	SCIENCE			English	Editorial Material									[Scheufele, Dietram A.; Xenos, Michael A.; Rose, Kathleen M.; Brossard, Dominique] Univ Wisconsin, Dept Life Sci Commun, Madison, WI 53706 USA; [Scheufele, Dietram A.; Brossard, Dominique] Morgridge Inst Res, Madison, WI 53715 USA; [Xenos, Michael A.] Univ Wisconsin, Dept Commun Arts, Madison, WI 53706 USA; [Howell, Emily L.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Hardy, Bruce W.] Temple Univ, Dept Strateg Commun, Philadelphia, PA 19122 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Scheufele, DA (corresponding author), Univ Wisconsin, Dept Life Sci Commun, Madison, WI 53706 USA.; Scheufele, DA (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.	scheufele@wisc.edu	Scheufele, Dietram A./A-8737-2008; Hardy, Bruce/AAW-9378-2020	Scheufele, Dietram A./0000-0002-9914-5407; Rose, Kathleen/0000-0003-2690-9848; Xenos, Michael/0000-0002-2604-172X	Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	The authors acknowledge the Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison (with funding from the Wisconsin Alumni Research Foundation) for its support of this research.	[Anonymous], 2016, US PUBLIC WARY BIOME; Ho SS, 2008, INT J PUBLIC OPIN R, V20, P171, DOI 10.1093/ijpor/edn017; National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI; National Academy of Sciences and National Academy of Medicine, 2017, HUM GEN ED SCI ETH G; STAT/Harvard, 2016, PUBL GEN ED TEST THE	5	83	84	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					553	554		10.1126/science.aan3708	http://dx.doi.org/10.1126/science.aan3708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1VM	28798120				2022-12-28	WOS:000407324800027
J	Lang, KS; Hall, AN; Merrikh, CN; Ragheb, M; Tabakh, H; Pollock, AJ; Woodward, JJ; Dreifus, JE; Merrikh, H				Lang, Kevin S.; Hall, Ashley N.; Merrikh, Christopher N.; Ragheb, Mark; Tabakh, Hannah; Pollock, Alex J.; Woodward, Joshua J.; Dreifus, Julia E.; Merrikh, Houra			Replication-Transcription Conflicts Generate R-Loops that Orchestrate Bacterial Stress Survival and Pathogenesis	CELL			English	Article							STABLE DNA-REPLICATION; BACILLUS-SUBTILIS; RNASE-H; POLYMERASE; INTERFERENCE; ESSENTIALITY; INSTABILITY; RESISTANCE; INITIATION; CHROMOSOME	Replication-transcription collisions shape genomes, influence evolution, and promote genetic diseases. Although unclear why, head-on transcription (lagging strand genes) is especially disruptive to replication and promotes genomic instability. Here, we find that head-on collisions promote R-loop formation in Bacillus subtilis. We show that pervasive R-loop formation at head-on collision regions completely blocks replication, elevates mutagenesis, and inhibits gene expression. Accordingly, the activity of the R-loop processing enzyme RNase HIII at collision regions is crucial for stress survival in B. subtilis, as many stress response genes are head-on to replication. Remarkably, without RNase HIII, the ability of the intracellular pathogen Listeria monocytogenes to infect and replicate in hosts is weakened significantly, most likely because many virulence genes are head-on to replication. We conclude that the detrimental effects of head-on collisions stem primarily from excessive R-loop formation and that the resolution of these structures is critical for bacterial stress survival and pathogenesis.	[Lang, Kevin S.; Hall, Ashley N.; Merrikh, Christopher N.; Ragheb, Mark; Tabakh, Hannah; Pollock, Alex J.; Woodward, Joshua J.; Dreifus, Julia E.; Merrikh, Houra] Univ Washington, Dept Microbiol, Hlth Sci Bldg,J Wing, Seattle, WA 98195 USA; [Hall, Ashley N.; Ragheb, Mark] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Merrikh, Houra] Univ Washington, Dept Genome Sci, Foege Bldg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Merrikh, H (corresponding author), Univ Washington, Dept Microbiol, Hlth Sci Bldg,J Wing, Seattle, WA 98195 USA.; Merrikh, H (corresponding author), Univ Washington, Dept Genome Sci, Foege Bldg, Seattle, WA 98195 USA.	merrikh@uw.edu		Tabakh, Hannah/0000-0002-5786-9394; Merrikh, Christopher/0000-0001-5017-6037; Ragheb, Mark/0000-0002-2790-9463; Hall, Ashley/0000-0001-7739-1706	Cell and Molecular Biology Training Grant [T32 GM 007270]; National Institutes of Health [AI116669, AI108698]; Pew Scholars Program in the Biomedical Sciences; National Institute of Health [DP2GM110773]; National Science Foundation [MCB1243492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI108698, R01AI116669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, T32GM007266, DP2GM110773] Funding Source: NIH RePORTER	Cell and Molecular Biology Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the Merrikh lab for helpful discussions and Richard Losick for his generous gift of the P<INF>spank(hy)</INF>-luxABCDE plasmid, pAH60. We thank Bonny Brewer for helpful discussions about the analysis of 2D gels. We thank Jay Shendure and Choli Lee for assistance in sequencing the DRIP-seq libraries. Finally, a special thank you to Sarah Mangiameli for performing the fluctuation tests on the mutation rate data. This work was supported by the Cell and Molecular Biology Training Grant T32 GM 007270 to A.N.H., the National Institutes of Health grants AI116669 and AI108698 and the Pew Scholars Program in the Biomedical Sciences to J.J.W. as well as the National Institute of Health New Innovator Award (DP2GM110773) and National Science Foundation grant MCB1243492 to H.M.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bigot A, 2009, MICROBIOL-SGM, V155, P891, DOI 10.1099/mic.0.022277-0; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; BREHM SP, 1973, J BACTERIOL, V115, P1063, DOI 10.1128/JB.115.3.1063-1070.1973; Cao M, 2005, J BACTERIOL, V187, P2948, DOI 10.1128/JB.187.9.2948-2956.2005; Chang EYC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010033; Chib S, 2016, J BIOL CHEM, V291, P5889, DOI 10.1074/jbc.M115.688648; Chon H, 2006, J MOL BIOL, V356, P165, DOI 10.1016/j.jmb.2005.11.017; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; CUTTING SM, 1990, MOL BIOL METHODS BAC; DROLET M, 1994, J BIOL CHEM, V269, P2068; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Ferguson CC, 2007, J BACTERIOL, V189, P7681, DOI 10.1128/JB.01053-07; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ganesan A, 2012, PROG MOL BIOL TRANSL, V110, P25, DOI 10.1016/B978-0-12-387665-2.00002-X; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Guariglia-Oropeza V, 2011, J BACTERIOL, V193, P6223, DOI 10.1128/JB.06023-11; Haruki M, 2002, FEBS LETT, V531, P204, DOI 10.1016/S0014-5793(02)03503-2; Itaya M, 1999, J BACTERIOL, V181, P2118, DOI 10.1128/JB.181.7.2118-2123.1999; Ivancic-Bace I, 2012, J MOL BIOL, V422, P607, DOI 10.1016/j.jmb.2012.06.024; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kochiwa H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-128; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YL, 2012, CURR GENOMICS, V13, P65, DOI 10.2174/138920212799034767; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Maduike NZ, 2014, MOL MICROBIOL, V91, P39, DOI 10.1111/mmi.12440; Masse E, 1999, J BIOL CHEM, V274, P16654, DOI 10.1074/jbc.274.23.16654; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; Merrikh CN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005289; Merrikh H, 2017, TRENDS MICROBIOL, V25, P516, DOI 10.1016/j.tim.2017.01.008; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Million-Weaver S, 2015, J BACTERIOL, V197, P2374, DOI 10.1128/JB.00237-15; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 1999, J BIOSCI BIOENG, V88, P12, DOI 10.1016/S1389-1723(99)80168-6; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; de los Mozos IR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004001; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; THOMAS M, 1976, P NATL ACAD SCI USA, V73, P2294, DOI 10.1073/pnas.73.7.2294; VONMEYENBURG K, 1987, J BACTERIOL, V169, P2650, DOI 10.1128/jb.169.6.2650-2658.1987; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zhang Y, 2014, MOL CELL, V53, P766, DOI 10.1016/j.molcel.2014.02.005; Zheng WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16431	66	121	124	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					787	+		10.1016/j.cell.2017.07.044	http://dx.doi.org/10.1016/j.cell.2017.07.044			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28802046	Bronze, Green Accepted			2022-12-28	WOS:000407445700018
J	Smith, K				Smith, Kerri			THE BRAIN-CIRCUIT CHALLENGE	NATURE			English	Editorial Material							CONNECTOME											Berck ME, 2016, ELIFE, V5, DOI 10.7554/eLife.14859; Eichler K, 2017, NATURE, V548, P175, DOI 10.1038/nature23455; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Hildebrand DGC, 2017, NATURE, V545, P345, DOI 10.1038/nature22356; Jovanic T, 2016, CELL, V167, P858, DOI 10.1016/j.cell.2016.09.009; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Plaza SM, 2014, CURR OPIN NEUROBIOL, V25, P201, DOI 10.1016/j.conb.2014.01.019; Tobin WF, 2017, ELIFE, V6, DOI 10.7554/eLife.24838; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	11	3	3	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					150	152		10.1038/548150a	http://dx.doi.org/10.1038/548150a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD1GB	28796220	Bronze			2022-12-28	WOS:000407284300021
J	Dyer, O				Dyer, Owen			Hundreds of Chinese researchers are sanctioned after mass retraction	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cyranoski D, 2007, NAT MED, V13, P889, DOI 10.1038/nm0807-889; Huang E., 2017, QUARTZ          0508; Parry J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2970; Stigbrand T., 2017, TUMOR BIOL, DOI [10.1007/s13277-017-5487-6, DOI 10.1007/S13277-017-5487-6]	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2017	358								j3838	10.1136/bmj.j3838	http://dx.doi.org/10.1136/bmj.j3838			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7YA	28798224				2022-12-28	WOS:000407740800004
J	Cholley, B; Caruba, T; Grosjean, S; Amour, J; Ouattara, A; Villacorta, J; Miguet, B; Guinet, P; Levy, F; Squara, P; Hamou, NA; Carillon, A; Boyer, J; Boughenou, MF; Rosier, S; Robin, E; Radutoiu, M; Durand, M; Guidon, C; Desebbe, O; Charles-Nelson, A; Menasche, P; Rozec, B; Girard, C; Fellahi, JL; Pirracchio, R; Chatellier, G				Cholley, Bernard; Caruba, Thibaut; Grosjean, Sandrine; Amour, Julien; Ouattara, Alexandre; Villacorta, Judith; Miguet, Bertrand; Guinet, Patrick; Levy, FranOois; Squara, Pierre; Hamou, Nora Ait; Carillon, Aude; Boyer, Julie; Boughenou, Marie-Fazia; Rosier, Sebastien; Robin, Emmanuel; Radutoiu, Mihail; Durand, Michel; Guidon, Catherine; Desebbe, Olivier; Charles-Nelson, Anais; Menasche, Philippe; Rozec, Bertrand; Girard, Claude; Fellahi, Jean-Luc; Pirracchio, Romain; Chatellier, Gilles			Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass The LICORN Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; HIGH-RISK PATIENTS; PERIOPERATIVE USE; HEART-FAILURE; SURGERY; METAANALYSIS; DOBUTAMINE; MORTALITY; PRETREATMENT; PREDICTORS	IMPORTANCE Low cardiac output syndrome after cardiac surgery is associated with high morbidity and mortality in patients with impaired left ventricular function. OBJECTIVE To assess the ability of preoperative levosimendan to prevent postoperative low cardiac output syndrome. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled trial conducted in 13 French cardiac surgical centers. Patients with a left ventricular ejection fraction less than or equal to 40% and scheduled for isolated or combined coronary artery bypass grafting with cardiopulmonary bypass were enrolled from June 2013 until May 2015 and followed during 6 months (last follow-up, November 30, 2015). INTERVENTIONS Patients were assigned to a 24-hour infusion of levosimendan 0.1 mu g/kg/min (n = 167) or placebo (n = 168) initiated after anesthetic induction. MAIN OUTCOMES AND MEASURES Composite end point reflecting lowcardiac output syndrome with need for a catecholamine infusion 48 hours after study drug initiation, need for a left ventricular mechanical assist device or failure to wean from it at 96 hours after study drug initiation when the device was inserted preoperatively, or need for renal replacement therapy at any time postoperatively. It was hypothesized that levosimendan would reduce the incidence of this composite end point by 15% in comparison with placebo. RESULTS Among 336 randomized patients (mean age, 68 years; 16% women), 333 completed the trial. The primary end point occurred in 87 patients (52%) in the levosimendan group and 101 patients (61%) in the placebo group (absolute risk difference taking into account center effect, -7%[95% CI, -17% to 3%]; P =.15). Predefined subgroup analyses found no interaction with ejection fraction less than 30%, type of surgery, and preoperative use of beta-blockers, intra-aortic balloon pump, or catecholamines. The prevalence of hypotension (57% vs 48%), atrial fibrillation (50% vs 40%), and other adverse events did not significantly differ between levosimendan and placebo. C ONCLUSIONS AND RELEVANCE Among patients with low ejection fraction whowere undergoing coronary artery bypass grafting with cardiopulmonary bypass, levosimendan compared with placebo did not result in a significant difference in the composite end point of prolonged catecholamine infusion, use of left ventricular mechanical assist device, or renal replacement therapy. These findings do not support the use of levosimendan for this indication.	[Cholley, Bernard; Boughenou, Marie-Fazia; Pirracchio, Romain] Hop Europeen Georges Pompidou, AP HP, Dept Anesthesiol & Crit Care Med, 20 Rue Leblanc, F-75908 Paris 15, France; [Cholley, Bernard; Caruba, Thibaut; Boughenou, Marie-Fazia] Univ Paris Descartes Sorbonne Paris Cite, Paris, France; [Caruba, Thibaut] Hop Europeen Georges Pompidou, AP HP, Dept Pharm, Paris, France; [Grosjean, Sandrine; Boyer, Julie; Girard, Claude] Ctr Hosp Univ Dijon, Dept Anesthesiol & Crit Care Med, Bourgogne, France; [Amour, Julien; Hamou, Nora Ait; Carillon, Aude] Hop La Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care Med, Paris, France; [Amour, Julien; Hamou, Nora Ait; Carillon, Aude] Univ Paris 06, F-75005 Paris, France; [Ouattara, Alexandre] Magellan Med Surg Ctr, Dept Anaesthesiol & Crit Care 2, Bordeaux, France; [Ouattara, Alexandre] Univ Bordeaux, INSERM, UMR 1034, Biol Cardiovasc Dis, Bordeaux, France; [Villacorta, Judith; Guidon, Catherine] CHU Timone, Dept Anesthesiol & Crit Care, Marseille, France; [Miguet, Bertrand; Rozec, Bertrand] Hop Laennec Nantes, Dept Anesthesiol & Crit Care Med, Nantes, France; [Guinet, Patrick; Rosier, Sebastien] Hop Pontchaillou, Dept Anesthesiol & Crit Care Med, Rennes, France; [Levy, FranOois] Nouvel Hop Civil, Dept Anesthesiol & Crit Care, Strasbourg, France; [Squara, Pierre] Clin Ambroise Pare, Dept Anesthesiol & Crit Care, Neuilly, France; [Robin, Emmanuel] Hop Claude Huriez, Dept Anesthesiol & Crit Care, Lille, France; [Radutoiu, Mihail] CHU Cote Nacre, Dept Anesthesiol & Crit Care, Caen, France; [Durand, Michel] CHU Grenoble Alpes, Dept Anesthesiol & Crit Care, Grenoble, France; [Desebbe, Olivier; Fellahi, Jean-Luc] Univ Claude Bernard, Hop Cardiol Louis Pradel, Dept Anesthesiol & Crit Care, Lyon, France; [Desebbe, Olivier; Fellahi, Jean-Luc] Univ Claude Bernard, INSERM, U1060, Lyon, France; [Charles-Nelson, Anais; Chatellier, Gilles] Hop Europeen Georges Pompidou, AP HP, Dept Biostat, Paris, France; [Charles-Nelson, Anais; Chatellier, Gilles] Univ Paris Descartes Sorbonne Paris Cite, Paris, France; [Menasche, Philippe] Hop Europeen Georges Pompidou, AP HP, Dept Cardiovasc Surg, Paris, France; [Menasche, Philippe] Univ Paris Descartes Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Nantes Universite; CHU de Nantes; CHU Rennes; CHU Strasbourg; Universite de Lille - ISITE; CHU Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Grenoble Alpes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Cholley, B (corresponding author), Hop Europeen Georges Pompidou, AP HP, Dept Anesthesiol & Crit Care Med, 20 Rue Leblanc, F-75908 Paris 15, France.	bernard.cholley@aphp.fr	Rozec, Bertrand/AAA-8152-2021; CHOLLEY, Bernard/AAK-5354-2020; Chavanon, Olivier/AAC-8171-2019; Carmen, Team3/Y-7384-2019	CHOLLEY, Bernard/0000-0001-6388-6011; Chavanon, Olivier/0000-0001-8625-691X; Carmen, Team3/0000-0002-3614-0924; Charles-Nelson, Anais/0000-0001-6437-7059; Robin, Emmanuel/0000-0003-3422-5622; Ouattara, Alexandre/0000-0002-7346-7539; Rozec, Bertrand/0000-0002-2226-3982; Porcher, Raphael/0000-0002-5277-4679; Lab, Carmen/0000-0002-5935-3236	French Ministry of Health (Programme Hospitalier de Recherche Clinique national) [MIN02-07]; Assistance Publique-Hopitaux de Paris	French Ministry of Health (Programme Hospitalier de Recherche Clinique national); Assistance Publique-Hopitaux de Paris	The LICORN study was funded by the French Ministry of Health (Programme Hospitalier de Recherche Clinique national 2011, MIN02-07) and sponsored by Assistance Publique-Hopitaux de Paris. Orion Pharma provided study drugs free of charge.	Algarni KD, 2011, ANN THORAC SURG, V92, P1678, DOI 10.1016/j.athoracsur.2011.06.017; Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Baysal A, 2014, J CARDIOTHOR VASC AN, V28, P586, DOI 10.1053/j.jvca.2013.09.004; Bragadottir G, 2013, CRIT CARE MED, V41, P2328, DOI 10.1097/CCM.0b013e31828e946a; Caruba T, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0530-z; Cuzick J, 2005, LANCET, V365, P1308, DOI 10.1016/S0140-6736(05)61026-4; De Hert SG, 2007, ANESTH ANALG, V104, P766, DOI 10.1213/01.ane.0000256863.92050.d3; Erb J, 2014, J INT MED RES, V42, P750, DOI 10.1177/0300060513516293; Eriksson HI, 2009, ANN THORAC SURG, V87, P448, DOI 10.1016/j.athoracsur.2008.10.029; Fellahi JL, 2008, ANESTHESIOLOGY, V108, P979, DOI 10.1097/ALN.0b013e318173026f; Follath F, 2002, LANCET, V360, P196, DOI 10.1016/S0140-6736(02)09455-2; Grieshaber P, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0556-2; Harrison RW, 2013, J CARDIOTHOR VASC AN, V27, P1224, DOI 10.1053/j.jvca.2013.03.027; Jiang WH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003754; Landoni G, 2007, MINERVA ANESTESIOL, V73, P559; Landoni G, 2017, NEW ENGL J MED, V376, P2021, DOI 10.1056/NEJMoa1616325; Landoni G, 2012, CRIT CARE MED, V40, P634, DOI 10.1097/CCM.0b013e318232962a; Levin R, 2012, EXP CLIN CARDIOL, V17, P125; Levin RL, 2008, REV ESP CARDIOL, V61, P471; Lim JY, 2015, J CARDIAC SURG, V30, P547, DOI 10.1111/jocs.12562; Lomivorotov VV, 2012, J CARDIOTHOR VASC AN, V26, P596, DOI 10.1053/j.jvca.2011.09.006; Maganti M, 2010, J THORAC CARDIOV SUR, V140, P790, DOI 10.1016/j.jtcvs.2009.11.022; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Mehta RH, 2017, NEW ENGL J MED, V376, P2032, DOI 10.1056/NEJMoa1616218; Nielsen DV, 2014, ANESTHESIOLOGY, V120, P1098, DOI 10.1097/ALN.0000000000000224; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Rao V, 1996, J THORAC CARDIOV SUR, V112, P38, DOI 10.1016/S0022-5223(96)70176-9; Toller W, 2015, INT J CARDIOL, V184, P323, DOI 10.1016/j.ijcard.2015.02.022; Tritapepe L, 2009, BRIT J ANAESTH, V102, P198, DOI 10.1093/bja/aen367; Zhou CH, 2016, AM J KIDNEY DIS, V67, P408, DOI 10.1053/j.ajkd.2015.09.015	30	114	125	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					548	556		10.1001/jama.2017.9973	http://dx.doi.org/10.1001/jama.2017.9973			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28787507	Green Published			2022-12-28	WOS:000407160100017
J	Rueda, M				Rueda, Manuel			The Green Helmets: providing care in Venezuela's protests	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					543	544		10.1016/S0140-6736(17)32099-8	http://dx.doi.org/10.1016/S0140-6736(17)32099-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28792387				2022-12-28	WOS:000406855800009
J	Airan, R				Airan, Raag			Neuromodulation with nanoparticles	SCIENCE			English	Editorial Material							IN-VIVO NEUROSTIMULATION; FOCUSED ULTRASOUND		[Airan, Raag] Stanford Univ, Dept Radiol Neuroimaging & Neurointervent, Palo Alto, CA 94304 USA	Stanford University	Airan, R (corresponding author), Stanford Univ, Dept Radiol Neuroimaging & Neurointervent, Palo Alto, CA 94304 USA.	rairan@stanford.edu		Airan, Raag/0000-0001-5259-5606				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Airan R. D., 2015, EXPANDING TREATMENT; Airan RD, 2017, NANO LETT, V17, P652, DOI 10.1021/acs.nanolett.6b03517; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Deffieux T, 2013, CURR BIOL, V23, P2430, DOI 10.1016/j.cub.2013.10.029; Ellens N. P. K., 2016, MR GUIDED FOCUSED UL; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Ghanouni P, 2015, AM J ROENTGENOL, V205, P150, DOI 10.2214/AJR.14.13632; Jorgenson L.A., 2015, PHILOS T R SOC LON B, V370, P214; King RL, 2014, ULTRASOUND MED BIOL, V40, P1512, DOI 10.1016/j.ultrasmedbio.2014.01.020; King RL, 2013, ULTRASOUND MED BIOL, V39, P312, DOI 10.1016/j.ultrasmedbio.2012.09.009; Lee W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34026; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Menz MD, 2013, J NEUROSCI, V33, P4550, DOI 10.1523/JNEUROSCI.3521-12.2013; Rapoport N, 2016, ADV EXP MED BIOL, V880, P221, DOI 10.1007/978-3-319-22536-4_13; Sassaroli E, 2016, J THER ULTRASOUND, V4, DOI 10.1186/s40349-016-0061-z; Sheeran PS, 2012, CURR PHARM DESIGN, V18, P2152; Ye PP, 2016, ULTRASOUND MED BIOL, V42, P1512, DOI 10.1016/j.ultrasmedbio.2016.02.012	18	20	20	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350							6350	10.1126/science.aao1200	http://dx.doi.org/10.1126/science.aao1200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5GF	28774921				2022-12-28	WOS:000426854200001
J	Hensgens, T; Fujita, T; Janssen, L; Li, X; Van Diepen, CJ; Reichl, C; Wegscheider, W; Das Sarma, S; Vandersypen, LMK				Hensgens, T.; Fujita, T.; Janssen, L.; Li, Xiao; Van Diepen, C. J.; Reichl, C.; Wegscheider, W.; Das Sarma, S.; Vandersypen, L. M. K.			Quantum simulation of a Fermi-Hubbard model using a semiconductor quantum dot array	NATURE			English	Article							COULOMB-BLOCKADE; SPIN; INSULATOR; SPECTROSCOPY; LATTICE; SYSTEM; STATES; ATOMS; QUBIT	Interacting fermions on a lattice can develop strong quantum correlations, which are the cause of the classical intractability of many exotic phases of matter(1-3). Current efforts are directed towards the control of artificial quantum systems that can be made to emulate the underlying Fermi-Hubbard models(4-6). Electrostatically confined conduction-band electrons define interacting quantum coherent spin and charge degrees of freedom that allow all-electrical initialization of low-entropy states and readily adhere to the Fermi-Hubbard Hamiltonian(7-17). Until now, however, the substantial electrostatic disorder of the solid state has meant that only a few attempts at emulating Fermi-Hubbard physics on solid-state platforms have been made(18,19). Here we show that for gate-defined quantum dots this disorder can be suppressed in a controlled manner. Using a semi-automated and scalable set of experimental tools, we homogeneously and independently set up the electron filling and nearest-neighbour tunnel coupling in a semiconductor quantum dot array so as to simulate a Fermi-Hubbard system. With this set-up, we realize a detailed characterization of the collective Coulomb blockade transition(20), which is the finite-size analogue of the interaction-driven Mott metal-to-insulator transition(1). As automation and device fabrication of semiconductor quantum dots continue to improve, the ideas presented here will enable the investigation of the physics of ever more complex many-body states using quantum dots.	[Hensgens, T.; Fujita, T.; Janssen, L.; Vandersypen, L. M. K.] Delft Univ Technol, QuTech, NL-2600 GA Delft, Netherlands; [Hensgens, T.; Fujita, T.; Janssen, L.; Vandersypen, L. M. K.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Li, Xiao; Das Sarma, S.] Univ Maryland, Condensed Matter Theory Ctr, College Pk, MD 20742 USA; [Li, Xiao; Das Sarma, S.] Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA; [Van Diepen, C. J.] QuTech, NL-2600 AD Delft, Netherlands; [Van Diepen, C. J.] Netherlands Org Appl Sci Res TNO, NL-2600 AD Delft, Netherlands; [Reichl, C.; Wegscheider, W.] Swiss Fed Inst Technol, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Delft University of Technology; Delft University of Technology; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Netherlands Organization Applied Science Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech, NL-2600 GA Delft, Netherlands.; Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl	Li, Xiao/ABG-8578-2021; Li, Xiao/A-1612-2013; Fujita, Takafumi/AAK-5182-2020; Sarma, Sankar Das/B-2400-2009; Janssen, Laurens/M-7471-2017	Li, Xiao/0000-0002-1708-4314; Li, Xiao/0000-0002-1708-4314; Sarma, Sankar Das/0000-0002-0439-986X; van Diepen, Cornelis Jacobus/0000-0001-8454-2859; Janssen, Laurens/0000-0002-6428-8168	Netherlands Organization of Scientific Research (NWO) VICI programme; European Commission via the integrated project SIQS; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad; LPS-MPO-CMTC; Swiss National Science Foundation	Netherlands Organization of Scientific Research (NWO) VICI programme(Netherlands Organization for Scientific Research (NWO)); European Commission via the integrated project SIQS; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); LPS-MPO-CMTC; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge discussions with M. Veldhorst, A. F. Otte, R. Sensarma and the members of the Vandersypen group, sample fabrication by F. R. Braakman, set-up preparation by T. A. Baart and experimental assistance from M. Ammerlaan, J. Haanstra, R. Roeleveld, R. Schouten and R. Vermeulen. This work was supported by the Netherlands Organization of Scientific Research (NWO) VICI programme, the European Commission via the integrated project SIQS, the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Research Abroad, LPS-MPO-CMTC and the Swiss National Science Foundation.	Anderson PW, 2013, J PHYS CONF SER, V449, DOI 10.1088/1742-6596/449/1/012001; Azurenko AM, 2017, NATURE, V545, P462, DOI 10.1038/nature22362; Baart TA, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4952624; Baart TA, 2016, NAT NANOTECHNOL, V11, P330, DOI [10.1038/NNANO.2015.291, 10.1038/nnano.2015.291]; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Barends R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8654; Barthel C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161308; Barthelemy P, 2013, ANN PHYS-BERLIN, V525, P808, DOI 10.1002/andp.201300124; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Byrnes T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075320; Colless JI, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046805; DiCarlo L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.226801; Farooq U, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.134303; Gray J, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.195136; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Lee SD, 2000, PHYS REV B, V62, pR7735, DOI 10.1103/PhysRevB.62.R7735; Livermore C, 1996, SCIENCE, V274, P1332, DOI 10.1126/science.274.5291.1332; Manousakis E, 2002, J LOW TEMP PHYS, V126, P1501, DOI 10.1023/A:1014295416763; Martins F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116801; Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]; Oosterkamp TH, 1998, NATURE, V395, P873, DOI 10.1038/27617; Petersson KD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246804; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Salfi J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11342; Seo M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046803; Singha A, 2011, SCIENCE, V332, P1176, DOI 10.1126/science.1204333; STAFFORD CA, 1994, PHYS REV LETT, V72, P3590, DOI 10.1103/PhysRevLett.72.3590; Tanese D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2760; Thalineau R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749811; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Wang X, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115301; Yang S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161301	37	164	166	6	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					70	+		10.1038/nature23022	http://dx.doi.org/10.1038/nature23022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28770852	Green Submitted			2022-12-28	WOS:000406831700038
J	Thompson, BT; Chambers, RC; Liu, KD				Thompson, B. Taylor; Chambers, Rachel C.; Liu, Kathleen D.			Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE LUNG INJURY; ANGIOTENSIN-CONVERTING ENZYME-2; HIGH-FREQUENCY OSCILLATION; MECHANICAL VENTILATION; BERLIN DEFINITION; HYPOPROTEINEMIC PATIENTS; SARS CORONAVIRUS; CLINICAL-TRIAL; ARDS; PRESSURE	Fifty years ago, Ashbaugh and colleagues described 12 patients with tachypnea, refractory hypoxemia, and diffuse opacities on chest radiographs after infection or trauma.(1) Prominent hyaline membranes were seen lining the alveolar spaces of the lungs in 6 of the 7 patients who died, findings previously thought to be specific for the respiratory distress syndrome of the newborn. Thus, the term adult (later changed to acute) respiratory distress syndrome (ARDS) was proposed. Since ARDS was last reviewed in the Journal, 17 years ago,(2) substantial progress has been made in the care of affected patients and those at risk for the disorder, with reductions in both incidence and mortality. However, ARDS remains a relatively common and lethal or disabling syndrome. In a recent international study involving 29,144 patients,(3) 10% of all patients admitted to the intensive care unit (ICU) and 23% of mechanically ventilated patients had ARDS. Mortality in the subgroup of patients with severe ARDS was 46%. 3 Patients who survive this disorder are at high risk for cognitive decline, depression, post-traumatic stress disorder, and persistent skeletal-muscle weakness.(4,5)	[Thompson, B. Taylor] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Bulfinch Bldg,Suite 148,55 Fruit St, Boston, MA 02114 USA; [Thompson, B. Taylor] Harvard Med Sch, Boston, MA USA; [Chambers, Rachel C.] UCL, Ctr Inflammat & Tissue Repair, London, England; [Chambers, Rachel C.] UCL, Div Med, London, England; [Liu, Kathleen D.] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Liu, Kathleen D.] Univ Calif San Francisco, Div Crit Care Med, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of London; University College London; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Thompson, BT (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Bulfinch Bldg,Suite 148,55 Fruit St, Boston, MA 02114 USA.	thompson.taylor@mgh.harvard.edu		Liu, Kathleen/0000-0003-4891-8649; Chambers, Rachel/0000-0003-1370-9417	Medical Research Council [G0800265] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; ASHBAUGH DG, 1967, LANCET, V2, P319; Aublanc M, 2017, CURR OPIN CRIT CARE, V23, P24, DOI 10.1097/MCC.0000000000000373; Bellani G, 2017, AM J RESP CRIT CARE, V195, P67, DOI 10.1164/rccm.201606-1306OC; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Christie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028268; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2; Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Herasevich V, 2009, INTENS CARE MED, V35, P1018, DOI 10.1007/s00134-009-1460-1; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Huang DT, 2017, ANN AM THORAC SOC, V14, P124, DOI 10.1513/AnnalsATS.201608-629OT; Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001; Meade MO, 2017, AM J RESP CRIT CARE; Meyer NJ, 2017, LANCET RESP MED, V5, P512, DOI 10.1016/S2213-2600(17)30187-X; Meyer NJ, 2013, SEMIN RESP CRIT CARE, V34, P459, DOI 10.1055/s-0033-1351121; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Semler MW, 2016, CRIT CARE MED, V44, P782, DOI 10.1097/CCM.0000000000001555; Shortt K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111953; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Thompson BT, 2016, INTENS CARE MED, V42, P653, DOI 10.1007/s00134-016-4296-5; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Villar J, 2016, CURR OPIN CRIT CARE, V22, P1, DOI 10.1097/MCC.0000000000000266; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Yadav H, 2017, AM J RESP CRIT CARE, V195, P725, DOI 10.1164/rccm.201609-1767CI; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716	63	827	887	12	204	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					562	572		10.1056/NEJMra1608077	http://dx.doi.org/10.1056/NEJMra1608077			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	29117492				2022-12-28	WOS:000407212600009
